Constitutive B-O B-NP_NP_NP_NP_JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
enhanced B-O B-NP_VBN
granulopoiesis B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
neonatal B-O B-NP_JJ
lethality B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha-deficient B-O B-JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Transcription B-O B-S_S_NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
belonging B-O B-VP_VBG
to B-O B-PP_TO
the B-O B-NP_DT
NF-kappa B-O B-NP_NN
B B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
inhibitory B-O B-NP_NP_JJ
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
mainly B-O B-ADVP_RB
" " B-O O-ADVP
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
and B-O B-CC
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Apparently B-O B-S_ADVP_RB
normal B-O B-JJ
at B-O B-PP_IN
birth B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
I B-O B-S_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha-/- B-O B-JJ
mice B-O B-NNS
" " B-O O-NP
exhibit B-O B-VP_VBP
severe B-O B-NP_NP_JJ
runting B-O B-NN
" " B-O O-NP
, B-O B-COMMA
skin B-O B-NP_NN
defects B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
extensive B-O B-NP_NP_JJ
granulopoiesis B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
postnatally B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
typically B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
dying B-O B-VP_VBG
by B-O B-PP_IN
8 B-O B-NP_CD
days B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Hematopoietic B-O B-S_NP_NP_JJ
tissues B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
these B-O B-NP_DT
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
display B-O B-VP_VBP
elevated B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
nuclear B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
mRNAs B-O B-NP_NNS
" " B-O O-NP
of B-O B-PP_IN
some B-O B-NP_NP_DT
" " B-O B-NP_O-NP
, B-O B-COMMA
but B-O B-CC
not B-O B-NP_RB
all B-O B-DT
" " B-O B-NP_O-NP
, B-O B-COMMA
genes B-O B-NP_NP_NNS
" " B-O O-NP
thought B-O B-VP_VBN
" " B-O B-S_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-kappa B-O B-S_NP_NP_NN
B B-O B-NN
" " B-O O-NP
elevation B-O B-NN
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
these B-O B-NP_DT
phenotypic B-O B-JJ
abnormalities B-O B-NNS
" " B-O O-NP
" " B-O O-PP
because B-O B-SBAR_IN
mice B-O B-S_NP_NP_NNS
" " B-O O-NP
lacking B-O B-VP_VBG
both B-O B-NP_CC
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
show B-O B-VP_VBP
a B-O B-NP_NP_DT
dramatically B-O B-ADJP_RB
delayed B-O B-VBN
" " B-O O-ADJP
onset B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
abnormalities B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
hematopoietic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha-/- B-O B-JJ
embryonic B-O B-JJ
fibroblasts B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
minimal B-O B-NP_NP_JJ
constitutive B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
normal B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
signal-dependent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
concomitant B-O B-ADJP_JJ
with B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
I B-O B-S_NP_NP_NN
kappa B-O B-NN
b B-O B-NN
beta B-O B-NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_NP_DT
signal-dependent B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_NP_DT
postinduction B-O B-JJ
repression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
fibroblasts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
define B-O B-VP_VP_VBP
distinct B-O B-NP_NP_JJ
roles B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
two B-O B-CD
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
demonstrate B-O B-VP_VBP
the B-O B-NP_NP_DT
necessity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
stringent B-O B-NP_NP_JJ
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Vitamin B-O B-S_S_NP_NP_NN
E B-O B-NN
therapy B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
acute B-O B-NP_JJ
CCl4-induced B-O B-JJ
hepatic B-O B-JJ
injury B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
mice B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Oxidative B-O B-S_S_NP_NP_JJ
stress B-O B-NN
" " B-O O-NP
, B-O B-COMMA
with B-O B-PP_IN
reactive B-O B-NP_JJ
oxygen B-O B-NN
intermediate B-O B-NN
formation B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
may B-O B-VP_MD
represent B-O B-VP_VB
a B-O B-NP_NP_DT
common B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
liver B-O B-S_NP_NN
injury B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
induced B-O B-VP_VBN
" " B-O B-NP_PP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Oxidative B-O B-S_S_NP_JJ
stress B-O B-NN
" " B-O O-NP
enhances B-O B-VP_VBZ
nuclear B-O B-NP_NP_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
NF-kappa B-O B-S_NP_NP_NN
B B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
enhance B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Acute B-O B-S_NP_NP_JJ
hepatic B-O B-JJ
injury B-O B-NN
" " B-O O-NP
caused B-O B-VP_VBN
by B-O B-NP_PP_IN
reactive B-O B-NP_JJ
oxygen B-O B-NN
intermediate B-O B-NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_NP_DT
intraperitoneal B-O B-JJ
injection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CCl4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
mice B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
injury B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
intravenous B-O B-NP_NP_JJ
pretreatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
water-soluble B-O B-JJ
emulsion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
alpha-tocopherol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Alpha-tocopherol B-O B-S_NP_NP_NN
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
mice B-O B-NNS
" " B-O O-NP
given B-O B-VP_VBN
the B-O B-NP_NP_DT
CCl4 B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBD
the B-O B-NP_DT
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
levels B-O B-NP_NP_NNS
" " B-O O-NP
approaching B-O B-VP_VBG
those B-O B-NP_NP_DT
" " B-O O-NP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
normal B-O B-NP_JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
monocyte/macrophage B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
CCl4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
led B-O B-VP_VBD
to B-O B-PP_TO
enhanced B-O B-NP_NP_VBN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
and B-O B-CC
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor-alpha B-O B-NN
( B-O B-LRB
TNF-alpha B-O B-NN
) B-O B-RRB
messenger B-O B-NN
RNA B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Liver B-O B-S_NP_NP_NN
specimens B-O B-NNS
" " B-O O-NP
taken B-O B-VP_VBN
from B-O B-NP_PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
acute B-O B-NP_ADJP_JJ
fulminant B-O B-JJ
" " B-O O-ADJP
hepatitis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
had B-O B-VP_VBD
markedly B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
comparison B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
normal B-O B-NP_JJ
livers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
abolishing B-O B-S_S_NP_VP_VBG
acute B-O B-NP_JJ
hepatic B-O B-JJ
injury B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
alpha-tocopherol B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
free B-O B-JJ
radical B-O B-NN
scavenger B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-S
also B-O B-ADVP_RB
" " B-O O-ADVP
eliminated B-O B-VP_VBD
increased B-O B-NP_VBN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-S_O-NP
is B-O B-VP_VBZ
tempting B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
speculate B-O B-VP_VB
that B-O B-SBAR_IN
enhanced B-O B-S_NP_NP_VBN
expression B-O B-NP_NN
" " B-O O-NP
caused B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
may B-O B-VP_MD
modulate B-O B-VP_VB
, B-O B-NP_COMMA
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Attenuation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
gamma B-O B-NP_NN
interferon-induced B-O B-JJ
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
mononuclear B-O B-NP_NP_JJ
phagocytes B-O B-NNS
" " B-O O-NP
infected B-O B-VP_VBN
with B-O B-NP_PP_IN
Leishmania B-O B-NP_FW
donovani B-O B-FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
selective B-O B-NP_NP_JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
signaling B-O B-NP_NP_NN
" " B-O O-NP
through B-O B-PP_IN
Janus B-O B-NP_NP_NN
kinases B-O B-NNS
" " B-O O-NP
and B-O B-CC
Stat1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_S_NP_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
gamma B-O B-NP_NN
interferon B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
impaired B-O B-ADJP_JJ
in B-O B-PP_IN
mononuclear B-O B-NP_NP_JJ
phagocytes B-O B-NNS
" " B-O O-NP
infected B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
fully B-O B-ADVP_RB
" " B-O O-ADVP
understood B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
brought B-O B-VP_VBN
about B-O B-NP_PRT_RP
" " B-O O-PRT
by B-O B-PP_IN
gamma B-O B-NP_NN
interferon B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
involve B-O B-VP_VB
transient B-O B-NP_NP_JJ
increases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
leading B-O B-S_NP_VP_VBG
to B-O B-PP_TO
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NP_NN
factor B-O B-NN
Stat1 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
investigate B-O B-VP_VB
the B-O B-NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
accounting B-O B-VP_VBG
for B-O B-PP_IN
the B-O B-NP_NP_DT
impaired B-O B-JJ
responses B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
a B-O B-S_NP_NP_DT
model B-O B-JJ
system B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
examining B-O B-S_NP_VP_VBG
overall B-O B-NP_NP_NP_JJ
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
developed B-O B-VP_VBN
in B-O B-NP_PP_IN
phorbol B-O B-NP_NN
12-myristate B-O B-NN
13-acetate-differentiated B-O B-JJ
U-937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
whole-cell B-O B-NP_JJ
lysates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
antiphosphotyrosine B-O B-NP_NN
immunoblotting B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
incubation B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
gamma B-O B-NP_NN
interferon B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
brought B-O B-VP_VBD
about B-O B-ADVP_RP
" " B-O O-ADVP
specific B-O B-NP_NP_JJ
increases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
phosphotyrosine B-O B-NP_NP_NN
labeling B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Increased B-O B-S_NP_NP_VBN
labeling B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurred B-O B-VP_VBD
to B-O B-PP_TO
similar B-O B-NP_JJ
extents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
control B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
had B-O B-S_NP_VP_VBD
been B-O B-VP_VBN
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Jak1 B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Jak2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Stat1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
immunoprecipitated B-O B-VP_VBN
from B-O B-NP_PP_IN
control B-O B-NP_NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
interferon-treated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
tyrosine B-O B-S_NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
detected B-O B-VP_VBN
by B-O B-NP_PP_IN
antiphosphotyrosine B-O B-NP_NN
immunoblotting B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
measured B-O B-VP_VBN
their B-O B-NP_PRPP
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Tyrosine B-O B-S_NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Jak1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Jak2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Stat1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
markedly B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
a B-O B-NP_DT
dose-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
U-937 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
incubated B-O B-VP_VBN
with B-O B-NP_PP_IN
gamma B-O B-NP_NN
interferon B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
infected B-O B-VP_VBN
with B-O B-NP_PP_IN
L. B-O B-NP_FW
donovani B-O B-FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Jak1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Jak2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Stat1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
markedly B-O B-ADJP_RB
impaired B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VBD
dependent B-O B-ADJP_JJ
upon B-O B-PP_IN
the B-O B-NP_NP_DT
duration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
exposure B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
maximal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
complete B-O B-ADJP_JJ
" " B-O O-ADJP
at B-O B-PP_IN
16 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Results B-O B-S_NP_NP_NNS
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
those B-O B-NP_NP_DT
" " B-O O-NP
observed B-O B-VP_VBN
with B-O B-NP_PP_IN
U-937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
obtained B-O B-VP_VBN
with B-O B-NP_PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
infection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
mononuclear B-O B-JJ
phagocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
L. B-O B-NP_FW
donovani B-O B-FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
impaired B-O B-NP_NP_JJ
gamma B-O B-NN
interferon-mediated B-O B-JJ
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
and B-O B-CC
selective B-O B-NP_NP_JJ
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Unresponsiveness B-O B-S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
gamma B-O B-NP_NN
interferon B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
explain B-O B-VP_VB
impaired B-O B-NP_NP_JJ
transcriptional B-O B-JJ
responses B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
leishmania-infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Nonopsonic B-O B-S_S_NP_NP_NP_JJ
phagocytosis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Pseudomonas B-O B-NP_FW
aeruginosa B-O B-FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
macrophages B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
polymorphonuclear B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
bacterial B-O B-JJ
flagellum B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Whereas B-O B-S_SBAR_IN
the B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nonopsonic B-O B-NP_NP_JJ
phagocytosis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Pseudomonas B-O B-NP_FW
aeruginosa B-O B-FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
described B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
bacterial B-O B-JJ
ligands B-O B-NNS
" " B-O O-NP
required B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
are B-O B-VP_VBP
poorly B-O B-ADVP_RB
" " B-O O-ADVP
understood B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
identify B-O B-VP_VB
the B-O B-NP_DT
requisite B-O B-JJ
bacterial B-O B-JJ
ligands B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
studies B-O B-S_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
isogenic B-O B-NP_NP_JJ
mutants B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
P. B-O B-NP_NP_NP_FW
aeruginosa B-O B-FW
" " B-O O-NP
PAK B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
lacking B-O B-VP_VBG
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
undertaken B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
RpoN B-O B-NN
mutant B-O B-NN
" " B-O O-NP
, B-O B-COMMA
lacking B-O B-VP_VBG
pili B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
flagella B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
nonpilus B-O B-NP_JJ
adhesins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
bound B-O B-VP_VP_VBD
poorly B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
resistant B-O B-ADJP_JJ
to B-O B-PP_TO
ingestion B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
both B-O B-NP_CC
macrophages B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
neutrophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Pili B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
absolutely B-O B-ADVP_RB
" " B-O O-ADVP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
binding B-O B-NP_NP_NP_NN
" " B-O O-NP
or B-O B-CC
phagocytosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
P. B-O B-NP_FW
aeruginosa B-O B-FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
flagellum B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VP_VBD
not B-O B-RB
required B-O B-VP_VBN
for B-O B-NP_PP_IN
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
P. B-O B-NP_FW
aeruginosa B-O B-FW
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
but B-O B-CC
was B-O B-VP_VBD
critical B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_DT
subsequent B-O B-JJ
internalization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
bacterium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
this B-O B-S_NP_NP_DT
factor B-O B-NN
" " B-O O-NP
or B-O B-CC
a B-O B-NP_NP_DT
surface B-O B-NN
ligand B-O B-NN
" " B-O O-NP
associated B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-NP
was B-O B-VP_VBD
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Mutually B-O B-NP_NP_NP_ADJP_RB
exclusive B-O B-JJ
" " B-O O-ADJP
interaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
novel B-O B-JJ
matrix B-O B-NP_NN
attachment B-O B-NN
region B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
NF-muNR B-O B-NP_NN
enhancer B-O B-NN
repressor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Implications B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
immunoglobulin B-O B-NP_NP_NN
heavy B-O B-JJ
chain B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_S_NP_DT
immunoglobulin B-O B-NP_NP_NN
heavy B-O B-NN
chain B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IgH B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
intronic B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
stimulates B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
functional B-O B-NP_NP_JJ
promoters B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
B B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
other B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_DT
observation B-O B-NN
that B-O B-SBAR_IN
binding B-O B-S_NP_NP_VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-NP_JJ
factor-mu B-O B-NN
negative B-O B-JJ
regulator B-O B-NN
( B-O B-LRB
NF-muNR B-O B-NN
) B-O B-RRB
enhancer B-O B-NN
repressor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
overlap B-O B-VP_VBP
nuclear B-O B-NP_NP_NP_JJ
matrix B-O B-NN
attachment B-O B-NN
regions B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
has B-O B-VP_VBZ
lead B-O B-VP_VBN
to B-O B-PP_TO
the B-O B-NP_DT
hypothesis B-O B-NN
that B-O B-SBAR_IN
might B-O B-S_NP_NP_PP_VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
Scheuermann B-O B-NP_NP_NP_NNP
" " B-O O-NP
, B-O B-COMMA
R. B-O B-NP_NNP
H. B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Chen B-O B-NP_NNP
, B-O B-COMMA
U. B-O B-NNP
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
1989 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
Genes B-O B-NP_NNP
& B-O B-CC
Dev. B-O B-NNP
3 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
1255-1266 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
understand B-O B-VP_VB
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
MARs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
IgH B-O B-NP_NP_NN
enhancer B-O B-NN
" " B-O O-NP
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
a B-O B-NP_NP_DT
novel B-O B-JJ
MAR-binding B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
MAR-BP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
from B-O B-PP_IN
soluble B-O B-NP_ADJP_JJ
nuclear B-O B-JJ
" " B-O O-ADJP
matrix B-O B-NN
preparations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
based B-O B-PP_VBN
on B-O B-PP_IN
its B-O B-NP_NP_PRPP
ability B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Purified B-O B-S_S_NP_VBN
MAR-BP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
migrates B-O B-VP_VBZ
as B-O B-PP_IN
a B-O B-NP_DT
33-kDa B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
found B-O B-VP_VBN
in B-O B-NP_PP_IN
nuclear B-O B-NP_NP_JJ
matrix B-O B-NN
preparations B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
specific B-O B-S_NP_JJ
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
difficult B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-SBAR_WHNP_S_NP_VP_TO
localize B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
NF-muNR B-O B-S_NP_NP_NN
" " B-O O-NP
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
critical B-O B-ADJP_JJ
for B-O B-PP_IN
efficient B-O B-NP_JJ
MAR-BP1 B-O B-NP_NN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Indeed B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IgH B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_PP_TO
either B-O B-CC
intact B-O B-NP_ADJP_JJ
nuclear B-O B-JJ
" " B-O O-ADJP
matrix B-O B-NN
preparations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
to B-O B-PP_TO
MAR-BP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mutually B-O B-ADJP_RB
exclusive B-O B-JJ
to B-O B-PP_TO
NF-muNR B-O B-NP_NP_NN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
a B-O B-NP_NP_DT
model B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
cell-type B-O B-NP_NP_ADJP_JJ
specific B-O B-JJ
" " B-O O-ADJP
regulation B-O B-NN
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
" " B-O B-WHNP_S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Identification B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
essential B-O B-NP_NP_JJ
GATA B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
Ets B-O B-NP_NN
binding B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_NP_DT
promoter B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
platelet B-O B-NP_NN
glycoprotein B-O B-NN
Ib B-O B-NN
alpha B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Platelet B-O B-S_S_NP_NP_NP_NN
glycoprotein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
Ib-IX-V B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
multisubunit B-O B-NP_JJ
adhesion B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
supports B-O B-S_NP_VP_VBZ
platelet B-O B-NP_NP_NN
attachment B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
congenital B-O B-JJ
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
a B-O B-NP_NP_DT
bleeding B-O B-JJ
disorder B-O B-NN
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
"""" B-O B-NP_LQT
giant B-O B-JJ
"""" B-O B-RQT
platelets B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
a B-O B-NP_NP_DT
condition B-O B-NN
" " B-O O-NP
linking B-O B-VP_VBG
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-PP_TO
platelet B-O B-NP_NN
morphogenesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
understand B-O B-VP_VB
better B-O B-NP_ADVP_JJR
" " B-O O-ADVP
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GP B-O B-NP_NN
Ib-IX-V B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
studies B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
undertaken B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
define B-O B-VP_VB
the B-O B-NP_NP_DT
essential B-O B-JJ
genetic B-O B-NP_JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
supporting B-O B-VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
GP B-O B-S_NP_NP_NN
Ib B-O B-NN
alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
evaluated B-O B-VP_VBN
by B-O B-NP_PP_IN
transfection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
erythroleukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
reporter B-O B-NP_NP_NN
plasmids B-O B-NNS
" " B-O O-NP
coding B-O B-VP_VBG
for B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Studies B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VP_VBD
initiated B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
fragment B-O B-NN
" " B-O O-NP
extending B-O B-VP_VBG
2,738 B-O B-NP_CD
nucleotides B-O B-NNS
5' B-O B-JJ
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
lead B-O B-VP_VBD
to B-O B-PP_TO
the B-O B-NP_NP_DT
identification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
253 B-O B-NP_NP_CD
nucleotides B-O B-NNS
" " B-O O-NP
retaining B-O B-VP_VBG
full B-O B-NP_JJ
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
nonhematopoietic B-O B-NP_JJ
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
human B-O B-NP_NP_ADJP_NP_JJ
endothelial B-O B-JJ
" " B-O O-NP
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
GP B-O B-NP_NN
Ib B-O B-NN
alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-ADJP_ADJP_RB
greater B-O B-JJR
" " B-O O-ADJP
than B-O B-PP_IN
background B-O B-NP_NP_NN
levels B-O B-NNS
" " B-O O-NP
obtained B-O B-VP_VBN
with B-O B-NP_PP_IN
promoterless B-O B-NP_JJ
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Gel B-O B-S_S_NP_NP_NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
and B-O B-CC
site-directed B-O B-NP_JJ
mutagenesis B-O B-NN
studies B-O B-NNS
" " B-O O-NP
" " B-O O-NP
defined B-O B-VP_VBD
essential B-O B-NP_NP_JJ
GATA B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
Ets B-O B-NP_NN
binding B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
93 B-O B-PP_NP_CD
and B-O B-CC
150 B-O B-CD
nucleotides B-O B-NNS
upstream B-O B-JJ
" " B-O O-NP
of B-O B-IN
the B-O B-NP_DT
transcription B-O B-NP_NN
start B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
a B-O B-NP_NP_DT
finding B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
further B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
substantiates B-O B-VP_VBZ
these B-O B-NP_DT
elements B-O B-NNS
" " B-O O-NP
as B-O B-PP_IN
important B-O B-NP_NP_JJ
determinants B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
megakaryocytic B-O B-NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
define B-O B-VP_VP_VBP
essential B-O B-NP_NP_JJ
cis-acting B-O B-NP_JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GP B-O B-NP_NN
Ib B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
provide B-O B-VP_VBP
insights B-O B-NP_NP_NNS
" " B-O O-NP
into B-O B-PP_IN
molecular B-O B-NP_NP_JJ
events B-O B-NNS
" " B-O O-NP
coinciding B-O B-VP_VBG
with B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Multiple B-O B-S_S_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
interact B-O B-VP_VBP
with B-O B-PP_IN
the B-O B-NP_NP_DT
nuclear B-O B-NP_JJ
inhibitory B-O B-JJ
protein B-O B-NN
repressor B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
interleukin-3 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
T B-O B-S_S_NP_NP_NN
cell B-O B-NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interleukin B-O B-NP_NP_NN
3 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
IL-3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
directed B-O B-VP_VBN
by B-O B-NP_PP_IN
positive B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
negative B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
cis-acting B-O B-NP_JJ
DNA B-O B-NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
clustered B-O B-ADJP_JJ
within B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_NP_NP_DT
strong B-O B-JJ
repressor B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
termed B-O B-VP_VBN
nuclear B-O B-S_NP_NP_NP_JJ
inhibitory B-O B-JJ
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NIP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
previously B-O B-ADVP_RB
" " B-O O-ADVP
mapped B-O B-VP_VBN
to B-O B-NP_PP_TO
a B-O B-NP_NP_DT
segment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
IL-3 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
between B-O B-PP_IN
nucleotides B-O B-NP_NNS
-271 B-O B-CD
and B-O B-CC
-250 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Functional B-O B-S_NP_NP_JJ
characterization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrates B-O B-VP_VBZ
that B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
can B-O B-VP_MD
mediate B-O B-VP_VB
repression B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
linked B-O B-S_NP_VP_VBN
in B-O B-NP_PP_IN
to B-O B-NP_PP_TO
" " B-O B-NP_ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNA B-O B-S_NP_NN
binding B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
carried B-O B-VP_VBN
out B-O B-PRT_RP
" " B-O O-PRT
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
characterize B-O B-VP_VB
the B-O B-NP_DT
repressor B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
varying B-O B-NP_JJ
conditions B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
three B-O B-S_NP_CD
distinct B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
interact B-O B-VP_VB
specifically B-O B-PP_ADVP_RB
" " B-O O-ADVP
with B-O B-IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
although B-O B-PP_IN
only B-O B-NP_QP_RB
one B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
repressor B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Complex B-O B-S_NP_NN
1 B-O B-CD
" " B-O O-NP
results B-O B-VP_VBZ
from B-O B-PP_IN
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
ubiquitous B-O B-JJ
polypeptide B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
and B-O B-S_NP_VP_VP_CC
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Complex B-O B-S_NP_NN
2 B-O B-CD
" " B-O O-NP
corresponds B-O B-VP_VBZ
to B-O B-PP_TO
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
upstream B-O B-NP_JJ
stimulatory B-O B-JJ
factor B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
an B-O B-NP_NP_DT
E-box B-O B-NP_NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNA B-O B-S_NP_NP_NN
binding B-O B-NN
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
complex B-O B-NP_NN
3 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
overlaps B-O B-VP_VP_VBZ
with B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
upstream B-O B-NP_JJ
stimulatory B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
is B-O B-VP_VBZ
clearly B-O B-ADJP_RB
distinct B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
determine B-O B-VP_VB
which B-O B-SBAR_WHNP_WHNP_WDT
" " B-O O-WHNP
of B-O B-PP_IN
the B-O B-NP_DT
latter B-O B-JJ
two B-O B-CD
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-WHNP
represents B-O B-S_NP_VP_VBZ
NIP B-O B-NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
incorporated B-O B-VP_VP_VBD
small B-O B-NP_JJ
alterations B-O B-NNS
" " B-O O-NP
into B-O B-PP_IN
the B-O B-NP_NP_DT
NIP B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
IL-3 B-O B-NP_NN
promoter-linked B-O B-JJ
reporter B-O B-NN
construct B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
examined B-O B-VP_VBD
their B-O B-NP_NP_PRPP
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
NIP-mediated B-O B-NP_JJ
repression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Functional B-O B-S_S_NP_NP_JJ
specificity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
repression B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
matches B-O B-VP_VBZ
the B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
complex B-O B-NP_NN
3 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
both B-O B-S_NP_DT
repressor B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
and B-O B-CC
complex B-O B-NP_NP_NN
3 B-O B-CD
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
" " B-O O-NP
require B-O B-VP_VBP
the B-O B-NP_DT
consensus B-O B-NP_NN
sequence B-O B-NN
" " B-O O-NP
CTCACNTNC B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Correlation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
differentiation-inducing B-O B-NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
retinoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
human B-O B-NP_NP_JJ
leukemia B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
HL-60 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NB4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Retinoids B-O B-S_S_NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
all-trans-retinoic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
, B-O B-COMMA
its B-O B-NP_PRPP
isomers B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
fifty B-O B-NP_NP_CD
synthetic B-O B-JJ
retinoids B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
retinobenzoic B-O B-NP_JJ
acids B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
tested B-O B-VP_VBN
for B-O B-NP_PP_IN
differentiation-inducing B-O B-NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
human B-O B-NP_NP_JJ
leukemia B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_NP_NP_DT
good B-O B-JJ
linear B-O B-NN
correlation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
with B-O B-PP_IN
an B-O B-NP_NP_DT
r B-O B-NN
value B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
0.91 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
between B-O B-PP_IN
the B-O B-NP_NP_DT
ED50 B-O B-NN
values B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_NP_DT
differentiation-inducing B-O B-JJ
activity B-O B-NN
" " B-O O-NP
towards B-O B-PP_IN
HL-60 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
that B-O B-NP_NP_DT
" " B-O O-NP
towards B-O B-PP_IN
NB4 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_NP_DT
signal B-O B-NN
transducer B-O B-NN
" " B-O O-NP
and B-O B-CC
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
STAT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
signaling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_DT
primary B-O B-JJ
T B-O B-NN
cell B-O B-NN
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Critical B-O B-NP_NP_JJ
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
IL-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_S_NP_DT
T B-O B-NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
initiated B-O B-VP_VBN
by B-O B-NP_PP_IN
interaction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_JJ
Ags B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
TCR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
followed B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
signal B-O B-NP_NP_NP_JJ
transducer B-O B-NN
" " B-O O-NP
and B-O B-CC
activator B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
( B-O B-LRB
STAT B-O B-NN
) B-O B-RRB
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_NP_DT
primary B-O B-JJ
TCR-mediated B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
explored B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
purified B-O B-NP_VBN
human B-O B-JJ
peripheral B-O B-JJ
blood B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
nuclear B-O B-NP_JJ
STAT B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
activated B-O B-VP_VBN
approximately B-O B-NP_PP_NP_QP_RB
3 B-O B-CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
after B-O B-IN
activation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
cross-linked B-O B-NP_JJ
anti-CD3 B-O B-NP_JJ
Abs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
STAT B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
by B-O B-NP_PP_IN
using B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
" " B-O B-NP_NP_PRN_O-NP
and B-O B-CC
related B-O B-NP_JJ
oligonucleotides B-O B-NNS
" " B-O O-NP
" " B-O O-NP
as B-O B-PP_IN
probes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
anti-STAT B-O B-NP_JJ
Abs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
contained B-O B-VP_VBD
STAT-3 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
additional B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
crossreactive B-O B-ADJP_JJ
with B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
STAT B-O B-NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
completely B-O B-NP_PP_ADVP_RB
" " B-O O-ADVP
by B-O B-IN
pretreatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
either B-O B-NP_CC
cycloheximide B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
cyclosporin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
thus B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
indicating B-O B-VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_DT
induction B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
due B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_SBAR_SBAR_IN
neutralizing B-O B-S_NP_NN
anti-IL-6 B-O B-JJ
Abs B-O B-NNS
" " B-O O-NP
effectively B-O B-ADVP_RB
" " B-O O-ADVP
down-regulated B-O B-VP_VBD
the B-O B-NP_NP_DT
early B-O B-JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
STAT B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
as B-O B-SBAR_IN
exogenously B-O B-S_NP_ADJP_RB
added B-O B-VBN
" " B-O O-ADJP
IL-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBD
DNA B-O B-NP_NP_NN
binding B-O B-NN
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
TCR-mediated B-O B-JJ
bindings B-O B-NNS
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
, B-O B-COMMA
it B-O B-S_NP_PRP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
concluded B-O B-VP_VBN
that B-O B-SBAR_IN
IL-6 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-NP_NP_ADJP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IkB B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
PKC- B-O B-NP_NP_NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
Ca(2+)-dependent B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
signal B-O B-NP_NN
transduction B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
Ca(2+)-dependent B-O B-NP_NP_JJ
phosphatase B-O B-NN
" " B-O O-NP
calcineurin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
target B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
FK506 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
CsA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
synergizes B-O B-VP_VBZ
with B-O B-PP_IN
PKC-induced B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
factor B-O B-NN
( B-O B-LRB
NF B-O B-NN
) B-O B-RRB
-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
whether B-O B-UCP_SBAR_IN
this B-O B-S_NP_DT
synergy B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
present B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
the B-O B-NP_NP_DT
mechanism B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
these B-O B-S_NP_DT
two B-O B-CD
pathways B-O B-NNS
" " B-O O-NP
lead B-O B-VP_VBP
to B-O B-PP_TO
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
While B-O B-S_SBAR_IN
this B-O B-S_NP_DT
synergy B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
present B-O B-ADJP_JJ
in B-O B-PP_IN
other B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
in B-O B-S_PP_IN
the B-O B-NP_DT
monocytic B-O B-NP_JJ
cell B-O B-NN
line B-O B-NN
U937 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
calcineurin B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
sufficient B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Having B-O B-S_S_NP_VP_VBG
previously B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
Ca(2+)- B-O B-S_NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
PKC- B-O B-NP_NN
" " B-O B-NP_O-NP
dependent B-O B-NP_JJ
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-NP
synergize B-O B-VP_VBP
by B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
focused B-O B-VP_VBD
on B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IkB B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
While B-O B-S_SBAR_IN
PKC-dependent B-O B-S_NP_JJ
pathways B-O B-NNS
" " B-O O-NP
sequentially B-O B-ADVP_RB
" " B-O O-ADVP
result B-O B-VP_VBP
in B-O B-PP_PP_IN
the B-O B-NP_DT
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-PP
and B-O B-CC
in B-O B-PP_IN
an B-O B-NP_DT
incomplete B-O B-JJ
degradation B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-PP
of B-O B-PP_IN
IkB B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
co-activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Ca(2+)-dependent B-O B-NP_JJ
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
accelerates B-O B-VP_VP_VBZ
the B-O B-NP_NP_DT
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IkB B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
results B-O B-VP_VBZ
in B-O B-PP_IN
its B-O B-NP_PRPP
complete B-O B-JJ
degradation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Ca(2+)-dependent B-O B-NP_NP_JJ
pathways B-O B-NNS
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
result B-O B-VP_VB
in B-O B-PP_IN
the B-O B-NP_NP_DT
phosphorylation B-O B-NP_NN
" " B-O O-NP
and/or B-O B-CC
degradation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
IkB B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
or B-O B-NP_CC
in B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
selective B-O B-JJ
PKC B-O B-NP_NN
" " B-O O-NP
inhibitor B-O B-NN
GF109203X B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
abrogates B-O B-VP_VBZ
the B-O B-NP_NP_NP_DT
PMA-induced B-O B-JJ
IkB B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
phosphorylation/degradation B-O B-NN
" " B-O O-NP
irrespective B-O B-ADJP_JJ
of B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Ca(2+)-dependent B-O B-NP_JJ
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_NP_DT
phosphorylation B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
degradation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
IkB B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Contrary B-O B-S_ADVP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
Ca(2+)-dependent B-O B-S_NP_JJ
pathways B-O B-NNS
" " B-O O-NP
synergize B-O B-VP_VBP
with B-O B-PP_IN
TNF-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
not B-O B-PP_PP_RB
at B-O B-IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IkB B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
at B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
degradation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
Ca(2+)-dependent B-O B-S_NP_NP_JJ
pathways B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
the B-O B-NP_DT
phosphatase B-O B-NP_NN
" " B-O O-NP
calcineurin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
participate B-O B-VP_VP_VBP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_DT
cell B-O B-NN
specific B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
synergize B-O B-VP_VBP
with B-O B-PP_IN
and B-O B-NP_NP_ADJP_CC
" " B-O B-NP_ADJP_NP_O-NP
pathways B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Triggering B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
complement B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
CR1 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
CD35 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
CR3 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
CD11b/CD18 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VP_VBZ
nuclear B-O B-NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
p50 B-O B-NP_NN
/p65 B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
enhances B-O B-VP_VBZ
viral B-O B-NP_NP_JJ
replication B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HIV-infected B-O B-NP_JJ
monocytic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Monocyte/macrophages B-O B-S_S_NP_NNS
" " B-O O-NP
may B-O B-VP_MD
harbor B-O B-VP_VB
HIV B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
nonproductive B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
prolonged B-O B-NP_NP_JJ
periods B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
time B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Viral B-O B-S_NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
reactivated B-O B-VP_VBN
by B-O B-NP_PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
LPS B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LPS B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
TNF-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
their B-O B-NP_NP_PRPP
ability B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
demonstrates B-O B-VP_VBZ
that B-O B-SBAR_IN
triggering B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
complement B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
and B-O B-NP_NP_NP_PRN_CC
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
enhances B-O B-VP_VBZ
viral B-O B-NP_NP_JJ
replication B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HIV-infected B-O B-NP_JJ
human B-O B-JJ
monocytic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Monocytic B-O B-S_NP_NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
and B-O B-CC
normal B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
infected B-O B-VP_VP_VBN
with B-O B-NP_PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
and B-O B-CC
cultured B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
the B-O B-NP_NP_DT
presence B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
absence B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
with B-O B-PP_IN
C3 B-O B-NP_NN
fragments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CR1 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
CR3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
a B-O B-NP_NP_DT
two- B-O B-ADJP_CD
to B-O B-TO
fourfold B-O B-JJ
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
amount B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cell-associated B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
released B-O B-ADJP_VBN
" " B-O O-ADJP
" " B-O O-ADJP
p24 B-O B-NP_NN
Ag B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
cell B-O B-NP_NN
cultures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
equivalent B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_VP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBD
that B-O B-SBAR_IN
stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CR1 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
CR3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
the B-O B-NP_NP_DT
nuclear B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
p50 B-O B-NP_NN
/p65 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Translocation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
p50 B-O B-NP_NN
/p65 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBN
following B-O B-NP_PP_VBG
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CR1 B-O B-NP_NP_NP_NN
" " B-O O-NP
or B-O B-CC
CR3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
amount B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NP_NN
" " B-O O-NP
translocated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
similar B-O B-ADJP_JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
observed B-O B-VP_VBN
when B-O B-NP_SBAR_WHADVP_WRB
" " B-O O-WHADVP
cells B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TNF-alpha B-O B-S_NP_NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
mediate B-O B-VP_VB
the B-O B-NP_NP_DT
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NP_NN
B B-O B-NN
" " B-O O-NP
p50 B-O B-NP_NN
/p65 B-O B-NN
" " B-O O-NP
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
these B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
HIV B-O B-S_NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
activated B-O B-VP_VBN
" " B-O B-NP_PP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
enhanced B-O B-S_NP_VBN
viral B-O B-JJ
replication B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Nuclear B-O B-S_S_NP_JJ
factor-IL6 B-O B-NN
" " B-O O-NP
activates B-O B-VP_VBZ
the B-O B-NP_NP_DT
human B-O B-NP_JJ
IL-4 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Positive B-O B-S_S_NP_NP_JJ
regulatory B-O B-JJ
element B-O B-NN
I B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PRE-I B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
strong B-O B-JJ
enhancer B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
essential B-O B-ADJP_JJ
for B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
identify B-O B-VP_VB
transcription B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
PRE-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
screened B-O B-VP_VP_VBD
a B-O B-NP_NP_DT
cDNA B-O B-NP_NN
expression B-O B-NN
library B-O B-NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
isolated B-O B-VP_VBD
a B-O B-NP_NP_DT
cDNA B-O B-NP_NN
" " B-O O-NP
encoding B-O B-NN
nuclear B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-NP_LRB
NF B-O B-NN
) B-O B-RRB
-IL6 B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
also B-O B-ADVP_RB
" " B-O O-ADVP
known B-O B-VP_VBN
as B-O B-NP_PP_IN
C/EBP B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
NF-IL6 B-O B-S_NP_NN
mRNA B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
in B-O B-NP_PP_PP_PP_IN
human B-O B-NP_JJ
Jurkat B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
the B-O B-NP_DT
mouse B-O B-NP_NP_NN
Th2 B-O B-NN
clone B-O B-NN
" " B-O O-NP
D10 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
Th1 B-O B-NP_NN
clone B-O B-NN
29 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
rNF-IL6 B-O B-S_NP_NP_NN
" " B-O O-NP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
bacteria B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
specifically B-O B-ADVP_RB
" " B-O O-ADVP
bind B-O B-VP_VB
to B-O B-PP_TO
PRE-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PRE-I B-O B-S_NP_NN
" " B-O O-NP
forms B-O B-VP_VBZ
multiple B-O B-NP_JJ
DNA-protein B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Some B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
demonstrated B-O B-VP_VBN
to B-O B-S_NP_VP_TO
contain B-O B-VP_VB
NF-IL6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
by B-O B-PP_IN
using B-O B-S_NP_VP_VBG
anti-C/EBP B-O B-NP_JJ
beta B-O B-NN
Abs B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Overexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-IL6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
enhanced B-O B-VP_VBD
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
chloramphenicol B-O B-NP_NN
acetyl B-O B-JJ
transferase B-O B-NN
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
or B-O B-NP_CC
the B-O B-NP_DT
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
more B-O B-NP_JJR
than B-O B-IN
10-fold B-O B-RB
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Promoter B-O B-S_NP_NN
deletion B-O B-NN
studies B-O B-NNS
" " B-O O-NP
revealed B-O B-VP_VBD
two B-O B-NP_NP_CD
additional B-O B-JJ
NF-IL6 B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
located B-O B-ADJP_JJ
at B-O B-PP_IN
positions B-O B-NP_NP_NNS
" " B-O O-NP
-44 B-O B-NP_NP_QP_CD
to B-O B-TO
-36 B-O B-CD
" " B-O O-QP
" " B-O O-NP
( B-O B-PRN_LRB
C/EBP B-O B-NP_NN
proximal B-O B-JJ
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
-87 B-O B-NP_NP_QP_CD
to B-O B-TO
-79 B-O B-CD
" " B-O O-QP
" " B-O O-NP
( B-O B-PRN_LRB
C/EBP B-O B-NP_NN
medial B-O B-JJ
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
NF-IL6 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
transcriptional B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Jak-STAT B-O B-JJ
1 B-O B-CD
signaling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
IL-5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
eosinophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
intracellular B-O B-JJ
signal B-O B-NN
transduction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
eosinophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
objective B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
to B-O B-S_NP_VP_TO
investigate B-O B-VP_VB
the B-O B-NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
newly B-O B-ADJP_RB
discovered B-O B-VBN
" " B-O O-ADJP
Jak-STAT B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
IL-5 B-O B-NP_NN
" " B-O O-NP
signal B-O B-NN
transduction B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Eosinophils B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
purified B-O B-VP_VP_VBN
from B-O B-NP_PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
discontinuous B-O B-NP_JJ
Percoll B-O B-NN
gradients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
IL-5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Jak B-O B-NP_NN
2 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
by B-O B-NP_PP_IN
immunoprecipitation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
followed B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
immunoblotting B-O B-NP_NP_VBG
" " B-O O-NP
for B-O B-PP_IN
tyrosine B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Jak B-O B-NP_NN
2 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
by B-O B-NP_PP_IN
autophosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
immunoprecipitated B-O B-NP_VBN
kinase B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Jak B-O B-S_NP_NN
2 B-O B-CD
" " B-O O-NP
was B-O B-VP_VBD
tyrosine B-O B-ADJP_NN
phosphorylated B-O B-JJ
within B-O B-PP_IN
1 B-O B-NP_NP_QP_CD
to B-O B-TO
3 B-O B-CD
" " B-O O-QP
min B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
eosinophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
IL-5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
immunoprecipitated B-O B-NP_VBN
Jak B-O B-NN
2 B-O B-CD
" " B-O O-NP
" " B-O O-NP
obtained B-O B-VP_VBN
from B-O B-NP_PP_IN
IL-5-stimulated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
underwent B-O B-VP_VBD
autophosphorylation B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Jak B-O B-S_NP_NN
2 B-O B-CD
" " B-O O-NP
coprecipitated B-O B-VP_VBD
with B-O B-PP_IN
the B-O B-NP_NP_DT
beta-subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-5 B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
physical B-O B-JJ
association B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
kinase B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
STAT-1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
p91 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
by B-O B-NP_PP_IN
immunoprecipitation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
followed B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
immunoblotting B-O B-NP_NP_VBG
" " B-O O-NP
for B-O B-PP_IN
tyrosine B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
STAT-1 B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
tyrosine B-O B-ADJP_NN
phosphorylated B-O B-JJ
within B-O B-PP_IN
15 B-O B-NP_NP_CD
min B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-5 B-O B-NP_NP_NN
" " B-O O-NP
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
STAT-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-JJ
extract B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
by B-O B-NP_PP_IN
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-5 B-O B-S_NP_NN
" " B-O O-NP
induced B-O B-VP_VBD
two B-O B-NP_NP_CD
proteins B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bound B-O B-S_NP_VP_VBD
to B-O B-PP_TO
the B-O B-NP_DT
gamma-activating B-O B-NP_JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
anti-STAT-1 B-O B-NP_JJ
Ab B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
band B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
supershifted B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
IL-5 B-O B-S_NP_NN
" " B-O O-NP
activated B-O B-VP_VBD
the B-O B-NP_DT
Jak B-O B-NN
2-STAT B-O B-NN
1 B-O B-CD
signaling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
eosinophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
speculate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
Jak B-O B-NN
2-STAT B-O B-NN
1 B-O B-CD
pathway B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Constitutively B-O B-NP_NP_NP_ADJP_RB
activated B-O B-VBN
" " B-O O-ADJP
Jak-STAT B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
transformed B-O B-VP_VBN
with B-O B-NP_PP_IN
HTLV-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Human B-O B-S_S_NP_NP_JJ
T B-O B-NN
cell B-O B-NN
lymphotropic B-O B-JJ
virus B-O B-NN
I B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-I B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
etiological B-O B-JJ
agent B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
adult B-O B-NP_NP_JJ
T B-O B-NN
cell B-O B-NN
leukemia B-O B-NN
" " B-O O-NP
and B-O B-CC
tropical B-O B-NP_NP_ADJP_JJ
spastic B-O B-JJ
" " B-O O-ADJP
paraparesis B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
also B-O B-ADVP_RB
" " B-O O-ADVP
termed B-O B-VP_VBN
) B-O B-S_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
HTLV-I-infected B-O B-S_S_NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
exhibit B-O B-VP_VBP
an B-O B-NP_NP_DT
initial B-O B-JJ
phase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interleukin-2 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
-dependent B-O B-JJ
growth B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
over B-O B-S_PP_IN
time B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
by B-O B-PP_IN
an B-O B-NP_DT
unknown B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
become B-O B-VP_VBP
IL-2-independent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Whereas B-O B-S_SBAR_IN
the B-O B-S_NP_NP_NP_DT
Jak B-O B-NP_NN
kinases B-O B-NNS
" " B-O O-NP
" " B-O O-NP
Jak1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Jak3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_NP_DT
signal B-O B-NN
transducer B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
activator B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
Stat3 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Stat5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
activated B-O B-VP_VBN
in B-O B-NP_PP_IN
normal B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
this B-O B-S_NP_DT
signaling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBN
in B-O B-NP_PP_IN
HTLV-I-transformed B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
HTLV-I-infected B-O B-NP_JJ
cord B-O B-NN
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
transition B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
IL-2-dependent B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
" " B-O O-PP
to B-O B-PP_TO
IL-2-independent B-O B-NP_JJ
growth B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-PP_IN
the B-O B-NP_NP_DT
acquisition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
constitutively B-O B-ADJP_RB
activated B-O B-JJ
" " B-O O-ADJP
Jak-STAT B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
suggests B-O B-S_NP_VP_VBZ
that B-O B-SBAR_IN
this B-O B-S_NP_DT
pathway B-O B-NN
" " B-O O-NP
participates B-O B-VP_VBZ
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Positive B-O B-NP_NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
negative B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
regulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
granulocyte-macrophage B-O B-NP_NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
AML1-related B-O B-NP_NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
PEBP2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
granulocyte-macrophage B-O B-NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
( B-O B-LRB
GM-CSF B-O B-NN
) B-O B-RRB
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
consensus B-O B-NN
sequence B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
polyomavirus B-O B-NP_NN
enhancer B-O B-NN
binding-protein B-O B-NN
2 B-O B-CD
( B-O B-LRB
PEBP2 B-O B-NN
) B-O B-RRB
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
consists B-O B-S_NP_VP_VBZ
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
are B-O B-VP_VBP
at B-O B-NP_NP_QP_IN
least B-O B-JJS
two B-O B-CD
" " B-O O-QP
genes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
alpha B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
alpha B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
encoding B-O B-VP_VBG
the B-O B-NP_DT
alpha B-O B-NP_NN
subunit B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
alpha B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
mouse B-O B-NP_NN
homologue B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
AML1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
detected B-O B-VP_VBN
at B-O B-NP_PP_IN
the B-O B-NP_NP_DT
breakpoints B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
alpha B-O B-NP_NP_NP_NN
A1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
an B-O B-NP_DT
alpha B-O B-NP_NN
A-gene B-O B-JJ
product B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
alpha B-O B-NP_NP_NP_NN
B1 B-O B-NN
" " B-O O-NP
and B-O B-CC
alpha B-O B-NP_NN
B2 B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
two B-O B-NP_CD
alpha B-O B-NP_NN
B-encoded B-O B-JJ
isomers B-O B-NNS
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
their B-O B-NP_NP_PRPP
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
GM-CSF B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PEBP2 B-O B-S_NP_NP_NN
alpha B-O B-NN
A1 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
alpha B-O B-NP_NN
B1 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
alpha B-O B-NP_NN
B2 B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
bound B-O B-VP_VBD
the B-O B-NP_NP_DT
PEBP2 B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_DT
mouse B-O B-NP_NN
GM-CSF B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PEBP2 B-O B-S_NP_NP_NN
alpha B-O B-NN
A1 B-O B-NN
" " B-O O-NP
and B-O B-CC
alpha B-O B-NP_NN
B1 B-O B-NN
" " B-O O-NP
" " B-O O-NP
enhanced B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GM-CSF B-O B-NP_NN
promoter-driven B-O B-JJ
reporter B-O B-NN
plasmid B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
unstimulated B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
12-O-tetradecanoylphorbol B-O B-NP_NN
13-acetate/phytohemagglutinin-stimulated B-O B-JJ
" " B-O B-NP_O-NP
human B-O B-NP_JJ
Jurkat B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
suppressed B-O B-VP_VBN
by B-O B-NP_PP_IN
alpha B-O B-NP_NN
B2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Coexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
alpha B-O B-NP_NP_NN
B1 B-O B-NN
" " B-O O-NP
and B-O B-CC
alpha B-O B-NP_NN
B2 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
determined B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
alpha B-O B-NN
B1/alpha B-O B-NN
B2 B-O B-NN
ratio B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Jurkat B-O B-S_NP_NN
cell B-O B-NN
extract B-O B-NN
" " B-O O-NP
contained B-O B-VP_VBD
PEBP2 B-O B-NP_NP_NP_NN
site-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
cross-reacted B-O B-S_NP_VP_VBD
with B-O B-PP_IN
antimouse B-O B-NP_JJ
alpha B-O B-NN
A1 B-O B-NN
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
indicated B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
PEBP2 B-O B-NP_NN
alpha B-O B-NN
A B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
alpha B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
AML1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
beta B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
further B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
the B-O B-NP_NP_DT
precise B-O B-JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_DT
present B-O B-JJ
findings B-O B-NNS
" " B-O O-NP
suggested B-O B-VP_VBD
the B-O B-NP_NP_DT
importance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
relative B-O B-JJ
ratio B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
different B-O B-NP_JJ
PEBP2 B-O B-NP_NN
isoforms B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
regulating B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Heterogeneous B-O B-NP_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
latent B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
endemic B-O B-NP_JJ
Burkitt B-O B-NN
's B-O B-POS
lymphoma B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Epstein-Barr B-O B-S_S_NP_JJ
virus B-O B-NN
( B-O B-LRB
EBV B-O B-NN
) B-O B-RRB
-infected B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
sustain B-O B-VP_VB
three B-O B-NP_NP_CD
distinct B-O B-JJ
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
virus B-O B-NP_NN
latency B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
lymphoblastoid B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
six B-O B-NP_NP_NP_CD
EBV-encoded B-O B-NP_JJ
nuclear B-O B-JJ
antigens B-O B-NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
EBNA1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
2 B-O B-NP_NP_CD
" " B-O O-NP
, B-O B-COMMA
3A B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
3B B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
3C B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
-LP B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
three B-O B-NP_NP_CD
latent B-O B-NP_JJ
membrane B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
LMP1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
2A B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
2B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
two B-O B-NP_NP_CD
nuclear B-O B-NP_JJ
RNAs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
EBERs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_NP_DT
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
latency B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
termed B-O B-VP_VBN
latency B-O B-S_NP_NP_NN
III B-O B-CD
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
encountered B-O B-VP_VBN
in B-O B-NP_PP_IN
some B-O B-NP_DT
posttransplant B-O B-JJ
lymphoproliferative B-O B-JJ
disorders B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
EBV-positive B-O B-NP_NP_JJ
cases B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Hodgkin B-O B-NP_NN
's B-O B-POS
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
EBERs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
EBNA1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_DT
LMPs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O B-PRN_O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VBN
" " B-O B-NP_O-VP
( B-O B-PRN_LRB
latency B-O B-NP_NN
II B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
, B-O B-COMMA
whereas B-O B-SBAR_IN
in B-O B-S_PP_IN
Burkitt B-O B-NP_NP_NP_NN
's B-O B-POS
" " B-O O-NP
lymphoma B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
BL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
only B-O B-NP_ADVP_RB
" " B-O O-ADVP
the B-O B-NP_DT
EBERs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
EBNA1 B-O B-NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
detected B-O B-VP_VBN
( B-O B-NP_PRN_LRB
latency B-O B-NP_NN
I B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
studied B-O B-VP_VBN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
EBV B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
17 B-O B-NP_NP_CD
cases B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
EBV-positive B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
endemic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
BL B-O B-NN
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
immunohistology B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Expression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
LMP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
variable B-O B-NP_NP_JJ
proportions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
tumor B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
EBNA2 B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
some B-O B-NP_NP_DT
tumor B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
three B-O B-NP_CD
other B-O B-JJ
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Also B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
BZLF1 B-O B-NP_NN
trans-activator B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
few B-O B-JJ
tumor B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
6 B-O B-NP_CD
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
entry B-O B-NP_NP_NN
" " B-O O-NP
into B-O B-PP_IN
the B-O B-NP_DT
lytic B-O B-JJ
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
phenotypic B-O B-JJ
drift B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
latency B-O B-NP_NN
I B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
latency B-O B-NP_NN
III B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
observed B-O B-VP_VBN
previously B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
some B-O B-NP_DT
BL B-O B-NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_DT
similar B-O B-JJ
phenomenon B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
occur B-O B-VP_VB
in B-O B-PP_IN
BL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
operational B-O B-JJ
definition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
EBV B-O B-NP_NN
latencies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
easily B-O B-ADVP_RB
" " B-O O-ADVP
applied B-O B-VP_VBN
to B-O B-NP_PP_TO
human B-O B-NP_JJ
tumors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Does B-O B-SQ_SQ_VBZ
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TAL1 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occur B-O B-VP_VB
in B-O B-PP_IN
a B-O B-NP_NP_DT
majority B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
T-cell B-O B-NP_NN
acute B-O B-JJ
lymphoblastic B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
? B-O B-PERIOD
" " B-O O-SQ
" " B-O O-SQ
  
A B-O B-NP_DT
pediatric B-O B-JJ
oncology B-O B-NN
group B-O B-NN
study B-O B-NN
. B-O B-PERIOD
" " B-O O-NP
  
Almost B-O B-S_S_NP_NP_QP_RB
25 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
T-cell B-O B-NP_NP_NN
acute B-O B-JJ
lymphoblastic B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
T-ALL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
tumor-specific B-O B-NP_NP_JJ
rearrangements B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TAL1 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Although B-O B-S_SBAR_IN
TAL1 B-O B-S_NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
not B-O B-RB
been B-O B-VP_VBN
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
normal B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
TAL1 B-O B-S_NP_NN
gene B-O B-NN
products B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
readily B-O B-ADVP_RB
" " B-O O-ADVP
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
leukemic B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
harbor B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Hence B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
proposed B-O B-VP_VBN
that B-O B-SBAR_IN
ectopic B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TAL1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
promotes B-O B-VP_VBZ
the B-O B-NP_NP_DT
development B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
TAL1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
, B-O B-NP_NP_NP_PP_COMMA
including B-O B-PP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
polymorphic B-O B-JJ
dinucleotide B-O B-NN
repeat B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
transcribed B-O B-VBN
sequences B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
TAL1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
the B-O B-NP_NP_DT
allele B-O B-NN
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Monoallelic B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TAL1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
leukemic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
all B-O B-NP_NP_DT
patients B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_QP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
bearing B-O B-VP_VBG
a B-O B-NP_DT
TAL1 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
rearrangement B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
leukemic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
without B-O B-PP_IN
detectable B-O B-NP_JJ
TAL1 B-O B-NP_NN
" " B-O O-NP
rearrangements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
TAL1 B-O B-NP_NP_NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
occurred B-O B-VP_VBD
in B-O B-PP_IN
either B-O B-NP_CC
a B-O B-NP_NP_DT
monoallelic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
3 B-O B-NP_QP_CD
of B-O B-IN
7 B-O B-CD
" " B-O O-QP
patients B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
or B-O B-CC
a B-O B-NP_NP_DT
biallelic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
4 B-O B-NP_QP_CD
of B-O B-IN
7 B-O B-CD
patients B-O B-NNS
" " B-O O-QP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
fashion B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
TAL1 B-O B-NP_NP_NP_NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
result B-O B-VP_VB
from B-O B-PP_IN
subtle B-O B-NP_NP_NP_JJ
alterations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
cis-acting B-O B-NP_NP_JJ
regulatory B-O B-JJ
sequences B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-VP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
or B-O B-CC
changes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
( B-O B-NP_NP_NP_SBAR_PRN_LRB
) B-O B-VP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_DT
peri-kappa B-O B-NP_NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
mediates B-O B-VP_VBZ
human B-O B-NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
2 B-O B-CD
enhancer B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Human B-O B-S_S_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
, B-O B-COMMA
" " B-O O-NP
like B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
causes B-O B-VP_VP_VBZ
AIDS B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
AIDS B-O B-NP_NP_NN
cases B-O B-NNS
" " B-O O-NP
primarily B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
West B-O B-NP_NNP
Africa B-O B-NNP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
HIV-1 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
HIV-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
display B-O B-VP_VBP
significant B-O B-NP_NP_JJ
differences B-O B-NNS
" " B-O O-NP
in B-O B-PP_PP_IN
nucleic B-O B-NP_NP_JJ
acid B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
the B-O B-NP_NP_DT
natural B-O B-JJ
history B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-NP
" " B-O O-PP
of B-O B-PP_IN
clinical B-O B-NP_JJ
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Consistent B-O B-S_ADVP_JJ
with B-O B-PP_IN
these B-O B-NP_DT
differences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
enhancer/promoter B-O B-NP_NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
HIV-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
functions B-O B-VP_VBZ
quite B-O B-ADVP_ADVP_RB
differently B-O B-RB
" " B-O O-ADVP
from B-O B-PP_IN
" " B-O B-NP_O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Whereas B-O B-S_S_SBAR_IN
activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
following B-O B-PP_VBG
T-cell B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
largely B-O B-NP_ADVP_RB
" " B-O O-ADVP
through B-O B-PP_IN
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
to B-O B-NP_PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-2 B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
four B-O B-NP_CD
cis-acting B-O B-NP_JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
: B-O B-COLON
a B-O B-NP_NP_DT
single B-O B-JJ
kappa B-O B-NP_NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
two B-O B-NP_NP_CD
purine-rich B-O B-NP_JJ
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
PuB1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
PuB2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
a B-O B-NP_DT
pets B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
now B-O B-ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VBN
a B-O B-NP_DT
novel B-O B-JJ
cis-acting B-O B-NP_JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_NP_DT
HIV-2 B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
immediately B-O B-ADVP_RB
upstream B-O B-JJ
of B-O B-PP_IN
the B-O B-NP_DT
kappa B-O B-NP_NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
designated B-O B-VP_VBN
peri-kappa B-O B-S_NP_NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
site B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
conserved B-O B-VP_VBN
among B-O B-NP_PP_IN
isolates B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
HIV-2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
immunodeficiency B-O B-ADJP_NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
transfection B-O B-S_NP_NN
assays B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
this B-O B-S_NP_DT
site B-O B-NN
" " B-O O-NP
to B-O B-VP_TO
mediate B-O B-VP_VB
HIV-2 B-O B-NP_NP_NP_NN
enhancer B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
following B-O B-PP_VBG
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
first B-O B-JJ
description B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
HIV-2 B-O B-NP_NN
enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
displays B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
no B-O B-S_NP_DT
comparable B-O B-JJ
enhancer B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
clearly B-O B-ADVP_RB
" " B-O O-ADVP
defined B-O B-VP_VBN
for B-O B-NP_PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
While B-O B-S_SBAR_IN
a B-O B-S_NP_NP_DT
nuclear B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
from B-O B-PP_IN
both B-O B-NP_CC
peripheral B-O B-NP_JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
binds B-O B-VP_VBZ
the B-O B-NP_DT
peri-kappa B-O B-NP_NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
electrophoretic B-O B-S_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
either B-O B-S_NP_CC
a B-O B-DT
different B-O B-JJ
protein B-O B-NN
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
this B-O B-NP_DT
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
versus B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
or B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
protein B-O B-NN
" " B-O O-NP
recognizing B-O B-VP_VBG
this B-O B-NP_DT
" " B-O B-NP_O-VP
" " B-O O-NP
undergoes B-O B-VP_VBZ
differential B-O B-NP_NP_JJ
modification B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
, B-O B-COMMA
thus B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
supporting B-O B-VP_VBG
the B-O B-NP_DT
transfection B-O B-NN
data B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
while B-O B-SBAR_IN
specific B-O B-S_NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
constitutive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
peri-kappa B-O B-NP_NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
phorbol B-O B-NP_NN
esters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
additional B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
binding B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Understanding B-O B-S_S_NP_VP_VBG
the B-O B-NP_NP_DT
monocyte-specific B-O B-JJ
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
peri-kappa B-O B-NP_NN
B B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
may B-O B-VP_MD
ultimately B-O B-ADVP_RB
" " B-O O-ADVP
provide B-O B-VP_VB
insight B-O B-NP_NP_NN
" " B-O O-NP
into B-O B-PP_IN
the B-O B-NP_NP_DT
different B-O B-JJ
role B-O B-NN
" " B-O O-NP
and B-O B-SBAR_WHNP_S_NP_NP_CC
play B-O B-NP_VP_VBP
" " B-O B-PP_NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inhibitory B-O B-NP_NP_NP_JJ
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nm23 B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
erythroid B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
leukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
recently B-O B-ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VBD
a B-O B-NP_DT
differentiation B-O B-NP_NP_NN
inhibitory B-O B-JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
I-factor B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
mouse B-O B-NP_NN
myeloid B-O B-JJ
leukemia B-O B-NN
M1 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_NP_DT
murine B-O B-NP_JJ
homolog B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
nm23-H2 B-O B-NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
nm23 B-O B-S_NP_NN
genes B-O B-NNS
" " B-O O-NP
encode B-O B-VP_VBP
proteins B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
participate B-O B-S_NP_VP_VBP
in B-O B-PP_PP_IN
tumor B-O B-NP_NN
metastasis B-O B-NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
various B-O B-NP_JJ
processes B-O B-ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
although B-O B-SBAR_IN
their B-O B-S_NP_NP_PRPP
mechanisms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
still B-O B-ADVP_RB
" " B-O O-ADVP
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
all B-O B-S_NP_DT
nm23 B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
contain B-O B-VP_VBP
nucleoside B-O B-NP_NP_NN
diphosphate B-O B-NN
( B-O B-LRB
NDP B-O B-NN
) B-O B-RRB
kinase B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
it B-O B-S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
not B-O B-RB
been B-O B-VP_VBN
established B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
enzyme B-O B-NN
activity B-O B-NN
" " B-O O-NP
mediated B-O B-VP_VBD
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
experiment B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nm23 B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
various B-O B-NP_NP_JJ
differentiation B-O B-NN
induction B-O B-NN
systems B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
leukemic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
including B-O B-PP_VBG
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Native B-O B-S_NP_JJ
human B-O B-JJ
erythrocyte B-O B-NN
NDP B-O B-NN
kinase B-O B-NN
protein B-O B-NN
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
erythroid B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HEL B-O B-NP_NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
KU812 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
K562 B-O B-NP_NN
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
monocytic B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
or B-O B-CC
granulocytic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
HL-60 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
U937 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
HEL/S B-O B-NP_NN
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
erythroid B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HEL B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
recombinant B-O B-NP_ADJP_JJ
" " B-O O-ADJP
human B-O B-NP_JJ
nm23-H1 B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
-H2 B-O B-NP_NN
" " B-O B-NP_O-NP
" " B-O O-NP
, B-O B-COMMA
mouse B-O B-NP_NN
nm23-M1 B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
-M2 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
" " B-O O-NP
proteins B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
both B-O B-NP_NP_CC
the B-O B-DT
mutant B-O B-NP_NP_JJ
nm23-H2His B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
truncated B-O B-NP_VBN
nm23-H2 B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
containing B-O B-VP_VBG
N-terminal B-O B-NP_JJ
( B-O B-LRB
1-60 B-O B-CD
) B-O B-RRB
peptide B-O B-NN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
do B-O B-S_NP_VP_VBP
not B-O B-RB
have B-O B-VP_VB
NDP B-O B-NP_NP_NN
kinase B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
erythroid B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HEL B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
( B-O B-S_S_LST_LRB
1 B-O B-LS
) B-O B-RRB
" " B-O O-LST
the B-O B-NP_NP_DT
differentiation B-O B-NN
inhibitory B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I-factor/nm23 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
restricted B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
( B-O B-S_LST_LRB
2 B-O B-LS
) B-O B-RRB
" " B-O O-LST
the B-O B-NP_DT
inhibitory B-O B-JJ
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
exhibited B-O B-VP_VBN
without B-O B-NP_PP_IN
species B-O B-NP_NNS
specificity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
( B-O B-S_LST_LRB
3 B-O B-LS
) B-O B-RRB
" " B-O O-LST
the B-O B-NP_NP_DT
differentiation B-O B-NN
inhibitory B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
nm23/NDP B-O B-NP_NN
kinase B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
independent B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
and B-O B-CC
requires B-O B-VP_VBZ
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_NP_DT
conserved B-O B-NP_VBN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
promoters B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_NP_JJ
cytokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
expressed B-O B-VP_VBN
by B-O B-NP_PP_IN
human B-O B-NP_JJ
Th2-type B-O B-JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
recently B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBN
a B-O B-NP_NP_DT
novel B-O B-JJ
conserved B-O B-NP_VBN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
promoters B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_DT
core B-O B-NP_NP_NN
sequence B-O B-NN
" " B-O O-NP
CTTGG B-O B-NP_NN
... B-O B-COLON
CCAAG B-O B-NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
present B-O B-ADJP_JJ
as B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
in B-O B-PP_IN
each B-O B-NP_DT
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
may B-O B-VP_MD
interact B-O B-VP_VB
with B-O B-PP_IN
a B-O B-NP_NP_DT
new B-O B-JJ
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
transfection B-O B-NP_NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
human B-O B-NP_JJ
GM-CSF B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
a B-O B-NP_NP_DT
strong B-O B-ADJP_JJ
positive B-O B-JJ
" " B-O O-ADJP
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
reporter B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_NP_JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
Jurkat B-O B-NP_NN
J6 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
DNA B-O B-NP_NN
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
this B-O B-NP_DT
sequence B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
give B-O B-VP_VB
either B-O B-NP_CC
six B-O B-NP_NP_CD
different B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
bands B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
competed B-O B-VP_VBN
" " B-O B-PRT_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
or B-O B-CC
one B-O B-NP_NP_CD
specific B-O B-JJ
band B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
competed B-O B-VP_VBN
" " B-O B-PRT_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
depending B-O B-PP_VBG
on B-O B-PP_IN
the B-O B-NP_DT
reconstitution B-O B-NN
conditions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
different B-O B-NP_JJ
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
core B-O B-NP_NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
separated B-O B-VP_VBN
by B-O B-NP_PP_IN
integer B-O B-NP_NP_NN
numbers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
helical B-O B-NP_JJ
turns B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Considering B-O B-S_S_NP_VP_VBG
the B-O B-NP_NP_NP_DT
strong B-O B-ADJP_JJ
positive B-O B-JJ
" " B-O O-ADJP
regulatory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
element B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
its B-O B-NP_NP_PRPP
presence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
several B-O B-NP_JJ
T-cell-expressed B-O B-NP_JJ
cytokine B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
it B-O B-S_NP_PRP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
crucial B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
coordinated B-O B-VBN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
" " B-O B-NP_O-PP
in B-O B-PP_IN
T B-O B-NP_NN
helper B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_DT
interleukin-5/receptor B-O B-NN
interaction B-O B-NN
" " B-O O-NP
activates B-O B-VP_VP_VBZ
Lyn B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
Jak2 B-O B-NP_NN
" " B-O B-NP_O-NP
tyrosine B-O B-NP_NN
kinases B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
propagates B-O B-VP_VBZ
signals B-O B-NP_NNS
" " B-O O-NP
via B-O B-PP_IN
the B-O B-NP_NP_NP_DT
Ras-Raf-1-MAP B-O B-NP_NN
kinase B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
Jak-STAT B-O B-JJ
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
eosinophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interleukin B-O B-NP_NN
( B-O B-LRB
IL B-O B-NN
) B-O B-RRB
-5 B-O B-CD
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
activates B-O B-VP_VBZ
Lyn B-O B-NP_NN
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
within B-O B-PP_IN
1 B-O B-NP_CD
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
Jak2 B-O B-NP_NN
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
within B-O B-PP_IN
min B-O B-NP_QP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
IL-5 B-O B-S_NP_NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
stimulates B-O B-VP_VBZ
GTP B-O B-NP_NP_NN
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
p21ras B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
signal B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
subsequently B-O B-ADVP_RB
" " B-O O-ADVP
propagated B-O B-VP_VBN
through B-O B-NP_PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Raf-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
MEK B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
MAP B-O B-NP_NN
kinases B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
as B-O B-SBAR_IN
shown B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
their B-O B-NP_PRPP
increased B-O B-VBN
autophosphorylation B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
and B-O B-CC
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-ADVP_FW
situ B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Jak2 B-O B-S_NP_NN
kinase B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
phosphorylate B-O B-VP_VB
STAT B-O B-NP_NN
nuclear B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
STAT B-O B-NP_NN
nuclear B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
by B-O B-NP_PP_IN
electrophoretic B-O B-NP_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
using B-O B-VP_VBG
a B-O B-NP_DT
gamma B-O B-NP_NP_NN
activation B-O B-NN
site B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
probe B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
IL-5 B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
two B-O B-NP_NP_NP_CD
GAS-binding B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
eosinophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
one B-O B-SBAR_WHNP_NP_CD
" " B-O O-NP
of B-O B-WHPP_IN
" " B-O B-WHNP_O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
IL-5 B-O B-S_NP_NP_NN
" " B-O O-NP
induced B-O B-JJ
signals B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
propagated B-O B-VP_VBN
through B-O B-NP_PP_IN
two B-O B-NP_CD
distinct B-O B-JJ
pathways B-O B-NNS
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
( B-O B-NP_NP_LST_LRB
1 B-O B-LS
) B-O B-RRB
" " B-O O-LST
Lyn B-O B-NP_NN
" " B-O O-NP
--> B-O B-ADJP_TO
Ras B-O B-NP_NP_NN
" " B-O O-NP
--> B-O B-ADJP_TO
Raf-1 B-O B-NP_NP_NN
" " B-O O-NP
--> B-O B-ADJP_TO
" " B-O B-NP_NP_ADJP_O-ADJP
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
and B-O B-CC
( B-O B-NP_LST_LRB
2 B-O B-LS
) B-O B-RRB
" " B-O O-LST
Jak2 B-O B-NP_NN
" " B-O O-NP
--> B-O B-ADJP_TO
STAT1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
Hematopoietic B-O B-NP_NP_NP_NP_JJ
lineage B-O B-NN
" " B-O O-NP
commitment B-O B-NN
: B-O B-COLON
" " B-O O-NP
role B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
This B-O B-S_S_NP_DT
review B-O B-NN
" " B-O O-NP
focuses B-O B-VP_VBZ
on B-O B-PP_IN
the B-O B-NP_NP_DT
roles B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
hematopoietic B-O B-NP_JJ
lineage B-O B-NN
commitment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_NP_NP_DT
brief B-O B-JJ
introduction B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
lineage B-O B-NP_NP_NN
commitment B-O B-NN
" " B-O O-NP
and B-O B-CC
asymmetric B-O B-NP_JJ
cell B-O B-NN
division B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
followed B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
discussion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_NP_JJ
methods B-O B-NNS
" " B-O O-NP
used B-O B-VP_VBN
" " B-O B-NP_S_NP_VP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Next B-O B-SINV_ADVP_RB
" " B-O O-ADVP
is B-O B-VP_VBZ
presented B-O B-VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
a B-O B-NP_NP_DT
discussion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
embryonic B-O B-NP_JJ
stem B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
targeted B-O B-NP_VBN
gene B-O B-NN
disruption B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
analyze B-O B-VP_VB
" " B-O B-NP_NP_PP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-SINV
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
status B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
our B-O B-NP_NP_PRPP
current B-O B-JJ
knowledge B-O B-NN
" " B-O O-NP
concerning B-O B-PP_VBG
the B-O B-NP_NP_DT
roles B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
commitment B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
summarized B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
E1A B-O B-S_S_NP_NP_NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
induces B-O B-VP_VBZ
susceptibility B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
killing B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
NK B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
following B-O B-PP_VBG
immortalization B-O B-NP_NP_NP_NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
adenovirus B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Adenovirus B-O B-S_S_NP_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
Ad B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
infection B-O B-NN
" " B-O O-NP
and B-O B-CC
E1A B-O B-NP_NP_NN
" " B-O O-NP
transfection B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
model B-O B-VP_VB
changes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Only B-O B-S_NP_RB
stably B-O B-RB
transfected B-O B-NP_VBN
target B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
exhibited B-O B-VP_VBD
cytolytic B-O B-NP_JJ
susceptibility B-O B-NN
" " B-O O-NP
, B-O B-COMMA
despite B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
equivalent B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
E1A B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Ad-infected B-O B-NP_JJ
targets B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
inability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E1A B-O B-NP_NP_NN
gene B-O B-NN
" " B-O O-NP
products B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
cytolytic B-O B-NP_JJ
susceptibility B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
infection B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
explained B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
an B-O B-NP_NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
viral B-O B-NP_JJ
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
otherwise B-O B-NP_ADJP_RB
susceptible B-O B-JJ
" " B-O O-ADJP
target B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
by B-O B-PP_IN
viral B-O B-NP_NP_NP_JJ
gene B-O B-NN
" " B-O O-NP
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
expression B-O B-NP_NP_NP_NN
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
differential B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E1A B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
cytolytic B-O B-JJ
phenotypes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
infected B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
stably B-O B-NP_ADJP_RB
transfected B-O B-VBN
" " B-O O-ADJP
" " B-O B-NP_O-NP
human B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
human B-O B-S_NP_JJ
NK B-O B-NN
cells B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VBP
an B-O B-NP_NP_DT
effective B-O B-ADJP_JJ
immunologic B-O B-JJ
" " B-O O-ADJP
barrier B-O B-NN
" " B-O O-NP
against B-O B-PP_IN
the B-O B-NP_NP_DT
and B-O B-ADJP_NP_CC
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
may B-O B-S_NP_VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Thapsigargin B-O B-S_S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
IL-2 B-O B-NP_NP_NN
receptor B-O B-NN
alpha-chain B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
peripheral B-O B-JJ
" " B-O O-NP
and B-O B-CC
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
via B-O B-PP_IN
a B-O B-NP_DT
protein B-O B-NN
kinase B-O B-NN
C-independent B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Thapsigargin B-O B-S_S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
TG B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Ca(2+)-ATPase B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
depletes B-O B-VP_VP_VBZ
intracellular B-O B-NP_JJ
Ca2+ B-O B-NN
stores B-O B-NNS
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
induces B-O B-VP_VBZ
a B-O B-NP_DT
sustained B-O B-JJ
Ca2+ B-O B-NN
influx B-O B-NN
" " B-O O-NP
" " B-O O-VP
without B-O B-PP_IN
altering B-O B-S_NP_VP_VBG
phosphatidyl B-O B-NP_JJ
inositol B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
TG B-O B-S_NP_NP_NP_NN
" " B-O O-NP
plus B-O B-CC
phorbol B-O B-NP_NP_NN
myristate B-O B-NN
acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
TG B-O B-NP_NP_NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-NP
induced B-O B-VP_VBD
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
TG B-O B-S_NP_NN
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
TG B-O B-NP_NN
" " B-O O-NP
induced B-O B-VP_VBD
increases B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
IL-2R B-O B-NP_NP_NP_NN
alpha B-O B-NN
protein B-O B-NN
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
IL-2R B-O B-NP_NN
alpha B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
dose-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
similar B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
IL-2R B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
TG B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
like B-O B-PP_IN
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
TG B-O B-NP_NN
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBD
NF B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
TG B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
exhibited B-O B-VP_VBD
a B-O B-NP_DT
synergistic B-O B-JJ
action B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
IL-2R B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
TG B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
induce B-O B-VP_VBP
IL-2R B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
distinct B-O B-NP_JJ
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PMA- B-O B-S_NP_NP_NN
" " B-O B-ADJP_NP_O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
TG-induced B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
IL-2R B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
PKC B-O B-NP_NN
" " B-O O-NP
inhibitor B-O B-NN
H7 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
whereas B-O B-SBAR_IN
TG- B-O B-S_NP_NP_NN
" " B-O B-ADJP_NP_O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
PMA-induced B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
IL-2R B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
cholera B-O B-NP_NP_NN
toxin B-O B-NN
" " B-O O-NP
, B-O B-COMMA
forskolin B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
1,9-dideoxy B-O B-NP_JJ
forskolin B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
toto B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
TG B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
IL-2R B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
through B-O B-PP_IN
a B-O B-NP_DT
PKC-independent B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_S_NP_DT
functional B-O B-JJ
T-cell B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
signaling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
p95vav B-O B-NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Stimulation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
T-cell B-O B-NP_NN
antigen B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
TCR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
multiple B-O B-NP_JJ
tyrosine B-O B-NP_NN
kinases B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
resulting B-O B-S_NP_VP_VBG
in B-O B-PP_IN
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
numerous B-O B-NP_JJ
intracellular B-O B-JJ
substrates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
One B-O B-S_NP_CD
substrate B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
p95vav B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
expressed B-O B-VP_VBN
exclusively B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
structural B-O B-NP_NP_JJ
motifs B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
Src B-O B-NP_NP_NN
homology B-O B-NN
2 B-O B-CD
, B-O B-COMMA
Src B-O B-NN
homology B-O B-NN
3 B-O B-CD
, B-O B-COMMA
and B-O B-CC
pleckstrin B-O B-NN
homology B-O B-NN
domains B-O B-NNS
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
putative B-O B-NP_JJ
guanine B-O B-NN
nucleotide B-O B-NN
exchange B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p95vav B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
TCR-mediated B-O B-NP_JJ
signaling B-O B-NN
processes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
unclear B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
overexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
p95vav B-O B-NP_NP_NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
p95vav B-O B-NP_NN
" " B-O O-NP
synergizes B-O B-VP_VBZ
with B-O B-PP_IN
TCR B-O B-NP_NP_NN
" " B-O O-NP
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
inducing B-O B-S_NP_VP_VBG
NFAT- B-O B-NP_NP_NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
interleukin-2-dependent B-O B-NP_JJ
" " B-O B-NP_O-NP
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NFAT B-O B-NP_NP_NP_NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
a B-O B-NP_DT
G-protein-coupled B-O B-NP_JJ
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
modulated B-O B-VP_VBN
by B-O B-NP_PP_IN
p95vav B-O B-NP_NP_NN
" " B-O O-NP
overexpression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
specific B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
removal B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
first B-O B-NP_JJ
67 B-O B-CD
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
p95vav B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
activates B-O B-VP_VBZ
its B-O B-NP_NP_PRPP
transforming B-O B-NN
potential B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
NIH B-O B-NP_NN
3T3 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
this B-O B-S_NP_DT
region B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
p95vav-induced B-O B-JJ
NFAT B-O B-NP_NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
mimicked B-O B-VP_VBN
by B-O B-NP_PP_IN
Ras B-O B-NP_NP_NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
though B-O B-SBAR_IN
its B-O B-S_NP_PRPP
function B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
dependent B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
activating B-O B-NN
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p95vav B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
its B-O B-S_NP_PRPP
activity B-O B-NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
depends B-O B-VP_VBZ
on B-O B-PP_IN
calcineurin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
further B-O B-ADVP_RB
" " B-O O-ADVP
dissect B-O B-VP_VB
p95vav B-O B-NP_NP_NP_NN
" " B-O O-NP
involvement B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
TCR B-O B-NP_NP_NN
" " B-O O-NP
signaling B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
analyzed B-O B-VP_VP_VBD
various B-O B-NP_NP_JJ
Jurkat B-O B-NP_NN
mutants B-O B-NNS
" " B-O O-NP
" " B-O O-NP
deficient B-O B-ADJP_JJ
in B-O B-PP_IN
signaling B-O B-NP_NP_NP_NN
function B-O B-NN
" " B-O O-NP
or B-O B-CC
expression B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
showed B-O B-VP_VBD
that B-O B-SBAR_IN
an B-O B-S_NP_DT
intact B-O B-JJ
TCR B-O B-NP_NN
" " B-O O-NP
signaling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_SBAR_WHNP_IN
" " B-O B-S_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
overexpression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
p95vav B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
appear B-O B-VP_VB
to B-O B-S_NP_VP_TO
influence B-O B-VP_VB
TCR-induced B-O B-NP_NP_JJ
protein B-O B-NN
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
or B-O B-CC
increases B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
our B-O B-S_NP_PRPP
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
p95vav B-O B-S_NP_NN
" " B-O O-NP
plays B-O B-VP_VBZ
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
an B-O B-NP_NP_DT
proximal B-O B-ADJP_JJ
position B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
phosphatase B-O B-NP_NP_NN
" " B-O O-NP
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
the B-O B-NP_NP_DT
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
phosphatase B-O B-NP_NN
2A-sensitive B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Activation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
various B-O B-NP_JJ
cellular B-O B-JJ
stimuli B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
the B-O B-NP_NP_DT
phosphorylation B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
subsequent B-O B-NP_JJ
degradation B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_NP_PRPP
inhibitor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
although B-O B-SBAR_IN
the B-O B-S_NP_DT
underlying B-O B-VBG
mechanism B-O B-NN
" " B-O O-NP
remains B-O B-VP_VBZ
unclear B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
serine/threonine B-O B-NP_NN
phosphatases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
studies B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
incubation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
low B-O B-NP_NP_NP_JJ
concentrations B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
induces B-O B-VP_VBZ
the B-O B-NP_NP_DT
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
even B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
any B-O B-NP_DT
cellular B-O B-JJ
stimulus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_NP_DT
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
phosphatase B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
affected B-O B-VP_VBN
by B-O B-NP_PP_IN
agents B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
block B-O B-S_NP_VP_VBP
" " B-O B-NP_NP_PP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_NP_DT
phosphorylated B-O B-NP_VBN
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
calyculin B-O B-NP_NN
A-treated B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
that B-O B-NP_NP_DT
" " B-O O-NP
from B-O B-PP_IN
TNF-alpha-stimulated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
sensitive B-O B-ADJP_JJ
to B-O B-PP_TO
PP-2A B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-ADJP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
fundamental B-O B-NP_NP_JJ
differences B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
both B-O B-NP_CC
TNF-alpha B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
phosphatase B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
subsequent B-O B-JJ
degradation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
TNF-alpha- B-O B-S_NP_NP_NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
calyculin B-O B-NP_NN
A-induced B-O B-JJ
" " B-O B-NP_O-NP
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
degradation B-O B-NN
" " B-O O-NP
" " B-O O-NP
exhibits B-O B-VP_VBZ
similar B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
identical B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
sensitivities B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_DT
proteasome B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
phosphorylation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
both B-O B-NP_NP_CC
the B-O B-DT
TNF-alpha-inducible B-O B-JJ
" " B-O B-NP_O-NP
and B-O B-CC
the B-O B-NP_DT
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
may B-O B-VP_MD
serve B-O B-VP_VB
to B-O B-S_NP_VP_TO
target B-O B-VP_NN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Functional B-O B-NP_NP_NP_JJ
roles B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
transcription B-O B-NP_NN
factor B-O B-NN
Oct-2A B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
high B-O B-NP_NP_JJ
mobility B-O B-NN
group B-O B-NN
protein B-O B-NN
" " B-O O-NP
I/Y B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
HLA-DRA B-O B-NP_NP_NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
class B-O B-NP_NN
II B-O B-CD
major B-O B-JJ
histocompatibility B-O B-NN
complex B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
HLA-DRA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
B B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
activated B-O B-NP_VBN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
in B-O B-PP_IN
antigen-presenting B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
HLA-DRA B-O B-NP_NP_NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
inducible B-O B-ADJP_JJ
in B-O B-PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
interferon-gamma B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IFN-gamma B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_DT
lymphoid-specific B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
Oct-2A B-O B-NN
" " B-O O-NP
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
critical B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
expression B-O B-NP_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_DT
high B-O B-NP_NP_JJ
mobility B-O B-NN
group B-O B-NN
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HMG B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
I/Y B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
multiple B-O B-NP_NP_JJ
sites B-O B-NNS
" " B-O O-NP
within B-O B-PP_IN
, B-O B-NP_COMMA
including B-O B-PP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Coexpression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HMG B-O B-NP_NP_NN
I/Y B-O B-NN
" " B-O O-NP
and B-O B-CC
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
lacking B-O B-VP_VBG
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HLA-DRA B-O B-NP_NP_NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
in B-O B-S_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
DNA-binding B-O B-JJ
studies B-O B-NNS
" " B-O O-NP
reveal B-O B-VP_VBP
that B-O B-SBAR_IN
HMG B-O B-S_NP_NN
I/Y B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
stimulates B-O B-VP_VBZ
Oct-2A B-O B-NP_NP_NP_NN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
Oct-2A B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
HMG B-O B-NP_NN
I/Y B-O B-NN
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
synergize B-O B-VP_VB
" " B-O O-VP
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
HLA-DRA B-O B-NP_NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
Oct-2A B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
IFN-gamma B-O B-NP_NN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
in B-O B-PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
antisense B-O B-S_NP_JJ
HMG B-O B-NN
I/Y B-O B-NN
" " B-O O-NP
dramatically B-O B-ADVP_RB
" " B-O O-ADVP
decreases B-O B-VP_VBZ
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
induction B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
distinct B-O B-S_NP_NP_JJ
sets B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
HMG B-O B-S_NP_NN
I/Y B-O B-NN
" " B-O O-NP
may B-O B-VP_VP_MD
be B-O B-VP_VB
important B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
RB B-O B-NP_NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
novel B-O B-JJ
E2F-1 B-O B-NP_NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
deficient B-O B-JJ
B-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
normal B-O B-NP_NP_JJ
IFN-gamma B-O B-NP_NN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
class B-O B-NP_NN
IL B-O B-NN
transactivator B-O B-NN
" " B-O O-NP
CIITA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
class B-O B-NP_NN
II B-O B-CD
non-inducible B-O B-JJ
RB-defective B-O B-JJ
tumor B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
major B-O B-NP_JJ
histocompatibility B-O B-NN
( B-O B-LRB
MHC B-O B-NN
) B-O B-RRB
class B-O B-NN
II B-O B-CD
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
encode B-O B-VP_VBP
cell B-O B-NP_NP_NN
surface B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bind B-O B-S_NP_VP_VBP
antigenic B-O B-NP_JJ
peptide B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
class B-O B-NP_NN
II B-O B-CD
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VP_VBP
expressed B-O B-VP_VBN
constitutively B-O B-NP_ADVP_RB
" " B-O O-ADVP
on B-O B-PP_IN
B-cells B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
EBV-transformed B-O B-NP_JJ
B-cells B-O B-NNS
, B-O B-COMMA
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
are B-O B-VP_VBP
inducible B-O B-ADJP_JJ
by B-O B-PP_IN
IFN-gamma B-O B-NP_NP_NN
" " B-O O-NP
on B-O B-PP_IN
a B-O B-NP_NP_DT
wide B-O B-JJ
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Retinoblastoma B-O B-S_NP_NP_NN
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RB B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VP_VBZ
a B-O B-NP_DT
tumor B-O B-NN
suppressor B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
functions B-O B-VP_VBZ
as B-O B-PP_IN
a B-O B-NP_DT
transcriptional B-O B-NP_JJ
repressor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
binding B-O B-S_NP_VP_VP_VBG
" " B-O B-NP_O-VP
and B-O B-CC
inactivating B-O B-VP_VBG
" " B-O B-NP_O-VP
the B-O B-NP_DT
transactivator B-O B-NP_NN
E2F-I B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
RB-defective B-O B-S_S_NP_JJ
tumor B-O B-NN
lines B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
non-inducible B-O B-ADJP_ADJP_JJ
for B-O B-PP_IN
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
IFN-gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
or B-O B-CC
very B-O B-ADJP_RB
weakly B-O B-RB
inducible B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
transfection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
2 B-O B-NP_CD
different B-O B-JJ
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
RB B-O B-NP_NN
expression B-O B-NN
vectors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
re-establishes B-O B-VP_VP_VBZ
" " B-O B-NP_O-VP
or B-O B-CC
substantially B-O B-ADVP_RB
" " B-O O-ADVP
enhances B-O B-VP_VBZ
" " B-O B-NP_O-VP
class B-O B-NP_NN
II B-O B-CD
inducibility B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
RB B-O B-NP_NN
" " B-O O-NP
status B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B-cell B-O B-NP_NP_NN
mutants B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_ADJP_JJ
matrix-bound B-O B-JJ
" " B-O O-ADJP
RB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
detectable B-O B-ADJP_JJ
in B-O B-PP_IN
all B-O B-NP_DT
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
loss B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
RB B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
second B-O B-JJ
E2F-I B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
most B-O B-NP_ADVP_RBS
likely B-O B-RB
" " B-O O-ADVP
DP-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
apparently B-O B-ADJP_RB
normal B-O B-JJ
in B-O B-PP_IN
both B-O B-NP_CC
class B-O B-NN
II-positive B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
-negative B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
B-cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
IFN-gamma B-O B-NP_NN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CIITA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
RB-defective B-O B-JJ
lines B-O B-NNS
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CIITA B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
class B-O B-NP_NN
II B-O B-CD
gene B-O B-NN
transactivator B-O B-NN
" " B-O O-NP
" " B-O O-NP
known B-O B-VP_VBN
to B-O B-S_NP_VP_VP_TO
be B-O B-VP_VB
defective B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-VP
and B-O B-CC
to B-O B-VP_TO
be B-O B-VP_VB
required B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CIITA B-O B-S_S_NP_NN
mRNA B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
normally B-O B-ADJP_RB
inducible B-O B-JJ
by B-O B-PP_IN
IFN-gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
class B-O B-NP_NN
II B-O B-CD
non-inducible B-O B-JJ
, B-O B-COMMA
RB-defective B-O B-JJ
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
in B-O B-S_PP_IN
one B-O B-NP_CD
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
re-expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
RB B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
CIITA B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
induction B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
block B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
MHC B-O B-NP_NP_NN
class B-O B-NN
II B-O B-CD
inducibility B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
RB-defective B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
due B-O B-ADJP_JJ
to B-O B-PP_TO
a B-O B-NP_NP_DT
block B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
CIITA B-O B-NP_NP_NN
" " B-O O-NP
inducibility B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interleukin B-O B-S_S_NP_NN
4 B-O B-CD
" " B-O O-NP
activates B-O B-VP_VBZ
a B-O B-NP_NP_DT
signal B-O B-NN
transducer B-O B-NN
and B-O B-CC
activator B-O B-NN
of B-O B-IN
transcription B-O B-NP_NN
( B-O B-LRB
Stat B-O B-NN
) B-O B-RRB
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
interacts B-O B-S_NP_VP_VBZ
with B-O B-PP_IN
" " B-O B-NP_NP_ADVP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Janus B-O B-NP_NP_NN
kinase B-O B-NN
3 B-O B-CD
" " B-O O-NP
and B-O B-CC
interleukin-4 B-O B-NP_NN
Stat B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Germ B-O B-S_S_NP_NN
line B-O B-NN
C B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
IL-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_NP_JJ
B B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
BL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Utilizing B-O B-S_S_NP_VP_VBG
a B-O B-NP_NP_DT
IFN-gamma B-O B-NP_NN
activation B-O B-NN
site-like B-O B-JJ
DNA B-O B-NN
sequence B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
located B-O B-ADJP_JJ
upstream B-O B-ADVP_RB
of B-O B-PP_IN
the B-O B-NP_DT
I B-O B-NP_NN
epsilon B-O B-NN
exon B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
demonstrated B-O B-VP_VBD
by B-O B-PP_IN
gel B-O B-NP_NN
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
IL-4 B-O B-S_NP_NN
" " B-O O-NP
induced B-O B-VP_VBD
a B-O B-NP_DT
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
cytosol B-O B-NN
" " B-O O-NP
and B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
factor B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VBD
designated B-O B-VP_VBN
IL-4 B-O B-S_NP_NP_NP_NN
NAF B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
IL-4-induced B-O B-NP_JJ
nuclear-activating B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
identified B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_NP_DT
tyrosine B-O B-NP_NN
phosphoprotein B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
translocates B-O B-S_NP_VP_VBZ
" " B-O B-PP_PP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
these B-O B-S_NP_DT
" " B-O O-NP
are B-O B-VP_VBP
the B-O B-NP_NP_DT
characteristics B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
signal B-O B-NP_NN
transducer B-O B-NN
and B-O B-CC
activator B-O B-NN
of B-O B-IN
transcription B-O B-NN
( B-O B-LRB
Stat B-O B-NN
) B-O B-RRB
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
determined B-O B-VP_VP_VBD
whether B-O B-SBAR_IN
antibodies B-O B-S_NP_NNS
to B-O B-TO
Stat B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
will B-O B-VP_MD
interfere B-O B-VP_VB
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
found B-O B-VP_VBD
that B-O B-SBAR_IN
antibodies B-O B-S_NP_NP_NP_NNS
to B-O B-TO
IL-4 B-O B-NN
Stat B-O B-NN
" " B-O O-NP
, B-O B-COMMA
also B-O B-ADVP_RB
" " B-O O-ADVP
known B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
antibodies B-O B-NP_NP_NNS
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
, B-O B-COMMA
" " B-O O-NP
interfere B-O B-VP_VBP
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Congruous B-O B-S_ADVP_JJ
with B-O B-PP_IN
the B-O B-NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
Stat B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
IL-4 B-O B-S_NP_NN
" " B-O O-NP
induced B-O B-VP_VBD
robust B-O B-NP_JJ
Janus B-O B-NP_NP_NN
kinase B-O B-NN
3 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
JAK3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
BL-2 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Cotransfection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
JAK3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
IL-4 B-O B-NP_NN
Stat B-O B-NN
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
COS-7 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
produced B-O B-VP_VBD
an B-O B-NP_NP_DT
intracellular B-O B-JJ
activity B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bound B-O B-S_NP_VP_VP_VBD
the B-O B-NP_DT
same B-O B-JJ
IFN-gamma B-O B-NP_NN
activation B-O B-NN
site-like B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
comigrated B-O B-VP_VBD
with B-O B-PP_IN
IL-4 B-O B-NP_NN
NAF B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
IL-4 B-O B-S_NP_NN
NAF B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
IL-4 B-O B-NP_NP_NN
Stat B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Latent B-O B-S_S_NP_JJ
membrane B-O B-NN
protein-1 B-O B-NN
" " B-O O-NP
induces B-O B-VP_VBZ
cyclin B-O B-NP_NP_NP_NP_NN
D2 B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
, B-O B-COMMA
pRb B-O B-NP_NP_NN
" " B-O O-NP
hyperphosphorylation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
loss B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TGF-beta B-O B-NP_NN
1-mediated B-O B-JJ
growth B-O B-NN
inhibition B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
EBV-positive B-O B-NP_JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_DT
normal B-O B-JJ
cell B-O B-NN
cycle B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
several B-O B-NP_NP_JJ
molecules B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
such B-O B-PP_JJ
as B-O B-IN
the B-O B-NP_NP_DT
, B-O B-NP_COMMA
the B-O B-NP_DT
, B-O B-NP_COMMA
the B-O B-NP_DT
, B-O B-NP_COMMA
and B-O B-CC
their B-O B-NP_PRPP
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
These B-O B-S_NP_DT
regulators B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
targeted B-O B-VP_VBN
by B-O B-NP_PP_IN
negative B-O B-NP_NP_JJ
growth B-O B-NN
regulatory B-O B-JJ
signals B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
such B-O B-PP_JJ
as B-O B-IN
that B-O B-NP_NP_DT
" " B-O O-NP
provided B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_CC
wild-type B-O B-NP_JJ
EBV B-O B-NN
" " B-O O-NP
or B-O B-CC
its B-O B-NP_PRPP
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TGF-beta B-O B-NP_NN
1-mediated B-O B-JJ
growth B-O B-NN
inhibition B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Chemical B-O B-S_S_NP_NP_JJ
cross-linking B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
125I-labeled B-O B-NP_JJ
TGF-beta B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
an B-O B-NP_DT
essentially B-O B-ADJP_RB
normal B-O B-JJ
" " B-O O-ADJP
TGF-beta B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
profile B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
EBV-positive B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
EBV-negative B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
Burkitt B-O B-NP_NN
's B-O B-POS
lymphoma B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
these B-O B-S_NP_DT
receptors B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
functional B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-S_O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
as B-O B-SBAR_IN
evidenced B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
TGF-beta B-O B-NN
1-mediated B-O B-JJ
modulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
TGF-beta B-O B-NP_NN
1 B-O B-CD
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
induce B-O B-VP_VB
dephosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
pRb B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
EBV B-O B-NP_NN
( B-O B-LRB
or B-O B-CC
LMP-1 B-O B-NN
) B-O B-RRB
-positive B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
as B-O B-SBAR_SBAR_IN
opposed B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
EBV B-O B-NP_JJ
-negative B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
suggesting B-O B-SBAR_NP_VP_VBG
a B-O B-NP_NP_NP_DT
dichotomy B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
signaling B-O B-NP_NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leading B-O B-VP_VBG
to B-O B-PP_TO
separable B-O B-NP_JJ
gene B-O B-NN
and B-O B-NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
LMP-1 B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
normal B-O B-S_NP_NP_JJ
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
or B-O B-CC
EBV-negative B-O B-NP_JJ
Burkitt B-O B-NN
's B-O B-POS
lymphoma B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
express B-O B-VP_VB
D-type B-O B-NP_JJ
cyclins B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
these B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
point B-O B-VP_VBP
to B-O B-PP_TO
a B-O B-NP_NP_DT
potential B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
underlying B-O B-VP_VBG
EBV-mediated B-O B-NP_NP_JJ
B B-O B-NN
cell B-O B-NN
transformation B-O B-NN
" " B-O O-NP
whereby B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Multiple B-O B-S_S_NP_JJ
signals B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
function B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
granulocyte-macrophage B-O B-JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_DT
human B-O B-NP_JJ
granulocyte-macrophage B-O B-JJ
CSF B-O B-NN
( B-O B-LRB
GM-CSF B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
activation B-O B-NP_NP_NP_NN
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
gene B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
proximal B-O B-NP_NP_JJ
functional B-O B-JJ
promoter B-O B-NN
region B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
-620 B-O B-NP_CD
to B-O B-TO
+34 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
a B-O B-NP_NP_DT
powerful B-O B-JJ
enhancer B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
located B-O B-ADJP_JJ
3 B-O B-ADVP_NP_CD
kb B-O B-NN
" " B-O O-NP
upstream B-O B-RB
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
both B-O B-SBAR_WHNP_NP_DT
" " B-O O-NP
of B-O B-WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
proximal B-O B-NP_JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
region B-O B-NN
" " B-O O-NP
termed B-O B-VP_VBN
CLEO B-O B-S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
-54 B-O B-NP_CD
to B-O B-TO
-31 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
consists B-O B-S_NP_VP_VBZ
of B-O B-PP_IN
, B-O B-NP_NP_NP_VP_COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
in B-O B-PP_IN
this B-O B-NP_DT
work B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
mutations B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
either B-O B-NP_CC
the B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
or B-O B-CC
the B-O B-NP_DT
NF-kappa B-O B-NP_NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
result B-O B-VP_VBP
in B-O B-PP_IN
reduced B-O B-NP_NP_VBN
PMA/Ca2+ B-O B-NN
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
" " B-O B-NP_O-PP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
major B-O B-JJ
inducible B-O B-NP_JJ
protein B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
the B-O B-NP_DT
human B-O B-NP_JJ
CLEO B-O B-NN
( B-O B-LRB
hCLEO B-O B-NN
) B-O B-RRB
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
AP-1-like B-O B-NP_JJ
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VP_VBZ
inducible B-O B-ADJP_JJ
by B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
shows B-O B-VP_VBZ
increased B-O B-NP_VBN
binding B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
together B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
Ca2+ B-O B-NP_NN
ionophore B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
the B-O B-S_NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
cyclosporin-sensitive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
promoter B-O B-S_NP_NN
induction B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
cyclosporin B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
second B-O B-ADJP_JJ
weak B-O B-JJ
inducible B-O B-JJ
" " B-O O-ADJP
complex B-O B-NN
" " B-O O-NP
resembling B-O B-VP_VBG
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
of B-O B-IN
activated B-O B-VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
NF-AT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBN
binding B-O B-NP_S_NP_VP_VBG
to B-O B-PP_TO
the B-O B-NP_DT
hCLEO B-O B-NP_NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
using B-O B-S_NP_VP_VBG
recombinant B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
we B-O B-S_S_NP_PRP
" " B-O O-NP
confirmed B-O B-VP_VBD
that B-O B-SBAR_IN
AP-1 B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
NF-ATp B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
a B-O B-NP_NP_DT
higher B-O B-JJR
order B-O B-NN
" " B-O O-NP
NF-ATp B-O B-NP_NN
/AP-1 B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
could B-O B-VP_MD
all B-O B-ADVP_DT
" " B-O O-ADVP
form B-O B-VP_VB
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
also B-O B-ADVP_RB
" " B-O O-ADVP
defined B-O B-VP_VBN
the B-O B-NP_NP_DT
sequence B-O B-NN
requirements B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_SBAR_IN
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
form B-O B-ADJP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
substitute B-O B-VP_VP_VB
for B-O B-PP_IN
" " B-O B-NP_O-VP
and B-O B-CC
synergize B-O B-VP_VB
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
conversely B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
mutant-activated B-O B-S_NP_JJ
Ras B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
substitute B-O B-VP_VP_VB
for B-O B-PP_IN
" " B-O B-NP_O-VP
and B-O B-CC
cooperate B-O B-VP_VB
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Co-expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Ras B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
calcineurin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
did B-O B-VP_VP_VBD
not B-O B-RB
activate B-O B-VP_VB
the B-O B-NP_DT
GM-CSF B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
required B-O B-VP_VBD
the B-O B-NP_NP_DT
additional B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
p65 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
imply B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
at B-O B-S_NP_QP_IN
least B-O B-JJS
three B-O B-CD
" " B-O O-QP
signals B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_DT
signals B-O B-NNS
" " B-O O-NP
impinge B-O B-VP_VBP
on B-O B-PP_IN
distinct B-O B-NP_NP_JJ
" " B-O B-NP_SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
C/EBP B-O B-S_S_NP_NN
proteins B-O B-NNS
" " B-O O-NP
activate B-O B-VP_VBP
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
macrophages/monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Three B-O B-S_S_S_NP_NP_CD
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
C/EBP B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
( B-O B-LRB
HIV-1 B-O B-NN
) B-O B-RRB
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
V.M. B-O B-NP_NP_NP_NNP
Tesmer B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
A.Rajadhyaksha B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
J.Babin B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
M.Bina B-O B-NP_NNP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
Proc.Natl.Acad.Sci. B-O B-NP_NNP
USA B-O B-NNP
90 B-O B-CD
" " B-O O-NP
: B-O B-COLON
7298-7302 B-O B-NP_CD
" " B-O O-NP
, B-O B-COMMA
1993 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
determined B-O B-VP_VBN
the B-O B-NP_NP_DT
functional B-O B-JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
C/EBP B-O B-NP_NP_NN
proteins B-O B-NNS
" " B-O O-NP
and B-O B-CC
C/EBP B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
regulating B-O B-S_NP_VP_VBG
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
endogenous B-O B-NP_JJ
C/EBP B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
using B-O B-VP_VBG
either B-O B-NP_CC
an B-O B-NP_NP_DT
excess B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
C/EBP B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
or B-O B-CC
a B-O B-NP_DT
"trans- dominant" B-O B-NP_JJ
negative B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
C/EBP B-O B-S_NP_NN
proteins B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
and B-O B-NP_NP_NP_CC
of B-O B-NP_NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
RNA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
blots B-O B-NP_NNS
" " B-O B-NP_O-NP
and B-O B-CC
binding B-O B-NP_NN
" " B-O B-NP_O-NP
assays B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
NF-IL6 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
only B-O B-RB
known B-O B-JJ
C/EBP B-O B-NP_NN
family B-O B-NN
member B-O B-NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-VP_SBAR_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutational B-O B-S_NP_NP_JJ
analyses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NP_NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_SBAR_IN
one B-O B-S_NP_CD
C/EBP B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_DT
two B-O B-CD
3' B-O B-JJ
C/EBP B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
functionally B-O B-ADJP_RB
equivalent B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
crippled B-O B-NP_NP_VBN
HIV-1 B-O B-NN
LTRs B-O B-NNS
" " B-O O-NP
lacking B-O B-VP_VBG
C/EBP B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
still B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
induced B-O B-VP_VBN
following B-O B-NP_PP_VBG
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Several B-O B-S_NP_JJ
models B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
suggested B-O B-VP_VBN
for B-O B-NP_PP_IN
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
elevated B-O B-S_NP_JJ
NF-IL6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
participate B-O B-VP_VB
in B-O B-PP_IN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
An B-O B-NP_NP_NP_DT
IRF-1-dependent B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
damage-induced B-O B-JJ
apoptosis B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
mitogen-activated B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Lymphocytes B-O B-S_S_NP_NNS
" " B-O O-NP
are B-O B-VP_VBP
particularly B-O B-ADJP_RB
susceptible B-O B-JJ
to B-O B-PP_TO
DNA B-O B-NP_NP_NN
damage-induced B-O B-JJ
apoptosis B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_DT
tumour B-O B-NP_NN
suppressor B-O B-NN
p53 B-O B-NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
regulate B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
an B-O B-S_NP_DT
as B-O B-ADJP_RB
yet B-O B-RB
unknown B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
p53-independent B-O B-JJ
pathway B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
mediate B-O B-VP_VB
the B-O B-NP_DT
same B-O B-JJ
event B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
mitogen-activated B-O B-NP_JJ
mature B-O B-JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
DNA B-O B-COMP_NP_NP_NN
damage-induced B-O B-JJ
apoptosis B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
the B-O B-NP_DT
antioncogenic B-O B-NP_NP_JJ
transcription B-O B-NN
factor B-O B-NN
interferon B-O B-NN
regulatory B-O B-JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-NP_LRB
IRF B-O B-NN
) B-O B-RRB
-1 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
two B-O B-NP_NP_CD
different B-O B-JJ
anti-onco-genic B-O B-NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
p53 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IRF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
distinct B-O B-NP_NP_JJ
apoptotic B-O B-JJ
pathways B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
show B-O B-VP_VBP
that B-O B-SBAR_IN
mitogen B-O B-S_NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
interleukin-1 B-O B-NP_NN
beta B-O B-NN
converting B-O B-NN
enzyme B-O B-NN
( B-O B-LRB
ICE B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
IRF-1-dependent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Ectopic B-O B-S_NP_NP_JJ
overexpression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IRF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
endogenous B-O B-NP_JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
ICE B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
enhances B-O B-VP_VBZ
the B-O B-NP_NP_DT
sensitivity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
radiation-induced B-O B-NP_JJ
apoptosis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Sp1 B-O B-S_S_NP_NN
" " B-O O-NP
functions B-O B-VP_VBZ
in B-O B-PP_IN
a B-O B-NP_DT
chromatin-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
augment B-O B-VP_VB
human B-O B-NP_NP_JJ
alpha-globin B-O B-NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
5' B-O B-NP_JJ
flanking B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
alpha-globin B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
highly B-O B-ADJP_RB
"G + C" B-O B-NN
rich B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
contains B-O B-VP_VBZ
multiple B-O B-NP_NP_JJ
copies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
consensus B-O B-NP_NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
"G + C-rich" B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
augmenting B-O B-S_NP_VP_VBG
alpha-globin B-O B-NP_NP_NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
in B-O B-S_PP_IN
transiently B-O B-NP_RB
transfected B-O B-VBN
erythroid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
deletion B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
alpha-globin B-O B-NP_NN
"G + C-rich" B-O B-JJ
5' B-O B-JJ
flanking B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
alpha-globin B-O B-NP_NP_NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
upon B-O B-PP_IN
stable B-O B-NP_NP_JJ
integration B-O B-NN
" " B-O O-NP
into B-O B-PP_IN
chromatin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
deletion B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
causes B-O B-VP_VBZ
a B-O B-NP_NP_DT
nearly B-O B-ADJP_QP_RB
90 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-ADJP
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
promoter B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
compared B-O B-PP_VBN
with B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
an B-O B-NP_NP_DT
alpha-globin B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
retaining B-O B-VP_VBG
this B-O B-NP_DT
region B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
alpha-globin B-O B-NP_NN
"G + C-rich" B-O B-JJ
5' B-O B-JJ
flanking B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
augments B-O B-VP_VBZ
alpha-globin B-O B-NP_NP_NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
chromatin-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
show B-O B-VP_VBP
that B-O B-SBAR_IN
this B-O B-S_NP_DT
"G + C-rich" B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
during B-O B-PP_IN
erythroid B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
by B-O B-PP_IN
both B-O B-NP_CC
footprint B-O B-NP_NN
analysis B-O B-NN
" " B-O O-NP
and B-O B-CC
functional B-O B-NP_JJ
assays B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
"G + C-rich" B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
increase B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
its B-O B-NP_NP_PRPP
for B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interleukin B-O B-S_S_NP_NN
12 B-O B-CD
" " B-O O-NP
induces B-O B-VP_VBZ
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
and B-O B-CC
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
STAT4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Interleukin B-O B-S_S_NP_NP_NN
12 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
IL-12 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
important B-O B-JJ
immunoregulatory B-O B-NP_JJ
cytokine B-O B-NN
" " B-O O-NP
" " B-O O-NP
whose B-O B-SBAR_WHNP_WPP
receptor B-O B-NN
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
a B-O B-NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
recently B-O B-ADVP_RB
" " B-O O-ADVP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
natural B-O B-NP_JJ
killer B-O B-NN
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
IL-12 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
, B-O B-COMMA
implicating B-O B-S_NP_VP_VBG
these B-O B-NP_DT
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recently B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
transcription B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
known B-O B-VP_VBN
as B-O B-NP_PP_IN
STATs B-O B-NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
signal B-O B-NP_NN
transducers B-O B-NNS
and B-O B-CC
activators B-O B-NNS
of B-O B-IN
transcription B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
tyrosine B-O B-UCP_ADJP_NN
phosphorylated B-O B-JJ
" " B-O O-ADJP
and B-O B-CC
activated B-O B-VP_VBN
" " B-O B-NP_PP_O-UCP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VP_VBP
that B-O B-SBAR_IN
IL-12 B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
tyrosine B-O B-NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
show B-O B-VP_VBP
that B-O B-SBAR_IN
STAT4 B-O B-S_NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
T-cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
IL-12 B-O B-S_NP_NN
" " B-O O-NP
stimulates B-O B-VP_VBZ
formation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
this B-O B-S_NP_DT
complex B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
STAT4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
data B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_NP_DT
recent B-O B-JJ
demonstration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
JAK B-O B-NP_NP_NP_NN
" " B-O O-NP
phosphorylation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
IL-12 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
identify B-O B-VP_VBP
a B-O B-NP_NP_DT
rapid B-O B-JJ
signal-transduction B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
likely B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
mediate B-O B-VP_VB
IL-12-induced B-O B-NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Overexpression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
DR-nm23 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
encoded B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
inhibits B-O B-VP_VP_VBZ
granulocyte B-O B-NP_NP_NN
" " B-O O-NP
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
induces B-O B-VP_VBZ
apoptosis B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
32Dc13 B-O B-NP_NN
myeloid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Chronic B-O B-S_S_S_NP_JJ
myelogenous B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
evolves B-O B-VP_VBZ
in B-O B-PP_IN
two B-O B-NP_CD
clinically B-O B-ADJP_RB
distinct B-O B-JJ
" " B-O O-ADJP
stages B-O B-NNS
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
a B-O B-NP_NP_DT
chronic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
a B-O B-NP_DT
blast B-O B-NN
crisis B-O B-NN
" " B-O B-NP_O-NP
phase B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
molecular B-O B-JJ
changes B-O B-NNS
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
chronic B-O B-NP_NP_JJ
phase B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
blast B-O B-NP_NN
crisis B-O B-NN
transition B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
largely B-O B-ADJP_RB
unknown B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
a B-O B-NP_NP_DT
cDNA B-O B-NP_NP_NN
clone B-O B-NN
" " B-O O-NP
, B-O B-COMMA
DR-nm23 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
differentially B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
blast-crisis B-O B-NP_JJ
cDNA B-O B-NN
library B-O B-NN
, B-O B-COMMA
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
has B-O B-S_NP_VP_VBZ
sequence B-O B-NP_NP_ADJP_NN
similarity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
deduced B-O B-VBN
amino B-O B-NN
acid B-O B-NN
sequence B-O B-NN
similarity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
proteins B-O B-NNS
" " B-O O-NP
encoded B-O B-VP_VBN
by B-O B-NP_PP_IN
these B-O B-NP_DT
two B-O B-CD
latter B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
approximately B-O B-NP_QP_RB
65 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
includes B-O B-VP_VBZ
domains B-O B-NP_NP_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
amino B-O B-NP_NN
acid B-O B-NN
residues B-O B-NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
and B-O B-NP_NP_NP_NP_CC
, B-O B-NP_COMMA
" " B-O B-NP_NP_PP_O-NP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
postulated B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
important B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DR-nm23 B-O B-S_NP_NN
mRNA B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
preferentially B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
at B-O B-NP_PP_IN
early B-O B-NP_NP_JJ
stages B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
myeloid B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
highly B-O B-NP_RB
purified B-O B-VBN
CD34+ B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Its B-O B-S_NP_NP_PRPP
constitutive B-O B-JJ
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
myeloid B-O B-NP_JJ
precursor B-O B-NN
32Dc13 B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
growth-factor B-O B-ADJP_NN
dependent B-O B-JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
results B-O B-VP_VP_VBZ
in B-O B-PP_IN
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
granulocytic B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
causes B-O B-VP_VBZ
apoptotic B-O B-NP_JJ
cell B-O B-NN
death B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
are B-O B-VP_VP_VBP
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
a B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
DR-nm23 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
normal B-O B-NP_JJ
hematopoiesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
raise B-O B-VP_VBP
the B-O B-NP_DT
possibility B-O B-NN
that B-O B-SBAR_IN
its B-O B-S_NP_PRPP
overexpression B-O B-NN
" " B-O O-NP
contributes B-O B-VP_VBZ
to B-O B-PP_TO
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcription B-O B-NP_NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
as B-O B-PP_IN
targets B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
oxidative B-O B-NP_NP_JJ
signalling B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
lymphocyte B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
previously B-O B-ADVP_RB
" " B-O O-ADVP
have B-O B-VP_VP_VBP
demonstrated B-O B-VP_VBN
a B-O B-NP_NP_DT
requirement B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
oxidative B-O B-NP_NP_JJ
events B-O B-NNS
" " B-O O-NP
during B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
have B-O B-VP_VBP
hypothesised B-O B-VP_VBN
that B-O B-SBAR_IN
reactive B-O B-S_NP_JJ
oxygen B-O B-NN
species B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
act B-O B-VP_VB
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
current B-O B-JJ
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
cysteamine B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
aminothiol B-O B-NN
compound B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
antioxidant B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
used B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
to B-O B-S_NP_VP_TO
further B-O B-ADVP_RB
" " B-O O-ADVP
investigate B-O B-VP_VB
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
oxidative B-O B-NP_JJ
signalling B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
lymphocyte B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
normal B-O B-NP_JJ
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
cysteamine B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
proliferation B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
dose-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_IN
essentially B-O B-S_ADVP_RB
" " B-O O-ADVP
complete B-O B-NP_JJ
inhibition B-O B-NN
" " B-O O-NP
occurring B-O B-VP_VBG
" " B-O B-PP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
limited B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
first B-O B-JJ
2 B-O B-CD
h B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
mitogenic B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
localizing B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
time-frame B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cysteamine B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-PP_TO
within B-O B-PP_IN
the B-O B-NP_DT
commitment B-O B-NN
period B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-S_O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
was B-O B-VP_VBD
of B-O B-PP_IN
interest B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
establish B-O B-VP_VB
which B-O B-SBAR_WHNP_WDT
" " B-O B-NP_O-WHNP
, B-O B-S_NP_COMMA
if B-O B-SBAR_IN
" " B-O B-FRAG_NP_O-SBAR
, B-O B-COMMA
commitment B-O B-NP_NN
events B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
affected B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taking B-O B-S_S_NP_VP_VBG
the B-O B-NP_DT
IL-2 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_DT
candidate B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cysteamine B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_PP_IN
early B-O B-NP_NP_NP_JJ
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
lymphocyte B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
on B-O B-PP_IN
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-SBAR_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Cysteamine B-O B-S_NP_NN
treatment B-O B-NN
" " B-O O-NP
inhibited B-O B-VP_VBD
both B-O B-NP_CC
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
secretion B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
the B-O B-NP_DT
culture B-O B-NN
medium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cysteamine B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
mediated B-O B-VP_VBN
at B-O B-NP_PP_ADVP_IN
least B-O B-JJS
" " B-O O-ADVP
in B-O B-IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
an B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
transcription B-O B-NP_NP_NN
factor B-O B-NN
" " B-O O-NP
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
as B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
activities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
extracted B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
cysteamine B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
Oct1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
affected B-O B-VP_VBN
by B-O B-NP_PP_IN
cysteamine B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
oxidative B-O B-S_NP_JJ
signalling B-O B-NN
processes B-O B-NNS
" " B-O O-NP
operate B-O B-VP_VBP
in B-O B-PP_IN
a B-O B-NP_DT
selective B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
identification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
regulatory B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
such B-O B-PP_JJ
as B-O B-IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
as B-O B-PP_IN
molecular B-O B-NP_NP_JJ
targets B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
oxidative B-O B-NP_JJ
signalling B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
provides B-O B-VP_VBZ
further B-O B-NP_NP_JJ
evidence B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHADVP_S_NP_VP_TO
implicate B-O B-VP_VB
oxidative B-O B-NP_JJ
signalling B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
hydroxyurea B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
K562 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
erythroid B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
[ B-O B-S_LRB
published B-O B-NP_VBN
erratum B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
in B-O B-PP_IN
Biochim B-O B-NP_NP_NNP
Biophys B-O B-NNP
Acta B-O B-NNP
1995 B-O B-CD
Dec B-O B-NNP
27 B-O B-CD
" " B-O O-NP
; B-O B-COLON
1264 B-O B-NP_CD
( B-O B-LRB
3 B-O B-CD
) B-O B-RRB
" " B-O O-NP
: B-O B-COLON
409 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
  
Hydroxyurea B-O B-S_S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
HU B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
antitumor B-O B-JJ
agent B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
also B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
induces B-O B-VP_VBZ
hemoglobinization B-O B-NP_NN
" " B-O O-NP
during B-O B-PP_IN
erythroid B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
HU B-O B-NP_NN
" " B-O O-NP
stimulates B-O B-VP_VBZ
the B-O B-NP_NP_DT
synthesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
fetal B-O B-NP_JJ
hemoglobin B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
sickle B-O B-NP_NN
cell B-O B-NN
anemia B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
further B-O B-ADVP_RB
" " B-O O-ADVP
understand B-O B-VP_VB
its B-O B-NP_NP_PRPP
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HU B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
prior B-O B-ADVP_ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
the B-O B-NP_NP_DT
onset B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
HU B-O B-S_NP_NN
" " B-O O-NP
induced B-O B-VP_VBD
a B-O B-NP_NP_DT
dose-dependent B-O B-JJ
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
elevated B-O B-VP_VBN
4 B-O B-NP_NP_CD
to B-O B-TO
7.5-fold B-O B-RB
" " B-O O-NP
by B-O B-PP_IN
HU B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
2 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
was B-O B-VP_VBD
followed B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
gradual B-O B-JJ
decline B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
basal B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
24 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
nuclear B-O B-NP_JJ
run-on B-O B-JJ
" " B-O B-NP_O-NP
and B-O B-CC
actinomycin B-O B-NP_NN
D B-O B-NN
pulse B-O B-NN
" " B-O B-NP_O-NP
experiments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
HU B-O B-S_NP_NN
" " B-O O-NP
regulates B-O B-VP_VBZ
c-jun B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
increasing B-O B-S_NP_VP_VP_VBG
as B-O B-NP_CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
stabilizing B-O B-VP_VBG
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
jun B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
elevated B-O B-ADJP_JJ
by B-O B-PP_IN
2 B-O B-NP_CD
to B-O B-TO
5-fold B-O B-NN
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
4 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
HU B-O B-NP_NN
treated B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
concentrations B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
HU B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
below B-O B-PP_IN
250 B-O B-NP_CD
microM B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
slightly B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBD
the B-O B-NP_DT
5X B-O B-NN
AP-1/CAT B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
HU B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
both B-O B-NP_NP_CC
transcriptional B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
post-transcription B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
regulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
erythroid B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Characterization B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
5' B-O B-NP_JJ
end B-O B-NN
of B-O B-IN
human B-O B-JJ
thromboxane B-O B-NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Organizational B-O B-NP_NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
and B-O B-CC
mapping B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
-- B-O B-COLON
responsive B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
regulating B-O B-VP_VBG
expression B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
platelets B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Platelet B-O B-S_S_NP_NN
thromboxane B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
acutely B-O B-ADVP_ADVP_RB
" " B-O O-ADVP
and B-O B-CC
reversibly B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-ADVP
upregulated B-O B-VP_VBN
after B-O B-NP_PP_IN
acute B-O B-NP_JJ
myocardial B-O B-JJ
infarction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
determine B-O B-VP_VB
if B-O B-SBAR_IN
platelet B-O B-S_NP_NN
thromboxane B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
under B-O B-PP_IN
transcriptional B-O B-NP_JJ
control B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
isolated B-O B-VP_VP_VBD
" " B-O B-NP_O-VP
and B-O B-CC
characterized B-O B-VP_VBD
" " B-O B-NP_O-VP
human B-O B-NP_NP_JJ
genomic B-O B-JJ
DNA B-O B-NN
clones B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_NP_DT
5' B-O B-NP_JJ
flanking B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
thromboxane B-O B-NP_NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
exon-intron B-O B-NP_JJ
structure B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
5' B-O B-NP_JJ
portion B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
thromboxane B-O B-NP_NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
initially B-O B-NP_ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
comparing B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
nucleotide B-O B-NP_NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_NP_PP_SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
major B-O B-JJ
transcription B-O B-NP_NN
initiation B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
located B-O B-ADJP_JJ
in B-O B-PP_IN
three B-O B-NP_CD
human B-O B-JJ
tissues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
approximately B-O B-NP_NP_NP_ADVP_RB
" " B-O O-ADVP
560 B-O B-NP_CD
bp B-O B-NN
upstream B-O B-JJ
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
translation B-O B-NP_NN
initiation B-O B-NN
codon B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
380 B-O B-NP_NP_CD
bp B-O B-NN
upstream B-O B-JJ
" " B-O O-NP
from B-O B-PP_IN
any B-O B-NP_DT
previously B-O B-ADJP_RB
identified B-O B-VBN
" " B-O O-ADJP
transcription B-O B-NP_NN
initiation B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
thromboxane B-O B-NP_NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
neither B-O B-NP_CC
a B-O B-NP_DT
TATA B-O B-NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
nor B-O B-CC
a B-O B-NP_DT
CAAT B-O B-NP_NN
consensus B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Promoter B-O B-S_NP_NP_NN
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
5' B-O B-NP_JJ
flanking B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
thromboxane B-O B-NP_NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
evaluated B-O B-VP_VBN
by B-O B-NP_PP_IN
transfection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
thromboxane B-O B-NP_NN
receptor B-O B-NN
gene B-O B-NN
promoter/chloramphenicol B-O B-NN
acetyltransferase B-O B-NN
( B-O B-LRB
CAT B-O B-NN
) B-O B-RRB
chimera B-O B-NN
plasmids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
platelet-like B-O B-NP_JJ
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thromboxane B-O B-S_NP_NN
receptor B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
, B-O B-COMMA
" " B-O O-NP
as B-O B-SBAR_IN
assessed B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
CAT B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
was B-O B-VP_VP_VBD
relatively B-O B-ADJP_RB
weak B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
but B-O B-CC
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBN
by B-O B-NP_PP_IN
phorbol B-O B-NP_NN
ester B-O B-NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Functional B-O B-S_NP_NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
5' B-O B-NP_NP_JJ
deletion B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
transfected B-O B-NP_VBN
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
gel B-O B-NP_NN
mobility B-O B-NN
shift B-O B-NN
" " B-O O-NP
" " B-O O-NP
localized B-O B-VP_VBD
the B-O B-NP_NP_DT
major B-O B-JJ
phorbol B-O B-NN
ester-responsive B-O B-JJ
motifs B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
thromboxane B-O B-NP_NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_NP_DT
cluster B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activator B-O B-NP_NP_NN
protein-2 B-O B-NN
( B-O B-LRB
AP-2 B-O B-NN
) B-O B-RRB
binding B-O B-NN
consensus B-O B-NN
sites B-O B-NNS
" " B-O O-NP
located B-O B-ADJP_JJ
kb B-O B-PP_NP_QP_NN
5' B-O B-JJ
" " B-O O-NP
from B-O B-IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
the B-O B-NP_NP_DT
first B-O B-JJ
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
determine B-O B-VP_VP_VB
" " B-O B-NP_NP_PP_O-VP
and B-O B-CC
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
" " B-O B-S_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
previously B-O B-NP_NP_ADJP_RB
described B-O B-VBN
" " B-O O-ADJP
upregulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
platelet B-O B-NP_NN
thromboxane B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
infarction B-O B-NP_ADJP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
increased B-O B-NP_NP_VBN
thromboxane B-O B-NP_NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
platelet-progenitor B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
IL-2 B-O B-S_S_NP_NP_NP_NP_NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
through B-O B-PP_IN
CD28 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
reactive B-O B-NP_NP_JJ
oxygen B-O B-NN
production B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
5-lipoxygenase B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Activation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD28 B-O B-NP_NN
surface B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
provides B-O B-VP_VBZ
a B-O B-NP_NP_DT
major B-O B-JJ
costimulatory B-O B-JJ
signal B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
resulting B-O B-VP_VBG
in B-O B-PP_IN
enhanced B-O B-NP_NP_NP_VBN
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
cell B-O B-NP_NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
primary B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
CD28 B-O B-S_NP_NP_NN
" " B-O O-NP
ligation B-O B-NN
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
rapid B-O B-JJ
intracellular B-O B-JJ
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Delineation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD28 B-O B-NP_NN
" " B-O O-NP
signaling B-O B-NN
cascade B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-VP_TO
involve B-O B-S_NP_VP_VB
protein B-O B-NP_NP_NN
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
, B-O B-COMMA
followed B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
lipoxygenase B-O B-S_NP_NN
metabolites B-O B-NNS
" " B-O O-NP
activate B-O B-VP_VBP
ROI B-O B-NP_NP_NN
formation B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
then B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
induce B-O B-VP_VBP
" " B-O B-NP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
should B-O B-VP_MD
be B-O B-VP_VB
useful B-O B-ADJP_JJ
for B-O B-PP_IN
therapeutic B-O B-NP_NP_JJ
strategies B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
development B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Flutamide B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hirsutism B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
long-term B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
clinical B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
endocrine B-O B-NP_JJ
changes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
androgen B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
behavior B-O B-NN
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
OBJECTIVE B-O B-NP_NP_NN
: B-O B-COLON
" " B-O O-NP
To B-O B-S_NP_VP_TO
investigate B-O B-VP_VB
the B-O B-NP_NP_DT
long-term B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_PP_IN
clinical B-O B-NP_NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
hormonal B-O B-NP_JJ
" " B-O B-NP_O-NP
parameters B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O B-PP_O-PP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
on B-O B-PP_IN
the B-O B-NP_NP_DT
status B-O B-NP_NN
" " B-O O-NP
" " B-O B-PP_O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
hirsute B-O B-NP_JJ
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
DESIGN B-O B-NP_NP_NN
: B-O B-COLON
" " B-O O-NP
Eighteen B-O B-S_NP_NP_CD
hirsute B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
regular B-O B-NP_JJ
menses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
studied B-O B-VP_VBN
basally B-O B-NP_UCP_ADVP_RB
" " B-O O-ADVP
and B-O B-CC
during B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_O-PP
, B-O B-COMMA
three B-O B-NP_NP_CD
times B-O B-NNS
" " B-O O-NP
per B-O B-PP_IN
" " B-O B-NP_O-NP
for B-O B-PP_IN
12 B-O B-NP_CD
months B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
  
Barrier B-O B-S_NP_NP_NN
" " B-O B-NP_O-NP
or B-O B-CC
intrauterine B-O B-NP_JJ
" " B-O B-NP_O-NP
contraception B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
during B-O B-NP_PP_IN
the B-O B-NP_NP_DT
study B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
sexually B-O B-NP_ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Safety B-O B-S_NP_NN
parameters B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
assessed B-O B-VP_VBN
throughout B-O B-NP_PP_IN
the B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Hirsutism B-O B-S_NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
graded B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
modified B-O B-VBN
Ferriman-Gallwey B-O B-JJ
score B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
hormonal B-O B-NP_JJ
parameters B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
evaluated B-O B-VP_VBN
basally B-O B-NP_UCP_ADVP_RB
" " B-O O-ADVP
and B-O B-CC
at B-O B-PP_IN
4-month B-O B-NP_NP_JJ
intervals B-O B-NNS
" " B-O O-NP
during B-O B-PP_IN
treatment B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Gonadotropin-releasing B-O B-S_NP_NP_ADJP_JJ
" " B-O O-ADJP
hormone B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
ACTH B-O B-NP_NN
stimulation B-O B-NN
" " B-O B-NP_O-NP
tests B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
performed B-O B-VP_VBN
before B-O B-NP_PP_PP_IN
" " B-O B-NP_O-PP
and B-O B-CC
after B-O B-PP_IN
" " B-O B-NP_O-PP
3 B-O B-NP_NP_QP_CD
to B-O B-TO
4 B-O B-CD
" " B-O O-QP
months B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
therapy B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
androgen B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
mononuclear B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
measured B-O B-VP_VBN
, B-O B-NP_COMMA
in B-O B-PP_IN
both B-O B-NP_NP_CC
the B-O B-DT
follicular B-O B-NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
luteal B-O B-NP_JJ
" " B-O B-NP_O-NP
phases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
menstrual B-O B-JJ
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
basally B-O B-UCP_ADVP_RB
" " B-O O-ADVP
and B-O B-CC
after B-O B-PP_IN
4 B-O B-NP_NP_CD
months B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
flutamide B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
RESULTS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
Flutamide B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
well B-O B-ADVP_RB
" " B-O O-ADVP
tolerated B-O B-VP_VBN
in B-O B-NP_PP_IN
all B-O B-NP_DT
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_IN
the B-O B-NP_NP_DT
noticeable B-O B-JJ
exception B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
one B-O B-NP_NP_CD
patient B-O B-NN
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
  
Hirsutism B-O B-S_NP_NN
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
improved B-O B-VP_VBD
in B-O B-PP_IN
all B-O B-NP_DT
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
the B-O B-NP_NP_DT
treatment B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Ferriman-Gallwey B-O B-NP_NP_NP_JJ
score B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
1 B-O B-NP_CD
year B-O B-NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
4.1 B-O B-NP_NP_QP_CD
+/- B-O B-CC
0.5 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
versus B-O B-CC
14.1 B-O B-NP_QP_CD
+/- B-O B-CC
0.9 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
reduction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
serum B-O B-NP_NN
androgens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_O-VP
, B-O B-COMMA
whereas B-O B-SBAR_IN
no B-O B-S_NP_DT
change B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
either B-O B-NP_CC
or B-O B-NP_CC
" " B-O B-NP_NP_O-PP
or B-O B-CC
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cycles B-O B-S_NP_NNS
" " B-O O-NP
remained B-O B-VP_VBD
ovulatory B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Before B-O B-S_PP_IN
treatment B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
androgen B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
higher B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
in B-O B-PP_IN
the B-O B-NP_DT
luteal B-O B-NN
" " B-O O-NP
" " B-O O-PP
than B-O B-PP_IN
in B-O B-PP_IN
the B-O B-NP_DT
follicular B-O B-JJ
phase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
rhythmic B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
disappeared B-O B-VP_VBD
after B-O B-SBAR_IN
the B-O B-S_NP_DT
patients B-O B-NNS
" " B-O O-NP
had B-O B-VP_VBD
been B-O B-VP_VBN
given B-O B-VP_VBN
the B-O B-NP_NP_DT
antiandrogen B-O B-JJ
drug B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CONCLUSIONS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
Flutamide B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
effective B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_NP_DT
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hirsutism B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
but B-O B-CC
requires B-O B-VP_VBZ
constant B-O B-NP_NP_JJ
surveillance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
liver B-O B-NP_NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
  
Androgen B-O B-S_NP_NN
receptor B-O B-NN
blockade B-O B-NN
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
potentiated B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
reduction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
serum B-O B-NP_NN
androgens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Flutamide B-O B-S_NP_NN
" " B-O O-NP
affects B-O B-VP_VBZ
androgen B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
behavior B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
the B-O B-NP_DT
menstrual B-O B-JJ
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
meaning B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
finding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remains B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
elucidated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
HIV-1 B-O B-S_S_S_NP_NN
envelope B-O B-NN
glycoproteins B-O B-NNS
" " B-O O-NP
induce B-O B-VP_VBP
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
protein-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
CD4+ B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
[ B-O B-S_LRB
published B-O B-NP_VBN
erratum B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
in B-O B-PP_IN
J B-O B-NP_NP_NNP
Biol B-O B-NNP
Chem B-O B-NNP
1995 B-O B-CD
Dec B-O B-NNP
1 B-O B-CD
" " B-O O-NP
; B-O B-COLON
270 B-O B-NP_CD
( B-O B-LRB
48 B-O B-CD
) B-O B-RRB
: B-O B-COLON
29038 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-S
" " B-O O-S
  
Activation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD4 B-O B-NP_NN
positive B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
primary B-O B-JJ
requirement B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
human B-O B-NP_NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
entry B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
efficient B-O B-NP_JJ
HIV B-O B-NN
replication B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
progression B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
AIDS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-S
" " B-O O-S
  
Utilizing B-O B-S_S_NP_VP_VBG
CD4 B-O B-NP_NP_NP_NN
positive B-O B-JJ
T B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
and B-O B-CC
purified B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
normal B-O B-NP_JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
native B-O B-S_NP_NP_JJ
envelope B-O B-NN
glycoproteins B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
induce B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
stimulatory B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
gp160 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
the B-O B-NP_DT
CD4 B-O B-NP_NN
molecule B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
since B-O B-SBAR_IN
treatment B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
gp160 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
soluble B-O B-NP_JJ
CD4-IgG B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
abrogates B-O B-VP_VBZ
its B-O B-NP_PRPP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
CD4 B-O B-S_NP_NN
negative B-O B-JJ
T B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
fail B-O B-VP_VBP
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Immunoprecipitation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
gp B-O B-NN
160-induced B-O B-JJ
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
polyclonal B-O B-NP_NP_JJ
antibodies B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
Fos B-O B-NP_NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
Jun B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicates B-O B-VP_VBZ
that B-O B-SBAR_IN
AP-1 B-O B-S_NP_NN
complex B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
comprised B-O B-VP_VBN
of B-O B-NP_PP_IN
members B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
gp160-induced B-O B-NP_JJ
AP-1 B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VP_VBZ
dependent B-O B-ADJP_JJ
upon B-O B-PP_IN
protein B-O B-NP_NN
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
protein B-O B-ADJP_NN
synthesis-independent B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
stimulation B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
abolished B-O B-VP_VBN
by B-O B-NP_PP_IN
inhibitors B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
unaffected B-O B-ADJP_JJ
by B-O B-PP_IN
calcium B-O B-NP_NP_NN
channel B-O B-NN
blocker B-O B-NN
" " B-O O-NP
or B-O B-CC
cyclosporine B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
gp160 B-O B-NP_NN
" " B-O O-NP
treatment B-O B-NN
" " B-O O-NP
adversely B-O B-ADVP_RB
" " B-O O-ADVP
affects B-O B-VP_VBZ
the B-O B-NP_NP_DT
functional B-O B-JJ
capabilities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
pre-treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD4+ B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
gp160 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
4 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
37 B-O B-NP_CD
degrees B-O B-NNS
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibited B-O B-VP_VBD
anti-CD3-induced B-O B-NP_JJ
interleukin-2 B-O B-NP_NN
" " B-O O-NP
secretion B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Effects B-O B-S_NP_NP_NNS
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
gp160 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
were B-O B-VP_VBD
seen B-O B-VP_VBN
with B-O B-NP_PP_IN
anti-CD4 B-O B-NP_JJ
mAb B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
aberrant B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
gp160 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
CD4 B-O B-NP_NN
positive B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
result B-O B-VP_VP_VB
in B-O B-PP_IN
up-regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cytokines B-O B-NP_NP_NNS
" " B-O O-NP
containing B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
concurrently B-O B-ADVP_RB
" " B-O O-ADVP
lead B-O B-VP_VBP
to B-O B-PP_TO
T B-O B-NP_NP_NN
cell B-O B-NN
" " B-O O-NP
unresponsiveness B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
inhibiting B-O B-S_NP_VP_VBG
interleukin-2 B-O B-NP_NP_NN
" " B-O O-NP
secretion B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cellular B-O B-NP_NP_NP_NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
molecular B-O B-NP_JJ
" " B-O B-NP_O-NP
mechanisms B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
IFN-gamma B-O B-NP_NP_NP_NN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-12 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_DT
human B-O B-NP_JJ
NK B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Interferon-gamma B-O B-S_S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IFN-gamma B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
important B-O B-JJ
immunoregulatory B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
produced B-O B-VP_VBN
predominantly B-O B-NP_ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
large B-O B-NP_NP_JJ
granular B-O B-JJ
lymphocytes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
different B-O B-NP_JJ
extracellular B-O B-JJ
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
particular B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
two B-O B-NP_NP_NP_CD
interleukins B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
ILs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-12 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
potent B-O B-NP_NP_JJ
inducers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
in B-O B-PP_IN
both B-O B-NP_CC
and B-O B-NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
reported B-O B-VP_VBN
that B-O B-SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
are B-O B-VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
there B-O B-S_NP_EX
" " B-O O-NP
has B-O B-VP_VBZ
as B-O B-ADVP_RB
yet B-O B-RB
" " B-O O-ADVP
been B-O B-VP_VBN
no B-O B-NP_NP_DT
report B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
natural B-O B-NP_JJ
killer B-O B-NN
( B-O B-LRB
NK B-O B-NN
) B-O B-RRB
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
present B-O B-VP_VBP
evidence B-O B-NP_NN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
cell B-O B-NP_NN
line B-O B-NN
NK3.3 B-O B-NN
" " B-O O-NP
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
human B-O B-NP_JJ
NK B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
responds B-O B-VP_VBZ
to B-O B-PP_TO
both B-O B-NP_CC
IL-2 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
IL-12 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_IN
measured B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
increases B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
used B-O B-S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
IL-2 B-O B-S_S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-12 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
synergized B-O B-VP_VBD
in B-O B-PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IFN-gamma B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
GM-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
this B-O B-S_NP_DT
synergy B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
attributed B-O B-VP_VBN
to B-O B-NP_PP_TO
an B-O B-NP_NP_DT
increased B-O B-VBN
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
investigate B-O B-VP_VB
the B-O B-NP_NP_DT
signaling B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
gene B-O B-NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
five B-O B-S_NP_NP_CD
inhibitors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
cyclosporin B-O B-NP_NP_NP_NN
A B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CsA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
transforming B-O B-NP_VBG
growth B-O B-NN
factor-beta B-O B-NN
" " B-O O-NP
, B-O B-COMMA
cycloheximide B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
genistein B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
staurosporine B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
in B-O B-NP_PP_IN
analyzing B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
on B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
activation B-O B-S_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
new B-O B-NP_JJ
protein B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
induction B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
IL-12 B-O B-NP_NP_NP_NN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IFN-gamma B-O B-NP_NN
cytoplasmic B-O B-JJ
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
only B-O B-ADVP_RB
partially B-O B-RB
" " B-O O-ADVP
depend B-O B-VP_VB
on B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
both B-O B-S_S_NP_CC
transforming B-O B-NP_VBG
growth B-O B-NN
factor-beta B-O B-NN
" " B-O O-NP
and B-O B-CC
genistein B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
tyrosine B-O B-NN
kinase B-O B-NN
inhibitor B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
could B-O B-VP_MD
suppress B-O B-VP_VB
IL-2 B-O B-NP_NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
IL-12 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
signaling B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
but B-O B-CC
CsA B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
generally B-O B-ADVP_RB
" " B-O O-ADVP
inactive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
was B-O B-VP_VBD
observed B-O B-VP_VBN
that B-O B-SBAR_IN
suppression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NP_NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
these B-O B-NP_DT
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
independent B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
IL-2 B-O B-S_S_NP_NP_NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
IL-12 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
induced B-O B-VP_VBD
nuclear B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
AP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
regulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
nuclear B-O B-JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
two B-O B-CD
DNA B-O B-NP_NN
binding B-O B-NN
protein B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
IFN-gamma B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
GM-CSF B-O B-NP_NN
" " B-O B-NP_O-NP
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
IL-2 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-12 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
have B-O B-VP_VB
distinct B-O B-NP_NP_JJ
signaling B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
leading B-O B-VP_VBG
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_DT
NK3.3 B-O B-NP_NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
serve B-O B-VP_VB
as B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Infection B-O B-NP_NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
replication B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
Tat- B-O B-NP_JJ
human B-O B-JJ
immunodeficiency B-O B-NN
viruses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
genetic B-O B-NP_NP_JJ
analyses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
LTR B-O B-NP_NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
tat B-O B-NP_NN
" " B-O B-NP_O-NP
mutations B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
primary B-O B-NP_NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
long-term B-O B-NP_JJ
" " B-O B-NP_O-NP
human B-O B-NP_JJ
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Tat B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
essential B-O B-JJ
regulatory B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
replication B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Mutations B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
tat B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
block B-O B-VP_VB
HIV B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Several B-O B-S_S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
established B-O B-VP_VBN
that B-O B-SBAR_IN
Tat B-O B-S_NP_NN
" " B-O O-NP
releases B-O B-VP_VBZ
an B-O B-NP_NP_DT
to B-O B-NP_PP_TO
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
not B-O B-RB
known B-O B-VP_VBN
" " B-O B-NP_O-VP
whether B-O B-SBAR_IN
this B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
is B-O B-VP_VBZ
sufficient B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
explain B-O B-VP_VB
" " B-O B-NP_SBAR_WHADVP_S_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
possible B-O B-ADJP_JJ
" " B-O O-ADJP
that B-O B-SBAR_IN
Tat B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
needed B-O B-VP_VBN
for B-O B-NP_PP_IN
other B-O B-NP_JJ
functions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
HIV B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
test B-O B-VP_VB
these B-O B-NP_DT
hypotheses B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
several B-O B-NP_NP_JJ
tat B-O B-NP_NN
mutants B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
two B-O B-NP_NP_CD
stop B-O B-NP_NN
codon B-O B-NN
mutants B-O B-NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
one B-O B-NP_CD
deletion B-O B-NP_NN
mutant B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
using B-O B-S_NP_VP_VBG
replication-competent B-O B-NP_NP_JJ
HIV-1 B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
carrying B-O B-VP_VBG
or B-O B-NP_NP_NP_CC
with B-O B-NP_NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
Tat- B-O B-S_S_NP_NP_JJ
HIV-1 B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
wild-type B-O B-NP_JJ
LTRs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
replicate B-O B-VP_VB
in B-O B-PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_NP_DT
virus B-O B-NN
" " B-O O-NP
produced B-O B-VP_VBN
from B-O B-NP_PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
can B-O B-VP_MD
infect B-O B-VP_VB
primary B-O B-NP_ADJP_JJ
" " B-O O-ADJP
peripheral B-O B-NP_JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
propagation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
containing B-O B-NP_VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
less B-O B-ADJP_ADJP_RBR
efficient B-O B-JJ
" " B-O O-ADJP
than B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Large B-O B-S_NP_NP_JJ
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
viral B-O B-NP_NP_JJ
RNA B-O B-NN
" " B-O O-NP
and B-O B-CC
particles B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
synthesized B-O B-VP_VBN
in B-O B-NP_PP_IN
infections B-O B-NP_NP_NNS
" " B-O O-NP
established B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
using B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
tat B-O B-NP_NN
mutants B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contain B-O B-S_NP_VP_VBP
modified B-O B-NP_VBN
LTRs B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
this B-O B-NP_NP_DT
efficient B-O B-JJ
propagation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
LTR-modified B-O B-NP_JJ
tat B-O B-NN
mutants B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
restricted B-O B-ADJP_JJ
to B-O B-PP_TO
some B-O B-NP_NP_DT
lymphoid B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
have B-O B-S_NP_VP_VBP
been B-O B-VP_VBN
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
despite B-O B-PP_IN
its B-O B-NP_NP_PRPP
essential B-O B-JJ
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
releasing B-O B-S_NP_VP_VBG
an B-O B-NP_DT
elongation B-O B-NP_NN
block B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
Tat B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
otherwise B-O B-ADVP_RB
" " B-O O-ADVP
absolutely B-O B-ADVP_RB
" " B-O O-ADVP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
synthesis B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
full-length B-O B-NP_JJ
HIV B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
assembly B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
virus B-O B-NP_NN
particles B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Direct B-O B-S_NP_NP_NP_JJ
sequencing B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
viral B-O B-NP_JJ
genomes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
reinfection B-O B-NP_NN
kinetics B-O B-NNS
" " B-O O-NP
" " B-O O-NP
showed B-O B-VP_VBD
no B-O B-NP_NP_DT
evidence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
wild-type B-O B-NP_JJ
reversion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
even B-O B-ADVP_RB
" " B-O O-ADVP
after B-O B-PP_IN
prolonged B-O B-NP_NP_JJ
infection B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
Tat- B-O B-JJ
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
implications B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
in B-O B-NP_NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
HIV-1 B-O B-NN
replication B-O B-NN
" " B-O O-NP
and B-O B-CC
potential B-O B-NP_NP_JJ
application B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_NP_DT
study B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
alternative B-O B-NP_JJ
function B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
discussed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Restoration B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
ZEBRA B-O B-NN
protein B-O B-NN
" " B-O O-NP
's B-O B-POS
capacity B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
disrupt B-O B-VP_VB
latency B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
heterologous B-O B-NP_JJ
activation B-O B-NN
regions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
ZEBRA B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
a B-O B-NP_DT
unique B-O B-JJ
biological B-O B-JJ
function B-O B-NN
" " B-O O-NP
among B-O B-PP_IN
herpesviral B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_NP_DT
disruption B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
latency B-O B-NP_NP_NP_PRN_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
lytic B-O B-JJ
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ZEBRA B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
bZIP B-O B-NP_NN
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VP_VBZ
as B-O B-PP_IN
a B-O B-NP_DT
dimer B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
directly B-O B-ADVP_RB
" " B-O O-ADVP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
employed B-O B-VP_VBN
the B-O B-NP_DT
ZEBRA/EBV B-O B-NN
biological B-O B-JJ
system B-O B-NN
" " B-O O-NP
" " B-O O-VP
to B-O B-S_NP_VP_TO
test B-O B-VP_VB
whether B-O B-SBAR_IN
a B-O B-S_NP_DT
heterologous B-O B-NP_JJ
activation B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
substitute B-O B-VP_VB
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
ZEBRA B-O B-NP_NN
activation B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
replaced B-O B-VP_VBN
with B-O B-NP_PP_PP_IN
the B-O B-NP_NP_DT
potent B-O B-JJ
acid B-O B-NP_NN
activation B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
herpes B-O B-NP_NN
simplex B-O B-JJ
virus B-O B-NN
VP16 B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
with B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NP_NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
EBV B-O B-NP_NN
R B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_DT
chimeras B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
transactivate B-O B-VP_VB
model B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
native B-O B-NP_JJ
" " B-O B-NP_O-NP
promoters B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
at B-O B-PP_IN
equivalent B-O B-NP_NP_JJ
" " B-O B-NP_O-NP
or B-O B-CC
better B-O B-NP_JJR
" " B-O B-NP_PP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
than B-O B-PP_IN
ZEBRA B-O B-NP_NP_NN
" " B-O O-NP
itself B-O B-NP_PRP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
target- B-O B-ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-NP_ADJP_O-ADJP
or B-O B-CC
cell-type B-O B-ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
dependent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
nor B-O B-CC
was B-O B-SINV_VBD
it B-O B-NP_PRP
" " B-O O-NP
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
virus B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-SINV
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
activation B-O B-NN
domains B-O B-NNS
" " B-O O-NP
restored B-O B-VP_VBD
ZEBRA B-O B-NP_NP_NP_NN
" " B-O O-NP
's B-O B-POS
ability B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_VP_TO
induce B-O B-VP_VB
early B-O B-NP_JJ
antigen B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
to B-O B-VP_TO
stimulate B-O B-VP_VB
origin B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
specificities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
some B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
dependent B-O B-ADJP_JJ
upon B-O B-PP_IN
the B-O B-NP_NP_DT
nature B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Expression B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
erythroid-specific B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
acute B-O B-NP_NP_NP_JJ
megakaryoblastic B-O B-JJ
leukaemia B-O B-NN
" " B-O O-NP
and B-O B-CC
transient B-O B-NP_JJ
myeloproliferative B-O B-JJ
disorder B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
Down B-O B-NP_NN
's B-O B-POS
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Acute B-O B-S_S_NP_NP_NP_NP_JJ
megakaryoblastic B-O B-JJ
leukaemia B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
M7 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
transient B-O B-NP_NP_JJ
myeloproliferative B-O B-JJ
disorder B-O B-NN
" " B-O O-NP
" " B-O B-PRN_O-NP
" " B-O O-NP
in B-O B-PP_IN
Down B-O B-NP_NN
's B-O B-POS
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
TMD B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
are B-O B-VP_VBP
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
rapid B-O B-NP_NP_JJ
growth B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
abnormal B-O B-NP_NP_JJ
blast B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
clarify B-O B-VP_VB
properties B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
blast B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
erythroid B-O B-NP_NP_JJ
markers B-O B-NNS
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
blasts B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
and B-O B-NP_NP_NP_PP_CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Erythroid-specific B-O B-S_NP_NP_JJ
mRNAs B-O B-NNS
" " B-O O-NP
encoding B-O B-VP_VBG
gamma-globin B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
erythroid B-O B-NP_JJ
delta-aminolevulinate B-O B-JJ
synthase B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
majorities B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
have B-O B-VP_VBP
" " B-O B-NP_NP_ADJP_NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
phenotypes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBD
that B-O B-SBAR_IN
mRNAs B-O B-S_NP_NP_NNS
" " B-O O-NP
encoding B-O B-VP_VBG
GATA-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
GATA-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
all B-O B-NP_DT
these B-O B-DT
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
M7 B-O B-S_NP_NP_NN
blasts B-O B-NNS
" " B-O O-NP
and B-O B-CC
TMD B-O B-NP_NN
blasts B-O B-NNS
" " B-O O-NP
" " B-O O-NP
correspond B-O B-VP_VBP
to B-O B-PP_TO
the B-O B-NP_DT
erythroid/megakaryocytic B-O B-NP_JJ
bipotential B-O B-JJ
progenitor B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-NP_NP_NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
nuclear B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
NFATp B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NFATc B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
in B-O B-PP_IN
human B-O B-NP_JJ
natural B-O B-JJ
killer B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
regulation B-O B-NP_NP_NN
" " B-O O-NP
upon B-O B-PP_IN
CD16 B-O B-NP_NP_NN
" " B-O O-NP
ligand B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
putative B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
couple B-O B-S_NP_VP_VBP
the B-O B-NP_NP_DT
signal B-O B-NN
transduction B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
surface B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
in B-O B-PP_IN
natural B-O B-NP_JJ
killer B-O B-NN
( B-O B-LRB
NK B-O B-NN
) B-O B-RRB
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
have B-O B-VP_VBP
not B-O B-RB
been B-O B-VP_VBN
elucidated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_NP_DT
nuclear B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
NFATp B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
cyclosporin B-O B-NP_NN
A B-O B-NN
( B-O B-LRB
CsA B-O B-NN
) B-O B-RRB
-sensitive B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
regulates B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
mediates B-O B-VP_VBZ
CD16-induced B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
NK B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CD16 B-O B-S_NP_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
Fc B-O B-NP_NN
gamma B-O B-NN
RIIIA B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
-induced B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
NK B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurs B-O B-VP_VBZ
via B-O B-PP_IN
a B-O B-NP_DT
CsA-sensitive B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
Ca(2+)-dependent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NK B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
CD16 B-O B-NP_NP_NN
" " B-O O-NP
ligands B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
NFAT-like B-O B-NP_JJ
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-SBAR_IN
detected B-O B-S_NP_VP_VBN
in B-O B-NP_PP_IN
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
occurs B-O B-VP_VBZ
with B-O B-PP_IN
fast B-O B-NP_JJ
kinetics B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
via B-O B-PP_IN
a B-O B-NP_NP_DT
CsA-sensitive B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
Ca(2+)-dependent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
mechanism B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
does B-O B-S_NP_VP_VBZ
not B-O B-RB
require B-O B-VP_VB
protein B-O B-NP_ADJP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NK B-O B-S_NP_NN
cell B-O B-NN
NFAT B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
present B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_NP_DT
cytosol B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nonstimulated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
migrates B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
can B-O B-VP_MD
associate B-O B-VP_VB
with B-O B-PP_IN
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_CD
distinct B-O B-JJ
molecules B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
NFATp B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NFATc B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
reported B-O B-VP_VBN
to B-O B-S_NP_VP_TO
mediate B-O B-VP_VB
NFAT B-O B-NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
results B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
supershift B-O B-NP_NP_NN
assays B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
NFATp- B-O B-NP_NP_NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
"NFATc- specific" B-O B-NP_JJ
" " B-O B-NP_O-NP
antibodies B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
NK B-O B-S_NP_NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
early B-O B-ADVP_RB
" " B-O O-ADVP
after B-O B-PP_IN
CD16 B-O B-NP_NP_NN
" " B-O O-NP
ligand B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
primarily B-O B-ADVP_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
if B-O B-CONJP_IN
not B-O B-RB
" " B-O O-CONJP
exclusively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-ADVP
, B-O B-COMMA
NFATp B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
Western B-O B-S_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
shows B-O B-VP_VBZ
that B-O B-SBAR_IN
this B-O B-S_NP_DT
" " B-O O-NP
has B-O B-VP_VBZ
the B-O B-NP_NP_NP_DT
same B-O B-JJ
electrophoretic B-O B-JJ
mobility B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
as B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
NK B-O B-S_S_NP_NN
cells B-O B-NNS
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
express B-O B-VP_VB
NFATc B-O B-NP_NN
" " B-O O-NP
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
NFATc B-O B-S_NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
accumulation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
2 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
supershift B-O B-NP_NP_NN
assays B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
the B-O B-NP_NP_DT
available B-O B-JJ
mAb B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
recognizing B-O B-VP_VBG
the B-O B-NP_DT
T B-O B-NP_NN
cell B-O B-NN
NFATc B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
revealed B-O B-VP_VBD
no B-O B-NP_DT
detectable B-O B-JJ
NFATc B-O B-NP_NN
" " B-O O-NP
protein B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
nuclear B-O B-NP_NP_NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
cytoplasmic B-O B-NP_JJ
" " B-O B-NP_O-NP
extracts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
CD16- B-O B-NP_NP_NN
" " B-O B-ADJP_NP_O-NP
or B-O B-CC
phorbol B-O B-NP_NN
ester-stimulated B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
any B-O B-NP_NP_NP_DT
time B-O B-NN
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
, B-O B-COMMA
up B-O B-NP_NP_QP_RB
to B-O B-TO
4 B-O B-CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VBP
the B-O B-NP_DT
first B-O B-JJ
direct B-O B-JJ
evidence B-O B-NN
that B-O B-SBAR_SBAR_IN
both B-O B-S_NP_NP_DT
CsA-sensitive B-O B-NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
NFATp B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NFATc B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
their B-O B-S_NP_PRPP
activation B-O B-NP_NN
" " B-O O-NP
and/or B-O B-CC
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
regulated B-O B-VP_VBN
" " B-O B-NP_PP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Relationship B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
Rap1 B-O B-NP_NP_NP_NP_NN
protein B-O B-NN
" " B-O O-NP
phosphorylation B-O B-NN
" " B-O O-NP
and B-O B-CC
regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Ca2+ B-O B-NP_NN
transport B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
platelets B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
a B-O B-NP_DT
new B-O B-JJ
approach B-O B-NN
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Although B-O B-S_S_SBAR_IN
the B-O B-S_NP_NP_DT
interrelationship B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
two B-O B-CD
messengers B-O B-NNS
" " B-O O-NP
Ca2+ B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
cyclic B-O B-NP_JJ
AMP B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
platelet B-O B-NP_NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
well B-O B-ADVP_RB
" " B-O O-ADVP
documented B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
its B-O B-S_NP_NP_PRPP
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
still B-O B-ADVP_RB
" " B-O O-ADVP
remains B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
established B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
here B-O B-ADVP_RB
" " B-O O-ADVP
the B-O B-NP_NP_DT
question B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
platelet B-O B-NP_NN
Ca(2+)-ATPases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
cyclic B-O B-NP_JJ
AMP B-O B-NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
the B-O B-NP_NP_DT
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
using B-O B-S_NP_VP_VBG
a B-O B-NP_DT
pathological B-O B-JJ
model B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
first B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBD
experimental B-O B-NP_NP_JJ
conditions B-O B-NNS
" " B-O O-NP
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
Ca(2+)-transport B-O B-S_NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
platelet B-O B-NP_NN
membrane B-O B-NN
vesicles B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-ADJP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Then B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
platelets B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
congestive B-O B-NP_JJ
heart B-O B-NN
failure B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
for B-O B-PP_IN
their B-O B-NP_NP_PRPP
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
potential B-O B-JJ
97 B-O B-NP_CD
kDa B-O B-NN
Ca(2+)-ATPase B-O B-NN
target B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
regulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
the B-O B-NP_NP_DT
Rap1 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
the B-O B-NP_NP_DT
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Rap1 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
using B-O B-S_NP_VP_VBG
the B-O B-NP_NP_NP_DT
catalytic B-O B-NP_JJ
subunit B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cyclic B-O B-NP_JJ
AMP-dependent B-O B-JJ
protein B-O B-NN
kinase B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
C. B-O B-NP_JJ
Sub. B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
first B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
no B-O B-NP_DT
significant B-O B-JJ
modification B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
97 B-O B-NP_CD
kDa B-O B-NN
Ca(2+)-ATPase B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
Western B-O B-NP_NP_NN
blotting B-O B-NN
" " B-O O-NP
using B-O B-VP_VBG
the B-O B-NP_NP_DT
PL/IM B-O B-NP_NN
430 B-O B-CD
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
specifically B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
recognized B-O B-VP_VBD
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
Rap1 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
differentially B-O B-ADVP_RB
" " B-O O-ADVP
phosphorylated B-O B-VP_VBN
" " B-O B-NP_O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
using B-O B-S_NP_VP_VBG
15 B-O B-NP_NP_CD
micrograms/ml B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
C. B-O B-NP_NN
Sub B-O B-NN
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
allowed B-O B-VP_VBD
us B-O B-S_NP_PRP
" " B-O O-NP
to B-O B-VP_TO
use B-O B-VP_VB
these B-O B-NP_DT
pathological B-O B-JJ
platelets B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
to B-O B-S_NP_VP_TO
study B-O B-VP_VB
the B-O B-NP_NP_DT
relationship B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
" " B-O B-NP_O-NP
by B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
could B-O B-VP_MD
show B-O B-VP_VP_VB
a B-O B-NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
the B-O B-NP_DT
expression B-O B-NN
" " B-O B-PP_O-NP
" " B-O O-PP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
the B-O B-NP_DT
phosphorylation B-O B-NN
" " B-O B-PP_O-NP
" " B-O O-PP
of B-O B-PP_IN
Rap1 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
demonstrate B-O B-VP_VB
a B-O B-NP_NP_DT
lower B-O B-JJR
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
C. B-O B-NP_JJ
Sub. B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
Ca2+ B-O B-NP_NN
transport B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
by B-O B-PP_IN
studying B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
further B-O B-JJ
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
could B-O B-VP_VP_MD
confirm B-O B-VP_VB
that B-O B-SBAR_IN
in B-O B-S_NP_NP_NP_NP_PP_PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
" " B-O O-NP
whatever B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
its B-O B-FRAG_NP_PRPP
extent B-O B-NN
" " B-O O-NP
" " B-O O-FRAG
" " B-O O-SBAR
, B-O B-COMMA
was B-O B-VP_VBD
variable B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
could B-O B-VP_MD
strictly B-O B-ADVP_RB
" " B-O O-ADVP
correlate B-O B-VP_VB
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Rap1 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
stimulatory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
C. B-O B-NP_JJ
Sub. B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
Ca2+ B-O B-NP_NN
transport B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Besides B-O B-S_PP_IN
the B-O B-NP_NP_DT
evidence B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
platelets B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
these B-O B-NP_DT
findings B-O B-NNS
" " B-O O-NP
constitute B-O B-VP_VBP
a B-O B-NP_NP_DT
new B-O B-JJ
approach B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
favour B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
platelet B-O B-NP_NN
Ca2+ B-O B-NN
transport B-O B-NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_NP_DT
LEF-1 B-O B-NP_NN
HMG B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
nucleosome-assembled B-O B-NP_NP_JJ
DNA B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Lymphoid B-O B-S_S_NP_NP_NN
enhancer-binding B-O B-JJ
factor B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
LEF-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
regulatory B-O B-NP_JJ
high B-O B-JJ
mobility B-O B-NN
group B-O B-NN
( B-O B-LRB
HMG B-O B-NN
) B-O B-RRB
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
activates B-O B-S_NP_VP_VBZ
the B-O B-NP_DT
T B-O B-NP_NN
cell B-O B-NN
receptor B-O B-NN
alpha B-O B-NN
( B-O B-LRB
TCR B-O B-NN
alpha B-O B-NN
) B-O B-RRB
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
context-restricted B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
paper B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
distal B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus-1 B-O B-NN
( B-O B-LRB
HIV-1 B-O B-NN
) B-O B-RRB
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contains B-O B-S_NP_VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
provides B-O B-VP_VBZ
a B-O B-NP_NP_DT
functional B-O B-JJ
context B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
First B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
mutations B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
LEF-1-binding B-O B-NP_JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibit B-O B-VP_VBP
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
LEF-1/GAL4 B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
activate B-O B-VP_VB
a B-O B-NP_DT
GAL4-substituted B-O B-NP_JJ
HIV-1 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
80- B-O B-NP_NP_CD
" " B-O B-NP_O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Second B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
recombinant B-O B-NP_JJ
LEF-1 B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
HIV-1 B-O B-NP_NP_NN
transcription B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
chromatin-assembled B-O B-NP_JJ
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
using B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
nucleosome-assembly B-O B-JJ
system B-O B-NN
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
Drosophila B-O B-NP_FW
embryos B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
find B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_NP_NP_DT
packaging B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
chromatin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
represses B-O B-VP_VBZ
HIV-1 B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
repression B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
counteracted B-O B-VP_VBN
efficiently B-O B-NP_ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Addition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TFE-3 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
an B-O B-NP_DT
" " B-O B-NP_ADVP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
augments B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Individually B-O B-S_ADVP_ADVP_RB
" " B-O O-ADVP
or B-O B-CC
collectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-ADVP
, B-O B-COMMA
none B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
three B-O B-CD
enhancer-binding B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
LEF-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Ets-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
TFE-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
activate B-O B-VP_VB
transcription B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Sp1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_NP_NP_DT
truncation B-O B-NP_NN
mutant B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
LEF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
HMG-88 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contains B-O B-S_NP_VP_VP_VBZ
the B-O B-NP_DT
HMG B-O B-NP_NN
box B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
lacks B-O B-VP_VBZ
the B-O B-NP_DT
trans-activation B-O B-NP_JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
activate B-O B-VP_VB
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
nucleosomal B-O B-NP_JJ
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
bending B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
sufficient B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
transcription B-O B-S_NP_NP_NP_NN
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
LEF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
chromatin-dependent B-O B-JJ
process B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
requires B-O B-S_NP_VP_VBZ
" " B-O B-NP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Phosphorylation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NP_NP_NN
factor B-O B-NN
" " B-O O-NP
NFATp B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibits B-O B-VP_VBZ
its B-O B-NP_NP_PRPP
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cyclosporin B-O B-NP_NP_NP_NN
A-treated B-O B-JJ
human B-O B-JJ
B B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
T B-O B-NP_NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Cyclosporin B-O B-S_S_NP_NP_NN
A B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CsA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
exerts B-O B-VP_VBZ
its B-O B-NP_PRPP
immunosuppressive B-O B-JJ
effect B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
inhibiting B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
thus B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
preventing B-O B-VP_VBG
transcriptional B-O B-NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_JJ
cytokine B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
largely B-O B-ADVP_RB
" " B-O O-ADVP
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-SBAR_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
CsA B-O B-S_NP_NP_NN
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Raji B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
Jurkat B-O B-NP_NN
T B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
yields B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
phosphorylated B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFATp B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Immunoblot B-O B-S_NP_NP_NN
analyses B-O B-NNS
" " B-O O-NP
and B-O B-CC
metabolic B-O B-NP_NP_JJ
labeling B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
[32P]orthophosphate B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
CsA B-O B-S_NP_NN
" " B-O O-NP
alters B-O B-VP_VBZ
NFATp B-O B-NP_NP_NP_NN
" " B-O O-NP
migration B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
SDS-polyacrylamide B-O B-NP_NN
gel B-O B-NN
electrophoresis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
increasing B-O B-S_NP_VP_VBG
its B-O B-NP_PRPP
phosphorylation B-O B-NN
level B-O B-NN
" " B-O O-NP
without B-O B-PP_IN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Dephosphorylation B-O B-S_NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
in B-O B-NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
treatment B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
calcineurin B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
alkaline B-O B-NP_NN
phosphatase B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
restores B-O B-VP_VBZ
NFATp B-O B-NP_NP_NP_NN
" " B-O O-NP
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
and B-O B-CC
its B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
reconstitute B-O B-VP_VB
an B-O B-NP_DT
NFAT B-O B-NP_NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
point B-O B-VP_VBP
to B-O B-PP_TO
a B-O B-NP_NP_DT
new B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
CsA-sensitive B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFATp B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-SBAR_WHPP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Constitutive B-O B-NP_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
different B-O B-NP_JJ
Jak B-O B-NP_NN
tyrosine B-O B-NN
kinases B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
T B-O B-NN
cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
( B-O B-LRB
HTLV-1 B-O B-NN
) B-O B-RRB
tax B-O B-NN
protein B-O B-NN
" " B-O O-NP
or B-O B-CC
virus-transformed B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
HTLV-1 B-O B-S_S_NP_NN
infection B-O B-NN
" " B-O O-NP
causes B-O B-VP_VBZ
an B-O B-NP_DT
adult B-O B-JJ
T B-O B-NN
cell B-O B-NN
leukemia B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
humans B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
viral B-O B-NP_JJ
encoded B-O B-VBN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
tax B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
play B-O B-VP_VB
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
oncogenesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_NP_PRPP
previous B-O B-JJ
data B-O B-NNS
" " B-O O-NP
obtained B-O B-VP_VBN
from B-O B-NP_PP_IN
a B-O B-NP_DT
tax B-O B-NP_NN
" " B-O O-NP
transgenic B-O B-JJ
mouse B-O B-NN
model B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
tax B-O B-S_NP_NN
" " B-O O-NP
transforms B-O B-VP_VBZ
mouse B-O B-NP_NP_NN
fibroblasts B-O B-NNS
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
thymocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
despite B-O B-PP_IN
comparable B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Constitutive B-O B-S_NP_NP_JJ
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
130-kD B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_PP_PP_IN
the B-O B-NP_DT
tax B-O B-NP_NN
" " B-O O-NP
transformed B-O B-NP_JJ
fibroblast B-O B-NN
B B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
HTLV-1 B-O B-NP_NN
transformed B-O B-JJ
human B-O B-JJ
lymphoid B-O B-JJ
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
thymocytes B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
Thy-tax B-O B-NP_NN
transgenic B-O B-JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Phosphotyrosine B-O B-S_NP_NP_NN
immunoprecipitation B-O B-NN
" " B-O O-NP
followed B-O B-VP_VBN
by B-O B-NP_PP_IN
Western B-O B-NP_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
set B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Jak B-O B-NP_NN
kinase B-O B-NN
specific B-O B-JJ
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
identified B-O B-VP_VBD
p130 B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_PP_IN
Jak2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
tax B-O B-NP_NN
" " B-O O-NP
transformed B-O B-JJ
mouse B-O B-NP_NN
fibroblastic B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
Jak3 B-O B-PP_NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
HTLV-1 B-O B-NP_NN
transformed B-O B-JJ
human B-O B-JJ
T B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Phosphorylation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Jak2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
tax B-O B-NP_NN
transformed B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
from B-O B-PP_IN
high B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tyrosine B-O B-S_NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
Balb/c3T3 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
using B-O B-S_NP_VP_VBG
a B-O B-NP_NP_NP_DT
supernatant B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
B B-O B-NP_NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
associated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
phosphorylation B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
proliferation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
IL-6 B-O B-NP_NN
neutralizing B-O B-NN
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Constitutive B-O B-S_NP_NP_JJ
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Jak B-O B-NP_NN
kinases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
facilitate B-O B-VP_VB
tumor B-O B-NP_NN
growth B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_CC
HTLV-1 B-O B-NP_NN
infected B-O B-JJ
human B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
transgenic B-O B-JJ
mouse B-O B-NN
model B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
erythropoietin B-O B-NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
proteins B-O B-NP_NP_NNS
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
GATA-1 B-O B-NP_NN
and B-O B-CC
Sp1 B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Erythropoietin B-O B-S_S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
Epo B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
primary B-O B-JJ
regulator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
erythroid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
acts B-O B-VP_VBZ
by B-O B-PP_IN
binding B-O B-S_NP_VP_VBG
to B-O B-PP_TO
a B-O B-NP_NP_DT
on B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
used B-O B-VP_VBD
deletion B-O B-NP_NP_NP_NN
analysis B-O B-NN
" " B-O O-NP
and B-O B-CC
transfection B-O B-NP_NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
reporter B-O B-NP_NN
gene B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-S_NP_VP_TO
examine B-O B-VP_VB
the B-O B-NP_NP_DT
transcription B-O B-NP_NN
control B-O B-NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
erythroid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
most B-O B-NP_NP_JJS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
contained B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
150 B-O B-NP_CD
bp B-O B-NN
promoter B-O B-NN
" " B-O O-NP
fragment B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
binding B-O B-NP_NP_VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
150 B-O B-NP_CD
bp B-O B-NN
hEpoR B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
exhibited B-O B-VP_VBD
high B-O B-NP_NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
low B-O B-NP_JJ
" " B-O B-NP_O-NP
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
erythroid B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
OCIM1 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
reflecting B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
high B-O B-NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
low B-O B-NP_JJ
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
constitutive B-O B-NP_JJ
hEpoR B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
GATA-1 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
Sp1 B-O B-NP_NN
" " B-O B-NP_O-NP
binding B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_NP_DT
promoter B-O B-NN
" " B-O O-NP
lacking B-O B-VP_VBG
a B-O B-NP_DT
TATA B-O B-NP_NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
a B-O B-NP_NP_DT
high B-O B-JJ
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Protein-DNA B-O B-S_NP_JJ
binding B-O B-NN
studies B-O B-NNS
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
Sp1 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
two B-O B-NP_NP_CD
other B-O B-JJ
CCGCCC B-O B-NP_NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_NP_ADJP_NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
could B-O B-VP_MD
bind B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_DT
Sp1 B-O B-NP_NN
binding B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
increasing B-O B-S_NP_VP_VBG
GATA-1 B-O B-NP_NP_NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
via B-O B-PP_IN
co-transfection B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
were B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
transactivate B-O B-VP_VB
the B-O B-NP_DT
hEpoR B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
the B-O B-NP_DT
" " B-O B-ADJP_NP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
, B-O B-COMMA
although B-O B-SBAR_IN
GATA-1 B-O B-S_NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
comparable B-O B-ADJP_JJ
in B-O B-PP_IN
OCIM1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
K562 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
we B-O B-S_NP_PRP
" " B-O O-NP
mutated B-O B-VP_VBD
the B-O B-NP_DT
Sp1 B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-ADVP_COMMA
resulting B-O B-S_NP_VP_VBG
in B-O B-PP_IN
a B-O B-NP_NP_DT
marked B-O B-JJ
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
could B-O B-VP_MD
restore B-O B-VP_VB
transactivation B-O B-NP_NN
" " B-O O-NP
by B-O B-PP_IN
increasing B-O B-S_NP_VP_VBG
GATA-1 B-O B-NP_NP_NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
OCIM1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
while B-O B-S_SBAR_IN
GATA-1 B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
transactivate B-O B-VP_VB
the B-O B-NP_DT
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hEpoR B-O B-NP_NP_NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
depend B-O B-VP_VB
on B-O B-PP_IN
" " B-O B-NP_NP_ADVP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Rather B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
hEpoR B-O B-NP_NP_NN
" " B-O O-NP
transcription B-O B-NN
activity B-O B-NN
" " B-O O-NP
depends B-O B-VP_VBZ
on B-O B-PP_IN
coordination B-O B-NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
Sp1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
other B-O B-NP_NP_JJ
cell-specific B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
possibly B-O B-ADVP_RB
" " B-O O-ADVP
other B-O B-NP_JJ
Sp1-like B-O B-NP_JJ
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
to B-O B-S_NP_VP_TO
provide B-O B-VP_VB
high B-O B-NP_ADJP_ADJP_JJ
level B-O B-NN
" " B-O O-ADJP
, B-O B-COMMA
tissue-specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
TCL1 B-O B-NP_NP_NP_NN
oncogene B-O B-NN
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
preleukemic B-O B-NP_NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
a B-O B-NP_NP_DT
case B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ataxia-telangiectasia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
TCL1 B-O B-NP_NN
oncogene B-O B-NN
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
human B-O B-NP_NP_JJ
chromosome B-O B-NN
" " B-O O-NP
14q32.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
chromosome B-O B-NP_NN
translocations B-O B-NP_NP_NNS
" " B-O O-NP
[ B-O B-PRN_LRB
and B-O B-NP_NP_CC
] B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
inversions B-O B-NP_NP_NP_NNS
" " B-O O-NP
[ B-O B-PRN_LRB
] B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
"T- acute" B-O B-NP_NP_NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
"- chronic" B-O B-NP_NP_JJ
" " B-O B-NP_O-NP
leukemias B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
arising B-O B-VP_VBG
in B-O B-PP_IN
cases B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_NP_JJ
chromosomal B-O B-JJ
rearrangements B-O B-NNS
" " B-O O-NP
occur B-O B-VP_VBP
also B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
the B-O B-NP_NP_DT
clonally B-O B-ADJP_RB
expanded B-O B-VBN
" " B-O O-ADJP
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
AT B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
before B-O B-PP_IN
the B-O B-NP_NP_DT
appearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
overt B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
analyzed B-O B-VP_VBN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TCL1 B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
and B-O B-CC
protein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_NP_NP_JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
PBLs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
from B-O B-PP_PP_IN
four B-O B-NP_CD
AT B-O B-NN
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
from B-O B-PP_IN
healthy B-O B-NP_JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
TCL1 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
overexpressed B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
" " B-O B-NP_NP_PP_O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Fluorescence B-O B-S_NP_NP_NN
in B-O B-ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TCL1 B-O B-NP_NN
genomic B-O B-JJ
locus B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
lymphocyte B-O B-NP_NP_NN
metaphases B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_NP_DT
AT B-O B-NN
patient B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
T-cell B-O B-NN
clonal B-O B-JJ
expansion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
breakpoint B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
t(14;14) B-O B-NN
translocation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
lies B-O B-VP_VP_VBZ
within B-O B-PP_IN
the B-O B-NP_DT
TCL1 B-O B-NP_NN
locus B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
TCL1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
activated B-O B-VP_VBN
in B-O B-NP_PP_IN
preleukemic B-O B-NP_JJ
clonal B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_NP_DT
consequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deregulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TCL1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
the B-O B-NP_NP_DT
first B-O B-JJ
event B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
initiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
malignancy B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_NP_DT
types B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
leukemias B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
represents B-O B-VP_VBZ
a B-O B-NP_NP_DT
potential B-O B-JJ
tool B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
clinical B-O B-NP_JJ
evaluation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Disruption B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
GATA B-O B-NP_NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
Duffy B-O B-NP_NN
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
abolishes B-O B-VP_VBZ
erythroid B-O B-NP_NP_NP_JJ
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Duffy-negative B-O B-NP_JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_NP_DT
mRNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
Duffy B-O B-NP_NN
blood B-O B-NN
group B-O B-NN
antigen B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
erythrocyte B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
Plasmodium B-O B-NN
vivax B-O B-NN
malaria B-O B-NN
parasite B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
recently B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
cloned B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
encode B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_DT
Duffy B-O B-NP_NP_NN
antigen/chemokine B-O B-NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
DARC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
a B-O B-NP_DT
single B-O B-JJ
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
most B-O B-S_NP_ADJP_JJS
Duffy-negative B-O B-JJ
" " B-O O-ADJP
blacks B-O B-NNS
" " B-O O-NP
carry B-O B-VP_VBP
a B-O B-NP_NP_DT
silent B-O B-NP_JJ
FY*B B-O B-NN
allele B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_DT
single B-O B-JJ
T B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-PP_TO
C B-O B-NP_NP_NN
substitution B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
mutation B-O B-NN
" " B-O O-NP
impairs B-O B-VP_VBZ
the B-O B-NP_NP_DT
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
erythroid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
disrupting B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
binding B-O B-NP_VBG
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
GATA1 B-O B-NP_NN
erythroid B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
With B-O B-S_PP_IN
the B-O B-NP_NP_DT
recent B-O B-JJ
characterization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
FY*A B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
FY*B B-O B-NP_NN
" " B-O B-NP_O-NP
alleles B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
these B-O B-NP_DT
findings B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VBP
the B-O B-NP_NP_NP_DT
molecular B-O B-JJ
basis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Duffy B-O B-NN
blood B-O B-NN
group B-O B-NN
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
an B-O B-NP_NP_DT
explanation B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
erythroid-specific B-O B-JJ
repression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
DARC B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Duffy-negative B-O B-NP_JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interleukin-2 B-O B-S_S_NP_NP_NP_NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Epstein-Barr B-O B-NP_JJ
virus-transformed B-O B-JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
nuclear B-O B-NP_JJ
factor-chi B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interleukin B-O B-NP_NP_NN
( B-O B-LRB
IL B-O B-NN
) B-O B-RRB
-2 B-O B-CD
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
investigated B-O B-VP_VBN
mainly B-O B-NP_PP_ADVP_RB
" " B-O O-ADVP
in B-O B-IN
T B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
predominant B-O B-JJ
producers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
synthesize B-O B-VP_VB
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
analyzed B-O B-VP_VBD
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NP_NP_NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Epstein-Barr B-O B-NP_NP_JJ
virus B-O B-NN
( B-O B-LRB
EBV B-O B-NN
) B-O B-RRB
-transformed B-O B-JJ
B B-O B-NN
cell B-O B-NN
clones B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transient B-O B-S_NP_NP_JJ
transfections B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
reporter B-O B-NP_NP_NN
constructs B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
multiples B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
[ B-O B-NP_NP_NP_PP_PRN_LRB
] B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
performed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
EBV-transformed B-O B-NP_JJ
B B-O B-NN
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
chi B-O B-NP_NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
exerted B-O B-VP_VBD
the B-O B-NP_DT
strongest B-O B-ADJP_ADJP_JJS
" " B-O O-ADJP
inducible B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
the B-O B-S_NP_DT
NF-AT B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
showed B-O B-VP_VBD
either B-O B-NP_CC
no B-O B-NP_DT
" " B-O B-NP_O-NP
or B-O B-CC
only B-O B-NP_ADJP_RB
weak B-O B-JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
compared B-O B-PP_VBN
to B-O B-PP_TO
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_DT
IL-2 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
bearing B-O B-VP_VBG
a B-O B-NP_DT
defective B-O B-JJ
NF-chi B-O B-NP_NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
completely B-O B-ADJP_RB
inactive B-O B-JJ
in B-O B-PP_IN
EBV-transformed B-O B-NP_NN
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
while B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
still B-O B-ADVP_RB
" " B-O O-ADVP
had B-O B-VP_VBD
activity B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
seven B-O B-NP_NP_CD
EBV-B B-O B-NP_NN
cell B-O B-NN
clones B-O B-NNS
" " B-O O-NP
or B-O B-CC
lines B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O O-NP
differing B-O B-VP_VBG
in B-O B-PP_IN
their B-O B-NP_PRPP
capacity B-O B-NN
to B-O B-S_NP_VP_TO
secrete B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
well B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
the B-O B-NP_NP_DT
status B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
secretion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similarly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
a B-O B-NP_NP_DT
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
whose B-O B-SBAR_WHNP_WPP
activity B-O B-NN
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
controlled B-O B-VP_VBN
through B-O B-NP_PP_IN
chi B-O B-NP_NN
B B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
active B-O B-ADJP_ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
, B-O B-COMMA
but B-O B-CC
inactive B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Electrophoretic B-O B-S_NP_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
protein B-O B-NP_NP_NP_NN
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
EBV-B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
IL-2 B-O B-NP_NN
" " B-O O-NP
NF-chi B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
probe B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
revealed B-O B-VP_VBD
the B-O B-NP_NP_DT
constitutive B-O B-JJ
generation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
chi B-O B-NP_NN
B B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
IL-2-secreting B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
consisting B-O B-VP_VBG
mainly B-O B-ADVP_RB
" " B-O O-ADVP
of B-O B-PP_IN
heterodimeric B-O B-NP_JJ
p50/p65 B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
weaker B-O B-JJR
chi B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
complex B-O B-JJ
formation B-O B-NN
" " B-O O-NP
and B-O B-CC
faster-migrating B-O B-NP_JJ
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
non-IL-2-secreting B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
IL-2 B-O B-NP_NN
NF-chi B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
indispensable B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
whereas B-O B-SBAR_IN
other B-O B-S_NP_JJ
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
appear B-O B-VP_VBP
" " B-O B-S_NP_VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcriptional B-O B-NP_NP_NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
gene B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
the B-O B-NP_NP_DT
human B-O B-NP_JJ
C-type B-O B-JJ
lectin B-O B-NN
leukocyte B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
AIM/CD69 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
functional B-O B-NP_NP_JJ
characterization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
tumor B-O B-NP_NN
necrosis B-O B-NN
factor-alpha-responsive B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
human B-O B-NP_JJ
activation B-O B-NN
antigen B-O B-NN
" " B-O O-NP
CD69 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
C-type B-O B-NP_JJ
animal B-O B-NN
lectin B-O B-NN
superfamily B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
functions B-O B-S_NP_VP_VBZ
as B-O B-PP_IN
a B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Although B-O B-S_SBAR_IN
the B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD69 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
induced B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
on B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
wide B-O B-JJ
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
in B-O B-S_ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
it B-O B-NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
mainly B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
by B-O B-NP_PP_IN
T-lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
located B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
elucidate B-O B-VP_VB
the B-O B-NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
regulate B-O B-S_NP_VP_VBP
" " B-O B-NP_NP_PP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
isolated B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
promoter B-O B-NP_NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD69 B-O B-NP_NN
" " B-O O-NP
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
carried B-O B-VP_VBD
out B-O B-PRT_RP
" " B-O O-PRT
its B-O B-NP_PRPP
functional B-O B-JJ
characterization B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Sequence B-O B-S_NP_NP_NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
5'-flanking B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD69 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
the B-O B-NP_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_NP_DT
potential B-O B-JJ
TATA B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-ADVP_ADVP_NP_PP_IN
" " B-O B-NP_O-ADVP
" " B-O O-NP
and B-O B-CC
several B-O B-NP_NP_ADJP_JJ
putative B-O B-JJ
binding B-O B-NN
" " B-O O-ADJP
sequences B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
might B-O B-S_NP_VP_MD
mediate B-O B-VP_VB
the B-O B-NP_NP_DT
inducible B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transient B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD69 B-O B-NP_NN
promoter-based B-O B-JJ
reporter B-O B-NN
gene B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
proximal B-O B-NP_JJ
promoter B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
spanning B-O B-VP_VBG
positions B-O B-NP_NP_NNS
" " B-O O-NP
-78 B-O B-NP_NP_CD
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
contained B-O B-VP_VBD
the B-O B-NP_NP_DT
cis-acting B-O B-NP_JJ
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-NP
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Removal B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
upstream B-O B-JJ
sequences B-O B-NNS
" " B-O O-NP
located B-O B-ADJP_JJ
between B-O B-PP_IN
positions B-O B-NP_NP_NNS
" " B-O O-NP
-78 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
-38 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VP_VBD
in B-O B-PP_IN
decreased B-O B-NP_VBN
promoter B-O B-NN
strength B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
abolished B-O B-VP_VBD
the B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
phorbol B-O B-NP_NN
12-myristate B-O B-NN
13-acetate B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBD
that B-O B-SBAR_IN
tumor B-O B-S_NP_NP_NN
necrosis B-O B-NN
factor-alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TNF-alpha B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
capable B-O B-ADJP_JJ
of B-O B-PP_IN
inducing B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
Ubiquitin-mediated B-O B-NP_NP_NP_JJ
processing B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NP_NN
B B-O B-NN
" " B-O O-NP
transcriptional B-O B-NP_JJ
activator B-O B-NN
precursor B-O B-NN
" " B-O O-NP
" " B-O O-NP
p105 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Reconstitution B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
cell-free B-O B-JJ
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
identification B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
ubiquitin-carrier B-O B-NP_NP_JJ
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
E2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
a B-O B-NP_DT
novel B-O B-JJ
ubiquitin-protein B-O B-NP_JJ
ligase B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
E3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
conjugation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
In B-O B-S_S_PP_IN
most B-O B-NP_JJS
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
transcriptional B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
heterodimer B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
consisting B-O B-VP_VBG
of B-O B-PP_IN
two B-O B-NP_NP_NP_CD
subunits B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
p50 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
translated B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_NP_DT
precursor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
105 B-O B-NP_CD
kDa B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
C-terminal B-O B-NP_JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
precursor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
degraded B-O B-VP_VBN
" " B-O B-NP_O-VP
, B-O B-COMMA
forming B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
mature B-O B-NP_JJ
p50 B-O B-NN
subunit B-O B-NN
" " B-O O-NP
" " B-O O-NP
consisted B-O B-VP_VBN
of B-O B-NP_PP_IN
the B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
generation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
known B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
suggested B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
ubiquitin-proteasome B-O B-JJ
system B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
however B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_NP_DT
specific B-O B-JJ
enzymes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
involved B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
limited B-O B-NP_NP_JJ
proteolysis B-O B-NN
" " B-O O-NP
, B-O B-COMMA
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
is B-O B-S_NP_NP_PP_VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
obscure B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Palombella B-O B-S_NP_NP_NP_NNP
" " B-O O-NP
and B-O B-CC
colleagues B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
Palombella B-O B-NP_NP_NP_NNP
, B-O B-COMMA
V.J. B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
Rando B-O B-NP_NNP
, B-O B-COMMA
O.J. B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
Goldberg B-O B-NP_NNP
, B-O B-COMMA
A.L. B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Maniatis B-O B-NP_NNP
, B-O B-COMMA
T. B-O B-NNP
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
1994 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
Cell B-O B-NP_NNP
78 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
773-785 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
ubiquitin B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
They B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
also B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
proteasome B-O B-S_NP_NP_NN
" " B-O O-NP
inhibitors B-O B-NNS
" " B-O O-NP
block B-O B-VP_VBP
the B-O B-NP_DT
processing B-O B-NN
" " B-O O-NP
both B-O B-ADVP_CC
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
and B-O B-CC
in B-O B-ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VP_VBP
reconstitution B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
cell-free B-O B-JJ
processing B-O B-NN
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
demonstrate B-O B-VP_VBP
directly B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
: B-O B-S_COLON
( B-O B-S_LST_LRB
a B-O B-LS
) B-O B-RRB
" " B-O O-LST
the B-O B-NP_DT
ubiquitin-proteasome B-O B-JJ
system B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
( B-O B-S_LST_LRB
b B-O B-LS
) B-O B-RRB
" " B-O O-LST
conjugation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ubiquitin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
precursor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_DT
essential B-O B-JJ
intermediate B-O B-JJ
step B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
processing B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
( B-O B-S_LST_LRB
c B-O B-LS
) B-O B-RRB
" " B-O O-LST
, B-O B-NP_NP_NP_NP_PP_COMMA
E2-F1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
( B-O B-S_LST_LRB
d B-O B-LS
) B-O B-RRB
" " B-O O-LST
a B-O B-NP_NP_DT
novel B-O B-JJ
, B-O B-COMMA
approximately B-O B-RB
320-kDa B-O B-NP_CD
species B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
ubiquitin-protein B-O B-NP_JJ
ligase B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
novel B-O B-JJ
enzyme B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
distinct B-O B-ADJP_JJ
from B-O B-PP_PP_IN
E6-AP B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
p53-conjugating B-O B-NP_NN
ligase B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
from B-O B-PP_IN
E3 B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
"""" B-O B-NP_LQT
N-end B-O B-JJ
rule B-O B-NN
"""" B-O B-RQT
ligase B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Nonradioactive B-O B-NP_NP_NP_JJ
quantification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
differentiation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
U937 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
describe B-O B-VP_VBP
a B-O B-NP_NP_NP_DT
method B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
relative B-O B-NP_NP_JJ
quantification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_JJ
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
using B-O B-VP_VBG
a B-O B-NP_NP_DT
nonradioactive B-O B-JJ
assay B-O B-NN
" " B-O O-NP
based B-O B-PP_VBN
on B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
As B-O B-S_SBAR_IN
the B-O B-S_NP_DT
target B-O B-NN
quantity B-O B-NN
" " B-O O-NP
increased B-O B-VP_VBD
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
that B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
double-labeled B-O B-JJ
probe B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
decreased B-O B-VP_VBD
in B-O B-PP_IN
accordance B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
mass B-O B-NN
action B-O B-NN
law B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
technique B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
successfully B-O B-ADVP_RB
" " B-O O-ADVP
applied B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
evaluate B-O B-VP_VB
differences B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
before B-O B-PP_PP_IN
" " B-O B-NP_O-PP
and B-O B-CC
after B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
12-O-tetradecanoylphorbol B-O B-NP_NP_NP_NN
13-acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TPA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
all-trans B-O B-NP_NP_JJ
retinoic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
1,25-dihydroxyvitamin B-O B-NP_NP_NN
D2 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
VD B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
that B-O B-SBAR_IN
TPA B-O B-S_NP_NN
treatment B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
and B-O B-NP_NP_NP_PP_CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
while B-O B-SBAR_IN
no B-O B-S_NP_DT
enhanced B-O B-VBN
GR B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
perceived B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_NP_DT
hematopoietic B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
PU.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
downregulated B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_JJ
multiple B-O B-JJ
myeloma B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
PU.1 B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
hematopoietic B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
belonging B-O B-VP_VBG
to B-O B-PP_TO
the B-O B-NP_DT
Ets-family B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
identical B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
Spi-1 B-O B-NP_NN
oncogene B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
implicated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PU.1 B-O B-S_S_NP_NN
" " B-O O-NP
seems B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
its B-O B-S_NP_NP_PRPP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
mature B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
preferentially B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
B-cell-and B-O B-NP_NN
monocyte/macrophage-differentiation B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
binds B-O B-VP_VBZ
the B-O B-NP_NP_DT
so-called B-O B-JJ
Pu B-O B-NP_NN
box B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
important B-O B-JJ
tissue-specific B-O B-NP_JJ
regulatory B-O B-JJ
DNA B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
a B-O B-NP_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
analyzed B-O B-VP_VBN
the B-O B-NP_NP_DT
expression B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
PU.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
human B-O B-NP_JJ
B-cell B-O B-NN
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
using B-O B-S_NP_VP_VBG
a B-O B-NP_NP_NP_DT
panel B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B-cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
representing B-O B-VP_VBG
different B-O B-NP_NP_NP_JJ
stages B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
from B-O B-PP_IN
early B-O B-NP_JJ
precursors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
differentiated B-O B-NP_VBN
plasma B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PU.1 B-O B-S_NP_NP_NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
and B-O B-CC
PU.1 B-O B-NP_NP_NN
" " B-O O-NP
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
as B-O B-SBAR_IN
measured B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
Northern B-O B-NP_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
and B-O B-CC
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
were B-O B-VP_VBD
evident B-O B-ADJP_JJ
in B-O B-PP_IN
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
representing B-O B-VP_VBG
pro-B B-O B-NP_NP_JJ
" " B-O B-NP_O-NP
, B-O B-COMMA
pre-B B-O B-NP_JJ
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
mature B-O B-NP_JJ
B B-O B-NN
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
could B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
show B-O B-VP_VB
Pu B-O B-NP_NP_NN
box-dependent B-O B-JJ
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
transient B-O B-NP_NP_JJ
transfections B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
a B-O B-NP_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
multiple B-O B-NP_JJ
myeloma B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
representing B-O B-VP_VBG
differentiated B-O B-NP_VBN
, B-O B-COMMA
plasma B-O B-NN
cell-like B-O B-JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
PU.1 B-O B-NP_NP_NP_NN
" " B-O O-NP
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
, B-O B-COMMA
mRNA B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Pu B-O B-NP_NN
box-dependent B-O B-JJ
transactivation B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
absent B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
detectable B-O B-ADJP_JJ
at B-O B-PP_IN
a B-O B-NP_DT
very B-O B-ADJP_RB
low B-O B-JJ
" " B-O O-ADJP
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
lymphoblastoid B-O B-NP_NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
exemplify B-O B-S_NP_VP_VBP
an B-O B-NP_NP_DT
intermediate B-O B-JJ
stage B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B-cell B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_DT
reduced B-O B-VBN
expression B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
findings B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
multiple B-O B-JJ
myeloma B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
represent B-O B-VP_VP_VBP
the B-O B-NP_NP_DT
first B-O B-JJ
examples B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
B B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
downregulated B-O B-NP_VBN
PU.1 B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
apparently B-O B-ADVP_RB
" " B-O O-ADVP
contradict B-O B-VP_VBP
observations B-O B-NP_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
murine B-O B-JJ
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
PU.1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-UCP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
active B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-UCP
in B-O B-PP_IN
plasmacytoma B-O B-NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
At B-O B-S_PP_IN
present B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
it B-O B-NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
unclear B-O B-ADJP_JJ
" " B-O O-ADJP
whether B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
lack B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PU.1 B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
multiple B-O B-JJ
myeloma B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
represents B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
malignancy-associated B-O B-JJ
defect B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
or B-O B-CC
exemplifies B-O B-VP_VBZ
a B-O B-NP_NP_DT
normal B-O B-JJ
developmental B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
terminally B-O B-NP_RB
differentiated B-O B-VBN
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Microtubules B-O B-S_S_NP_NNS
" " B-O O-NP
mediate B-O B-VP_VBP
cellular B-O B-NP_NP_JJ
25-hydroxyvitamin B-O B-NN
D3 B-O B-NN
trafficking B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
genomic B-O B-JJ
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
1,25-dihydroxyvitamin B-O B-NP_NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
normal B-O B-NP_JJ
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
genomic B-O B-JJ
actions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
1,25-dihydroxyvitamin B-O B-NP_NP_NN
D3 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
intracellular B-O B-JJ
vitamin B-O B-NP_NP_NN
D B-O B-NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
VDR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Although B-O B-S_SBAR_IN
immunocytochemistry B-O B-S_NP_NN
" " B-O O-NP
has B-O B-VP_VBZ
shown B-O B-VP_VBN
that B-O B-SBAR_IN
disruption B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
prevents B-O B-VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
microtubules B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
not B-O B-RB
been B-O B-VP_VBN
studied B-O B-VP_VBN
in B-O B-NP_PP_IN
viable B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
studies B-O B-NNS
" " B-O O-NP
examined B-O B-VP_VBD
this B-O B-NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
normal B-O B-NP_JJ
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Monocytes B-O B-S_NP_NNS
" " B-O O-NP
convert B-O B-VP_VBP
25(OH)D3 B-O B-NP_NN
" " B-O O-NP
to B-O B-PP_PP_TO
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
to B-O B-PP_TO
24-hydroxylated B-O B-NP_NP_JJ
metabolites B-O B-NNS
" " B-O O-NP
more B-O B-ADJP_ADJP_RBR
polar B-O B-JJ
" " B-O O-ADJP
than B-O B-PP_IN
1,25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Microtubule B-O B-S_NP_NN
disruption B-O B-NN
" " B-O O-NP
totally B-O B-ADVP_RB
" " B-O O-ADVP
abolished B-O B-VP_VBD
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
exogenous B-O B-NP_JJ
1,25(OH)2D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_VP_TO
suppress B-O B-VP_VB
its B-O B-NP_PRPP
own B-O B-JJ
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
to B-O B-VP_TO
induce B-O B-VP_VB
24-hydroxylase B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
and B-O B-CC
activity B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
, B-O B-COMMA
without B-O B-PP_IN
affecting B-O B-S_NP_VP_VBG
either B-O B-NP_CC
total B-O B-NP_JJ
1,25(OH)2D3 B-O B-NN
uptake B-O B-NN
" " B-O O-NP
or B-O B-CC
maximal B-O B-NP_JJ
1,25(OH)2D3-VDR B-O B-JJ
binding B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
intact B-O B-NP_JJ
microtubules B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
essential B-O B-ADJP_JJ
for B-O B-PP_IN
1,25(OH)2D3-dependent B-O B-NP_NP_JJ
modulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
microtubule B-O B-NP_NP_NN
" " B-O O-NP
disruption B-O B-NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-VP_VBD
monocyte B-O B-NP_NP_NN
" " B-O O-NP
1,25(OH)2D3 B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
, B-O B-COMMA
not B-O B-PP_RB
by B-O B-PP_IN
decreasing B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
Vmax B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
monocyte B-O B-NP_NN
mitochondrial B-O B-JJ
1 B-O B-CD
alpha-hydroxylase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
but B-O B-CC
through B-O B-PP_IN
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
Km B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
25(OH)2D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
25(OH)D3 B-O B-NP_NN
transport B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Microtubule B-O B-S_NP_NN
disruption B-O B-NN
" " B-O O-NP
did B-O B-VP_VP_VBD
not B-O B-RB
affect B-O B-VP_VB
total B-O B-NP_JJ
cellular B-O B-JJ
25(OH)D3 B-O B-NN
uptake B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
but B-O B-CC
reduced B-O B-VP_VBD
its B-O B-NP_NP_PRPP
intracellular B-O B-JJ
trafficking B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
mitochondria B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
microtubules B-O B-S_S_NP_NNS
" " B-O O-NP
participate B-O B-VP_VBP
in B-O B-PP_IN
intracellular B-O B-NP_JJ
25(OH)D3 B-O B-NN
transport B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
their B-O B-S_NP_PRPP
integrity B-O B-NN
" " B-O O-NP
determines B-O B-VP_VBZ
normal B-O B-NP_JJ
1,25(OH)2D3 B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_S_NP_NP_DT
regulatory B-O B-NP_JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
interleukin B-O B-NN
2 B-O B-CD
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
binding B-O B-NP_VBG
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
zinc B-O B-NP_NP_NN
finger B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
Sp1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
EGR-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Activation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
interleukin B-O B-NP_NN
2 B-O B-CD
( B-O B-LRB
IL-2 B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
antigen B-O B-NP_NN
recognition B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
critical B-O B-JJ
event B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
proliferation B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
effector B-O B-NP_NN
function B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Prior B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
several B-O B-NP_NP_JJ
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contribute B-O B-S_NP_VP_VBP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
describe B-O B-VP_VBP
a B-O B-NP_NP_DT
novel B-O B-JJ
regulatory B-O B-NP_JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_NP_DT
IL-2 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
located B-O B-ADJP_JJ
immediately B-O B-ADVP_RB
upstream B-O B-RB
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_NP_DT
region B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
termed B-O B-VP_VBN
the B-O B-S_NP_NP_DT
zinc B-O B-NP_NP_NN
finger B-O B-NN
protein B-O B-NN
binding B-O B-NN
region B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
serves B-O B-VP_VBZ
as B-O B-PP_IN
binding B-O B-NP_NP_VBG
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
two B-O B-NP_CD
differently B-O B-ADJP_RB
regulated B-O B-VBN
" " B-O O-ADJP
zinc B-O B-NP_NN
finger B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
the B-O B-NP_NP_NP_DT
constitutively B-O B-NP_RB
expressed B-O B-VBN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
Sp1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
inducible B-O B-NP_NP_JJ
early B-O B-JJ
growth B-O B-NN
response B-O B-NN
protein B-O B-NN
" " B-O O-NP
EGR-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
unstimulated B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
do B-O B-S_NP_VP_VBP
not B-O B-RB
secrete B-O B-VP_VB
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
only B-O B-NP_ADVP_RB
" " B-O O-ADVP
Sp1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
this B-O B-NP_DT
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
while B-O B-SBAR_IN
in B-O B-S_PP_IN
stimulated B-O B-NP_VBN
IL-2 B-O B-NN
secreting B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
inducible B-O B-NP_JJ
EGR-1 B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
recognizes B-O B-VP_VBZ
this B-O B-NP_DT
element B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-S_S_NP_DT
ZIP B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
serves B-O B-VP_VBZ
as B-O B-PP_IN
an B-O B-NP_NP_DT
activator B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
a B-O B-S_NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ZIP B-O B-NP_NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
NFAT B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
maximal B-O B-NP_JJ
IL-2 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
a B-O B-NP_NP_DT
critical B-O B-JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
ZIP B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_DT
zinc B-O B-NN
finger B-O B-NN
transcription B-O B-NN
factor B-O B-NN
Egr-1 B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
restricts B-O B-VP_VBZ
" " B-O B-NP_O-VP
" " B-O O-VP
differentiation B-O B-NP_NP_NN
" " B-O O-NP
along B-O B-PP_IN
the B-O B-NP_DT
macrophage B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
isolated B-O B-VP_VBN
cDNA B-O B-NP_NP_NN
clones B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
myeloid B-O B-NP_NP_NP_JJ
differentiation B-O B-NN
primary B-O B-JJ
response B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MyD B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
activated B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-DT
absence B-O B-NN
of B-O B-IN
de B-O B-NP_NP_ADJP_FW
novo B-O B-FW
" " B-O O-ADJP
protein B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
following B-O B-PP_VBG
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
cDNA B-O B-NN
clone B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
primary B-O B-JJ
response B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
expressed B-O B-VP_VBN
upon B-O B-NP_PP_IN
macrophage B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
encoded B-O B-VP_VBD
for B-O B-PP_IN
Egr-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
zinc B-O B-NN
finger B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
Egr-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VP_VP_VB
transcriptionally B-O B-ADVP_RB
" " B-O O-ADVP
silent B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
" " B-O B-NP_O-VP
, B-O B-COMMA
but B-O B-CC
active B-O B-VP_ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
, B-O B-COMMA
the B-O B-S_NP_DT
latter B-O B-JJ
two B-O B-CD
" " B-O O-NP
being B-O B-VP_VBG
predetermined B-O B-ADJP_VBN
" " B-O O-ADJP
for B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Egr-1 B-O B-S_NP_NP_NN
antisense B-O B-JJ
oligomers B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
culture B-O B-NN
media B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
blocked B-O B-VP_VBD
macrophage B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_DT
myeloid B-O B-NP_JJ
leukemia B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
and B-O B-CC
normal B-O B-NP_JJ
myeloblasts B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HL-60 B-O B-S_NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
constitutively B-O B-VP_ADVP_RB
" " B-O O-ADVP
expressing B-O B-VBG
an B-O B-NP_NP_DT
Egr-1 B-O B-NN
transgene B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HL-60Egr-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
induced B-O B-VP_VBN
for B-O B-NP_PP_IN
macrophage B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
granulocyte B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Egr-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
restricts B-O B-VP_VBZ
" " B-O B-NP_O-VP
" " B-O O-VP
differentiation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
myeloblasts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
along B-O B-PP_IN
the B-O B-NP_DT
macrophage B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
tal-1 B-O B-NP_ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
GATA-binding B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
human B-O B-NP_JJ
hematopoiesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Tal-1 B-O B-S_NP_NN
rearrangements B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
nearly B-O B-NP_NP_QP_RB
30 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
acute B-O B-JJ
lymphoblastic B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tal-1 B-O B-S_NP_NN
gene B-O B-NN
" " B-O O-NP
encodes B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
putative B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_DT
basic B-O B-JJ
helix-loop-helix B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
predominantly B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tal-1 B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
purified B-O B-NP_VBN
human B-O B-JJ
hematopoietic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
in B-O B-NP_NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
and B-O B-CC
reverse B-O B-NP_JJ
transcriptase B-O B-NN
polymerase B-O B-NN
chain B-O B-NN
reaction B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_DT
methods B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
tal-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
basophilic B-O B-NP_JJ
granulocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
our B-O B-NP_PRPP
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
tal-1 B-O B-NN
1A B-O B-NN
promoter B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contains B-O B-S_NP_VP_VBZ
two B-O B-NP_CD
consensus B-O B-NN
GATA-binding B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
active B-O B-ADJP_JJ
" " B-O O-ADJP
mainly B-O B-PP_RB
in B-O B-IN
these B-O B-NP_DT
lineages B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
the B-O B-S_NP_DT
GATA-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
transactivate B-O B-VP_VB
" " B-O B-NP_NP_ADJP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
GATA-1 B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
purified B-O B-VBN
hematopoietic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
GATA-1 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
tal-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
genes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
coexpressed B-O B-VP_VBN
in B-O B-NP_PP_IN
these B-O B-NP_DT
three B-O B-CD
lineages B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Remarkably B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
downmodulated B-O B-VP_VBN
during B-O B-NP_PP_IN
erythroid B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
megakaryocytic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
terminal B-O B-JJ
maturation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
immature B-O B-NP_JJ
hematopoietic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
tal-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
genes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
coexpressed B-O B-VP_VBN
in B-O B-NP_PP_IN
committed B-O B-NP_NP_VBN
progenitors B-O B-NNS
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
CD34+/CD38(2+) B-O B-NP_JJ
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
whereas B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
detectable B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
the B-O B-NP_NP_DT
cells B-O B-ADJP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
GATA-2 B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
strongly B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
both B-O B-NP_NP_CC
" " B-O B-NP_ADJP_NP_O-NP
and B-O B-CC
committed B-O B-NP_VBN
progenitors B-O B-NNS
" " B-O B-NP_O-NP
" " B-O O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
GATA-3 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
mostly B-O B-ADVP_RB
" " B-O O-ADVP
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
most B-O B-NP_ADJP_RBS
primitive B-O B-JJ
" " B-O O-ADJP
ones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Altogether B-O B-S_ADVP_RB
" " B-O O-ADVP
our B-O B-NP_PRPP
results B-O B-NNS
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
GATA-1 B-O B-S_NP_NN
" " B-O O-NP
modulates B-O B-VP_VBZ
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tal-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
during B-O B-PP_IN
the B-O B-NP_NP_DT
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
lineages B-O B-ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cell B-O B-S_NP_NP_ADJP_ADJP_NP_NN
type- B-O B-NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
stage-specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD20/B1 B-O B-NN
antigen B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
diverged B-O B-JJ
octamer B-O B-NN
DNA B-O B-NN
motif B-O B-NN
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
its B-O B-NP_PRPP
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
CD20 B-O B-NN
( B-O B-LRB
B1 B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_NP_DT
B B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
B B-O B-NN
cell B-O B-NN
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Studies B-O B-S_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
5' B-O B-NP_JJ
deletion B-O B-NN
CD20 B-O B-NN
promoter-CAT B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-VP_ADVP_RB
" " B-O O-ADVP
revealed B-O B-VBN
two B-O B-NP_NP_CD
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
between B-O B-PP_PP_IN
bases B-O B-NP_NNS
-186 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
-280 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
between B-O B-PP_IN
bases B-O B-NP_NNS
-280 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
-454 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contained B-O B-S_NP_VP_VBD
positive B-O B-NP_JJ
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
identified B-O B-VP_VBD
a B-O B-NP_NP_DT
sequence B-O B-NN
element B-O B-NN
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_NP_NP_DT
most B-O B-ADJP_RBS
proximal B-O B-JJ
" " B-O O-ADJP
region B-O B-NN
" " B-O O-NP
located B-O B-ADJP_JJ
between B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
, B-O B-COMMA
TTCTTCTAATTAA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
important B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
and B-O B-NP_NP_NP_PP_PP_CC
" " B-O B-NP_NP_PP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
sequence B-O B-NN
element B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
referred B-O B-VP_VBN
to B-O B-PP_TO
" " B-O B-NP_O-PP
as B-O B-PP_IN
the B-O B-NP_DT
BAT B-O B-NN
box B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
its B-O B-S_NP_PRPP
deletion B-O B-NN
" " B-O O-NP
significantly B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBD
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
CD20 B-O B-NN
promoter-CAT B-O B-JJ
construct B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Mobility B-O B-S_NP_NP_NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
various B-O B-NP_NP_JJ
mutant B-O B-JJ
probes B-O B-NNS
" " B-O O-NP
and B-O B-CC
B B-O B-NP_NN
cell B-O B-NN
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
core B-O B-NN
sequence B-O B-NN
TAAT B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
essential B-O B-ADJP_JJ
for B-O B-PP_IN
binding B-O B-S_NP_VP_VBG
" " B-O B-PP_O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cross B-O B-S_NP_NP_NN
competition B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
an B-O B-NP_NP_NP_DT
octamer B-O B-NN
sequence B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
Ig B-O B-NN
heavy B-O B-JJ
chain B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
BAT B-O B-NN
box B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
a B-O B-NP_NP_DT
TA-rich B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_DT
CD21 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
all B-O B-S_NP_DT
three B-O B-CD
sequences B-O B-NNS
" " B-O O-NP
bound B-O B-VP_VBD
the B-O B-NP_DT
same B-O B-JJ
nuclear B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Southwestern B-O B-S_NP_NP_NN
blotting B-O B-NN
" " B-O O-NP
and B-O B-CC
UV B-O B-NP_NN
cross-linking B-O B-NN
studies B-O B-NNS
" " B-O O-NP
" " B-O O-NP
confirmed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
BAT B-O B-NN
box B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
Oct-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
affinity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
BAT B-O B-NN
box B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
BAT B-O B-NN
box B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
approximately B-O B-ADJP_ADJP_ADVP_RB
25-fold B-O B-RB
" " B-O O-ADVP
less B-O B-JJR
" " B-O O-ADJP
than B-O B-PP_IN
for B-O B-FRAG_PP_IN
the B-O B-NP_DT
octamer B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_DT
BAT B-O B-NN
box B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
dissociated B-O B-VP_VBD
from B-O B-PP_IN
the B-O B-NP_DT
BAT B-O B-NN
box B-O B-NN
" " B-O O-NP
" " B-O O-PP
10-fold B-O B-ADVP_ADVP_ADVP_RB
more B-O B-RBR
" " B-O O-ADVP
rapidly B-O B-RB
" " B-O O-ADVP
than B-O B-PP_IN
from B-O B-FRAG_PP_IN
the B-O B-NP_DT
octamer B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Despite B-O B-S_PP_IN
this B-O B-NP_DT
lower B-O B-JJR
affinity B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_DT
trimer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
BAT B-O B-NN
box B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
as B-O B-ADVP_ADVP_IN
efficiently B-O B-RB
" " B-O O-ADVP
" " B-O B-SBAR_O-ADVP
transactivated B-O B-VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_DT
Oct-2 B-O B-NN
expression B-O B-NN
vector B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-SBAR_IN
was B-O B-SINV_VBD
a B-O B-NP_NP_DT
trimer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
octamer B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O B-VP_O-SINV
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
BAT B-O B-NP_NP_NN
box B-O B-NN
" " B-O O-NP
and B-O B-CC
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
implicated B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD20 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
pre-B B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
PB-697 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
via B-O B-PP_IN
phorbol B-O B-NP_NN
esters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD20 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
temporally B-O B-VP_ADVP_RB
" " B-O O-ADVP
associated B-O B-VBN
with B-O B-NP_PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Oct-2 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
a B-O B-S_NP_DT
BAT B-O B-ADJP_NN
box-deleted B-O B-JJ
" " B-O O-ADJP
CD20-CAT B-O B-NN
construct B-O B-NN
" " B-O O-NP
, B-O B-COMMA
in B-O B-PP_IN
contrast B-O B-NN
to B-O B-TO
the B-O B-NP_DT
wild B-O B-JJ
type B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
was B-O B-VP_VBD
poorly B-O B-VP_ADVP_RB
" " B-O O-ADVP
induced B-O B-VBN
by B-O B-NP_PP_IN
phorbol B-O B-NP_NN
esters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
BAT B-O B-NN
box B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
are B-O B-VP_VP_VBP
important B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-ADJP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
perhaps B-O B-VP_ADVP_RB
" " B-O O-ADVP
CD21 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Functional B-O B-NP_NP_JJ
antagonism B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
vitamin B-O B-NP_NP_NN
D3 B-O B-NN
" " B-O O-NP
and B-O B-CC
retinoic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD14 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
CD23 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
monocytic B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
U-937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
1,25 B-O B-S_NP_NP_NP_CD
alpha-Dihydroxicholecalciferol B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
VitD3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
retinoic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
important B-O B-NP_NP_JJ
regulators B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
proliferation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
paper B-O B-NN
" " B-O O-NP
describes B-O B-VP_VBZ
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
monocyte-macrophage B-O B-JJ
Ag B-O B-NN
" " B-O O-NP
, B-O B-COMMA
CD14 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_NP_DT
low B-O B-JJ
affinity B-O B-NN
Fc B-O B-NN
receptor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
IgE B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
CD23 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
inversely B-O B-VP_ADVP_RB
" " B-O O-ADVP
regulated B-O B-VBN
during B-O B-NP_PP_IN
monocytic B-O B-NP_NP_ADJP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PMA B-O B-S_NP_NN
" " B-O O-NP
induced B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_NP_CC
CD14 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
CD23 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
mRNA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
protein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Exposure B-O B-S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
VitD3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBD
the B-O B-NP_NP_DT
de B-O B-ADJP_FW
novo B-O B-FW
" " B-O O-ADJP
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD14 B-O B-NP_NN
mRNA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
protein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cycloheximide B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
completely B-O B-ADVP_RB
" " B-O O-ADVP
blocked B-O B-VP_VBD
the B-O B-NP_NP_DT
VitD3 B-O B-NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD14 B-O B-NP_NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_DT
induction B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
While B-O B-S_SBAR_IN
inducing B-O B-S_NP_VP_VBG
CD14 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
VitD3 B-O B-NP_NN
" " B-O O-NP
concomitantly B-O B-ADVP_RB
" " B-O O-ADVP
suppressed B-O B-VP_VBD
the B-O B-NP_DT
basal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
PMA- B-O B-ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
, B-O B-COMMA
and B-O B-CC
RA-inducible B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
CD23 B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
dose-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
U-937 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBD
their B-O B-NP_NP_PRPP
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD23 B-O B-NP_NN
mRNA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
protein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
they B-O B-S_NP_PRP
" " B-O O-NP
completely B-O B-ADVP_RB
" " B-O O-ADVP
lacked B-O B-VP_VBD
detectable B-O B-NP_JJ
CD14 B-O B-NN
cell B-O B-NP_NP_NN
surface B-O B-NN
" " B-O O-NP
or B-O B-CC
mRNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_NP_DT
VitD3- B-O B-ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
the B-O B-NP_DT
PMA-induced B-O B-JJ
" " B-O B-NP_O-NP
" " B-O O-NP
CD14 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_NP_DT
temporal B-O B-JJ
consequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
RA-induced B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
exists B-O B-VP_VBZ
a B-O B-NP_NP_DT
functional B-O B-JJ
antagonism B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
VitD3 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
may B-O B-S_NP_VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Adenovirus B-O B-S_NP_NN
E1A B-O B-NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
IFN-induced B-O B-NP_NP_JJ
resistance B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
cytolysis B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
natural B-O B-NP_JJ
killer B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Infection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
target B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
cytopathic B-O B-NP_JJ
viruses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibits B-O B-VP_VBZ
IFN B-O B-NP_NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytolytic B-O B-NP_NP_JJ
resistance B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
NK B-O B-NP_ADJP_NN
cell-mediated B-O B-JJ
" " B-O O-ADJP
cytolysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
[ B-O B-PRN_LRB
IFN-mediated B-O B-NP_NP_JJ
cytoprotection B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IFN-MCP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
thought B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
virally B-O B-ADJP_RB
induced B-O B-VBN
" " B-O O-ADJP
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IFN-MCP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
secondary B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Group B-O B-S_NP_NN
C B-O B-NN
, B-O B-COMMA
adenovirus B-O B-NP_NP_NN
serotype B-O B-NN
5 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
Ad5 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
infection B-O B-NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
both B-O B-NP_CC
IFN-MCP B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
cellular B-O B-NP_JJ
protein B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
study B-O B-NN
" " B-O O-NP
determined B-O B-VP_VBD
if B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
Ad5-induced B-O B-JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IFN-MCP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
independent B-O B-ADJP_ADJP_JJ
of B-O B-PP_IN
infection B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
and B-O B-CC
secondary B-O B-ADJP_JJ
only B-O B-PP_RB
to B-O B-TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
test B-O B-VP_VB
this B-O B-NP_DT
hypothesis B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
4-h B-O B-NP_JJ
NK B-O B-NN
cytolysis B-O B-NN
assays B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
performed B-O B-VP_VBN
on B-O B-NP_PP_IN
IFN-gamma-treated B-O B-NP_NP_JJ
human B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
infected B-O B-ADJP_ADJP_VBN
with B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-ADJP
, B-O B-COMMA
or B-O B-CC
transfected B-O B-ADJP_VBN
with B-O B-PP_IN
the B-O B-NP_DT
Ad5 B-O B-NN
E1A B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IFN-MCP B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
infection B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
dl343 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
despite B-O B-PP_IN
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
large B-O B-NP_NP_JJ
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NN
to B-O B-TO
E1A-negative B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
parental B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
IFN-MCP B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
blocked B-O B-VP_VBN
in B-O B-NP_PP_IN
Ad5 B-O B-NP_ADJP_NN
E1A-transfected B-O B-JJ
" " B-O O-ADJP
epithelial B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
fibroblastic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Genetic B-O B-S_NP_NP_JJ
mapping B-O B-NN
studies B-O B-NNS
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_DT
E1A B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
only B-O B-NP_NP_RB
the B-O B-DT
first B-O B-JJ
exon B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E1A B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
sufficient B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNA B-O B-S_NP_NP_NN
sequence B-O B-NN
homology B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E1A B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
between B-O B-PP_IN
different B-O B-NP_NP_JJ
Ad B-O B-NN
groups B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
group B-O B-FRAG_FRAG_NP_NN
A B-O B-NN
" " B-O O-NP
, B-O B-COMMA
Ad12 B-O B-NP_NN
" " B-O O-NP
" " B-O O-FRAG
; B-O B-COLON
group B-O B-FRAG_NP_NN
C B-O B-NN
" " B-O O-NP
, B-O B-COMMA
Ad5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-FRAG
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
limited B-O B-VP_VBN
almost B-O B-NP_PP_ADVP_RB
entirely B-O B-RB
" " B-O O-ADVP
to B-O B-TO
three B-O B-NP_NP_CD
conserved B-O B-VBN
regions B-O B-NNS
" " B-O O-NP
located B-O B-ADJP_JJ
within B-O B-PP_IN
the B-O B-NP_NP_DT
first B-O B-JJ
exon B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
IFN-MCP B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
blocked B-O B-VP_VBN
in B-O B-NP_PP_IN
Ad12 B-O B-NP_NN
E1A-transfected B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
one B-O B-NP_NP_QP_CD
or B-O B-CC
more B-O B-JJR
" " B-O O-QP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
E1A-conserved B-O B-JJ
regions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
necessary B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
IFN-MCP B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
summary B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E1A B-O B-NP_NN
gene B-O B-NN
products B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibited B-O B-VP_VBD
IFN-MCP B-O B-NP_NN
" " B-O O-NP
independently B-O B-ADVP_RB
" " B-O O-ADVP
of B-O B-PP_IN
virus B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
E1A B-O B-S_NP_NP_NP_NN
's B-O B-POS
" " B-O O-NP
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IFN-MCP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
the B-O B-NP_NP_DT
net B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
promoting B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
selective B-O B-JJ
NK B-O B-ADJP_NN
cell-mediated B-O B-JJ
" " B-O O-ADJP
clearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_ADJP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_DT
mutation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
primary B-O B-NP_JJ
cortisol B-O B-NN
resistance B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
precise B-O B-JJ
molecular B-O B-JJ
abnormalities B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
cause B-O B-S_NP_VP_VBP
primary B-O B-NP_JJ
cortisol B-O B-NN
resistance B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
have B-O B-VP_VBP
not B-O B-RB
been B-O B-VP_VBN
completely B-O B-VP_ADVP_RB
" " B-O O-ADVP
described B-O B-VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
a B-O B-NP_NP_DT
subject B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
primary B-O B-NP_JJ
cortisol B-O B-NN
resistance B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
observed B-O B-VP_VBN
glucocorticoid B-O B-NP_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
hGR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
decreased B-O B-VBN
affinity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
hypothesize B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
mutation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hGR B-O B-NN
glucocorticoid-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
cause B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cortisol B-O B-NP_NN
resistance B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Total B-O B-S_S_NP_NP_JJ
RNA B-O B-NN
" " B-O O-NP
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_NP_DT
index B-O B-NN
subject B-O B-NN
's B-O B-POS
" " B-O O-NP
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
produce B-O B-VP_VB
first B-O B-NP_JJ
strand B-O B-NN
hGR B-O B-NN
cDNAs B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_DT
entire B-O B-JJ
hGR B-O B-NN
cDNA B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
amplified B-O B-VP_VP_VBN
in B-O B-NP_PP_IN
segments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
sequenced B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
At B-O B-S_PP_IN
nucleotide B-O B-NP_NN
2,317 B-O B-CD
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
identified B-O B-VP_VBD
a B-O B-NP_NP_DT
homozygous B-O B-JJ
A B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
G B-O B-NP_NP_NN
point B-O B-NN
mutation B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
predicts B-O B-S_NP_VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_NP_DT
wild-type B-O B-JJ
hGR B-O B-NN
" " B-O O-NP
and B-O B-CC
hGR-Ile B-O B-NP_NN
729 B-O B-CD
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
expressed B-O B-VP_VP_VP_VBN
in B-O B-NP_PP_IN
COS-1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
assayed B-O B-VP_VBN
for B-O B-NP_PP_IN
[3H]-Dexamethasone B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_DT
dissociation B-O B-NN
constants B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
0.799 B-O B-NP_NP_QP_QP_CD
+/- B-O B-CC
0.068 B-O B-CD
" " B-O O-QP
and B-O B-CC
1.54 B-O B-QP_CD
+/- B-O B-CC
0.06 B-O B-CD
" " B-O O-QP
" " B-O O-QP
nM B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
mean B-O B-NP_NP_NN
" " B-O O-NP
+/- B-O B-CC
SEM B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
( B-O B-PRN_LRB
P B-O B-S_NP_NN
" " B-O O-NP
< B-O B-NP_QP_JJR
0.01 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_NP_DT
wild-type B-O B-JJ
hGR B-O B-NN
" " B-O O-NP
and B-O B-CC
hGR-Ile B-O B-NP_NN
729 B-O B-CD
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
CV-1 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_DT
hGR-Ile B-O B-NN
729 B-O B-CD
" " B-O O-NP
conferred B-O B-VP_VBD
a B-O B-NP_NP_DT
fourfold B-O B-JJ
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
apparent B-O B-NP_JJ
potency B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
on B-O B-PP_IN
dexamethasone B-O B-NP_NP_NN
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CAT B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
isoleucine B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
valine B-O B-NP_NP_NN
substitution B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
amino B-O B-NP_NN
acid B-O B-NN
729 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
impairs B-O B-VP_VP_VBZ
the B-O B-NP_NP_DT
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hGR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
likely B-O B-JJ
cause B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
primary B-O B-NP_NP_JJ
cortisol B-O B-NN
resistance B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
subject B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
interleukin-1 B-O B-NP_NP_NN
beta B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-1 B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
mycobacterial B-O B-NP_NP_JJ
components B-O B-NNS
" " B-O O-NP
and B-O B-CC
lipopolysaccharide B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
two B-O B-NP_CD
nuclear B-O B-JJ
factor-IL6 B-O B-JJ
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
cytokines B-O B-NNS
interleukin-1 B-O B-NP_NP_NP_NN
beta B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-1 B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TNF-alpha B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VP_VBP
released B-O B-VP_VBN
by B-O B-NP_PP_IN
mononuclear B-O B-NP_JJ
phagocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
after B-O B-PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
mycobacteria B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
are B-O B-VP_VBP
considered B-O B-VP_VBN
to B-O B-S_NP_VP_TO
mediate B-O B-VP_VB
pathophysiologic B-O B-NP_NP_JJ
events B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrated B-O B-VP_VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
Mycobacterium B-O B-NN
tuberculosis B-O B-NN
cell B-O B-NN
wall B-O B-NN
component B-O B-NN
lipoarabinomannan B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
LAM B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
very B-O B-ADJP_RB
potent B-O B-JJ
" " B-O O-ADJP
inducer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
localized B-O B-VP_VBD
the B-O B-NP_DT
LAM- B-O B-ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
, B-O B-COMMA
lipopolysaccharide B-O B-ADJP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
LPS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
- B-O B-COLON
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
, B-O B-COMMA
and B-O B-CC
TNF-alpha-inducible B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_NP_DT
-131/+15 B-O B-ADJP_ADJP_CD
" " B-O O-ADJP
( B-O B-PRN_LRB
positions B-O B-NP_NNS
to B-O B-NP_NP_TO
" " B-O B-NP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
DNA B-O B-NN
fragment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-1 B-O B-NN
beta B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
deletion B-O B-NP_NP_NN
analysis B-O B-NN
" " B-O O-NP
and B-O B-CC
chloramphenicol B-O B-NP_NN
acetyltransferase B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Within B-O B-S_PP_IN
this B-O B-NP_DT
DNA B-O B-NN
fragment B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
were B-O B-VP_VBD
two B-O B-NP_NP_NP_CD
novel B-O B-JJ
9-bp B-O B-JJ
motifs B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
-90/-82 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
-40/-32 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
with B-O B-PP_IN
high B-O B-NP_NP_JJ
homology B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
nuclear B-O B-NP_NP_JJ
factor-IL6 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Site-directed B-O B-S_NP_JJ
mutagenesis B-O B-NN
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_DT
two B-O B-CD
NF-IL-6 B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
independently B-O B-VP_ADVP_RB
" " B-O O-ADVP
activated B-O B-VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
acted B-O B-VP_VBD
in B-O B-PP_IN
an B-O B-NP_DT
orientation-independent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNA B-O B-S_NP_NN
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
revealed B-O B-VP_VBD
specific B-O B-NP_NP_JJ
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
protein B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
from B-O B-PP_IN
LAM- B-O B-NP_ADJP_ADJP_NN
" " B-O B-ADJP_O-ADJP
, B-O B-COMMA
LPS- B-O B-ADJP_NN
" " B-O B-ADJP_O-ADJP
, B-O B-COMMA
or B-O B-CC
"TNF-alpha- stimulated" B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
THP-1 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
NF-IL6 B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
two B-O B-CD
NF-IL6 B-O B-NN
sites B-O B-NNS
" " B-O O-NP
mediate B-O B-VP_VBP
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-1 B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
the B-O B-NP_DT
stimuli B-O B-NNS
LAM B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
LPS B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
TNF-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cytokine B-O B-NP_NP_NN
modulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Cytokines B-O B-S_NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
peptide B-O B-NN
hormones B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
control B-O B-S_NP_VP_VP_VBP
the B-O B-NP_NP_DT
homeostasis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
and B-O B-CC
also B-O B-RB
play B-O B-VP_VBP
a B-O B-NP_DT
fundamental B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
reactions B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
involved B-O B-VP_VBN
at B-O B-NP_PP_IN
multiple B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
pathogenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Infection B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
production B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
both B-O B-ADVP_CC
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
and B-O B-CC
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Conversely B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
several B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
modulate B-O B-VP_VBP
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
infected B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_ADJP_CC
T B-O B-ADJP_NN
lymphocytic B-O B-JJ
" " B-O O-ADJP
and B-O B-CC
mononuclear B-O B-ADJP_JJ
phagocytic B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activated B-O B-S_NP_NP_VBN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
particularly B-O B-NP_NP_RB
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
in B-O B-PP_IN
a B-O B-NP_NP_DT
state B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
in B-O B-PP_IN
HIV B-O B-NP_ADJP_NN
infected B-O B-JJ
" " B-O O-ADJP
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
release B-O B-VP_VP_VBP
HIV-inductive B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
thus B-O B-RB
play B-O B-VP_VBP
a B-O B-NP_DT
potentially B-O B-ADJP_RB
important B-O B-JJ
" " B-O O-ADJP
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
pathogenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
FK506 B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
ciclosporin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
: B-O B-COLON
molecular B-O B-NP_NP_JJ
probes B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
studying B-O B-S_NP_VP_VBG
intracellular B-O B-NP_JJ
signal B-O B-NN
transduction B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
immunosuppressants B-O B-NNS
ciclosporin B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
block B-O B-VP_VBP
the B-O B-NP_NP_DT
Ca(2+)-dependent B-O B-JJ
signal-transduction B-O B-NN
pathway B-O B-NN
" " B-O O-NP
emanating B-O B-VP_VBG
from B-O B-PP_IN
the B-O B-NP_DT
T-cell B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
thereby B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
inhibiting B-O B-VP_VBG
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
helper B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
these B-O B-NP_DT
drugs B-O B-NNS
" " B-O O-NP
as B-O B-PP_IN
probes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
chemists B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
biologists B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
uncovered B-O B-VP_VBN
several B-O B-NP_NP_JJ
intracellular B-O B-JJ
signalling B-O B-NN
molecules B-O B-NNS
" " B-O O-NP
bridging B-O B-VP_VBG
the B-O B-NP_NP_NP_DT
generation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
second-messenger B-O B-NP_NN
Ca2+ B-O B-NN
ions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
among B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
are B-O B-SINV_VP_VBP
" " B-O B-PP_O-VP
calmodulin B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
calcineurin B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
( B-O B-NP_NP_NP_PP_PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-SINV
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Hence B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
Ca2+ B-O B-NP_NN
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
calmodulin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
leading B-O B-S_NP_VP_VBG
to B-O B-PP_TO
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
calmodulin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
calcineurin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
the B-O B-S_NP_DT
activated B-O B-VBN
calcineurin B-O B-NN
" " B-O O-NP
, B-O B-COMMA
in B-O B-PP_IN
turn B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
may B-O B-VP_MD
dephosphorylate B-O B-VP_VB
the B-O B-NP_NP_DT
cytoplasmic B-O B-JJ
subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
resulting B-O B-S_NP_VP_VBG
in B-O B-PP_IN
its B-O B-NP_NP_PRPP
translocation B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
into B-O B-NP_PP_IN
" " B-O B-NP_SBAR_WHADVP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_SBAR_IN
described B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
Jun B-O B-NP_NNP
Liu B-O B-NNP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
these B-O B-NP_DT
drugs B-O B-NNS
" " B-O O-NP
manifest B-O B-VP_VBP
their B-O B-NP_PRPP
effects B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
an B-O B-NP_DT
unprecedented B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
They B-O B-S_NP_PRP
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
directly B-O B-ADVP_RB
" " B-O O-ADVP
intercept B-O B-VP_VB
intracellular B-O B-NP_JJ
signalling B-O B-NN
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Instead B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
they B-O B-NP_PRP
" " B-O O-NP
form B-O B-VP_VP_VBP
tight B-O B-NP_JJ
complexes B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
two B-O B-NP_NP_CD
different B-O B-JJ
classes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
abundant B-O B-NP_NP_JJ
cytosolic B-O B-JJ
receptors B-O B-NNS
" " B-O O-NP
called B-O B-VP_VBN
" " B-O B-S_NP_NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
entering B-O B-S_NP_VP_VBG
the B-O B-NP_DT
cell B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
consequently B-O B-VP_ADVP_RB
" " B-O O-ADVP
inhibit B-O B-VBP
their B-O B-NP_PRPP
peptidyl B-O B-JJ
prolyl B-O B-JJ
cis-trans B-O B-JJ
isomerase B-O B-NN
activities B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
two B-O B-CD
structurally B-O B-ADJP_RB
distinct B-O B-JJ
" " B-O O-ADJP
immunophilin-drug B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
bind B-O B-VP_VP_VP_VBP
to B-O B-PP_TO
" " B-O B-NP_O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
inhibit B-O B-VP_VBP
" " B-O B-NP_O-VP
, B-O B-COMMA
" " B-O O-VP
the B-O B-NP_NP_DT
phosphatase B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
calcineurin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
latency B-O B-NN
reactivation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
dehydroepiandrosterone B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
DHEA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
an B-O B-NP_NP_DT
analog B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DHEA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
initial B-O B-JJ
infection B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
most B-O B-NP_JJS
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
usually B-O B-ADVP_RB
" " B-O O-ADVP
results B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
establishment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
latent B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
chronic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
before B-O B-PP_IN
eventual B-O B-NP_NP_JJ
progression B-O B-NN
" " B-O O-NP
toward B-O B-PP_IN
acquired B-O B-NP_VBN
immunodeficiency B-O B-NN
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HIV-1 B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
establish B-O B-VP_VB
a B-O B-NP_DT
latent B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
persistent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
infection B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
some B-O B-NP_NP_DT
T B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
show B-O B-S_NP_VP_VBP
minimal B-O B-NP_JJ
constitutive B-O B-JJ
virus B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
T B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
leading B-O B-VP_VBG
to B-O B-PP_TO
enhanced B-O B-NP_VBN
HIV-1 B-O B-NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
antigens B-O B-NP_NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
mitogens B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
cytokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
, B-O B-NP_NP_NP_PRN_COMMA
interleukin B-O B-NP_NN
1 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
interleukin-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Various B-O B-S_NP_NP_JJ
gene B-O B-NN
products B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
other B-O B-NP_NP_JJ
viruses B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
HSV B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
EBV B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
CMV B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
HBV B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
HHV-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
enhance B-O B-VP_VB
HIV-1 B-O B-NP_NN
long B-O B-ADJP_JJ
terminal B-O B-JJ
repeat B-O B-NN
( B-O B-LRB
LTR B-O B-NN
) B-O B-RRB
-driven B-O B-JJ
" " B-O O-ADJP
reporter B-O B-NN
gene B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-DT
basis B-O B-NN
of B-O B-IN
these B-O B-NP_DT
observations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
proposed B-O B-VP_VBN
that B-O B-SBAR_IN
reactivation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
plays B-O B-VP_VBZ
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
So B-O B-S_ADVP_RB
far B-O B-RB
" " B-O O-ADVP
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
are B-O B-VP_VBP
no B-O B-NP_NP_DT
drugs B-O B-NP_NP_NNS
" " B-O O-NP
or B-O B-CC
therapy B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
available B-O B-ADJP_JJ
" " B-O O-ADJP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
can B-O B-S_NP_VP_MD
provide B-O B-VP_VB
protection B-O B-NP_NP_NN
" " B-O O-NP
against B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ACH-2 B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
a B-O B-NP_NP_DT
human B-O B-JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CEM B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
chronically B-O B-ADJP_RB
infected B-O B-VBN
with B-O B-PP_IN
HIV-1 B-O B-NN
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
with B-O B-PP_IN
low B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
constitutive B-O B-NP_JJ
virus B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ACH-2 B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
converted B-O B-VP_VBN
to B-O B-NP_PP_TO
productive B-O B-NP_NP_NP_JJ
infection B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
infection B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
HSV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
the B-O B-NP_DT
ACH-2 B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
good B-O B-JJ
candidate B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
studying B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
drugs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
HIV-1 B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Previously B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
reported B-O B-VP_VBN
that B-O B-SBAR_IN
DHEA B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
synthetic B-O B-NP_NP_JJ
analogs B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
DHEA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
modest B-O B-NP_NP_JJ
inhibitors B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
in B-O B-PP_IN
phytohemagglutinin-stimulated B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
lymphocyte B-O B-NN
cultures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LRB
ABSTRACT B-O B-NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-S
Nitric B-O B-NP_NP_ADJP_JJ
oxide-stimulated B-O B-JJ
" " B-O O-ADJP
guanine B-O B-NN
nucleotide B-O B-NN
exchange B-O B-NN
on B-O B-PP_IN
p21ras B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
protooncogene B-O B-NP_NN
p21ras B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
monomeric B-O B-NP_JJ
G B-O B-NN
protein B-O B-NN
family B-O B-NN
member B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
critical B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
converting B-O B-S_NP_VP_VBG
extracellular B-O B-NP_JJ
signals B-O B-NNS
" " B-O O-NP
into B-O B-PP_IN
intracellular B-O B-NP_JJ
biochemical B-O B-JJ
events B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
nitric B-O B-S_NP_NP_JJ
oxide B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NO B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
activates B-O B-VP_VBZ
p21ras B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-SBAR_IN
evidenced B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
studies B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
pure B-O B-NP_JJ
recombinant B-O B-JJ
p21ras B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
activation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
direct B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
reversible B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Circular B-O B-S_NP_JJ
dichroism B-O B-NN
analysis B-O B-NN
" " B-O O-NP
reveals B-O B-VP_VBZ
that B-O B-SBAR_IN
NO B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
a B-O B-NP_DT
profound B-O B-JJ
conformational B-O B-JJ
change B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
p21ras B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
association B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
GDP/GTP B-O B-NP_NN
exchange B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
due B-O B-ADJP_JJ
to B-O B-PP_TO
S-nitrosylation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
critical B-O B-JJ
cysteine B-O B-NN
residue B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
stimulates B-O B-S_NP_VP_VBZ
guanine B-O B-NP_NN
nucleotide B-O B-NN
exchange B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
p21ras B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
endogenous B-O B-S_NP_JJ
NO B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
activate B-O B-VP_VB
p21ras B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
same B-O B-JJ
cell B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
identify B-O B-VP_VBP
p21ras B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
target B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
same B-O B-JJ
cell B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
identify B-O B-VP_VP_VBP
p21ras B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
target B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NO B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
NO B-O B-S_NP_NN
" " B-O O-NP
activates B-O B-VP_VBZ
p21ras B-O B-NP_NN
" " B-O O-NP
by B-O B-PP_IN
an B-O B-NP_NP_DT
action B-O B-NN
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcriptional B-O B-NP_NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
vacuolar B-O B-NP_JJ
H(+)-ATPase B-O B-NN
B2 B-O B-NN
subunit B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
differentiating B-O B-NP_VBG
THP-1 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Monocyte-macrophage B-O B-S_S_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_NP_DT
model B-O B-NN
system B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
studying B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VP_VBD
mRNA B-O B-NP_NP_NP_NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
various B-O B-NP_JJ
V-ATPase B-O B-NP_NN
" " B-O O-NP
subunits B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
during B-O B-PP_IN
differentiation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
native B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
" " B-O B-NP_NP_NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
found B-O B-VP_VBD
that B-O B-SBAR_IN
transcriptional B-O B-S_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
post-transcriptional B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
mechanisms B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
could B-O B-VP_MD
account B-O B-VP_VB
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
From B-O B-S_PP_IN
nuclear B-O B-NP_JJ
runoff B-O B-JJ
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
one B-O B-S_NP_NP_CD
subunit B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
particular B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
B2 B-O B-NP_NP_NN
isoform B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_NP_ADJP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
amplified B-O B-VP_VBN
primarily B-O B-NP_ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
transcriptional B-O B-NP_JJ
means B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
begun B-O B-VP_VBN
to B-O B-S_NP_VP_TO
examine B-O B-VP_VB
the B-O B-NP_NP_DT
structure B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Isolation B-O B-S_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
sequencing B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
first B-O B-NP_JJ
exon B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
5'-flanking B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reveal B-O B-VP_VBP
a B-O B-NP_NP_DT
TATA-less B-O B-NP_JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_DT
high B-O B-JJ
G B-O B-NN
+ B-O B-CC
C B-O B-NN
content B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Primer B-O B-S_NP_NP_NN
extension B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
ribonuclease B-O B-NP_NP_NN
" " B-O O-NP
protection B-O B-NN
" " B-O B-NP_O-NP
analyses B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
indicate B-O B-VP_VBP
a B-O B-NP_DT
single B-O B-JJ
major B-O B-NP_JJ
transcriptional B-O B-JJ
start B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
transfected B-O B-VP_VBD
promoter-luciferase B-O B-NP_NN
reporter B-O B-NN
plasmids B-O B-NNS
" " B-O O-NP
into B-O B-PP_IN
THP-1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
define B-O B-VP_VB
sequences B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
mediate B-O B-S_NP_VP_VBP
" " B-O B-NP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
sequences B-O B-S_NP_NP_NNS
" " B-O O-NP
downstream B-O B-ADVP_RB
from B-O B-PP_IN
the B-O B-NP_DT
transcriptional B-O B-JJ
start B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-NP
were B-O B-VP_VBD
sufficient B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
confer B-O B-VP_VB
increased B-O B-NP_VBN
expression B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNase B-O B-S_NP_NP_NN
I B-O B-CD
" " B-O O-NP
footprinting B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
sequence B-O B-NP_NN
" " B-O B-NP_O-NP
analysis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
revealed B-O B-VP_VBD
the B-O B-NP_NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
multiple B-O B-NP_ADJP_JJ
" " B-O O-ADJP
AP2 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
Sp1 B-O B-NP_NN
" " B-O B-NP_O-NP
binding B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
5'-untranslated B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
proximal B-O B-NP_ADJP_JJ
coding B-O B-VBG
" " B-O O-ADJP
" " B-O B-NP_O-NP
regions B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Functional B-O B-NP_NP_NP_JJ
characterization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
novel B-O B-NP_JJ
IL-2 B-O B-NP_NN
" " B-O O-NP
transcriptional B-O B-JJ
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
IL-2-mediated B-O B-S_S_NP_JJ
T B-O B-NP_NN
cell B-O B-NN
" " B-O O-NP
proliferation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
critical B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
early B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
event B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
inflammatory B-O B-JJ
process B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Formation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NFAT-1 B-O B-NP_NN
transcriptional B-O B-JJ
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
a B-O B-NP_NP_DT
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
stably B-O B-ADVP_RB
" " B-O O-ADVP
transfected B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
screened B-O B-VP_VBD
for B-O B-PP_IN
inhibitors B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
NFAT-1-mediated B-O B-NP_JJ
beta-galactosidase B-O B-NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
WIN B-O B-S_NP_NP_NN
61058 B-O B-CD
" " B-O O-NP
and B-O B-CC
WIN B-O B-NP_NN
53071 B-O B-CD
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
as B-O B-NP_PP_IN
microM B-O B-NP_NN
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
compounds B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
beta-galactosidase B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_NP_NP_JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFAT-1-mediated B-O B-NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
second B-O B-JJ
cell B-O B-NP_NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
stably B-O B-ADVP_RB
" " B-O O-ADVP
transfected B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
At B-O B-S_PP_IN
10 B-O B-NP_CD
microM B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
both B-O B-NP_DT
compounds B-O B-NNS
" " B-O O-NP
inhibited B-O B-VP_VBD
IL-2 B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
protein B-O B-NP_NN
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_PP_IN
the B-O B-NP_DT
NFAT-1-linked B-O B-NP_JJ
lac-Z B-O B-NN
transfectants B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
in B-O B-PP_IN
human B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_S_NP_DT
compounds B-O B-NNS
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_DT
mixed B-O B-JJ
lymphocyte B-O B-NN
reaction B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
this B-O B-S_NP_DT
inhibition B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
reversed B-O B-VP_VBN
by B-O B-NP_PP_IN
exogenous B-O B-NP_JJ
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
WIN B-O B-S_NP_NN
53071 B-O B-CD
" " B-O O-NP
inhibited B-O B-VP_VBD
IL-2 B-O B-NP_NP_NP_NN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
calcium-dependent B-O B-ADJP_JJ
" " B-O O-ADJP
PMA B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
ionomycin B-O B-NP_NN
" " B-O B-NP_O-NP
pathway B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Conversely B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
calcium-independent B-O B-NP_NP_NP_JJ
anti-CD28 B-O B-JJ
Ab B-O B-NN
" " B-O O-NP
and B-O B-CC
PMA-induced B-O B-NP_JJ
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
resistant B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_DT
compounds B-O B-NNS
" " B-O O-NP
altered B-O B-VP_VBD
the B-O B-NP_DT
NFAT-1 B-O B-NP_NN
transcriptional B-O B-JJ
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
causing B-O B-S_NP_VP_VBG
its B-O B-NP_NP_PRPP
retarded B-O B-VBN
mobility B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
gels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
these B-O B-NP_DT
functional B-O B-JJ
criteria B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
believe B-O B-VP_VBP
we B-O B-COMP_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
two B-O B-NP_NP_CD
structurally B-O B-ADJP_ADVP_RB
" " B-O O-ADVP
distinct B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
novel B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
inhibitors B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
NFAT-1-mediated B-O B-NP_JJ
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
cDNA B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
cloning B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
NGFI-B/nur77-related B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
an B-O B-NP_DT
apoptotic B-O B-NP_JJ
human B-O B-JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
A B-O B-S_S_NP_NP_DT
human B-O B-NP_JJ
T B-O B-NN
lymphoid B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
PEER B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
dies B-O B-VP_VBZ
by B-O B-PP_IN
apoptosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PMA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
calcium B-O B-NP_NN
ionophore B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_NP_NP_DT
new B-O B-JJ
gene B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
TINUR B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
cloned B-O B-VP_VBN
from B-O B-NP_PP_IN
apoptotic B-O B-NP_JJ
PEER B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TINUR B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
induced B-O B-VP_VBN
within B-O B-NP_PP_IN
1 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
the B-O B-NP_NP_DT
cross-linking B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TINUR B-O B-S_NP_NN
" " B-O O-NP
belongs B-O B-VP_VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
NGFI-B/nur77 B-O B-NP_NN
family B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
steroid B-O B-NP_NN
receptor B-O B-NN
superfamily B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
an B-O B-NP_DT
orphan B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TINUR B-O B-S_NP_NN
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_DT
same B-O B-JJ
DNA B-O B-NP_NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
NGFI-B/nur77 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
NGFI-B/nur77 B-O B-NP_NN
family B-O B-NN
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
classified B-O B-VP_VBN
into B-O B-NP_PP_IN
two B-O B-NP_CD
subtypes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Effects B-O B-NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
intranasal B-O B-NP_JJ
glucocorticoids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
endogenous B-O B-NP_ADJP_JJ
" " B-O O-ADJP
glucocorticoid B-O B-NN
peripheral B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
central B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
function B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Glucocorticoids B-O B-S_S_NP_NNS
" " B-O O-NP
are B-O B-VP_VBP
among B-O B-PP_IN
the B-O B-NP_NP_DT
most B-O B-ADJP_RBS
potent B-O B-JJ
antiinflammatory B-O B-JJ
" " B-O O-ADJP
agents B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
can B-O B-S_NP_VP_MD
be B-O B-VP_VB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Their B-O B-S_S_NP_NP_PRPP
mechanisms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
multiple B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
complex B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
a B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
reports B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
describe B-O B-VP_VBP
significant B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
systemic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
locally B-O B-NP_ADJP_RB
administered B-O B-VBN
" " B-O O-ADJP
glucocorticoids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-S_NP_VP_TO
evaluate B-O B-VP_VB
the B-O B-NP_NP_DT
short-term B-O B-ADJP_JJ
systemic B-O B-JJ
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
intranasally B-O B-NP_ADJP_RB
administered B-O B-VBN
" " B-O O-ADJP
glucocorticoids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
14 B-O B-S_NP_CD
normal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
healthy B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
subjects B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
two B-O B-NP_NP_CD
doses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_CC
or B-O B-NP_NP_PRN_CC
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
2 B-O B-NP_CD
weeks B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Before B-O B-S_UCP_PP_IN
treatment B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
at B-O B-PP_IN
regular B-O B-NP_NP_JJ
intervals B-O B-NNS
" " B-O O-NP
during B-O B-PP_IN
the B-O B-NP_DT
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
1 B-O B-NP_NP_NP_CD
week B-O B-NN
" " B-O O-NP
and B-O B-CC
finally B-O B-ADVP_RB
" " B-O O-ADVP
6 B-O B-NP_CD
weeks B-O B-NNS
" " B-O O-NP
" " B-O O-NP
after B-O B-PP_IN
termination B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
treatment B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-UCP
, B-O B-COMMA
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
and B-O B-CC
methallothionein B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
MTIIa B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
mRNA B-O B-NN
expression B-O B-NN
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
in B-O B-NP_PP_IN
peripheral B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
using B-O B-S_NP_VP_VBG
a B-O B-NP_DT
solution B-O B-NN
hybridization B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Serum B-O B-S_NP_NP_NN
cortisol B-O B-NN
" " B-O B-NP_O-NP
, B-O B-COMMA
osteocalcin B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
urinary B-O B-NP_JJ
cortisol B-O B-NN
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
determined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_DT
insulin B-O B-NP_NP_NN
tolerance B-O B-NN
test B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ITT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
performed B-O B-VP_VBN
at B-O B-NP_PP_PP_IN
the B-O B-NP_NP_DT
end B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
second B-O B-JJ
week B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
at B-O B-PP_IN
the B-O B-NP_NP_DT
end B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
6-week B-O B-JJ
washout B-O B-NN
period B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
with B-O B-PP_IN
no B-O B-NP_NP_DT
statistically B-O B-ADJP_RB
significant B-O B-JJ
" " B-O O-ADJP
change B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cortisol B-O B-NP_NN
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
peripheral B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
GR B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
down-regulated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
MTIIa B-O B-S_NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
increased B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Serum B-O B-S_NP_NN
osteocalcin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
decreased B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
during B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
both B-O B-NP_CC
BUD B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
FP B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Serum B-O B-S_NP_NN
cortisol B-O B-NN
" " B-O O-NP
decreased B-O B-VP_VBD
after B-O B-PP_IN
1 B-O B-NP_NP_CD
week B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
treatment B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
whereas B-O B-SBAR_IN
urinary B-O B-S_NP_JJ
cortisol B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
affected B-O B-VP_VBN
until B-O B-NP_PP_IN
the B-O B-NP_NP_DT
second B-O B-JJ
week B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
conclusion B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
intranasal B-O B-NP_NP_JJ
glucocorticoids B-O B-NNS
" " B-O O-NP
at B-O B-PP_IN
clinically B-O B-ADJP_RB
recommended B-O B-VBN
" " B-O O-ADJP
doses B-O B-NNS
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VP_VBP
not B-O B-CONJP_RB
only B-O B-RB
" " B-O O-CONJP
significant B-O B-NP_ADJP_JJ
systemic B-O B-JJ
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
adrenal B-O B-NP_JJ
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
have B-O B-VP_VBP
an B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
specific B-O B-NP_NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
effects B-O B-NNS
" " B-O O-NP
are B-O B-VP_VP_VBP
receptor-dependent B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
reversible B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
according B-O B-PP_VBG
to B-O B-PP_TO
serum B-O B-NP_NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
urinary B-O B-NP_JJ
cortisol B-O B-NN
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
ITT B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
leave B-O B-VP_VBP
the B-O B-S_NP_DT
hypothalamic-pituitary-adrenal B-O B-JJ
function B-O B-NN
" " B-O O-NP
intact B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
short-term B-O B-ADJP_JJ
systemic B-O B-JJ
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
any B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
noticeable B-O B-JJ
side-effects B-O B-NNS
" " B-O O-NP
usually B-O B-VP_ADVP_RB
" " B-O O-ADVP
observed B-O B-VBN
during B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcriptional B-O B-NP_NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
core B-O B-NP_NN
binding B-O B-NN
factor-alpha B-O B-NP_NN
( B-O B-LRB
AML1 B-O B-NN
) B-O B-RRB
" " B-O O-NP
and B-O B-CC
beta B-O B-NP_NP_NN
" " B-O O-NP
subunits B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
murine B-O B-NP_JJ
leukemia B-O B-NN
virus B-O B-NN
enhancer B-O B-NN
cores B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Core B-O B-S_S_NP_NP_NP_NN
binding B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CBF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
also B-O B-ADVP_RB
" " B-O O-ADVP
known B-O B-VP_VBN
as B-O B-NP_PP_IN
polyomavirus B-O B-NP_NP_NN
enhancer-binding B-O B-JJ
protein B-O B-NN
2 B-O B-CD
" " B-O O-NP
and B-O B-CC
SL3 B-O B-NP_NN
enhancer B-O B-NN
factor B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
mammalian B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_NP_VP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
core B-O B-NP_NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
SL3 B-O B-NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
important B-O B-NP_NP_JJ
genetic B-O B-JJ
determinants B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
and B-O B-NP_NP_CC
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CBF B-O B-S_NP_NN
" " B-O O-NP
consists B-O B-VP_VBZ
of B-O B-PP_IN
two B-O B-NP_NP_CD
subunits B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_NP_DT
DNA B-O B-NP_NN
binding B-O B-NN
subunit B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
CBF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
a B-O B-NP_NP_NP_DT
second B-O B-JJ
subunit B-O B-NN
" " B-O O-NP
, B-O B-COMMA
CBF B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
stimulates B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
encodes B-O B-S_NP_VP_VBZ
a B-O B-NP_DT
CBF B-O B-NP_NN
alpha B-O B-NN
subunit B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
AML1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
also B-O B-ADVP_RB
" " B-O O-ADVP
called B-O B-VP_VBN
Cbf B-O B-S_NP_NP_NN
alpha B-O B-NN
2 B-O B-CD
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
locus B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
rearranged B-O B-VP_VBN
by B-O B-NP_PP_IN
chromosomal B-O B-NP_NP_JJ
translocations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
myeloproliferative B-O B-JJ
disorders B-O B-NNS
" " B-O O-NP
and B-O B-CC
leukemias B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_DT
exogenously B-O B-ADJP_RB
expressed B-O B-VBN
" " B-O O-ADJP
Cbf B-O B-NP_NP_NN
alpha B-O B-NN
2-encoded B-O B-JJ
subunit B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CBF B-O B-NP_NN
alpha B-O B-NN
2-451 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
stimulated B-O B-VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
SL3 B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
P19 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activity B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
the B-O B-NP_DT
core B-O B-NP_NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Three B-O B-S_NP_NP_CD
different B-O B-JJ
isoforms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
CBF B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
tested B-O B-VP_VBN
for B-O B-NP_PP_IN
transcriptional B-O B-NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
SL3 B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
longest B-O B-JJS
form B-O B-NN
" " B-O O-NP
, B-O B-COMMA
CBF B-O B-NP_NN
beta-187 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
increased B-O B-VP_VBD
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
stimulation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
CBF B-O B-NP_NN
alpha B-O B-NN
2-451 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
twofold B-O B-NP_JJ
" " B-O O-NP
in B-O B-PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
although B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
P19 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transcriptional B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
CBF B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
required B-O B-VP_VBD
binding B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
CBF B-O B-NP_NN
alpha B-O B-NN
subunit B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_IN
a B-O B-S_NP_NP_NP_NP_DT
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CBF B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
lacked B-O B-S_NP_VP_VBD
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
CBF B-O B-NP_NN
beta-148 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
increase B-O B-VP_VB
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
at B-O B-S_PP_ADVP_IN
least B-O B-JJS
" " B-O O-ADVP
in B-O B-IN
certain B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
maximum B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CBF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
required B-O B-VP_VBD
both B-O B-NP_DT
subunits B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
They B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
provided B-O B-VP_VBD
support B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
hypothesis B-O B-NN
that B-O B-SBAR_IN
CBF B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-NP_NP_SBAR_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
examined B-O B-VP_VBD
whether B-O B-SBAR_IN
CBF B-O B-S_NP_NN
" " B-O O-NP
could B-O B-VP_MD
distinguish B-O B-VP_VB
a B-O B-NP_NP_DT
1-bp B-O B-JJ
difference B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
difference B-O B-NN
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
affects B-O B-VP_VBZ
transcription B-O B-NP_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
leukemogenicity B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
SL3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
no B-O B-NP_NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CBF B-O B-NP_NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
CBF B-O B-NP_NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
subunits B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
we B-O B-S_NP_PRP
" " B-O O-NP
tested B-O B-VP_VBD
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
was B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
distinguish B-O B-VP_VB
the B-O B-NP_NP_DT
1-bp B-O B-JJ
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
transcription B-O B-NP_NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
a B-O B-NP_NP_DT
complete B-O B-JJ
understanding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
T B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
recognize B-O B-VP_VBP
the B-O B-NP_DT
SL3 B-O B-NP_NN
core B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-PP
" " B-O O-NP
remains B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
elucidated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Platelet-activating B-O B-S_S_NP_JJ
factor B-O B-NN
" " B-O O-NP
stimulates B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
heparin-binding B-O B-NP_JJ
epidermal B-O B-JJ
growth B-O B-NN
factor-like B-O B-JJ
growth B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Correlation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
an B-O B-NP_DT
increased B-O B-VBN
kappa B-O B-NN
B B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Human B-O B-S_S_NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
responded B-O B-VP_VBD
to B-O B-PP_TO
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
platelet-activating B-O B-NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PAF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
up-regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_NP_DT
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PAF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
at B-O B-NP_PP_IN
nanomolar B-O B-NP_NP_JJ
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
ligand B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
starting B-O B-S_NP_VP_VBG
at B-O B-PP_IN
30 B-O B-NP_NP_CD
min B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
PAF-induced B-O B-JJ
up-regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HB-EGF B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
kappa B-O B-NP_NN
B B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
functions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
PAF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
the B-O B-NP_DT
cell B-O B-NP_NN
surface B-O B-NN
PAF B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
as B-O B-SBAR_IN
two B-O B-S_NP_NP_CD
PAF B-O B-NP_NN
" " B-O O-NP
receptor B-O B-NN
antagonists B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
WEB B-O B-NP_NP_NN
2086 B-O B-CD
" " B-O O-NP
and B-O B-CC
L-659 B-O B-NP_NN
, B-O B-COMMA
989 B-O B-CD
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
blocked B-O B-VP_VBD
both B-O B-NP_NP_CC
the B-O B-NP_NP_DT
up-regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
kappa B-O B-NP_NN
B B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
PAF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
antagonists B-O B-NNS
, B-O B-COMMA
" " B-O O-NP
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
had B-O B-VP_VBD
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
phorbol B-O B-NP_NP_NN
ester-induced B-O B-JJ
up-regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HB-EGF B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
and B-O B-CC
kappa B-O B-NP_NN
B B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Pretreatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
pertussis B-O B-NP_NN
toxin B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibited B-O B-VP_VBD
these B-O B-NP_NP_DT
functions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
PAF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
cholera B-O B-S_NP_NN
toxin B-O B-NN
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Pyrrolidine B-O B-S_NP_NP_NN
dithiocarbamate B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBD
PAF-stimulated B-O B-NP_NP_JJ
kappa B-O B-NN
B B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
up-regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HB-EGF B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VP_VBP
a B-O B-NP_NP_DT
potential B-O B-JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PAF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
HB-EGF B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
provide B-O B-VP_VBP
evidence B-O B-NP_NN
that B-O B-SBAR_IN
this B-O B-S_NP_DT
stimulation B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
occur B-O B-VP_VB
through B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
IL-1 B-O B-S_S_NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
TCR B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
signals B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
synergize B-O B-VP_VBP
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
NF-kappa B-O B-NP_NN
B-mediated B-O B-JJ
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Previous B-O B-S_S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
- B-O B-S_NP_NP_NP_NP_PRN_COLON
" " B-O B-NP_O-NP
and B-O B-CC
TCR-initiated B-O B-NP_JJ
signals B-O B-NNS
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
interact B-O B-VP_VB
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
describe B-O B-VP_VBP
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
signals B-O B-S_NP_NP_NNS
" " B-O O-NP
initiated B-O B-VP_VBN
through B-O B-NP_PP_IN
the B-O B-NP_DT
type B-O B-NP_NN
I B-O B-CD
IL-1R B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
interact B-O B-VP_VBP
with B-O B-PP_IN
signals B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
antigen B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
augment B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O B-ADVP_O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
synergistic B-O B-JJ
antigen B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
initiated B-O B-JJ
signals B-O B-NNS
" " B-O O-NP
are B-O B-VP_VP_VBP
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
because B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
mimicked B-O B-VP_VBN
, B-O B-NP_PP_PP_COMMA
but B-O B-CC
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
; B-O B-COLON
and B-O B-CC
are B-O B-VP_VBP
staurosporine B-O B-ADJP_ADJP_NN
sensitive B-O B-JJ
" " B-O O-ADJP
but B-O B-CC
cyclosporine B-O B-ADJP_NN
resistant B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Gel B-O B-S_NP_NN
shift B-O B-NN
analyses B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NP_NN
B B-O B-NN
" " B-O O-NP
nuclear B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
stimulated B-O B-VP_VBN
primarily B-O B-NP_ADVP_RB
" " B-O O-ADVP
by B-O B-PP_PP_IN
IL-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
by B-O B-PP_IN
signals B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Western B-O B-S_NP_NP_NN
blot B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
phosphorylation B-O B-NP_NN
" " B-O B-NP_O-NP
analyses B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
synergistic B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
functional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
independent B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
not B-O B-RB
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
nuclear B-O B-NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
IL-1-induced B-O B-JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
DNA B-O B-NN
nuclear B-O B-JJ
localization B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
transient B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
can B-O B-VP_MD
be B-O B-VP_VB
prolonged B-O B-ADJP_JJ
either B-O B-PP_CC
by B-O B-PP_IN
an B-O B-NP_DT
antigen B-O B-NN
receptor-initiated B-O B-JJ
signal B-O B-NN
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
by B-O B-PP_IN
inhibiting B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
IL-1 B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
both B-O B-NP_CC
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
nuclear B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
synthesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_ADJP_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Antigen B-O B-S_NP_NN
receptor B-O B-NN
signals B-O B-NNS
" " B-O O-NP
prolong B-O B-VP_VP_VBP
NF-kappa B-O B-NP_NN
B-DNA B-O B-NN
interaction B-O B-NN
" " B-O O-NP
, B-O B-COMMA
probably B-O B-ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
functionally B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
antagonizing B-O B-VP_VBG
the B-O B-NP_NP_DT
IL-1-induced B-O B-JJ
synthesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_ADJP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
consequently B-O B-ADVP_RB
" " B-O O-ADVP
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
enhance B-O B-VP_VBP
IL-1-induced B-O B-NP_JJ
NF-kappa B-O B-NN
B-dependent B-O B-JJ
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_NP_DT
newly B-O B-ADJP_RB
established B-O B-JJ
" " B-O O-ADJP
megakaryoblastic/erythroid B-O B-NP_JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
differentiates B-O B-S_NP_VP_VP_VBZ
to B-O B-PP_TO
red B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
produces B-O B-VP_VBZ
platelet-like B-O B-NP_JJ
particles B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
In B-O B-S_S_PP_IN
August B-O B-NP_NP_NNP
" " B-O O-NP
, B-O B-COMMA
1992 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
established B-O B-VP_VBD
a B-O B-NP_DT
leukemic B-O B-NP_NP_JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NS-Meg B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
a B-O B-NP_NP_DT
patient B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
megakaryoblastic B-O B-NP_NP_JJ
transformation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Philadelphia B-O B-NP_NN
chromosome-positive B-O B-JJ
chronic B-O B-JJ
myeloid B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
NS-Meg B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
positive B-O B-ADJP_JJ
for B-O B-PP_PP_IN
alpha-naphthyl B-O B-NP_NP_NP_JJ
acetate B-O B-NN
esterase B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
periodic B-O B-NP_NP_JJ
acid-Schiff B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PAS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
staining B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
for B-O B-PP_IN
surface B-O B-NP_NN
CD4 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD7 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD13 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD34 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
, B-O B-COMMA
CD41a B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
glycophorin B-O B-NP_NN
A B-O B-NN
antigens B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Ultrastructurally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
had B-O B-VP_VBD
alpha-granules B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
demarcation B-O B-NP_NN
membranes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
platelet B-O B-NP_NP_NN
peroxidase B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
NS-Meg B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
spontaneously B-O B-ADVP_RB
" " B-O O-ADVP
produced B-O B-VP_VBD
platelet-like B-O B-NP_NP_JJ
particles B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contained B-O B-S_NP_VP_VBD
alpha-granules B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
mitochondria B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
dense B-O B-NP_JJ
bodies B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
strongly B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
suggesting B-O B-VP_VBG
platelet B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Erythropoietin B-O B-S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
Epo B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
granulocyte/macrophage B-O B-NP_NP_JJ
colony B-O B-NN
stimulating B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GM-CSF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
interleukin B-O B-NP_NP_NN
3 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
IL-3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
promoted B-O B-VP_VBD
the B-O B-NP_NP_DT
growth B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NS-Meg B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Phorbol-12-myristate-13-acetate B-O B-S_NP_NN
" " B-O O-NP
increased B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
CD41a B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
CD61 B-O B-NP_NN
" " B-O B-NP_O-NP
antigens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Ten-day B-O B-S_NP_NP_JJ
exposure B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
Epo B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induced B-O B-VP_VBD
mature B-O B-NP_NP_JJ
erythroblasts B-O B-NNS
" " B-O O-NP
and B-O B-CC
red B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
benzidine-positive B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
positive B-O B-ADJP_JJ
for B-O B-PP_IN
hemoglobin B-O B-NP_NP_NN
" " B-O O-NP
F B-O B-NN
staining B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Untreated B-O B-S_NP_JJ
NS-Meg B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
expressed B-O B-VP_VBD
mRNA B-O B-NP_NN
" " B-O O-NP
for B-O B-PP_PP_IN
the B-O B-NP_NP_DT
Epo B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
EpoR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
for B-O B-PP_IN
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
for B-O B-PP_IN
alpha B-O B-NP_NP_NN
1 B-O B-CD
" " B-O B-NP_O-NP
, B-O B-COMMA
alpha B-O B-NP_NN
2 B-O B-CD
" " B-O B-NP_O-NP
and B-O B-CC
gamma B-O B-NP_NN
" " B-O B-NP_O-NP
globin B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
NS-Meg B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
undergo B-O B-VP_VBP
terminal B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
" " B-O B-NP_ADJP_NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
lineages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
cell B-O B-NP_NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
should B-O B-VP_MD
be B-O B-VP_VB
a B-O B-NP_NP_DT
very B-O B-ADJP_RB
useful B-O B-JJ
" " B-O O-ADJP
tool B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
investigation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
" " B-O B-NP_ADJP_NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
maturation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Identification B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
purification B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
Stat B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
activated B-O B-VP_VBN
in B-O B-NP_PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
interleukin-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
A B-O B-S_S_NP_NP_DT
key B-O B-JJ
cytokine B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
induced B-O B-VP_VBN
during B-O B-NP_PP_IN
the B-O B-NP_DT
immune B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Following B-O B-S_PP_VBG
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
genes B-O B-NNS
" " B-O O-NP
encoding B-O B-VP_VBG
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
various B-O B-JJ
chains B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
transcriptionally B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
turn B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
secreted B-O B-NP_VBN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
serves B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
stimulate B-O B-VP_VB
the B-O B-NP_NP_DT
proliferation B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Several B-O B-S_NP_JJ
recent B-O B-JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
implicated B-O B-VP_VBN
Jak B-O B-NP_NP_NN
kinases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
signaling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Following B-O B-S_S_NP_VP_VBG
this B-O B-NP_DT
lead B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
set B-O B-VP_VBD
out B-O B-PRT_RP
" " B-O O-PRT
to B-O B-S_NP_VP_TO
identify B-O B-VP_VB
transcription B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
observed B-O B-VP_VBN
to B-O B-S_NP_VP_TO
contain B-O B-VP_VB
several B-O B-NP_JJ
IL-2-inducible B-O B-JJ
DNA B-O B-NN
binding B-O B-NN
activities B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_NP_JJ
activities B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
transformed B-O B-NP_VBN
human B-O B-JJ
lymphocyte B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
termed B-O B-VP_VBN
YT B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
purified B-O B-VP_VP_VBN
these B-O B-NP_DT
activities B-O B-NNS
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
found B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
principal B-O B-JJ
IL-2-inducible B-O B-NP_JJ
component B-O B-NN
" " B-O O-NP
" " B-O O-NP
bears B-O B-VP_VBZ
significant B-O B-NP_NP_JJ
relatedness B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
hypothesize B-O B-VP_VBP
that B-O B-SBAR_IN
activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
designated B-O B-VP_VBN
" " B-O B-S_NP_NP_O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
helps B-O B-VP_VBZ
govern B-O B-S_NP_VP_VB
the B-O B-NP_NP_DT
biological B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
during B-O B-PP_IN
the B-O B-NP_DT
immune B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
shared B-O B-NP_NP_JJ
receptor B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
and B-O B-CC
common B-O B-NP_JJ
Stat B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
generation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NP_NN
" " B-O O-NP
pleiotropy B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
redundancy B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
IL-4 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
IL-7 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
IL-13 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
IL-15 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
To B-O B-S_S_S_NP_VP_TO
understand B-O B-VP_VB
the B-O B-NP_NP_DT
molecular B-O B-JJ
bases B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
cytokine B-O B-NP_NN
redundancy B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
pleiotropy B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
compared B-O B-VP_VBN
the B-O B-NP_NP_DT
Stat B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
activated B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_PRN_O-PP
by B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Interleukin-2 B-O B-S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBD
Stat5 B-O B-NP_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
fresh B-O B-NP_JJ
PBL B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Stat3 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Stat5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
preactivated B-O B-NP_JJ
PBL B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-7 B-O B-S_S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-15 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
induced B-O B-VP_VBD
the B-O B-NP_DT
same B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
as B-O B-PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
a B-O B-NP_NP_DT
feature B-O B-NN
" " B-O O-NP
explained B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
similar B-O B-NP_JJ
tyrosine-phosphorylated B-O B-NP_JJ
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
IL-13 B-O B-S_S_NP_NN
" " B-O O-NP
Induced B-O B-VP_VBD
the B-O B-NP_NP_DT
same B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
as B-O B-PP_IN
IL-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
a B-O B-NP_NP_DT
finding B-O B-NN
" " B-O O-NP
explained B-O B-VP_VBN
by B-O B-NP_PP_IN
our B-O B-NP_NP_PRPP
studies B-O B-NNS
" " B-O O-NP
implicating B-O B-VP_VBG
IL-4R B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
shared B-O B-JJ
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_DT
single B-O B-JJ
cytokine B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
activate B-O B-VP_VB
different B-O B-NP_NP_JJ
combinations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
under B-O B-PP_IN
conditions B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
also B-O B-ADVP_RB
" " B-O O-ADVP
indicate B-O B-VP_VBP
two B-O B-NP_NP_CD
mechanisms B-O B-NNS
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
distinct B-O B-S_NP_JJ
cytokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
activate B-O B-VP_VB
the B-O B-NP_DT
same B-O B-JJ
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Induction B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
aspirin-like B-O B-NP_JJ
drugs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Aspirin-like B-O B-S_S_NP_NP_JJ
drugs B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
ALD B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
induce B-O B-VP_VP_VBP
calcium B-O B-NP_NP_NN
mobilization B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
essential B-O B-JJ
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
do B-O B-VP_VBP
not B-O B-RB
induce B-O B-VP_VB
the B-O B-NP_NP_DT
biosynthesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
understand B-O B-VP_VB
the B-O B-NP_NP_DT
extent B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHPP_TO
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
ALD B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
mimic B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
cytoplasmic B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
nuclear B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
signaling B-O B-NP_NN
steps B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
ALD-treated B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
ALD B-O B-S_NP_NN
" " B-O O-NP
induce B-O B-VP_VP_VBP
a B-O B-NP_NP_DT
transient B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
have B-O B-VP_VBP
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
) B-O B-RRB
" " B-O O-PRN
on B-O B-PP_PP_IN
protein B-O B-NP_NN
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
nor B-O B-CC
on B-O B-PP_IN
PCL B-O B-NP_NN
gamma B-O B-NN
1 B-O B-CD
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ALD-induced B-O B-S_NP_JJ
calcium B-O B-NP_NN
mobilization B-O B-NN
" " B-O O-NP
and B-O B-CC
PKC B-O B-NP_NP_NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
independent B-O B-ADJP_JJ
of B-O B-PP_IN
tyrosine B-O B-NP_NP_NN
protein B-O B-NN
kinase B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
as B-O B-SBAR_IN
shown B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
lack B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_S_SBAR_IN
we B-O B-S_NP_PRP
" " B-O O-NP
detected B-O B-VP_VBD
no B-O B-NP_DT
IL-2 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
ALD-treated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
nuclei B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contain B-O B-VP_VBP
proteins B-O B-NP_NP_NNS
" " B-O O-NP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
binding B-O B-S_NP_VP_VBG
" " B-O B-PP_O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
: B-O B-COLON
NFAT B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
binding B-O B-NN
activities B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VBN
only B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
depended B-O B-VP_VBD
on B-O B-PP_IN
calcium B-O B-NP_NP_NN
mobilization B-O B-NN
" " B-O O-NP
and B-O B-CC
PKC B-O B-NP_NP_NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
ALD B-O B-S_NP_NN
" " B-O O-NP
cause B-O B-VP_VBP
transient B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
but B-O B-CC
significant B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
transmembrane B-O B-NN
signaling B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
although B-O B-SBAR_IN
some B-O B-S_NP_NP_DT
events B-O B-NNS
" " B-O O-NP
induced B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
are B-O B-VP_VBP
not B-O B-RB
induced B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
signal B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
transmitted B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
induces B-O B-VP_VBZ
DNA-binding B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
several B-O B-NP_JJ
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
ALD B-O B-NN
stimulus B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
capable B-O B-ADJP_JJ
of B-O B-PP_IN
causing B-O B-S_NP_VP_VBG
complete B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Functional B-O B-NP_NP_NP_JJ
roles B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_FW
vivo B-O B-FW
footprinted B-O B-VBN
DNA B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
an B-O B-NP_DT
alpha-globin B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Erythroid B-O B-NP_NP_JJ
lineage B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
developmental B-O B-NP_JJ
stage B-O B-NN
" " B-O B-NP_O-NP
specificities B-O B-NP_NNS
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
Transcriptional B-O B-S_S_NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_NP_JJ
alpha-like B-O B-JJ
globin B-O B-NN
genes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
embryonic B-O B-NP_NP_JJ
zeta B-O B-NN
2 B-O B-CD
" " B-O O-NP
and B-O B-CC
adult B-O B-NP_JJ
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
during B-O B-PP_IN
erythroid B-O B-NP_JJ
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
distal B-O B-NP_JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
HS-40 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Previous B-O B-S_NP_JJ
protein-DNA B-O B-JJ
binding B-O B-NN
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
HS-40 B-O B-S_NP_NN
" " B-O O-NP
consists B-O B-VP_VBZ
of B-O B-PP_IN
multiple B-O B-NP_NP_JJ
" " B-O B-NP_SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
systematically B-O B-ADVP_RB
" " B-O O-ADVP
analyzed B-O B-VP_VBN
the B-O B-NP_NP_DT
functional B-O B-JJ
roles B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_NP_DT
factor B-O B-NP_NN
binding B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
HS-40 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
site-directed B-O B-NP_NP_NP_JJ
mutagenesis B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
transient B-O B-NP_JJ
expression B-O B-NN
" " B-O B-NP_O-NP
assay B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
erythroid B-O B-NP_JJ
cell B-O B-NN
cultures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Three B-O B-S_NP_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
HS-40 B-O B-NP_NN
enhancer B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
5'NF-E2/AP1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
GT B-O B-NP_NN
II B-O B-CD
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
GATA-1(c) B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
positively B-O B-ADVP_RB
" " B-O O-ADVP
regulate B-O B-VP_VBP
the B-O B-NP_NP_NP_DT
zeta B-O B-NP_NN
2-globin B-O B-NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
embryonic/fetal B-O B-NP_JJ
erythroid B-O B-JJ
K562 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
adult B-O B-NP_JJ
alpha-globin B-O B-NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
adult B-O B-NP_JJ
erythroid B-O B-JJ
MEL B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-NP_DT
other B-O B-JJ
hand B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-S_S_NP_DT
3'NF-E2/AP1 B-O B-NP_NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
exert B-O B-VP_VB
both B-O B-NP_CC
and B-O B-NP_CC
on B-O B-NP_NP_PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
this B-O B-S_NP_DT
dual B-O B-JJ
function B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
modulated B-O B-VP_VBN
through B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Mutation B-O B-S_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
GATA-1(d) B-O B-NP_NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
exhibits B-O B-S_NP_VP_VBZ
an B-O B-NP_DT
adult B-O B-NP_JJ
erythroid-specific B-O B-JJ
genomic B-O B-JJ
footprint B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
decreases B-O B-VP_VBZ
the B-O B-NP_DT
HS-40 B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
function B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
dimethyl B-O B-NP_JJ
sulfoxide-induced B-O B-JJ
MEL B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
defined B-O B-VP_VBN
the B-O B-NP_NP_DT
regulatory B-O B-JJ
roles B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
different B-O B-JJ
HS-40 B-O B-NP_NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
remarkable B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
genomic B-O B-NP_NP_JJ
footprinting B-O B-NN
data B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
mutagenesis B-O B-NN
results B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
erythroid B-O B-JJ
lineage- B-O B-NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
developmental B-O B-NP_ADJP_JJ
stage-specific B-O B-JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
regulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
alpha-like B-O B-JJ
globin B-O B-NN
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
indeed B-O B-ADVP_RB
" " B-O O-ADVP
modulated B-O B-VP_VBN
by B-O B-NP_PP_IN
stable B-O B-NP_NP_JJ
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interleukin B-O B-S_S_NP_NN
( B-O B-LRB
IL B-O B-NN
) B-O B-RRB
-10 B-O B-CD
" " B-O O-NP
inhibits B-O B-VP_VBZ
nuclear B-O B-NP_NP_NP_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
IL-10 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
suppress B-O B-VP_VBP
cytokine B-O B-NP_NP_NN
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
different B-O B-NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_S_NP_NP_PRPP
previous B-O B-JJ
studies B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
interleukin B-O B-S_NP_NN
( B-O B-LRB
IL B-O B-NN
) B-O B-RRB
-10 B-O B-CD
" " B-O O-NP
inhibits B-O B-VP_VBZ
lipopolysaccharide B-O B-NP_NP_NN
( B-O B-LRB
LPS B-O B-NN
) B-O B-RRB
-stimulated B-O B-JJ
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
by B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
electrophoretic B-O B-NP_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
EMSA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
now B-O B-ADVP_RB
" " B-O O-ADVP
show B-O B-VP_VBP
that B-O B-SBAR_IN
, B-O B-S_COMMA
in B-O B-PP_IN
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
IL-10 B-O B-NP_NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
nuclear B-O B-NP_NP_JJ
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Several B-O B-S_NP_NP_ADJP_JJ
other B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
including B-O B-PP_VBG
NF-IL-6 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
AP-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
AP-2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
GR B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
CREB B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
Oct-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Sp-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
affected B-O B-VP_VBN
by B-O B-NP_PP_IN
IL-10 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
selective B-O B-JJ
inhibition B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
IL-10 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
of B-O B-PP_IN
NF B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurs B-O B-VP_VP_VBZ
rapidly B-O B-UCP_ADVP_RB
" " B-O O-ADVP
and B-O B-CC
in B-O B-PP_IN
a B-O B-NP_DT
dose-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-UCP
" " B-O O-VP
and B-O B-CC
correlates B-O B-VP_VBZ
well B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
IL-10 B-O B-NP_NP_NN
" " B-O O-NP
's B-O B-POS
cytokine B-O B-NP_NN
" " B-O O-NP
synthesis B-O B-NN
inhibitory B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
terms B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
kinetics B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
dose B-O B-NP_NN
responsiveness B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
compounds B-O B-NP_NP_NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
tosylphenylalanyl B-O B-NP_NP_NP_NN
chloromethyl B-O B-NN
ketone B-O B-NN
" " B-O O-NP
and B-O B-CC
pyrrolidinedithiocarbamate B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
known B-O B-VP_VBN
" " B-O B-S_NP_VP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
block B-O B-VP_VBP
cytokine B-O B-NP_NP_NN
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
LPS-stimulated B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
these B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
an B-O B-NP_NP_DT
important B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
IL-4 B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
another B-O B-NP_NP_DT
cytokine B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
inhibits B-O B-S_NP_VP_VBZ
cytokine B-O B-NP_NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
accumulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
shows B-O B-VP_VBZ
little B-O B-NP_JJ
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
LPS-induced B-O B-NP_JJ
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_NP_RB
examination B-O B-NN
" " B-O O-NP
reveals B-O B-VP_VBZ
that B-O B-SBAR_IN
, B-O B-S_COMMA
unlike B-O B-PP_IN
IL-10 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
IL-4 B-O B-NP_NN
" " B-O O-NP
enhances B-O B-VP_VP_VBZ
mRNA B-O B-NP_NP_NN
" " B-O O-NP
degradation B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
does B-O B-VP_VBZ
not B-O B-RB
suppress B-O B-VP_VB
cytokine B-O B-NP_NN
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
IL-10 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibit B-O B-VP_VBP
cytokine B-O B-NP_NP_NP_NN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
different B-O B-NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Identification B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
major B-O B-JJ
positive B-O B-NP_JJ
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
located B-O B-ADJP_JJ
5' B-O B-JJ
to B-O B-PP_TO
the B-O B-NP_DT
human B-O B-NP_JJ
zeta-globin B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
zeta-globin B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
using B-O B-S_NP_VP_VBG
a B-O B-NP_NP_NP_DT
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
zeta-globin B-O B-NP_NN
promoter B-O B-NN
deletion B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-SBAR_WHADVP_S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
promoters B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
without B-O B-NP_PP_PP_IN
enhancers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
or B-O B-CC
with B-O B-PP_IN
enhancers B-O B-NP_NP_NP_NNS
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
alpha-globin B-O B-NP_NN
HS-40 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
transfected B-O B-S_NP_VP_VBN
into B-O B-NP_PP_IN
K562 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
express B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
comparable B-O B-NP_NP_JJ
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
obtained B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_NP_DT
-557 B-O B-NP_CD
and B-O B-CC
-417 B-O B-CD
zeta-luciferase B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
alpha-luciferase B-O B-NP_NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
no B-O B-S_NP_NP_DT
enhancers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
or B-O B-CC
the B-O B-NP_DT
alpha-globin B-O B-NP_NN
locus B-O B-NN
enhancers B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
constructs B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
transfected B-O B-VP_VBN
into B-O B-NP_PP_IN
OCIM1 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_DT
zeta-globin B-O B-NP_NN
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
at B-O B-ADJP_ADJP_ADVP_IN
best B-O B-RB
" " B-O O-ADVP
20 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
as B-O B-IN
active B-O B-JJ
" " B-O O-ADJP
as B-O B-PP_IN
the B-O B-NP_DT
alpha-globin B-O B-NP_NN
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
sequences B-O B-S_NP_NP_NNS
from B-O B-IN
-417 B-O B-CD
to B-O B-TO
-207 B-O B-CD
5' B-O B-JJ
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
zeta-globin B-O B-NP_NN
mRNA B-O B-NN
cap B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
deleted B-O B-VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
up B-O B-S_NP_NP_QP_IN
to B-O B-TO
95 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
zeta-globin B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
lost B-O B-VP_VBN
in B-O B-NP_PP_IN
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Reinsertion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
zeta-luciferase B-O B-NP_NP_NN
constructs B-O B-NNS
" " B-O O-NP
missing B-O B-VP_VBG
the B-O B-NP_DT
-417 B-O B-CD
to B-O B-TO
-207 B-O B-CD
region B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
sequences B-O B-NNS
" " B-O O-NP
lack B-O B-VP_VBP
classical B-O B-NP_JJ
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Point B-O B-S_NP_NP_NN
mutation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
GATA-1 B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
-230 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reduced B-O B-VP_VBD
promoter B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
37 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Point B-O B-S_NP_NP_NN
mutation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
CCACC B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
-240 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Electrophoretic B-O B-S_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
-230 B-O B-NP_CD
GATA-1 B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
a B-O B-NP_NP_DT
relatively B-O B-ADJP_RB
low B-O B-JJ
" " B-O O-ADJP
affinity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
experiments B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
the B-O B-COMP_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
strong B-O B-JJ
positive-acting B-O B-NP_JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
located B-O B-ADJP_JJ
between B-O B-PP_IN
-417 B-O B-NP_NP_CD
and B-O B-CC
-207 B-O B-CD
bp B-O B-NN
5' B-O B-JJ
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
is B-O B-VP_VBZ
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
high-level B-O B-NP_JJ
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
element B-O B-NN
" " B-O O-NP
requires B-O B-VP_VBZ
GATA-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
additional B-O B-NP_JJ
unknown B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
maximal B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Analysis B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
kinase B-O B-NN
C-alpha B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
-epsilon B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
-zeta B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
T B-O B-S_S_S_NP_NN
cells B-O B-NNS
" " B-O O-NP
express B-O B-VP_VBP
multiple B-O B-NP_NP_JJ
isotypes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PKC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
although B-O B-S_S_IN
it B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
well B-O B-ADVP_RB
" " B-O O-ADVP
accepted B-O B-VP_VBN
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
, B-O B-COMMA
little B-O B-S_NP_JJ
" " B-O B-PP_O-NP
is B-O B-VP_VBZ
known B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
about B-O B-PP_IN
the B-O B-NP_NP_DT
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
individual B-O B-NP_JJ
PKC B-O B-NP_NN
isotypes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
address B-O B-VP_VB
this B-O B-NP_DT
issue B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
mutationally B-O B-S_S_NP_ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
PKC-alpha B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
-epsilon B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
-zeta B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
transfected B-O B-VP_VBN
into B-O B-NP_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_NP_DT
consequences B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
determined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
p21ras B-O B-S_NP_NN
" " B-O O-NP
plays B-O B-VP_VBZ
an B-O B-NP_DT
essential B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Accordingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
constitutively B-O B-NP_RB
active B-O B-JJ
PKCs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
compared B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
mutationally B-O B-NP_ADJP_RB
activated B-O B-VBN
" " B-O O-ADJP
p21ras B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
PKC-epsilon B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
, B-O B-COMMA
to B-O B-PP_TO
a B-O B-NP_DT
lesser B-O B-JJR
extent B-O B-NN
" " B-O O-NP
" " B-O O-PP
PKC-alpha B-O B-NP_NP_NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
-zeta B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
can B-O B-VP_MD
regulate B-O B-VP_VB
the B-O B-NP_NP_DT
" " B-O B-NP_NP_NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PKC-epsilon B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
transactivation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-AT-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
was B-O B-VP_VBD
similar B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
stimulatory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
constitutively B-O B-NP_RB
activated B-O B-VBN
p21ras B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PKC-epsilon B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
PKC-alpha B-O B-NP_NP_NN
" " B-O O-NP
nor B-O B-CC
activated B-O B-NP_JJ
p21ras B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
NF-KB B-O B-NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Phorbol B-O B-S_NP_NN
esters B-O B-NNS
" " B-O O-NP
induce B-O B-VP_VBP
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD69 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
whereas B-O B-SBAR_IN
none B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
activated B-O B-NP_VBN
PKC B-O B-NN
isotypes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activated B-O B-S_NP_VBN
Src B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
p21ras B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
CD69 B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
selective B-O B-NP_NP_JJ
functions B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
different B-O B-NP_JJ
PKC B-O B-NP_NN
isotypes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
data B-O B-NNS
" " B-O O-NP
comparing B-O B-VP_VBG
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_NP_VBN
Ras B-O B-NN
" " B-O O-NP
and B-O B-CC
PKC B-O B-NP_NN
mutants B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
PKC-alpha B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p21ras B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
PKC-epsilon B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
positioned B-O B-ADJP_JJ
linearly B-O B-ADVP_RB
" " B-O O-ADVP
on B-O B-PP_IN
a B-O B-NP_DT
single B-O B-JJ
signal B-O B-NN
transduction B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-E1 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
YY1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_NP_DT
newly B-O B-ADJP_RB
identified B-O B-VBN
" " B-O O-ADJP
element B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
first B-O B-JJ
exon B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
A B-O B-S_S_NP_NP_DT
previously B-O B-ADJP_RB
unrecognized B-O B-JJ
" " B-O O-ADJP
element B-O B-NN
" " B-O B-SBAR_O-NP
, B-O B-COMMA
located B-O B-ADJP_JJ
downstream B-O B-ADVP_RB
of B-O B-PP_IN
the B-O B-NP_NP_DT
start B-O B-NP_NN
site B-O B-NN
of B-O B-IN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-ADJP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
defined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
enhances B-O B-S_NP_VP_VBZ
promoter B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
up B-O B-NP_IN
to B-O B-TO
eightfold B-O B-JJ
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
position-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Mutations B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
DNA-binding B-O B-NP_JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
abolished B-O B-VP_VP_VBD
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
nuclear B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
B B-O B-NN
cell B-O B-NN
nuclear B-O B-JJ
extract B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
decreased B-O B-VP_VBD
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
DR B-O B-NP_NN
alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_DT
basal B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Significant B-O B-S_NP_NP_JJ
sequence B-O B-NN
homology B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
element B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
DNA B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
DR B-O B-NP_NN
beta B-O B-NN
" " B-O B-NP_O-NP
, B-O B-COMMA
DP B-O B-NP_NN
alpha B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
-beta B-O B-NP_NN
" " B-O B-NP_O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
DQ B-O B-NP_NN
alpha B-O B-NN
" " B-O B-NP_O-NP
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
always B-O B-ADVP_RB
" " B-O O-ADVP
located B-O B-ADJP_JJ
downstream B-O B-ADVP_RB
of B-O B-PP_IN
the B-O B-NP_DT
transcriptional B-O B-NP_JJ
start B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
nuclear B-O B-JJ
factor B-O B-NN
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_PP_TO
the B-O B-NP_DT
DR B-O B-NP_NN
alpha B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
DP B-O B-NP_NN
alpha B-O B-NN
" " B-O B-NP_O-NP
element B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
to B-O B-TO
the B-O B-NP_NP_DT
element B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
DQ B-O B-NP_NN
alpha B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
as B-O B-NP_PP_IN
NF-E1 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
YY1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
previously B-O B-ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VBN
by B-O B-NP_PP_IN
its B-O B-NP_NP_PRPP
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
Ig B-O B-NP_NN
kappa B-O B-NN
3' B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
Ig B-O B-NP_NN
heavy B-O B-JJ
chain B-O B-NN
mu B-O B-NN
E1 B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
thus B-O B-ADVP_RB
" " B-O O-ADVP
also B-O B-ADVP_RB
" " B-O O-ADVP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
quite B-O B-ADJP_RB
important B-O B-JJ
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Mouse B-O B-NP_NP_NP_NN
interleukin-2 B-O B-NN
receptor B-O B-NN
alpha B-O B-NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Interleukin-1 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
interleukin-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
control B-O B-VP_VBP
transcription B-O B-NP_NN
" " B-O O-NP
via B-O B-PP_IN
distinct B-O B-NP_JJ
cis-acting B-O B-NP_JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
interleukin-1 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
control B-O B-VP_VBP
IL-2 B-O B-NP_NP_NN
receptor B-O B-NN
alpha B-O B-NN
( B-O B-LRB
IL-2R B-O B-NN
alpha B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
CD4-CD8- B-O B-NP_JJ
murine B-O B-JJ
T B-O B-NN
lymphocyte B-O B-NN
precursors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
map B-O B-VP_VBP
the B-O B-NP_NP_DT
cis-acting B-O B-NP_JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
mediate B-O B-S_NP_VP_VBP
interleukin B-O B-NP_NP_NN
responsiveness B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
using B-O B-S_NP_VP_VBG
a B-O B-NP_DT
thymic B-O B-NP_NP_JJ
lymphoma-derived B-O B-JJ
hybridoma B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PC60 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
transcriptional B-O B-JJ
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2R B-O B-NP_NN
alpha B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
stimulation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
IL-1 B-O B-NP_NP_NN
" " B-O O-NP
+ B-O B-CC
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
biphasic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-1 B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
rapid B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
protein B-O B-ADJP_NN
synthesis-independent B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
appearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2R B-O B-NP_NN
alpha B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
primes B-O B-VP_VP_VBZ
cells B-O B-NP_NNS
" " B-O O-NP
to B-O B-S_NP_VP_TO
become B-O B-VP_VB
IL-2 B-O B-ADJP_NP_NN
" " B-O O-NP
responsive B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
and B-O B-CC
thereby B-O B-ADVP_RB
" " B-O O-ADVP
prepares B-O B-VP_VBZ
the B-O B-NP_NP_DT
second B-O B-JJ
phase B-O B-NN
" " B-O O-NP
, B-O B-COMMA
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
IL-2 B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
a B-O B-NP_DT
100-fold B-O B-ADJP_RB
further B-O B-JJ
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
IL-2R B-O B-NP_NN
alpha B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transient B-O B-S_NP_JJ
transfection B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
several B-O B-S_NP_NP_JJ
elements B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
promoter-proximal B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contribute B-O B-VP_VBP
to B-O B-PP_TO
IL-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
responsiveness B-O B-NN
" " B-O O-NP
, B-O B-COMMA
most B-O B-ADVP_RBS
importantly B-O B-RB
" " B-O O-ADVP
an B-O B-NP_NP_DT
conserved B-O B-NP_VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-2 B-O B-S_NP_NP_NN
" " B-O O-NP
responsiveness B-O B-NN
, B-O B-COMMA
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
other B-O B-JJ
hand B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
depends B-O B-VP_VBZ
on B-O B-PP_IN
a B-O B-NP_NP_DT
78-nucleotide B-O B-NP_JJ
segment B-O B-NN
" " B-O O-NP
" " B-O O-NP
1.3 B-O B-ADVP_NP_CD
kilobases B-O B-NNS
" " B-O O-NP
upstream B-O B-RB
of B-O B-PP_IN
the B-O B-NP_DT
major B-O B-NP_JJ
transcription B-O B-NN
start B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
segment B-O B-NN
" " B-O O-NP
functions B-O B-VP_VP_VBZ
as B-O B-PP_IN
an B-O B-NP_DT
IL-2-inducible B-O B-NP_JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
lies B-O B-VP_VBZ
within B-O B-PP_IN
a B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
becomes B-O B-S_NP_VP_VBZ
hypersensitive B-O B-ADJP_NP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-2 B-O B-S_NP_NP_NN
" " B-O O-NP
responsiveness B-O B-NN
" " B-O O-NP
requires B-O B-VP_VBZ
three B-O B-NP_NP_CD
distinct B-O B-JJ
elements B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_DT
enhancer B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
potential B-O B-NP_NP_JJ
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
STAT B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Coupling B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
signal B-O B-NP_NN
response B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
multiple B-O B-NP_NP_JJ
pathways B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
eukaryotic B-O B-NP_NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
central B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
the B-O B-NP_NP_DT
induced B-O B-VBN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
many B-O B-NP_NP_JJ
aspects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
genetic B-O B-JJ
program B-O B-NN
" " B-O O-NP
mediating B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
nuclear B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
tightly B-O B-ADVP_RB
" " B-O O-ADVP
regulated B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_DT
cytoplasmic B-O B-JJ
compartment B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
an B-O B-NP_NP_DT
inhibitory B-O B-NP_JJ
subunit B-O B-NN
" " B-O O-NP
" " B-O O-NP
called B-O B-VP_VBN
I B-O B-S_NP_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
cytoplasmic B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
phosphorylated B-O B-VP_VP_VBN
" " B-O O-VP
and B-O B-CC
degraded B-O B-VP_VBN
" " B-O O-VP
" " B-O B-NP_O-VP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_NP_DT
diverse B-O B-JJ
set B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B-inducing B-O B-JJ
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
including B-O B-PP_VBG
T-cell B-O B-NP_NP_NN
mitogens B-O B-NNS
, B-O B-COMMA
" " B-O O-NP
proinflammatory B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
explore B-O B-VP_VB
these B-O B-NP_NP_DT
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
alpha-dependent B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
identified B-O B-VP_VBD
novel B-O B-NP_NP_NP_JJ
mutants B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
uncouple B-O B-S_NP_VP_VBP
its B-O B-NP_PRPP
and B-O B-ADJP_ADJP_CC
functions B-O B-NP_NNS
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Specifically B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
removal B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
N-terminal B-O B-NP_JJ
36 B-O B-CD
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
disrupt B-O B-VP_VB
its B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
form B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
this B-O B-NP_DT
deletion B-O B-NN
mutation B-O B-NN
" " B-O O-NP
prevented B-O B-VP_VBD
the B-O B-NP_NP_NP_DT
induced B-O B-VBN
phosphorylation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
degradative B-O B-NP_JJ
loss B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
functional B-O B-NP_NP_JJ
release B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
Tax-expressing B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Alanine B-O B-S_NP_NP_NN
substitutions B-O B-NNS
" " B-O O-NP
introduced B-O B-VP_VBN
at B-O B-NP_PP_IN
two B-O B-NP_NP_CD
serine B-O B-NN
residues B-O B-NNS
" " B-O O-NP
positioned B-O B-ADJP_JJ
within B-O B-PP_IN
this B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
yielded B-O B-VP_VBD
constitutive B-O B-NP_NP_JJ
repressors B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_SBAR_WHNP_WDT
" " B-O O-WHNP
escaped B-O B-S_NP_VP_VBD
from B-O B-PP_IN
Tax-induced B-O B-NP_JJ
turnover B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
potently B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
, B-O B-NP_NP_NP_PP_COMMA
including B-O B-PP_VBG
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
introduction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
phosphoserine B-O B-NN
" " B-O O-NP
mimetic B-O B-ADJP_JJ
at B-O B-PP_IN
these B-O B-NP_DT
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
rectified B-O B-VP_VBD
this B-O B-NP_DT
functional B-O B-JJ
defect B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
a B-O B-NP_NP_DT
finding B-O B-NN
" " B-O O-NP
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
a B-O B-NP_NP_DT
causal B-O B-JJ
linkage B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_NP_DT
phosphorylation B-O B-NN
status B-O B-NN
" " B-O O-NP
and B-O B-CC
proteolytic B-O B-NP_JJ
stability B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
in B-O B-ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
studies B-O B-NNS
" " B-O O-NP
define B-O B-VP_VBP
a B-O B-NP_NP_DT
critical B-O B-JJ
signal B-O B-NN
response B-O B-NN
domain B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
coordinately B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
controls B-O B-VP_VBZ
the B-O B-NP_NP_DT
biologic B-O B-JJ
activities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
HIV B-O B-NP_NP_NP_NN
type B-O B-NN
1 B-O B-CD
protease B-O B-NP_NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
T B-O B-NP_NN
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
NF-kappa B-O B-S_S_NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
nuclear B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
rel B-O B-NP_NN
oncogene B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-NP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
reported B-O B-VP_VBN
that B-O B-SBAR_IN
HIV-1 B-O B-S_NP_NN
protease B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
cleave B-O B-VP_VB
the B-O B-NP_DT
precursor B-O B-NP_NN
" " B-O O-NP
to B-O B-PP_TO
in B-O B-NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
protease B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
precursor B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
in B-O B-NP_PP_IN
Jurkat B-O B-NP_NN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
introducing B-O B-S_NP_VP_VBG
a B-O B-NP_DT
protease B-O B-NP_NN
expression B-O B-NN
vector B-O B-NN
" " B-O O-NP
" " B-O O-NP
into B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Increased B-O B-S_S_NP_VBN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
this B-O B-S_NP_DT
increased B-O B-VBN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
specific B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
viral B-O B-NP_JJ
protease B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Viral B-O B-S_NP_JJ
transcription B-O B-NN
, B-O B-COMMA
" " B-O O-NP
as B-O B-SBAR_IN
measured B-O B-S_NP_VP_VBN
using B-O B-NP_S_NP_VP_VBG
LTR-CAT B-O B-NP_JJ
assays B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
was B-O B-VP_VBD
only B-O B-ADVP_RB
slightly B-O B-RB
" " B-O O-ADVP
enhanced B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
HIV-protease B-O B-NP_NN
expressing B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
while B-O B-SBAR_IN
secretion B-O B-S_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NP_NN
" " B-O O-NP
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
affected B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
limited B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
HIV B-O B-NP_NN
protease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appears B-O B-VP_VBZ
unlikely B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
a B-O B-NP_DT
significant B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
virus B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
or B-O B-CC
T B-O B-NP_NN
cell B-O B-NN
function B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Neutrophils B-O B-S_S_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
express B-O B-VP_VBP
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
PU.1 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
Spi-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
Spi-B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
PU.1 B-O B-S_S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
the B-O B-NP_DT
Spi-1 B-O B-NP_NN
oncogene B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
Spi-B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
closely B-O B-NP_NP_ADJP_RB
related B-O B-JJ
" " B-O O-ADJP
members B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
ets B-O B-NP_NN
transcription B-O B-NN
factor B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
sharing B-O B-S_NP_VP_VBG
similar B-O B-NP_NP_JJ
DNA B-O B-NN
binding B-O B-NN
specificities B-O B-NNS
" " B-O O-NP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
similar B-O B-NP_JJ
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
PU.1 B-O B-S_S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Spi-B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
previously B-O B-ADVP_RB
" " B-O O-ADVP
described B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
as B-O B-SBAR_IN
being B-O B-S_NP_VP_VBG
predominantly B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
coordinately B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
their B-O B-S_NP_NP_PRPP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
early B-O B-NP_JJ
hematopoietic B-O B-JJ
stages B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
during B-O B-PP_IN
the B-O B-NP_NP_DT
course B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
myeloid B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
or B-O B-PP_PP_CC
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
not B-O B-RB
been B-O B-VP_VBN
extensively B-O B-ADVP_RB
" " B-O O-ADVP
investigated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
PU.1 B-O B-S_NP_NN
mRNA B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
upregulated B-O B-VP_VBN
during B-O B-NP_PP_IN
myeloid B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PU.1 B-O B-S_NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
maintained B-O B-ADJP_JJ
at B-O B-PP_IN
stable B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
differentiation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
myeloid B-O B-NP_NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
U937 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
HL-60 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
monocytic B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
neutrophilic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PU.1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
at B-O B-NP_PP_IN
highest B-O B-NP_JJS
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
mature B-O B-NP_NP_JJ
human B-O B-JJ
monocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
neutrophils B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
PU.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
significant B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Spi-B B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
and B-O B-CC
protein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VP_VBP
found B-O B-VP_VBN
only B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
some B-O B-NP_DT
B-cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
and B-O B-CC
spleen B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
but B-O B-CC
are B-O B-VP_VBP
not B-O B-RB
found B-O B-VP_VBN
in B-O B-NP_PP_IN
myeloid B-O B-NP_NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
neutrophils B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
translated B-O B-VBN
Spi-B B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
bind B-O B-VP_VP_VB
to B-O B-PP_TO
PU.1 B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
myeloid B-O B-NP_JJ
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
transactivate B-O B-VP_VB
these B-O B-NP_DT
promoters B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
nonmyeloid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
although B-O B-SBAR_IN
PU.1 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Spi-B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
bind B-O B-VP_VP_VB
to B-O B-PP_TO
similar B-O B-NP_JJ
DNA B-O B-NN
control B-O B-NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
have B-O B-VP_VBP
redundancy B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transactivation B-O B-NP_NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
lack B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
significant B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Spi-B B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
myeloid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
makes B-O B-VP_VBZ
it B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
unlikely B-O B-ADJP_JJ
" " B-O O-ADJP
that B-O B-SBAR_IN
Spi-B B-O B-S_NP_NN
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
significant B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
PU.1 B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
at B-O B-NP_PP_IN
high B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
not B-O B-PP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
in B-O B-PP_IN
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
in B-O B-PP_IN
neutrophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
PU.1 B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
activate B-O B-VP_VB
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
acute B-O B-NP_NP_JJ
lymphoblastic B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
childhood B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Molecular B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
cellular B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
clinical B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
considerations B-O B-NP_NNS
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
Glucocorticoids B-O B-S_S_NP_NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
included B-O B-VP_VBN
in B-O B-NP_PP_IN
almost B-O B-NP_NP_ADJP_RB
all B-O B-DT
" " B-O O-ADJP
treatment B-O B-NN
regimens B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
childhood B-O B-NP_NN
acute B-O B-JJ
lymphoblastic B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
decades B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
optimal B-O B-NP_ADJP_JJ
" " B-O O-ADJP
agents B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
doses B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
and/or B-O B-CC
schedules B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
yet B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
defined B-O B-VP_VBN
despite B-O B-NP_PP_IN
application B-O B-NP_ADJP_ADJP_ADJP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
New B-O B-S_NP_NP_JJ
data B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
pharmacokinetics B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
pharmacodynamics B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
molecular B-O B-NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
suggested B-O B-VP_VBN
alternative B-O B-NP_NP_JJ
approaches B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
ALL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
prolonged B-O B-S_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
i.e. B-O B-PP_FW
" " B-O O-PP
28 B-O B-NP_CD
day B-O B-NN
" " B-O O-NP
" " B-O O-ADJP
, B-O B-COMMA
glucocorticoid B-O B-NN
therapy B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
unnecessary B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
as B-O B-SBAR_IN
exposure B-O B-S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
induces B-O B-VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Dexamethasone B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
superior B-O B-ADJP_JJ
to B-O B-PP_TO
prednisone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
conventional B-O B-NP_ADJP_JJ
equi-effective B-O B-JJ
" " B-O O-ADJP
doses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Blast B-O B-S_NP_NP_NN
sensitivity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VBZ
closely B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_PP_IN
sensitivity B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
other B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
putatively B-O B-ADJP_RB
non-cross-resisting B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
with B-O B-PP_IN
outcome B-O B-NP_NP_NN
" " B-O O-NP
after B-O B-PP_IN
multi-agent B-O B-NP_JJ
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
overlapping B-O B-UCP_NP_NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
focusing B-O B-S_NP_VP_VBG
attention B-O B-NP_NN
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-UCP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Increasing B-O B-S_NP_NP_VBG
success B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
childhood B-O B-NP_NN
acute B-O B-JJ
lymphoblastic B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
led B-O B-VP_VBN
to B-O B-PP_TO
increasing B-O B-NP_NP_VBG
awareness B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
avascular B-O B-NP_NP_JJ
necrosis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
bone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_NP_DT
potentially B-O B-ADJP_RB
disabling B-O B-JJ
" " B-O O-ADJP
sequela B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
especially B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Differential B-O B-NP_NP_NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-AT B-O B-NP_NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
restimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T-cell B-O B-NP_NN
anergy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Stimulation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
CD4+ B-O B-JJ
T-cell B-O B-NN
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
the B-O B-NP_DT
T-cell B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TcR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
high B-O B-NP_NP_JJ
doses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_JJ
peptide B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_NP_DT
long-lived B-O B-JJ
state B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
During B-O B-S_PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
anergy B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
phenotypically B-O B-ADJP_RB
similar B-O B-JJ
to B-O B-PP_TO
cells B-O B-NP_NP_NNS
" " B-O O-NP
responding B-O B-VP_VBG
to B-O B-PP_TO
an B-O B-NP_DT
immunogenic B-O B-JJ
stimulus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
amount B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TcR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
surface B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
downmodulated B-O B-VP_VBN
" " B-O B-NP_O-VP
, B-O B-COMMA
whereas B-O B-SBAR_IN
the B-O B-S_NP_DT
CD2 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
CD25 B-O B-NP_NN
" " B-O B-NP_O-NP
receptors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
increased B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
restimulated B-O B-S_NP_VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
anergic B-O B-S_NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
fail B-O B-VP_VP_VBP
to B-O B-S_NP_VP_TO
up-regulate B-O B-VP_VB
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
and B-O B-CC
in B-O B-PP_IN
consequence B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
do B-O B-VP_VBP
not B-O B-RB
produce B-O B-VP_VB
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
compared B-O B-VP_VBN
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
various B-O B-NP_JJ
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Factors B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_NP_DT
nuclei B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
binding B-O B-NP_NP_NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
restimulated B-O B-NP_VBN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_NP_DT
pattern B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
has B-O B-S_NP_VP_VBZ
previously B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
measured B-O B-VBN
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_DT
TCF-1 B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_DT
same B-O B-JJ
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
nuclei B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
resting B-O B-NP_NP_VBG
" " B-O B-NP_O-NP
, B-O B-COMMA
activated B-O B-NP_VBN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
anergized B-O B-NP_VBN
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
inducible B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
NK-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
beta B-O B-NP_NN
E2 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
CD28RC B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VP_VBP
not B-O B-RB
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
resting B-O B-NP_VBG
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
are B-O B-VP_VBP
twofold B-O B-ADJP_RB
lower B-O B-RBR
in B-O B-PP_IN
anergized B-O B-NP_VBN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
as B-O B-SBAR_IN
compared B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
activated B-O B-NP_VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
anergic B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
express B-O B-VP_VBP
approximately B-O B-NP_NP_ADJP_NP_RB
eightfold B-O B-RB
" " B-O O-NP
lower B-O B-JJR
" " B-O O-ADJP
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
regulates B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
Erythropoietin B-O B-S_S_NP_NN
" " B-O O-NP
stimulates B-O B-VP_VBZ
transcription B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TAL1/SCL B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
protein B-O B-NP_NN
products B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Activation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
TAL1 B-O B-NP_NN
( B-O B-LRB
or B-O B-CC
SCL B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
originally B-O B-ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VBN
through B-O B-NP_PP_IN
its B-O B-NP_NP_PRPP
involvement B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
most B-O B-ADJP_RBS
frequent B-O B-JJ
molecular B-O B-JJ
" " B-O O-ADJP
lesion B-O B-NN
" " B-O O-NP
recognized B-O B-VP_VBN
in B-O B-NP_PP_IN
T-cell B-O B-NP_NN
acute B-O B-JJ
lymphoblastic B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
protein B-O B-NP_NN
products B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contain B-O B-VP_VBP
the B-O B-NP_NP_DT
basic-helix-loop-helix B-O B-NP_JJ
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
characteristic B-O B-ADJP_JJ
of B-O B-PP_IN
a B-O B-NP_NP_DT
large B-O B-JJ
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TAL1 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_PP_IN
erythroid B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
in B-O B-ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
chemical-induced B-O B-NP_NP_JJ
erythroleukemia B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
in B-O B-ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
suggested B-O B-VP_VBD
the B-O B-COMP_NP_DT
gene B-O B-NN
" " B-O O-NP
might B-O B-VP_MD
regulate B-O B-VP_VB
aspects B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
erythroid B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
the B-O B-S_NP_NP_DT
terminal B-O B-JJ
events B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
erythropoiesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
glycoprotein B-O B-NP_NP_NN
hormone B-O B-NN
erythropoietin B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
whether B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
expression B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
and B-O B-NP_CC
its B-O B-NP_PRPP
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
affected B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Epo B-O B-S_NP_NN
" " B-O O-NP
elicited B-O B-VP_VBD
a B-O B-NP_NP_DT
rapid B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
dose-related B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
TAL1 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
increasing B-O B-S_NP_VP_VP_VBG
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
stabilizing B-O B-VP_VBG
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_DT
Epo-inducible B-O B-JJ
TAL1 B-O B-NP_NN
" " B-O O-NP
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
FVA B-O B-NP_NP_NN
cell B-O B-NN
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
subsequently B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
decayed B-O B-VP_VBD
despite B-O B-PP_IN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
associated B-O B-VP_VBN
temporally B-O B-NP_ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
Epo-induced B-O B-NP_NP_JJ
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
TAL1 B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VP_VBP
that B-O B-SBAR_IN
Epo B-O B-S_NP_NN
" " B-O O-NP
acts B-O B-VP_VBZ
at B-O B-PP_IN
both B-O B-NP_NP_CC
and B-O B-NP_CC
on B-O B-NP_NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
in B-O B-PP_IN
Friend B-O B-NP_NN
virus-induced B-O B-JJ
erythroblasts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
establish B-O B-VP_VBP
a B-O B-NP_NP_DT
link B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
Epo B-O B-NP_NP_NP_NN
" " B-O O-NP
signaling B-O B-NN
mechanisms B-O B-NNS
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_DT
retinoblastoma B-O B-NP_NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
" " B-O O-NP
negatively B-O B-ADVP_RB
" " B-O O-ADVP
regulates B-O B-VP_VBZ
transcriptional B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
cytomegalovirus B-O B-NN
IE2 B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
IE2 B-O B-NP_NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
cytomegalovirus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HCMV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
few B-O B-JJ
viral B-O B-NP_JJ
regulatory B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
expressed B-O B-VP_VBN
immediately B-O B-NP_ADVP_RB
" " B-O O-ADVP
upon B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
potent B-O B-JJ
transcriptional B-O B-NP_JJ
activator B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
many B-O B-NP_JJ
viral B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
cellular B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
promoters B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
retinoblastoma B-O B-NP_NP_NN
susceptibility B-O B-NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Rb B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
dramatically B-O B-ADVP_RB
" " B-O O-ADVP
suppressed B-O B-VP_VBD
this B-O B-NP_NP_DT
IE2 B-O B-NP_NN
" " B-O O-NP
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
various B-O B-NP_JJ
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
unlike B-O B-PP_IN
another B-O B-NP_NP_DT
tumor B-O B-NP_NN
suppressor B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
p53 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
Rb B-O B-NP_NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
have B-O B-VP_VB
any B-O B-NP_DT
significant B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
basal B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
Rb B-O B-S_NP_NN
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
interacts B-O B-VP_VBZ
with B-O B-PP_IN
" " B-O B-NP_NP_CONJP_NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
by B-O B-PP_IN
protein-affinity B-O B-NP_JJ
chromatography B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
Rb B-O B-S_NP_NP_NN
" " B-O O-NP
in B-O B-UCP_PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
produced B-O B-VP_VBN
by B-O B-NP_PP_IN
translation B-O B-NP_ADJP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-UCP
" " B-O O-NP
directly B-O B-ADVP_RB
" " B-O O-ADVP
bound B-O B-VP_VBD
to B-O B-PP_TO
IE2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
Rb B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
regulate B-O B-VP_VB
the B-O B-NP_NP_DT
life B-O B-NN
cycle B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-SBAR_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
data B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
provide B-O B-VP_VB
new B-O B-NP_NP_JJ
insights B-O B-NNS
" " B-O O-NP
into B-O B-PP_IN
the B-O B-NP_NP_NP_DT
slow B-O B-JJ
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
possible B-O B-JJ
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HCMV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
tumorigenesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Epstein-Barr B-O B-NP_NP_NP_NP_JJ
virus B-O B-NN
replicative B-O B-JJ
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
de B-O B-NP_NP_ADJP_FW
novo B-O B-FW
" " B-O O-ADJP
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
thymocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
simultaneous B-O B-NP_NP_ADJP_JJ
early B-O B-JJ
" " B-O O-ADJP
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
BZLF-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
its B-O B-NP_NP_PRPP
repressor B-O B-NN
" " B-O O-NP
RAZ B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Epstein-Barr B-O B-S_S_NP_NP_JJ
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EBV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
infect B-O B-VP_VB
B B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
epithelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_NP_PRP
" " B-O O-NP
and B-O B-CC
others B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
EBV B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
infect B-O B-VP_VB
a B-O B-NP_NP_DT
subset B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Infection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
thymocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
appearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
linear B-O B-NP_JJ
EBV B-O B-NN
genome B-O B-NN
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
8 B-O B-NP_NP_CD
hr B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
infection B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Circularization B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
EBV B-O B-NP_NN
genome B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
detected B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
is B-O B-VP_VBZ
in B-O B-PP_IN
contrast B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
infection B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
B B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_WHADVP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
appearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
BamHI B-O B-NP_NP_NN
ZLF-1 B-O B-NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
, B-O B-COMMA
ZEBRA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
by B-O B-PP_IN
RT-PCR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
within B-O B-NP_PP_IN
8 B-O B-NP_NP_CD
hr B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
infection B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
appearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_NP_DT
novel B-O B-JJ
fusion B-O B-NP_NN
transcript B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
RAZ B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
comprised B-O B-S_NP_VP_VBD
regions B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
by B-O B-NP_PP_IN
RT-PCR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ZEBRA B-O B-S_NP_NN
protein B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
infected B-O B-NP_JJ
thymocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
immunoprecipitation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
EBNA-1 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
infected B-O B-NP_JJ
thymocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
transcribed B-O B-VP_VBN
from B-O B-NP_PP_PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
, B-O B-COMMA
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
from B-O B-PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transcripts B-O B-S_S_NP_NP_NNS
" " B-O O-NP
encoding B-O B-VP_VBG
gp350/220 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
major B-O B-NP_JJ
coat B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
EBV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
we B-O B-S_NP_PRP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
find B-O B-VP_VB
any B-O B-NP_NP_DT
evidence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
in B-O B-PP_IN
infected B-O B-NP_JJ
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
de B-O B-S_NP_NP_ADJP_FW
novo B-O B-FW
" " B-O O-ADJP
EBV B-O B-NN
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
thymocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
differs B-O B-VP_VBZ
from B-O B-PP_IN
infection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
main B-O B-JJ
difference B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
that B-O B-SBAR_IN
with B-O B-S_PP_IN
thymocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
no B-O B-NP_DT
evidence B-O B-NN
" " B-O B-SBAR_O-NP
could B-O B-VP_MD
be B-O B-VP_VB
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
virus B-O B-NN
" " B-O O-NP
ever B-O B-ADVP_RB
" " B-O O-ADVP
circularizes B-O B-VP_VBZ
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
  
Rather B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
EBV B-O B-NP_NN
" " B-O O-NP
remains B-O B-VP_VBZ
in B-O B-PP_IN
a B-O B-NP_NP_DT
linear B-O B-JJ
configuration B-O B-NN
" " B-O O-NP
from B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
replicative B-O B-S_NP_JJ
genes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
transcribed B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Induction B-O B-NP_NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Sp1 B-O B-NP_NP_NN
" " B-O O-NP
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NP_NP_NN
B-independent B-O B-JJ
HIV B-O B-NN
promoter B-O B-NN
" " B-O O-NP
domain B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
by B-O B-NP_PP_IN
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
In B-O B-S_S_PP_IN
contrast B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
purely B-O B-ADJP_RB
enhancer-dependent B-O B-JJ
" " B-O O-ADJP
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokines B-O B-NP_NP_NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
" " B-O B-NP_O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
that B-O B-SBAR_IN
okadaic B-O B-S_NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
OKA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
activates B-O B-VP_VBZ
HIV B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
both B-O B-NP_CC
the B-O B-NP_DT
enhancer B-O B-NN
" " B-O B-PP_O-NP
, B-O B-COMMA
, B-O B-S_NP_VP_COMMA
and B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
inducibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
LTR-driven B-O B-JJ
luciferase B-O B-NN
expression B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
lymphoblastoid B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
by B-O B-NP_PP_IN
OKA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
depended B-O B-VP_VBD
on B-O B-PP_IN
both B-O B-NP_CC
functional B-O B-NP_JJ
Sp1 B-O B-NN
binding B-O B-NN
elements B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TATA B-O B-NP_NN
box B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
the B-O B-NP_DT
protein B-O B-NN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
both B-O B-NP_CC
transformed B-O B-NP_VBN
" " B-O B-NP_O-NP
and B-O B-CC
normal B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
OKA B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBD
intense B-O B-NP_NP_JJ
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
constitutively B-O B-ADJP_RB
expressed B-O B-VBN
" " B-O O-ADJP
Sp1 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
a B-O B-NP_NP_DT
property B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
OKA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
not B-O B-RB
shared B-O B-VP_VBN
by B-O B-NP_PP_IN
TNF B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
phorbol B-O B-NP_NN
ester B-O B-NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
PHA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
interleukin B-O B-NP_NN
2 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
Responsiveness B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
LTR B-O B-NP_NP_NN
constructs B-O B-NNS
" " B-O O-NP
deleted B-O B-VP_VBN
of B-O B-NP_PP_IN
kappa B-O B-NP_NN
B B-O B-NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
HIV B-O B-NP_NP_NN
Tat B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
increased B-O B-VP_VBN
upon B-O B-NP_PP_IN
OKA B-O B-NP_NP_NN
" " B-O B-NP_O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
TNF B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
SP1 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
phosphorylation B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
OKA B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
facilitates B-O B-VP_VBZ
the B-O B-NP_NP_DT
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
involving B-O B-NP_VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
would B-O B-VP_MD
increase B-O B-VP_VB
, B-O B-COMMA
independently B-O B-UCP_ADVP_ADVP_RB
" " B-O O-ADVP
of B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-ADVP
an B-O B-DT
in B-O B-PP_NN
synergy B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-UCP
, B-O B-COMMA
the B-O B-NP_NP_DT
low B-O B-ADJP_JJ
basal B-O B-JJ
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NP_NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
normal B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-NP_NP_NP_JJ
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
gene B-O B-NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
directed B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
carboxyl B-O B-NP_NN
terminus B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
CIITA B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Type B-O B-S_S_NP_NP_NP_NN
II B-O B-CD
major B-O B-JJ
histocompatibility B-O B-NN
complex B-O B-NN
" " B-O O-NP
combined B-O B-JJ
immune B-O B-JJ
deficiency B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
type B-O B-NP_NP_NN
II B-O B-CD
MHC B-O B-NP_NN
" " B-O O-NP
CID B-O B-NN
" " B-O O-NP
or B-O B-CC
bare B-O B-NP_JJ
lymphocyte B-O B-NN
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
congenital B-O B-JJ
immunodeficiency B-O B-NN
disease B-O B-NN
" " B-O O-NP
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
absent B-O B-NP_JJ
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Four B-O B-S_NP_CD
distinct B-O B-JJ
complementation B-O B-NN
groups B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recently B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
defective B-O B-NP_JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
group B-O B-NP_NN
II B-O B-CD
type B-O B-NN
II B-O B-CD
MHC B-O B-NP_NN
" " B-O O-NP
CID B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
isolated B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
termed B-O B-VP_VBN
CIITA B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
CIITA B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_DT
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
gene-specific B-O B-JJ
transcription B-O B-NN
activator B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
transcription B-O B-NN
activation B-O B-NN
function B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
provided B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
N-terminal B-O B-NP_NP_JJ
acidic B-O B-JJ
domain B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
amino B-O B-NP_NN
acids B-O B-NNS
26-137 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
experimentally B-O B-ADJP_RB
exchangeable B-O B-JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CIITA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
three B-O B-NP_NP_CD
major B-O B-JJ
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
DR B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
DQ B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
DP B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
its B-O B-NP_PRPP
remaining B-O B-VBG
C-terminal B-O B-NP_NP_JJ
residues B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
amino B-O B-NP_NN
acids B-O B-NNS
317-1130 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
multiple B-O B-NP_NP_NP_JJ
cis B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
especially B-O B-ADVP_RB
" " B-O O-ADVP
S B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
X2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
of B-O B-PP_IN
the B-O B-NP_NP_DT
DR B-O B-NP_NN
alpha B-O B-NN
proximal B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
group B-O B-NP_NN
II B-O B-CD
CID B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
CIITA B-O B-ADJP_NP_NN
" " B-O O-NP
dependent B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
CIITA B-O B-S_NP_NP_NP_NN
" " B-O O-NP
overexpression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
normal B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
increase B-O B-VP_VB
class B-O B-NP_NN
II B-O B-CD
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
initiation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CIITA B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
serves B-O B-VP_VBZ
as B-O B-PP_IN
the B-O B-NP_DT
on-off B-O B-JJ
switch B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
while B-O B-SBAR_IN
limits B-O B-S_NP_NP_PP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
CAG B-O B-NP_NP_NP_NN
repeat B-O B-NN
length B-O B-NN
variation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
sperm B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
a B-O B-NP_NP_DT
patient B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
Kennedy B-O B-NP_NN
's B-O B-POS
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Using B-O B-S_S_S_NP_VP_VBG
a B-O B-NP_DT
modified B-O B-VBN
sperm B-O B-NP_NN
" " B-O O-NP
typing B-O B-NN
protocol B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
the B-O B-S_NP_NP_DT
mutation B-O B-NN
frequency B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CAG B-O B-NP_NN
repeat B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
the B-O B-NP_DT
androgen B-O B-NP_NN
receptor B-O B-NN
locus B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
measured B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
using B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
rare B-O B-JJ
semen B-O B-NN
sample B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Among B-O B-S_PP_IN
258 B-O B-NP_CD
X B-O B-NP_NN
chromosome-containing B-O B-JJ
sperm B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
19 B-O B-S_S_NP_ADJP_CD
% B-O B-NN
" " B-O O-ADJP
" " B-O B-NP_O-NP
had B-O B-VP_VBD
a B-O B-NP_NP_NP_DT
repeat B-O B-NN
number B-O B-NN
" " B-O O-NP
equal B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_O-PP
" " B-O O-ADJP
" " B-O O-NP
( B-O B-PRN_LRB
47 B-O B-NP_CD
repeats B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
66 B-O B-S_NP_ADJP_CD
% B-O B-NN
" " B-O O-ADJP
" " B-O B-NP_O-NP
were B-O B-VP_VBD
expansions B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
15 B-O B-S_NP_ADJP_CD
% B-O B-NN
" " B-O O-ADJP
" " B-O B-NP_O-NP
were B-O B-VP_VBD
contractions B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
average B-O B-JJ
expansion B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
2.7 B-O B-NP_CD
repeats B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
More B-O B-S_S_NP_NP_QP_JJR
than B-O B-IN
half B-O B-NN
" " B-O O-QP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
expansions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involved B-O B-VP_VBD
one B-O B-NP_NP_CD
" " B-O B-NP_O-NP
or B-O B-CC
two B-O B-NP_CD
" " B-O B-NP_O-NP
repeats B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
the B-O B-S_NP_DT
largest B-O B-JJS
" " B-O B-NP_O-NP
was B-O B-VP_VBD
11 B-O B-NP_CD
repeats B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
68 B-O B-S_S_NP_NP_CD
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
contractions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
one B-O B-NP_NP_CD
" " B-O B-NP_O-NP
or B-O B-CC
two B-O B-NP_CD
" " B-O B-NP_O-NP
repeats B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
but B-O B-CC
six B-O B-S_NP_NP_CD
" " B-O O-NP
( B-O B-PRN_LRB
16 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
were B-O B-VP_VBD
very B-O B-ADJP_ADJP_RB
large B-O B-JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
12-25 B-O B-NP_QP_CD
" " B-O O-QP
repeats B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_CD
contraction B-O B-NN
" " B-O O-NP
generated B-O B-VP_VBD
an B-O B-NP_NP_DT
allele B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
an B-O B-NP_NP_DT
intermediate B-O B-JJ
size B-O B-NN
range B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
33-39 B-O B-NP_QP_CD
" " B-O O-QP
repeats B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Such B-O B-S_NP_JJ
alleles B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
not B-O B-RB
been B-O B-VP_VBN
observed B-O B-VP_VBN
among B-O B-NP_PP_IN
more B-O B-NP_NP_QP_JJR
than B-O B-IN
900 B-O B-CD
" " B-O O-QP
normal B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
SBMA B-O B-NP_NN
X-chromosomes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
have B-O B-S_NP_VP_VBP
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Comparison B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
SBMA B-O B-NN
sperm B-O B-NP_NN
" " B-O O-NP
typing B-O B-NN
results B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
mutation B-O B-NP_NP_NN
frequency B-O B-NN
data B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
normal B-O B-NP_JJ
alleles B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
supports B-O B-VP_VBZ
the B-O B-NP_DT
hypothesis B-O B-NN
that B-O B-SBAR_IN
trinucleotide B-O B-S_NP_NP_NN
repeat B-O B-NN
" " B-O O-NP
expansions B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
have B-O B-VP_VB
a B-O B-NP_NP_DT
different B-O B-JJ
molecular B-O B-JJ
origin B-O B-NN
" " B-O O-NP
than B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Isolation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
differentially B-O B-NP_ADJP_RB
expressed B-O B-VBN
" " B-O O-ADJP
sequence B-O B-NN
tags B-O B-NNS
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
steroid-responsive B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
using B-O B-S_NP_VP_VBG
mRNA B-O B-NP_NP_NN
" " B-O O-NP
differential B-O B-JJ
display B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Transcriptional B-O B-S_S_NP_NP_JJ
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
steroid-regulated B-O B-NP_JJ
gene B-O B-NN
networks B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
nuclear B-O B-NP_JJ
receptor B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
coordinate B-O B-NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
limited B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
target B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Although B-O B-S_SBAR_IN
much B-O B-S_NP_JJ
" " B-O B-PP_O-NP
is B-O B-VP_VBZ
known B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
about B-O B-PP_IN
the B-O B-NP_NP_DT
structure B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
function B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
steroid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
relatively B-O B-S_NP_ADJP_RB
few B-O B-JJ
" " B-O O-ADJP
cell-specific B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
steroid-regulated B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
genes B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
isolated B-O B-VP_VP_VBN
" " B-O O-VP
and B-O B-CC
characterized B-O B-VP_VBN
" " B-O O-VP
" " B-O O-VP
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
paper B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
describe B-O B-VP_VBP
results B-O B-NP_NP_NNS
" " B-O O-NP
using B-O B-VP_VBG
mRNA B-O B-NP_NP_NN
" " B-O O-NP
differential B-O B-NP_NP_JJ
display B-O B-NN
reverse B-O B-NP_JJ
transcriptase B-O B-NN
" " B-O O-NP
PCR B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
DDPCR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
to B-O B-S_NP_VP_TO
identify B-O B-VP_VP_VB
" " B-O B-NP_O-VP
and B-O B-CC
isolate B-O B-VP_VB
" " B-O B-NP_O-VP
short B-O B-NP_NP_JJ
cDNA B-O B-NN
sequence B-O B-NN
tags B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
thymocyte B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
prostate B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
under B-O B-PP_IN
various B-O B-NP_JJ
hormone B-O B-NN
conditions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
this B-O B-NP_DT
technique B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
isolated B-O B-VP_VBN
several B-O B-NP_JJ
differentially B-O B-NP_NP_RB
expressed B-O B-VBN
sequence B-O B-NN
tags B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
DESTs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
mouse B-O B-NP_NP_NN
thymocyte B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
WEHI B-O B-NP_NN
7.2 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
DESTs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
GIG10 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
GIG18 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
2 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
treatment B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
GIG10 B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
novel B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
GIG18 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
mouse B-O B-NN
homologue B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
human B-O B-NP_JJ
expressed B-O B-VBN
sequence B-O B-NN
tag B-O B-NN
" " B-O O-NP
" " B-O O-NP
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
activated B-O B-NP_VBN
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
used B-O B-VP_VBD
DDPCR B-O B-NP_NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
isolate B-O B-VP_VB
DESTs B-O B-NP_NNS
" " B-O B-SBAR_O-NP
from B-O B-PP_IN
androgen-modulated B-O B-NP_JJ
rat B-O B-NN
ventral B-O B-JJ
prostate B-O B-NN
tissue B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
one B-O B-SBAR_WHNP_NP_CD
" " B-O O-NP
of B-O B-WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
" " B-O O-WHNP
we B-O B-S_NP_PRP
" " B-O O-NP
characterized B-O B-VP_VP_VBD
" " B-O B-NP_O-VP
and B-O B-CC
found B-O B-VP_VBD
to B-O B-S_NP_VP_TO
correspond B-O B-VP_VB
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
  
Modifications B-O B-S_S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
original B-O B-JJ
DDPCR B-O B-NN
protocol B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
we B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
" " B-O B-S_COMP_S_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
described B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_NP_DT
merits B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
DDPCR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
relative B-O B-ADJP_JJ
to B-O B-PP_TO
other B-O B-NP_JJ
differential B-O B-JJ
cDNA B-O B-NN
cloning B-O B-NN
strategies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
are B-O B-VP_VBP
discussed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Identification B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_NP_CD
novel B-O B-JJ
regulatory B-O B-NP_JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_NP_DT
5'-untranslated B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
A B-O B-NN
gamma-globin B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Interaction B-O B-S_S_NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_NP_DT
stage B-O B-NP_NP_NN
selector B-O B-NN
element B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
proximal B-O B-NP_JJ
gamma-globin B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
hypersensitivity B-O B-NP_NP_NN
site B-O B-NN
2 B-O B-CD
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
locus B-O B-NP_NN
control B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
partly B-O B-ADVP_RB
" " B-O O-ADVP
mediates B-O B-VP_VBZ
the B-O B-NP_NP_DT
competitive B-O B-JJ
silencing B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
beta-globin B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
fetal B-O B-JJ
developmental B-O B-JJ
stage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
now B-O B-ADVP_RB
" " B-O O-ADVP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
second B-O B-JJ
SSE-like B-O B-NP_JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
contributes B-O B-VP_VBZ
to B-O B-PP_TO
this B-O B-NP_NP_DT
competitive B-O B-JJ
silencing B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Utilizing B-O B-S_S_NP_VP_VBG
transient B-O B-NP_JJ
transfection B-O B-NN
assays B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
fetal B-O B-NP_NP_JJ
erythroid B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
K562 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
core B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
hypersensitivity B-O B-NP_NN
site B-O B-NN
2 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
preferentially B-O B-ADVP_RB
" " B-O O-ADVP
interact B-O B-VP_VB
with B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
, B-O B-COMMA
completely B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
silencing B-O B-VP_VBG
" " B-O B-NP_O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Mutation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
20-base B-O B-JJ
pair B-O B-NN
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
gamma-gene B-O B-NP_NP_NN
5'-untranslated B-O B-JJ
region B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
UTR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
led B-O B-VP_VBD
to B-O B-PP_TO
derepression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
beta-promoter B-O B-NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
marked B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gamma-promoter B-O B-NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBN
with B-O B-NP_PP_IN
this B-O B-NP_DT
mutation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
repressor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Fine B-O B-S_NP_JJ
mutagenesis B-O B-NN
" " B-O O-NP
dissected B-O B-VP_VBD
these B-O B-NP_DT
activities B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
different B-O B-NP_NP_JJ
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
5'-UTR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
stage B-O B-NN
selector B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
localized B-O B-VP_VBN
to B-O B-NP_PP_TO
a B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
centered B-O B-ADJP_JJ
on B-O B-PP_IN
nucleotides B-O B-NP_NNS
+13 B-O B-CD
to B-O B-TO
+15 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Electromobility B-O B-S_NP_NP_NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
utilizing B-O B-VP_VBG
this B-O B-NP_DT
sequence B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
demonstrated B-O B-VP_VBD
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
fetal B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
erythroid-specific B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
protein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
repressor B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
5'-UTR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
localized B-O B-VP_VBN
to B-O B-NP_PP_TO
tandem B-O B-NP_NP_JJ
GATA-like B-O B-NP_JJ
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
appear B-O B-S_NP_VP_VBP
" " B-O B-S_NP_VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
5'-UTR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
gamma-gene B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contains B-O B-VP_VBZ
sequences B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
may B-O B-S_NP_VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Abnormal B-O B-S_S_NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
lpr B-O B-NP_NN
CD4-CD8- B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
constitutive B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
novel B-O B-NP_JJ
nuclear B-O B-JJ
factor B-O B-NN
of B-O B-IN
activated B-O B-VBN
T B-O B-NN
cells-binding B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
inert B-O B-JJ
quality B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
MRL-Ipr/Ipr B-O B-NP_NN
( B-O B-LRB
Ipr B-O B-NN
) B-O B-RRB
peripheral B-O B-JJ
CD4-CD8- B-O B-JJ
( B-O B-LRB
CD4-8- B-O B-JJ
) B-O B-RRB
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
manifests B-O B-VP_VBZ
primarily B-O B-ADVP_RB
" " B-O O-ADVP
as B-O B-PP_IN
an B-O B-NP_DT
inability B-O B-NN
to B-O B-S_NP_VP_TO
proliferate B-O B-VP_VP_VB
" " B-O B-NP_O-VP
or B-O B-CC
produce B-O B-VP_VB
" " B-O B-NP_O-VP
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Yet B-O B-S_ADVP_RB
" " B-O O-ADVP
these B-O B-NP_DT
same B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
do B-O B-VP_VBP
initiate B-O B-VP_VB
early B-O B-NP_NP_JJ
TCR-mediated B-O B-JJ
signaling B-O B-NN
events B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
such B-O B-PP_JJ
as B-O B-IN
generation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
inositol B-O B-NP_JJ
phosphates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
increased B-O B-NP_VBN
intracellular B-O B-JJ
calcium B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
They B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
display B-O B-VP_VBP
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
p59fyn B-O B-NP_NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
CD3 B-O B-NP_NP_NN
zeta B-O B-NN
" " B-O O-NP
tyrosine B-O B-NN
" " B-O B-NP_O-NP
phosphorylation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
generation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
second B-O B-NP_JJ
messengers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
normally B-O B-ADVP_RB
" " B-O O-ADVP
leads B-O B-VP_VBZ
to B-O B-PP_TO
downstream B-O B-NP_NP_JJ
signaling B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
results B-O B-S_NP_VP_VBZ
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
, B-O B-COMMA
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
compared B-O B-VP_VBD
the B-O B-NP_NP_DT
activation B-O B-NN
state B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NP_NN
gene B-O B-NN
promoter B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
freshly B-O B-NP_NP_ADJP_RB
isolated B-O B-VBN
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
stimulated B-O B-NP_VBN
" " B-O B-NP_O-NP
Ipr B-O B-NP_NN
CD4-8- B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
with B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
normal B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Levels B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
octamer B-O B-NN
" " B-O O-NP
, B-O B-COMMA
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
p50-p65 B-O B-NP_NN
heterodimer B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
, B-O B-COMMA
and B-O B-CC
AP-1 B-O B-NP_NN
transcriptional B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
elevated B-O B-VP_VBN
in B-O B-NP_PP_IN
freshly B-O B-NP_ADJP_RB
isolated B-O B-VBN
" " B-O O-ADJP
Ipr B-O B-NP_NN
CD4-8- B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_NP_DT
activated B-O B-VBN
phenotype B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Upon B-O B-S_PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
mitogens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
formation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
transactivating B-O B-VBG
complex B-O B-NN
" " B-O O-NP
, B-O B-COMMA
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
of B-O B-IN
activated B-O B-VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
NF-AT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
occurs B-O B-VP_VBZ
with B-O B-PP_IN
normal B-O B-NP_JJ
kinetics B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Ipr B-O B-NP_NN
CD4-8- B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Yet B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
activating B-O B-VBG
NF-AT B-O B-NP_NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
never B-O B-ADVP_RB
" " B-O O-ADVP
reach B-O B-VP_VBP
those B-O B-NP_NP_DT
" " B-O O-NP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
similarly B-O B-NP_ADJP_RB
stimulated B-O B-VBN
" " B-O O-ADJP
normal B-O B-JJ
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
Ipr B-O B-NP_NN
CD4-8- B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
display B-O B-VP_VBP
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
novel B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_NP_DT
NF-AT B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
present B-O B-ADJP_JJ
at B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Upon B-O B-S_PP_IN
mitogenic B-O B-NP_JJ
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
novel B-O B-JJ
NF-AT-binding B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
down-regulated B-O B-VP_VBN
in B-O B-NP_PP_IN
normal B-O B-NP_JJ
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
persists B-O B-VP_VBZ
at B-O B-PP_IN
high B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Ipr B-O B-NP_NN
CD4-8- B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
two B-O B-CD
abnormalities B-O B-NNS
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
NF-AT B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
provide B-O B-VP_VBP
a B-O B-NP_NP_DT
potential B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHADVP_S_NP_VP_TO
account B-O B-VP_VB
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
GM-CSF B-O B-S_S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
share B-O B-VP_VBP
common B-O B-NP_JJ
control B-O B-NN
mechanisms B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
costimulatory B-O B-NP_NP_JJ
signals B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Antigen B-O B-S_S_NP_NP_NN
" " B-O O-NP
complexed B-O B-VP_VBN
with B-O B-NP_PP_IN
major B-O B-NP_JJ
histocompatibility B-O B-NN
complex B-O B-NN
class B-O B-NN
I B-O B-NP_CD
" " B-O B-NP_O-NP
or B-O B-CC
II B-O B-NP_CD
" " B-O B-NP_O-NP
molecules B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
surface B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
antigen B-O B-NP_NN
presenting B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
interacts B-O B-VP_VP_VBZ
with B-O B-PP_IN
the B-O B-NP_DT
T B-O B-NP_NP_NN
cell B-O B-NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TCR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
surface B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
initiates B-O B-VP_VBZ
an B-O B-NP_DT
activation B-O B-NN
cascade B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
So B-O B-S_NP_NP_ADJP_RB
called B-O B-VBN
" " B-O O-ADJP
costimulatory B-O B-JJ
signals B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
other B-O B-NP_NP_JJ
cell B-O B-NN
surface B-O B-NN
interactions B-O B-NNS
" " B-O O-NP
or B-O B-CC
soluble B-O B-NP_NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
produced B-O B-VP_VBN
by B-O B-NP_PP_IN
antigen B-O B-NP_NN
presenting B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
also B-O B-ADVP_RB
" " B-O O-ADVP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
complete B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
High B-O B-S_NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NP_NN
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
required B-O B-VP_VBD
both B-O B-NP_CC
TCR B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
costimulatory B-O B-NP_JJ
" " B-O B-NP_O-NP
signals B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
granulocyte-macrophage B-O B-NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
requires B-O B-VP_VBZ
sequences B-O B-NP_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
promoter B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
a B-O B-NP_NP_DT
powerful B-O B-JJ
enhancer B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
located B-O B-ADJP_JJ
3kb B-O B-ADVP_NP_RB
" " B-O O-NP
upstream B-O B-RB
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
to B-O B-S_NP_VP_TO
respond B-O B-VP_VB
to B-O B-PP_TO
TCR-like B-O B-JJ
signals B-O B-NNS
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
promoter B-O B-NP_NN
and B-O B-CC
enhancer B-O B-NN
regions B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
mainly B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
transcription B-O B-NP_NP_NN
factor B-O B-NN
nuclear B-O B-JJ
factor B-O B-NN
of B-O B-IN
activated B-O B-VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
NFAT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFAT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
TCR B-O B-NP_NP_NN
" " B-O O-NP
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
well B-O B-ADVP_RB
" " B-O O-ADVP
described B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_NP_NP_NP_NP_PRN_NP_O-NP
and B-O B-CC
IL-4 B-O B-NP_NN
" " B-O B-NP_O-NP
gene B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Costimulatory B-O B-S_NP_NP_JJ
signals B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
such B-O B-PP_JJ
as B-O B-IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD28 B-O B-NP_NN
cell B-O B-NN
surface B-O B-NN
molecule B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
lead B-O B-VP_VBP
to B-O B-PP_TO
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
a B-O B-NP_NP_DT
distinct B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
granulocyte-macrophage B-O B-NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
( B-O B-LRB
GM-CSF B-O B-NN
) B-O B-RRB
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
region B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
termed B-O B-VP_VBN
the B-O B-S_NP_NP_DT
CK-1 B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
CD28RE B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
specific B-O B-NP_NP_JJ
members B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_NP_NP_JJ
T B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
infects B-O B-VP_VP_VBZ
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
can B-O B-VP_MD
lead B-O B-VP_VB
to B-O B-S_NP_VP_TO
increase B-O B-VP_VB
GM-CSF B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
found B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
HTLV-1 B-O B-NP_NN
transactivator B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
tax B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
acts B-O B-VP_VBZ
as B-O B-PP_IN
a B-O B-NP_NP_DT
costimulatory B-O B-JJ
signal B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tax B-O B-S_NP_NN
" " B-O O-NP
activates B-O B-VP_VP_VBZ
the B-O B-NP_DT
GM-CSF B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
through B-O B-PP_IN
the B-O B-NP_DT
CK-1/CD28RE B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
also B-O B-ADVP_RB
" " B-O O-ADVP
activates B-O B-VP_VBZ
nuclear B-O B-NP_NP_JJ
factor-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
this B-O B-NP_DT
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
other B-O B-NP_NP_JJ
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
or B-O B-CC
coactivators B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
tax B-O B-NP_NP_NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
but B-O B-CC
these B-O B-S_NP_DT
" " B-O O-NP
remain B-O B-VP_VBP
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
CK-1/CD28RE B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GM-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
shows B-O B-VP_VBZ
a B-O B-NP_NP_DT
high B-O B-JJ
degree B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
similarity B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
IL-2 B-O B-NP_NN
" " B-O O-NP
CD28RE B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_DT
IL-3 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
contains B-O B-VP_VBZ
a B-O B-NP_DT
related B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
observation B-O B-NN
, B-O B-COMMA
" " B-O O-NP
together B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
the B-O B-NP_DT
fact B-O B-NN
that B-O B-SBAR_IN
both B-O B-S_NP_CC
GM-CSF B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
respond B-O B-VP_VBP
to B-O B-PP_TO
TCR B-O B-NP_NP_NN
" " B-O O-NP
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
via B-O B-PP_IN
NFAT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
implies B-O B-VP_VBZ
a B-O B-NP_NP_DT
high B-O B-JJ
degree B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
conservation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NP_NN
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
MIP1 B-O B-NP_NP_NP_NP_NN
alpha B-O B-NN
nuclear B-O B-JJ
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MNP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
novel B-O B-JJ
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
hematopoietic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
crucial B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Murine B-O B-S_S_NP_NP_NP_JJ
macrophage B-O B-NN
inflammatory B-O B-JJ
protein B-O B-NN
1 B-O B-CD
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MIP-1 B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
its B-O B-NP_NP_PRPP
human B-O B-NP_JJ
equivalent B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
GOS19 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
LD78 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
AT464 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
members B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
-C-C B-O B-NP_NN
family B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
low-molecular-weight B-O B-NP_JJ
chemokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Secreted B-O B-S_S_NP_VP_VBN
from B-O B-NP_PP_IN
activated B-O B-NP_NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
bone B-O B-S_NP_NN
marrow-derived B-O B-NP_JJ
MIP-1 B-O B-NN
alpha/GOS19 B-O B-NN
" " B-O O-NP
" " B-O O-NP
inhibits B-O B-VP_VP_VBZ
primitive B-O B-NP_JJ
hematopoietic B-O B-JJ
stem B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
induces B-O B-VP_VBZ
chemotaxis B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
inflammatory B-O B-NP_JJ
responses B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
mature B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-NP_NP_PRP
" " B-O O-NP
" " B-O B-S_O-NP
is B-O B-VP_VBZ
important B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
understand B-O B-VP_VB
the B-O B-NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
control B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Previous B-O B-S_NP_JJ
work B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
shown B-O B-VP_VBN
that B-O B-SBAR_IN
in B-O B-S_PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_NP_DT
set B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_ADJP_NP_O-PP
" " B-O O-NP
( B-O B-PRN_LRB
the B-O B-NP_DT
ICK-1 B-O B-NP_NN
family B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
affect B-O B-VP_VBP
the B-O B-NP_DT
GOS19 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
member B-O B-NN
" " B-O O-NP
, B-O B-COMMA
ICK-1A B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
behaves B-O B-VP_VBZ
as B-O B-PP_IN
a B-O B-NP_DT
strong B-O B-NP_JJ
negative B-O B-JJ
regulator B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
communication B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
provide B-O B-VP_VBP
evidence B-O B-NP_NN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
pathway B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
induction B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_NP_NP_O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
different B-O B-ADJP_JJ
from B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
ICK-1 B-O B-NP_NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
confer B-O B-VP_VB
negative B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
provide B-O B-VP_VBP
evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
an B-O B-NP_NP_DT
additional B-O B-JJ
binding B-O B-NP_VBG
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
MIP-1 B-O B-NP_NN
alpha B-O B-NN
nuclear B-O B-JJ
protein B-O B-NN
( B-O B-LRB
MNP B-O B-NN
) B-O B-RRB
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
overlaps B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interaction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
various B-O B-NP_NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
and B-O B-CC
tissue B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
MNP B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
fast-migrating B-O B-NP_JJ
protein-DNA B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
similar B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
but B-O B-CC
distinct B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
electrophoretic B-O B-JJ
mobilities B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
mutation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
MNP B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
does B-O B-S_NP_VP_VBZ
not B-O B-RB
abrogate B-O B-VP_VB
ICK-1 B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inactivates B-O B-VP_VP_VBZ
the B-O B-NP_NP_DT
GOS19.1 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
reduces B-O B-VP_VBZ
its B-O B-NP_PRPP
activity B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
fourfold B-O B-NP_RB
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
MNP B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
binding B-O B-VP_VBG
at B-O B-PP_IN
the B-O B-NP_DT
MNP B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
constitutes B-O B-VP_VBZ
a B-O B-NP_NP_DT
novel B-O B-JJ
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
hematopoietic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Ligand-dependent B-O B-NP_NP_NP_JJ
repression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
erythroid B-O B-NP_NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
estrogen B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
High-dose B-O B-S_S_NP_JJ
estrogen B-O B-NN
administration B-O B-NN
" " B-O O-NP
induces B-O B-VP_VBZ
anemia B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
mammals B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
chickens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
estrogens B-O B-NP_NNS
" " B-O O-NP
stimulate B-O B-VP_VP_VBP
outgrowth B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
bone B-O B-NP_NN
marrow-derived B-O B-JJ
erythroid B-O B-JJ
progenitor B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
delay B-O B-VP_VBP
their B-O B-NP_PRPP
maturation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
delay B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
down-regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
many B-O B-NP_NP_JJ
erythroid B-O B-NP_JJ
cell-specific B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
estrogens B-O B-S_NP_NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
reduce B-O B-VP_VBP
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
erythroid B-O B-NP_JJ
progenitor B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
primary B-O B-NP_JJ
human B-O B-JJ
bone B-O B-NN
marrow B-O B-NN
cultures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
address B-O B-VP_VB
potential B-O B-NP_NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
estrogens B-O B-S_NP_NNS
" " B-O O-NP
suppress B-O B-VP_VBP
erythropoiesis B-O B-NP_NN
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
their B-O B-NP_NP_PRPP
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
GATA-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
" " B-O B-NP_SBAR_WHNP_S_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_NP_DT
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
strongly B-O B-ADVP_RB
" " B-O O-ADVP
repressed B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
in B-O B-PP_IN
a B-O B-NP_DT
ligand-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
this B-O B-S_NP_DT
repression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
reversible B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ER-mediated B-O B-S_NP_NP_JJ
repression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurs B-O B-VP_VBZ
on B-O B-PP_PP_IN
an B-O B-NP_NP_DT
artificial B-O B-NP_JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
containing B-O B-VP_VBG
a B-O B-NP_DT
single B-O B-JJ
GATA-binding B-O B-NP_JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
the B-O B-NP_NP_DT
context B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
intact B-O B-NP_JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
GATA-1 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
ER B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
bind B-O B-VP_VBP
to B-O B-PP_TO
each B-O B-NP_DT
other B-O B-JJ
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
in B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
coimmunoprecipitation B-O B-NP_NP_NN
experiments B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
transfected B-O B-NP_VBN
COS B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
GATA-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
ER B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
associate B-O B-VP_VBP
in B-O B-PP_IN
a B-O B-NP_DT
ligand-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mapping B-O B-S_NP_NN
experiments B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
GATA-1 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
ER B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
form B-O B-VP_VBP
at B-O B-NP_NP_QP_IN
least B-O B-JJS
two B-O B-CD
" " B-O O-QP
contacts B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
involve B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
speculate B-O B-VP_VBP
that B-O B-SBAR_IN
estrogens B-O B-S_NP_NNS
" " B-O O-NP
exert B-O B-VP_VBP
effects B-O B-NP_NNS
" " B-O O-NP
on B-O B-PP_IN
erythropoiesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
modulating B-O B-S_NP_VP_VBG
activity B-O B-NP_NP_NN
" " B-O O-NP
through B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
A B-O B-S_S_NP_DT
Myc-associated B-O B-NP_JJ
zinc B-O B-NN
finger B-O B-NN
protein B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
four B-O B-NP_NP_CD
important B-O B-JJ
functional B-O B-NP_JJ
regions B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
CD4 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_DT
CD4 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
plays B-O B-VP_VBZ
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
developmental B-O B-JJ
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD4 B-O B-NP_NP_NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
minimal B-O B-JJ
CD4 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
four B-O B-NP_NP_CD
factor B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
each B-O B-SBAR_WHNP_NP_DT
" " B-O O-NP
of B-O B-WHPP_IN
" " B-O B-WHNP_O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
biochemical B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
mutagenesis B-O B-NP_NN
" " B-O B-NP_O-NP
analyses B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
determined B-O B-VP_VBD
that B-O B-SBAR_IN
multiple B-O B-S_NP_JJ
nuclear B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
bind B-O B-VP_VBP
to B-O B-PP_TO
these B-O B-NP_DT
independent B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
determined B-O B-VP_VBD
that B-O B-SBAR_IN
an B-O B-S_NP_NP_NP_DT
initiator-like B-O B-NP_JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
present B-O B-ADJP_JJ
at B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-NP
and B-O B-CC
an B-O B-NP_DT
Ets B-O B-NP_NN
consensus B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
full B-O B-NP_JJ
promoter B-O B-NP_NN
" " B-O O-NP
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
Myc-associated B-O B-NP_NP_JJ
zinc B-O B-NN
finger B-O B-NN
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MAZ B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-NP_NP_VP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
last B-O B-JJ
site B-O B-NN
" " B-O O-NP
closely B-O B-ADVP_RB
" " B-O O-ADVP
resembles B-O B-VP_VBZ
the B-O B-NP_NP_DT
ME1a1 B-O B-NP_NN
G3AG4AG3 B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
previously B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
a B-O B-NP_NP_DT
critical B-O B-JJ
element B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
believe B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
MAZ B-O B-NP_NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
likely B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
play B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_NP_DT
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
Nm23H2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
binds B-O B-VP_VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_O-PP
" " B-O O-VP
and B-O B-CC
activates B-O B-VP_VBZ
" " B-O B-NP_O-VP
the B-O B-NP_NP_DT
translocated B-O B-VBN
c-myc B-O B-NP_NN
allele B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
Burkitt B-O B-NP_NN
's B-O B-POS
lymphoma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
an B-O B-NP_NP_DT
in B-O B-ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
footprint B-O B-NN
" " B-O O-NP
over B-O B-PP_IN
the B-O B-NP_NP_DT
PuF B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
PuF B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
silent B-O B-NP_JJ
normal B-O B-JJ
c-myc B-O B-NN
allele B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
unoccupied B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrated B-O B-VP_VBD
by B-O B-PP_IN
electrophoretic B-O B-NP_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
, B-O B-COMMA
electrophoretic B-O B-NP_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
antibody B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
UV B-O B-NP_NP_NN
cross-linking B-O B-NN
" " B-O O-NP
followed B-O B-VP_VBN
by B-O B-NP_PP_IN
SDS-gel B-O B-NP_NN
electrophoresis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Western B-O B-NP_NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
Nm23H2 B-O B-S_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
B B-O B-NP_NN
cell B-O B-NN
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
bound B-O B-VP_VBD
to B-O B-PP_TO
the B-O B-NP_DT
c-myc B-O B-NN
PuF B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transfection B-O B-S_NP_NP_NN
experiments B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
c-myc B-O B-NP_NP_NN
promoter B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_CC
DHL-9 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
Raji B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
PuF B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
functioned B-O B-VP_VBD
as B-O B-PP_IN
a B-O B-NP_DT
positive B-O B-NP_JJ
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
drop B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Access B-O B-S_S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
this B-O B-NP_DT
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
blocked B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
normal B-O B-NP_JJ
silent B-O B-JJ
c-myc B-O B-NN
allele B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
these B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
Nm23H2 B-O B-NP_NN
" " B-O O-NP
protein B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-NP_NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
pp90rsk B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
early B-O B-NP_NP_NP_JJ
growth B-O B-NN
response-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
pokeweed B-O B-NP_NN
mitogen B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
present B-O B-JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
pokeweed B-O B-NP_NP_NN
mitogen B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PWM B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
normal B-O B-NP_JJ
human B-O B-JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
PWM B-O B-S_NP_NN
" " B-O O-NP
regulates B-O B-VP_VBZ
EGR-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
both B-O B-NP_CC
transcriptional B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
post-transcriptional B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
mechanisms B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transient B-O B-S_NP_NP_JJ
transfection B-O B-NN
assays B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
EGR-1 B-O B-NP_NP_NN
promoter B-O B-NN
fragments B-O B-NNS
" " B-O O-NP
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
chloramphenicol B-O B-NP_NN
acetyltransferase B-O B-NN
( B-O B-LRB
CAT B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
PWM B-O B-S_NP_NP_NN
" " B-O O-NP
induced B-O B-JJ
EGR-1 B-O B-NP_NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
conferred B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
in B-O B-NP_NP_PRN_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
demonstrated B-O B-VP_VBD
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
S6 B-O B-NP_NP_NN
kinase B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
pp90rsk B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
evidenced B-O B-VP_VBN
by B-O B-NP_PP_IN
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
S6 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
peptides B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
in B-O B-PP_IN
PWM B-O B-NP_NN
treated B-O B-JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
these B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
PWM B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Infection B-O B-S_S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
Theileria B-O B-NP_FW
annulata B-O B-FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
expression B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
matrix B-O B-NP_NP_NN
metalloproteinase B-O B-NN
9 B-O B-CD
" " B-O O-NP
and B-O B-CC
transcription B-O B-NP_NP_NN
factor B-O B-NN
" " B-O O-NP
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
bovine B-O B-NP_JJ
leucocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Theileria B-O B-S_S_NP_FW
annulata B-O B-FW
" " B-O O-NP
infects B-O B-VP_VP_VBZ
bovine B-O B-NP_JJ
leucocytes B-O B-NNS
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
results B-O B-VP_VBZ
in B-O B-PP_IN
their B-O B-NP_PRPP
reversible B-O B-JJ
transformation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
such B-O B-SBAR_IN
that B-O B-IN
they B-O B-S_NP_PRP
" " B-O O-NP
become B-O B-VP_VBP
immortalised B-O B-ADJP_ADJP_VBN
" " B-O O-ADJP
and B-O B-CC
metastatic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
describes B-O B-VP_VBZ
parasite-induced B-O B-NP_NP_NP_JJ
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
host B-O B-NP_NP_NN
cell B-O B-NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
have B-O B-S_NP_VP_VBP
a B-O B-NP_DT
direct B-O B-JJ
bearing B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
this B-O B-NP_DT
transformation B-O B-NN
process B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
T. B-O B-S_NP_FW
annulata-infected B-O B-JJ
leucocytes B-O B-NNS
" " B-O O-NP
produce B-O B-VP_VBP
a B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
novel B-O B-NP_JJ
metalloproteinase B-O B-NP_NN
" " B-O O-NP
activities B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
previously B-O B-ADVP_RB
" " B-O O-ADVP
called B-O B-VP_VBN
B1 B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
97-kDa B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VP_VBZ
secreted B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
and B-O B-CC
has B-O B-VP_VBZ
been B-O B-VP_VBN
purified B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_DT
antiserum B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
this B-O B-NP_DT
enzyme B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
isolate B-O B-VP_VB
a B-O B-NP_DT
cDNA B-O B-NP_NN
clone B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
predicted B-O B-VBN
protein B-O B-NN
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
81 B-O B-ADJP_NP_CD
% B-O B-NN
" " B-O O-NP
identical B-O B-JJ
to B-O B-PP_TO
human B-O B-NP_JJ
matrix B-O B-NP_NP_NN
metalloproteinase B-O B-NN
9 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
MMP9 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
demonstrating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
bovine B-O B-JJ
homologue B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
RNAase B-O B-S_NP_NP_NN
" " B-O O-NP
protection B-O B-NN
assays B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
MMP9 B-O B-NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
, B-O B-COMMA
unique B-O B-ADJP_JJ
to B-O B-PP_TO
infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
due B-O B-ADJP_JJ
to B-O B-PP_TO
increased B-O B-NP_VBN
MMP9 B-O B-NP_NN
" " B-O O-NP
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
assayed B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
factor B-O B-NN
" " B-O O-NP
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
constitutively B-O B-ADJP_RB
present B-O B-JJ
in B-O B-PP_IN
increased B-O B-NP_VBN
amounts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Theileria-infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
assayed B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mRNA B-O B-NP_NP_NN
" " B-O O-NP
encoding B-O B-VP_VBG
c-Fos B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-NP_NP_PP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
observed B-O B-VP_VBD
that B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
indeed B-O B-ADVP_RB
" " B-O O-ADVP
up-regulated B-O B-VP_VBN
in B-O B-NP_PP_IN
infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
AP-1 B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
implicated B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
MMP9 B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
confer B-O B-VP_VB
metastatic B-O B-NP_JJ
properties B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
these B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
of B-O B-PP_IN
considerable B-O B-NP_JJ
significance B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
respect B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
transformed B-O B-VBN
phenotype B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Reduced B-O B-NP_NP_NP_NP_VBN
mitogenic B-O B-JJ
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_NP_DT
prognostic B-O B-JJ
parameter B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
course B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
breast B-O B-NP_NN
cancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
a B-O B-NP_DT
prospective B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
longitudinal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
study B-O B-NN
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Immunosuppression B-O B-S_S_NP_NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
often B-O B-ADVP_RB
" " B-O O-ADVP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
course B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
malignant B-O B-NP_JJ
diseases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
PBMCs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
mitogenic B-O B-NP_NP_JJ
stimulation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
phytohaemagglutinin B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
assessed B-O B-VP_VBN
prospectively B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
90 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
stage B-O B-NP_NN
I-III B-O B-CD
breast B-O B-NN
cancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Whereas B-O B-S_SBAR_IN
PHA-induced B-O B-S_NP_NP_JJ
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PBMCs B-O B-NP_NP_NNS
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
preoperatively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-VP_VBN
" " B-O B-NP_O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
compared B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
degree B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
defect B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
PHA-induced B-O B-NP_NP_JJ
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PBMCs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
depended B-O B-VP_VBD
upon B-O B-PP_IN
the B-O B-NP_DT
tumour B-O B-NN
burden B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-SBAR_IN
manifested B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
and B-O B-NP_NP_NP_CC
( B-O B-NP_PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
PHA-induced B-O B-S_NP_NP_JJ
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PBMCs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
dropped B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_PP_IN
patients B-O B-NP_NP_NP_NNS
" " B-O O-NP
who B-O B-SBAR_WHNP_WP
" " B-O O-WHNP
received B-O B-S_NP_VP_VBD
" " B-O B-NP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NP_NN
" " B-O O-NP
< B-O B-ADJP_JJR
0.01 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
under B-O B-PP_IN
adjuvant B-O B-NP_NP_JJ
treatment B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_ADVP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_PP_PP_IN
an B-O B-NP_DT
additional B-O B-JJ
6 B-O B-CD
months B-O B-NNS
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
i.e. B-O B-PP_FW
" " B-O O-PP
12 B-O B-PP_NP_CD
months B-O B-NNS
" " B-O O-NP
after B-O B-IN
surgery B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-PP
, B-O B-COMMA
PHA-induced B-O B-NP_NP_JJ
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PBMCs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VP_VBD
similar B-O B-ADJP_JJ
in B-O B-PP_PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
after B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
those B-O B-NP_NP_NP_DT
" " B-O O-NP
receiving B-O B-VP_VBG
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
) B-O B-NP_NP_ADJP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
in B-O B-PP_IN
all B-O B-NP_DT
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
still B-O B-ADVP_RB
significantly B-O B-RB
" " B-O O-ADVP
decreased B-O B-VP_VBD
as B-O B-SBAR_IN
compared B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
healthy B-O B-NP_NP_JJ
controls B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
data B-O B-S_NP_NP_NNS
" " B-O O-NP
obtained B-O B-VP_VBN
preoperatively B-O B-NP_UCP_ADVP_RB
" " B-O O-ADVP
and B-O B-CC
after B-O B-PP_IN
12 B-O B-NP_CD
months B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
compared B-O B-VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
that B-O B-SBAR_IN
out B-O B-S_PP_RB
of B-O B-PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-PP
, B-O B-COMMA
14 B-O B-NP_NP_CD
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
61 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
had B-O B-VP_VBD
developed B-O B-VP_VBN
metastatic B-O B-NP_JJ
disease B-O B-NN
" " B-O O-NP
" " B-O B-PP_PP_PRN_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
out B-O B-PP_RB
of B-O B-PP_IN
59 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
whose B-O B-SBAR_WHNP_WPP
PBMCs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-WHNP
showed B-O B-S_NP_VP_VBD
an B-O B-NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
their B-O B-NP_PRPP
PHA-induced B-O B-JJ
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
only B-O B-NP_NP_QP_RB
one B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
2 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
presented B-O B-VP_VBD
with B-O B-PP_IN
disease B-O B-NP_NN
progression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
thus B-O B-ADVP_RB
" " B-O O-ADVP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
PHA-induced B-O B-S_NP_NP_JJ
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PBMCs B-O B-NP_NP_NNS
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
depends B-O B-VP_VP_VBZ
upon B-O B-PP_IN
the B-O B-NP_DT
tumour B-O B-NN
load B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
a B-O B-NP_DT
good B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
clinical B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
predictor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
further B-O B-JJ
course B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Modulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
factor B-O B-NN
NF B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_PP_IN
intracellular B-O B-NP_JJ
glutathione B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
by B-O B-PP_IN
variations B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
extracellular B-O B-JJ
cysteine B-O B-NN
supply B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
HIV-infected B-O B-S_S_NP_NP_JJ
individuals B-O B-NNS
" " B-O O-NP
and B-O B-CC
SIV-infected B-O B-NP_JJ
rhesus B-O B-NN
macaques B-O B-NNS
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
, B-O B-COMMA
on B-O B-PP_IN
the B-O B-NP_DT
average B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
decreased B-O B-NP_NP_VBN
plasma B-O B-NP_NN
cysteine B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
cystine B-O B-NP_NN
" " B-O B-NP_O-NP
concentrations B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
decreased B-O B-NP_VBN
intracellular B-O B-JJ
glutathione B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
now B-O B-ADVP_RB
" " B-O O-ADVP
show B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
depletion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
intracellular B-O B-NP_JJ
glutathione B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_DT
human B-O B-NP_NP_JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibits B-O B-VP_VBZ
the B-O B-NP_NP_DT
activation B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
nuclear B-O B-NP_JJ
translocation B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NP_NN
factor B-O B-NN
NF B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
incubation B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
inhibits B-O B-VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
inhibition B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
DNA-binding B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
increasing B-O B-NP_VBG
intracellular B-O B-JJ
glutathione B-O B-NN
disulfide B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
GSSG B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
our B-O B-S_NP_PRPP
studies B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
GSSG B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
physiologically B-O B-ADJP_RB
relevant B-O B-JJ
" " B-O O-ADJP
inhibitor B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
intact B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
NF B-O B-S_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
controls B-O B-VP_VBZ
many B-O B-NP_JJ
immunologically B-O B-NP_RB
important B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
so B-O B-SBAR_RB
our B-O B-S_NP_PRPP
studies B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
immune B-O B-JJ
system B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
" " B-O B-ADJP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Expression B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Ah B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TCDD B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
human B-O B-NP_JJ
monocytic B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBN
a B-O B-NP_NP_DT
high B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
Ah B-O B-NN
receptor B-O B-NN
( B-O B-LRB
TCDD B-O B-NN
receptor B-O B-NN
) B-O B-RRB
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
cells B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
individuals B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
paper B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
blood B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
first B-O B-ADVP_RB
" " B-O O-ADVP
investigated B-O B-VP_VBN
in B-O B-NP_PP_IN
fractions B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
nucleated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
revealing B-O B-S_NP_VP_VBG
predominant B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Ah B-O B-NP_NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
monocyte B-O B-NP_NN
fraction B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Then B-O B-S_ADVP_RB
" " B-O O-ADVP
the B-O B-NP_NP_DT
expression B-O B-NN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
AhR B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
various B-O B-NP_JJ
hematopoietic B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
Arnt B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
P450IA1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
AhR B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
expressed B-O B-VP_VBN
at B-O B-NP_PP_PP_IN
high B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytoid B-O B-NP_NP_JJ
U937 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
THP1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
HEL/S B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
at B-O B-PP_IN
moderate B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
promyelocytic B-O B-NP_NP_JJ
HL60 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
erythroblastic B-O B-NP_JJ
HEL B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
detected B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
lymphoid B-O B-NP_NP_NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
MOLT4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
T B-O B-NP_NN
cell B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
BALL1 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
B B-O B-NP_NN
cell B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
nor B-O B-CC
in B-O B-PP_IN
K562 B-O B-NP_NN
erythroblasts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
a B-O B-NP_NP_DT
specific B-O B-JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AhR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
monocytic B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
in B-O B-NP_PP_IN
HL60 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
HEL B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HL60 B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
induced B-O B-VP_VBN
to B-O B-S_NP_VP_TO
differentiate B-O B-VP_VB
toward B-O B-PP_IN
monocytes-macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
incubation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
showing B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
5- B-O B-ADJP_CD
to B-O B-TO
2-fold B-O B-JJ
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AhR B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
incubation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
transforming B-O B-NP_NP_VBG
growth B-O B-NN
factor B-O B-NN
beta B-O B-NN
1 B-O B-CD
" " B-O O-NP
and B-O B-CC
1 B-O B-NP_CD
alpha,25-dihydroxyvitamin B-O B-NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_DT
5- B-O B-ADJP_CD
to B-O B-TO
7-fold B-O B-JJ
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AhR B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
HEL B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
exhibited B-O B-VP_VBD
a B-O B-NP_NP_DT
similar B-O B-JJ
elevation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AhR B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
they B-O B-S_NP_PRP
" " B-O O-NP
had B-O B-VP_VBD
differentiated B-O B-VP_VBN
toward B-O B-PP_IN
monocyte-macrophage B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
these B-O B-NP_DT
combined B-O B-JJ
inducers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
little B-O B-S_NP_NP_JJ
change B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
mRNA B-O B-NN
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
induced B-O B-VP_VBN
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
differentiated B-O B-NP_VBN
HL60 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
3-methylcholanthrene B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
ligand B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AhR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
induced B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
P450IA1 B-O B-NP_NN
" " B-O O-NP
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_SBAR_IN
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
AhR B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBN
during B-O B-NP_PP_IN
monocytic B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_DT
differentiated B-O B-NP_VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
responsive B-O B-ADJP_JJ
to B-O B-PP_TO
xenobiotics B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
AhR B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
play B-O B-VP_VB
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
" " B-O B-NP_NP_PP_O-PP
and B-O B-CC
also B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Physiological B-O B-S_S_NP_NP_JJ
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
estradiol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibits B-O B-VP_VBZ
polymorphonuclear B-O B-NP_NP_JJ
leukocyte B-O B-NN
" " B-O O-NP
chemotaxis B-O B-NN
" " B-O O-NP
via B-O B-PP_IN
a B-O B-NP_DT
receptor B-O B-NN
mediated B-O B-JJ
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Estrogen B-O B-S_S_NP_NN
" " B-O O-NP
exhibits B-O B-VP_VBZ
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
actions B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
immuno-modulatory B-O B-NP_NP_JJ
effects B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-ADVP_ADVP_CC
" " B-O B-ADVP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
estrogen B-O B-S_NP_NN
" " B-O O-NP
exerts B-O B-VP_VBZ
its B-O B-NP_PRPP
anti-inflammatory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
yet B-O B-ADVP_RB
" " B-O O-ADVP
understood B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
possible B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
estradiol B-O B-NP_NP_NN
" " B-O O-NP
acting B-O B-VP_VBG
via B-O B-PP_IN
the B-O B-NP_NP_DT
, B-O B-NP_COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
agent B-O B-NN
" " B-O O-NP
, B-O B-COMMA
17 B-O B-NP_NP_CD
beta-estradiol B-O B-NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
17 B-O B-NP_CD
alpha-estradiol B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
significantly B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBD
PMNs B-O B-NP_NP_NP_NNS
" " B-O O-NP
chemotaxis B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
FMLP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
dose-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
control B-O B-NP_NP_NP_NN
" " B-O O-NP
vs B-O B-CC
estrogen B-O B-NP_NP_NN
" " B-O O-NP
M B-O B-NP_QP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
P B-O B-NP_NP_NN
" " B-O O-NP
< B-O B-ADJP_JJR
0.05 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Physiological B-O B-S_NP_NP_JJ
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
estradiol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
significantly B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBD
the B-O B-NP_NP_DT
chemotaxis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PMNs B-O B-NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
10(-10) B-O B-NP_QP_CD
" " B-O O-QP
mol B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Pre-incubation B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
clomiphene B-O B-NP_NP_NP_NN
" " B-O O-NP
or B-O B-CC
tamoxifen B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
estrogen B-O B-NP_NN
receptor B-O B-NN
antagonists B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
eliminated B-O B-VP_VBD
the B-O B-NP_NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
17 B-O B-NP_CD
beta-estradiol B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
chemotaxis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PMNs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
restoring B-O B-S_NP_VP_VBG
it B-O B-NP_PRP
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
control B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
17 B-O B-S_NP_CD
beta-estradiol B-O B-NN
" " B-O O-NP
suppressed B-O B-VP_VBD
the B-O B-NP_NP_DT
chemotaxis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PMNs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
a B-O B-NP_DT
receptor-dependent B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
estradiol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
plasma B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHPP_PP_WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
PMNs B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
drawn B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
showed B-O B-VP_VBD
a B-O B-NP_NP_NP_DT
close B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
inverse B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
correlation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
PMNs B-O B-NP_NNS
" " B-O O-NP
chemotaxis B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
FMLP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
r B-O B-NP_NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
-0.821 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
p B-O B-NP_NP_NN
" " B-O O-NP
< B-O B-ADJP_JJR
0.001 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Estrogen B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
modify B-O B-VP_VP_VB
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
neutrophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
during B-O B-PP_PP_IN
the B-O B-NP_DT
normal B-O B-JJ
menstrual B-O B-JJ
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
not B-O B-CONJP_RB
only B-O B-RB
" " B-O O-CONJP
during B-O B-PP_IN
pregnancy B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
influence B-O B-VP_NN
inflammation B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Platelet-activating B-O B-S_S_NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PAF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
positively B-O B-ADVP_RB
" " B-O O-ADVP
auto-regulates B-O B-VP_VBZ
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
PAF B-O B-NN
receptor B-O B-NN
transcript B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
leukocyte-type B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
through B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_DT
human B-O B-NP_JJ
platelet-activating B-O B-JJ
factor B-O B-NN
receptor B-O B-NN
( B-O B-LRB
PAFR B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
transcribed B-O B-VP_VBN
by B-O B-NP_PP_IN
two B-O B-NP_NP_CD
distinct B-O B-JJ
promoters B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
promoter B-O B-NP_NP_NN
1 B-O B-CD
" " B-O O-NP
and B-O B-CC
promoter B-O B-NP_NN
2 B-O B-CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
to B-O B-S_NP_VP_TO
generate B-O B-VP_VB
two B-O B-NP_NP_CD
transcripts B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
designated B-O B-VP_VBN
) B-O B-NP_PP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
though B-O B-SBAR_IN
their B-O B-S_NP_PRPP
open B-O B-JJ
reading B-O B-NN
frames B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
identical B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
By B-O B-S_PP_IN
primer B-O B-NP_NP_NN
extension B-O B-NN
analysis B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
discriminate B-O B-VP_VB
two B-O B-NP_CD
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
PAFR B-O B-NP_NP_NP_NN
transcript B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
PAFR B-O B-NP_NP_NN
transcript B-O B-NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
upregulated B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
PAF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
by B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Functional B-O B-S_NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
promoter B-O B-NP_NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
transient B-O B-JJ
expression B-O B-NN
assay B-O B-NN
" " B-O O-NP
using B-O B-VP_VBG
chloramphenicol B-O B-NP_NN
acetyltransferase B-O B-NN
( B-O B-LRB
CAT B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_DT
reporter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
both B-O B-S_NP_CC
PAF B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
TPA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
activated B-O B-VP_VBD
the B-O B-NP_NP_DT
promoter B-O B-NP_NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_NP_DT
deleted B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
lacking B-O B-VP_VBG
" " B-O B-NP_NP_PP_ADJP_O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
a B-O B-NP_NP_DT
molecular B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
positive B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PAFR B-O B-NP_NP_NN
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_PP_IN
PAF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
possibly B-O B-ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
a B-O B-NP_NP_DT
phosphorylation B-O B-NN
reaction B-O B-NN
" " B-O O-NP
involving B-O B-VP_VBG
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-NP_LRB
The B-O B-NP_DT
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
asthmatic B-O B-NP_JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
] B-O B-RRB
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
GCR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
by B-O B-NP_PP_IN
radioligand-binding B-O B-NP_JJ
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
extrinsic B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
intrinsic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
asthmatics B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Their B-O B-S_NP_PRPP
corresponding B-O B-JJ
plasma B-O B-NN
cortisol B-O B-NN
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
assessed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_S_NP_NP_DT
average B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GCR B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADJP_ADJP_RB
lower B-O B-JJR
" " B-O O-ADJP
than B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
( B-O B-PRN_LRB
P B-O B-S_NP_NN
" " B-O O-NP
" " B-O B-NP_QP_O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
there B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_NP_DT
linear B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Besides B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
a B-O B-NP_NP_DT
linear B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GCR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
age B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
initial B-O B-JJ
attack B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_NP_DT
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
plasma B-O B-NP_NN
cortisol B-O B-NN
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
between B-O B-NP_PP_IN
asthmatics B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
healthy B-O B-NP_JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
there B-O B-S_S_NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
no B-O B-NP_NP_DT
and B-O B-ADJP_ADJP_CC
impairment B-O B-ADJP_NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
metabolism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
asthmatics B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
the B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GCR B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
lower B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GCR B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
asthmatics B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-PRN_COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
think B-O B-VP_VBP
" " B-O B-S_O-VP
" " B-O O-S
, B-O B-COMMA
" " B-O O-PRN
is B-O B-VP_VBZ
related B-O B-ADJP_JJ
to B-O B-PP_TO
heredity B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
repeated B-O B-NP_NP_VBN
attacks B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
asthma B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Identification B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
TCL1 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
T-cell B-O B-NP_NP_NN
" " B-O O-NP
malignancies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
TCL1 B-O B-NP_NN
locus B-O B-NN
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
chromosome B-O B-NP_NN
14q32.1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
frequently B-O B-ADVP_RB
" " B-O O-ADVP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
chromosomal B-O B-NP_ADJP_JJ
" " B-O O-ADJP
translocations B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
inversions B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
chromosome B-O B-NP_NN
14 B-O B-CD
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
translocated B-O B-VP_VP_VBN
" " B-O O-VP
or B-O B-CC
rearranged B-O B-VP_VBN
" " B-O O-VP
" " B-O O-VP
" " B-O B-NP_O-NP
involves B-O B-VP_VBZ
approximately B-O B-NP_NP_QP_RB
350 B-O B-CD
" " B-O O-QP
kb B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
at B-O B-PP_IN
chromosome B-O B-NP_NN
band B-O B-NN
14q32.1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Within B-O B-S_PP_IN
this B-O B-NP_DT
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
a B-O B-NP_NP_NP_DT
gene B-O B-NN
" " B-O O-NP
coding B-O B-VP_VBG
for B-O B-PP_IN
a B-O B-NP_DT
1.3-kb B-O B-NP_JJ
transcript B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
expressed B-O B-VP_VP_VBN
only B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
restricted B-O B-NP_NP_JJ
subsets B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
expressed B-O B-VP_VBN
at B-O B-NP_PP_IN
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
cognate B-O B-NP_JJ
cDNA B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
reveals B-O B-VP_VBZ
an B-O B-NP_NP_DT
open B-O B-NP_JJ
reading B-O B-NN
frame B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
342 B-O B-NP_CD
nt B-O B-NN
" " B-O O-NP
" " B-O O-PP
encoding B-O B-VP_VBG
a B-O B-NP_DT
protein B-O B-NP_NN
of B-O B-IN
14 B-O B-CD
kDa B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
TCL1 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
sequence B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
, B-O B-S_NP_COMMA
to B-O B-PP_TO
our B-O B-NP_PRPP
knowledge B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
shows B-O B-VP_VBZ
no B-O B-NP_NP_DT
sequence B-O B-NN
homology B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
other B-O B-NP_JJ
human B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
preferentially B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
early B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
T- B-O B-NP_NP_NN
" " B-O B-NP_NP_O-NP
and B-O B-CC
B-lymphocyte B-O B-NP_NN
" " B-O B-NP_O-NP
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_DT
transcription B-O B-NP_NN
factor B-O B-NN
Sp1 B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
murine B-O B-NP_JJ
GM-CSF B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
cis-acting B-O B-NP_NP_JJ
region B-O B-NN
" " B-O O-NP
, B-O B-COMMA
GM-kappa B-O B-NP_NP_NN
B/GC-box B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
positions B-O B-NP_NP_NNS
-95 B-O B-CD
" " B-O O-NP
and B-O B-CC
-73 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
within B-O B-PP_IN
the B-O B-NP_DT
murine B-O B-NP_NN
GM-CSF B-O B-NN
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
maximal B-O B-NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
GM-kappa B-O B-S_S_NP_NN
B B-O B-NN
" " B-O O-NP
defines B-O B-VP_VBZ
a B-O B-NP_DT
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
GC-box B-O B-S_NP_NN
" " B-O O-NP
defines B-O B-VP_VBZ
a B-O B-NP_DT
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
three B-O B-NP_NP_NP_CD
" " B-O O-NP
( B-O B-PRN_LRB
A1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
A2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
constitutive B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
three B-O B-S_NP_NP_CD
copies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GC-box B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
functionally B-O B-ADVP_RB
" " B-O O-ADVP
compensate B-O B-VP_VB
for B-O B-PP_IN
the B-O B-NP_DT
GM-kappa B-O B-NP_NN
B/GC-box B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
major B-O B-JJ
GC-box B-O B-NP_NP_NP_NN
" " B-O O-NP
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
A1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
purified B-O B-VP_VP_VBN
" " B-O O-VP
and B-O B-CC
identified B-O B-VP_VBN
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O B-NP_O-VP
as B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NP_NN
factor B-O B-NN
Sp1 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
depletion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Sp1 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
A1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
decreases B-O B-VP_VBZ
in B-O B-NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
transcription B-O B-NN
activity B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
GM-CSF B-O B-NP_NP_NN
" " B-O O-NP
templates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
the B-O B-S_NP_DT
human B-O B-NP_JJ
GM-CSF B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
a B-O B-NP_DT
base B-O B-NN
difference B-O B-NN
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_DT
GC-box B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
speculate B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
this B-O B-S_NP_DT
" " B-O O-NP
may B-O B-VP_MD
explain B-O B-VP_VB
" " B-O B-SBAR_WHADVP_S_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
an B-O B-S_NP_DT
upstream B-O B-NP_JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_NP_DT
C-terminus B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
B B-O B-NP_NP_NN
cell B-O B-NN
activator B-O B-NN
" " B-O O-NP
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
functions B-O B-VP_VBZ
as B-O B-PP_IN
an B-O B-NP_DT
activation B-O B-NP_NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
yeast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Oct-1 B-O B-S_S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
human B-O B-NP_NP_JJ
transcriptional B-O B-NP_JJ
activators B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bind B-O B-S_NP_VP_VP_VBP
to B-O B-PP_TO
" " B-O B-NP_O-VP
but B-O B-CC
activate B-O B-VP_VBP
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
expressed B-O B-VP_VP_VBD
these B-O B-NP_DT
factors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
S. B-O B-NP_FW
cerevisiae B-O B-FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
observed B-O B-VP_VBD
greater B-O B-NP_NP_ADJP_JJR
than B-O B-IN
5-fold B-O B-JJ
" " B-O O-ADJP
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
lacZ B-O B-NP_NN
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
only B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transfer B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Oct-2 B-O B-NP_NN
C-terminal B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
onto B-O B-PP_IN
either B-O B-NP_CC
Oct-1 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
Oct1.2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
or B-O B-CC
a B-O B-NP_NP_DT
nonactivating B-O B-NP_JJ
DNA-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
GAL4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
created B-O B-VP_VBD
activators B-O B-NP_NP_NNS
" " B-O O-NP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
greater B-O B-NP_NP_ADJP_JJR
than B-O B-IN
15 B-O B-CD
and B-O B-CC
10-fold B-O B-JJ
" " B-O O-ADJP
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
C-terminus B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
sufficient B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
confer B-O B-VP_VB
activation B-O B-NP_NN
potential B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
nonactive B-O B-NP_NP_JJ
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Characterization B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD48 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrates B-O B-VP_VBZ
a B-O B-NP_NP_DT
positive B-O B-JJ
element B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VP_VBZ
specific B-O B-ADJP_JJ
" " B-O B-PP_O-VP
and B-O B-CC
contains B-O B-VP_VBZ
an B-O B-NP_DT
essential B-O B-JJ
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Epstein-Barr B-O B-S_S_NP_NP_NP_NP_JJ
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EBV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mature B-O B-NP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
resting B-O B-NP_VBG
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
drives B-O B-VP_VBZ
them B-O B-NP_PRP
" " B-O O-NP
to B-O B-S_NP_VP_TO
become B-O B-VP_VB
lymphoblasts B-O B-NP_NP_NNS
" " B-O O-NP
expressing B-O B-VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
on B-O B-PP_IN
the B-O B-NP_NP_DT
identification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_NP_DT
enhancer B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
reproducibly B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
confers B-O B-VP_VBZ
" " B-O B-NP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
element B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
activated B-O B-VP_VBN
upon B-O B-NP_PP_IN
infection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
established B-O B-NP_JJ
EBV-negative B-O B-NP_JJ
B-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
EBV B-O B-S_NP_NN
" " B-O O-NP
fails B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_DT
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
an B-O B-NP_NP_DT
essential B-O B-JJ
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
alone B-O B-ADVP_RB
" " B-O O-ADVP
is B-O B-VP_VBZ
not B-O B-RB
sufficient B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
account B-O B-VP_VB
for B-O B-PP_IN
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
or B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VP_VBP
detected B-O B-VP_VBN
a B-O B-NP_NP_DT
specific B-O B-JJ
nuclear B-O B-NP_JJ
protein B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
show B-O B-VP_VBP
that B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NP_NN
B1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
p50 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
part B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
EBV-encoded B-O B-NP_JJ
latent B-O B-JJ
membrane B-O B-NN
protein B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
capable B-O B-ADJP_JJ
of B-O B-PP_IN
transactivating B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
isolated B-O B-VBN
CD48 B-O B-NP_NN
" " B-O O-NP
NF-kappa B-O B-NP_NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
intact B-O B-NP_JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
latent B-O B-JJ
membrane B-O B-NN
protein B-O B-NN
1-driven B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B/Rel B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
must B-O B-VP_MD
interact B-O B-VP_VB
with B-O B-PP_IN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
as B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
An B-O B-S_S_NP_NP_DT
AP1 B-O B-NP_NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
upstream B-O B-ADVP_JJ
of B-O B-PP_IN
the B-O B-NP_DT
kappa B-O B-NP_NN
immunoglobulin B-O B-NN
intron B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-NP
binds B-O B-VP_VP_VBZ
inducible B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
contributes B-O B-VP_VBZ
to B-O B-PP_TO
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Expression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
kappa B-O B-NN
immunoglobulin B-O B-NN
light B-O B-JJ
chain B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
developmental- B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O B-ADJP_O-ADJP
and B-O B-CC
tissue-specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
regulation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
trans-acting B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
interact B-O B-S_NP_VP_VBP
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_NP_DT
new B-O B-JJ
protein-DNA B-O B-JJ
interaction B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
identified B-O B-VP_VBN
upstream B-O B-NP_ADVP_RB
of B-O B-PP_IN
the B-O B-NP_DT
intron B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
within B-O B-PP_IN
the B-O B-NP_NP_DT
matrix-associated B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
J-C B-O B-NP_JJ
intron B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
greatly B-O B-ADJP_RB
inducible B-O B-JJ
in B-O B-PP_IN
pre-B B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
bacterial B-O B-NP_NP_JJ
lipopolysaccharide B-O B-NN
" " B-O O-NP
and B-O B-CC
interleukin-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
but B-O B-CC
specific B-O B-S_NP_JJ
complexes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
found B-O B-VP_VBN
at B-O B-NP_PP_IN
all B-O B-NP_NP_DT
stages B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
B B-O B-NP_NP_NN
cell B-O B-NN
development B-O B-NN
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
footprinted B-O B-NP_VBN
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
homologous B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_DT
consensus B-O B-NP_NN
AP1 B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
protein B-O B-NN
components B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VP_VBP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
competed B-O B-VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_DT
AP1 B-O B-NP_NN
consensus B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
were B-O B-VP_VBD
shown B-O B-VP_VBN
by B-O B-PP_IN
supershift B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
include B-O B-VP_VB
c-Jun B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-Fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_SBAR_IN
this B-O B-S_NP_DT
binding B-O B-NP_VBG
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_DT
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
and B-O B-NP_CC
of B-O B-NP_NP_PP_IN
" " B-O B-NP_O-NP
play B-O B-VP_VBP
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
AP1 B-O B-NP_NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
context B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
intron B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
decrease B-O B-VP_VB
enhancer-mediated B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_CC
and B-O B-NP_NP_VP_CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Identification B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
promoter B-O B-NP_NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
chicken B-O B-NP_NP_NP_NN
anemia B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CAV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
containing B-O B-VP_VBG
a B-O B-NP_DT
novel B-O B-JJ
enhancer-like B-O B-NP_JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_NP_NP_DT
single B-O B-JJ
promoter B-O B-NP_NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
cloned B-O B-VBN
genome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
[ B-O B-PRN_LRB
Noteborn B-O B-NP_NP_NNP
et B-O B-FW
al. B-O B-FW
" " B-O O-NP
, B-O B-COMMA
J. B-O B-NP_NNP
Virol. B-O B-NNP
65 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
1991 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
3131-3139 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
chicken B-O B-NP_NP_NP_NN
anemia B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CAV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
chicken B-O B-NP_NN
T-cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
analysed B-O B-VP_JJ
via B-O B-NP_PP_IN
CAT B-O B-NP_NP_NN
" " B-O O-NP
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_NP_NP_DT
unique B-O B-JJ
region B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
four B-O B-NP_ADJP_QP_CD
or B-O B-CC
five B-O B-CD
" " B-O O-QP
near-perfect B-O B-JJ
" " B-O O-ADJP
direct B-O B-NP_NP_JJ
repeats B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
DR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
21 B-O B-NP_CD
bp B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
with B-O B-PP_IN
one B-O B-NP_CD
12-bp B-O B-NP_JJ
insert B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
proven B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
the B-O B-NP_NP_DT
main B-O B-JJ
transcription-activation B-O B-NP_JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
with B-O B-PP_IN
enhancer-like B-O B-NP_JJ
characteristics B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PCR B-O B-S_NP_NN
studies B-O B-NNS
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
CAV B-O B-S_NP_NP_NN
isolates B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
across B-O B-PP_IN
the B-O B-NP_DT
world B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
all B-O B-ADVP_DT
" " B-O O-ADVP
contained B-O B-VP_VBD
this B-O B-NP_DT
promoter B-O B-NP_NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Electrophoretic B-O B-S_NP_NP_JJ
mobility-shift B-O B-JJ
assays B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
EMSA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
individual B-O B-S_NP_NP_JJ
DR B-O B-NN
units B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
the B-O B-NP_DT
12-bp B-O B-NP_JJ
insert B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
can B-O B-VP_MD
bind B-O B-VP_VB
to B-O B-PP_TO
nuclear B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Competition B-O B-S_NP_NN
assays B-O B-NNS
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
DR B-O B-NP_NN
units B-O B-NNS
" " B-O O-NP
" " B-O O-NP
bound B-O B-VP_VBD
to B-O B-PP_TO
factors B-O B-NP_NP_NNS
" " B-O O-NP
other B-O B-ADJP_JJ
than B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
synthetic B-O B-JJ
oligodeoxyribonucleotide B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
an B-O B-NP_NP_DT
SP1-box B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
5'-GGGCGG B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
could B-O B-VP_MD
compete B-O B-VP_VB
with B-O B-PP_IN
factors B-O B-NP_NP_NNS
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
the B-O B-NP_DT
12-bp B-O B-NP_JJ
insert B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Purified B-O B-S_NP_VBN
human B-O B-NP_JJ
SP1 B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
very B-O B-NP_NP_ADJP_RB
strong B-O B-JJ
" " B-O O-ADJP
affinity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
thymocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
infection B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
EBV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_NP_DT
discovery B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
EBV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
certain B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
malignancies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
EBV B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
CR2/CD21 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
on B-O B-PP_IN
a B-O B-NP_NP_DT
population B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immature B-O B-NP_NP_JJ
thymocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
T B-O B-NP_NN
lymphoblastoid B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
childhood B-O B-NP_NN
acute B-O B-JJ
T B-O B-NN
lymphoblastic B-O B-JJ
leukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
EBV-receptor B-O B-S_NP_NP_NN
interactions B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
of B-O B-PP_IN
importance B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
, B-O B-COMMA
within B-O B-S_PP_IN
the B-O B-NP_DT
thymus B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_DT
population B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
large B-O B-NP_JJ
, B-O B-COMMA
immature B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
expresses B-O B-VP_VBZ
CD21 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
EBV B-O B-S_NP_NN
" " B-O O-NP
altered B-O B-VP_VBD
the B-O B-NP_NP_DT
activation B-O B-NN
responses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
immature B-O B-NP_JJ
thymocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Triggering B-O B-S_S_NP_VP_VBG
through B-O B-PP_IN
CD2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
is B-O B-VP_VBZ
mitogenic B-O B-ADJP_JJ
for B-O B-PP_IN
mature B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
immature B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
during B-O B-PP_IN
infection B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
EBV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
ligation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
caused B-O B-VP_VBD
thymocytes B-O B-S_NP_NNS
" " B-O O-NP
to B-O B-VP_TO
proliferate B-O B-VP_VB
in B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
exogenous B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
function B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VBD
a B-O B-NP_NP_DT
result B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
EBV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
its B-O B-NP_NP_PRPP
receptor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
CD21 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
was B-O B-VP_VBD
caused B-O B-VP_VBN
by B-O B-NP_PP_IN
infection B-O B-NP_NP_NN
" " B-O O-NP
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
surface B-O B-NP_NN
signaling B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
because B-O B-SBAR_IN
neither B-O B-S_NP_CC
specific B-O B-NP_JJ
mAb B-O B-NN
" " B-O O-NP
nor B-O B-CC
the B-O B-NP_NP_DT
P3HR-1 B-O B-NN
strain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
virus B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
mimicked B-O B-VP_VBD
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B95-8 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Immature B-O B-S_NP_JJ
thymocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
infected B-O B-VP_VBN
by B-O B-NP_PP_IN
EBV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_NP_DT
internalization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
its B-O B-NP_PRPP
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Consistent B-O B-S_ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B95-8 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
EBNA-2 B-O B-NP_NN
transcripts B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
within B-O B-NP_PP_IN
infected B-O B-NP_JJ
thymocyte B-O B-NN
populations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
components B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
viral B-O B-JJ
replicative B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
expressed B-O B-VP_VBN
during B-O B-NP_PP_IN
infection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
thymocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
components B-O B-NNS
" " B-O O-NP
included B-O B-VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
BZLF-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
early B-O B-NP_JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
characterizes B-O B-S_NP_VP_VBZ
" " B-O B-NP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
second B-O B-JJ
transcript B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
as B-O B-NP_PP_IN
encoding B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
recently B-O B-ADJP_RB
characterized B-O B-VBD
" " B-O O-ADJP
RAZ B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_ADVP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
consequences B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
EBV B-O B-NP_NP_NN
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
an B-O B-NP_NP_DT
early B-O B-JJ
stage B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
lead B-O B-VP_VB
to B-O B-PP_TO
failure B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
normal B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
repertoire B-O B-NP_NN
development B-O B-NN
" " B-O O-NP
, B-O B-COMMA
autoimmunity B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
malignancy B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Distinct B-O B-NP_NP_NP_JJ
roles B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
molecular B-O B-JJ
chaperone B-O B-NP_NN
hsp90 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
modulating B-O B-S_NP_VP_VBG
dioxin B-O B-NP_NN
receptor B-O B-NN
function B-O B-NN
" " B-O O-NP
via B-O B-PP_IN
the B-O B-NP_NP_DT
basic B-O B-JJ
helix-loop-helix B-O B-NP_JJ
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
PAS B-O B-NP_NN
domains B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
intracellular B-O B-NP_JJ
dioxin B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
mediates B-O B-VP_VP_VBZ
signal B-O B-NP_NN
transduction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
dioxin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
functions B-O B-VP_VBZ
as B-O B-PP_IN
a B-O B-NP_DT
ligand-activated B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
basic B-O B-NP_JJ
helix-loop-helix B-O B-JJ
( B-O B-LRB
bHLH B-O B-JJ
) B-O B-RRB
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
contiguous B-O B-ADJP_JJ
with B-O B-PP_IN
a B-O B-NP_DT
Per-Arnt-Sim B-O B-NP_NN
( B-O B-LRB
PAS B-O B-NN
) B-O B-RRB
homology B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
extracts B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
nonstimulated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
recovered B-O B-VP_VBN
in B-O B-NP_PP_IN
an B-O B-NP_NP_DT
inducible B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
cytoplasmic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
form B-O B-NN
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
, B-O B-NP_NP_NP_PRN_COMMA
a B-O B-NP_DT
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
reconstituted B-O B-VP_VBN
ligand-dependent B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_DT
DNA-binding B-O B-NP_JJ
form B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
using B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
dioxin B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
expressed B-O B-NP_NP_NP_NP_VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
PAS B-O B-NP_NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
constitutive B-O B-NP_NP_JJ
dimerization B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
Arnt B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
this B-O B-NP_DT
receptor B-O B-NN
mutant B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
low B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
xenobiotic B-O B-NP_JJ
response B-O B-NN
element-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_DT
PAS B-O B-NP_NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
important B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-S_O-NP
was B-O B-VP_VBD
not B-O B-RB
possible B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
reconstitute B-O B-VP_VB
dioxin B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
function B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
proteins B-O B-NP_NP_NNS
" " B-O O-NP
expressed B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
line B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
these B-O B-NP_DT
observations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
reticulocyte B-O B-NP_NP_NN
lysate B-O B-NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
wheat B-O B-NP_NN
germ B-O B-NN
lysate B-O B-NN
" " B-O O-NP
" " B-O O-NP
promoted B-O B-VP_VBD
the B-O B-NP_NP_DT
association B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
de B-O B-NP_ADJP_FW
novo B-O B-FW
" " B-O O-ADJP
synthesized B-O B-VBN
dioxin B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
hsp90 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
At B-O B-S_S_NP_NP_QP_IN
least B-O B-JJS
two B-O B-CD
" " B-O O-QP
distinct B-O B-JJ
domains B-O B-NNS
" " B-O B-NP_O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
mediated B-O B-VP_VBD
interaction B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
hsp90 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
the B-O B-NP_NP_NP_DT
ligand-binding B-O B-NP_JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
located B-O B-ADJP_JJ
within B-O B-PP_IN
the B-O B-NP_DT
PAS B-O B-NP_NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
and B-O B-CC
, B-O B-COMMA
surprisingly B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
bHLH B-O B-NP_JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
Whereas B-O B-S_SBAR_IN
ligand-binding B-O B-S_NP_JJ
activity B-O B-NN
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-PP_IN
association B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
hsp90 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
bHLH-hsp90 B-O B-S_NP_JJ
interaction B-O B-NN
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
important B-O B-ADJP_JJ
for B-O B-PP_PP_IN
but B-O B-NP_CC
not B-O B-PP_RB
for B-O B-IN
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Several B-O B-S_S_NP_NP_ADJP_JJ
distinct B-O B-JJ
" " B-O O-ADJP
roles B-O B-NNS
" " B-O B-NP_O-NP
for B-O B-PP_IN
hsp90 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
modulating B-O B-S_NP_VP_VBG
dioxin B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
function B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
likely B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
correct B-O B-NP_NP_NP_JJ
folding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
ligand-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
interference B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
Arnt B-O B-NP_NP_NN
" " B-O O-NP
heterodimerization B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
folding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
DNA-binding B-O B-JJ
conformation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
bHLH B-O B-NP_JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
dioxin B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
system B-O B-NN
" " B-O O-NP
provides B-O B-VP_VBZ
a B-O B-NP_NP_DT
complex B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
interesting B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
model B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
hsp90 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
T-cell B-O B-NP_NP_NP_NN
functional B-O B-JJ
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
IL-3 B-O B-NN
proximal B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
human B-O B-NP_JJ
interleukin-3 B-O B-NN
( B-O B-LRB
IL-3 B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
almost B-O B-NP_ADVP_RB
exclusively B-O B-RB
" " B-O O-ADVP
in B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Its B-O B-S_NP_PRPP
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
at B-O B-NP_PP_IN
both B-O B-NP_CC
the B-O B-DT
transcriptional B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
post-transcriptional B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
level B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
and B-O B-NP_NP_NP_PRN_CC
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
activated B-O B-VP_VBD
transcription B-O B-NP_NP_NN
initiation B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
define B-O B-VP_VB
the B-O B-NP_NP_DT
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
gene B-O B-NN
" " B-O O-NP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
generated B-O B-VP_VBD
a B-O B-NP_NP_DT
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
reporter B-O B-NP_NP_NN
constructs B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VBG
different B-O B-NP_NP_JJ
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
positive B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
negative B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
regulatory B-O B-NP_JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
proximal B-O B-NP_JJ
5' B-O B-JJ
flanking B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-3 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
promoter B-O B-NP_NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
between B-O B-PP_IN
-173 B-O B-NP_CD
and B-O B-CC
-60 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contained B-O B-VP_VBD
the B-O B-NP_DT
strongest B-O B-JJS
activating B-O B-NP_VBG
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
transcription B-O B-NP_NP_NN
factor B-O B-NN
" " B-O O-NP
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
could B-O B-VP_MD
bind B-O B-VP_VB
to B-O B-PP_TO
this B-O B-NP_NP_DT
positive B-O B-JJ
activator B-O B-NN
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
examined B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
IL-3 B-O B-NP_NN
CK-1/CK-2 B-O B-NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
found B-O B-VP_VBD
that B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
acted B-O B-VP_VP_VBD
as B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
but B-O B-CC
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
inducible B-O B-ADJP_JJ
by B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Alternate B-O B-NP_NP_NP_JJ
immune B-O B-JJ
system B-O B-NN
targets B-O B-VBZ
" " B-O O-NP
for B-O B-PP_IN
TCDD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
lymphocyte B-O B-NP_NP_NN
stem B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
extrathymic B-O B-NP_JJ
T-cell B-O B-NN
development B-O B-NN
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
here B-O B-ADVP_RB
" " B-O O-ADVP
summarize B-O B-VP_VBP
evidence B-O B-NP_NN
that B-O B-SBAR_IN
thymic B-O B-S_NP_NP_JJ
atrophy B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-VP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
mediated B-O B-VP_VBN
, B-O B-NP_COMMA
in B-O B-PP_ADVP_IN
, B-O B-NP_COMMA
by B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
atrophy B-O B-NN
induction B-O B-NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
involve B-O B-VP_VB
apoptotic B-O B-NP_NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
thymocytes B-O B-NP_NP_NNS
" " B-O O-NP
affected B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
bcl-2 B-O B-NN
proto-oncogene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TCDD B-O B-S_NP_NN
" " B-O O-NP
mediates B-O B-VP_VBZ
atrophy B-O B-NP_NN
induction B-O B-NN
" " B-O O-NP
through B-O B-PP_PP_IN
its B-O B-NP_NP_PRPP
specific B-O B-JJ
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
the B-O B-NP_DT
AhR B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
not B-O B-PP_RB
through B-O B-IN
effects B-O B-NP_NP_NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
estrogen B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
TCDD B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
estradiol B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
induce B-O B-VP_VBP
extrathymic B-O B-NP_NP_JJ
T-cell B-O B-NN
differentiation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
liver B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
extrathymic B-O B-JJ
T-cell B-O B-NN
populations B-O B-NNS
" " B-O O-NP
include B-O B-VP_VBP
cells B-O B-NP_NP_NNS
" " B-O O-NP
expressing B-O B-VP_VBG
elevated B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
V B-O B-NP_NP_NN
beta B-O B-NN
T-cell B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
B-cell B-O B-NP_NP_NP_NP_NP_NN
" " B-O O-NP
proliferation B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
induction B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
early B-O B-NP_JJ
G1-regulating B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
Epstein-Barr B-O B-NP_NP_JJ
virus B-O B-NN
mutants B-O B-NNS
" " B-O O-NP
conditional B-O B-ADJP_JJ
for B-O B-PP_IN
EBNA2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Infection B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
primary B-O B-NP_JJ
B-lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
Epstein-Barr B-O B-NP_NP_JJ
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EBV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
growth B-O B-NP_NP_NN
transformation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
B-cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
EBV B-O B-S_NP_NP_NP_NN
nuclear B-O B-JJ
antigen B-O B-NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
EBNA2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
first B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VBN
after B-O B-NP_PP_IN
EBV B-O B-NP_NP_NN
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
viral B-O B-NP_JJ
and B-O B-CC
cellular B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_DT
transforming B-O B-VBG
potential B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
generated B-O B-VP_VBD
conditional B-O B-NP_JJ
EBV B-O B-NN
mutants B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
expressing B-O B-S_NP_VP_VBG
EBNA2 B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
chimeric B-O B-NP_NP_JJ
fusion B-O B-NN
protein B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
genetic B-O B-JJ
background B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Growth B-O B-S_NP_NP_NN
transformation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
primary B-O B-NP_JJ
normal B-O B-JJ
B-cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
mutant B-O B-NP_JJ
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
estrogen-dependent B-O B-NP_NP_JJ
lymphoblastoid B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
expressing B-O B-VP_VBG
the B-O B-NP_DT
chimeric B-O B-JJ
EBNA2 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
estrogen B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
about B-O B-NP_NP_QP_RB
half B-O B-NN
" " B-O O-QP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
enter B-O B-VP_VBP
a B-O B-NP_DT
quiescent B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
non-proliferative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
state B-O B-NN
" " B-O O-NP
whereas B-O B-SBAR_IN
the B-O B-S_NP_DT
others B-O B-NNS
" " B-O O-NP
die B-O B-VP_VBP
by B-O B-PP_IN
apoptosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
EBNA2 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
thus B-O B-ADVP_RB
" " B-O O-ADVP
required B-O B-VP_VBN
not B-O B-NP_PP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
for B-O B-PP_IN
initiation B-O B-NP_NN
" " B-O O-NP
" " B-O B-PP_O-PP
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
for B-O B-PP_IN
maintenance B-O B-NP_NN
" " B-O O-NP
" " B-O B-PP_O-PP
of B-O B-PP_IN
transformation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Growth B-O B-S_NP_NN
arrest B-O B-NN
" " B-O O-NP
occurred B-O B-VP_VBD
at B-O B-PP_IN
G1 B-O B-NP_NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
G2 B-O B-NP_NN
" " B-O B-NP_O-NP
stages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
functional B-O B-S_NP_JJ
EBNA2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
at B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Growth B-O B-S_NP_NN
arrest B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
reversible B-O B-ADJP_JJ
for B-O B-PP_IN
G1/G0 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
as B-O B-SBAR_IN
indicated B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
sequential B-O B-ADJP_JJ
" " B-O O-ADJP
accumulation B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
modification B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NN
cycle B-O B-NN
regulating B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
EBV B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
the B-O B-NP_NP_DT
same B-O B-JJ
cell B-O B-NN
cycle B-O B-NN
regulating B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
as B-O B-PP_IN
polyclonal B-O B-NP_NP_JJ
stimuli B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
primary B-O B-NP_JJ
B-cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
EBV B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
using B-O B-VP_VBG
a B-O B-NP_NP_DT
common B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
B-cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
bypassing B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
requirement B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Evaluation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
respiratory B-O B-JJ
epithelium B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
normals B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
individuals B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
cystic B-O B-NP_JJ
fibrosis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
adenovirus B-O B-NP_NP_NN
E1a B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
relevant B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Lung B-O B-S_S_NP_NP_NN
disease B-O B-NN
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
disorders B-O B-NP_NP_NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
cystic B-O B-NP_NP_JJ
fibrosis B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
amenable B-O B-ADJP_JJ
to B-O B-PP_TO
somatic B-O B-NP_NP_JJ
gene B-O B-NN
therapy B-O B-NN
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
" " B-O B-WHNP_S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
For B-O B-S_PP_IN
safety B-O B-NP_NN
reasons B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
Ad B-O B-NN
vectors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
rendered B-O B-VP_VBN
replication B-O B-S_NP_ADJP_NN
deficient B-O B-JJ
by B-O B-PP_IN
deletion B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
theoretical B-O B-JJ
possibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-S_NP_DT
E1a- B-O B-JJ
replication-deficient B-O B-JJ
vector B-O B-NN
" " B-O O-NP
replicating B-O B-VP_VBG
as B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
this B-O B-S_NP_DT
study B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
directed B-O B-VP_VBN
toward B-O B-NP_PP_IN
evaluating B-O B-S_NP_VP_VBG
respiratory B-O B-NP_NP_NN
epithelium B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
Ad B-O B-NP_NP_NN
2/5 B-O B-CD
E1a-specific B-O B-JJ
primers B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
polymerase B-O B-NN
chain B-O B-NN
reaction B-O B-NN
" " B-O O-NP
" " B-O O-NP
to B-O B-S_NP_VP_TO
evaluate B-O B-VP_VB
DNA B-O B-NP_NP_NN
" " B-O O-NP
recovered B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
E1a B-O B-S_NP_NN
sequences B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
respiratory B-O B-NP_NP_JJ
epithelium B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
normals B-O B-NP_NP_QP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
E1a-positive B-O B-JJ
samples B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
average B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E1a B-O B-NP_NN
copy B-O B-NN
number B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
55 B-O B-NP_QP_CD
+/- B-O B-CC
18/10(3) B-O B-CD
" " B-O O-QP
recovered B-O B-VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
CF B-O B-NP_NN
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
7 B-O B-NP_NP_QP_CD
of B-O B-IN
52 B-O B-CD
" " B-O O-QP
" " B-O O-NP
( B-O B-PRN_LRB
13 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
had B-O B-VP_VBD
detectable B-O B-NP_JJ
E1a B-O B-NP_NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
respiratory B-O B-JJ
epithelium B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_IN
E1a B-O B-NP_NP_NN
copy B-O B-NN
number B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
positive B-O B-JJ
samples B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
80 B-O B-NP_QP_CD
+/- B-O B-CC
21/10(3) B-O B-CD
" " B-O O-QP
recovered B-O B-VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
are B-O B-VP_VBP
detectable B-O B-NP_JJ
Ad B-O B-NP_NN
2/5 B-O B-CD
E1a B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
respiratory B-O B-JJ
epithelium B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_PP_IN
of B-O B-IN
the B-O B-NP_NP_DT
theoretical B-O B-JJ
potential B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
such B-O B-S_NP_JJ
sequences B-O B-NNS
" " B-O O-NP
supporting B-O B-VP_VBG
replication B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
E1a- B-O B-NP_JJ
Ad B-O B-NN
vectors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
human B-O B-NP_NP_JJ
gene B-O B-NN
therapy B-O B-NN
protocols B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
CF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
utilizing B-O B-VP_VBG
such B-O B-NP_JJ
vectors B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
should B-O B-VP_MD
consider B-O B-VP_VB
evaluating B-O B-S_NP_VP_VBG
study B-O B-NP_NN
individuals B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Two B-O B-S_S_NP_CD
distinct B-O B-JJ
signalling B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
biphasic B-O B-JJ
transcription B-O B-NP_NN
" " B-O O-NP
induced B-O B-VP_VBN
" " B-O B-NP_PP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
measured B-O B-VP_VBN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
junB B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
under B-O B-PP_IN
interleukin-6 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-6 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
IL-6 B-O B-S_NP_NN
" " B-O O-NP
increases B-O B-VP_VBZ
junB B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
biphasic B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
first B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
early-induced B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
peak B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VBD
transient B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
likely B-O B-ADVP_RB
" " B-O O-ADVP
corresponds B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
well B-O B-ADJP_ADJP_RB
documented B-O B-VBN
" " B-O O-ADJP
typical B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
junB B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
stimulated B-O B-VP_VBN
in B-O B-NP_PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
At B-O B-S_PP_IN
variance B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
second B-O B-JJ
peak B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
has B-O B-S_NP_VP_VBZ
never B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
reported B-O B-VP_VBN
previously B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
lasted B-O B-VP_VBD
several B-O B-NP_JJ
hours B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_PP_IN
a B-O B-NP_NP_DT
consequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_NP_PRPP
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
junB B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
IL-6 B-O B-NP_NN
" " B-O O-NP
stimulated B-O B-VP_VBD
, B-O B-COMMA
in B-O B-PP_IN
a B-O B-NP_DT
biphasic B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
nuclear B-O B-JJ
accumulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
JunB B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_SBAR_IN
IL-6 B-O B-S_NP_NP_NN
" " B-O O-NP
regulation B-O B-NN
" " B-O O-NP
occurred B-O B-VP_VBD
exclusively B-O B-ADVP_RB
" " B-O O-ADVP
at B-O B-PP_IN
the B-O B-NP_DT
transcriptional B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
bimodal B-O B-JJ
increase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
junB B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
and B-O B-CC
JunB B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
accounted B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
our B-O B-NP_PRPP
data B-O B-NNS
" " B-O O-NP
point B-O B-VP_VBP
to B-O B-PP_TO
two B-O B-NP_NP_CD
major B-O B-JJ
differences B-O B-NNS
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
control B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
First B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
cycloheximide B-O B-NP_NN
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
potentiated B-O B-VP_VBD
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
second B-O B-JJ
wave B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
affect B-O B-VP_VB
the B-O B-NP_DT
early-induced B-O B-JJ
burst B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Second B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
tyrphostin B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
tyrosine B-O B-NN
kinase B-O B-NN
inhibitor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
impaired B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
first B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
second B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
junB B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
peak B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Conversely B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
genistein B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
another B-O B-NP_DT
tyrosine B-O B-NN
kinase B-O B-NN
inhibitor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
totally B-O B-ADVP_RB
" " B-O O-ADVP
abolished B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
second B-O B-JJ
peak B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
junB B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
whereas B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
affect B-O B-VP_VB
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
first B-O B-JJ
peak B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Altogether B-O B-S_ADVP_RB
" " B-O O-ADVP
these B-O B-NP_DT
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
, B-O B-S_COMMA
in B-O B-PP_IN
7TD1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
IL-6 B-O B-NP_NN
" " B-O O-NP
controls B-O B-VP_VBZ
junB B-O B-NP_NP_NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
biphasic B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
means B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_CD
separate B-O B-JJ
transduction B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Biphasic B-O B-NP_NP_NP_NP_JJ
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
factor-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
T B-O B-NP_NN
cell B-O B-NN
receptor B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
role B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
tumor B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_NP_JJ
factor B-O B-NN
( B-O B-LRB
NF B-O B-NN
) B-O B-RRB
-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_DT
T B-O B-NP_NN
cell B-O B-NN
receptor B-O B-NN
( B-O B-LRB
TcR B-O B-NN
) B-O B-RRB
/CD3 B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
primary B-O B-NP_JJ
human B-O B-JJ
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
studied B-O B-VP_VBN
at B-O B-NP_PP_IN
various B-O B-NP_NP_JJ
times B-O B-NNS
" " B-O O-NP
after B-O B-PP_IN
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Only B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
p50 B-O B-NP_NN
NF-kappa B-O B-NN
B B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
bound B-O B-VP_VBD
the B-O B-NP_NP_DT
kappa B-O B-NP_NN
B B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
interleukin-2 B-O B-NP_NN
receptor B-O B-NN
( B-O B-LRB
IL-2R B-O B-NN
) B-O B-RRB
alpha B-O B-NN
chain B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
on B-O B-PP_IN
resting B-O B-NP_VBG
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
immediately B-O B-ADVP_RB
" " B-O O-ADVP
after B-O B-PP_PP_IN
TcR/CD3 B-O B-NP_NP_NN
" " B-O O-NP
cross-linking B-O B-JJ
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
after B-O B-PP_PP_IN
approximately B-O B-NP_QP_RB
1 B-O B-CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
; B-O B-COLON
immediate B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-PP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-PP
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
p50.p65 B-O B-NP_NN
heterodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
p50.c-rel B-O B-S_S_NP_NN
heterodimers B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
detected B-O B-VP_VBN
bound B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
this B-O B-NP_DT
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
early B-O B-NP_NP_JJ
time B-O B-NN
points B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
both B-O B-S_NP_DT
" " B-O O-NP
remained B-O B-VP_VBD
active B-O B-ADJP_JJ
at B-O B-PP_IN
later B-O B-NP_NP_NP_JJR
time B-O B-NN
points B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
; B-O B-NP_NP_COLON
) B-O B-ADJP_RRB
" " B-O O-PRN
" " B-O O-NP
after B-O B-PP_IN
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
regulation B-O B-NN
" " B-O O-NP
takes B-O B-VP_VBZ
place B-O B-NP_NN
" " B-O O-NP
mainly B-O B-PP_ADVP_RB
" " B-O O-ADVP
at B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
at B-O B-PP_IN
immediate B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
early B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
time B-O B-NP_NN
points B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_NP_NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBD
c-rel B-O B-NP_NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
p105/p50 B-O B-NP_NN
" " B-O B-NP_O-NP
mRNA B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
p65 B-O B-NP_NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
whose B-O B-SBAR_WHNP_WPP
expression B-O B-NN
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
constitutive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
all B-O B-NP_NP_PDT
those B-O B-DT
early B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
late B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
events B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
immediate B-O B-JJ
ones B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_DT
neutralizing B-O B-VBG
anti-tumor B-O B-NP_JJ
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
( B-O B-LRB
TNF-alpha B-O B-NN
) B-O B-RRB
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similarly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
cycloheximide B-O B-NP_NN
" " B-O O-NP
prevented B-O B-VP_VBD
the B-O B-NP_NP_DT
p65 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
c-rel B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
translocation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
consequent B-O B-NP_NP_JJ
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
active B-O B-NP_JJ
binding B-O B-NN
heterodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
at B-O B-PP_IN
early B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
late B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
times B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cyclosporin B-O B-S_S_NP_NN
A B-O B-NN
" " B-O O-NP
impaired B-O B-VP_VBD
not B-O B-NP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
early B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
late B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
immediate B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
events B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
however B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
addition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TNF-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
prevented B-O B-VP_VBD
all B-O B-NP_DT
inhibition B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
T B-O B-NP_NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
biphasic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
TcR/CD3 B-O B-S_NP_NN
" " B-O O-NP
triggers B-O B-VP_VBZ
its B-O B-NP_NP_PRPP
immediate B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
transient B-O B-ADJP_JJ
" " B-O O-ADJP
if B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
TNF-alpha B-O B-S_NP_NN
, B-O B-COMMA
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
emerges B-O B-VP_VBZ
as B-O B-PP_IN
the B-O B-NP_NP_DT
main B-O B-JJ
factor B-O B-NN
" " B-O O-NP
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
a B-O B-NP_NP_DT
second B-O B-JJ
phase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
regulation B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
controlling B-O B-S_NP_VP_VBG
both B-O B-NP_CC
translocation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
p65 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
new B-O B-NP_NP_JJ
mRNA B-O B-NP_NN
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
c-rel B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
p105/p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Protein B-O B-S_S_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
a B-O B-NP_NP_DT
downstream B-O B-JJ
effector B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p21ras B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
aim B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
to B-O B-S_NP_VP_TO
investigate B-O B-VP_VB
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
, B-O B-ADVP_COMMA
" " B-O B-PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
reported B-O B-VP_VBN
that B-O B-SBAR_IN
PKC B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Data B-O B-S_NP_NNS
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
presented B-O B-VP_VBN
" " B-O B-NP_O-VP
, B-O B-COMMA
using B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
potent B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
selective B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
PKC B-O B-NP_NP_NP_NN
" " B-O O-NP
inhibitor B-O B-NN
" " B-O O-NP
Ro B-O B-NP_NN
31-8425 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
transient B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
constitutively B-O B-ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
ras B-O B-NN
mutant B-O B-JJ
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
clearly B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
shows B-O B-VP_VBZ
that B-O B-SBAR_IN
PKC B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
downstream B-O B-ADVP_JJ
of B-O B-PP_IN
" " B-O B-NP_O-ADVP
in B-O B-PP_PP_IN
and B-O B-NP_CC
in B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
  
Reporter B-O B-S_NP_NN
gene B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NP_NN
B B-O B-NN
" " B-O O-NP
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
affected B-O B-VP_VBN
by B-O B-NP_PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
signaling B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
involving B-O B-VP_VBG
PKC B-O B-NP_NP_NP_NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
calcium B-O B-NP_NN
mobilization B-O B-NN
" " B-O O-NP
and B-O B-CC
ras B-O B-NP_NP_NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
combine B-O B-VP_VBP
to B-O B-S_NP_VP_TO
provide B-O B-VP_VB
the B-O B-NP_NP_DT
necessary B-O B-JJ
components B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
production B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
during B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Association B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
alterations B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
moieties B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
HIV B-O B-NP_NP_NN
type B-O B-NN
1 B-O B-CD
proviral B-O B-JJ
latency B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
certain B-O B-NP_JJ
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Human B-O B-S_S_NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
replication B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
complex B-O B-JJ
array B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_ADJP_NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
proteins B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_NP_NP_DT
wide B-O B-JJ
spectrum B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
levels B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
demonstrated B-O B-VP_VBN
in B-O B-NP_PP_IN
various B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
both B-O B-UCP_CC
in B-O B-PP_IN
cell B-O B-NP_NN
culture B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Molecular B-O B-S_NP_NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
leading B-O B-VP_VBG
to B-O B-PP_TO
restricted B-O B-NP_JJ
HIV-1 B-O B-NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
may B-O B-VP_MD
differ B-O B-VP_VB
between B-O B-PP_IN
certain B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
now B-O B-ADVP_RB
" " B-O O-ADVP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
HIV-1 B-O B-S_NP_NP_NN
proviral B-O B-JJ
latency B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
, B-O B-NP_COMMA
" " B-O B-SBAR_WHPP_S_O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
predominance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p50 B-O B-NP_NP_NP_NN
NF-kappa B-O B-NN
B B-O B-NN
moieties B-O B-NNS
" " B-O O-NP
and B-O B-CC
possibly B-O B-ADVP_RB
" " B-O O-ADVP
p50 B-O B-NP_NP_NN
homodimers B-O B-NNS
" " B-O O-NP
or B-O B-CC
closely B-O B-NP_ADJP_RB
related B-O B-JJ
" " B-O O-ADJP
species B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
the B-O B-NP_NP_DT
p50-p56 B-O B-NP_NN
heterodimer B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
the B-O B-NP_DT
predominant B-O B-JJ
species B-O B-NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
demonstrated B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
nuclei B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
U1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B-related B-O B-JJ
moieties B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
differs B-O B-VP_VBZ
from B-O B-PP_PP_IN
the B-O B-NP_DT
latently B-O B-NP_RB
infected B-O B-JJ
T B-O B-NN
lymphocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
ACH-2 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
from B-O B-PP_IN
the B-O B-NP_NP_DT
U937 B-O B-NP_NN
monocytic B-O B-JJ
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
parental B-O B-NP_JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
U1 B-O B-NP_NN
cellular B-O B-JJ
clone B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_PP_IN
such B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
these B-O B-NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
different B-O B-S_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
proximal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
mechanisms B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
lead B-O B-VP_VB
to B-O B-PP_TO
restricted B-O B-NP_NP_JJ
HIV-1 B-O B-NN
replication B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Overexpression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
kinase B-O B-NN
C-zeta B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
stimulates B-O B-VP_VBZ
leukemic B-O B-NP_NP_JJ
cell B-O B-NN
" " B-O O-NP
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_S_NP_NP_DT
function B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
protein B-O B-NP_NP_NP_NN
kinase B-O B-NN
C-zeta B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PKC-zeta B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
phorbol B-O B-NN
ester B-O B-NN
protein B-O B-ADJP_ADJP_ADJP_NP_NN
kinase B-O B-NN
C B-O B-NN
subfamily B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
modulating B-O B-S_NP_VP_VBG
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
leukemic B-O B-NP_JJ
U937 B-O B-NN
cell B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Transfected B-O B-S_NP_NP_VBN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
stably B-O B-VP_ADVP_RB
" " B-O O-ADVP
overexpressing B-O B-VBG
PKC-zeta B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
displayed B-O B-VP_VBD
a B-O B-NP_NP_DT
longer B-O B-ADVP_RBR
" " B-O O-ADVP
doubling B-O B-JJ
time B-O B-NN
" " B-O O-NP
, B-O B-COMMA
lower B-O B-NP_NP_JJR
saturation B-O B-NN
density B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
confluency B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
adherence B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
plastic B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
as B-O B-SBAR_IN
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
control B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PKC-zeta B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VP_VBD
a B-O B-NP_DT
more B-O B-ADJP_RBR
differentiated B-O B-VBN
" " B-O O-ADJP
phenotype B-O B-NN
" " B-O O-NP
as B-O B-SBAR_IN
assessed B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
, B-O B-NP_NP_NP_PP_COMMA
surface B-O B-NP_NN
antigen B-O B-NN
expression B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
activities B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
were B-O B-VP_VBD
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
parental B-O B-NP_NP_JJ
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
parental B-O B-NP_JJ
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
PKC-zeta B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBD
mRNA B-O B-NP_NN
transcripts B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
low B-O B-JJ
mobility B-O B-NN
AP-1 B-O B-NP_NN
" " B-O O-NP
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
PKC-zeta B-O B-NP_NP_NN
" " B-O O-NP
overexpression B-O B-NN
" " B-O O-NP
stimulates B-O B-VP_VBZ
a B-O B-NP_NP_DT
type B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
phenotypic B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
differs B-O B-S_NP_VP_VBZ
significantly B-O B-ADVP_RB
" " B-O O-ADVP
from B-O B-PP_IN
maturation B-O B-NP_NP_NN
" " B-O O-NP
occurring B-O B-VP_VBG
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Increased B-O B-S_NP_NP_NP_NP_VBN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-jun B-O B-NP_NN
" " B-O O-NP
protooncogene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
AP-1 B-O B-NP_NP_NN
" " B-O O-NP
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
PKC-zeta B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
provides B-O B-VP_VBZ
a B-O B-NP_NP_DT
potential B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
explaining B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
altered B-O B-JJ
differentiation B-O B-NN
status B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
cell B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Posttranscriptional B-O B-NP_NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
macrophage B-O B-NP_NN
tissue B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
antioxidants B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Tissue B-O B-S_S_NP_NP_NP_NP_NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
monocyte/macrophage B-O B-NP_NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
represents B-O B-VP_VBZ
an B-O B-NP_NP_DT
important B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
underlying B-O B-VP_VBG
the B-O B-NP_NP_DT
initiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
fibrin B-O B-NP_NP_NN
" " B-O O-NP
deposition B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
sites B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Recent B-O B-S_NP_JJ
evidence B-O B-NN
" " B-O O-NP
suggests B-O B-VP_VBZ
a B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
oxidant B-O B-NP_NP_JJ
stress B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
signalling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
various B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
virtue B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
antioxidant B-O B-NP_JJ
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
lipopolysaccharide B-O B-NP_NN
( B-O B-LRB
LPS B-O B-NN
) B-O B-RRB
-induced B-O B-JJ
TF B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
in B-O B-NP_PP_IN
murine B-O B-NP_NP_NN
peritoneal B-O B-JJ
macrophages B-O B-NNS
" " B-O O-NP
and B-O B-CC
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
pyrrolidine B-O B-NP_NP_NN
dithiocarbamate B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_DT
oxidant B-O B-JJ
scavenger B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
N-acetyl-cysteine B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
precursor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
endogenous B-O B-JJ
antioxidant B-O B-JJ
" " B-O O-NP
glutathione B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
inhibited B-O B-VP_VBD
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
macrophage B-O B-NP_NN
procoagulant B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
neither B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reduced B-O B-VP_VBD
LPS-stimulated B-O B-NP_JJ
TF B-O B-NP_NN
" " B-O O-NP
mRNA B-O B-NN
accumulation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
thereby B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
suggesting B-O B-VP_VBG
a B-O B-NP_NP_DT
posttranscriptional B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Immunofluorescence B-O B-S_NP_NP_NN
studies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
using B-O B-VP_VBG
polyclonal B-O B-NP_JJ
anti-TF B-O B-NP_JJ
antibody B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
N-acetyl-cysteine B-O B-S_NP_NN
treatment B-O B-NN
" " B-O O-NP
prevented B-O B-VP_VBD
the B-O B-NP_NP_DT
characteristic B-O B-JJ
plasmalemmal B-O B-JJ
localization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TF B-O B-NP_NN
antigen B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
occurs B-O B-S_NP_VP_VBZ
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Western B-O B-S_S_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
N-acetyl-cysteine B-O B-S_NP_NN
" " B-O O-NP
reduced B-O B-VP_VBD
the B-O B-NP_NP_DT
accumulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
in B-O B-PP_IN
LPS-treated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
a B-O B-NP_NP_DT
finding B-O B-NN
" " B-O O-NP
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_NP_DT
results B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
immunofluorescence B-O B-NN
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
conditions B-O B-NNS
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
result B-O B-VP_VB
in B-O B-PP_IN
an B-O B-NP_NP_DT
accumulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
less B-O B-ADJP_RBR
mature B-O B-JJ
" " B-O O-ADJP
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
TF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
considered B-O B-S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
these B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
antioxidants B-O B-S_NP_NNS
" " B-O O-NP
exert B-O B-VP_VBP
their B-O B-NP_PRPP
effects B-O B-NNS
" " B-O O-NP
by B-O B-PP_PP_IN
" " B-O B-S_NP_VP_O-PP
and/or B-O B-CC
by B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
antioxidants B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
tumor B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
species B-O B-ADJP_NNS
specific B-O B-JJ
, B-O B-COMMA
with B-O B-PP_PP_IN
" " B-O B-NP_NP_PP_O-PP
, B-O B-COMMA
but B-O B-CC
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
posttranscriptional B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
antioxidants B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
TF B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
data B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
a B-O B-NP_NP_DT
novel B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
whereby B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
these B-O B-S_NP_DT
agents B-O B-NNS
" " B-O O-NP
might B-O B-VP_MD
modulate B-O B-VP_VB
monocyte/macrophage B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
1,25-Dihydroxyvitamin B-O B-NP_NP_NP_NN
D3 B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_ADJP_NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
hyperparathyroidism B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
A B-O B-S_S_NP_NP_DT
decreased B-O B-VBN
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
calcitriol B-O B-NP_NN
( B-O B-LRB
1,25(OH)2D3 B-O B-NN
) B-O B-RRB
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
parathyroid B-O B-NP_NP_JJ
glands B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
uremic B-O B-NP_JJ
animals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
humans B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
studies B-O B-NP_NP_NNS
" " B-O O-NP
carried B-O B-VP_VBN
out B-O B-PRT_RP
" " B-O O-PRT
in B-O B-NP_PP_IN
surgically B-O B-NP_ADJP_RB
removed B-O B-VBN
" " B-O O-ADJP
parathyroid B-O B-JJ
glands B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
calcitriol B-O B-S_NP_NN
binding B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
higher B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
in B-O B-PP_IN
" " B-O B-NP_ADJP_NP_O-NP
" " B-O O-PP
than B-O B-PP_IN
in B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
specific B-O B-S_NP_NP_JJ
receptors B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
calcitriol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
described B-O B-VP_VBN
in B-O B-NP_PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
the B-O B-NP_NP_DT
specific B-O B-JJ
uptake B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
3H-labelled B-O B-NP_JJ
1,25(OH)2D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
PBMC B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
median B-O B-JJ
dissociation B-O B-NP_NP_NN
constant B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Kd B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
similar B-O B-ADJP_JJ
in B-O B-PP_PP_IN
all B-O B-NP_NP_DT
three B-O B-CD
groups B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
healthy B-O B-NP_JJ
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
mean B-O B-NP_NP_NP_NP_NN
+/- B-O B-CC
S.D. B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
range B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
: B-O B-COLON
" " B-O O-NP
PHP B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
1.2 B-O B-NP_NP_NP_CD
+/- B-O B-CC
1.0 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
0.2-4 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
x B-O B-CC
10(-10) B-O B-NP_CD
M B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
SH B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
0.6 B-O B-NP_NP_NP_CD
+/- B-O B-CC
0.4 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
0.2-1.2 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
x B-O B-CC
10(-10) B-O B-NP_CD
M B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
RT B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
1.1 B-O B-NP_NP_NP_CD
+/- B-O B-CC
0.5 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
0.4-1.9 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
x B-O B-CC
10(-10) B-O B-NP_CD
M B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
controls B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
1.0 B-O B-NP_NP_NP_CD
+/- B-O B-CC
0.6 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
0.3-2.6 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
x B-O B-CC
10(-10) B-O B-NP_CD
M B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
maximal B-O B-JJ
binding B-O B-NN
capacity B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Nmax B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VP_VP_VBN
in B-O B-NP_PP_IN
PHP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
( B-O B-PRN_LRB
fmol/10(7) B-O B-NP_NP_NP_NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
vs. B-O B-CC
fmol/10(7) B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
controls B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
; B-O B-COLON
P B-O B-NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
0.0006 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
and B-O B-CC
decreased B-O B-VP_VP_VBN
in B-O B-NP_PP_IN
SH B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
vs. B-O B-NP_NP_NP_NP_CC
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
; B-O B-COLON
P B-O B-NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
" " B-O B-NP_O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
whereas B-O B-SBAR_IN
no B-O B-S_NP_DT
changes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
RT B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
three B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
PHP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
who B-O B-SBAR_WHNP_WP
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
subjected B-O B-VP_VBN
to B-O B-NP_PP_TO
parathyroidectomy B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
calcitriol B-O B-NN
number B-O B-NN
" " B-O O-NP
came B-O B-VP_VBD
down B-O B-PRT_RB
" " B-O O-PRT
to B-O B-PP_TO
normal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Changes B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
calcitriol B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
primary B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
secondary B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
hyperparathyroidism B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_VP_MD
magnify B-O B-VP_VB
the B-O B-NP_NP_DT
consequences B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
disturbances B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
might B-O B-VP_MD
play B-O B-VP_VB
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
development B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
secondary B-O B-NP_NP_JJ
hyperparathyroidism B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Effects B-O B-NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
antisense B-O B-JJ
myb B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
hemin- B-O B-NP_NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
"erythropoietin- induced" B-O B-NP_JJ
erythroid B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
In B-O B-S_S_SBAR_IN
order B-O B-NN
to B-O B-S_NP_VP_TO
elucidate B-O B-VP_VB
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-myb B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_VP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
constructed B-O B-VP_VBD
recombinant B-O B-NP_NP_JJ
plasmid B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
could B-O B-S_NP_VP_MD
produce B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
During B-O B-S_PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
Hm B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
K562 B-O B-S_S_NP_NN
cells B-O B-NNS
" " B-O O-NP
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBD
c-myb B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
50 B-O B-S_NP_NP_CD
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
them B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
began B-O B-VP_VBD
to B-O B-S_NP_VP_TO
synthesize B-O B-VP_VB
hemoglobin B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Expression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
antisense B-O B-NP_JJ
myb B-O B-NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reduced B-O B-VP_VBD
the B-O B-NP_NP_DT
amount B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-myb B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_NP_DT
percentage B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Hb-synthesizing B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
decreased B-O B-VP_VBN
to B-O B-NP_PP_TO
20 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Epo B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
c-myb B-O B-S_S_NP_NN
mRNA B-O B-NN
" " B-O O-NP
declined B-O B-VP_VBD
" " B-O O-VP
" " B-O O-S
and B-O B-CC
20 B-O B-S_NP_NP_CD
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
synthesized B-O B-VP_VBD
Hb B-O B-NP_NN
" " B-O O-NP
regardless B-O B-ADVP_JJ
of B-O B-PP_IN
antisense B-O B-NP_NP_JJ
myb B-O B-NN
RNA B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
suggested B-O B-VP_VBN
that B-O B-SBAR_SBAR_IN
constitutive B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-myb B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
Hm-induced B-O B-JJ
differentiation B-O B-NN
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
suppresses B-O B-VP_VBZ
Hm-induced B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
amount B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-myb B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
reduced B-O B-VP_VBN
during B-O B-NP_PP_IN
the B-O B-NP_NP_DT
differentiation B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
Epo B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VP_VBD
almost B-O B-ADJP_RB
constant B-O B-JJ
during B-O B-PP_IN
Hm-induced B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
increased B-O B-VP_VBD
during B-O B-PP_IN
Epo B-O B-NP_NP_NN
" " B-O O-NP
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
supposed B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Hm-induced B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
distinguished B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Alteration B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
structural B-O B-NP_NP_JJ
order B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
erythrocyte B-O B-NN
ghost B-O B-NN
membrane B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
influence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NN
receptor B-O B-NN
antagonist B-O B-NN
RU B-O B-NN
486 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
High-dose B-O B-S_NP_JJ
pulse B-O B-NN
glucocorticoid B-O B-NN
therapy B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
used B-O B-VP_VBN
successfully B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
the B-O B-NP_DT
clinic B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
severe B-O B-NP_JJ
pathological B-O B-JJ
conditions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
about B-O B-NP_QP_RB
20 B-O B-CD
" " B-O O-QP
years B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mode B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
administration B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
such B-O B-NP_JJ
megadoses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
inexplicable B-O B-ADJP_JJ
" " B-O O-ADJP
up B-O B-PP_RP
to B-O B-TO
now B-O B-NP_RB
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
supposed B-O B-VP_VBN
that B-O B-SBAR_IN
some B-O B-S_NP_DT
effects B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
due B-O B-PP_JJ
to B-O B-TO
membrane B-O B-NP_NN
alterations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
in-vitro B-O B-ADJP_FW
" " B-O O-ADJP
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
of B-O B-PP_IN
further B-O B-NP_JJ
glucocorticoids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
of B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NN
receptor B-O B-NN
antagonist B-O B-NN
RU B-O B-NN
486 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
on B-O B-PP_IN
structural B-O B-NP_NP_JJ
order B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
erythrocyte B-O B-NN
ghost B-O B-NN
membranes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
by B-O B-NP_PP_IN
determining B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
steady-state B-O B-JJ
fluorescence B-O B-NN
anisotropy B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Dexamethasone B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
a B-O B-NP_NP_DT
significant B-O B-JJ
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
membrane B-O B-NP_NN
structural B-O B-JJ
order B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
at B-O B-PP_IN
concentrations B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_DT
concentration-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
a B-O B-NP_NP_DT
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_NP_DT
uptake B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
ghost B-O B-NN
membranes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
structural B-O B-JJ
order B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
other B-O B-JJ
glucocorticoids B-O B-NNS
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
, B-O B-COMMA
methylprednisolone B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
corticosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
effective B-O B-ADJP_JJ
" " B-O O-ADJP
at B-O B-PP_IN
concentrations B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
10(-5) B-O B-NP_CD
M B-O B-NN
or B-O B-QP_CC
greater B-O B-JJR
" " B-O O-QP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
no B-O B-NP_NP_DT
change B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
membrane B-O B-NP_NN
structural B-O B-JJ
order B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
RU B-O B-NP_NP_NN
486 B-O B-CD
" " B-O O-NP
up B-O B-PP_IN
to B-O B-TO
a B-O B-NP_NP_DT
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
10(-4) B-O B-NP_CD
M B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
simultaneous B-O B-NP_NP_JJ
incubation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RU B-O B-NP_NN
486 B-O B-CD
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
caused B-O B-VP_VBD
a B-O B-NP_NP_DT
distinct B-O B-JJ
interference B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RU B-O B-NP_NN
486 B-O B-CD
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
glucocorticoid-induced B-O B-JJ
membrane B-O B-NN
perturbation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
possibility B-O B-NN
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
it B-O B-NP_PRP
" " B-O O-NP
by B-O B-PP_IN
RU B-O B-NP_NN
486 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_NP_DT
inactivity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
structurally B-O B-ADJP_RB
related B-O B-JJ
" " B-O O-ADJP
progesterone B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
refer B-O B-VP_VBP
to B-O B-PP_TO
relatively B-O B-NP_NP_ADJP_RB
specific B-O B-JJ
" " B-O O-ADJP
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
glucocorticoids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
membrane B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
erythrocyte B-O B-NP_NN
ghosts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NP_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
and B-O B-CC
p105 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
monocytes B-O B-NP_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
persistently B-O B-VP_ADVP_RB
" " B-O O-ADVP
infected B-O B-VBN
with B-O B-NP_PP_IN
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
regulating B-O B-VP_VBG
human B-O B-NP_NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
persistence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes/macrophages B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
partially B-O B-ADVP_RB
" " B-O O-ADVP
understood B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Persistent B-O B-S_NP_NP_JJ
HIV B-O B-NN
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
U937 B-O B-NP_NN
monocytic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Whether B-O B-S_SBAR_IN
virus-induced B-O B-S_NP_JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
favors B-O B-S_NP_VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
remains B-O B-VP_VBZ
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
further B-O B-ADVP_RB
" " B-O O-ADVP
delineate B-O B-VP_VB
the B-O B-NP_NP_DT
molecular B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
focused B-O B-VP_VBN
on B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
First B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
persistent B-O B-S_NP_JJ
HIV B-O B-NN
infection B-O B-NN
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
not B-O B-PP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
in B-O B-PP_IN
but B-O B-NP_CONJP_CC
also B-O B-RB
" " B-O O-CONJP
in B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
HIV-infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
protein B-O B-NN
levels B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
decreased B-O B-VP_VBN
secondary B-O B-NP_ADJP_JJ
to B-O B-PP_TO
enhanced B-O B-NP_VBN
protein B-O B-NN
degradation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
parallels B-O B-VP_VBZ
the B-O B-NP_NP_DT
increased B-O B-VBN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
secondary B-O B-ADJP_JJ
to B-O B-PP_TO
increased B-O B-NP_NP_VBN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
, B-O B-COMMA
i.e. B-O B-PP_FW
" " B-O O-PP
, B-O B-COMMA
increased B-O B-NP_NP_VBN
RNA B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
promoter-enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Another B-O B-S_S_NP_NP_NP_DT
protein B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
p105 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
modified B-O B-VP_VBN
in B-O B-NP_PP_IN
HIV-infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
p105 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
p50 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
steady-state B-O B-NP_JJ
protein B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
increased B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_NP_DT
result B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_NP_CC
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Transcriptional B-O B-S_NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p105 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBN
in B-O B-NP_PP_IN
infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
a B-O B-NP_DT
specific B-O B-JJ
kappa B-O B-NP_NN
B B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
the B-O B-NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
triple B-O B-JJ
autoregulatory B-O B-JJ
loop B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
involving B-O B-VP_VBG
HIV B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p105 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
MAD3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_IN
the B-O B-NP_NP_DT
end B-O B-NN
result B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
persistent B-O B-NP_NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
and B-O B-CC
viral B-O B-NP_JJ
persistence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
persistent B-O B-NP_NP_JJ
HIV B-O B-NN
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
provides B-O B-VP_VBZ
a B-O B-NP_NP_DT
useful B-O B-JJ
model B-O B-NN
" " B-O O-NP
with B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
to B-O B-S_NP_VP_TO
study B-O B-VP_VB
concomitant B-O B-NP_NP_JJ
modifications B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Detection B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
chromosome B-O B-NP_NN
16 B-O B-CD
CBF B-O B-NN
beta-MYH11 B-O B-NN
fusion B-O B-NN
transcript B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
myelomonocytic B-O B-NP_JJ
leukemias B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Karyotypic B-O B-S_S_NP_NP_JJ
detection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
chromosomal B-O B-NP_NP_JJ
16 B-O B-CD
abnormalities B-O B-NNS
" " B-O O-NP
classically B-O B-VP_ADVP_RB
" " B-O O-ADVP
associated B-O B-VBN
with B-O B-NP_PP_IN
AML B-O B-NP_NN
M4Eo B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
difficult B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Characterization B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
two B-O B-CD
genes B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
inv(16)(p13q22) B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
CBF B-O B-NP_NP_NN
beta B-O B-NN
" " B-O O-NP
and B-O B-CC
MYH11 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
allowed B-O B-VP_VBN
the B-O B-NP_NP_DT
detection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
fusion B-O B-NP_NN
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
reverse-transcriptase B-O B-NP_NP_NN
polymerase B-O B-NN
chain B-O B-NN
reaction B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RT-PCR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
analyzed B-O B-VP_VBN
CBF B-O B-NP_NN
beta-MYH11 B-O B-NN
fusion B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
RT-PCR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
myelomonocytic B-O B-NP_JJ
leukemias B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_PP_IN
" " B-O B-NP_O-PP
or B-O B-CC
without B-O B-PP_IN
" " B-O B-NP_O-PP
eosinophilia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
their B-O B-S_NP_PRPP
presence B-O B-NN
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Fifty-three B-O B-S_NP_NP_CD
cases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
11 B-O B-NP_NP_NP_QP_CD
" " B-O O-QP
" " B-O B-NP_O-NP
AML B-O B-NP_NN
M4Eo B-O B-NN
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
1 B-O B-NP_NP_QP_CD
" " B-O O-QP
AML B-O B-NP_NP_NP_NN
M4 B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
atypical B-O B-NP_JJ
abnormal B-O B-JJ
eosinophils B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
AML B-O B-NP_NN
M4 B-O B-NN
"""" B-O B-LQT
Eo B-O B-NN
"""" B-O B-RQT
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
29 B-O B-NP_NP_QP_CD
" " B-O O-QP
" " B-O B-NP_O-NP
AML B-O B-NP_NN
M4 B-O B-NN
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
8 B-O B-NP_NP_QP_CD
" " B-O O-QP
" " B-O B-NP_O-NP
AML B-O B-NP_NN
M5 B-O B-NN
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
3 B-O B-NP_NP_QP_CD
" " B-O O-QP
" " B-O B-NP_O-NP
CMML B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
and B-O B-CC
1 B-O B-NP_NP_QP_CD
" " B-O O-QP
" " B-O B-NP_O-NP
AML B-O B-NP_NP_NN
M2 B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
eosinophilia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
were B-O B-VP_VBD
analyzed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_DT
11 B-O B-CD
typical B-O B-JJ
AML B-O B-NN
M4Eo B-O B-NN
" " B-O O-NP
were B-O B-VP_VBD
CBF B-O B-ADJP_NN
beta-MYH11 B-O B-NN
positive B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
single B-O B-JJ
case B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AML B-O B-NP_NP_NN
M4 B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
distinctive B-O B-NP_JJ
eosinophil B-O B-NN
abnormalities B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
negative B-O B-ADJP_JJ
by B-O B-PP_IN
karyotype B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
RT-PCR B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
fluorescent B-O B-NP_NP_JJ
in B-O B-ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
FISH B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Three B-O B-S_S_NP_NP_CD
" " B-O B-SBAR_O-NP
of B-O B-PP_IN
29 B-O B-NP_NP_NP_CD
" " B-O O-NP
( B-O B-PRN_LRB
10 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
AML B-O B-NP_NP_NN
M4 B-O B-NN
" " B-O O-NP
without B-O B-PP_IN
abnormal B-O B-NP_JJ
eosinophils B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
CBF B-O B-ADJP_NN
beta-MYH11 B-O B-NN
positive B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
1 B-O B-SBAR_WHNP_NP_CD
" " B-O O-NP
of B-O B-WHPP_IN
" " B-O O-WHPP
which B-O B-WDT
" " B-O O-WHNP
did B-O B-S_NP_VP_VBD
not B-O B-RB
show B-O B-VP_VB
any B-O B-NP_DT
apparent B-O B-JJ
chromosome B-O B-NP_NN
16 B-O B-CD
" " B-O O-NP
abnormalities B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
classical B-O B-NP_JJ
metaphase B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-S
( B-O B-PRN_LRB
2 B-O B-NP_NP_CD
" " B-O O-NP
not B-O B-VP_RB
tested B-O B-VBN
" " B-O B-NP_O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_NP_DT
cases B-O B-NNS
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
showed B-O B-VP_VBD
MYH11 B-O B-NP_NP_NN
" " B-O O-NP
genomic B-O B-JJ
rearrangement B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
" " B-O B-S_NP_NP_NN_O-NP
of B-O B-PP_IN
the B-O B-NP_DT
other B-O B-JJ
leukemias B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
RT-PCR B-O B-ADJP_NN
positive B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Follow-up B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
three B-O B-NP_CD
patient B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
residual B-O B-NP_NP_JJ
positivity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
apparent B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
complete B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
remission B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
CBF B-O B-S_NP_NN
beta-MYH11 B-O B-NN
fusion B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
occur B-O B-VP_VBP
not B-O B-PP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
in B-O B-PP_IN
the B-O B-NP_NP_DT
vast B-O B-JJ
majority B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
in B-O B-PP_IN
, B-O B-NP_NP_NP_PP_COMMA
" " B-O B-NP_NP_SBAR_O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
the B-O B-NP_NP_DT
detection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CBF B-O B-NP_NN
beta-MYH11 B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
apparent B-O B-NP_JJ
abnormalities B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
classical B-O B-NP_JJ
banding B-O B-NN
techniques B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
these B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
additional B-O B-S_NP_NP_JJ
screening B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
either B-O B-NP_CC
RT-PCR B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
FISH B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
should B-O B-VP_MD
be B-O B-VP_VB
performed B-O B-VP_VBN
in B-O B-NP_PP_IN
, B-O B-NP_COMMA
regardless B-O B-ADVP_RB
" " B-O B-PP_O-VP
" " B-O O-VP
, B-O B-COMMA
to B-O B-S_NP_VP_TO
allow B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Expression B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
genomic B-O B-NP_JJ
configuration B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
GM-CSF B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
IL-3 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
M-CSF B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
C-FMS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
early B-O B-NP_NP_JJ
growth B-O B-NN
response B-O B-NN
gene-1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EGR-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
M-CSF B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
primary B-O B-NP_JJ
myelodysplastic B-O B-JJ
syndromes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Peripheral B-O B-S_S_NP_NP_JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
seventeen B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
primary B-O B-NP_NP_NP_JJ
myelodysplastic B-O B-JJ
syndromes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
advanced B-O B-NP_JJ
stage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
enriched B-O B-UCP_ADJP_JJ
for B-O B-PP_IN
blasts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
and B-O B-CC
tested B-O B-VP_VBN
for B-O B-NP_PP_IN
karyotype B-O B-NP_NP_NP_LST_NN
" " B-O O-NP
, B-O B-COMMA
genomic B-O B-NP_LST_JJ
configuration B-O B-NN
" " B-O O-NP
and B-O B-CC
expression B-O B-NP_LST_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
M-CSF B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
has B-O B-S_NP_VP_VBZ
been B-O B-VP_VBN
recently B-O B-ADVP_RB
" " B-O O-ADVP
reassigned B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
investigated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Aims B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
to B-O B-S_NP_VP_TO
( B-O B-VP_VP_LST_LRB
1 B-O B-LS
) B-O B-RRB
" " B-O O-LST
assess B-O B-VB
the B-O B-NP_NP_DT
potential B-O B-JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
( B-O B-VP_LST_LRB
2 B-O B-LS
) B-O B-RRB
" " B-O O-LST
search B-O B-VB
for B-O B-PP_IN
or B-O B-NP_NP_ADJP_NP_CC
of B-O B-NP_PP_IN
followed B-O B-NP_VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
latter B-O B-JJ
issue B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
by B-O B-NP_PP_IN
comparing B-O B-S_NP_VP_VBG
, B-O B-COMMA
in B-O B-PP_IN
8 B-O B-NP_CD
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
constitutive B-O B-NP_NP_JJ
DNA B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Eleven B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
17 B-O B-CD
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
abnormal B-O B-NP_JJ
karyotypes B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
M-CSF B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
6 B-O B-NP_CD
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_NP_DT
FMS B-O B-NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
the B-O B-NP_DT
EGR-1 B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
2 B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
latter B-O B-JJ
cases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_DT
autocrine B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
growth B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
hypothesized B-O B-VP_VBN
only B-O B-NP_ADVP_RB
" " B-O O-ADVP
for B-O B-PP_IN
the B-O B-NP_NP_DT
2 B-O B-CD
patients B-O B-NNS
" " B-O O-NP
whose B-O B-SBAR_WHNP_WPP
cells B-O B-NNS
" " B-O O-WHNP
expressed B-O B-S_NP_VP_VBD
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_DT
germline B-O B-NN
changes B-O B-NP_NNS
" " B-O O-NP
or B-O B-CC
rearrangements B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
any B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
genes B-O B-NNS
" " B-O O-NP
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
deregulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
encoding B-O B-VP_VBG
for B-O B-PP_IN
certain B-O B-NP_JJ
hemopoietic B-O B-NP_JJ
growth B-O B-NN
factors B-O B-NNS
" " B-O O-NP
or B-O B-CC
receptors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
seem B-O B-VP_VB
to B-O B-S_NP_VP_TO
represent B-O B-VP_VB
a B-O B-NP_NP_DT
major B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
MDS B-O B-NP_NN
progression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
OBF-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
novel B-O B-NP_JJ
B B-O B-NN
cell-specific B-O B-JJ
coactivator B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
stimulates B-O B-S_NP_VP_VBZ
immunoglobulin B-O B-NP_NP_NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
association B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Recent B-O B-S_S_NP_ADJP_JJ
" " B-O O-ADJP
biochemical B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
genetic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
studies B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
in B-O B-S_PP_IN
addition B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
other B-O B-NP_JJ
B B-O B-NP_NN
cell B-O B-NN
components B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
activity B-O B-NP_ADJP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
a B-O B-NP_NP_DT
genetic B-O B-JJ
screen B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
yeast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
isolated B-O B-VP_VBN
B B-O B-NP_NP_NN
cell-derived B-O B-JJ
cDNAs B-O B-NNS
" " B-O O-NP
encoding B-O B-VP_JJ
Oct-binding B-O B-NP_NP_NP_JJ
factor B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
novel B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Biochemical B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
OBF-1 B-O B-S_NP_NN
" " B-O O-NP
has B-O B-VP_VP_VBZ
no B-O B-NP_DT
intrinsic B-O B-JJ
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
recognizes B-O B-VP_VBZ
the B-O B-NP_NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
OBF-1 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
highly B-O B-ADJP_RB
cell-specific B-O B-JJ
" " B-O O-ADJP
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
being B-O B-S_NP_VP_VBG
most B-O B-ADJP_ADJP_ADJP_RBS
abundant B-O B-JJ
" " B-O O-ADJP
in B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
and B-O B-CC
essentially B-O B-ADVP_RB
" " B-O O-ADVP
absent B-O B-ADJP_JJ
in B-O B-PP_IN
most B-O B-NP_NP_JJS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
OBF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
selectively B-O B-ADVP_RB
" " B-O O-ADVP
stimulates B-O B-VP_VBZ
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
natural B-O B-JJ
immunoglobulin B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
an B-O B-NP_DT
octamer B-O B-NN
site-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
OBF-1 B-O B-NP_NN
" " B-O O-NP
has B-O B-VP_VBZ
all B-O B-NP_NP_PDT
the B-O B-DT
properties B-O B-NNS
" " B-O O-NP
expected B-O B-VP_VBN
for B-O B-NP_PP_IN
a B-O B-NP_DT
B B-O B-NP_NN
cell-specific B-O B-JJ
transcriptional B-O B-JJ
coactivator B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Glucocorticoid-induced B-O B-S_S_NP_NP_JJ
apoptosis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
leukemic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
caused B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
repressive B-O B-JJ
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Induction B-O B-S_S_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
apoptosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
may B-O B-S_NP_VP_MD
account B-O B-VP_VB
for B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
depends B-O B-VP_VBZ
on B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
events B-O B-NNS
" " B-O O-NP
leading B-O B-VP_VBG
from B-O B-PP_IN
the B-O B-NP_DT
activated B-O B-VBN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
cell B-O B-NP_NN
lysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
understood B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
prevailing B-O B-VBG
hypothesis B-O B-NN
" " B-O O-NP
postulates B-O B-VP_VBZ
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
so-called B-O B-NP_JJ
' B-O B-LQT
lysis B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
' B-O B-RQT
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
activated B-O B-NP_VBN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
an B-O B-S_NP_DT
activation-deficient B-O B-NP_JJ
glucocorticoid B-O B-NN
receptor B-O B-NN
mutant B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
as B-O B-ADJP_RB
effective B-O B-JJ
as B-O B-PP_IN
the B-O B-NP_DT
wild-type B-O B-NP_JJ
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
, B-O B-NP_NP_NP_PP_COMMA
, B-O B-NP_NP_PP_COMMA
and B-O B-NP_NP_PP_CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
retinoic B-O B-S_NP_JJ
acid B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
induce B-O B-VP_VB
apoptosis B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
the B-O B-NP_NP_DT
, B-O B-NP_COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
primary B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
glucocorticoid-mediated B-O B-NP_JJ
apoptosis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VP_VBZ
with B-O B-PP_IN
transcriptional B-O B-NP_ADJP_JJ
" " B-O O-ADJP
repression B-O B-NP_NN
" " B-O O-NP
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
could B-O B-VP_MD
be B-O B-VP_VB
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
interference B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
HIV-1 B-O B-S_S_NP_NN
Tat B-O B-NN
" " B-O O-NP
potentiates B-O B-VP_VBZ
TNF-induced B-O B-NP_JJ
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
and B-O B-CC
cytotoxicity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
by B-O B-PP_IN
altering B-O B-S_NP_VP_VBG
the B-O B-NP_DT
cellular B-O B-JJ
redox B-O B-NN
state B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_S_NP_DT
study B-O B-NN
" " B-O O-NP
demonstrates B-O B-VP_VBZ
that B-O B-SBAR_IN
human B-O B-S_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
( B-O B-LRB
HIV-1 B-O B-NN
) B-O B-RRB
Tat B-O B-NN
protein B-O B-NN
" " B-O O-NP
amplifies B-O B-VP_VBZ
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
HeLa B-O B-NP_NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
stably B-O B-VP_ADVP_RB
" " B-O O-ADVP
transfected B-O B-VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NP_NN
tat B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
( B-O B-PRN_LRB
HeLa-tat B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Tat B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
enhanced B-O B-VP_VBD
both B-O B-NP_CC
TNF-induced B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
TNF-mediated B-O B-NP_JJ
cytotoxicity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
similar B-O B-JJ
potentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TNF B-O B-NP_NP_NN
" " B-O O-NP
effects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
Jurkat B-O B-NP_NP_NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
soluble B-O B-NP_JJ
Tat B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TNF-mediated B-O B-S_NP_JJ
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
cytotoxicity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
involves B-O B-VP_VBZ
the B-O B-NP_NP_DT
intracellular B-O B-JJ
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
reactive B-O B-NP_JJ
oxygen B-O B-NN
intermediates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
Tat-mediated B-O B-NP_NP_JJ
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
cellular B-O B-JJ
redox B-O B-NN
state B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
analyzed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
both B-O B-NP_CC
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
HIV-1 B-O B-NP_NN
Tat B-O B-NN
" " B-O O-NP
suppressed B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Mn-dependent B-O B-NP_NP_NP_JJ
superoxide B-O B-NN
dismutase B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Mn-SOD B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
mitochondrial B-O B-NP_JJ
enzyme B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
Mn-SOD B-O B-NP_NP_NN
" " B-O O-NP
RNA B-O B-NN
protein B-O B-NN
levels B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
markedly B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Tat B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Decreased B-O B-S_NP_VBN
Mn-SOD B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
decreased B-O B-NP_NP_NP_VBN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
glutathione B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
lower B-O B-JJR
ratio B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
: B-O B-NP_ADJP_ADJP_COLON
glutathione B-O B-ADJP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_NP_DT
truncated B-O B-VBN
Tat B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
Tat1-72 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
transactivate B-O B-VP_VB
the B-O B-NP_DT
HIV-1 B-O B-NP_NP_NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
no B-O B-ADVP_RB
longer B-O B-RBR
" " B-O O-ADVP
affected B-O B-VP_VBD
Mn-SOD B-O B-NP_NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
cellular B-O B-JJ
redox B-O B-NN
state B-O B-NN
" " B-O O-NP
or B-O B-CC
TNF-mediated B-O B-NP_JJ
cytotoxicity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
our B-O B-NP_PRPP
experiments B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
C-terminal B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
Tat B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_VP_TO
suppress B-O B-VP_VB
" " B-O B-NP_O-VP
and B-O B-CC
to B-O B-VP_TO
induce B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
Expression B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Runt B-O B-NP_NN
domain-encoding B-O B-JJ
PEBP2 B-O B-NN
alpha B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
thymic B-O B-NP_JJ
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
PEBP2 B-O B-NP_NN
alpha B-O B-NN
A B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
PEBP2 B-O B-NP_NN
alpha B-O B-NN
B B-O B-NN
" " B-O B-NP_O-NP
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
encode B-O B-VP_VBP
the B-O B-NP_NP_NP_DT
DNA-binding B-O B-NP_JJ
subunit B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
murine B-O B-NP_NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
PEBP2 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
implicated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
These B-O B-S_NP_DT
two B-O B-CD
related B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
share B-O B-VP_VBP
the B-O B-NP_NP_DT
evolutionarily B-O B-ADJP_RB
conserved B-O B-VBN
" " B-O O-ADJP
region B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
the B-O B-NP_DT
Runt B-O B-NP_NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PEBP2 B-O B-S_NP_NN
alpha B-O B-NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
murine B-O B-NP_NN
counterpart B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
AML1 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
located B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
RNA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
blots B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
various B-O B-NP_JJ
adult B-O B-JJ
mouse B-O B-NN
tissues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
most B-O B-ADJP_RBS
prominent B-O B-JJ
in B-O B-PP_IN
the B-O B-NP_DT
thymus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
transcripts B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
PEBP2 B-O B-NP_NP_NN
alpha B-O B-NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
mouse B-O B-NP_NN
AML1/PEBP2 B-O B-NN
alpha B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
T B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
thymuses B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
by B-O B-PP_IN
in B-O B-NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
persisted B-O B-VP_VBD
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
lymph B-O B-NN
nodes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
adult B-O B-NP_JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
transcripts B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
all B-O B-NP_PDT
the B-O B-DT
CD4- B-O B-NP_JJ
CD8- B-O B-JJ
" " B-O B-NP_O-NP
, B-O B-COMMA
CD4+ B-O B-NP_JJ
CD8+ B-O B-JJ
" " B-O B-NP_O-NP
, B-O B-COMMA
CD4+ B-O B-NP_JJ
CD8- B-O B-JJ
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
CD4- B-O B-NP_JJ
CD8+ B-O B-JJ
" " B-O B-NP_O-NP
cell B-O B-NP_NN
populations B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
both B-O B-S_NP_DT
genes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
throughout B-O B-PP_IN
their B-O B-NP_PRPP
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
supporting B-O B-S_NP_VP_VBG
the B-O B-NP_DT
notion B-O B-NN
that B-O B-SBAR_IN
PEBP2 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transcripts B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
mouse B-O B-NP_NN
AML1/PEBP2 B-O B-NN
alpha B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
detected B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
day B-O B-NP_NN
12 B-O B-CD
fetal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
hematopoietic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
liver B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
the B-O B-NP_NP_DT
bone B-O B-NP_NN
marrow B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
newborn B-O B-NP_JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
implication B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mouse B-O B-NP_NN
AML1/PEBP2 B-O B-NP_NN
alpha B-O B-NN
B B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
hematopoietic B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
other B-O B-ADJP_JJ
than B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
T-cell B-O B-NP_NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
discussed B-O B-VP_VBN
in B-O B-NP_PP_IN
relation B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
myeloid B-O B-NP_JJ
leukemogenesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cell-type-specific B-O B-NP_JJ
interleukin-2 B-O B-NP_NN
receptor B-O B-NN
alpha-chain B-O B-NN
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
potential B-O B-NP_NP_JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
physical B-O B-NP_NP_JJ
interactions B-O B-NNS
" " B-O O-NP
between B-O B-PP_IN
Elf-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
HMG-I(Y) B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
family B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
interleukin B-O B-NP_NN
2 B-O B-CD
receptor B-O B-NN
alpha-chain B-O B-NN
( B-O B-LRB
IL-2R B-O B-NN
alpha B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
rapidly B-O B-ADVP_ADVP_RB
" " B-O O-ADVP
and B-O B-CC
potently B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-ADVP
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
mitogenic B-O B-NP_JJ
stimuli B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Previously B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
an B-O B-NP_NP_NP_DT
inducible B-O B-NP_JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
between B-O B-PP_IN
nucleotides B-O B-NP_NNS
-299 B-O B-CD
and B-O B-CC
-228 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contains B-O B-S_NP_VP_VBZ
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
CArG B-O B-NP_NN
" " B-O B-NP_O-NP
motifs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
now B-O B-ADVP_RB
" " B-O O-ADVP
report B-O B-VP_VBP
the B-O B-NP_NP_DT
characterization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_NP_DT
second B-O B-JJ
essential B-O B-NP_JJ
positive B-O B-JJ
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
located B-O B-ADJP_JJ
between B-O B-PP_IN
" " B-O B-NP_NP_O-PP
" " B-O O-ADJP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
and B-O B-NP_NP_CC
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
element B-O B-NN
" " B-O O-NP
had B-O B-VP_VBD
maximal B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
paralleling B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
cell B-O B-NN
type B-O B-NN
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Elf-1 B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transcription B-O B-S_NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
IL-2R B-O B-NP_NN
alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
" " B-O B-NP_O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
either B-O B-S_NP_CC
the B-O B-NP_DT
Elf-1 B-O B-NN
" " B-O B-NP_O-NP
or B-O B-CC
the B-O B-NP_DT
HMG-I(Y) B-O B-NN
" " B-O B-NP_O-NP
binding B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
mutated B-O B-VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Coexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
activated B-O B-VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
-137 B-O B-NP_CD
to B-O B-TO
-64 B-O B-CD
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
COS-7 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Elf-1 B-O B-S_NP_NN
" " B-O O-NP
physically B-O B-ADVP_RB
" " B-O O-ADVP
associated B-O B-VP_VBD
with B-O B-PP_PP_IN
HMG-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
with B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
p50 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
c-Rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
protein-protein B-O B-S_NP_JJ
interactions B-O B-NNS
" " B-O O-NP
might B-O B-VP_MD
functionally B-O B-ADVP_RB
" " B-O O-ADVP
coordinate B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
first B-O B-JJ
report B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
physical B-O B-JJ
interaction B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
an B-O B-NP_NP_DT
Ets B-O B-NN
family B-O B-NN
member B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
family B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VP_VBP
significant B-O B-NP_NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
new B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
insights B-O B-NNS
" " B-O O-NP
into B-O B-PP_IN
the B-O B-NP_DT
protein-protein B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
protein-DNA B-O B-NP_JJ
" " B-O B-NP_O-NP
interactions B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
regulate B-O B-S_NP_VP_VBP
and B-O B-NP_ADJP_ADJP_CC
IL-2R B-O B-ADJP_NP_NN
alpha B-O B-NN
" " B-O O-NP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
also B-O B-ADVP_RB
" " B-O O-ADVP
have B-O B-VP_VBP
implications B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
other B-O B-NP_NP_JJ
genes B-O B-NNS
" " B-O O-NP
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Effects B-O B-NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
transcription B-O B-NP_NP_NN
factor B-O B-NN
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Glucocorticoids B-O B-S_S_S_NP_NNS
" " B-O O-NP
have B-O B-VP_VBP
an B-O B-NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
inflammatory B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
immune B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
responses B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
this B-O B-S_NP_DT
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
through B-O B-PP_IN
the B-O B-NP_NP_DT
modulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
activator B-O B-NP_NP_NP_NN
protein-1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
AP-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
cAMP-responsive B-O B-NP_NP_JJ
element B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CREB B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
DNA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
GR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
analyzed B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
gel B-O B-NP_NN
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TNF-alpha B-O B-S_NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
IL-1 B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
and B-O B-CC
phorbol B-O B-NP_NP_NN
myristate B-O B-NN
acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
treatment B-O B-NN
" " B-O O-NP
increased B-O B-VP_VP_VBD
AP-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
up B-O B-NP_QP_RB
to B-O B-TO
200 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
decreased B-O B-VP_VBD
CREB B-O B-NP_NP_NN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
38 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
over B-O B-PP_IN
a B-O B-NP_DT
60-min B-O B-JJ
time B-O B-NN
course B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Dexamethasone B-O B-S_NP_NN
" " B-O O-NP
produced B-O B-VP_VBD
a B-O B-NP_NP_NP_DT
rapid B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
sustained B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
response B-O B-NN
element B-O B-NN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_NP_DT
concomitant B-O B-JJ
40-50 B-O B-ADJP_QP_CD
" " B-O O-QP
% B-O B-NN
" " B-O O-ADJP
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
AP-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
CREB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
latter B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
due B-O B-ADJP_JJ
to B-O B-PP_PP_TO
increases B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
nuclear B-O B-JJ
localization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
not B-O B-RB
to B-O B-PP_TO
reduced B-O B-NP_NP_VBN
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
other B-O B-JJ
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
in B-O B-S_PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
GR B-O B-NP_NP_NN
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
interacts B-O B-VP_VBZ
with B-O B-PP_IN
cytokine-stimulated B-O B-NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_NP_DT
process B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cross B-O B-NP_JJ
coupling B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
an B-O B-NP_NP_DT
important B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
molecular B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
site B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
steroid B-O B-NP_NN
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Isolation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cDNA B-O B-NP_NP_NP_NN
clones B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
42 B-O B-NP_CD
different B-O B-JJ
Kruppel-related B-O B-NP_JJ
zinc B-O B-NN
finger B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
monoblast B-O B-NN
cell B-O B-NN
line B-O B-NN
U-937 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
To B-O B-S_S_S_S_NP_VP_TO
study B-O B-VP_VB
the B-O B-NP_NP_NP_DT
complexity B-O B-NN
" " B-O O-NP
and B-O B-CC
structural B-O B-NP_JJ
characteristics B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
to B-O B-S_NP_VP_TO
isolate B-O B-VP_VB
novel B-O B-NP_NP_JJ
regulators B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
blood B-O B-NP_NN
cell B-O B-NN
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
, B-O B-COMMA
a B-O B-S_NP_NP_DT
degenerate B-O B-JJ
oligonucleotide B-O B-NN
probe B-O B-NN
" " B-O O-NP
specific B-O B-ADJP_JJ
for B-O B-PP_IN
a B-O B-NP_DT
consensus B-O B-NP_NN
zinc B-O B-NN
finger B-O B-NN
peptide B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
isolate B-O B-VP_VB
63 B-O B-NP_NP_CD
for B-O B-NP_PP_IN
" " B-O B-NP_O-NP
from B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
By B-O B-S_PP_IN
extensive B-O B-NP_NP_JJ
nucleotide B-O B-NN
sequence B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
Northern B-O B-NP_NN
blot B-O B-NN
" " B-O B-NP_O-NP
analysis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
these B-O B-NP_DT
cDNA B-O B-NP_NN
clones B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
originate B-O B-VP_VB
from B-O B-PP_IN
" " B-O B-NP_NP_NP_PRN_SBAR_WHPP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
majority B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
expressed B-O B-VP_VBN
at B-O B-NP_PP_IN
comparable B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
U-937 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
large B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
individual B-O B-NP_NP_JJ
genes B-O B-NNS
" " B-O O-NP
represented B-O B-VP_VBN
among B-O B-NP_PP_IN
the B-O B-NP_NP_DT
63 B-O B-CD
clones B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
their B-O B-NP_PRPP
apparent B-O B-ADJP_JJ
non-cell-type-specific B-O B-JJ
" " B-O O-ADJP
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
majority B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Kruppel-related B-O B-NP_JJ
zinc B-O B-NN
finger B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
likely B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
some B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
displayed B-O B-VP_VBD
a B-O B-NP_DT
restricted B-O B-JJ
expression B-O B-NN
pattern B-O B-NN
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
represent B-O B-VP_VBP
potential B-O B-NP_NP_JJ
regulators B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Detailed B-O B-S_NP_NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
structural B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
first B-O B-JJ
12 B-O B-CD
cDNAs B-O B-NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
HZF B-O B-NP_NN
1-10 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
partial B-O B-JJ
characterization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HZF B-O B-NP_NN
11-42 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
common B-O B-JJ
feature B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
Kruppel-related B-O B-JJ
zinc B-O B-NN
finger B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_NP_PP_VP_SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
several B-O B-NP_NP_ADJP_JJ
novel B-O B-JJ
" " B-O O-ADJP
KRAB-containing B-O B-NP_JJ
zinc B-O B-NN
finger B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
novel B-O B-JJ
conserved B-O B-NP_VBN
sequence B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Calcium/calmodulin-dependent B-O B-S_S_NP_JJ
protein B-O B-NN
kinase B-O B-NN
II B-O B-CD
" " B-O O-NP
downregulates B-O B-VP_VBZ
both B-O B-NP_NP_CC
calcineurin B-O B-NP_NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
protein B-O B-NP_NN
kinase B-O B-NN
C-mediated B-O B-JJ
" " B-O B-NP_O-NP
pathways B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
cytokine B-O B-NP_NP_NP_NN
gene B-O B-NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Engagement B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
T B-O B-NP_NN
cell B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
antigen B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
activates B-O B-VP_VBZ
phospholipase B-O B-NP_NN
C B-O B-NN
" " B-O O-NP
resulting B-O B-S_NP_VP_VBG
in B-O B-PP_IN
an B-O B-NP_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Increased B-O B-S_NP_VBN
[Ca2+]i B-O B-NN
" " B-O O-NP
activates B-O B-VP_VBZ
Ca2+/calmodulin-dependent B-O B-NP_NP_JJ
kinases B-O B-NNS
" " B-O O-NP
including B-O B-PP_VBG
the B-O B-NP_NP_DT
multifunctional B-O B-JJ
Ca2+/calmodulin-dependent B-O B-NP_NP_JJ
protein B-O B-NN
kinase B-O B-NN
II B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
CaM-K B-O B-NP_NN
II B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
calcineurin B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
type B-O B-NP_NN
2B B-O B-NN
protein B-O B-NN
phosphatase B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recent B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
calcineurin B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
key B-O B-JJ
enzyme B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
-2 B-O B-NP_NP_NP_NP_PRN_CD
" " B-O B-NP_O-NP
and B-O B-CC
IL-4 B-O B-NP_NN
" " B-O B-NP_O-NP
promoter B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CaM-K B-O B-NP_NN
II B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remains B-O B-VP_VBZ
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
used B-O B-VP_VBN
mutants B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_NP_DT
kinases B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
phosphatases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
and B-O B-NP_NP_NP_CC
, B-O B-NP_COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
to B-O B-S_NP_VP_TO
explore B-O B-VP_VB
their B-O B-NP_NP_PRPP
relative B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
transcription B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
gamma B-O B-S_NP_NP_NP_NN
B*CaM-K B-O B-NN
" " B-O O-NP
and B-O B-CC
delta B-O B-NP_NN
CaM-AI B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
exhibit B-O B-VP_VB
constitutive B-O B-NP_ADJP_JJ
Ca(2+)-independent B-O B-JJ
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
cotransfected B-O B-VP_VBN
( B-O B-NP_PRN_LRB
alone B-O B-UCP_ADVP_RB
" " B-O O-ADVP
or B-O B-CC
in B-O B-PP_IN
combination B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-UCP
) B-O B-RRB
" " B-O O-PRN
in B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
plasmid B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_DT
intact B-O B-JJ
IL-2 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
driving B-O B-VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cotransfection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
gamma B-O B-NP_NN
B*CaM-K B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NP_NN
promoter B-O B-NN
construct B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
downregulated B-O B-VP_VBD
its B-O B-NP_PRPP
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
ionomycin B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CaM-K B-O B-NP_NN
II B-O B-CD
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
IL-2 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
decreased B-O B-NP_NP_VBN
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
AP-1 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
NF-AT B-O B-NP_NN
" " B-O B-NP_O-NP
transactivating B-O B-NP_NN
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Under B-O B-S_PP_IN
the B-O B-NP_DT
same B-O B-JJ
conditions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
delta B-O B-NP_NN
CaM-AI B-O B-NN
" " B-O O-NP
superinduced B-O B-VP_VBD
IL-2 B-O B-NP_NP_NP_NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
approximately B-O B-NP_ADJP_RB
twofold B-O B-JJ
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
both B-O B-S_NP_DT
mutants B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
in B-O B-NP_PP_IN
combination B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
gamma B-O B-S_NP_NN
B*CaM-K B-O B-NN
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
delta B-O B-NP_NN
CaM-AI B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_NP_JJ
results B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
obtained B-O B-VP_VBN
" " B-O B-NP_O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
a B-O B-S_NP_NP_DT
construct B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_DT
IL-4 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
was B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
gamma B-O B-S_NP_NN
B*CaM-K B-O B-NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
downregulated B-O B-VP_VBD
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
transfection B-O B-NP_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_DT
mutant B-O B-ADJP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-NP
or B-O B-CC
stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VP_VBP
that B-O B-SBAR_IN
CaM-K B-O B-S_NP_NN
II B-O B-CD
" " B-O O-NP
may B-O B-VP_MD
exert B-O B-VP_VB
negative B-O B-NP_JJ
influences B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
provide B-O B-VP_VBP
preliminary B-O B-NP_NP_JJ
evidence B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
negative B-O B-NP_NP_JJ
cross-talk B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
calcineurin- B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
PKC- B-O B-NP_NN
" " B-O B-NP_O-NP
dependent B-O B-NP_JJ
signaling B-O B-NN
systems B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Deleted B-O B-NP_NP_NP_NP_NP_JJ
chromosome B-O B-NP_NN
20 B-O B-CD
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
a B-O B-NP_NP_DT
patient B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
Alagille B-O B-NP_NN
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
isolated B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
cell B-O B-NN
hybrid B-O B-NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
leucine B-O B-NP_NN
transport B-O B-NN
selection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
: B-O B-COLON
" " B-O O-NP
study B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
three B-O B-NP_CD
candidate B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Alagille B-O B-S_S_NP_NP_NN
syndrome B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
AGS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
well-defined B-O B-JJ
genetic B-O B-JJ
entity B-O B-NN
" " B-O O-NP
assigned B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
short B-O B-NP_JJ
arm B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
Chromosome B-O B-NP_NN
( B-O B-LRB
Chr B-O B-NN
) B-O B-RRB
20 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
a B-O B-NP_NP_DT
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
By B-O B-S_PP_IN
fusing B-O B-S_NP_VP_VBG
lymphoblastoid B-O B-NP_NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
AGS B-O B-NN
patient B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
exhibited B-O B-S_NP_VP_VBD
a B-O B-NP_DT
microdeletion B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
with B-O B-PP_IN
rodent B-O B-NP_NP_NP_JJ
thermosensitive B-O B-JJ
mutant B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
CHOtsH1-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
deficient B-O B-ADJP_JJ
in-leucyl-tRNA B-O B-NP_JJ
synthetase B-O B-NN
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
isolated B-O B-VP_VBD
a B-O B-NP_NP_DT
somatic B-O B-NP_JJ
cell B-O B-NN
hybrid B-O B-NN
" " B-O O-NP
" " B-O O-NP
segregating B-O B-VP_VBG
the B-O B-NP_DT
deleted B-O B-JJ
human B-O B-JJ
Chr B-O B-NP_NN
20 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_S_NP_NP_DT
hybrid B-O B-NN
clone B-O B-NN
" " B-O O-NP
, B-O B-COMMA
designated B-O B-VP_VBN
NR2 B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
several B-O B-NP_NP_JJ
methods B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
, B-O B-NP_NP_COMMA
" " B-O B-PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
D20S5 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
D20S41 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
D20S42 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
D20S56 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
D20S57 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
D20S58 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
adenosine B-O B-NP_NP_NN
deaminase B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ADA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Prion B-O B-NP_NP_NN
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PRIP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
Restriction B-O B-NP_NP_NP_NP_NN
Fragment B-O B-NN
Length B-O B-NN
Polymorphism B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RFLP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
analyses B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
four B-O B-NP_NP_CD
genomic B-O B-NP_JJ
anonymous B-O B-JJ
probes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
D20S5 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
cD3H12 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
D20S17 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
D20S18 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-S
; B-O B-COLON
and B-O B-CC
fluorescent B-O B-NP_NP_NP_JJ
in B-O B-ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
FISH B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
with B-O B-PP_IN
total B-O B-NP_NP_JJ
human B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
and B-O B-CC
D20Z1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
sequence B-O B-NN
" " B-O O-NP
specific B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-PP_IN
probes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
NR2 B-O B-NP_NN
hybrid B-O B-NN
" " B-O O-NP
" " B-O O-NP
allowed B-O B-VP_VBD
us B-O B-S_NP_PRP
" " B-O O-NP
to B-O B-VP_TO
exclude B-O B-VP_VB
three B-O B-NP_NP_CD
candidate B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
AGS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
hepatic B-O B-NP_NP_NP_NP_JJ
nuclear B-O B-JJ
factor B-O B-NN
3 B-O B-CD
beta B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HNF3 B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
paired B-O B-NP_NP_JJ
box B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
PAX1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
cystatin B-O B-NP_NP_NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CST3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
as B-O B-SBAR_IN
shown B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
their B-O B-NP_NP_PRPP
localization B-O B-NN
" " B-O O-NP
outside B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
NR2 B-O B-NP_NN
hybrid B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
powerful B-O B-JJ
tool B-O B-NN
" " B-O O-NP
for B-O B-PP_PP_IN
the B-O B-NP_NP_DT
mapping B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
new B-O B-NP_NP_JJ
probes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
for B-O B-PP_IN
obtaining B-O B-S_NP_VP_VBG
probes B-O B-NP_NP_ADJP_NNS
" " B-O O-NP
specific B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Such B-O B-S_NP_JJ
markers B-O B-NNS
" " B-O O-NP
will B-O B-VP_MD
be B-O B-VP_VB
useful B-O B-ADJP_JJ
for B-O B-PP_IN
linkage B-O B-NP_NP_NP_NN
analysis B-O B-NN
" " B-O O-NP
and B-O B-CC
screening B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
cDNA B-O B-NP_NN
libraries B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Control B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NP_NN
kappa B-O B-NN
B-alpha B-O B-NN
" " B-O O-NP
proteolysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
site-specific B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
signal-induced B-O B-NP_JJ
" " B-O O-NP
" " B-O O-ADJP
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
I B-O B-S_S_NP_NN
kappa B-O B-NN
B-alpha B-O B-NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
factor B-O B-NN
" " B-O O-NP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
by B-O B-PP_IN
retaining B-O B-S_NP_VP_VBG
it B-O B-NP_PRP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Various B-O B-S_NP_NP_JJ
stimuli B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
typically B-O B-ADVP_RB
" " B-O O-ADVP
those B-O B-NP_NP_DT
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
stress B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
pathogens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
inactivate B-O B-VP_VBP
I B-O B-NP_NN
kappa B-O B-NN
B-alpha B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
liberates B-O B-VP_VP_VBZ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
translocate B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
and B-O B-CC
initiate B-O B-VP_VB
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
important B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VP_VBZ
with B-O B-PP_IN
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B-alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
requires B-O B-VP_VBZ
the B-O B-NP_NP_DT
proteolysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
inhibitor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
either B-O B-S_NP_NP_CC
serine-32 B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
serine-36 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B-alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
mutated B-O B-VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_S_NP_DT
protein B-O B-NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
undergo B-O B-VP_VB
signal-induced B-O B-NP_ADJP_JJ
" " B-O O-ADJP
phosphorylation B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
degradation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
activated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
phosphorylation B-O B-S_NP_NP_NN
" " B-O O-NP
at B-O B-PP_IN
one B-O B-NP_NP_CD
" " B-O B-PP_O-NP
or B-O B-CC
both B-O B-NP_DT
" " B-O B-PP_O-NP
of B-O B-PP_IN
these B-O B-NP_DT
residues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
critical B-O B-ADJP_JJ
for B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_NP_NP_DT
germline B-O B-NP_NN
TaqI B-O B-NN
restriction B-O B-NN
fragment B-O B-NN
length B-O B-NN
polymorphism B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
progesterone B-O B-NP_NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
ovarian B-O B-NP_JJ
carcinoma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
[ B-O B-S_LRB
see B-O B-NP_VP_VB
comments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
  
Clinical B-O B-S_S_NP_NP_JJ
outcome B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
ovarian B-O B-NP_JJ
carcinoma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
predicted B-O B-VP_VBN
by B-O B-NP_PP_IN
progesterone B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
status B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
an B-O B-NP_NP_DT
endocrine B-O B-JJ
aspect B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
this B-O B-NP_DT
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Peripheral B-O B-S_NP_JJ
leucocyte B-O B-NN
genomic B-O B-JJ
DNAs B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
obtained B-O B-VP_VBN
from B-O B-NP_PP_PP_IN
41 B-O B-NP_NP_NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
83 B-O B-NP_CD
controls B-O B-NNS
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
Ireland B-O B-NP_NNP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
from B-O B-PP_IN
26 B-O B-NP_NP_NP_CD
primary B-O B-JJ
ovarian B-O B-JJ
carcinoma B-O B-NN
patients B-O B-NNS
" " B-O O-NP
and B-O B-CC
101 B-O B-NP_CD
controls B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
Germany B-O B-NP_NNP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Southern B-O B-S_S_NP_NP_NN
analysis B-O B-NN
" " B-O O-NP
using B-O B-VP_VBG
a B-O B-NP_DT
human B-O B-NP_JJ
progesterone B-O B-NN
receptor B-O B-NN
( B-O B-LRB
hPR B-O B-NN
) B-O B-RRB
cDNA B-O B-NN
probe B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
identified B-O B-VP_VBD
a B-O B-NP_NP_DT
germline B-O B-NP_NP_NN
TaqI B-O B-NN
restriction B-O B-NN
fragment B-O B-NN
length B-O B-NN
polymorphism B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RFLP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
defined B-O B-VP_VBN
by B-O B-NP_PP_IN
two B-O B-NP_CD
alleles B-O B-NNS
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
T1 B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
represented B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_DT
2.7 B-O B-NP_CD
kb B-O B-NN
fragment B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
; B-O B-COLON
and B-O B-CC
T2 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
represented B-O B-VP_VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_DT
1.9 B-O B-NP_CD
kb B-O B-NN
fragment B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
characterised B-O B-VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_DT
additional B-O B-JJ
TaqI B-O B-NP_NN
restriction B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
respect B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
T1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_NP_DT
over-representation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
ovarian B-O B-NP_JJ
cancer B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
compared B-O B-VP_VBN
with B-O B-NP_PP_IN
controls B-O B-NP_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
pooled B-O B-JJ
Irish/German B-O B-NNP
population B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NP_NN
" " B-O O-NP
< B-O B-ADJP_JJR
0.025 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_NP_DT
difference B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NP_NN
" " B-O O-NP
< B-O B-ADJP_JJR
0.02 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
distribution B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
RFLP B-O B-NP_NN
" " B-O O-NP
genotypes B-O B-NNS
" " B-O O-NP
between B-O B-PP_IN
Irish B-O B-NP_NP_NNP
" " B-O B-NP_O-NP
and B-O B-CC
German B-O B-NP_NNP
" " B-O B-NP_O-NP
control B-O B-NP_JJ
populations B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
allele B-O B-NN
distributions B-O B-NNS
" " B-O O-NP
could B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
differ B-O B-VP_VB
significantly B-O B-ADVP_RB
" " B-O O-ADVP
from B-O B-PP_IN
Hardy-Weinberg B-O B-NP_JJ
distribution B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
any B-O B-NP_DT
subgroup B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
hPR B-O B-NP_NN
cDNA B-O B-NN
region-specific B-O B-JJ
probes B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
the B-O B-S_NP_DT
extra B-O B-JJ
TaqI B-O B-NN
restriction B-O B-NN
site B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
mapped B-O B-VP_VBN
to B-O B-NP_PP_TO
intron B-O B-NP_NP_NN
G B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hPR B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
HIV-1 B-O B-S_S_NP_NN
Nef B-O B-NN
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
inhibition B-O B-NP_NP_NP_NN
" " B-O O-NP
or B-O B-CC
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
depending B-O B-PP_VBG
on B-O B-PP_IN
its B-O B-NP_PRPP
intracellular B-O B-JJ
localization B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Nef B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
primate B-O B-NP_JJ
lentiviruses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
viremia B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
progression B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-NP
in B-O B-PP_IN
monkeys B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Negative B-O B-S_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
positive B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
no B-O B-NP_DT
" " B-O B-NP_O-NP
effects B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
Nef B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
also B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
reported B-O B-VP_VBN
on B-O B-NP_PP_IN
viral B-O B-NP_NP_JJ
replication B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
reconcile B-O B-VP_VB
these B-O B-NP_DT
observations B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
expressed B-O B-VP_VBD
a B-O B-NP_DT
hybrid B-O B-NP_NN
CD8-Nef B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_CD
opposite B-O B-JJ
phenotypes B-O B-NNS
" " B-O B-SBAR_O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
depended B-O B-S_NP_VP_VBD
on B-O B-PP_IN
the B-O B-NP_NP_DT
intracellular B-O B-JJ
localization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Nef B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
  
Expressed B-O B-S_S_NP_VP_VBN
in B-O B-NP_PP_PP_IN
the B-O B-NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
on B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
surface B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
the B-O B-S_NP_DT
chimera B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibited B-O B-VP_VP_VBD
" " B-O B-NP_O-VP
or B-O B-CC
activated B-O B-VP_VBD
" " B-O B-NP_O-VP
early B-O B-NP_NP_JJ
signaling B-O B-NN
events B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
T B-O B-NP_NN
cell B-O B-NN
antigen B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Activated B-O B-S_S_NP_VBN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
died B-O B-VP_VBD
by B-O B-PP_IN
apoptosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
only B-O B-S_ADVP_RB
" " B-O O-ADVP
cells B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
mutated B-O B-NP_NP_VBN
nef B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
expressing B-O B-VP_VBG
truncated B-O B-NP_VBN
Nefs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O B-SBAR_O-NP
survived B-O B-VP_VBD
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
rendered B-O B-S_NP_VP_VBD
Nef B-O B-S_NP_NP_NN
" " B-O O-NP
nonfunctional B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
mutations B-O B-NNS
" " B-O O-NP
paralleled B-O B-VP_VBD
those B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_IN
other B-O B-NP_NP_JJ
viral B-O B-JJ
strains B-O B-NNS
" " B-O O-NP
passaged B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Not B-O B-S_SINV_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
do B-O B-VBP
these B-O B-NP_NP_DT
positional B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Nef B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reconcile B-O B-VP_VP_VB
diverse B-O B-NP_NP_JJ
phenotypes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Nef B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
suggest B-O B-VP_VB
a B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
its B-O B-NP_PRPP
N-terminal B-O B-JJ
myristylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-SINV
, B-O B-COMMA
but B-O B-CC
they B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
explain B-O B-VP_VBP
effects B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
Nef B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
HIV B-O B-NP_NP_NN
infection B-O B-NN
" " B-O O-NP
and B-O B-CC
progression B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
AIDS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Missense B-O B-S_S_NP_NP_NN
mutation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
exon B-O B-NP_NN
7 B-O B-CD
" " B-O O-NP
" " B-O O-PP
of B-O B-PP_IN
the B-O B-NP_DT
common B-O B-NP_JJ
gamma B-O B-NN
chain B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
causes B-O B-VP_VBZ
a B-O B-NP_NP_DT
moderate B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
X-linked B-O B-NP_JJ
combined B-O B-JJ
immunodeficiency B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Clinical B-O B-S_S_NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
immunologic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
features B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
recently B-O B-ADJP_RB
recognized B-O B-VBN
" " B-O O-ADJP
X-linked B-O B-NP_NP_JJ
combined B-O B-JJ
immunodeficiency B-O B-NN
disease B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
XCID B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
XCID B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
X-linked B-O B-NP_NP_JJ
severe B-O B-JJ
combined B-O B-JJ
immunodeficiency B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
XSCID B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
might B-O B-VP_MD
arise B-O B-VP_VB
from B-O B-PP_IN
defects B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
recent B-O B-JJ
discovery B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mutations B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_NP_DT
common B-O B-NP_JJ
gamma B-O B-NN
chain B-O B-NN
( B-O B-LRB
gamma B-O B-NN
c B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
constituent B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
, B-O B-COMMA
in B-O B-PP_IN
XSCID B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
provided B-O B-VP_VBD
an B-O B-NP_NP_DT
opportunity B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHADVP_S_NP_VP_TO
test B-O B-VP_VB
directly B-O B-ADVP_RB
" " B-O O-ADVP
whether B-O B-ADVP_SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
status B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
X B-O B-NP_NP_NP_NN
chromosome B-O B-NN
" " B-O O-NP
inactivation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
blood B-O B-NP_NP_NN
leukocytes B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
obligate B-O B-NP_NP_JJ
carriers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_NP_NP_DT
polymorphic B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
short B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
tandem B-O B-JJ
repeats B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
CAG B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
in B-O B-PP_IN
the B-O B-NP_NP_DT
androgen B-O B-NP_NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_ADVP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_PP_IN
in B-O B-PP_IN
XSCID B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
X-chromosome B-O B-NP_NP_NN
inactivation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
obligate B-O B-NP_NP_JJ
carriers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
XCID B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
nonrandom B-O B-ADJP_JJ
in B-O B-PP_IN
T B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
B B-O B-NP_NN
" " B-O B-NP_O-NP
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
X B-O B-NP_NP_NP_NN
chromosome B-O B-NN
" " B-O O-NP
inactivation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
PMNs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
variable B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Findings B-O B-S_NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
this B-O B-NP_DT
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
prompted B-O B-VP_VBD
sequencing B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
gamma B-O B-NP_NN
c B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
pedigree B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
missense B-O B-NN
mutation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
coding B-O B-VP_VBG
for B-O B-PP_IN
the B-O B-NP_NP_DT
cytoplasmic B-O B-JJ
portion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
three B-O B-NP_CD
affected B-O B-VBN
males B-O B-NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
a B-O B-NP_DT
normal B-O B-JJ
brother B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
this B-O B-NP_NP_DT
point B-O B-NN
mutation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
gamma B-O B-NP_NN
c B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
a B-O B-NP_NP_NP_NP_DT
less B-O B-ADJP_RBR
severe B-O B-JJ
" " B-O O-ADJP
degree B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
deficiency B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
cellular B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
humoral B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
immunity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
than B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
XSCID B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
LMP-1 B-O B-S_S_NP_NN
" " B-O O-NP
activates B-O B-VP_VBZ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
targeting B-O B-S_NP_VP_VBG
the B-O B-NP_DT
inhibitory B-O B-NP_JJ
molecule B-O B-NN
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
LMP-1 B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
membrane B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
expressed B-O B-VP_VBN
during B-O B-NP_PP_IN
latent B-O B-NP_JJ
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
oncogenic B-O B-NP_JJ
properties B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_IN
judged B-O B-S_NP_VP_VBN
from B-O B-NP_PP_IN
its B-O B-NP_PRPP
ability B-O B-NN
" " B-O B-S_NP_VP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
LMP-1 B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_PP_IN
bcl2 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
oncogene B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
encoding B-O B-VP_VBG
other B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
LMP-1 B-O B-S_NP_NN
" " B-O O-NP
upregulates B-O B-VP_VBZ
these B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
it B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
plausible B-O B-ADJP_JJ
" " B-O O-ADJP
that B-O B-SBAR_IN
LMP-1 B-O B-S_NP_NN
" " B-O O-NP
modifies B-O B-VP_VBZ
signal B-O B-NP_NP_NN
transduction B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
NF-kappa B-O B-S_NP_NP_NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
controlling B-O B-VP_VBG
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mechanism B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
regulating B-O B-VP_VBG
this B-O B-NP_DT
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
remains B-O B-VP_VBZ
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
increased B-O B-S_NP_VBN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
DNA B-O B-NP_NP_NN
binding B-O B-NN
" " B-O O-NP
and B-O B-CC
functional B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
present B-O B-ADJP_JJ
in B-O B-PP_IN
B-lymphoid B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
or B-O B-ADVP_ADVP_CC
expressing B-O B-ADVP_VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
I B-O B-S_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
selectively B-O B-ADVP_RB
" " B-O O-ADVP
modified B-O B-VP_VBN
in B-O B-NP_PP_IN
LMP-1-expressing B-O B-NP_JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_NP_DT
phosphorylated B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
increased B-O B-NP_VBN
protein B-O B-NN
turnover-degradation B-O B-NN
" " B-O O-NP
" " B-O O-NP
correlate B-O B-VP_VBP
with B-O B-PP_IN
increased B-O B-NP_VBN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
nuclear B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
increased B-O B-NP_NP_VBN
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B-dependent-genes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
those B-O B-NP_NP_DT
" " B-O O-NP
encoding B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
LMP-1 B-O B-S_NP_NN
" " B-O O-NP
activates B-O B-VP_VBZ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
B-cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
targeting B-O B-S_NP_VP_VBG
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Identification B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
pathways B-O B-NNS
" " B-O O-NP
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
LMP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
result B-O B-VP_VB
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
will B-O B-VP_MD
aid B-O B-VP_VB
in B-O B-PP_IN
determining B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Treatment B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HL60 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
various B-O B-NP_NP_JJ
combinations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
retinoids B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
1 B-O B-NP_CD
alpha B-O B-NN
, B-O B-COMMA
25 B-O B-CD
dihydroxyvitamin B-O B-NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
differentiation B-O B-NP_NP_NP_NN
" " B-O O-NP
towards B-O B-PP_IN
neutrophils B-O B-NP_NP_NNS
" " B-O O-NP
or B-O B-CC
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
or B-O B-CC
a B-O B-NP_NP_DT
failure B-O B-NN
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-NP
and B-O B-CC
apoptosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
well B-O B-ADVP_RB
" " B-O O-ADVP
documented B-O B-VP_VBN
that B-O B-SBAR_IN
treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
serum-grown B-O B-NP_JJ
HL60 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
" " B-O B-NP_NP_NP_O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
neutrophil B-O B-NP_NP_NN
" " B-O O-NP
differentiation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
recent B-O B-NP_JJ
investigations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
using B-O B-S_NP_VP_VBG
serum-free B-O B-NP_JJ
grown B-O B-JJ
HL60 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
that B-O B-SBAR_SBAR_IN
all-trans B-O B-S_NP_NP_JJ
RA B-O B-NN
" " B-O O-NP
, B-O B-COMMA
at B-O B-PP_IN
M B-O B-NP_QP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
induce B-O B-VP_VB
neutrophil B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
all-trans B-O B-S_NP_NP_JJ
RA B-O B-NN
" " B-O O-NP
, B-O B-COMMA
at B-O B-PP_IN
M B-O B-NP_QP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
reduced B-O B-VP_VBD
the B-O B-NP_NP_DT
D3 B-O B-NN
concentration B-O B-NN
" " B-O O-NP
required B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
co-operative B-O B-NP_NP_JJ
interactions B-O B-NNS
" " B-O O-NP
between B-O B-PP_IN
all-trans B-O B-NP_NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
9-cis B-O B-NP_JJ
" " B-O B-NP_O-NP
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
promote B-O B-S_NP_VP_VBP
of B-O B-NP_NP_NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
analysed B-O B-VP_VBN
in B-O B-NP_PP_IN
detail B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
serum-free B-O B-NP_JJ
grown B-O B-JJ
HL60 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
5 B-O B-NP_NP_QP_CD
x B-O B-CC
10(-7) B-O B-CD
" " B-O O-QP
M B-O B-NN
" " B-O O-NP
all-trans B-O B-NP_NP_JJ
RA B-O B-NN
" " B-O O-NP
or B-O B-CC
9-cis B-O B-NP_JJ
RA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
sub-optimal B-O B-NP_NP_JJ
neutrophil B-O B-NN
differentiation B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
up B-O B-NP_ADJP_QP_RB
to B-O B-TO
25 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-ADJP
mature B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_SBAR_IN
shown B-O B-S_NP_VP_VBN
for B-O B-NP_PP_IN
all-trans B-O B-NP_JJ
RA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
9-cis B-O B-S_NP_JJ
RA B-O B-NN
" " B-O O-NP
cooperated B-O B-VP_VBD
with B-O B-PP_IN
D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
promote B-O B-VP_VB
monocyte B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Culture B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HL60 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
5 B-O B-NP_ADJP_QP_CD
x B-O B-CC
10(-7) B-O B-CD
" " B-O O-QP
M B-O B-NN
" " B-O O-ADJP
9-cis B-O B-JJ
RA B-O B-NN
" " B-O O-NP
" " B-O O-PP
together B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
a B-O B-NP_NP_DT
wide B-O B-JJ
range B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
concentrations B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
promotion B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
neutrophil B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
10(-15)-10(-12) B-O B-NP_QP_CD
" " B-O O-QP
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_NP_DT
failure B-O B-NN
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-NP
and B-O B-CC
apoptosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
at B-O B-PP_IN
10(-11)-10(-10) B-O B-NP_ADJP_QP_CD
" " B-O O-QP
M B-O B-NN
" " B-O O-ADJP
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
followed B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
co-operativity B-O B-NP_NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
in B-O B-PP_IN
inducing B-O B-S_NP_VP_VBG
" " B-O B-NP_PP_O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_NP_JJ
results B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
obtained B-O B-VP_VBN
" " B-O B-NP_O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
HL60 B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
5 B-O B-NP_QP_CD
x B-O B-CC
10(-7) B-O B-CD
" " B-O O-QP
all-trans B-O B-JJ
RA B-O B-NN
" " B-O O-NP
" " B-O O-PP
together B-O B-PP_ADVP_RB
" " B-O O-ADVP
with B-O B-IN
a B-O B-NP_NP_DT
wide B-O B-JJ
range B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cross B-O B-S_NP_NP_NN
titration B-O B-NN
analyses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
9-cis B-O B-NP_NP_JJ
RA B-O B-NN
" " B-O O-NP
and B-O B-CC
D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
HL60 B-O B-NP_NP_NN
cell B-O B-NN
" " B-O O-NP
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
undertaken B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
the B-O B-NP_NP_DT
boundaries B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_NP_PP_COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
observed B-O B-VBN
cooperativities B-O B-NNS
" " B-O O-NP
between B-O B-PP_IN
either B-O B-NP_NP_CC
9-cis B-O B-NP_JJ
RA B-O B-NN
" " B-O O-NP
or B-O B-CC
all-trans B-O B-NP_JJ
RA B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
important B-O B-NP_JJ
implications B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
combinations B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
differentiation B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cloning B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
characterization B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
NF-ATc B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF-ATp B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
the B-O B-NP_NP_DT
cytoplasmic B-O B-JJ
components B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Present B-O B-S_NP_JJ
evidence B-O B-NN
" " B-O O-NP
indicates B-O B-VP_VBZ
a B-O B-NP_NP_DT
pathway B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
signal B-O B-NP_NN
transmission B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
outlined B-O B-VP_VBN
in B-O B-NP_PP_IN
figure B-O B-NP_NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
elevation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
intracellular B-O B-NP_JJ
calcium B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
interactions B-O B-NP_NP_NNS
" " B-O O-NP
at B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
calcium-dependent B-O B-JJ
phosphatase B-O B-NN
calcineurin B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
in B-O B-PP_IN
turn B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
leads B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
nuclear B-O B-JJ
association B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
cytosolic B-O B-JJ
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-ATc B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
calcineurin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
nuclear B-O B-JJ
import B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-ATc B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
both B-O B-ADVP_DT
" " B-O O-ADVP
be B-O B-VP_VB
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
cyclosporin B-O B-NP_NP_NP_NN
A B-O B-NN
" " B-O O-NP
or B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
complex B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Once B-O B-S_SBAR_RB
in B-O B-S_NP_PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
NF-ATc B-O B-NP_NN
" " B-O O-NP
interacts B-O B-VP_VBZ
with B-O B-PP_IN
NF-ATn B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
form B-O B-VP_VB
an B-O B-NP_DT
active B-O B-JJ
transcriptional B-O B-JJ
complex B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-ATn B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
a B-O B-NP_DT
ubiquitous B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
can B-O B-VP_MD
be B-O B-VP_VB
synthesized B-O B-VP_VBN
in B-O B-NP_PP_IN
response B-O B-NN
to B-O B-TO
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
has B-O B-VP_VBZ
many B-O B-NP_NP_JJ
similarities B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
NF-ATc B-O B-S_NP_NN
" " B-O O-NP
enters B-O B-VP_VBZ
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
although B-O B-S_SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
require B-O B-VP_VB
calcineurin B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
NF-ATc B-O B-NP_NN
" " B-O O-NP
has B-O B-VP_VBZ
not B-O B-RB
yet B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Alternative B-O B-S_NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
include B-O B-VP_VBP
the B-O B-NP_DT
possibility B-O B-NN
that B-O B-SBAR_SBAR_IN
NF-ATc B-O B-S_NP_NN
" " B-O O-NP
operates B-O B-VP_VBZ
on B-O B-PP_IN
some B-O B-NP_DT
cytoplasmic B-O B-JJ
anchor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
or B-O B-CC
that B-O B-SBAR_IN
other B-O B-S_NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
carry B-O B-VP_VBP
out B-O B-PRT_RP
" " B-O O-PRT
the B-O B-NP_NP_DT
nuclear B-O B-JJ
import B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
NF-ATp B-O B-S_NP_NN
" " B-O O-NP
copurifies B-O B-VP_VBZ
with B-O B-PP_IN
NF-ATc B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
as B-O B-ADVP_RB
yet B-O B-RB
" " B-O O-ADVP
no B-O B-NP_NP_DT
understanding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
NF-ATp B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
functioning B-O B-VP_VBG
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Now B-O B-S_ADVP_RB
that B-O B-SBAR_IN
these B-O B-S_NP_DT
proteins B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
purified B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
cloned B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
major B-O B-JJ
goals B-O B-NNS
" " B-O O-NP
will B-O B-VP_MD
be B-O B-VP_VB
to B-O B-S_NP_VP_TO
understand B-O B-VP_VB
their B-O B-NP_NP_NP_PRPP
role B-O B-NN
" " B-O O-NP
and B-O B-CC
" " B-O B-NP_NP_PP_O-NP
in B-O B-PP_IN
thymic B-O B-NP_JJ
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
retinoic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
cellular B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
retinoic B-O B-NP_JJ
acid B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
OBJECTIVES B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
To B-O B-S_NP_VP_TO
analyze B-O B-VP_VP_VB
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
retinoic B-O B-NP_NP_JJ
acids B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
HIV-1 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
correlate B-O B-VP_VB
this B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
expression B-O B-NP_NP_NN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
DESIGN B-O B-NP_NP_NP_NN
" " B-O O-NP
AND B-O B-CC
METHODS B-O B-NP_NNS
" " B-O O-NP
: B-O B-COLON
" " B-O O-NP
The B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
all-trans B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
9-cis B-O B-NP_JJ
" " B-O B-NP_O-NP
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
HIV-1 B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T-lymphoid B-O B-NP_NP_NP_JJ
" " B-O O-NP
( B-O B-PRN_LRB
H9 B-O B-NP_NN
, B-O B-COMMA
CEM B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
monocytoid B-O B-NP_JJ
( B-O B-LRB
U937 B-O B-NN
, B-O B-COMMA
THP-1 B-O B-NN
) B-O B-RRB
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
measured B-O B-VP_VBN
during B-O B-NP_PP_IN
acute B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
chronic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
infection B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_NP_JJ
RAR B-O B-NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
hRAR B-O B-NP_NP_NN
alpha B-O B-NN
, B-O B-COMMA
receptor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
all-trans B-O B-NP_JJ
RA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
human B-O B-NP_JJ
retinoid-X B-O B-NN
receptor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
hRXR B-O B-NP_NP_NN
alpha B-O B-NN
receptor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
9-cis B-O B-NP_JJ
RA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
determined B-O B-VP_VBN
by B-O B-NP_PP_IN
Northern B-O B-NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
RESULTS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
Both B-O B-S_NP_CC
all-trans B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
9-cis B-O B-NP_JJ
" " B-O B-NP_O-NP
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibited B-O B-VP_VBD
virus B-O B-NP_NP_NN
replication B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HIV-1 B-O B-NP_NN
IIIB-infected B-O B-JJ
monocytoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
absence B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
co-stimulatory B-O B-JJ
agent B-O B-NN
" " B-O O-NP
phorbol B-O B-NP_NP_NN
myristate B-O B-NN
acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
The B-O B-S_NP_DT
retinoids B-O B-NNS
" " B-O O-NP
had B-O B-VP_VBD
weak B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
or B-O B-CC
no B-O B-NP_DT
" " B-O B-NP_O-NP
stimulatory B-O B-NP_JJ
effects B-O B-NNS
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
HIV B-O B-NP_NP_NN
production B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
T-cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HIV B-O B-S_NP_NP_NN
production B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
PMA-stimulated B-O B-NP_JJ
T-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
these B-O B-NP_DT
retinoids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
9-cis B-O B-JJ
RA B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
generally B-O B-ADJP_ADJP_ADVP_RB
" " B-O O-ADVP
more B-O B-ADJP_RBR
effective B-O B-JJ
" " B-O O-ADJP
than B-O B-PP_IN
all-trans B-O B-NP_JJ
RA B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
inhibiting B-O B-S_NP_VP_VBG
HIV B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
and B-O B-CC
in B-O B-PP_IN
combination B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
generally B-O B-ADJP_ADVP_RB
" " B-O O-ADVP
more B-O B-ADJP_RBR
effective B-O B-JJ
" " B-O O-ADJP
than B-O B-PP_IN
the B-O B-NP_NP_DT
single B-O B-JJ
agents B-O B-NNS
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_NP_JJ
RAR B-O B-NN
alpha B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
expressed B-O B-UCP_VP_VBN
in B-O B-NP_PP_IN
H9 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
U937 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
THP-1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
almost B-O B-ADJP_RB
undetectable B-O B-JJ
in B-O B-PP_IN
CEM B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_NP_JJ
RXR B-O B-NN
alpha B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-UCP_ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
U937 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
THP-1 B-O B-NP_NN
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
weakly B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
H9 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
not B-O B-RB
detectable B-O B-ADJP_JJ
in B-O B-PP_IN
CEM B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
RXR B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
increased B-O B-VP_VBD
in B-O B-PP_PP_IN
H9 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
CEM B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_NP_JJ
RAR B-O B-NN
alpha B-O B-NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
unchanged B-O B-UCP_ADJP_JJ
in B-O B-PP_IN
H9 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
CEM B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
and B-O B-CC
elevated B-O B-VP_VBD
in B-O B-NP_PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
after B-O B-PP_IN
PMA B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CONCLUSION B-O B-NP_NP_NN
: B-O B-COLON
" " B-O O-NP
The B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
HIV-1 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
cell-type-dependent B-O B-UCP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
partially B-O B-ADVP_RB
" " B-O O-ADVP
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
cellular B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RARs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
Endogenous B-O B-S_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
or B-O B-CC
exogenously B-O B-NP_ADVP_RB
" " B-O O-ADVP
administered B-O B-VBN
" " B-O B-NP_O-NP
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
have B-O B-VP_VB
a B-O B-NP_DT
significant B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HIV B-O B-NP_NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interleukin-5 B-O B-S_S_NP_NP_NP_NN
" " B-O O-NP
signaling B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
eosinophils B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
JAK2 B-O B-NP_NP_NN
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
and B-O B-CC
Stat1 B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Signaling B-O B-S_S_NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
a B-O B-NP_NP_DT
wide B-O B-JJ
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokines B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
involves B-O B-VP_VBZ
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
JAK B-O B-NP_NP_NN
kinases B-O B-NNS
" " B-O O-NP
and B-O B-CC
Stat B-O B-NP_NNS
( B-O B-LRB
Signal B-O B-NN
transducers B-O B-NNS
and B-O B-CC
activators B-O B-NNS
of B-O B-IN
transcription B-O B-NN
) B-O B-RRB
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
At B-O B-S_PP_IN
present B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
not B-O B-NP_RB
much B-O B-RB
" " B-O B-PP_O-NP
is B-O B-VP_VBZ
known B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
about B-O B-PP_IN
the B-O B-NP_NP_DT
molecular B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
interleukin-5 B-O B-S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-5 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
exerts B-O B-VP_VBZ
its B-O B-NP_PRPP
diverse B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
biologic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_NP_JJ
eosinophils B-O B-NNS
" " B-O O-NP
are B-O B-VP_VP_VBP
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
most B-O B-ADJP_RBS
important B-O B-JJ
" " B-O O-ADJP
target B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
IL-5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
were B-O B-VP_VBD
used B-O B-VP_VBN
here B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
to B-O B-S_NP_VP_TO
study B-O B-VP_VB
IL-5 B-O B-NP_NP_NP_NN
" " B-O O-NP
signaling B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-5 B-O B-S_NP_NN
" " B-O O-NP
induced B-O B-VP_VBD
rapid B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
transient B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
JAK2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
IL-5 B-O B-NP_NN
" " B-O O-NP
induced B-O B-VP_VBD
at B-O B-NP_QP_IN
least B-O B-JJS
two B-O B-CD
" " B-O O-QP
DNA-binding B-O B-NP_JJ
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
using B-O B-S_NP_VP_VBG
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
normal B-O B-NP_NP_JJ
human B-O B-NP_JJ
eosinophils B-O B-NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
an B-O B-NP_DT
electromobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
From B-O B-S_PP_IN
supershift B-O B-NP_NN
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
it B-O B-NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
concluded B-O B-VP_VBN
that B-O B-SBAR_IN
one B-O B-S_NP_CD
DNA-binding B-O B-NP_JJ
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
contained B-O B-VP_VBD
Stat1 B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
, B-O B-COMMA
probably B-O B-ADVP_RB
" " B-O O-ADVP
as B-O B-PP_IN
a B-O B-NP_DT
homodimer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_DT
DNA-binding B-O B-NP_JJ
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_DT
phosphotyrosine B-O B-NP_NP_NN
antibody B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
4G10 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
tyrosine B-O B-S_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-3 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
granulocyte-macrophage B-O B-NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
induced B-O B-VP_VBD
, B-O B-COMMA
similar B-O B-ADJP_JJ
to B-O B-PP_TO
IL-5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
two B-O B-NP_NP_NP_CD
DNA-binding B-O B-NP_JJ
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
eosinophils B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
Stat1 B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
for B-O B-PP_IN
the B-O B-NP_DT
first B-O B-JJ
time B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
molecular B-O B-S_NP_NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
IL-5 B-O B-NP_NP_NP_NN
" " B-O O-NP
signaling B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
eosinophils B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involve B-O B-VP_VBP
members B-O B-NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
members B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Identification B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
TR2 B-O B-NN
orphan B-O B-NN
receptor B-O B-NN
response B-O B-NN
element B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
transcriptional B-O B-NP_JJ
initiation B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
[ B-O B-S_LRB
published B-O B-NP_VBN
erratum B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
in B-O B-PP_IN
J B-O B-NP_NP_NNP
Biol B-O B-NNP
Chem B-O B-NNP
1995 B-O B-CD
Nov B-O B-NNP
3 B-O B-CD
" " B-O O-NP
; B-O B-COLON
270 B-O B-NP_CD
( B-O B-LRB
44 B-O B-CD
) B-O B-RRB
" " B-O O-NP
: B-O B-COLON
26721 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
  
A B-O B-S_S_NP_NP_NP_DT
DNA B-O B-NP_NN
response B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
TR2RE-SV40 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
TR2 B-O B-NP_NN
orphan B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
steroid-thyroid B-O B-NP_JJ
hormone B-O B-NN
receptor B-O B-NN
superfamily B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
simian B-O B-NP_JJ
virus B-O B-NN
40 B-O B-CD
( B-O B-LRB
SV40 B-O B-NN
) B-O B-RRB
+55 B-O B-CD
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
, B-O B-NP_NP_COMMA
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Electrophoretic B-O B-S_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
, B-O B-COMMA
" " B-O O-NP
using B-O B-S_NP_VP_VBG
in B-O B-NP_NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
translated B-O B-VBN
TR2 B-O B-NP_NN
orphan B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
molecular B-O B-JJ
mass B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
67 B-O B-NP_CD
kilodaltons B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
showed B-O B-VP_VBD
a B-O B-NP_NP_DT
specific B-O B-JJ
binding B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
high B-O B-NP_NP_JJ
affinity B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
dissociation B-O B-NP_NP_NN
constant B-O B-NN
" " B-O O-NP
= B-O B-ADJP_JJ
9 B-O B-NP_CD
nM B-O B-NN
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
this B-O B-NP_DT
DNA B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNA-swap B-O B-S_NP_NP_NN
experiments B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
chloramphenicol B-O B-NP_NP_NN
acetyl-transferase B-O B-NN
" " B-O O-NP
assay B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
androgen B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
suppress B-O B-VP_VB
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
activities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
SV40 B-O B-NP_NN
early B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
via B-O B-PP_IN
the B-O B-NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
this B-O B-NP_DT
TR2RE-SV40 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
function B-O B-VP_VB
as B-O B-PP_IN
a B-O B-NP_NP_DT
repressor B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
suppress B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
the B-O B-COMP_NP_DT
TR2RE-SV40 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
represent B-O B-VP_VB
the B-O B-NP_NP_NP_DT
first B-O B-JJ
identified B-O B-VBN
natural B-O B-JJ
DNA B-O B-NP_NN
response B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
TR2 B-O B-NP_NN
orphan B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
may B-O B-S_NP_VP_MD
function B-O B-VP_VB
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Mapping B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
interaction B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
defective B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
class B-O B-NP_NN
II B-O B-CD
major B-O B-JJ
histocompatibility B-O B-NN
complex B-O B-NN
mutant B-O B-JJ
cell B-O B-NN
line B-O B-NN
clone-13 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
divergent B-O B-NP_JJ
X2-box B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
described B-O B-VP_VBN
a B-O B-NP_NP_NP_DT
mutant B-O B-NP_JJ
B B-O B-NN
lymphoblastoid B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
Clone-13 B-O B-NP_NN
, B-O B-COMMA
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
expresses B-O B-S_NP_VP_VBZ
HLA-DQ B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Several B-O B-S_NP_JJ
criteria B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
defect B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
influences B-O B-VP_VBZ
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
isotype-specific B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Indeed B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
transient B-O B-NP_NP_JJ
transfection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HLA-DRA B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
DQB B-O B-NP_NN
" " B-O B-NP_O-NP
reporter B-O B-NP_NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
affected B-O B-VBN
factor B-O B-NN
" " B-O O-NP
operates B-O B-VP_VBZ
via B-O B-PP_IN
cis-elements B-O B-NP_NP_NNS
" " B-O O-NP
located B-O B-ADJP_JJ
between B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hybrid B-O B-NP_NN
DRA/DQB B-O B-NN
reporter B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
generated B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_PP_TO
further B-O B-ADVP_JJ
" " B-O O-ADVP
map B-O B-VP_VB
the B-O B-NP_DT
relevant B-O B-JJ
cis-elements B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-PP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Insertion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
oligonucleotides B-O B-NP_NP_NNS
" " B-O O-NP
spanning B-O B-VP_VBG
the B-O B-NP_NP_NP_DT
DQB B-O B-NP_NN
X-box B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
or B-O B-NP_NP_CC
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
upstream B-O B-NP_JJ
of B-O B-IN
-141 B-O B-CD
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
DRA B-O B-NP_NN
reporter B-O B-NN
plasmid B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
rescued B-O B-VP_VBD
expression B-O B-NP_NN
" " B-O O-NP
to B-O B-PP_TO
nearly B-O B-NP_ADJP_RB
wild-type B-O B-JJ
" " B-O O-ADJP
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Substitution B-O B-S_NP_NN
promoters B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
then B-O B-ADVP_RB
" " B-O O-ADVP
generated B-O B-VP_VBN
" " B-O B-NP_O-VP
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_ADVP_NP_NP_NP_DT
entire B-O B-JJ
X-box B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
only B-O B-NP_RB
the B-O B-DT
X1- B-O B-NP_NN
" " B-O B-NP_O-NP
or B-O B-CC
X2-boxes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
HLA-DRA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
replaced B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
analogous B-O B-JJ
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
DQB B-O B-NP_NN
X2-box B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
restore B-O B-VP_VB
expression B-O B-NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
silent B-O B-NP_JJ
DRA B-O B-NN
reporter B-O B-NN
construct B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
replacement B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
DQB B-O B-NP_NN
X2-box B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
DRA B-O B-NP_NN
X2-box B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
diminished B-O B-VP_VBD
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
DQB B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
mutant B-O B-NP_JJ
cell B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
" " B-O B-S_NP_NP_NN_O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hybrid B-O B-NP_NN
reporter B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
defective B-O B-ADJP_JJ
" " B-O O-ADJP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
transfected B-O B-S_NP_VP_VBN
into B-O B-NP_PP_IN
the B-O B-NP_NP_DT
wild-type B-O B-NP_JJ
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
HLA-DR/-DQ B-O B-NP_NN
positive B-O B-JJ
parental B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
Jijoye B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
divergent B-O B-NP_JJ
X2-box B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
class B-O B-NP_NN
II B-O B-CD
major B-O B-JJ
histocompatibility B-O B-NN
complex B-O B-NN
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
plays B-O B-VP_VBZ
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
influencing B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
specificity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
MNDA B-O B-NP_NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
macrophages B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
leukemia/B B-O B-NP_NN
lymphoma B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_NP_JJ
myeloid B-O B-JJ
cell B-O B-NN
nuclear B-O B-JJ
differentiation B-O B-NN
antigen B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MNDA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
specifically B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
granulocyte-macrophage B-O B-JJ
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
our B-O B-NP_PRPP
earlier B-O B-JJR
reports B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
MNDA B-O B-NP_NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
granulocyte-macrophage B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
reexamined B-O B-VP_VBN
in B-O B-NP_PP_IN
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
established B-O B-VP_VBN
from B-O B-NP_PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cell B-O B-S_S_S_NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
expressed B-O B-S_NP_VP_VBD
MNDA B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
exhibited B-O B-VP_VBD
myeloid B-O B-NP_JJ
cell B-O B-NN
features B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
granulocyte B-O B-S_NP_NP_NN
" " B-O B-NP_O-NP
or B-O B-CC
monocyte B-O B-NP_NN
" " B-O B-NP_O-NP
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
induced B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
while B-O B-SBAR_IN
cell B-O B-S_NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
exhibiting B-O B-VP_VBG
properties B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
express B-O B-VP_VB
MNDA B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Cells B-O B-S_NP_NP_NNS
" " B-O O-NP
originating B-O B-VP_VBG
from B-O B-PP_IN
cases B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
Burkitt B-O B-NP_NN
's B-O B-POS
lymphoma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
negative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
three B-O B-S_S_NP_NP_CD
lymphoblastoid B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
immortalized B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
with B-O B-PP_IN
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
were B-O B-VP_VBD
weakly B-O B-ADJP_RB
positive B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
MNDA B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
up-regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
interferon-alpha B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_S_SBAR_IN
we B-O B-S_NP_PRP
" " B-O O-NP
reported B-O B-VP_VBD
previously B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
MNDA B-O B-S_NP_NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
level B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
adherent B-O B-NP_JJ
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
elevated B-O B-VP_VBN
by B-O B-NP_PP_IN
IFN-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
; B-O B-COLON
in B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
assessed B-O B-VP_VBD
MNDA B-O B-NP_NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
monocyte-derived B-O B-JJ
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Three B-O B-S_NP_NP_NP_CD
additional B-O B-JJ
agents B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
endotoxin B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
phytohemagglutinin B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
phorbol B-O B-NP_NN
ester B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
other B-O B-NP_NP_JJ
conditions B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
affect B-O B-S_NP_VP_VBP
function B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
, B-O B-NP_NP_NP_NP_COMMA
, B-O B-NP_COMMA
and/or B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
for B-O B-NP_PP_IN
their B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
alter B-O B-VP_VB
expression B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
varied B-O B-VP_VBD
with B-O B-PP_IN
the B-O B-NP_NP_DT
agent B-O B-NN
" " B-O O-NP
, B-O B-COMMA
cell B-O B-NP_NN
type B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
stage B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Changes B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
MNDA B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurred B-O B-VP_VBD
slowly B-O B-ADVP_ADVP_RB
" " B-O O-ADVP
( B-O B-PRN_LRB
hours B-O B-NP_NP_NNS
" " B-O O-NP
to B-O B-PP_TO
days B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADVP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
MNDA B-O B-S_NP_NN
" " B-O O-NP
could B-O B-VP_MD
mediate B-O B-VP_VB
" " B-O B-NP_NP_VP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
reveal B-O B-VP_VBP
a B-O B-NP_NP_DT
discordance B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
certain B-O B-NP_JJ
MNDA B-O B-NP_NN
positive B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
between B-O B-PP_IN
steady-state B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
or B-O B-CC
changes B-O B-NP_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
indicating B-O B-VP_VBG
that B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Changes B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
MNDA B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
a B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
opposing B-O B-S_NP_VP_VBG
and B-O B-NP_NP_CC
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-PRN_PRN_LRB
Regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
interleukin-2 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B-lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-PRN
  
Since B-O B-S_S_SBAR_IN
most B-O B-S_NP_NP_JJS
B B-O B-NP_NN
cell B-O B-NN
clones B-O B-NNS
" " B-O O-NP
" " B-O O-NP
immortalized B-O B-VP_VBN
with B-O B-NP_PP_IN
EBV B-O B-NP_NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
induced B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
to B-O B-S_NP_VP_TO
produce B-O B-VP_VB
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
different B-O B-NP_NP_JJ
elements B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
in B-O B-PP_IN
such B-O B-NP_JJ
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
transfection B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
, B-O B-COMMA
in B-O B-PP_IN
particular B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
element B-O B-NN
" " B-O O-NP
TCEd B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
very B-O B-ADJP_RB
active B-O B-JJ
in B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
element B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
no B-O B-NP_DT
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Jurkat B-O B-NP_NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
NFATd B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VP_VBZ
the B-O B-NP_NP_DT
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
NFAT-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
very B-O B-ADJP_RB
active B-O B-JJ
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
only B-O B-ADJP_RB
weakly B-O B-RB
active B-O B-JJ
in B-O B-PP_PP_IN
one B-O B-NP_CD
B B-O B-NP_NN
clone B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
not B-O B-ADVP_RB
at B-O B-IN
all B-O B-DT
" " B-O O-ADVP
in B-O B-PP_IN
another B-O B-NP_DT
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Different B-O B-S_NP_JJ
elements B-O B-NNS
" " B-O O-NP
thus B-O B-ADVP_RB
" " B-O O-ADVP
contribute B-O B-VP_VBP
to B-O B-PP_TO
IL-2 B-O B-NP_NP_NP_NN
promoter B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
different B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Changes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
triiodothyronine B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
T3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
mononuclear B-O B-JJ
leukocyte B-O B-NN
receptor B-O B-NN
kinetics B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
T3 B-O B-NP_NP_NN
administration B-O B-NN
" " B-O O-NP
and B-O B-CC
multiple B-O B-NP_JJ
cold-air B-O B-JJ
exposures B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Repeated B-O B-S_NP_VBN
cold-air B-O B-JJ
exposures B-O B-NNS
" " B-O O-NP
increase B-O B-VP_VBP
human B-O B-NP_JJ
triiodothyronine B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
T3 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
plasma B-O B-NN
clearance B-O B-NN
rates B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
study B-O B-VP_VB
the B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
nuclear B-O B-JJ
T3 B-O B-NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NT3R B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
this B-O B-NP_DT
condition B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
binding B-O B-NP_VBG
characteristics B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
analyzed B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_JJ
mononuclear B-O B-NP_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
MNL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
supplemented B-O B-VP_VBD
one B-O B-NP_NP_CD
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
individuals B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
daily B-O B-RB
oral B-O B-JJ
replacement B-O B-NN
dose B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
isolate B-O B-VP_VB
the B-O B-NP_NP_DT
influence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_NP_CC
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
receptor B-O B-NP_NN
kinetics B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
subjects B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
exposed B-O B-VP_VBN
to B-O B-NP_PP_TO
cold B-O B-NP_NP_JJ
air B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
4 B-O B-NP_CD
degrees B-O B-NNS
C B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
twice/d B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
30 B-O B-NP_CD
min/exposure B-O B-NN
" " B-O O-NP
, B-O B-COMMA
for B-O B-PP_IN
a B-O B-NP_NP_DT
total B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
80 B-O B-NP_CD
exposures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_S_NP_DT
T3- B-O B-JJ
subjects B-O B-NNS
" " B-O O-NP
received B-O B-VP_VBD
placebo B-O B-NP_NP_NN
" " B-O O-NP
[ B-O B-PRN_LRB
n B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
8 B-O B-NP_CD
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_DT
T3+ B-O B-ADJP_JJ
" " B-O O-ADJP
subjects B-O B-NNS
" " B-O O-NP
received B-O B-VP_VBD
T3 B-O B-NP_NP_CD
" " B-O O-NP
( B-O B-PRN_LRB
30 B-O B-NP_CD
micrograms/d B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
[ B-O B-PRN_LRB
n B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
8 B-O B-NP_CD
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
in B-O B-PP_IN
a B-O B-NP_DT
double-blind B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-S
  
Mononuclear B-O B-S_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
isolated B-O B-VP_VP_VBN
from B-O B-NP_PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
" " B-O O-NP
" " B-O O-PP
before B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
cold B-O B-JJ
exposure B-O B-NN
" " B-O O-NP
and B-O B-CC
drug B-O B-NP_NN
regimen B-O B-NNS
" " B-O O-NP
" " B-O O-NP
began B-O B-VP_VBD
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
then B-O B-RB
after B-O B-VP_PP_IN
every B-O B-NP_QP_DT
20 B-O B-CD
" " B-O O-QP
exposures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
dissociation B-O B-NP_NP_NP_NN
constant B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Kd B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
maximum B-O B-NP_NP_NN
binding B-O B-NN
capacity B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MBC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NT3R B-O B-NN
values B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
log B-O B-VP_NN
transformed B-O B-VBN
to B-O B-NP_S_NP_VP_TO
minimize B-O B-VP_VB
between-subject B-O B-NP_JJ
variability B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
T3+ B-O B-JJ
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
serum B-O B-NP_NP_NP_NN
total B-O B-VBP
thyroxine B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TT4 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
free B-O B-NP_NP_JJ
T4 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
FT4 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
TSH B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
approx B-O B-ADJP_ADJP_NP_QP_RB
50 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
lower B-O B-JJR
" " B-O O-ADJP
than B-O B-PP_IN
both B-O B-NP_CC
basal B-O B-NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
T3-values B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_S_NP_DT
log10Kd B-O B-NN
" " B-O O-NP
increased B-O B-VP_VBD
0.304 B-O B-NP_QP_CD
+/- B-O B-CC
0.139 B-O B-CD
" " B-O O-QP
" " B-O O-NP
( B-O B-PRN_LRB
p B-O B-S_NP_NN
" " B-O O-NP
< B-O B-NP_QP_JJR
0.04 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_DT
log10MBC B-O B-NN
" " B-O O-NP
increased B-O B-VP_VBD
0.49 B-O B-NP_QP_CD
+/- B-O B-CC
0.10 B-O B-CD
" " B-O O-QP
" " B-O O-NP
( B-O B-PRN_LRB
p B-O B-S_NP_NN
" " B-O O-NP
< B-O B-NP_QP_JJR
0.001 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-S
" " B-O O-S
in B-O B-PP_IN
the B-O B-NP_DT
T3+ B-O B-JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
compared B-O B-PP_VBN
to B-O B-PP_TO
baseline B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
change B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
MBC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
represents B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
311 B-O B-CD
% B-O B-NN
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
MBC B-O B-NN
" " B-O O-NP
" " B-O O-PP
over B-O B-PP_IN
baseline B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
fivefold B-O B-JJ
increase B-O B-NN
" " B-O O-NP
over B-O B-PP_IN
placebo-treated B-O B-NP_JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
T3- B-O B-JJ
group B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
no B-O B-NP_NP_DT
change B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
MBC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
over B-O B-PP_IN
the B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
describe B-O B-VP_VBP
for B-O B-PP_IN
the B-O B-NP_DT
first B-O B-JJ
time B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
rapid B-O B-JJ
modulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NT3R B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
the B-O B-NP_NP_DT
combined B-O B-JJ
influence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cold B-O B-NP_NP_JJ
exposure B-O B-NN
" " B-O O-NP
and B-O B-CC
reduced B-O B-NP_VBN
circulating B-O B-VBG
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Differences B-O B-NP_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
steroid-resistant B-O B-NP_JJ
asthma B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Although B-O B-S_S_SBAR_IN
glucocorticosteroids B-O B-S_NP_NNS
" " B-O O-NP
are B-O B-VP_VBP
a B-O B-NP_NP_DT
very B-O B-ADJP_RB
effective B-O B-JJ
" " B-O O-ADJP
treatment B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
asthma B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
other B-O B-NP_JJ
diseases B-O B-ADJP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
a B-O B-S_NP_NP_DT
small B-O B-JJ
proportion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
resistant B-O B-ADJP_JJ
to B-O B-PP_TO
their B-O B-NP_PRPP
therapeutic B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
molecular B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
this B-O B-NP_DT
steroid B-O B-NN
resistance B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
unclear B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Steroid B-O B-S_NP_NN
resistance B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
explained B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
pharmacokinetic B-O B-NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
by B-O B-PP_IN
a B-O B-NP_NP_DT
defect B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
nor B-O B-CC
by B-O B-PP_IN
defective B-O B-NP_NP_JJ
nuclear B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
thereby B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
suggesting B-O B-VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_DT
molecular B-O B-JJ
abnormality B-O B-NN
" " B-O O-NP
lies B-O B-VP_VBZ
distal B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
translocated B-O B-VBN
glucocorticoid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
to B-O B-PP_TO
their B-O B-NP_PRPP
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
using B-O B-S_NP_VP_VBG
electrophoretic B-O B-NP_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
PBMC B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
DNA B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
using B-O B-S_NP_VP_VBG
Scatchard B-O B-NP_NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Dexamethasone B-O B-S_S_NP_NN
" " B-O O-NP
induced B-O B-VP_VBD
a B-O B-NP_NP_DT
significant B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
rapid B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
sustained B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
twofold B-O B-JJ
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
GRE B-O B-NP_NP_NP_NN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
PBMCs B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
this B-O B-S_NP_DT
" " B-O O-NP
was B-O B-VP_VBD
markedly B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBN
in B-O B-NP_PP_IN
steroid-resistant B-O B-NP_JJ
asthmatic B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Scatchard B-O B-S_NP_NP_NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptor-GRE B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VP_VBD
no B-O B-NP_DT
change B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
binding B-O B-NP_NN
affinity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
did B-O B-VP_VBD
show B-O B-VP_VB
a B-O B-NP_NP_DT
reduced B-O B-VBN
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
receptors B-O B-NP_NP_NNS
" " B-O O-NP
available B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
is B-O B-VP_VBZ
impaired B-O B-ADJP_JJ
in B-O B-PP_IN
steroid-resistant B-O B-NP_JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
because B-O B-PP_IN
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Increased B-O B-S_NP_VBN
natural B-O B-JJ
killer B-O B-NN
cell B-O B-NN
activity B-O B-NN
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
low B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
negative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HER-2/neu B-O B-NN
oncogene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
breast B-O B-NP_NN
cancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
BACKGROUND B-O B-NP_NN
. B-O B-PERIOD
" " B-O O-NP
  
Increased B-O B-S_NP_NP_VBN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HER-2/neu B-O B-NN
oncogene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
breast B-O B-NP_NN
cancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VP_VBZ
with B-O B-PP_IN
decreased B-O B-NP_VBN
estrogen B-O B-NN
receptor B-O B-NN
concentration B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
seems B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
an B-O B-NP_DT
important B-O B-JJ
prognostic B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
authors B-O B-NNS
" " B-O O-NP
investigated B-O B-VP_VBD
whether B-O B-SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
and B-O B-NP_NP_NP_CC
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
METHOD B-O B-NP_NN
. B-O B-PERIOD
" " B-O O-NP
  
A B-O B-S_S_NP_DT
Western B-O B-JJ
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
investigate B-O B-VP_VB
HER-2/neu B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
a B-O B-S_NP_NP_DT
chromium-release B-O B-NN
assay B-O B-NN
" " B-O O-NP
using B-O B-VP_VBG
the B-O B-NP_DT
K562 B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
target B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
measure B-O B-VP_VB
cell B-O B-NP_NP_NP_PRN_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
RESULTS B-O B-NP_NNS
. B-O B-PERIOD
" " B-O O-NP
  
In B-O B-S_PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
breast B-O B-NP_NN
cancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NK B-O B-NP_NN
cell B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADJP_RB
higher B-O B-JJR
" " B-O O-ADJP
compared B-O B-PP_VBN
with B-O B-PP_IN
patients B-O B-NP_NP_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
benign B-O B-NP_JJ
tumors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
" " B-O B-NP_O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
or B-O B-CC
healthy B-O B-NP_NP_JJ
control B-O B-NN
subjects B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
" " B-O B-NP_O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
23.3 B-O B-NP_NP_CD
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
breast B-O B-NP_NN
cancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
an B-O B-NP_NP_DT
overexpression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HER-2/neu B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Within B-O B-S_PP_IN
this B-O B-NP_NP_DT
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NK B-O B-NP_NN
cell B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADJP_ADJP_RB
lower B-O B-JJR
" " B-O O-ADJP
( B-O B-PRN_LRB
45.6 B-O B-NP_QP_CD
+/- B-O B-CC
16.1 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
compared B-O B-PP_VBN
with B-O B-PP_IN
the B-O B-NP_NP_NP_DT
group B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
no B-O B-NP_DT
HER-2/neu B-O B-NN
overexpression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
57.3 B-O B-NP_QP_CD
+/- B-O B-CC
11.0 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NK B-O B-S_NP_NN
cell B-O B-NN
activity B-O B-NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
increase B-O B-VP_VB
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
HER-2/neu B-O B-NP_NN
overexpression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_NP_DT
statistically B-O B-ADJP_RB
significant B-O B-JJ
" " B-O O-ADJP
correlation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytolytic B-O B-NP_JJ
effector B-O B-NN
cell B-O B-NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
HER-2/neu B-O B-NP_NP_NP_NP_NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
tumor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
" " B-O B-NP_O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
HER-2/neu B-O B-NP_NP_NP_NN
overexpression B-O B-NN
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
" " B-O B-NP_O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CONCLUSION B-O B-NP_NN
. B-O B-PERIOD
" " B-O O-NP
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
add B-O B-VP_VBP
further B-O B-NP_JJ
evidence B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
previous B-O B-NP_NP_JJ
observations B-O B-NNS
" " B-O B-SBAR_O-NP
from B-O B-PP_IN
the B-O B-NP_NP_DT
authors B-O B-NNS
' B-O B-POS
" " B-O O-NP
laboratory B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
certain B-O B-S_NP_JJ
tumor B-O B-NN
characteristics B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
associated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Effects B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
CD45 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Implications B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
replication B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Increased B-O B-S_NP_NP_VBN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
replication B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
observed B-O B-VP_VBN
after B-O B-NP_PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
infected B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
the B-O B-NP_DT
TCR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
anti-CD45 B-O B-NP_JJ
antibodies B-O B-NNS
" " B-O O-NP
inhibit B-O B-VP_VBP
these B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
infected B-O B-NP_JJ
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
interrelationships B-O B-NP_NP_NNS
" " B-O O-NP
between B-O B-PP_IN
CD45 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
measured B-O B-VP_VBD
effects B-O B-NP_NP_NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
T B-O B-NP_NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
lacked B-O B-S_NP_VP_VBD
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
First B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
anti-CD45 B-O B-NP_JJ
antibodies B-O B-NNS
" " B-O O-NP
did B-O B-VP_VP_VP_VBD
not B-O B-RB
affect B-O B-VP_VB
basal B-O B-NP_JJ
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
but B-O B-CC
decreased B-O B-VP_VBD
activated B-O B-NP_JJ
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
levels B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Second B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
lack B-O B-S_NP_VP_VP_VBP
CD45 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
can B-O B-VP_MD
not B-O B-RB
signal B-O B-VP_VB
via B-O B-PP_IN
the B-O B-NP_DT
TCR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
supported B-O B-VP_VBD
higher B-O B-NP_NP_JJR
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
viral B-O B-NP_NP_JJ
replication B-O B-NN
" " B-O O-NP
and B-O B-CC
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
was B-O B-VP_VBD
due B-O B-PP_JJ
to B-O B-TO
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
active B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
nucleus B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD45- B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Additionally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
infected B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
displayed B-O B-VP_VBD
lower B-O B-NP_NP_JJR
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
CD45 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
on B-O B-PP_IN
their B-O B-NP_PRPP
surfaces B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
CD45 B-O B-NP_NN
" " B-O O-NP
plays B-O B-VP_VBZ
an B-O B-NP_DT
active B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
the B-O B-NP_NP_DT
physiology B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
the B-O B-NP_NP_DT
replication B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
ERP B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
new B-O B-JJ
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
ets B-O B-NN
transcription B-O B-NN
factor/oncoprotein B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
: B-O B-COLON
" " B-O O-NP
cloning B-O B-NP_NP_NP_VBG
" " B-O O-NP
, B-O B-COMMA
characterization B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
differential B-O B-NP_JJ
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
during B-O B-PP_IN
B-lymphocyte B-O B-NP_NN
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
ets B-O B-NN
gene B-O B-NN
family B-O B-NN
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_NP_DT
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
proteins B-O B-NP_NP_NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
and B-O B-S_NP_VP_VP_CC
, B-O B-COMMA
, B-O B-SBAR_COMMA
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
recently B-O B-ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VBN
two B-O B-NP_NP_NP_NP_CD
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
murine B-O B-NN
immunoglobulin B-O B-NN
heavy-chain B-O B-JJ
( B-O B-LRB
IgH B-O B-NN
) B-O B-RRB
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
pi B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
microB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
exhibit B-O B-S_NP_VP_VBP
striking B-O B-NP_NP_JJ
similarity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
identify B-O B-VP_VB
ets-related B-O B-NP_NP_JJ
transcriptional B-O B-JJ
regulators B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
pre-B B-O B-NP_NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
used B-O B-VP_VBN
a B-O B-NP_NP_DT
PCR B-O B-NN
approach B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
degenerate B-O B-NP_NP_JJ
oligonucleotides B-O B-NNS
" " B-O O-NP
encoding B-O B-VP_VBG
conserved B-O B-NP_VBN
sequences B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
cloned B-O B-VP_VBN
the B-O B-NP_NP_DT
gene B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
a B-O B-NP_DT
new B-O B-JJ
ets-related B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
ERP B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
ets-related B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
from B-O B-PP_PP_IN
the B-O B-NP_DT
murine B-O B-NP_NN
pre-B B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
BASC B-O B-NP_NN
6C2 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
from B-O B-PP_IN
mouse B-O B-NP_NN
lung B-O B-NN
tissue B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
ERP B-O B-NN
protein B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
high B-O B-NP_NP_JJ
homology B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
ETS B-O B-NN
DNA-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
common B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Three B-O B-S_NP_CD
additional B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
smaller B-O B-ADJP_JJR
" " B-O O-ADJP
" " B-O O-ADJP
regions B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
homology B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
ELK-1 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
SAP-1 B-O B-NP_NN
" " B-O B-NP_O-NP
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
subgroup B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
ets B-O B-NN
gene B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Full-length B-O B-S_NP_JJ
ERP B-O B-NN
" " B-O O-NP
expresses B-O B-VP_VBZ
only B-O B-NP_RB
negligible B-O B-JJ
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
itself B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Removal B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
carboxy B-O B-NN
terminus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
enables B-O B-VP_VBZ
ERP B-O B-S_NP_NN
" " B-O O-NP
to B-O B-VP_TO
interact B-O B-VP_VB
with B-O B-PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
a B-O B-NP_DT
carboxy-terminal B-O B-JJ
negative B-O B-JJ
regulatory B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
At B-O B-S_NP_QP_IN
least B-O B-JJS
three B-O B-CD
" " B-O O-QP
ERP-related B-O B-JJ
transcripts B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tissues B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
within B-O B-PP_IN
the B-O B-NP_DT
B-cell B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
ERP B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
highly B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
primarily B-O B-NP_ADVP_RB
" " B-O O-ADVP
at B-O B-PP_IN
early B-O B-NP_NP_JJ
stages B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
B-lymphocyte B-O B-NP_NN
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
expression B-O B-S_NP_NN
" " B-O O-NP
declines B-O B-VP_VBZ
drastically B-O B-ADVP_RB
" " B-O O-ADVP
upon B-O B-PP_IN
B-cell B-O B-NP_NN
maturation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
correlating B-O B-S_NP_VP_VBG
with B-O B-PP_IN
the B-O B-NP_NP_DT
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IgH B-O B-NN
pi B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
ERP B-O B-S_NP_NN
" " B-O O-NP
might B-O B-VP_MD
play B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
B-cell B-O B-NP_NN
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
IgH B-O B-NP_NN
gene B-O B-NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-S_S_NP_JJ
interleukin-13 B-O B-NN
" " B-O O-NP
activates B-O B-VP_VBZ
the B-O B-NP_NP_DT
interleukin-4-dependent B-O B-NP_NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
NF-IL4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
sharing B-O B-VP_VBG
a B-O B-NP_DT
DNA B-O B-NN
binding B-O B-NN
motif B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
an B-O B-NP_DT
interferon-gamma-induced B-O B-JJ
nuclear B-O B-JJ
binding B-O B-VBG
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
interleukin-13 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-13 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
interleukin-4 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-4 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
cellular B-O B-NP_JJ
functions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
quite B-O B-ADJP_RB
similar B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
provide B-O B-VP_VBP
evidence B-O B-NP_NN
that B-O B-SBAR_IN
in B-O B-S_PP_PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
both B-O B-NP_CC
IL-4 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
IL-13 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
activate B-O B-VP_VBP
the B-O B-NP_NP_DT
same B-O B-ADJP_JJ
recently B-O B-RB
identified B-O B-VBN
" " B-O O-ADJP
" " B-O B-NP_NP_NP_O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
nuclear B-O B-JJ
factor B-O B-NN
" " B-O O-NP
activated B-O B-VP_VBN
by B-O B-PP_IN
interferon-gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
interacts B-O B-VP_VBZ
with B-O B-PP_IN
the B-O B-NP_DT
IL-4RE B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
differs B-O B-VP_VBZ
from B-O B-PP_IN
NF-IL4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
the B-O B-NP_NP_DT
electrophoretic B-O B-JJ
mobility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
complex B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
its B-O B-NP_PRPP
DNA-binding B-O B-JJ
specificity B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
the B-O B-NP_NP_DT
proteins B-O B-NNS
" " B-O O-NP
interacting B-O B-VP_VBG
with B-O B-PP_IN
the B-O B-NP_DT
DNA B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Sensitivity B-O B-S_NP_NP_NN
" " B-O O-NP
against B-O B-PP_IN
various B-O B-NP_JJ
enzyme B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
components B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
signal B-O B-NN
transduction B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
shared B-O B-VP_VBN
by B-O B-NP_PP_IN
all B-O B-NP_DT
three B-O B-CD
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Pentoxifylline B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
infection B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Cytokine B-O B-S_NP_NP_NN
dysregulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VP_VBZ
been B-O B-VP_VBN
documented B-O B-VP_VBN
in B-O B-NP_PP_IN
numerous B-O B-NP_JJ
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
has B-O B-VP_VBZ
been B-O B-VP_VBN
cited B-O B-VP_VBN
as B-O B-NP_PP_IN
an B-O B-NP_NP_DT
important B-O B-JJ
component B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Pharmacological B-O B-S_NP_NP_JJ
modification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NN
dysregulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
therefore B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
has B-O B-VP_VBZ
been B-O B-VP_VBN
suggested B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_NP_DT
therapeutic B-O B-JJ
modality B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
HIV-1 B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Dr. B-O B-S_NP_NP_NNP
Dezube B-O B-NNP
" " B-O O-NP
of B-O B-PP_IN
Beth B-O B-NP_NP_NNP
Israel B-O B-NNP
Hospital B-O B-NNP
" " B-O O-NP
( B-O B-PRN_LRB
Boston B-O B-NP_NNP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
concisely B-O B-ADVP_RB
" " B-O O-ADVP
reviews B-O B-VP_VBZ
the B-O B-NP_NP_DT
state B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
our B-O B-NP_NP_PRPP
knowledge B-O B-NN
" " B-O O-NP
regarding B-O B-PP_VBG
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
pentoxifylline B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Pentoxifylline B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
trisubstituted B-O B-JJ
xanthine B-O B-NN
derivative B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VP_VBZ
been B-O B-VP_VBN
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
decrease B-O B-VP_VB
blood B-O B-NP_NN
viscosity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
reasonably B-O B-VP_ADVP_RB
well B-O B-RB
" " B-O O-ADVP
tolerated B-O B-VBN
by B-O B-NP_PP_IN
most B-O B-NP_NP_JJS
recipients B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
drug B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Results B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
preliminary B-O B-NP_NP_JJ
studies B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
many B-O B-SBAR_WHNP_NP_JJ
" " B-O O-NP
of B-O B-WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
conducted B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
use B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
agent B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
combination B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
antiretroviral B-O B-NP_JJ
compounds B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
prove B-O B-VP_VB
useful B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
NF-kappa B-O B-NP_NP_NP_NN
B-dependent B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
-independent B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
pathways B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NP_NN
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
chronically B-O B-ADVP_RB
" " B-O O-ADVP
infected B-O B-JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
J B-O B-S_S_NP_NN
delta B-O B-NN
K B-O B-NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
isolated B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_DT
chronically B-O B-RB
infected B-O B-JJ
survivor B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
following B-O B-PP_VBG
infection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Jurkat B-O B-NP_NN
CD4+ B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
dl-NF B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
J B-O B-S_NP_NN
delta B-O B-NN
K B-O B-NN
cells B-O B-NNS
" " B-O O-NP
exhibited B-O B-VP_VBD
very B-O B-NP_NP_ADJP_RB
low B-O B-JJ
" " B-O O-ADJP
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
constitutive B-O B-NP_JJ
HIV B-O B-NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HIV-1 B-O B-S_NP_NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
activated B-O B-VP_VBN
from B-O B-NP_PP_IN
J B-O B-NP_NN
delta B-O B-NN
K B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
phorbol B-O B-NP_NP_NP_NN
myristate B-O B-NN
acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
sodium B-O B-NP_NP_NN
butyrate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
hexamethylene B-O B-NP_NP_NN
bisacetamide B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
confirming B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
mediating B-O B-S_NP_VP_VBG
TNF-alpha B-O B-NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
strong B-O B-JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
NaB B-O B-NP_NP_NP_NN
" " B-O O-NP
or B-O B-CC
HMBA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
J B-O B-NP_NN
delta B-O B-NN
K B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
clearly B-O B-ADVP_RB
" " B-O O-ADVP
demonstrates B-O B-VP_VBZ
the B-O B-NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B-independent B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NP_NN
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
chronically B-O B-NP_RB
infected B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
J B-O B-S_NP_NN
delta B-O B-NN
K B-O B-NN
cells B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
provide B-O B-VP_VB
a B-O B-NP_NP_DT
useful B-O B-JJ
model B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
characterizing B-O B-S_NP_VP_VBG
NF-kappa B-O B-NP_NP_NN
B-independent B-O B-JJ
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_S_NP_NP_DT
novel B-O B-JJ
human B-O B-JJ
homeobox B-O B-NN
gene B-O B-NN
" " B-O O-NP
distantly B-O B-ADJP_RB
related B-O B-JJ
to B-O B-PP_TO
proboscipedia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
lymphoid B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
pancreatic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
tissues B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_S_NP_NP_DT
novel B-O B-JJ
human B-O B-JJ
homeobox B-O B-NN
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
HB9 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
a B-O B-NP_NP_DT
cDNA B-O B-NN
library B-O B-NN
" " B-O O-NP
prepared B-O B-VP_VBN
from B-O B-NP_PP_PP_IN
and B-O B-NP_CC
from B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
HB9 B-O B-NN
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
3 B-O B-NP_NP_CD
exons B-O B-NNS
" " B-O O-NP
spread B-O B-VP_VBN
over B-O B-NP_PP_IN
6 B-O B-NP_NP_CD
kilobases B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_DT
open B-O B-JJ
reading B-O B-NN
frame B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1206 B-O B-NP_CD
nucleotides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
in B-O B-PP_IN
frame B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_DT
diverged B-O B-JJ
homeodomain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
predicted B-O B-VBN
HB9 B-O B-NN
protein B-O B-NN
" " B-O O-NP
has B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
molecular B-O B-JJ
mass B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
41 B-O B-NP_CD
kilodaltons B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
enriched B-O B-ADJP_JJ
for B-O B-PP_IN
alanine B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
glycine B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
leucine B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
HB9 B-O B-NN
homeodomain B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
most B-O B-ADJP_RBS
similar B-O B-JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Drosophila B-O B-NP_NP_FW
melanogaster B-O B-FW
homeobox B-O B-NN
gene B-O B-NN
" " B-O O-NP
proboscipedia B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
poly(A) B-O B-NP_NP_NN
RNA B-O B-NN
" " B-O O-NP
purified B-O B-VP_VBN
from B-O B-NP_PP_PP_IN
the B-O B-NP_DT
human B-O B-JJ
B B-O B-NN
cell B-O B-NN
line B-O B-NN
RPMI B-O B-NN
8226 B-O B-CD
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
from B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
a B-O B-NP_NP_DT
major B-O B-JJ
mRNA B-O B-NN
transcript B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
2.2 B-O B-NP_CD
kilobases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
poly(A) B-O B-NP_NP_NN
RNA B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
adult B-O B-NP_JJ
tissues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
HB9 B-O B-NP_NP_NN
transcripts B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
pancreas B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
small B-O B-NP_JJ
intestine B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
colon B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Reverse B-O B-S_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
transcriptase-polymerase B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
chain B-O B-NN
reaction B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
examine B-O B-VP_VB
HB9 B-O B-NP_NP_NN
RNA B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
hematopoietic B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HB9 B-O B-S_NP_NN
RNA B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
most B-O B-ADJP_RBS
prevalent B-O B-JJ
in B-O B-PP_IN
several B-O B-NP_NP_JJ
human B-O B-JJ
B B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
and B-O B-CC
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
transcripts B-O B-S_S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
RNA B-O B-NP_NP_NN
" " B-O O-NP
prepared B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
in B-O B-S_NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
studies B-O B-NNS
" " B-O O-NP
localized B-O B-VP_VBD
them B-O B-NP_PRP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
germinal B-O B-JJ
center B-O B-NN
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
adult B-O B-NP_JJ
tonsil B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
the B-O B-NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HB9 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
regulating B-O B-S_NP_VP_VBG
gene B-O B-NP_NP_NN
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Epstein-Barr B-O B-NP_NP_NP_NP_NP_JJ
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EBV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
replicative B-O B-JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
tumour B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
AIDS-related B-O B-NP_JJ
non-Hodgkin B-O B-JJ
's B-O B-POS
lymphoma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
relation B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
CD4 B-O B-NP_NP_NN
cell B-O B-NN
number B-O B-NN
" " B-O O-NP
and B-O B-CC
antibody B-O B-NP_NP_NN
titres B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
EBV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
OBJECTIVE B-O B-NP_NP_NN
: B-O B-COLON
" " B-O O-NP
To B-O B-S_S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
is B-O B-VP_VP_VBZ
and B-O B-VP_CC
influences B-O B-VP_VBZ
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
[ B-O B-PRN_LRB
anti-Z B-O B-NP_NP_NP_JJ
Epstein-Barr B-O B-JJ
replicative B-O B-JJ
activator B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ZEBRA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
anti-early B-O B-NP_NP_JJ
antigen B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
anti-viral B-O B-NP_NP_JJ
capsid B-O B-NN
antigen B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
VCA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
DESIGN B-O B-NP_NP_NN
: B-O B-COLON
" " B-O O-NP
Retrospective B-O B-NP_NP_NP_NP_JJ
study B-O B-NN
" " B-O O-NP
based B-O B-PP_VBN
on B-O B-PP_IN
immunohistochemistry B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
in B-O B-NP_NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
detect B-O B-VP_VB
EBV B-O B-NP_NN
replicative B-O B-JJ
gene B-O B-NN
products B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
correlation B-O B-NP_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
CD4+ B-O B-NP_JJ
cell B-O B-NN
counts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
results B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
EBV B-O B-NP_NP_NN
serology B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
including B-O B-PP_VBG
anti-ZEBRA B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
sera B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
same B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
METHODS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
Seventeen B-O B-S_NP_NP_QP_CD
out B-O B-IN
of B-O B-IN
22 B-O B-CD
" " B-O O-QP
cases B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
ARNHL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
selected B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_DT
presence B-O B-NN
of B-O B-PP_IN
EBV B-O B-NP_NP_NN
" " B-O O-NP
[ B-O B-PRN_LRB
] B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
Immunohistochemistry B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
performed B-O B-VP_VBN
with B-O B-NP_PP_IN
anti-ZEBRA B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
anti-EA-restricted B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
anti-VCA B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
antibodies B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
in B-O B-NP_NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
BHLF1/NotI B-O B-NP_NP_NN
oligoprobes B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Results B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
statistically B-O B-ADVP_RB
" " B-O O-ADVP
correlated B-O B-VP_VBN
with B-O B-NP_PP_PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
CD4+ B-O B-NP_NP_JJ
cell B-O B-NN
counts B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
with B-O B-PP_IN
anti-EBV B-O B-NP_NP_NP_JJ
antibody B-O B-NN
titres B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_QP_RRB
" " B-O O-PRN
" " B-O O-NP
assessed B-O B-VP_VBN
using B-O B-NP_S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
RESULTS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
BZLF1 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
ZEBRA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
or B-O B-CC
early B-O B-NP_NP_JJ
gene B-O B-NN
products B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
EA-R B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
EA-D/BHLF1/NotI B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_NP_DT
small B-O B-JJ
proportion B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_ADJP_RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
tumour B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
eight B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
immunohistochemistry B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
in B-O B-NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
Demonstration B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
replicative B-O B-NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
correlate B-O B-VP_VB
with B-O B-PP_IN
either B-O B-NP_CC
low B-O B-NP_NP_JJ
CD4+ B-O B-JJ
cell B-O B-NN
counts B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NP_NN
" " B-O O-NP
> B-O B-ADJP_JJR
" " B-O B-NP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
or B-O B-CC
anti-EBV B-O B-NP_NP_JJ
antibody B-O B-NN
titres B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
P B-O B-NP_NP_NN
" " B-O O-NP
> B-O B-ADJP_JJR
" " B-O B-NP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Anti-ZEBRA B-O B-S_NP_JJ
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
significantly B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBN
in B-O B-NP_PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
affected B-O B-VP_VBN
with B-O B-NP_PP_IN
ARNHL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
the B-O B-SBAR_WHNP_NP_DT
cells B-O B-NNS
" " B-O O-NP
of B-O B-WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
" " B-O O-WHNP
expressed B-O B-S_NP_VP_VBD
" " B-O B-NP_NP_PRN_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CONCLUSION B-O B-NP_NP_NN
: B-O B-COLON
" " B-O O-NP
The B-O B-S_NP_NP_DT
degree B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immunodeficiency B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
clearly B-O B-ADVP_RB
" " B-O O-ADVP
enhance B-O B-VP_VB
replicative B-O B-NP_NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
tumour B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
ARNHL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
EBV B-O B-S_NP_NP_NN
serology B-O B-NN
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
anti-ZEBRA B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
a B-O B-NP_NP_DT
reliable B-O B-JJ
tool B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
predicting B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
occurrence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
such B-O B-NP_JJ
proliferations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Solution B-O B-NP_NP_NP_NP_NN
structure B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
POU-specific B-O B-JJ
homeodomain B-O B-NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
3D-NMR B-O B-NP_NP_NN
studies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
B-cell B-O B-NP_NP_NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
POU B-O B-NN
DNA-binding B-O B-JJ
motif B-O B-NN
" " B-O O-NP
defines B-O B-VP_VBZ
a B-O B-NP_NP_DT
conserved B-O B-VBN
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
eukaryotic B-O B-NP_NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_DT
bipartite B-O B-JJ
motif B-O B-NN
" " B-O O-NP
consists B-O B-VP_VBZ
of B-O B-PP_IN
an B-O B-NP_NP_DT
N-terminal B-O B-NP_NP_JJ
POU-specific B-O B-JJ
domain B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
POUs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
flexible B-O B-JJ
linker B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
a B-O B-NP_DT
C-terminal B-O B-NP_NP_JJ
POU-specific B-O B-JJ
homeodomain B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
POUHD B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
describe B-O B-VP_VBP
the B-O B-NP_NP_DT
solution B-O B-NN
structure B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
POU-specific B-O B-JJ
homeodomain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_DT
NMR B-O B-NN
model B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
obtained B-O B-VP_VBN
from B-O B-NP_PP_IN
Oct-2 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
human B-O B-JJ
B-cell B-O B-NN
specific B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
participates B-O B-S_NP_VP_VBZ
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
fragment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Oct-2 B-O B-NP_NP_NN
" " B-O O-NP
containing B-O B-VP_NN
POUHD B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
an B-O B-NP_DT
adjoining B-O B-JJ
linker B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
expressed B-O B-VP_VP_VBN
in B-O B-NP_PP_IN
Escherichia B-O B-NP_FW
coli B-O B-FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
three-dimensional B-O B-NP_NP_NP_JJ
nuclear B-O B-JJ
magnetic B-O B-JJ
resonance B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
3D-NMR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
spectroscopy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Complete B-O B-S_NP_NP_ADJP_JJ
" " B-O O-ADJP
1H B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
15N B-O B-NP_NN
" " B-O B-NP_O-NP
resonance B-O B-NP_NN
assignment B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
POUHD B-O B-NN
moiety B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
presented B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
POUHD B-O B-NN
solution B-O B-NN
structure B-O B-NN
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_IN
calculated B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
distance B-O B-NP_NP_NP_NN
geometry B-O B-NN
" " B-O O-NP
and B-O B-CC
simulated B-O B-NP_JJ
annealing B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
DG/SA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
similar B-O B-ADJP_JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
canonical B-O B-NP_JJ
homeodomains B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
salient B-O B-JJ
difference B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
solution B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
crystal B-O B-NP_JJ
structures B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
C-terminal B-O B-JJ
segment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
alpha-helix B-O B-NP_NP_NP_JJ
3 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
this B-O B-S_NP_DT
segment B-O B-NN
" " B-O O-NP
presumably B-O B-ADVP_RB
" " B-O O-ADVP
folds B-O B-VP_VBZ
upon B-O B-PP_IN
specific B-O B-NP_JJ
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
its B-O B-S_NP_NP_PRPP
flexibility B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
solution B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
reduce B-O B-VP_VB
the B-O B-NP_NP_DT
intrinsic B-O B-JJ
DNA B-O B-NN
affinity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
POUHD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
POUs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Appraisal B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
potential B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
therapeutic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
index B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
antioxidants B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
basis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
their B-O B-NP_NP_PRPP
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
and B-O B-NP_NP_NP_PP_CC
interleukin B-O B-NP_NN
2-induced B-O B-JJ
lymphocyte B-O B-NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Antioxidant B-O B-S_S_NP_JJ
molecules B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
suggested B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
evaluate B-O B-VP_VB
this B-O B-NP_DT
possibility B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_NP_CD
types B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
antioxidant B-O B-NP_JJ
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_PP_IN
terms B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
also B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
terms B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
modulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
tested B-O B-VP_VBD
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
BHA B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
phenolic B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
lipid-soluble B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
chain-breaking B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
antioxidant B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
NAC B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
known B-O B-JJ
glutathione B-O B-NN
precursor B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
some B-O B-NP_DT
scavenging B-O B-ADJP_NN
properties B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-ADVP_RB
well B-O B-RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
on B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
and B-O B-ADVP_NP_CC
in B-O B-PP_IN
" " B-O B-ADVP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_DT
antioxidants B-O B-NNS
" " B-O O-NP
inhibited B-O B-VP_VBD
TNF- B-O B-NP_NP_NP_NP_NN
" " B-O B-ADJP_NP_O-NP
or B-O B-CC
PMA-induced B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
NF-kappa B-O B-NP_NN
B B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
U1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
the B-O B-NP_NP_DT
sustained B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
activity B-O B-NN
" " B-O O-NP
permanently B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
virus B-O B-NN
itself B-O B-PRP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
chronically B-O B-ADVP_RB
" " B-O O-ADVP
HIV-infected B-O B-NP_JJ
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
only B-O B-NP_ADVP_RB
" " B-O O-ADVP
a B-O B-NP_NP_DT
partial B-O B-JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TNF- B-O B-NP_NP_NN
" " B-O B-ADJP_NP_O-NP
or B-O B-CC
"PMA- induced" B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
HIV B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
U1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
no B-O B-NP_NP_DT
detectable B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
HIV B-O B-NP_NP_NN
replication B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
chronically B-O B-NP_RB
infected B-O B-JJ
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
the B-O B-NP_NP_DT
first B-O B-JJ
limitation B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
potential B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
antiviral B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
antioxidant B-O B-NP_JJ
therapies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Another B-O B-S_NP_DT
limitation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
that B-O B-SBAR_IN
antioxidant B-O B-S_NP_NP_JJ
concentrations B-O B-NNS
" " B-O O-NP
high B-O B-ADJP_JJ
enough B-O B-RB
to B-O B-S_NP_VP_TO
block B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-NP
were B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
" " B-O B-NP_PP_ADVP_O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
because B-O B-SBAR_IN
NAC B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
BHA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
blocked B-O B-VP_VBD
IL-2-induced B-O B-NP_JJ
PBMC B-O B-NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
warrant B-O B-VP_VBP
prudence B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
design B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
antioxidant-based B-O B-NP_NP_JJ
therapies B-O B-NNS
" " B-O O-NP
aimed B-O B-VP_VBN
at B-O B-NP_PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Signals B-O B-S_S_NP_NP_NNS
" " B-O O-NP
transduced B-O B-VP_VBN
through B-O B-NP_PP_IN
the B-O B-NP_DT
CD4 B-O B-NN
molecule B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
activate B-O B-VP_VBP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
native B-O B-S_NP_NP_NP_JJ
envelope B-O B-NN
glycoproteins B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
gp160 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
induce B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
stimulatory B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
gp160 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
the B-O B-NP_DT
CD4 B-O B-NN
molecule B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
since B-O B-SBAR_IN
pretreatment B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
soluble B-O B-NP_JJ
CD4 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
abrogates B-O B-VP_VBZ
its B-O B-NP_PRPP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
gp160-induced B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
complex B-O B-NN
" " B-O O-NP
consists B-O B-VP_VBZ
of B-O B-PP_IN
p65 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p50 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
c-rel B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
stimulatory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gp160 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
protein B-O B-ADJP_NN
synthesis B-O B-NN
independent B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
is B-O B-VP_VBZ
dependent B-O B-VP_ADJP_JJ
upon B-O B-PP_IN
protein B-O B-NP_NN
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
and B-O B-CC
abrogated B-O B-VP_VBN
by B-O B-NP_PP_IN
inhibitors B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
gp160-mediated B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
CD4 B-O B-NP_NN
positive B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
biological B-O B-NP_NP_JJ
effects B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
e.g. B-O B-PP_FW
" " B-O O-PP
, B-O B-COMMA
enhanced B-O B-NP_NP_VBN
HIV B-O B-NN
replication B-O B-NN
" " B-O O-NP
, B-O B-COMMA
hypergammaglobulinemia B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
increased B-O B-NP_VBN
cytokine B-O B-NN
secretion B-O B-NN
" " B-O O-NP
, B-O B-COMMA
hypercellularity B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
apoptosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Role B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
Nef B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
activation B-O B-NP_NP_NN
pathways B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
CD4+ B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
( B-O B-LRB
HIV-1 B-O B-NN
) B-O B-RRB
Nef B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
" " B-O B-NP_O-VP
using B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
Jurkat B-O B-NN
CD4+ B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
stably B-O B-VP_ADVP_RB
" " B-O O-ADVP
transfected B-O B-VBN
with B-O B-NP_PP_IN
a B-O B-NP_DT
Nef B-O B-NN
expression B-O B-NN
vector B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Secretion B-O B-S_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
TNF-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
surface B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2R B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
DNA-binding B-O B-NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
( B-O B-LRB
Fos/Jun B-O B-NN
) B-O B-RRB
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
phorbol B-O B-NP_NP_NP_NN
myristate B-O B-NN
acetate B-O B-NN
" " B-O O-NP
, B-O B-COMMA
TNF-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
immobilized B-O B-NP_NP_VBN
antibodies B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
monitored B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
parameters B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
modified B-O B-VP_VBN
by B-O B-NP_PP_IN
Nef B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
whereas B-O B-SBAR_IN
stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
same B-O B-JJ
stimuli B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
partial B-O B-NP_NP_JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LTR B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Nef+ B-O B-NP_JJ
Jurkat B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
inhibition B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
Nef B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
Thr-15 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
GTP-binding B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
because B-O B-SBAR_IN
mutations B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
critical B-O B-NP_JJ
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
alter B-O B-VP_VB
this B-O B-NP_DT
inhibition B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
truncated B-O B-NP_VBN
LTRs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
confirmed B-O B-VP_VBD
that B-O B-SBAR_IN
inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
LTR B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
mediated B-O B-VP_VBN
through B-O B-NP_PP_PP_IN
NF-kappa B-O B-NP_NN
B-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
through B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
Nef B-O B-S_NP_NN
" " B-O O-NP
downmodulates B-O B-VP_VBZ
LTR B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
without B-O B-PP_IN
significantly B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
inhibiting B-O B-VP_VBG
" " B-O B-NP_NP_PP_S_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Marked B-O B-NP_NP_NP_NP_JJ
basophilia B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
acute B-O B-NP_NP_JJ
promyelocytic B-O B-JJ
leukaemia B-O B-NN
" " B-O O-NP
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
all-trans B-O B-NP_ADJP_JJ
retinoic B-O B-JJ
" " B-O O-ADJP
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
molecular B-O B-NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
cell B-O B-NN
origin B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
basophils B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
a B-O B-NP_NP_NP_DT
patient B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
acute B-O B-NP_JJ
promyelocytic B-O B-JJ
leukaemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
who B-O B-SBAR_WHNP_WP
" " B-O O-WHNP
developed B-O B-S_NP_VP_VBD
marked B-O B-NP_JJ
basophilia B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
all-trans B-O B-NP_JJ
retinoic B-O B-JJ
acid B-O B-NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
genomic B-O B-NP_NP_NP_JJ
DNA B-O B-NN
" " B-O O-NP
and B-O B-CC
RNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
extracted B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_DT
patient B-O B-NN
's B-O B-POS
peripheral B-O B-JJ
leucocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
in B-O B-SBAR_IN
order B-O B-NN
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
the B-O B-NP_NP_DT
origin B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
basophils B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_NP_DT
RAR B-O B-NN
alpha B-O B-NN
rearranged B-O B-JJ
band B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
Southern B-O B-NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
chimaeric B-O B-JJ
product B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PML-RAR B-O B-NP_JJ
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
polymerase B-O B-NP_NN
chain B-O B-NN
reaction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
strongly B-O B-ADJP_RB
visible B-O B-JJ
before B-O B-PP_IN
ATRA B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
at B-O B-S_PP_IN
the B-O B-NP_NP_DT
time B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
maximal B-O B-NP_JJ
basophilia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
both B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
them B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
markedly B-O B-ADVP_RB
" " B-O O-ADVP
diminished B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
basophils B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
appeared B-O B-S_NP_VP_VBD
during B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
are B-O B-VP_VBP
reactive B-O B-ADJP_JJ
in B-O B-PP_IN
nature B-O B-NP_NP_NN
" " B-O B-NP_O-NP
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
a B-O B-NP_DT
leukaemic B-O B-JJ
clone B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_NP_DT
low B-O B-JJ
NM23.H1 B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
identifying B-O B-VP_VBG
high B-O B-NP_JJ
malignancy B-O B-NN
human B-O B-JJ
melanomas B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_S_NP_DT
NM23 B-O B-NN
gene B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
proposed B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_DT
metastasis-suppressor B-O B-JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
its B-O B-S_NP_PRPP
use B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
suggested B-O B-VP_VBN
as B-O B-NP_PP_IN
prognostic B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
NM23 B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
system B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
murine B-O B-NP_NN
melanoma B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
an B-O B-S_NP_DT
inverse B-O B-JJ
relationship B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_PP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
a B-O B-NP_DT
human B-O B-JJ
malignant B-O B-JJ
melanoma B-O B-NN
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
NM23 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
significantly B-O B-ADJP_RB
lower B-O B-JJR
in B-O B-PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
present B-O B-JJ
paper B-O B-NN
" " B-O O-NP
studies B-O B-VP_VBZ
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NM23.H1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
derive B-O B-S_NP_VP_VBP
from B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
relation B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
staging B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
infiltration B-O B-NP_NN
degree B-O B-NN
" " B-O O-NP
, B-O B-COMMA
lymphocytic B-O B-NP_JJ
infiltration B-O B-NN
" " B-O O-NP
, B-O B-COMMA
cell B-O B-NP_NN
morphology B-O B-NN
" " B-O O-NP
, B-O B-COMMA
cell B-O B-NP_NN
pigmentation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
karyotype B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
disease-free B-O B-NP_JJ
survival B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mRNA B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NM23 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
significantly B-O B-ADJP_ADJP_RB
lower B-O B-JJR
" " B-O O-ADJP
in B-O B-PP_IN
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
derive B-O B-S_NP_VP_VBP
from B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
than B-O B-PP_IN
in B-O B-PP_IN
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
obtained B-O B-VP_VBN
from B-O B-NP_PP_IN
tumours B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
tumours B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
express B-O B-VP_VBP
the B-O B-NP_DT
NM23 B-O B-NN
gene B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
higher B-O B-NP_NP_JJR
levels B-O B-NNS
" " B-O O-NP
than B-O B-PP_IN
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
obtained B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Novel B-O B-NP_NP_NP_NP_JJ
membrane B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
aldosterone B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
a B-O B-NP_NP_DT
50 B-O B-ADJP_CD
kDa B-O B-NN
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
SDS-PAGE B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Fast B-O B-S_S_NP_NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_DT
Na+/H(+)-exchanger B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
inositoltrisphosphate B-O B-NP_NP_NP_NN
generation B-O B-NN
" " B-O O-NP
and B-O B-CC
corresponding B-O B-NP_NP_VBG
specific B-O B-JJ
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
plasma B-O B-NP_NN
membranes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
at B-O B-PP_IN
Kd-values B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
approximately B-O B-NP_QP_RB
0.1 B-O B-CD
" " B-O O-QP
nM B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
found B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
vascular B-O B-NP_JJ
smooth B-O B-JJ
muscle B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
novel B-O B-JJ
aldosterone B-O B-NN
membrane B-O B-NN
receptor B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
analyzed B-O B-VP_VBN
on B-O B-NP_PP_IN
SDS-PAGE B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
labeling B-O B-NP_NP_VBG
" " B-O O-NP
of B-O B-PP_IN
microsomal B-O B-NP_NP_JJ
membranes B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
human B-O B-NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_DT
[125I]-aldosterone-derivative B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
use B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
BASED B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_DT
photoactivatable B-O B-JJ
crosslinker B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
1 B-O B-NP_QP_CD
nM B-O B-NN
" " B-O O-QP
[125I]-aldosterone B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
at B-O B-NP_PP_IN
a B-O B-NP_NP_NP_DT
molecular B-O B-JJ
weight B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
approximately B-O B-NP_QP_RB
50 B-O B-CD
" " B-O O-QP
kDa B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
absent B-O B-ADJP_JJ
, B-O B-PP_COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
" " B-O B-ADJP_NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
aldosterone-selectivity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
typical B-O B-ADJP_ADJP_JJ
" " B-O B-PP_O-ADJP
and B-O B-CC
discriminatory B-O B-ADJP_JJ
" " B-O B-PP_O-ADJP
for B-O B-PP_IN
the B-O B-NP_DT
new B-O B-JJ
aldosterone B-O B-NN
membrane B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Solubilization B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
membranes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
high B-O B-NP_NP_JJ
salt B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
1 B-O B-NP_NP_ADJP_CD
M B-O B-NN
" " B-O O-ADJP
NaCl B-O B-NN
" " B-O O-NP
, B-O B-COMMA
1 B-O B-NP_ADJP_CD
mM B-O B-NN
" " B-O O-ADJP
EDTA B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
achieved B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
, B-O B-COMMA
" " B-O O-NP
thus B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
appears B-O B-VP_VBZ
as B-O B-PP_IN
an B-O B-NP_DT
integral B-O B-JJ
membrane B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Dithiothreitol B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
sulfhydryl B-O B-NN
agent B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
reduce B-O B-VP_VB
specific B-O B-NP_JJ
aldosterone B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-VP
indicating B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
SH-groups B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
binding B-O B-NN
domain B-O B-NN
" " B-O O-NP
or B-O B-CC
sensitive B-O B-NP_NP_JJ
structures B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
the B-O B-NP_NP_DT
first B-O B-JJ
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
characterize B-O B-VP_VB
the B-O B-NP_NP_DT
novel B-O B-JJ
membrane B-O B-NN
receptor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
findings B-O B-NNS
" " B-O O-NP
and B-O B-CC
other B-O B-NP_JJ
related B-O B-JJ
results B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
reviewed B-O B-VP_VBN
here B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
T B-O B-S_S_S_NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
renal B-O B-NP_JJ
cell B-O B-NN
carcinoma B-O B-NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
exhibit B-O B-VP_VBP
an B-O B-NP_NP_DT
abnormal B-O B-JJ
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
kappa B-O B-NP_NN
B-specific B-O B-JJ
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
a B-O B-NP_DT
preliminary B-O B-JJ
report B-O B-NN
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Recent B-O B-S_S_NP_JJ
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
poor B-O B-JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
T-cell B-O B-NN
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
related B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
T B-O B-S_NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
RCC B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
two B-O B-NP_CD
alterations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
kappa B-O B-NP_NN
B B-O B-NN
motif-specific B-O B-JJ
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
first B-O B-JJ
alteration B-O B-NN
" " B-O O-NP
involves B-O B-VP_VBZ
the B-O B-NP_NP_NP_DT
constitutive B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
substantial B-O B-NP_JJ
kappa B-O B-NN
B-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
electrophoretic B-O B-JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
magnitude B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
kappa B-O B-NP_NP_NN
B B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
unstimulated B-O B-NP_JJ
patient B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
similar B-O B-ADJP_JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_NP_PP_SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-NP_NP_DT
basis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Western B-O B-NP_NP_NN
blotting B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
antibodies B-O B-NP_NP_NNS
" " B-O O-NP
to B-O B-PP_TO
kappa B-O B-NP_NN
B/Rel B-O B-NN
family B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
kappa B-O B-NN
B-binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
constitutively B-O B-VP_ADVP_RB
" " B-O O-ADVP
expressed B-O B-VBN
in B-O B-NP_PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
RCC B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
composed B-O B-VP_VBN
mostly B-O B-NP_ADVP_RB
" " B-O O-ADVP
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B1 B-O B-NN
( B-O B-LRB
p50 B-O B-NN
) B-O B-RRB
subunit B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
second B-O B-JJ
abnormality B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
kappa B-O B-NP_NP_NN
B-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
these B-O B-NP_DT
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
that B-O B-SBAR_IN
RelA B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Rel B-O B-NN
homology B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
following B-O B-PP_VBG
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Western B-O B-S_NP_NN
blotting B-O B-NN
analysis B-O B-NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
detect B-O B-VP_VB
any B-O B-NP_DT
RelA B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
either B-O B-PP_CC
before B-O B-PP_IN
" " B-O B-NP_O-PP
or B-O B-CC
after B-O B-PP_IN
" " B-O B-NP_O-PP
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
altered B-O B-JJ
kappa B-O B-NN
B-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
RCC B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
impair B-O B-VP_VB
their B-O B-NP_PRPP
capacity B-O B-NN
to B-O B-S_NP_VP_TO
respond B-O B-VP_VB
normally B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
various B-O B-NP_JJ
stimuli B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
multiple B-O B-NP_JJ
phosphorylations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
intact B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mechanistically B-O B-ADVP_RB
" " B-O O-ADVP
not B-O B-RB
well B-O B-ADVP_RB
" " B-O O-ADVP
understood B-O B-VP_JJ
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
investigated B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
modifications B-O B-NNS
" " B-O O-NP
imposed B-O B-VP_VBN
on B-O B-NP_PP_IN
NF-kappa B-O B-NP_NN
B/I B-O B-NN
kappa B-O B-NN
B B-O B-NN
components B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
following B-O B-PP_VBG
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
final B-O B-JJ
step B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
involves B-O B-VP_VBZ
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
TNF-alpha B-O B-NP_NN
" " B-O O-NP
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBD
nuclear B-O B-NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
primarily B-O B-PP_ADVP_RB
" " B-O O-ADVP
of B-O B-PP_IN
p50-p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
of B-O B-IN
c-rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
NF-kappa B-O B-NP_NN
B B-O B-NN
precursors B-O B-NNS
" " B-O O-NP
and B-O B-CC
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
became B-O B-VP_VBD
strongly B-O B-ADVP_RB
" " B-O O-ADVP
phosphorylated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
same B-O B-JJ
kinetics B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
inducible B-O B-JJ
phosphorylation B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
B B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VBG
constitutive B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
nuclear B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
revealed B-O B-VP_VBD
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
phosphorylated B-O B-NP_VBN
p65 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Phosphorylation B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
induced B-O B-NP_NP_VBN
processing B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
precursors B-O B-NNS
p100 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
p105 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
by B-O B-PP_IN
degradation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_PP_IN
an B-O B-NP_DT
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
model B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
phosphorylation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
p105 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
impedes B-O B-VP_VBZ
its B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
interact B-O B-VP_VB
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_IN
has B-O B-S_NP_VP_VBZ
been B-O B-VP_VBN
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Surprisingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
even B-O B-NP_ADVP_RB
" " B-O O-ADVP
p65 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
c-rel B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
phosphorylated B-O B-VP_VBN
after B-O B-NP_PP_IN
induction B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_SBAR_IN
TNF-alpha B-O B-S_NP_NN
" " B-O O-NP
selectively B-O B-ADVP_RB
" " B-O O-ADVP
activates B-O B-VP_VBZ
" " B-O B-NP_ADVP_NP_O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
modifications B-O B-S_NP_NNS
" " B-O O-NP
regulate B-O B-VP_VBP
" " B-O B-NP_CONJP_NP_CONJP_NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
fact B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
cellular B-O B-S_S_NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
phosphorylation-dependent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p65-containing B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
enhanced B-O B-VP_VBN
by B-O B-NP_PP_IN
phosphorylation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
hydrogen B-O B-NP_NN
peroxide B-O B-NN
" " B-O O-NP
" " B-O O-PP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
translocation B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
assumed B-O B-VP_VBN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
coincided B-O B-VP_VBD
with B-O B-PP_IN
incorporation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
phosphate B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
phosphorylation B-O B-NP_NN
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
a B-O B-NP_NP_DT
general B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
In B-O B-NP_NP_NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
modification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
major B-O B-NP_JJ
histocompatibility B-O B-NN
complex B-O B-NN
class B-O B-NN
II B-O B-CD
DRA B-O B-NN
promoter B-O B-NN
occupancy B-O B-NN
" " B-O O-NP
" " B-O O-PP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
AIR-1 B-O B-NN
trans-activator B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
RJ B-O B-S_S_NP_NN
2.2.5 B-O B-CD
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
human B-O B-JJ
B B-O B-NN
cell B-O B-NN
mutant B-O B-NN
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_NP_DT
Burkitt B-O B-NN
lymphoma B-O B-NN
Raji B-O B-NN
cell B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_DT
locus B-O B-NN
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_NP_DT
transcriptional B-O B-JJ
trans-activator B-O B-NN
" " B-O O-NP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_NP_DT
constitutive B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
major B-O B-NP_JJ
histocompatibility B-O B-NN
complex B-O B-NN
( B-O B-LRB
MHC B-O B-NN
) B-O B-RRB
class B-O B-NN
II B-O B-CD
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
, B-O B-COMMA
by B-O B-PP_IN
in B-O B-NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
DNase B-O B-NN
I B-O B-CD
footprinting B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
that B-O B-SBAR_IN
the B-O B-S_NP_DT
AIR-1 B-O B-NN
locus B-O B-NN
defect B-O B-NN
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
changes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
DRA B-O B-NN
promoter B-O B-NN
occupancy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
reexpression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
MHC B-O B-NN
class B-O B-NN
II B-O B-CD
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
RJ B-O B-NP_NN
2.2.5 B-O B-CD
x B-O B-NN
mouse B-O B-NN
spleen B-O B-NN
cell B-O B-NN
hybrids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
partial B-O B-NP_NP_JJ
reversion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DRA B-O B-NP_NN
promoter B-O B-NN
occupancy B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
Raji B-O B-NN
pattern B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DRA B-O B-S_NP_NP_NN
promoter B-O B-NN
occupancy B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
other B-O B-NP_NP_JJ
class B-O B-NN
II-negative B-O B-JJ
B B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
bare B-O B-NP_JJ
lymphocyte B-O B-NN
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
drastically B-O B-ADJP_RB
different B-O B-JJ
from B-O B-PP_IN
the B-O B-NP_NP_DT
one B-O B-NN
" " B-O O-NP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
RJ B-O B-NP_NP_NN
2.2.5 B-O B-CD
" " B-O O-NP
and B-O B-CC
Raji B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
DNase B-O B-NN
I B-O B-CD
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
an B-O B-NP_DT
in B-O B-ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
footprinting B-O B-NN
agent B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reveals B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_DT
patients B-O B-NNS
' B-O B-POS
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
display B-O B-VP_VB
a B-O B-NP_DT
completely B-O B-ADVP_RB
" " B-O O-ADVP
"""" B-O B-LQT
bare B-O B-JJ
promoter B-O B-NN
"""" B-O B-RQT
" " B-O O-NP
" " B-O O-VP
as B-O B-SBAR_IN
previously B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
reported B-O B-VP_VBN
" " B-O B-NP_S_NP_VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNase B-O B-NP_NN
I B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
allowed B-O B-VP_VBD
us B-O B-S_NP_PRP
, B-O B-COMMA
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
first B-O B-JJ
time B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
to B-O B-VP_TO
correlate B-O B-VP_VP_VB
the B-O B-NP_DT
AIR-1 B-O B-NN
locus B-O B-NN
defect B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
class B-O B-NP_NN
II B-O B-CD
promoter B-O B-NN
occupancy B-O B-NN
alterations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
distinguish B-O B-VP_VB
these B-O B-NP_DT
alterations B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_NP_DT
ones B-O B-NNS
" " B-O O-NP
observed B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Mechanism B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
antiandrogen B-O B-NP_JJ
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
conformational B-O B-NP_NP_JJ
changes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Androgen B-O B-S_S_S_NP_NN
receptor B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
translated B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
androgen- B-O B-S_NP_NP_NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
antiandrogen-bound B-O B-NP_JJ
" " B-O B-NP_O-NP
receptor B-O B-NP_NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
using B-O B-S_NP_VP_VBG
digestion B-O B-NP_NP_ADJP_ADJP_ADJP_NN
" " B-O O-NP
by B-O B-PP_IN
trypsin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Partial B-O B-S_NP_NP_JJ
proteolysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
androgen-bound B-O B-NP_JJ
receptor B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_DT
29-kDa B-O B-NP_JJ
proteolysis-resisting B-O B-JJ
fragment B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
whereas B-O B-SBAR_IN
antiandrogen B-O B-S_NP_JJ
binding B-O B-NN
" " B-O O-NP
stabilised B-O B-VP_VBD
a B-O B-NP_DT
35-kDa B-O B-NP_JJ
fragment B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_S_NP_DT
fragments B-O B-NNS
" " B-O O-NP
contain B-O B-VP_VBP
the B-O B-NP_DT
entire B-O B-JJ
ligand B-O B-NP_NN
binding B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_DT
35-kDa B-O B-NP_JJ
fragment B-O B-NN
" " B-O O-NP
" " B-O O-NP
extended B-O B-VP_VBD
into B-O B-PP_IN
the B-O B-NP_NP_DT
hinge B-O B-NP_NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Several B-O B-S_S_NP_JJ
antiandrogens B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
agonistic B-O B-NP_NP_JJ
properties B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
a B-O B-NP_NP_DT
mutated B-O B-NP_VBN
androgen B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
LNCaP B-O B-NP_NN
cell B-O B-NN
variant B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
trypsin B-O B-S_NP_NP_NP_NN
" " B-O O-NP
digestion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
antiandrogen-bound B-O B-NP_JJ
mutated B-O B-VBN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_DT
29-kDa B-O B-NP_JJ
fragment B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
point B-O B-VP_VBP
to B-O B-PP_TO
an B-O B-NP_NP_DT
important B-O B-JJ
difference B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
antiandrogens B-O B-NP_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
antagonists B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_JJ
steroid B-O B-NP_NN
hormone B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Antiandrogens B-O B-S_NP_NNS
" " B-O O-NP
result B-O B-VP_VBP
in B-O B-PP_IN
protection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_NP_CC
the B-O B-NP_DT
hinge B-O B-NP_NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
C-terminus B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
androgen B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
agonist B-O B-NN
proteolytic B-O B-JJ
attack B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
whereas B-O B-SBAR_IN
other B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
antiestrogens B-O B-S_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
antiprogestagens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
expose B-O B-VP_VBP
to B-O B-NP_NP_PP_PP_TO
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Differences B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
conformation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hinge B-O B-NP_NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
distinguish B-O B-VP_VBP
androgen-bound B-O B-NP_ADJP_NP_JJ
" " B-O O-NP
" " B-O O-ADJP
" " B-O B-NP_O-NP
from B-O B-PP_IN
antiandrogen-bound B-O B-NP_JJ
receptor B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
represents B-O B-S_NP_VP_VBZ
an B-O B-NP_NP_DT
important B-O B-JJ
feature B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
antiandrogen B-O B-NP_JJ
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
An B-O B-S_S_NP_DT
active B-O B-JJ
v-abl B-O B-NP_JJ
protein B-O B-NN
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
" " B-O O-NP
blocks B-O B-VP_VBZ
immunoglobulin B-O B-NP_NP_NN
light-chain B-O B-JJ
gene B-O B-NN
" " B-O O-NP
rearrangement B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Lymphoid B-O B-S_S_NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
transformed B-O B-VP_VBN
by B-O B-NP_PP_IN
Abelson B-O B-NP_NN
murine B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
have B-O B-VP_VBP
provided B-O B-VP_VBN
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
classic B-O B-JJ
models B-O B-NNS
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
study B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Most B-O B-S_NP_NP_JJS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
rearranged B-O B-VP_VBN
their B-O B-NP_NP_PRPP
heavy-chain B-O B-NP_JJ
locus B-O B-NN
" " B-O O-NP
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
their B-O B-NP_PRPP
light B-O B-NP_JJ
chain B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
an B-O B-S_NP_DT
active B-O B-JJ
v-abl B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
interferes B-O B-VP_VBZ
with B-O B-PP_IN
this B-O B-NP_DT
differentiation B-O B-NN
step B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
test B-O B-VP_VB
this B-O B-NP_DT
hypothesis B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
light-chain B-O B-S_NP_JJ
gene B-O B-NN
structure B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
pre-B B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
transformed B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
derivatives B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
studies B-O B-NNS
" " B-O O-NP
reveal B-O B-VP_VBP
that B-O B-SBAR_IN
inactivation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
v-abl B-O B-NP_JJ
protein B-O B-NN
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
triggers B-O B-VP_NNS
high-frequency B-O B-NP_NP_VBP
rearrangement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
kappa B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
lambda B-O B-NP_NN
" " B-O B-NP_O-NP
light-chain B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
events B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
marked B-O B-NP_NP_JJ
increases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RAG-1 B-O B-NP_NN
and B-O B-CC
RAG-2 B-O B-NN
RNAs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
increases B-O B-NNS
" " B-O O-NP
occur B-O B-VP_VP_VBP
in B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
are B-O B-VP_VBP
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
inactivation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
v-abl B-O B-NP_JJ
protein B-O B-NN
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_SBAR_SBAR_IN
documented B-O B-S_NP_VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
accompanying B-O B-VBG
paper B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
( B-O B-PRN_LRB
Klug B-O B-NP_NP_NN
et B-O B-FW
al. B-O B-FW
" " B-O O-NP
, B-O B-COMMA
this B-O B-NP_DT
issue B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-SBAR
, B-O B-COMMA
an B-O B-S_NP_DT
active B-O B-JJ
v-abl B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
suppresses B-O B-VP_VBZ
the B-O B-NP_NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B/rel B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
expression B-O B-NP_NP_NN
" " B-O O-NP
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
kappa B-O B-NP_NN
intron B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
these B-O B-NP_DT
data B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
v-abl B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
interferes B-O B-VP_VBZ
with B-O B-PP_IN
light-chain B-O B-NP_NP_JJ
gene B-O B-NN
" " B-O O-NP
rearrangement B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
suppressing B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
tyrosine B-O B-S_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
important B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-S_PRN_LRB
An B-O B-S_NP_NP_DT
overexpression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
retinoic B-O B-NP_JJ
acid B-O B-NN
receptor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
blocks B-O B-VP_VBZ
myeloid B-O B-NP_NP_JJ
cell B-O B-NN
" " B-O O-NP
differentiation B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
promyelocyte B-O B-JJ
stage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
] B-O B-RRB
" " B-O O-PRN
" " B-O O-S
  
Retinoic B-O B-S_S_NP_NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
vitamin B-O B-NN
A B-O B-NN
derivative B-O B-JJ
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
exerts B-O B-VP_VBZ
a B-O B-NP_NP_DT
wide B-O B-JJ
range B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
biological B-O B-NP_NP_JJ
effects B-O B-NNS
" " B-O O-NP
related B-O B-ADJP_JJ
to B-O B-PP_TO
cell B-O B-NP_NN
and B-O B-NP_CC
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
pleiotropic B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
" " B-O B-NP_ADJP_NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
RARs B-O B-S_NP_NNS
" " B-O O-NP
are B-O B-VP_VP_VBP
members B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
steroid/thyroid B-O B-NP_NN
hormone B-O B-NN
receptor B-O B-NN
superfamily B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
exhibit B-O B-VP_VBP
a B-O B-NP_NP_DT
molecular B-O B-JJ
structure B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
possess B-O B-S_NP_VP_VBP
discrete B-O B-NP_ADJP_JJ
" " B-O O-ADJP
DNA-binding B-O B-NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
RA B-O B-NP_NN
( B-O B-LRB
ligand B-O B-NN
) B-O B-RRB
-binding B-O B-JJ
domains B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
hematopoietic B-O B-NP_JJ
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
RA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
RARs B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
predominantly B-O B-ADVP_RB
" " B-O O-ADVP
RAR B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
play B-O B-VP_VB
key B-O B-NP_JJ
roles B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
proliferation B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
hematopoietic B-O B-NP_JJ
progenitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
currently B-O B-ADVP_RB
" " B-O O-ADVP
unknown B-O B-ADJP_JJ
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
RA B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
RARs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_ADVP_PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
make B-O B-VP_VB
clear B-O B-S_ADJP_JJ
" " B-O O-ADJP
the B-O B-NP_NP_DT
roles B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
RA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
RAR B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
normal B-O B-JJ
hematopoiesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
I B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
introduced B-O B-VP_VP_VBN
the B-O B-NP_NP_DT
construct B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
RAR B-O B-NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
into B-O B-PP_IN
murine B-O B-NP_NN
bone B-O B-NN
marrow B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
retroviral B-O B-NP_JJ
vector B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
selected B-O B-VP_VBN
infected B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
cultured B-O B-NP_NP_NP_PRN_VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
analyzed B-O B-VP_VBN
the B-O B-NP_NP_DT
behavior B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
procedure B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
done B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Most B-O B-S_NP_NP_JJS
cells B-O B-NNS
" " B-O O-NP
infected B-O B-VP_VBN
with B-O B-NP_PP_IN
hRAR B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
exhibited B-O B-VP_VP_VBD
promyelocytic B-O B-NP_JJ
morphology B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
were B-O B-VP_VBD
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
blocked B-O B-VP_VBN
at B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
immature B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
differentiated B-O B-VP_VBD
terminally B-O B-ADVP_RB
" " B-O O-ADVP
into B-O B-PP_IN
mature B-O B-NP_JJ
granulocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
adding B-O B-S_NP_VP_VBG
with B-O B-PP_IN
RA B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
M B-O B-NP_QP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
RAR B-O B-S_NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
differentiate B-O B-VP_VB
into B-O B-PP_IN
mature B-O B-NP_JJ
macrophages B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
both B-O B-CC
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-UCP_SBAR_IN
an B-O B-S_NP_NP_DT
overexpression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RAR B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
effective B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
suppress B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
RAR B-O B-COMP_S_NP_NN
alpha B-O B-NN
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
crucial B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
terminal B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
myeloid B-O B-NP_JJ
precursors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
system B-O B-NN
" " B-O O-NP
described B-O B-VP_VBN
here B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-NP
may B-O B-VP_MD
serve B-O B-VP_VB
as B-O B-PP_IN
a B-O B-NP_NP_DT
model B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
studying B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
interleukin-2 B-O B-NP_NP_NN
receptor B-O B-NN
alpha B-O B-NN
chain B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
nuclear B-O B-NP_NP_NP_JJ
factor.kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Autocrine B-O B-NP_NP_NN
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tumor B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_S_NP_NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interleukin-2 B-O B-NP_NP_NP_NN
receptor B-O B-NN
alpha B-O B-NN
chain B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2R B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
nuclear B-O B-NP_NP_NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
protein B-O B-NP_NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PKC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
resting B-O B-NP_VBG
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
resting B-O B-NP_VBG
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
phorbol B-O B-NP_NN
esters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBD
the B-O B-NP_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2R B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF.kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
activation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
due B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p65 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-Rel B-O B-NP_NP_NN
" " B-O O-NP
NF.kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
cytoplasmic B-O B-NP_JJ
stores B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_NP_DT
nucleus B-O B-NN
" " B-O O-NP
, B-O B-COMMA
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
all B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
those B-O B-NP_DT
events B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
largely B-O B-UCP_ADJP_RB
indirect B-O B-JJ
" " B-O O-ADJP
and B-O B-CC
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
endogenously B-O B-NP_ADJP_RB
secreted B-O B-VBN
" " B-O O-ADJP
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-UCP
, B-O B-COMMA
as B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
were B-O B-VP_VBD
strongly B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_DT
neutralizing B-O B-NP_VBG
anti-TNF B-O B-JJ
alpha B-O B-NN
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
cyclosporin B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
blocked B-O B-S_NP_VP_VBD
TNF B-O B-NP_NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
IL-2R B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
and B-O B-CC
NF.kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_CC
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
or B-O B-CC
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
partially B-O B-ADVP_RB
" " B-O O-ADVP
recovered B-O B-VP_VBD
cyclosporin B-O B-NP_NN
A-induced B-O B-JJ
IL-2R B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
inhibition B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
only B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
completely B-O B-ADVP_RB
" " B-O O-ADVP
recovered B-O B-VP_VBD
NF.kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Those B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
, B-O B-S_COMMA
in B-O B-PP_IN
resting B-O B-NP_VBG
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
PKC B-O B-NP_NP_NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
only B-O B-NP_RB
a B-O B-DT
triggering B-O B-VBG
role B-O B-NN
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
the B-O B-S_NP_DT
endogenously B-O B-ADJP_RB
secreted B-O B-VBN
" " B-O O-ADJP
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
plays B-O B-VP_VBZ
an B-O B-NP_DT
essential B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cellular B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
E2F B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cdc2 B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
cell B-O B-NP_NP_NN
cycle B-O B-NN
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
hematopoietic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
cdc2 B-O B-S_S_NP_NN
mRNA B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
were B-O B-VP_VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
immature B-O B-NP_JJ
bone B-O B-NN
marrow B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
became B-O B-VP_VBD
undetectable B-O B-ADJP_JJ
along B-O B-PP_IN
with B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Peripheral B-O B-S_S_NP_JJ
blood B-O B-NN
resting B-O B-NN
cells B-O B-NNS
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
express B-O B-VP_VB
cdc2 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
T-lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
cells B-O B-NNS
" " B-O O-NP
reentered B-O B-VP_VBD
the B-O B-NP_DT
cell B-O B-NN
cycle B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
cdc2 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
granulocytes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
even B-O B-ADVP_RB
" " B-O O-ADVP
after B-O B-PP_IN
the B-O B-NP_NP_DT
culture B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
appropriate B-O B-JJ
stimulants B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-S_NP_VP_TO
investigate B-O B-VP_VB
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
isolated B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
5'-flanking B-O B-NP_JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cdc2 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
found B-O B-VP_VBD
the B-O B-NP_DT
putative B-O B-JJ
E2F B-O B-NN
binding B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
position B-O B-NN
of B-O B-PP_IN
nucleotides B-O B-NP_NNS
-124 B-O B-CD
to B-O B-TO
-117 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E2F B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
this B-O B-NP_DT
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
gel-retardation B-O B-NN
assay B-O B-NN
" " B-O O-NP
and B-O B-CC
DNaseI B-O B-NP_NP_NP_NN
" " B-O O-NP
footprinting B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
phytohemagglutinin-stimulated B-O B-NP_JJ
T-lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
coincident B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
E2F B-O B-S_NP_NP_NN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
both B-O B-NP_CC
granulocytes B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transient B-O B-S_NP_JJ
chloramphenicol B-O B-NP_NN
acetyltransferase B-O B-NN
" " B-O O-NP
assay B-O B-NN
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-UCP_SBAR_IN
the B-O B-S_NP_NP_DT
region B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
E2F B-O B-NP_NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
had B-O B-VP_VBD
a B-O B-NP_DT
strong B-O B-JJ
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
introduction B-O B-COMP_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
mutation B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
the B-O B-NP_DT
E2F B-O B-NP_NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_DT
significant B-O B-JJ
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
E2F-1 B-O B-S_NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
DP-1 B-O B-NP_NN
" " B-O B-NP_O-NP
mRNAs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VP_VBD
not B-O B-RB
detectable B-O B-ADJP_JJ
in B-O B-PP_IN
granulocytes B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
monocytes B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
resting B-O B-NP_VBG
T-lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
but B-O B-CC
were B-O B-VP_VBD
induced B-O B-VP_VBN
after B-O B-NP_PP_IN
the B-O B-NP_NP_DT
mitogenic B-O B-JJ
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T-lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E2F B-O B-NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
preceded B-O B-VP_VBD
the B-O B-NP_DT
appearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cdc2 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
cdc2 B-O B-S_NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
related B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
E2F B-O B-S_NP_NN
" " B-O O-NP
plays B-O B-VP_VBZ
some B-O B-NP_DT
roles B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Protease B-O B-S_S_NP_NN
inhibitors B-O B-NNS
" " B-O O-NP
block B-O B-VP_VBP
lipopolysaccharide B-O B-NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tissue B-O B-NP_NN
factor B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
preventing B-O B-S_NP_VP_VBG
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel/p65 B-O B-NP_NN
heterodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Tissue B-O B-S_S_NP_NP_NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
rapidly B-O B-NP_ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
human B-O B-NP_NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
exposed B-O B-VP_VBN
to B-O B-NP_PP_TO
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Transcriptional B-O B-S_NP_JJ
regulation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel/p65 B-O B-NP_NN
heterodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_NP_DT
kappa B-O B-NP_NN
B-like B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytosolic B-O B-NP_NP_JJ
c-Rel/p65 B-O B-NN
heterodimers B-O B-NNS
" " B-O O-NP
and B-O B-CC
other B-O B-NP_NP_JJ
members B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NP_NN
B/Rel B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
dissociation B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
proteolytic B-O B-NP_JJ
degradation B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
inhibitor B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
protease B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
N B-O B-NP_NP_NP_NN
alpha-tosylphenylalanyl B-O B-JJ
chloromethyl B-O B-NN
ketone B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TPCK B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
N B-O B-NP_NP_NN
alpha-tosyl-L-lysine B-O B-NN
chloromethyl B-O B-NN
ketone B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TLCK B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
block B-O B-VP_VBP
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B/Rel B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
preventing B-O B-S_NP_VP_VBG
degradation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
determine B-O B-VP_VB
if B-O B-SBAR_IN
TPCK B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
TLCK B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibited B-O B-VP_VBD
LPS B-O B-NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
freshly B-O B-S_NP_ADJP_RB
isolated B-O B-VBN
" " B-O O-ADJP
human B-O B-NP_NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
monocytic B-O B-NP_JJ
THP-1 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
pretreated B-O B-VP_VBN
with B-O B-NP_PP_IN
these B-O B-NP_DT
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
30 B-O B-NP_CD
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
before B-O B-PP_IN
LPS B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
TPCK B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
TLCK B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibited B-O B-VP_VBD
LPS B-O B-NP_NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TF B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
TF B-O B-NP_NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
TF B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
promoter B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
dose-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
inhibitors B-O B-NNS
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
prevented B-O B-VP_VBD
degradation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
nuclear B-O B-NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel/p65 B-O B-NP_NN
heterodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
TPCK B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
TLCK B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
block B-O B-VP_VB
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
immediate-early B-O B-NP_JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
encoding B-O B-VP_VBG
the B-O B-NP_NP_DT
, B-O B-NP_COMMA
Egr-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
these B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
inhibiting B-O B-S_NP_NP_VBG
nuclear B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel/p65 B-O B-NP_NN
heterodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
prevented B-O B-VP_VBD
LPS B-O B-NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
C/EBP B-O B-NP_NP_NP_NP_NN
beta B-O B-NN
" " B-O O-NP
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
tumor B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Activated B-O B-S_S_NP_VBN
macrophages B-O B-NNS
" " B-O O-NP
contribute B-O B-VP_VBP
to B-O B-PP_TO
chronic B-O B-NP_JJ
inflammation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_NP_DT
secretion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokines B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
proteinases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Tumor B-O B-S_NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
particularly B-O B-ADJP_RB
important B-O B-JJ
in B-O B-PP_IN
this B-O B-NP_DT
process B-O B-NN
" " B-O O-NP
" " B-O O-PP
because B-O B-PP_IN
of B-O B-PP_IN
its B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
regulate B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mechanism B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_DT
cell B-O B-NN
type-specific B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
known B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
present B-O B-VP_VBP
data B-O B-NP_NP_NNS
" " B-O O-NP
to B-O B-SBAR_WHADVP_S_NP_VP_TO
show B-O B-VP_VB
that B-O B-ADVP_SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
C/EBP B-O B-S_NP_NN
beta B-O B-NN
" " B-O O-NP
activated B-O B-VP_VP_VBD
the B-O B-NP_DT
TNF B-O B-NP_NN
alpha B-O B-NN
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
cotransfection B-O B-NP_NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
bound B-O B-VP_VBD
to B-O B-PP_TO
it B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
a B-O B-NP_NP_DT
site B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
failed B-O B-S_NP_VP_VBD
" " B-O B-S_NP_VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
a B-O B-NP_NP_DT
dominant-negative B-O B-JJ
version B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
C/EBP B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
blocked B-O B-VP_VBD
TNF B-O B-NP_NP_NN
alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
myeloid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
implicate B-O B-VP_VBP
C/EBP B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
an B-O B-NP_NP_DT
important B-O B-JJ
regulator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
myelomonocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Simultaneous B-O B-NP_NP_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Ig B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
reduction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
surface B-O B-NP_NN
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
IL-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Terminal B-O B-S_S_NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
plasma B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
is B-O B-VP_VBZ
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
secretion B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Ig B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
extinction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
surface B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
IL-6 B-O B-S_NP_NP_NN
" " B-O O-NP
signaling B-O B-NN
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
marked B-O B-NP_NP_JJ
increases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
IL-6-induced B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
resemble B-O B-VP_VBP
plasma B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
in B-O B-PP_PP_IN
ultrastructure B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
reduced B-O B-NP_NP_VBN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
surface B-O B-NP_NN
MHC B-O B-NN
class B-O B-NN
II B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Enhanced B-O B-S_NP_VBN
Ig B-O B-NP_NN
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
result B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
coordinated B-O B-NP_NP_NP_VBN
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Ig B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
without B-O B-PP_IN
promoter B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
isotype B-O B-NP_NN
specificity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
differential B-O B-NP_NP_JJ
accumulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
encoding B-O B-NP_VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
saturable B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
subject B-O B-ADJP_JJ
to B-O B-PP_TO
negative B-O B-NP_JJ
control B-O B-NN
" " B-O O-NP
" " B-O O-PP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
IL-6 B-O B-S_NP_NP_NN
" " B-O O-NP
stimulation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
prolonged B-O B-ADJP_JJ
" " B-O B-ADVP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Coordinate B-O B-S_ADVP_JJ
with B-O B-PP_IN
temporal B-O B-NP_NP_JJ
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
Ig B-O B-NP_NP_NN
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-S_NP_NP_DT
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
synthesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
B B-O B-NP_NP_NN
cell-enriched B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
regulated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
differentiation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
IL-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
recapitulates B-O B-VP_VBZ
the B-O B-NP_NP_DT
hallmarks B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
terminal B-O B-NP_JJ
B B-O B-NN
differentiation B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
Oct-2 B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
have B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
process B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_S_NP_NP_DT
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
serine B-O B-NP_NP_NN
proteases B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VBN
exclusively B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
myelo-monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
processes B-O B-VP_VP_VBZ
the B-O B-NP_DT
nuclear B-O B-NP_JJ
factor-kappa B-O B-NN
B B-O B-NN
subunit B-O B-NN
p65 B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
and B-O B-CC
may B-O B-VP_MD
impair B-O B-VP_VB
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
replication B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Two B-O B-S_S_NP_NP_CD
groups B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
U937 B-O B-NP_NN
promonocytic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
obtained B-O B-VP_VBN
by B-O B-NP_PP_IN
limiting B-O B-S_NP_VP_VBG
dilution B-O B-NP_NP_NN
cloning B-O B-NN
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
"""" B-O B-S_NP_LQT
Plus B-O B-JJ
"""" B-O B-RQT
clones B-O B-NNS
" " B-O O-NP
replicated B-O B-VP_VBD
the B-O B-NP_DT
virus B-O B-NN
" " B-O O-NP
efficiently B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
whereas B-O B-SBAR_IN
"""" B-O B-S_NP_LQT
minus B-O B-JJ
"""" B-O B-RQT
clones B-O B-NNS
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
these B-O B-NP_DT
clones B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
differences B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
nuclear B-O B-NP_NP_NP_JJ
factor B-O B-NN
( B-O B-LRB
NF B-O B-NN
) B-O B-RRB
-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
might B-O B-S_NP_VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
plus B-O B-NP_CC
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
liberated B-O B-VP_VBD
the B-O B-NP_DT
classical B-O B-JJ
p50-p65 B-O B-NP_NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
cytoplasmic B-O B-NP_JJ
pools B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
whereas B-O B-SBAR_IN
minus B-O B-S_NP_JJ
clones B-O B-NNS
" " B-O O-NP
produced B-O B-VP_VBD
an B-O B-NP_DT
apparently B-O B-ADJP_RB
novel B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
faster-migrating B-O B-NP_JJ
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
as B-O B-SBAR_IN
judged B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
surprising B-O B-ADJP_JJ
" " B-O O-ADJP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
faster-migrating B-O B-NP_JJ
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
composed B-O B-VP_VBN
also B-O B-NP_ADVP_RB
" " B-O O-ADVP
of B-O B-PP_IN
p50 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
p65 B-O B-NP_NN
subunit B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
COOH-terminally B-O B-ADVP_RB
" " B-O O-ADVP
truncated B-O B-VP_VBN
" " B-O B-NP_O-VP
, B-O B-COMMA
as B-O B-SBAR_IN
shown B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
immunoprecipitation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
truncation B-O B-NN
" " B-O O-NP
resulted B-O B-VP_VBD
from B-O B-PP_IN
limited B-O B-NP_NP_JJ
proteolysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
cellular B-O B-NP_NP_JJ
extraction B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
released B-O B-S_NP_VP_VBD
particular B-O B-NP_NP_JJ
, B-O B-NP_COMMA
such B-O B-PP_JJ
as B-O B-IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
specific B-O B-JJ
proteases B-O B-NNS
" " B-O O-NP
are B-O B-VP_VP_VBP
coordinately B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
and B-O B-CC
were B-O B-VP_VBD
present B-O B-ADJP_JJ
exclusively B-O B-PP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
the B-O B-NP_DT
minus B-O B-NP_JJ
U937 B-O B-NN
clones B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
the B-O B-NP_DT
plus B-O B-NP_JJ
clones B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
as B-O B-SBAR_IN
demonstrated B-O B-S_NP_VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
case B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
these B-O B-NP_DT
proteases B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
certain B-O B-NP_NP_JJ
subclones B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
THP-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
HL-60 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
primary B-O B-NP_JJ
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
in B-O B-S_NP_PP_IN
each B-O B-NP_DT
case B-O B-NN
" " B-O O-NP
" " B-O O-PP
correlating B-O B-VP_VBG
with B-O B-PP_IN
the B-O B-NP_NP_DT
truncated B-O B-VBN
from B-O B-IN
" " B-O O-NP
of B-O B-PP_IN
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
in B-O B-NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
cleavage B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
purified B-O B-NP_VBN
elastase B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
cathepsin B-O B-NP_NN
G B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
possible B-O B-ADJP_JJ
" " B-O O-ADJP
that B-O B-SBAR_IN
particular B-O B-S_NP_JJ
serine B-O B-NP_NN
proteases B-O B-NNS
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
have B-O B-VP_VB
inhibiting B-O B-NP_NN
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
replication B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
special B-O B-S_NP_JJ
precautions B-O B-NNS
" " B-O O-NP
must B-O B-VP_MD
be B-O B-VP_VB
taken B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
making B-O B-S_NP_VP_VBG
extracts B-O B-NP_NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Positive B-O B-NP_NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
negative B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
regulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
composite B-O B-NP_JJ
octamer B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
interleukin B-O B-NP_NN
2 B-O B-CD
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
AP-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Oct-2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
retinoic B-O B-NP_JJ
acid B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
differentiating B-O B-VBG
agent B-O B-NN
retinoic B-O B-JJ
acid B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
previously B-O B-ADVP_RB
" " B-O O-ADVP
reported B-O B-VP_VBN
to B-O B-S_NP_VP_TO
interfere B-O B-VP_VB
with B-O B-PP_IN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
IL-2 B-O B-NP_NN
octamer B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
composite B-O B-JJ
cis-element B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
Oct-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Oct-2 B-O B-NP_NN
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
a B-O B-NP_NP_DT
, B-O B-NP_COMMA
previously B-O B-ADVP_RB
" " B-O O-ADVP
termed B-O B-VP_VBN
" " B-O B-S_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
Oct-2 B-O B-S_NP_NN
, B-O B-COMMA
" " B-O O-NP
despite B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
activation B-O B-ADJP_ADJP_ADJP_NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
requires B-O B-VP_VBZ
TPA/Ca(2+)-induced B-O B-NP_JJ
signals B-O B-NNS
" " B-O O-NP
to B-O B-S_NP_VP_TO
strongly B-O B-ADVP_RB
" " B-O O-ADVP
transactivate B-O B-VP_VB
the B-O B-NP_DT
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
Oct-2-dependent B-O B-JJ
transactivation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
intact B-O B-NP_JJ
COOH-terminal B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contributes B-O B-VP_VBZ
to B-O B-PP_TO
both B-O B-NP_CC
TPA/Ca(2+)-induced B-O B-NP_JJ
transactivation B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
RA-mediated B-O B-JJ
repression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
show B-O B-VP_VBP
that B-O B-SBAR_IN
both B-O B-S_NP_NP_CC
Fos B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
Jun B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
components B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
AP-1 B-O B-NP_NN
" " B-O O-NP
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
participate B-O B-VP_VBP
in B-O B-PP_IN
the B-O B-NP_DT
OAP40 B-O B-NP_NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
transfected B-O B-NP_VBN
c-jun B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
jun-B B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
jun-D B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
c-fos B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
or B-O B-CC
Fos-B B-O B-NP_NN
" " B-O B-NP_O-NP
expression B-O B-NP_NN
vectors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
partially B-O B-ADVP_RB
" " B-O O-ADVP
substitute B-O B-VP_VP_VBP
for B-O B-PP_IN
TPA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Ca2+ B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
cooperate B-O B-VP_VBP
with B-O B-PP_IN
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
the B-O B-NP_NP_DT
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
combined B-O B-JJ
OAP/octamer B-O B-NP_NN
cis-element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutations B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
genuine B-O B-NP_JJ
octamer-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
abrogate B-O B-VP_VBP
both B-O B-NP_CC
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Oct-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
TPA/Ca(2+)-induced B-O B-JJ
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
OAP/octamer B-O B-NP_NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
OAP B-O B-S_NP_NN
" " B-O O-NP
confers B-O B-VP_VBZ
to B-O B-PP_TO
Oct-2 B-O B-NP_NP_NP_NN
" " B-O O-NP
responsivity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
both B-O B-NP_CC
TPA/Ca2+ B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
since B-O B-SBAR_IN
specific B-O B-S_NP_NP_JJ
mutations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
AP-1/OAP-binding B-O B-NP_JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
significantly B-O B-ADVP_RB
" " B-O O-ADVP
reduce B-O B-VP_VP_VBP
the B-O B-NP_NP_DT
transactivation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
Oct-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
abolish B-O B-VP_VBP
the B-O B-NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
retinoic B-O B-NP_NP_NP_JJ
acid B-O B-NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RAR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
alpha B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
the B-O B-NP_NP_DT
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
, B-O B-COMMA
resulting B-O B-S_NP_VP_VBG
in B-O B-PP_IN
the B-O B-NP_NP_DT
interference B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
Oct-2-dependent B-O B-NP_NP_JJ
cis-regulatory B-O B-JJ
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
TPA/calcium-activated B-O B-JJ
AP-1/OAP B-O B-NN
element B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
main B-O B-JJ
target B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
or B-O B-NP_NP_NP_CC
influencing B-O B-NP_NP_VP_VBG
, B-O B-NP_COMMA
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-S_S_NP_NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
I B-O B-CD
Tax B-O B-NP_NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B/Rel B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
phosphorylation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
degradation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
RelA B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
p65 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
-mediated B-O B-JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-rel B-O B-NP_JJ
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
tax B-O B-NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
I B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-I B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
potent B-O B-JJ
transcriptional B-O B-NP_JJ
activator B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
both B-O B-S_NP_VP_CC
stimulates B-O B-VP_VBZ
viral B-O B-NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
activates B-O B-VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Tax B-O B-S_NP_NN
" " B-O O-NP
acts B-O B-VP_VBZ
indirectly B-O B-ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
inducing B-O B-S_NP_VP_VP_VBG
" " B-O B-NP_O-VP
or B-O B-CC
modifying B-O B-VP_VBG
" " B-O B-NP_O-VP
the B-O B-NP_NP_DT
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
various B-O B-NP_NP_JJ
host B-O B-NN
, B-O B-NP_COMMA
including B-O B-PP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
resting B-O B-NP_VBG
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
many B-O B-NP_NP_JJ
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
NF-kappa B-O B-NP_NN
B/Rel B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
sequestered B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
various B-O B-NP_NP_JJ
ankyrin-rich B-O B-NP_JJ
inhibitory B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HTLV-I B-O B-S_S_NP_NP_NN
Tax B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
constitutive B-O B-JJ
nuclear B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
biologically B-O B-NP_NP_ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
c-Rel B-O B-NP_NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
however B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
biochemical B-O B-JJ
mechanism B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
underlying B-O B-VP_VBG
this B-O B-NP_DT
response B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
remains B-O B-VP_VBZ
poorly B-O B-VP_ADVP_RB
" " B-O O-ADVP
understood B-O B-VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
Tax-stimulated B-O B-S_NP_NP_JJ
nuclear B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
both B-O B-NP_CC
HTLV-I-infected B-O B-NP_JJ
and B-O B-CC
Tax-transfected B-O B-JJ
human B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
and B-O B-NP_CC
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
prior B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
" " B-O O-ADJP
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
at B-O B-NP_NP_ADVP_IN
least B-O B-JJS
" " B-O O-ADVP
a B-O B-NP_DT
fraction B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
phosphorylated B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remains B-O B-VP_VP_VBZ
physically B-O B-ADVP_RB
" " B-O O-ADVP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NP_NN
B B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
but B-O B-CC
is B-O B-VP_VBZ
subject B-O B-ADJP_JJ
to B-O B-PP_TO
rapid B-O B-NP_JJ
degradation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
thereby B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
promoting B-O B-VP_VBG
the B-O B-NP_NP_DT
nuclear B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
active B-O B-JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
Tax B-O B-S_NP_NP_NP_NN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
c-Rel B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
, B-O B-NP_NP_NP_PP_COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
normal B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
subsequent B-O B-JJ
accumulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
c-Rel B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
acts B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
its B-O B-NP_PRPP
own B-O B-JJ
continued B-O B-JJ
production B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
autoregulatory B-O B-JJ
loop B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
Inhibition B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
rat B-O B-NP_NP_NN
splenocyte B-O B-NN
" " B-O O-NP
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
methylprednisolone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
in B-O B-NP_NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
liposomal B-O B-NP_JJ
formulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
liposomal B-O B-JJ
formulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
methylprednisolone B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
MPL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphocyte B-O B-NP_NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
spleen B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
following B-O B-NP_PP_VBG
IV B-O B-NP_NP_CD
dosing B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
rats B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Liposomes B-O B-S_NP_NNS
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
alter B-O B-VP_VB
the B-O B-NP_NP_DT
suppressive B-O B-JJ
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
MPL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
placed B-O B-NP_S_VP_VBN
in B-O B-NP_PP_IN
lymphocyte B-O B-NP_NN
culture B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Rat B-O B-S_NP_NN
splenocytes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
greater B-O B-NP_NP_NP_JJR
sensitivity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
) B-O B-NP_NP_ADJP_RRB
" " B-O O-PRN
" " B-O O-NP
than B-O B-SBAR_IN
do B-O B-SINV_VBP
" " B-O B-NP_NP_PRN_O-SINV
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
studies B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
rats B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
utilized B-O B-VP_VBD
2 B-O B-NP_NP_CD
mg/kg B-O B-NN
IV B-O B-CD
bolus B-O B-NN
doses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
liposomal B-O B-NP_JJ
MPL B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
compared B-O B-PP_VBN
to B-O B-PP_TO
drug B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
solution B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Animals B-O B-S_S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
sacrificed B-O B-VP_VBN
at B-O B-NP_PP_IN
various B-O B-NP_NP_JJ
times B-O B-NNS
" " B-O O-NP
post-dosing B-O B-ADJP_JJ
until B-O B-PP_IN
120 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
spleen B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
excised B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
, B-O B-COMMA
after B-O B-S_PP_IN
incubation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
PHA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
splenocyte B-O B-NP_NN
blastogenic B-O B-JJ
responses B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
assessed B-O B-VP_VBN
by B-O B-NP_PP_IN
measuring B-O B-S_NP_VP_VBG
cellular B-O B-NP_NP_JJ
incorporation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
suppressive B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
liposomal B-O B-NP_JJ
MPL B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
comparison B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
free B-O B-NP_JJ
drug B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
was B-O B-VP_VBD
significantly B-O B-ADJP_RB
prolonged B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
> B-O B-ADJP_ADJP_JJR
120 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-ADJP
vs B-O B-CC
< B-O B-ADJP_JJR
18 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
Inhibition B-O B-S_NP_NP_NN
effects B-O B-NNS
" " B-O O-NP
versus B-O B-CC
time B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
described B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_DT
pharmacodynamic B-O B-JJ
model B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
using B-O B-S_NP_VP_VBG
MPL B-O B-NP_NP_NN
concentrations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
plasma B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-PP_IN
an B-O B-NP_DT
input B-O B-NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
nonlinear B-O B-JJ
relationship B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
between B-O B-NP_PP_IN
suppression B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
splenocyte B-O B-NP_NP_NN
" " B-O O-NP
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
bound B-O B-NP_NP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Only B-O B-S_NP_RB
partial B-O B-JJ
receptor B-O B-NN
occupancy B-O B-NN
" " B-O O-NP
accompanied B-O B-VP_VBD
complete B-O B-NP_JJ
lymphocyte B-O B-NN
suppression B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
suppression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
endogenous B-O B-NP_JJ
corticosterone B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
plasma B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
both B-O B-NP_DT
treatments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
similar B-O B-ADJP_JJ
with B-O B-PP_IN
values B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
L-MPL B-O B-NP_NN
rats B-O B-NNS
" " B-O O-NP
" " B-O O-PP
returning B-O B-VP_VBG
to B-O B-PP_TO
baseline B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
24 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
enhanced B-O B-NP_NP_VBN
efficacy B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
local B-O B-NP_NP_JJ
immunosuppression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
targeting B-O B-S_NP_VP_VBG
spleen B-O B-NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Arrested B-O B-NP_NP_NP_VBN
development B-O B-NN
: B-O B-COLON
" " B-O O-NP
understanding B-O B-S_NP_VP_VBG
v-abl B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
protein B-O B-NP_NN
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
v-abl B-O B-NP_NN
oncogene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
demonstrated B-O B-VP_VBN
to B-O B-S_NP_VP_TO
subvert B-O B-VP_VB
" " B-O B-NP_NP_VP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Transformation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
bone B-O B-NP_NN
marrow B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
Abelson B-O B-NN
murine B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
appearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B B-O B-NP_NP_NN
cell B-O B-NN
lineage B-O B-NN
cells B-O B-NNS
" " B-O O-NP
arrested B-O B-VP_VBN
at B-O B-NP_PP_IN
the B-O B-NP_DT
pre-B B-O B-JJ
cell B-O B-NN
stage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recent B-O B-S_NP_JJ
reports B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
characterized B-O B-VP_VBN
these B-O B-NP_NP_DT
cells B-O B-NNS
" " B-O O-NP
expressing B-O B-VP_VBG
high B-O B-NP_JJ
v-abl B-O B-NP_NN
" " B-O O-NP
kinase B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
as B-O B-PP_IN
deficient B-O B-ADJP_JJ
in B-O B-PP_IN
detectable B-O B-NP_NP_JJ
NF-kappaB B-O B-NP_NN
" " B-O O-NP
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
and B-O B-CC
low B-O B-NP_JJ
level B-O B-NN
RAG B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
v-abl B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
inhibiting B-O B-VP_VBG
the B-O B-NP_NP_DT
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
by B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Distinct B-O B-S_S_NP_JJ
DNase-I B-O B-NP_NN
hypersensitive B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
TAL-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_ADJP_NP_NP_O-NP
and B-O B-CC
T-cell B-O B-NP_NN
" " B-O B-NP_O-NP
lines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
tal-1 B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
frequently B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_JJ
T-cell B-O B-NP_NP_NN
acute B-O B-JJ
lymphoblastic B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
T-ALL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
erythroid B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
megakaryocytic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
mast B-O B-NP_NN
" " B-O B-NP_O-NP
cell B-O B-NP_NN
lineages B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
normal B-O B-NP_JJ
hematopoiesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
gain B-O B-VP_VB
further B-O B-NP_NP_JJ
insight B-O B-NN
" " B-O O-NP
into B-O B-PP_IN
the B-O B-NP_NP_DT
molecular B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
tal-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
chromatin B-O B-NN
structure B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
erythroid/megakaryocytic B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
T-cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
either B-O B-PP_CC
with B-O B-PP_IN
" " B-O B-NP_O-PP
or B-O B-CC
without B-O B-PP_IN
" " B-O B-NP_O-PP
tal-1 B-O B-NP_NN
rearrangements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Tal-1 B-O B-S_NP_NN
transcription B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
monoallelic B-O B-ADJP_JJ
in B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Methylation B-O B-S_NP_NN
studies B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
tal-15 B-O B-NP_NN
' B-O B-POS
GC-rich B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
behaves B-O B-VP_VBZ
like B-O B-PP_IN
a B-O B-NP_NP_DT
CpG B-O B-NP_NN
island B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
hypomethylated B-O B-VP_VP_VBN
, B-O B-NP_PP_COMMA
and B-O B-CC
methylated B-O B-VP_VBN
" " B-O B-NP_ADVP_PP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Five B-O B-S_NP_CD
major B-O B-JJ
DNase-I B-O B-NP_NP_NN
hypersensitive B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
HS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
mapped B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
tal-1 B-O B-NP_NN
" " B-O O-NP
locus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HS B-O B-S_NP_NN
I B-O B-NP_CD
" " B-O O-NP
, B-O B-COMMA
IV B-O B-NP_CD
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
V B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
exclusively B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
erythroid/megakaryocytic B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
express B-O B-S_NP_VP_VBP
tal-1 B-O B-NP_NN
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HS B-O B-S_NP_NN
II B-O B-CD
" " B-O O-NP
was B-O B-VP_VBD
weak B-O B-UCP_ADJP_JJ
in B-O B-PP_IN
hematopoietic B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
absent B-O B-ADJP_JJ
in B-O B-PP_IN
Hela B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
and B-O B-CC
greatly B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBN
in B-O B-NP_PP_IN
Jurkat B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-UCP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
this B-O B-S_NP_DT
region B-O B-NN
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
implicated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HS B-O B-S_NP_NN
III B-O B-CD
" " B-O O-NP
was B-O B-VP_VBD
weak B-O B-UCP_ADJP_JJ
in B-O B-PP_IN
HEL B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Jurkat B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
and B-O B-CC
greatly B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBN
in B-O B-NP_PP_IN
DU528 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
T-cell B-O B-NP_NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
distinct B-O B-S_NP_JJ
regulatory B-O B-NP_JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Functions B-O B-NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
glutathione B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
glutathione B-O B-NP_NN
disulfide B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
immunology B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
immunopathology B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Even B-O B-S_S_NP_ADVP_RB
" " B-O O-ADVP
a B-O B-NP_DT
moderate B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
cellular B-O B-JJ
cysteine B-O B-NN
supply B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
elevates B-O B-VP_VP_VBZ
the B-O B-NP_DT
intracellular B-O B-ADJP_JJ
" " B-O O-ADJP
glutathione B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
GSH B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
and B-O B-CC
glutathione B-O B-NP_NP_NN
disulfide B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GSSG B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
potentiates B-O B-VP_VBZ
immunological B-O B-NP_NP_JJ
functions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
At B-O B-S_PP_IN
low B-O B-NP_JJ
GSSG B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
not B-O B-RB
optimally B-O B-ADVP_RB
" " B-O O-ADVP
activate B-O B-VP_VB
the B-O B-NP_DT
immunologically B-O B-ADJP_RB
important B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NP_NP_NN
factor B-O B-NN
" " B-O O-NP
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
whereas B-O B-SBAR_IN
high B-O B-S_NP_JJ
GSSG B-O B-NN
levels B-O B-NNS
" " B-O O-NP
inhibit B-O B-VP_VBP
the B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
GSSG B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
antagonized B-O B-VP_VBN
by B-O B-NP_PP_IN
reduced B-O B-NP_VBN
thioredoxin B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
TRX B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_SBAR_IN
the B-O B-S_NP_NP_DT
protein B-O B-NP_NN
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
activities B-O B-NNS
" " B-O O-NP
p56lck B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
p59fyn B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
activated B-O B-VP_VBN
in B-O B-NP_PP_IN
intact B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
hydrogen B-O B-NP_NN
peroxide B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
they B-O B-S_NP_PRP
" " B-O O-NP
are B-O B-VP_VBP
likely B-O B-NP_NP_JJ
targets B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
GSSG B-O B-NP_NN
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
redox-regulated B-O B-NP_JJ
enzymes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
trigger B-O B-VP_VP_VBP
signal B-O B-NP_NN
cascades B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
NF B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
transduce B-O B-VP_VBP
signals B-O B-NP_NNS
" " B-O O-NP
from B-O B-PP_PP_IN
the B-O B-NP_DT
T B-O B-NP_NN
cell B-O B-NN
antigen B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
from B-O B-PP_IN
CD4 B-O B-NP_NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
and B-O B-CC
CD8 B-O B-NP_NN
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
from B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NP_NN
receptor B-O B-NN
beta-chain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
effector B-O B-NN
phase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytotoxic B-O B-NP_NP_JJ
T B-O B-NN
cell B-O B-NN
" " B-O O-NP
responses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
IL-2-dependent B-O B-NP_JJ
functions B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
inhibited B-O B-VP_VBN
even B-O B-NP_PP_ADVP_RB
" " B-O O-ADVP
by B-O B-IN
a B-O B-NP_NP_DT
partial B-O B-JJ
depletion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
intracellular B-O B-JJ
GSH B-O B-NN
pool B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_SBAR_IN
signal B-O B-S_NP_NN
transduction B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
facilitated B-O B-VP_VBN
by B-O B-NP_PP_IN
prooxidant B-O B-NP_JJ
conditions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
well-known B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
immunological B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
consequences B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
GSH B-O B-NP_NN
depletion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
ultimately B-O B-ADVP_RB
" " B-O O-ADVP
may B-O B-VP_MD
be B-O B-VP_VB
results B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_SBAR_IN
HIV-infected B-O B-S_NP_NP_JJ
patients B-O B-NNS
" " B-O O-NP
and B-O B-CC
SIV-infected B-O B-NP_JJ
rhesus B-O B-NN
macaques B-O B-NNS
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
, B-O B-COMMA
on B-O B-PP_IN
the B-O B-NP_DT
average B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
significantly B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-NP_VBN
plasma B-O B-NP_NN
cyst B-O B-NN
( B-O B-LRB
e B-O B-NN
) B-O B-RRB
ine B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
intracellular B-O B-NP_JJ
GSH B-O B-NN
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
hypothesize B-O B-VP_VBP
that B-O B-SBAR_IN
AIDS B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
the B-O B-NP_NP_DT
consequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
as B-O B-ADVP_RB
well B-O B-RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Erythropoietin-dependent B-O B-NP_NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hemoglobin B-O B-NP_NP_NN
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_DT
cytokine-dependent B-O B-NP_NP_JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
M-TAT B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
M-TAT B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
cytokine-dependent B-O B-NP_JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
potential B-O B-NN
to B-O B-S_NP_VP_TO
differentiate B-O B-VP_VB
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
cultured B-O B-VP_VBD
M-TAT B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
long B-O B-NP_NP_JJ
term B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
> B-O B-ADJP_JJR
1 B-O B-NP_CD
year B-O B-NN
" " B-O O-NP
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
continuous B-O B-JJ
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
erythropoietin B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
EPO B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
granulocyte-macrophage B-O B-NP_NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GM-CSF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
stem B-O B-NP_NP_NN
cell B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
SCF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
long B-O B-JJ
term B-O B-NN
cultures B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
referred B-O B-VP_VBN
to B-O B-PP_TO
" " B-O B-NP_O-PP
as B-O B-PP_IN
M-TAT/EPO B-O B-NP_NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
M-TAT/GM-CSF B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
M-TAT/SCF B-O B-NP_NN
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Hemoglobin B-O B-S_NP_NP_NP_NN
" " B-O O-NP
concentration B-O B-NN
" " B-O O-NP
and B-O B-CC
gamma-globin B-O B-NP_NP_NP_NN
" " B-O O-NP
" " B-O B-NP_NP_O-NP
and B-O B-CC
erythroid B-O B-NP_NP_JJ
delta-aminolevulinate B-O B-JJ
synthase B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
significantly B-O B-ADJP_ADJP_RB
higher B-O B-JJR
" " B-O O-ADJP
in B-O B-PP_IN
M-TAT/EPO B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
than B-O B-PP_IN
in B-O B-PP_IN
M-TAT/GM-CSF B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
supplemented B-O B-VBN
cytokine B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
switched B-O B-VP_VBN
from B-O B-NP_PP_IN
GM-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
EPO B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
hemoglobin B-O B-S_S_NP_NP_NP_NN
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
M-TAT/GM-CSF B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
rapidly B-O B-ADVP_ADVP_RB
" " B-O O-ADVP
( B-O B-PRN_LRB
within B-O B-PP_IN
5 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GM-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
M-TAT/EPO B-O B-NP_NN
cell B-O B-NN
culture B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
decreased B-O B-VP_VBD
the B-O B-NP_NP_DT
amount B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hemoglobin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
even B-O B-PP_ADVP_RB
" " B-O O-ADVP
in B-O B-IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
EPO B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
EPO B-O B-NP_NN
" " B-O O-NP
signal B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
erythroid B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
suppressed B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
erythroid B-O B-NP_NP_JJ
development B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
M-TAT B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
promoted B-O B-VP_VP_VBN
by B-O B-NP_PP_IN
EPO B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
suppressed B-O B-VP_VBN
by B-O B-NP_PP_IN
GM-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
support B-O B-VP_VBP
the B-O B-NP_DT
hypothesis B-O B-NN
that B-O B-SBAR_IN
EPO B-O B-S_NP_NN
" " B-O O-NP
actively B-O B-ADVP_RB
" " B-O O-ADVP
influences B-O B-VP_VBZ
the B-O B-NP_NP_DT
programming B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
One B-O B-NP_NP_NP_NP_CD
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
two B-O B-NP_CD
transcripts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
: B-O B-COLON
" " B-O O-NP
isolation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
alternative B-O B-JJ
transcript B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
for B-O B-PP_IN
the B-O B-NP_NP_DT
from B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
A B-O B-S_S_NP_DT
cDNA B-O B-NP_NN
library B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
prepared B-O B-VP_VBN
from B-O B-NP_PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
autoimmune B-O B-JJ
patient B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
cDNA B-O B-NP_NN
library B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
screened B-O B-VP_VBN
" " B-O B-NP_O-VP
with B-O B-PP_IN
the B-O B-S_NP_DT
patients B-O B-NNS
own B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
autoimmune B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
serum B-O B-NN
" " B-O O-NP
being B-O B-VP_VBG
monospecific B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-NP_JJ
autoantigen B-O B-NN
La/SS-B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thereby B-O B-S_ADVP_RB
" " B-O O-ADVP
an B-O B-NP_NP_DT
alternative B-O B-JJ
type B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
La B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-SBAR_O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
differed B-O B-S_NP_VP_VBD
from B-O B-PP_IN
the B-O B-NP_DT
known B-O B-JJ
La B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
due B-O B-ADJP_JJ
to B-O B-PP_TO
an B-O B-NP_NP_DT
exchange B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
  
Sequencing B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
genomic B-O B-JJ
region B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_DT
exons B-O B-NNS
1 B-O B-NP_CD
" " B-O O-NP
and B-O B-CC
2 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
alternative B-O B-NP_JJ
5'-end B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
part B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
intron B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
alternative B-O B-NP_JJ
promoter B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
exists B-O B-S_NP_VP_VBZ
within B-O B-PP_IN
" " B-O B-NP_NP_ADVP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
became B-O B-VP_VBD
evident B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
consequence B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
alternative B-O B-NP_JJ
La B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
result B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
promoter B-O B-NN
switching B-O B-NN
" " B-O O-NP
combined B-O B-VP_VBN
with B-O B-NP_PP_IN
an B-O B-NP_DT
alternative B-O B-JJ
splicing B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
intron B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
further B-O B-NP_NP_JJ
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
a B-O B-NP_DT
NF-kappa B-O B-NP_NN
B B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
leading B-O B-S_NP_VP_VBG
to B-O B-PP_TO
the B-O B-NP_DT
suggestion B-O B-NN
that B-O B-SBAR_IN
alters B-O B-S_NP_NP_PP_VP_VBZ
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Functional B-O B-S_S_NP_JJ
Myc-Max B-O B-NP_NN
heterodimer B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
activation-induced B-O B-NP_NP_JJ
apoptosis B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
hybridomas B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
T B-O B-S_S_S_NP_NN
cell B-O B-NN
hybridomas B-O B-NNS
" " B-O O-NP
respond B-O B-VP_VBP
to B-O B-PP_TO
activation B-O B-NP_NN
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
undergoing B-O B-S_NP_VP_VBG
apoptotic B-O B-NP_JJ
cell B-O B-NN
death B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
this B-O B-S_NP_DT
" " B-O O-NP
is B-O B-VP_VBZ
likely B-O B-ADJP_RB
to B-O B-S_NP_VP_TO
represent B-O B-VP_VB
" " B-O B-NP_NP_ADJP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Previous B-O B-S_NP_NP_JJ
studies B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
antisense B-O B-NP_JJ
oligonucleotides B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
implicated B-O B-VP_VBD
the B-O B-NP_DT
c-Myc B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
phenomenon B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activation-induced B-O B-NP_JJ
apoptosis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
c-Myc B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
apoptosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
now B-O B-ADVP_RB
" " B-O O-ADVP
confirmed B-O B-VP_VBN
in B-O B-NP_PP_IN
studies B-O B-NP_NP_NNS
" " B-O O-NP
using B-O B-VP_VBG
a B-O B-NP_NP_NP_DT
of B-O B-ADJP_PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
Max B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
coexpression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
reciprocally B-O B-NP_RB
mutant B-O B-JJ
Myc B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
forming B-O B-S_NP_VP_VBG
functional B-O B-NP_JJ
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
compensate B-O B-VP_VP_VB
for B-O B-PP_IN
the B-O B-NP_DT
dominant B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
negative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
restore B-O B-VP_VB
activation-induced B-O B-NP_JJ
apoptosis B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
imply B-O B-VP_VBP
that B-O B-SBAR_IN
Myc B-O B-S_NP_NN
" " B-O O-NP
promotes B-O B-VP_VBZ
activation-induced B-O B-NP_JJ
apoptosis B-O B-NN
" " B-O O-NP
by B-O B-PP_PP_IN
obligatory B-O B-NP_NP_JJ
heterodimerization B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
therefore B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
by B-O B-PP_IN
regulating B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
DNA-binding B-O B-NP_NP_NP_NP_JJ
studies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Epstein-Barr B-O B-NP_NP_JJ
virus B-O B-NN
nuclear B-O B-JJ
antigen B-O B-NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
EBNA-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
complex B-O B-NP_NP_JJ
formation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
latent B-O B-NP_NP_JJ
membrane B-O B-NN
protein B-O B-NN
gene B-O B-NN
promoter-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
EBNA-2-positive B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
Epstein-Barr B-O B-NP_NP_JJ
virus B-O B-NN
( B-O B-LRB
EBV B-O B-NN
) B-O B-RRB
nuclear B-O B-JJ
antigen B-O B-NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
EBNA-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
protein B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_DT
immortalization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-ADJP_NP_JJ
primary B-O B-JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-PP
by B-O B-PP_IN
EBV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
EBNA-2 B-O B-S_NP_NN
" " B-O O-NP
trans-activates B-O B-VP_VBZ
cellular B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
viral B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
like B-O B-PP_IN
CD23 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
c-fgr B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
latent B-O B-NP_NP_JJ
membrane B-O B-NN
protein B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
LMP1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
terminal B-O B-NP_NP_JJ
protein B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
TP1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Trans-activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_PP_IN
the B-O B-NP_DT
TP1 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
of B-O B-PP_IN
the B-O B-NP_DT
BamHI B-O B-NP_NN
C B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VP_VBZ
already B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
investigated B-O B-VP_VBN
in B-O B-NP_PP_IN
detail B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
mediated B-O B-VP_VBN
via B-O B-NP_PP_PP_IN
and B-O B-NP_CC
not B-O B-RB
by B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
EBNA-2 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
trans-activate B-O B-VP_VB
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
in B-O B-PP_IN
several B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Various B-O B-S_NP_JJ
reports B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
delineated B-O B-VP_VBN
the B-O B-NP_NP_DT
cis-acting B-O B-NP_JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
LMP B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
through B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
EBNA-2 B-O B-S_NP_NN
" " B-O O-NP
mediates B-O B-VP_VBZ
trans-activation B-O B-NP_NN
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
EBNA-2 B-O B-S_NP_NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
trans-activates B-O B-VP_VBZ
the B-O B-NP_DT
LMP B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
by B-O B-PP_IN
protein-protein B-O B-NP_JJ
interactions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
performed B-O B-VP_VBD
a B-O B-NP_NP_DT
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gel B-O B-NP_NP_NP_NN
retardation B-O B-NN
assays B-O B-NNS
" " B-O O-NP
and B-O B-CC
competition B-O B-NP_NN
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
LMP B-O B-NP_NP_NN
promoter B-O B-NN
fragments B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
determined B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
protein-binding B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
LMP B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
within B-O B-PP_IN
a B-O B-NP_NP_DT
42 B-O B-NP_CD
bp B-O B-NN
fragment B-O B-NN
" " B-O O-NP
" " B-O O-NP
encompassing B-O B-VP_VBG
" " B-O B-NP_NP_ADJP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
" " B-O B-S_NP_NP_NN_O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
DNA B-O B-NN
fragments B-O B-NNS
" " B-O O-NP
investigated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicated B-O B-VP_VBD
interaction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
EBNA-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
via B-O B-PP_IN
protein-protein B-O B-NP_JJ
interactions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_NP_DT
significant B-O B-JJ
differences B-O B-NNS
" " B-O O-NP
between B-O B-PP_IN
EBNA-2-positive B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
EBNA-2-negative B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
gel B-O B-NN
retardation B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
under B-O B-PP_IN
conditions B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
clearly B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
showed B-O B-VP_VBD
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
analysis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
sucrose B-O B-NP_NP_NN
gradient B-O B-NN
fractions B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
gel B-O B-NN
retardation B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
provided B-O B-VP_VBD
evidence B-O B-NP_NN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
LMP B-O B-NP_NN
promoter-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
form B-O B-VP_VBP
a B-O B-NP_NP_DT
complex B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
higher B-O B-NP_JJR
M(r) B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
EBNA-2-positive B-O B-NP_NP_JJ
cell B-O B-NN
" " B-O O-NP
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
complexes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
destroyed B-O B-VP_VBN
by B-O B-NP_PP_IN
detergent B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
deduce B-O B-VP_VBP
from B-O B-PP_IN
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
EBNA-2-positive B-O B-S_NP_JJ
cells B-O B-NNS
" " B-O O-NP
might B-O B-VP_MD
indeed B-O B-ADVP_RB
" " B-O O-ADVP
contain B-O B-VP_VB
specific B-O B-NP_NP_JJ
complexes B-O B-NNS
" " B-O O-NP
bound B-O B-VP_VBN
to B-O B-NP_PP_TO
" " B-O B-NP_O-VP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Enhanced B-O B-S_S_NP_NP_VBN
responsiveness B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
nuclear B-O B-NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contributes B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
unique B-O B-JJ
phenotype B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
simian B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
variant B-O B-NN
" " B-O O-NP
SIVsmmPBj14 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Infection B-O B-S_S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_NP_DT
variant B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
simian B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
SIVsmmPBj14 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
severe B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
acute B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
disease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
macaques B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_DT
study B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
designed B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_VP_TO
investigate B-O B-VP_VB
the B-O B-NP_NP_DT
functional B-O B-JJ
significance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
to B-O B-VP_TO
elucidate B-O B-VP_VB
their B-O B-NP_NP_PRPP
contribution B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LTR-directed B-O B-S_NP_JJ
transcription B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
measured B-O B-VP_VBN
by B-O B-NP_PP_IN
using B-O B-S_NP_VP_VBG
luciferase B-O B-NP_NP_NN
reporter B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
a B-O B-NP_NP_DT
wide B-O B-JJ
range B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
basal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
transcriptional B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
LTR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
SIVsmmPBj14 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
2- B-O B-ADJP_ADJP_NP_CD
to B-O B-TO
4.5-fold B-O B-RB
" " B-O O-NP
higher B-O B-JJR
" " B-O O-ADJP
than B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
LTRs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
differ B-O B-VP_VBP
by B-O B-PP_IN
five B-O B-NP_NP_CD
point B-O B-NN
mutations B-O B-NNS
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
22-bp B-O B-NP_JJ
duplication B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
SIVsmmPBj14 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
includes B-O B-S_NP_VP_VBZ
a B-O B-NP_DT
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transcriptional B-O B-S_NP_NP_JJ
differences B-O B-NNS
" " B-O O-NP
between B-O B-PP_IN
these B-O B-NP_DT
LTRs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
further B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBN
by B-O B-NP_PP_IN
two- B-O B-NP_CD
to B-O B-TO
threefold B-O B-RB
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
phorbol B-O B-NP_NP_NN
ester B-O B-NN
" " B-O O-NP
or B-O B-CC
tumor B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
by B-O B-PP_IN
cotransfection B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
plasmids B-O B-NP_NP_NNS
" " B-O O-NP
expressing B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutagenesis B-O B-S_NP_NP_NN
studies B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
reporter B-O B-NN
construct B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
an B-O B-NP_DT
enhancerless B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
these B-O B-S_NP_DT
transcriptional B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
due B-O B-ADJP_JJ
principally B-O B-PP_ADVP_RB
" " B-O O-ADVP
to B-O B-TO
the B-O B-NP_NP_DT
and B-O B-NP_CC
" " B-O B-NP_NP_VP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
infectious B-O B-NP_NP_JJ
virus B-O B-NN
stocks B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
isogenic B-O B-ADJP_JJ
except B-O B-PP_IN
for B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
were B-O B-VP_VBD
generated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
LTR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
SIVsmmPBj14 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
confer B-O B-VP_VB
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
in B-O B-PP_IN
cultured B-O B-NP_VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Inclusion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
LTR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
recombinant B-O B-NP_JJ
SIVs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_DT
two- B-O B-ADJP_CD
to B-O B-TO
threefold B-O B-JJ
" " B-O O-ADJP
rise B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
extent B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cellular B-O B-NP_NP_JJ
proliferation B-O B-NN
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_DT
hypothesis B-O B-NN
that B-O B-SBAR_IN
LTR B-O B-S_NP_NP_NN
" " B-O O-NP
mutations B-O B-NNS
" " B-O O-NP
assist B-O B-VP_VP_VBP
and B-O B-NP_PP_CC
allow B-O B-VP_VBP
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Identification B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
directs B-O B-S_NP_VP_VP_VBZ
" " B-O B-NP_NP_PP_O-VP
and B-O B-CC
binds B-O B-VP_VBZ
" " B-O B-NP_NP_PRN_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
receptor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
macrophage B-O B-NP_NP_NN
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
or B-O B-CC
colony-stimulating B-O B-NP_NP_JJ
factor B-O B-NN
1 B-O B-CD
" " B-O O-NP
[ B-O B-PRN_LRB
] B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
from B-O B-NP_PP_IN
different B-O B-NP_NP_JJ
promoters B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
monocytic B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
placental B-O B-NP_JJ
trophoblasts B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
monocyte-specific B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
at B-O B-NP_PP_IN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
D.-E.Zhang B-O B-NP_NP_NP_NNP
" " B-O O-NP
, B-O B-COMMA
C.J.Hetherington B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
H.-M.Chen B-O B-NP_NNP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
D.G.Tenen B-O B-NP_NNP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
Mol B-O B-NP_NNP
.Cell. B-O B-NNP
Biol. B-O B-NNP
14 B-O B-CD
" " B-O O-NP
: B-O B-COLON
373-381 B-O B-NP_CD
" " B-O O-NP
, B-O B-COMMA
1994 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
tissue B-O B-NN
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
promoter B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
sequences B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
analyzed B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
DNase B-O B-NP_NP_NN
" " B-O O-NP
footprinting B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
region B-O B-S_NP_NN
II B-O B-CD
" " B-O O-NP
was B-O B-VP_VBD
protected B-O B-VP_VBN
preferentially B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Electrophoretic B-O B-S_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
confirmed B-O B-VP_VBD
that B-O B-SBAR_IN
region B-O B-S_NP_NN
II B-O B-CD
" " B-O O-NP
interacts B-O B-VP_VBZ
specifically B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_CD
gel B-O B-NP_NN
shift B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
Mono B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
and B-O B-CC
Mono B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
were B-O B-VP_VBD
formed B-O B-VP_VBN
with B-O B-NP_PP_IN
separate B-O B-NP_NP_JJ
sequence B-O B-NN
elements B-O B-NNS
" " B-O O-NP
within B-O B-PP_IN
this B-O B-NP_DT
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Competition B-O B-S_NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
supershift B-O B-NP_NN
" " B-O B-NP_O-NP
experiments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
Mono B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
polyomavirus B-O B-NP_NN
enhancer-binding B-O B-JJ
protein B-O B-NN
2/core-binding B-O B-JJ
factor B-O B-NN
( B-O B-LRB
PEBP2/CBF B-O B-NN
) B-O B-RRB
family B-O B-NN
, B-O B-COMMA
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
includes B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
while B-O B-SBAR_IN
Mono B-O B-S_NP_NN
A B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-NP_NP_VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Promoter B-O B-S_NP_NP_NN
constructs B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
mutations B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
sequence B-O B-NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
no B-O B-ADVP_RB
longer B-O B-RBR
" " B-O O-ADVP
expressed B-O B-VP_VBN
specifically B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
multimerized B-O B-NP_JJ
region B-O B-NN
II B-O B-CD
sequence B-O B-NN
elements B-O B-NNS
" " B-O O-NP
enhanced B-O B-VP_VBD
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
heterologous B-O B-JJ
thymidine B-O B-NN
kinase B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytic B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
other B-O B-NP_NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
monocyte/B-cell-specific B-O B-NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
PU.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
Mono B-O B-NP_NN
A B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
Mono B-O B-NP_NN
B B-O B-NN
" " B-O B-NP_O-NP
protein B-O B-NP_NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
act B-O B-VP_VBP
in B-O B-PP_IN
concert B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
regulate B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_S_NP_NP_DT
factor B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
regulates B-O B-S_NP_VP_VBZ
the B-O B-NP_DT
class B-O B-NP_NP_NN
II B-O B-CD
major B-O B-JJ
histocompatibility B-O B-NN
complex B-O B-NN
gene B-O B-NN
" " B-O O-NP
DPA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_NP_DT
subfamily B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
zinc B-O B-NP_NN
finger B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
includes B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_S_NP_NP_NP_DT
novel B-O B-JJ
DNA B-O B-NP_NN
sequence B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
termed B-O B-VP_VBN
the B-O B-S_NP_NP_DT
J B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
regulated B-O B-VBN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
class B-O B-NP_NN
II B-O B-CD
major B-O B-JJ
histocompatibility B-O B-NN
complex B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
recently B-O B-ADVP_RB
" " B-O O-ADVP
described B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
study B-O B-VP_VB
this B-O B-NP_NP_DT
element B-O B-NN
" " B-O O-NP
and B-O B-CC
its B-O B-NP_NP_PRPP
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
class B-O B-NP_NP_NN
II B-O B-CD
gene B-O B-NN
" " B-O O-NP
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
a B-O B-S_NP_DT
cDNA B-O B-NP_NN
library B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
screened B-O B-VP_VBN
with B-O B-NP_PP_IN
oligonucleotide B-O B-NP_NP_NN
probes B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VBG
both B-O B-NP_NP_CC
and B-O B-NP_CC
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Several B-O B-S_NP_JJ
DNA B-O B-NP_NN
clones B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_O-NP
were B-O B-VP_VBD
obtained B-O B-VP_VBN
by B-O B-NP_PP_IN
this B-O B-NP_DT
procedure B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
one B-O B-SBAR_WHNP_NP_CD
" " B-O O-NP
of B-O B-WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
" " B-O O-WHNP
, B-O B-S_NP_COMMA
clone B-O B-NP_NN
18 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
is B-O B-VP_VBZ
reported B-O B-VP_VP_VBN
" " B-O O-VP
and B-O B-CC
characterized B-O B-VP_VBN
" " B-O O-VP
" " B-O O-VP
here B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
predicted B-O B-VP_VBN
to B-O B-S_NP_VP_TO
contain B-O B-VP_VB
688 B-O B-NP_NP_CD
amino B-O B-NN
acid B-O B-NN
residues B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
160 B-O B-NP_CD
N-terminal B-O B-JJ
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
nonfinger B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
clone B-O B-NP_NN
18 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
highly B-O B-ADJP_RB
homologous B-O B-JJ
with B-O B-PP_IN
similar B-O B-NP_NP_JJ
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_ADJP_JJ
other B-O B-JJ
" " B-O O-ADJP
human B-O B-NP_JJ
" " B-O B-NP_O-NP
, B-O B-COMMA
mouse B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
Drosophila B-O B-NP_FW
" " B-O B-NP_O-NP
sequences B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
defining B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
subfamily B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Kruppel-like B-O B-NP_NP_JJ
zinc B-O B-NP_NN
finger B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
termed B-O B-VP_VBN
" " B-O B-S_NP_NP_ADVP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Drosophila B-O B-NP_FW
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
ttk B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
developmental B-O B-NP_JJ
control B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
while B-O B-SBAR_IN
a B-O B-S_NP_DT
second B-O B-JJ
" " B-O O-NP
does B-O B-VP_VP_VBZ
not B-O B-RB
contain B-O B-VP_VB
a B-O B-NP_DT
zinc B-O B-NP_NN
finger B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
but B-O B-CC
encodes B-O B-VP_VBZ
a B-O B-NP_NP_DT
structure B-O B-NN
" " B-O O-NP
important B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_DT
acidic B-O B-NP_JJ
activation B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
located B-O B-ADJP_JJ
between B-O B-PP_IN
the B-O B-NP_NP_NP_DT
N-terminal B-O B-NP_JJ
conserved B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
clone B-O B-NP_NN
18 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
its B-O B-NP_PRPP
zinc B-O B-NP_NN
fingers B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
protein B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
require B-O B-VP_VB
both B-O B-NP_NP_CC
the B-O B-DT
S B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
J B-O B-NP_NN
" " B-O B-NP_O-NP
elements B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Antisense B-O B-S_NP_NP_JJ
cDNA B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
clone B-O B-NP_NN
18 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
reporter B-O B-NN
construct B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_DT
DPA B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
its B-O B-NP_NP_PRPP
functional B-O B-JJ
importance B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Epstein-Barr B-O B-NP_NP_NP_JJ
virus B-O B-NN
SM B-O B-NN
protein B-O B-NN
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
protein B-O B-NN
products B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Epstein-Barr B-O B-NP_NP_JJ
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EBV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
BMLF1 B-O B-NN
open B-O B-JJ
reading B-O B-NN
frame B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
characterized B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
cycle B-O B-ADJP_ADJP_ADJP_NN
" " B-O O-NP
in B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
SM B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_NP_DT
spliced B-O B-VBN
RNA B-O B-NN
" " B-O O-NP
joining B-O B-VP_VBG
BSLF2 B-O B-NP_NN
" " B-O O-NP
to B-O B-PP_TO
BMLF1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
much B-O B-NP_ADJP_RB
the B-O B-DT
most B-O B-RBS
abundant B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
SM B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
phosphoprotein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
EBV-infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
can B-O B-VP_MD
be B-O B-VP_VB
phosphorylated B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
with B-O B-PP_IN
casein B-O B-NP_NP_NN
kinase B-O B-NN
II B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
CKII B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Computer B-O B-S_NP_NP_NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
SM B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VP_VBD
a B-O B-S_NP_NP_DT
C B-O B-NP_NN
terminal B-O B-JJ
section B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
SM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-VP_TO
be B-O B-VP_VB
related B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
and B-O B-CC
revealed B-O B-VP_VBD
consensus B-O B-NP_NP_NN
CKII B-O B-NN
sites B-O B-NNS
" " B-O O-NP
near B-O B-PP_JJ
the B-O B-NP_NP_DT
N B-O B-NP_NN
termini B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
, B-O B-NP_COMMA
the B-O B-NP_DT
and B-O B-NP_CC
the B-O B-NP_DT
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Site-directed B-O B-S_NP_NP_JJ
mutagenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
consensus B-O B-NP_NN
CKII B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
EBV B-O B-NP_NN
SM B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
greatly B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBD
the B-O B-NP_NP_DT
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
SM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
CKII B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transactivation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
BMLF1 B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
controversial B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
but B-O B-CC
SM B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
transactivate B-O B-VP_VB
gene B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-NP
by B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Mutagenesis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
CKII B-O B-NP_NN
" " B-O O-NP
site B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
SM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
made B-O B-VP_VBD
no B-O B-NP_DT
difference B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
transactivation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
this B-O B-NP_DT
transient B-O B-JJ
transfection B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Prevalence B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
aneuploidy B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
overexpressed B-O B-NP_JJ
ER B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
overexpressed B-O B-NP_JJ
EGFR B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
random B-O B-NP_NP_JJ
breast B-O B-NN
aspirates B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
women B-O B-NP_NP_NNS
" " B-O O-NP
at B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Breast B-O B-S_NP_NP_NN
tissue B-O B-NN
biomarkers B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
accurately B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
predict B-O B-VP_VBP
breast B-O B-NP_NP_NN
cancer B-O B-NN
development B-O B-NN
" " B-O O-NP
within B-O B-PP_IN
a B-O B-NP_DT
10 B-O B-ADJP_CD
year B-O B-NN
" " B-O O-ADJP
period B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
high B-O B-NP_ADJP_JJ
risk B-O B-NN
" " B-O O-ADJP
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
are B-O B-VP_VBP
needed B-O B-UCP_VP_VBN
" " B-O B-NP_O-VP
but B-O B-CC
currently B-O B-ADJP_ADVP_RB
" " B-O O-ADVP
not B-O B-RB
available B-O B-JJ
" " B-O O-ADJP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
initiated B-O B-VP_VBD
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
1 B-O B-UCP_NP_LST_LS
) B-O B-RRB
" " B-O O-LST
the B-O B-NP_DT
prevalence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
2 B-O B-SBAR_LST_LS
) B-O B-RRB
" " B-O O-LST
if B-O B-IN
is B-O B-S_NP_NP_PP_VP_VBZ
" " B-O B-ADJP_PP_PP_O-S
" " B-O O-SBAR
" " B-O O-UCP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Eligible B-O B-S_NP_JJ
high B-O B-JJ
risk B-O B-NN
women B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
those B-O B-NP_NP_DT
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
first B-O B-ADJP_JJ
degree B-O B-NN
" " B-O O-ADJP
relative B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
breast B-O B-NP_NP_NN
cancer B-O B-NN
" " B-O O-NP
, B-O B-COMMA
prior B-O B-NP_JJ
breast B-O B-NN
cancer B-O B-NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
precancerous B-O B-NP_JJ
mastopathy B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Low B-O B-S_NP_JJ
risk B-O B-NN
women B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
those B-O B-NP_NP_DT
" " B-O O-NP
without B-O B-PP_IN
these B-O B-NP_NP_DT
" " B-O O-NP
or B-O B-CC
other B-O B-NP_JJ
major B-O B-JJ
identifiable B-O B-JJ
risk B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Ductal B-O B-S_NP_JJ
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
obtained B-O B-VP_VP_VBN
via B-O B-NP_PP_IN
random B-O B-NP_JJ
fine B-O B-JJ
needle B-O B-NN
aspirations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
cytologically B-O B-VP_ADVP_RB
" " B-O O-ADVP
classified B-O B-VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Biomarkers B-O B-S_NP_NNS
" " B-O O-NP
included B-O B-VP_VBD
DNA B-O B-NP_NP_NN
ploidy B-O B-NN
" " B-O O-NP
, B-O B-COMMA
estrogen B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ER B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
epidermal B-O B-NP_NP_JJ
growth B-O B-NN
factor B-O B-NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EGFR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_S_NP_NP_DT
prevalence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
aneuploidy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
30 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
overexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
ER B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
10 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
overexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
EGFR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
35 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-S
" " B-O O-S
, B-O B-COMMA
in B-O B-PP_IN
the B-O B-NP_NP_DT
206 B-O B-CD
high B-O B-JJ
risk B-O B-NN
women B-O B-NNS
" " B-O O-NP
whose B-O B-SBAR_WHNP_NP_WPP
median B-O B-JJ
10 B-O B-ADJP_CD
year B-O B-NN
" " B-O O-ADJP
Gail B-O B-NN
risk B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
projected B-O B-NP_VBN
probability B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
developing B-O B-S_NP_VP_VBG
breast B-O B-NP_NN
cancer B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
4.5 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
prevalence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
aneuploidy B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
overexpressed B-O B-NP_JJ
EGFR B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADJP_ADJP_RB
higher B-O B-JJR
" " B-O O-ADJP
" " B-O B-PP_O-ADJP
in B-O B-PP_IN
the B-O B-NP_DT
high B-O B-JJ
risk B-O B-NN
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
than B-O B-PP_IN
in B-O B-FRAG_PP_IN
the B-O B-NP_NP_NP_DT
25 B-O B-CD
low B-O B-JJ
risk B-O B-NN
controls B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-S_NP_NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
whose B-O B-SBAR_WHNP_WPP
median B-O B-JJ
10 B-O B-ADJP_CD
year B-O B-NN
" " B-O O-ADJP
Gail B-O B-NN
risk B-O B-NN
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
prevalence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ER B-O B-NP_NN
overexpression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
between B-O B-PP_IN
high B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
low B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
risk B-O B-NN
groups B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
statistically B-O B-ADVP_RB
" " B-O O-ADVP
significant B-O B-ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
p B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
0.095 B-O B-NP_CD
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
due B-O B-PP_JJ
to B-O B-TO
the B-O B-NP_NP_NP_DT
low B-O B-JJ
prevalence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
overexpressed B-O B-NP_JJ
ER B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
small B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
controls B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
significant B-O B-JJ
difference B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
noted B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
prevalence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
one B-O B-NP_QP_CD
or B-O B-CC
more B-O B-JJR
" " B-O O-QP
abnormal B-O B-JJ
biomarkers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
between B-O B-PP_IN
the B-O B-NP_DT
high B-O B-NP_NP_JJ
risk B-O B-NN
" " B-O O-NP
and B-O B-CC
low B-O B-NP_JJ
risk B-O B-NN
" " B-O O-NP
" " B-O O-NP
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
p B-O B-S_NP_NN
" " B-O O-NP
< B-O B-NP_QP_JJR
0.001 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
large B-O B-JJ
prospective B-O B-JJ
trial B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
needed B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
determine B-O B-VP_VB
if B-O B-SBAR_IN
, B-O B-S_NP_NP_PP_COMMA
is B-O B-VP_VBZ
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Glucocorticoid-induced B-O B-NP_NP_NP_JJ
apoptosis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NN
death B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
earliest B-O B-NP_ADVP_JJS
" " B-O O-ADVP
" " B-O B-NP_O-NP
and B-O B-CC
most B-O B-NP_ADVP_JJS
thoroughly B-O B-RB
" " B-O O-ADVP
" " B-O B-NP_O-NP
studied B-O B-NP_VBN
models B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
apoptosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Although B-O B-S_SBAR_IN
the B-O B-S_NP_NP_DT
exact B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
apoptosis B-O B-S_NP_NN
" " B-O O-NP
occurs B-O B-VP_VBZ
in B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
many B-O B-S_NP_JJ
biochemical B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
molecular B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
changes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
occur B-O B-VP_VB
in B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
chromatin B-O B-NP_NP_NP_NN
" " B-O O-NP
degradation B-O B-NN
" " B-O O-NP
and B-O B-CC
endonucleases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
apoptotic B-O B-JJ
process B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-NP_O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
closely B-O B-ADVP_RB
" " B-O O-ADVP
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
the B-O B-NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_JJ
oncogenes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
glucocorticoid-induced B-O B-NP_JJ
cell B-O B-NN
lysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
clinical B-O B-JJ
importance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid-induced B-O B-NP_NP_JJ
apoptosis B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphoid B-O B-NP_JJ
neoplasms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
recently B-O B-ADVP_RB
" " B-O O-ADVP
received B-O B-VP_VBN
increased B-O B-NP_VBN
attention B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFATp B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
cyclosporin B-O B-NP_NP_NN
A-sensitive B-O B-JJ
tumor B-O B-NN
necrosis B-O B-NN
factor-alpha B-O B-NN
gene B-O B-NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
tumor B-O B-NP_NN
necrosis B-O B-NN
factor-alpha B-O B-NN
( B-O B-LRB
TNF B-O B-NN
alpha B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
immediate B-O B-JJ
early B-O B-JJ
gene B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
in B-O B-PP_IN
that B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBN
without B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Maximal B-O B-S_NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TNF B-O B-NP_NN
alpha B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
calcium B-O B-NP_NP_NN
ionophores B-O B-NNS
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
via B-O B-PP_IN
a B-O B-NP_NP_DT
calcineurin-dependent B-O B-JJ
process B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VBN
a B-O B-NP_NP_NP_DT
promoter B-O B-NP_NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
kappa B-O B-NP_NN
3 B-O B-CD
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
kappa B-O B-NP_NN
3 B-O B-CD
binding B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
contains B-O B-VP_VBZ
NFATp B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
cyclosporin-sensitive B-O B-NP_JJ
DNA-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NFATp B-O B-S_S_NP_NN
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
two B-O B-NP_NP_CD
sites B-O B-NNS
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_DT
kappa B-O B-NP_NN
3 B-O B-CD
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
occupancy B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
TNF B-O B-NP_NP_NN
" " B-O O-NP
alpha B-O B-NN
gene B-O B-NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
although B-O B-SBAR_IN
the B-O B-S_NP_DT
kappa B-O B-NP_NN
3 B-O B-CD
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
little B-O B-NP_NP_JJ
sequence B-O B-NN
similarity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
other B-O B-NP_JJ
NFATp-binding B-O B-NP_JJ
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
it B-O B-S_NP_PRP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
function B-O B-VP_VB
as B-O B-PP_IN
a B-O B-NP_DT
cyclosporin-sensitive B-O B-NP_JJ
promoter B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFATp B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_NP_DT
the B-O B-DT
interleukin-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
TNF B-O B-NP_NN
alpha B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
this B-O B-S_NP_DT
factor B-O B-NN
" " B-O O-NP
plays B-O B-VP_VBZ
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
coordinate B-O B-JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
multiple B-O B-NP_JJ
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
starting B-O B-S_NP_VP_VBG
at B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inhibition B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
a B-O B-NP_DT
Tat-activated B-O B-NP_JJ
, B-O B-COMMA
transduced B-O B-VBN
interferon B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
targeted B-O B-NP_NP_VBN
expression B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1-infected B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
feasibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
using B-O B-S_NP_VP_VBG
gene B-O B-NP_NP_NN
transfer B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
limit B-O B-VP_VB
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
transduced B-O B-VBN
HIV-1 B-O B-NP_NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
( B-O B-LRB
LTR B-O B-NN
) B-O B-RRB
-IFNA2 B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-S_NP_VP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
hybrid B-O B-S_NP_NP_NP_NN
gene B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
HIV-1-infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
HIV-1 B-O B-NP_NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
modified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Deletion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
NF-kappa B-O B-NP_NN
B B-O B-NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NP_NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
significantly B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
Tat-mediated B-O B-NP_JJ
transactivation B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
T-cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
a B-O B-NP_NP_DT
monocyte B-O B-NP_NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
U937 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Replacement B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
NF-kappa B-O B-NP_NN
B B-O B-NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NP_NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
a B-O B-NP_NP_DT
DNA B-O B-NP_NN
fragment B-O B-NN
" " B-O O-NP
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_NP_DT
5'-flanking B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
partially B-O B-ADVP_RB
" " B-O O-ADVP
restored B-O B-VP_VBD
Tat-mediated B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LTR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Insertion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
chimeric B-O B-NP_NP_JJ
promoter B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ISG15 B-O B-NP_NN
LTR B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
upstream B-O B-ADVP_JJ
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_JJ
IFNA2 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-NP
directed B-O B-VP_VBD
high B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
IFN B-O B-NP_NP_NN
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
Tat-expressing B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
while B-O B-SBAR_IN
this B-O B-S_NP_DT
promoter B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
responsive B-O B-ADJP_JJ
to B-O B-PP_TO
tumor B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha-mediated B-O B-JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ISG15-LTR-IFN B-O B-S_NP_NP_JJ
hybrid B-O B-NN
gene B-O B-NN
" " B-O O-NP
inserted B-O B-VP_VBN
into B-O B-NP_PP_IN
the B-O B-NP_DT
retrovirus B-O B-NP_NN
vector B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
transduced B-O B-VP_VBN
into B-O B-NP_PP_IN
Jurkat B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Selected B-O B-S_S_NP_VBN
transfected B-O B-NP_VBN
clones B-O B-NNS
" " B-O O-NP
" " B-O O-NP
produced B-O B-VP_VBD
low B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
IFN B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IFNA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
their B-O B-S_NP_PRPP
abilities B-O B-NNS
to B-O B-S_NP_VP_TO
express B-O B-VP_VB
interleukin-2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
interleukin-2 B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
upon B-O B-PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
were B-O B-VP_VBD
retained B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Enhancement B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IFNA B-O B-NP_NP_NN
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
observed B-O B-VP_VBN
upon B-O B-NP_PP_IN
HIV-1 B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
significant B-O B-NP_NP_JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
a B-O B-NP_NP_DT
period B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
at B-O B-NP_QP_IN
least B-O B-JJS
30 B-O B-CD
" " B-O O-QP
days B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Virus B-O B-S_NP_NP_NN
" " B-O O-NP
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
IFNA-producing B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
replicate B-O B-VP_VB
in B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
but B-O B-CC
did B-O B-VP_VBD
not B-O B-RB
replicate B-O B-VP_VB
efficiently B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
U937 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
transduced B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
targeting B-O B-S_S_NP_VP_VBG
IFN B-O B-NP_NP_NN
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
HIV-1-infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
is B-O B-VP_VBZ
an B-O B-NP_DT
attainable B-O B-JJ
goal B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
autocrine B-O B-S_NP_NN
IFN B-O B-NP_NN
" " B-O O-NP
synthesis B-O B-NN
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
a B-O B-NP_NP_DT
suppression B-O B-ADJP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Epstein-Barr B-O B-S_S_NP_NP_NP_JJ
virus B-O B-NN
nuclear B-O B-JJ
protein B-O B-NN
2 B-O B-CD
" " B-O O-NP
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
latent B-O B-NP_JJ
membrane B-O B-NN
protein B-O B-NN
1 B-O B-CD
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
J B-O B-NP_NP_NN
kappa B-O B-NN
" " B-O O-NP
and B-O B-CC
PU.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Expression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
( B-O B-LRB
EBV B-O B-NN
) B-O B-RRB
latent B-O B-JJ
membrane B-O B-NN
protein B-O B-NN
1 B-O B-CD
( B-O B-LRB
LMP-1 B-O B-NN
) B-O B-RRB
oncogene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
EBV B-O B-NP_NN
nuclear B-O B-JJ
protein B-O B-NN
2 B-O B-CD
( B-O B-LRB
EBNA-2 B-O B-NN
) B-O B-RRB
transactivator B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
EBNA-2 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
interact B-O B-VP_VB
with B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
recruited B-O B-VP_VBN
to B-O B-NP_PP_TO
promoters B-O B-NP_NP_NNS
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_DT
GTGGGAA B-O B-NN
J B-O B-NP_NN
kappa B-O B-NN
recognition B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
minimal B-O B-NP_JJ
EBNA-2-responsive B-O B-JJ
LMP-1 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
includes B-O B-VP_VBZ
one B-O B-NP_CD
J B-O B-NP_NN
kappa-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
we B-O B-S_NP_PRP
" " B-O O-NP
now B-O B-ADVP_RB
" " B-O O-ADVP
show B-O B-VP_VBP
that B-O B-SBAR_IN
mutation B-O B-S_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
that B-O B-NP_DT
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
such B-O B-NP_NP_JJ
" " B-O O-NP
that B-O B-SBAR_WHNP_IN
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
reduces B-O B-VP_VBZ
EBNA-2 B-O B-NP_NP_NN
" " B-O O-NP
responsiveness B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
60 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
identify B-O B-VP_VB
other B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
interact B-O B-S_NP_VP_VBP
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
a B-O B-S_NP_DT
-236/-145 B-O B-NP_JJ
minimal B-O B-JJ
E2RE B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_DT
probe B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
an B-O B-NP_DT
electrophoretic B-O B-JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
previously B-O B-ADJP_RB
characterized B-O B-VBN
" " B-O O-ADJP
factors B-O B-NNS
" " B-O O-NP
J B-O B-NP_NP_NN
kappa B-O B-NN
" " B-O O-NP
, B-O B-COMMA
PU.1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
AML1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
bind B-O B-VP_VBP
to B-O B-PP_TO
the B-O B-NP_DT
LMP-1 B-O B-NP_NN
E2RE B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
along B-O B-PP_IN
with B-O B-PP_IN
six B-O B-NP_NP_CD
other B-O B-ADJP_JJ
unidentified B-O B-JJ
" " B-O O-ADJP
factors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
LBF2 B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
LBF7 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_NP_VBG
sites B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
mapped B-O B-VP_VBN
for B-O B-NP_PP_IN
each B-O B-NP_DT
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LBF4 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
B- B-O B-ADJP_NN
and B-O B-CC
T-cell B-O B-NN
specific B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
recognizes B-O B-VP_VBZ
the B-O B-NP_DT
PU.1 B-O B-NP_NN
GGAA B-O B-NN
core B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
as B-O B-SBAR_IN
shown B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
methylation B-O B-NP_NN
interference B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LBF4 B-O B-S_NP_NN
" " B-O O-NP
has B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
molecular B-O B-JJ
mass B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
105 B-O B-NP_CD
kDa B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
probably B-O B-ADVP_RB
" " B-O O-ADVP
unrelated B-O B-ADJP_JJ
to B-O B-PP_TO
PU.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LBF2 B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
only B-O B-NP_PP_RB
in B-O B-IN
epithelial B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
whereas B-O B-SBAR_IN
LBF3 B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
LBF5 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
LBF6 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
LBF7 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
cell B-O B-ADJP_NN
type B-O B-NN
specific B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutations B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
AML1- B-O B-NP_NN
" " B-O B-ADJP_NP_O-NP
or B-O B-CC
LBF4-binding B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
sites B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
EBNA-2 B-O B-NP_NP_NN
" " B-O O-NP
transactivation B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
whereas B-O B-SBAR_IN
mutation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
PU.1-binding B-O B-NP_JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
completely B-O B-ADVP_RB
" " B-O O-ADVP
eliminated B-O B-VP_VBD
EBNA-2 B-O B-NP_NP_NN
" " B-O O-NP
responses B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
gst-EBNA-2 B-O B-NP_NN
fusion B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
depleted B-O B-VP_VP_VBD
PU.1 B-O B-NP_NN
" " B-O O-NP
from B-O B-PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
bound B-O B-VP_VBD
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
translated B-O B-NP_VBN
PU.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
providing B-O B-S_NP_VP_VBG
biochemical B-O B-NP_NP_JJ
evidence B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
a B-O B-NP_DT
direct B-O B-JJ
EBNA-2-PU.1 B-O B-JJ
interaction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
EBNA-2 B-O B-NP_NP_NP_NN
" " B-O O-NP
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
LMP-1 B-O B-NP_NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
interaction B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
at B-O B-NP_NP_QP_IN
least B-O B-JJS
two B-O B-CD
" " B-O O-QP
DNA-binding B-O B-ADJP_ADJP_ADJP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
J B-O B-NP_NP_NN
kappa B-O B-NN
" " B-O O-NP
and B-O B-CC
PU.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LBF3 B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
LBF5 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
LBF6 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
LBF7 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
involved B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
, B-O B-COMMA
since B-O B-SBAR_IN
their B-O B-S_NP_PRPP
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
contribute B-O B-VP_VBP
to B-O B-PP_TO
EBNA-2 B-O B-NP_NP_NN
" " B-O O-NP
responsiveness B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Pyrrolidine B-O B-S_S_NP_NP_NN
dithiocarbamate B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
potent B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
prevents B-O B-VP_VBZ
apoptosis B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
promyelocytic B-O B-NP_JJ
leukemia B-O B-NN
HL-60 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
thymocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
pyrrolidine B-O B-NP_NP_NP_NN
dithiocarbamate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PDTC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
potently B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
blocks B-O B-VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
on B-O B-PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
apoptosis B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
human B-O B-NP_NP_JJ
promyelocytic B-O B-JJ
leukemia B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
HL-60 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_IN
10 B-O B-NP_NP_CD
micrograms/mL B-O B-NNS
etoposide B-O B-NN
" " B-O O-NP
or B-O B-CC
2 B-O B-NP_CD
microM B-O B-NN
1-beta-D-arabinofuranosylcytosine B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induced B-O B-VP_VP_VBD
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
within B-O B-PP_IN
1 B-O B-NP_CD
hr B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
subsequently B-O B-ADVP_RB
" " B-O O-ADVP
caused B-O B-VP_VBD
apoptosis B-O B-NP_NN
" " B-O O-NP
within B-O B-PP_IN
3-4 B-O B-NP_QP_JJ
" " B-O O-QP
hr B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
simultaneous B-O B-JJ
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
50-500 B-O B-NP_ADJP_QP_CD
" " B-O O-QP
microM B-O B-NN
" " B-O O-ADJP
PDTC B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
these B-O B-NP_DT
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
blocked B-O B-VP_VP_VBD
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
completely B-O B-ADVP_RB
" " B-O O-ADVP
abrogated B-O B-VP_VBD
both B-O B-NP_CC
morphologically B-O B-ADVP_RB
" " B-O O-ADVP
apoptotic B-O B-NP_JJ
changes B-O B-NNS
" " B-O O-NP
and B-O B-CC
internucleosomal B-O B-NP_JJ
DNA B-O B-NN
fragmentation B-O B-NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
up B-O B-NP_QP_RB
to B-O B-TO
6 B-O B-CD
" " B-O O-QP
hr B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
PDTC B-O B-NP_NN
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
the B-O B-NP_NP_DT
endonuclease B-O B-NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
contained B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
whole B-O B-JJ
cell B-O B-NN
lysates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PDTC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
etoposide- B-O B-NP_NP_NP_NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
dexamethasone-induced B-O B-NP_JJ
" " B-O B-NP_O-NP
apoptosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
thymocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
a B-O B-NP_NP_DT
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
microM B-O B-NP_QP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
PDTC B-O B-S_NP_NN
" " B-O O-NP
has B-O B-VP_VBZ
both B-O B-NP_CC
antioxidant B-O B-NP_ADJP_NN
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
metal-ion B-O B-NP_JJ
" " B-O O-NP
chelating B-O B-NP_NP_NN
activities B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
tested B-O B-VP_VBD
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
N-acetyl-L-cysteine B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
( B-O B-PRN_LRB
antioxidant B-O B-ADJP_JJ
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
or B-O B-CC
o-phenanthroline B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
( B-O B-PRN_LRB
metal-ion B-O B-NP_JJ
chelator B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
apoptosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Pretreatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HL-60 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
or B-O B-CC
thymocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
100-500 B-O B-NP_NP_ADJP_QP_CD
" " B-O O-QP
microM B-O B-NN
" " B-O O-ADJP
OP B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
2 B-O B-NP_CD
hr B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
10-60 B-O B-NP_ADJP_QP_CD
" " B-O O-QP
mM B-O B-NN
" " B-O O-ADJP
NAC B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
suppressed B-O B-VP_VBD
subsequent B-O B-NP_NP_JJ
occurrence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
apoptosis B-O B-NP_NP_NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
etoposide B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
plays B-O B-VP_VBZ
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
apoptotic B-O B-JJ
process B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
hematopoietic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
No B-O B-NP_NP_NP_NP_DT
evidence B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
progesterone B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
pregnancy B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
[ B-O B-S_LRB
see B-O B-NP_VP_VB
comments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
progesterone B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
analysed B-O B-VP_VBN
" " B-O B-NP_O-VP
, B-O B-COMMA
using B-O B-S_NP_VP_VBG
an B-O B-NP_NP_DT
enzyme B-O B-NN
linked B-O B-JJ
immunosorbent B-O B-JJ
assay B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Abbott B-O B-NP_NN
PgR-EIA B-O B-NN
monoclonal B-O B-JJ
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
in B-O B-SBAR_IN
order B-O B-NN
to B-O B-S_NP_VP_TO
evaluate B-O B-VP_VB
its B-O B-NP_PRPP
prognostic B-O B-JJ
character B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Cytosols B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
prepared B-O B-VP_VBN
from B-O B-NP_PP_IN
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
24 B-O B-NP_NP_NP_CD
women B-O B-ADJP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
seven B-O B-NP_CD
women B-O B-ADJP_ADJP_ADJP_NNS
" " B-O O-NP
, B-O B-COMMA
nine B-O B-NP_NP_CD
women B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
six B-O B-NP_CD
healthy B-O B-JJ
men B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_NP_DT
human B-O B-NP_JJ
breast B-O B-NN
carcinoma B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
ZR-75-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
expresses B-O B-S_NP_VP_VBZ
the B-O B-NP_DT
progesterone B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
analysed B-O B-VP_VBN
throughout B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
ZR-75-1 B-O B-NP_NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-NP
showed B-O B-VP_VBD
an B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
642 B-O B-NP_CD
fmol/mg B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
whereas B-O B-SBAR_IN
lymphocytes B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
pregnant B-O B-NP_JJ
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
an B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
< B-O B-NP_NP_ADJP_JJR
" " B-O O-ADJP
" " B-O B-NP_O-NP
or B-O B-CC
= B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
4 B-O B-NP_CD
fmol/mg B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Lymphocytes B-O B-S_S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
non-pregnant B-O B-NP_NP_JJ
women B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
women B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
threatened B-O B-NP_VBN
pre-term B-O B-JJ
delivery B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
men B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
equivalent B-O B-NP_JJ
levels B-O B-NNS
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
3 B-O B-NP_NP_NP_QP_CD
+/- B-O B-CC
1 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
, B-O B-COMMA
3 B-O B-NP_QP_CD
+/- B-O B-CC
2 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
and B-O B-CC
5 B-O B-NP_QP_CD
+/- B-O B-CC
4 B-O B-CD
" " B-O O-QP
" " B-O B-NP_O-NP
fmol/mg B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
show B-O B-VP_VP_VBP
that B-O B-SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
no B-O B-NP_NP_DT
evidence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
exclude B-O B-VP_VBP
any B-O B-NP_NP_DT
prognostic B-O B-JJ
character B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
spontaneous B-O B-NP_JJ
abortion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
progesterone B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
known B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
progesterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
excluded B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Differential B-O B-NP_NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
proto-oncogenes B-O B-NP_NP_NNS
" " B-O O-NP
c-jun B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
activated B-O B-VP_VBN
through B-O B-NP_PP_IN
CD28 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
T B-O B-NP_NN
cell B-O B-NN
surface B-O B-NN
molecule B-O B-NN
" " B-O O-NP
" " B-O O-NP
CD28 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
ligands B-O B-NP_NP_NNS
" " B-O O-NP
on B-O B-PP_IN
accessory B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
APCs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
playing B-O B-S_NP_VP_VBG
an B-O B-NP_DT
important B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
costimulatory B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
Ags B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Our B-O B-S_NP_NP_PRPP
knowledge B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
intracellular B-O B-JJ
signaling B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
coupled B-O B-VP_VBN
to B-O B-NP_PP_TO
this B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
incomplete B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
phospholipase B-O B-NP_NN
C B-O B-NN
gamma B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
ligation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
seems B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
a B-O B-NP_DT
calcium-independent B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
CD28-specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
pathway B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
paper B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
cross-linking B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD28 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
or B-O B-CC
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
an B-O B-NP_NP_DT
elevation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_IN
only B-O B-NP_NP_RB
minimal B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CD28-dependent B-O B-S_NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VP_VBZ
protein B-O B-NP_NP_NN
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
does B-O B-VP_VBZ
not B-O B-RB
depend B-O B-VP_VB
on B-O B-PP_IN
activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
or B-O B-CC
elevation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cytosolic B-O B-NP_JJ
calcium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
CD28-dependent B-O B-NP_NP_JJ
elevation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
appear B-O B-VP_VB
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
mediated B-O B-VP_VBN
at B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
mechanism B-O B-NN
" " B-O B-WHADVP_O-NP
is B-O B-VP_VBZ
suggested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
whereby B-O B-WHADVP_WRB
" " B-O O-WHADVP
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
junB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
members B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
fos B-O B-NP_NN
family B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
can B-O B-VP_MD
prevent B-O B-VP_VB
inappropriate B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
caused B-O B-VP_VBN
by B-O B-NP_PP_IN
ligation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Influence B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
age B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Fos B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
influenza B-O B-NP_NN
virus-exposed B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
This B-O B-S_S_NP_DT
study B-O B-NN
" " B-O O-NP
investigated B-O B-VP_VBD
age-related B-O B-NP_NP_JJ
T B-O B-NN
cell B-O B-NN
responses B-O B-NNS
" " B-O O-NP
after B-O B-PP_IN
in B-O B-NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
exposure B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
influenza B-O B-NP_NN
A B-O B-NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Mononuclear B-O B-S_NP_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
young B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
or B-O B-CC
elderly B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
persons B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
sham-exposed B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
or B-O B-CC
exposed B-O B-VP_VBN
to B-O B-NP_PP_TO
influenza B-O B-NP_NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
1 B-O B-NP_NP_CD
" " B-O B-NP_O-NP
, B-O B-COMMA
24 B-O B-NP_CD
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
72 B-O B-NP_CD
" " B-O B-NP_O-NP
h B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Immunofluorescent B-O B-S_NP_NP_JJ
staining B-O B-NN
" " B-O O-NP
and B-O B-CC
flow B-O B-NP_NN
cytometric B-O B-JJ
analysis B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
then B-O B-ADVP_RB
" " B-O O-ADVP
used B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
detect B-O B-VP_VB
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
producing B-O B-VP_VBG
the B-O B-NP_NP_DT
and B-O B-NP_NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Fewer B-O B-S_NP_NP_JJR
virus-exposed B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
elderly B-O B-NP_JJ
donors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
stained B-O B-VP_VBN
for B-O B-PP_IN
Fos B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
each B-O B-NP_DT
data B-O B-NNS
point B-O B-NN
" " B-O O-NP
" " B-O O-PP
compared B-O B-PP_VBD
with B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
young B-O B-NP_JJ
donors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Flow B-O B-S_NP_NN
cytometric B-O B-JJ
analysis B-O B-NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
at B-O B-S_PP_IN
72 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
virus B-O B-NP_NN
exposure B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
fewer B-O B-NP_NP_JJR
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
elderly B-O B-JJ
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
produced B-O B-VP_VBD
interferon-gamma B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IFN-gamma B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-VP_VBG
a B-O B-NP_NP_DT
link B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
failure B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
virus-exposed B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
produce B-O B-VP_VB
Fos B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
could B-O B-VP_MD
contribute B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
illness B-O B-NP_NP_NN
" " B-O O-NP
due B-O B-PP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-PP
in B-O B-PP_IN
the B-O B-NP_DT
elderly B-O B-JJ
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Constitutive B-O B-NP_NP_NP_JJ
nuclear B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
monocyte B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
In B-O B-S_S_PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
nuclear B-O B-NP_JJ
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
invoked B-O B-VP_VBN
as B-O B-NP_PP_IN
an B-O B-NP_NP_DT
important B-O B-JJ
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_PP_IN
and B-O B-NP_CC
in B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
such B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
DNA B-O B-NP_NP_NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
detected B-O B-VP_VBN
without B-O B-NP_PP_IN
intentional B-O B-NP_JJ
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
our B-O B-NP_PRPP
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
cells B-O B-NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_NP_JJ
monocytic B-O B-JJ
line B-O B-NN
" " B-O O-NP
Mono B-O B-NP_NN
Mac B-O B-NN
6 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
cultured B-O B-VP_VBN
in B-O B-NP_PP_IN
medium B-O B-NP_NP_NN
" " B-O O-NP
containing B-O B-VP_VBG
fetal-calf B-O B-NP_NP_JJ
serum B-O B-NN
" " B-O O-NP
and B-O B-CC
low B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
exhibit B-O B-VP_VBP
such B-O B-NP_ADJP_JJ
' B-O B-LQT
constitutive B-O B-JJ
' B-O B-RQT
" " B-O O-ADJP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_IN
demonstrated B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
mobility-shift B-O B-NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
nuclear B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
still B-O B-ADVP_RB
" " B-O O-ADVP
present B-O B-ADJP_JJ
" " B-O O-ADJP
when B-O B-SBAR_SBAR_WHADVP_WRB
" " B-O O-WHADVP
contaminant B-O B-S_NP_JJ
LPS B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
removed B-O B-VP_VBN
by B-O B-NP_PP_IN
ultrafiltration B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
serum B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
omitted B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O B-ADVP_O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Protein-DNA B-O B-S_S_NP_NP_JJ
complexes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
constitutive B-O B-NP_JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
similar B-O B-ADJP_JJ
in B-O B-PP_IN
mobility B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
LPS-induced B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
both B-O B-S_NP_DT
" " B-O O-NP
are B-O B-VP_VBP
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_NP_DT
antibody B-O B-NN
" " B-O O-NP
specific B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
treatment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
pyrrolidine B-O B-NP_NP_NN
dithiocarbamate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PDTC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
will B-O B-VP_MD
only B-O B-ADVP_RB
" " B-O O-ADVP
block B-O B-VP_VB
LPS-induced B-O B-NP_NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
constitutive B-O B-NP_JJ
binding B-O B-VBG
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
LPS-free B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
serum-free B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
conditions B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
constitutive B-O B-S_NP_JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
detected B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
different B-O B-NP_NP_JJ
of B-O B-NP_PP_IN
( B-O B-NP_PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
Molt B-O B-NP_NP_NN
4 B-O B-CD
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
or B-O B-CC
K562 B-O B-NP_NN
stem B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
ordered B-O B-S_NP_VP_VBN
according B-O B-NP_PP_VBG
to B-O B-PP_TO
stage B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
maturation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
amount B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
constitutive B-O B-NP_JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
increased B-O B-VP_VBN
in B-O B-NP_PP_IN
more B-O B-NP_RBR
mature B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
inducing B-O B-S_NP_VP_VBG
differentiation B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
Mono B-O B-NP_NN
Mac B-O B-NN
6 B-O B-CD
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
with B-O B-PP_IN
vitamin B-O B-NP_NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
no B-O B-S_NP_NP_DT
change B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
constitutive B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
or B-O B-CC
inducible B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
detected B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
primary B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
substantial B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
constitutive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
NF-kappa B-O B-NN
B-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
blood B-O B-NP_NP_NN
monocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
pleural B-O B-NP_JJ
macrophages B-O B-NNS
" " B-O O-NP
and B-O B-CC
alveolar B-O B-NP_JJ
macrophages B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
constitutive B-O B-JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
functionally B-O B-ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
since B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
low B-O B-JJ
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tumour B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
( B-O B-LRB
TNF B-O B-NN
) B-O B-RRB
transcript B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
detectable B-O B-ADJP_JJ
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
this B-O B-S_NP_DT
level B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
increased B-O B-VP_VBN
by B-O B-NP_PP_IN
blocking B-O B-S_NP_VP_VBG
transcript B-O B-NP_NN
degradation B-O B-NN
" " B-O O-NP
" " B-O B-S_NP_VP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
constitutive B-O B-NP_JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
variable B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
frequently B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
lower B-O B-ADJP_JJR
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Constitutive B-O B-S_NP_JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
maintained B-O B-VP_VBN
by B-O B-NP_PP_IN
autocrine B-O B-NP_NP_JJ
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokines B-O B-NP_NP_NNS
" " B-O O-NP
TNF B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
interleukin B-O B-NP_NN
6 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
10 B-O B-NP_NP_CD
" " B-O O-NP
, B-O B-COMMA
granulocyte-macrophage B-O B-NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
or B-O B-CC
macrophage B-O B-NP_NN
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
since B-O B-SBAR_IN
neutralizing B-O B-S_NP_VBG
antibodies B-O B-NNS
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
reduce B-O B-VP_VB
constitutive B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
DNA-binding B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
blockade B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
prostaglandin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
or B-O B-CC
leukotriene B-O B-NP_NN
biosynthesis B-O B-NN
" " B-O O-NP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
affect B-O B-VP_VB
constitutive B-O B-NP_JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
400 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
Analysis B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Oct2-isoform B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lipopolysaccharide-stimulated B-O B-NP_JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Oct2-isoform B-O B-S_S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
splenic B-O B-NP_NP_JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
lipopolysaccharide B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
plus B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
analysed B-O B-VP_VBN
by B-O B-NP_PP_IN
cDNA B-O B-NP_NN
cloning B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
frequency B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Oct2-positive B-O B-NP_JJ
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
1/15,000 B-O B-NP_QP_CD
" " B-O O-QP
" " B-O B-NP_O-NP
in B-O B-PP_IN
both B-O B-NP_DT
libraries B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_CD
new B-O B-JJ
isoforms B-O B-NNS
" " B-O B-SBAR_O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
generate B-O B-S_NP_VP_VBP
novel B-O B-NP_ADJP_JJ
" " B-O O-ADJP
amino- B-O B-NP_NN
" " B-O B-ADJP_NP_O-NP
or B-O B-CC
carboxy-terminal B-O B-NP_JJ
" " B-O B-NP_O-NP
sequences B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_DT
isoform B-O B-NN
" " B-O O-NP
lacking B-O B-VP_VBG
exon B-O B-NP_NN
11 B-O B-CD
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
destroyed B-O B-VP_VP_VBD
the B-O B-NP_DT
carboxy-terminal B-O B-JJ
leucin-zipper B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
introduced B-O B-VP_VBD
a B-O B-NP_NP_DT
frame B-O B-NN
shift B-O B-NN
" " B-O O-NP
creating B-O B-VP_VBG
a B-O B-NP_DT
novel B-O B-JJ
, B-O B-COMMA
proline-rich B-O B-JJ
carboxy B-O B-NN
terminus B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
new B-O B-JJ
exon B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
a B-O B-NP_NP_DT
highly B-O B-ADJP_RB
basic B-O B-JJ
" " B-O O-ADJP
region B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
4c B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
characterized B-O B-VP_VBN
, B-O B-NP_COMMA
between B-O B-NP_IN
exons B-O B-NNS
4 B-O B-CD
and B-O B-CC
5 B-O B-CD
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
exon B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
inserted B-O B-VP_VBN
between B-O B-NP_NP_NP_IN
glutamine-rich B-O B-JJ
regions B-O B-NNS
2 B-O B-CD
and B-O B-CC
3 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
carboxy B-O B-NP_NP_JJ
terminal B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
tentative B-O B-JJ
leucine-zipper B-O B-NN
structure B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_DT
new B-O B-JJ
combination B-O B-NN
isoform B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
Oct2a B-O B-NP_NP_NP_NN
's B-O B-POS
amino B-O B-NN
terminal B-O B-JJ
insert B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
exon B-O B-NP_NN
7a B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
Oct2b B-O B-NP_NP_NN
's B-O B-POS
carboxy B-O B-NN
terminal B-O B-JJ
insert B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
exon B-O B-NP_NN
13 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O B-SBAR_O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
created B-O B-S_NP_VP_VBD
a B-O B-NP_NP_DT
novel B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
large B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
isoform B-O B-NN
" " B-O O-NP
, B-O B-COMMA
Oct2ab B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
  
More B-O B-S_NP_NP_ADJP_RBR
frequent B-O B-JJ
" " B-O O-ADJP
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
classical B-O B-ADJP_JJ
" " B-O O-ADJP
Oct2a B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
Oct2b B-O B-NP_NN
" " B-O B-NP_O-NP
isoforms B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
lipopolysaccharide-stimulated B-O B-JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
while B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
preference B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
Oct2ab B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
Oct2ba B-O B-NP_NN
" " B-O B-NP_O-NP
isoforms B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
lipopolysaccharide B-O B-NP_NN
plus B-O B-CC
phorbol-di-butyrate-treated B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Function B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
immune B-O B-JJ
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
ubiquitous B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nevertheless B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
its B-O B-NP_PRPP
properties B-O B-NNS
" " B-O O-NP
seem B-O B-VP_VBP
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
most B-O B-VP_ADVP_RBS
extensively B-O B-RB
" " B-O O-ADVP
exploited B-O B-VBN
in B-O B-NP_PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Among B-O B-SINV_PP_IN
these B-O B-NP_DT
properties B-O B-NNS
" " B-O O-NP
" " B-O O-PP
are B-O B-VP_VBP
" " B-O B-PP_O-VP
NF-kappa B-O B-NP_NP_NP_NP_NN
B B-O B-NN
's B-O B-POS
" " B-O O-NP
rapid B-O B-JJ
posttranslational B-O B-JJ
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
many B-O B-NP_JJ
pathogenic B-O B-JJ
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
its B-O B-NP_NP_PRPP
direct B-O B-JJ
participation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cytoplasmic/nuclear B-O B-NP_ADJP_JJ
" " B-O O-ADJP
signaling B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
its B-O B-NP_PRPP
potency B-O B-NN
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-SINV
  
In B-O B-S_PP_IN
vertebrates B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
five B-O B-NP_CD
distinct B-O B-JJ
DNA B-O B-NN
binding B-O B-NN
subunits B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
currently B-O B-ADVP_RB
" " B-O O-ADVP
known B-O B-VP_VBN
which B-O B-NP_NP_SBAR_WHNP_WDT
" " B-O O-WHNP
might B-O B-S_NP_VP_MD
extensively B-O B-ADVP_RB
" " B-O O-ADVP
heterodimerize B-O B-VP_VB
, B-O B-COMMA
" " B-O B-S_NP_ADVP_VP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
binding B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
dimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
tightly B-O B-VP_ADVP_RB
" " B-O O-ADVP
controlled B-O B-VBN
by B-O B-NP_PP_IN
accessory B-O B-NP_NP_NN
proteins B-O B-NNS
" " B-O O-NP
called B-O B-VP_VBN
I B-O B-S_NP_NP_NN
kappa B-O B-NN
B B-O B-NN
subunits B-O B-NNS
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
of B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
there B-O B-S_NP_EX
" " B-O O-NP
are B-O B-VP_VBP
also B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O B-NP_NP_PP_VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
I B-O B-S_NP_NN
kappa B-O B-NN
B B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
inhibit B-O B-VP_VP_VP_VBP
DNA B-O B-NP_NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-NP
" " B-O O-VP
and B-O B-CC
prevent B-O B-VP_VBP
nuclear B-O B-NP_NP_JJ
uptake B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-VP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_DT
exception B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
Bcl-3 B-O B-NN
protein B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
in B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
can B-O B-NP_VP_MD
function B-O B-VP_VB
as B-O B-PP_IN
a B-O B-NP_DT
transcription B-O B-NN
activating B-O B-NN
subunit B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
th B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Other B-O B-S_NP_JJ
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
rather B-O B-VP_ADVP_RB
" " B-O O-ADVP
involved B-O B-VBN
in B-O B-NP_PP_IN
terminating B-O B-S_NP_VP_VBG
NF-kappa B-O B-NP_NP_NP_NN
B B-O B-NN
's B-O B-POS
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
intracellular B-O B-JJ
events B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
lead B-O B-S_NP_VP_VBP
to B-O B-PP_TO
the B-O B-NP_NP_DT
inactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
i.e. B-O B-NP_ADVP_FW
" " B-O O-ADVP
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
complex B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
They B-O B-S_NP_PRP
" " B-O O-NP
involve B-O B-VP_VP_VBP
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
proteolytic B-O B-NP_JJ
reactions B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
seem B-O B-VP_VBP
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
redox B-O B-NP_NP_NN
status B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interference B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
beneficial B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
suppressing B-O B-S_NP_VP_VBG
toxic/septic B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
shock B-O B-NN
" " B-O O-NP
, B-O B-COMMA
graft-vs-host B-O B-NP_JJ
reactions B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
acute B-O B-NP_JJ
inflammatory B-O B-JJ
reactions B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
acute B-O B-NP_JJ
phase B-O B-NN
response B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
radiation B-O B-NP_NN
damage B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
antioxidants B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
specific B-O B-NP_JJ
protease B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
provide B-O B-VP_VB
a B-O B-NP_NP_DT
pharmacological B-O B-JJ
basis B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
interfering B-O B-S_NP_VP_VBG
with B-O B-PP_IN
these B-O B-NP_DT
acute B-O B-JJ
processes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Gene B-O B-S_S_NP_NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
a B-O B-NP_DT
tissue-specific B-O B-NP_NP_JJ
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
or B-O B-NP_NP_CC
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
early B-O B-NP_NP_JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
adipocytes B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
olfactory B-O B-NP_JJ
neurons B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
located B-O B-ADJP_JJ
on B-O B-PP_IN
human B-O B-NP_NP_NP_JJ
chromosome B-O B-NN
5 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
band B-O B-NP_NN
q34 B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
proximal B-O B-NP_JJ
mouse B-O B-NN
chromosome B-O B-NN
11 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Murine B-O B-S_S_NP_NP_NN
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
adipocytes B-O B-NP_ADJP_NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
olfactory B-O B-NP_ADJP_JJ
neurons B-O B-NNS
" " B-O O-NP
" " B-O O-NP
contain B-O B-VP_VBP
a B-O B-NP_NP_DT
DNA-binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
participates B-O B-S_NP_VP_VBZ
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Purification B-O B-S_NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
cloning B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
termed B-O B-VP_VBN
early B-O B-S_NP_NP_NP_RB
B-cell B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
from B-O B-PP_IN
murine B-O B-NP_NN
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
independent B-O B-NP_NP_JJ
cloning B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
termed B-O B-VP_VBN
Olf-1 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
from B-O B-PP_IN
olfactory B-O B-NP_JJ
neuronal B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
revealed B-O B-VP_VBD
virtual B-O B-NP_ADJP_JJ
complete B-O B-JJ
" " B-O O-ADJP
amino B-O B-NN
acid B-O B-NN
sequence B-O B-NN
identity B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
these B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_PP_IN
a B-O B-NP_NP_DT
first B-O B-JJ
step B-O B-NN
" " B-O O-NP
towards B-O B-PP_IN
identifying B-O B-S_NP_VP_VBG
a B-O B-NP_NP_NP_DT
human B-O B-JJ
genetic B-O B-JJ
disorder B-O B-NN
" " B-O O-NP
or B-O B-CC
mouse B-O B-NP_NN
mutation B-O B-NN
" " B-O O-NP
" " B-O O-NP
for B-O B-SBAR_WHPP_IN
" " B-O B-WHNP_S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
chromosomally B-O B-ADVP_RB
" " B-O O-ADVP
mapped B-O B-VP_VBN
the B-O B-NP_NP_DT
corresponding B-O B-JJ
locus B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_DT
species B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
Southern B-O B-NP_NP_NP_NN
hybridization B-O B-NN
analyses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
somatic B-O B-NP_JJ
cell B-O B-NN
hybrid B-O B-NN
panels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
murine B-O B-NP_NN
cDNA B-O B-NN
probe B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
fluorescence B-O B-NP_NP_NP_NN
chromosomal B-O B-JJ
in B-O B-ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
FISH B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_ADJP_JJ
genomic B-O B-JJ
" " B-O O-ADJP
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
analysis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
recombinant B-O B-NP_ADJP_JJ
inbred B-O B-JJ
" " B-O O-ADJP
mouse B-O B-NN
strains B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
found B-O B-VP_VBN
single B-O B-NP_NP_JJ
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
EBF B-O B-NP_NN
homologous B-O B-JJ
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_PP_IN
5 B-O B-NP_NP_NP_ADJP_NP_CD
" " B-O O-NP
, B-O B-COMMA
band B-O B-NP_NN
q34 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
and B-O B-CC
on B-O B-PP_IN
proximal B-O B-NP_JJ
mouse B-O B-NN
Chr B-O B-NN
11 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
an B-O B-NP_DT
evolutionarily B-O B-RB
conserved B-O B-VBN
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Increased B-O B-NP_NP_VBN
interleukin B-O B-NN
2 B-O B-CD
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
murine B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
ciprofloxacin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
fluoroquinolone B-O B-JJ
antibiotic B-O B-JJ
" " B-O O-NP
, B-O B-COMMA
ciprofloxacin B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
cipro B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
induces B-O B-VP_VBZ
hyperproduction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
interleukin B-O B-NP_NP_NP_NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
interferon-gamma B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IFN-gamma B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
stimulated B-O B-NP_VBN
human B-O B-JJ
peripheral B-O B-JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
investigation B-O B-NN
" " B-O O-NP
" " B-O O-PP
an B-O B-NP_DT
enhanced B-O B-ADJP_ADJP_VBN
" " B-O O-ADJP
and B-O B-CC
prolonged B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-2 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
response B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
detected B-O B-VBN
in B-O B-NP_PP_PP_IN
both B-O B-CC
stimulated B-O B-NP_ADJP_NP_VBN
( B-O B-LRB
T B-O B-NP_NN
cell B-O B-NN
or B-O B-NP_NP_CC
" " B-O B-NP_O-NP
) B-O B-RRB
" " B-O O-ADJP
murine B-O B-JJ
splenocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
the B-O B-NP_DT
stimulated B-O B-VBN
murine B-O B-JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
EL-4 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
ciprofloxacin B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
5-80 B-O B-NP_QP_CD
" " B-O O-QP
micrograms/ml B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
as B-O B-SBAR_IN
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
control B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
without B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-PP_IN
contrast B-O B-NN
to B-O B-TO
human B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
IFN-gamma B-O B-S_S_NP_NN
production B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
IFN-gamma B-O B-S_NP_NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
unaffected B-O B-VP_VP_VP_JJ
at B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
only B-O B-VP_ADVP_RB
slightly B-O B-RB
" " B-O O-ADVP
upregulated B-O B-VBN
at B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
of B-O B-PP_IN
culture B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
murine B-O B-NP_NP_JJ
splenocytes B-O B-NNS
" " B-O O-NP
incubated B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
EL-4 B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
transfected B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
plasmid B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_NP_DT
IL-2 B-O B-NN
and B-O B-NP_NP_CC
region B-O B-NP_NN
" " B-O O-NP
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CAT B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
cipro B-O B-S_NP_NN
" " B-O O-NP
enhanced B-O B-VP_VBD
IL-2 B-O B-NP_NN
gene B-O B-NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
EL-4 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
incubated B-O B-VP_VBN
with B-O B-NP_PP_IN
ciprofloxacin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
showed B-O B-VP_VBD
an B-O B-NP_NP_DT
early B-O B-JJ
peak B-O B-NN
" " B-O O-NP
and B-O B-CC
more B-O B-NP_ADJP_RBR
activated B-O B-VBN
" " B-O O-ADJP
nuclear B-O B-NP_NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
NFAT-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
as B-O B-SBAR_IN
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
control B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
without B-O B-PP_IN
antibiotics B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cipro B-O B-S_NP_NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
affect B-O B-VP_VB
the B-O B-NP_DT
nuclear B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
AP-1 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
NFIL-2A B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
cipro B-O B-NP_NN
" " B-O O-NP
inhibited B-O B-VP_VP_VBD
IFN-gamma B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
enhanced B-O B-VP_VBD
IL-2 B-O B-NP_NP_NN
production B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
murine B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
means B-O B-NNS
of B-O B-IN
influencing B-O B-S_NP_VP_VP_VBG
NFAT-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
causing B-O B-VP_VBG
an B-O B-NP_DT
increased B-O B-VBN
IL-2 B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Multiple B-O B-S_NP_JJ
prolactin-responsive B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
mediate B-O B-VP_VBP
G1 B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
S B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
phase B-O B-NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
interferon B-O B-NN
regulatory B-O B-JJ
factor-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
interferon B-O B-NP_NP_NN
regulatory B-O B-JJ
factor-1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IRF-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
both B-O B-NP_NP_CC
an B-O B-NP_DT
immediate-early B-O B-JJ
G1 B-O B-NN
phase B-O B-NN
gene B-O B-NN
" " B-O O-NP
and B-O B-CC
an B-O B-NP_DT
S B-O B-NN
phase B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
inducible B-O B-ADJP_JJ
by B-O B-PP_IN
PRL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
rat B-O B-NP_NN
Nb2 B-O B-NN
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
understand B-O B-VP_VB
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
PRL B-O B-S_NP_NN
" " B-O O-NP
regulates B-O B-VP_VBZ
" " B-O B-NP_NP_PP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
cloned B-O B-VP_VP_VBD
the B-O B-NP_DT
rat B-O B-NN
IRF-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
functionally B-O B-VP_ADVP_RB
" " B-O O-ADVP
characterized B-O B-VBD
the B-O B-NP_DT
IRF-1 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Upon B-O B-S_PP_IN
transfection B-O B-NP_NP_NN
" " B-O O-NP
into B-O B-PP_IN
Nb2 B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
1.7 B-O B-NP_NP_CD
kilobases B-O B-NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
kb B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
IRF-1 B-O B-NP_NP_NN
5'-flanking B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
a B-O B-NP_DT
chloramphenicol B-O B-NP_NP_NN
acetyl B-O B-JJ
transferase B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
mediated B-O B-VP_VBD
a B-O B-NP_NP_DT
30-fold B-O B-JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CAT B-O B-NP_NN
enzyme B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
24 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PRL B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletion B-O B-S_NP_NP_NN
mutants B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VBG
1.3 B-O B-NP_ADJP_QP_CD
, B-O B-COMMA
0.6 B-O B-CD
, B-O B-COMMA
and B-O B-CC
0.2 B-O B-CD
" " B-O O-QP
kb B-O B-NN
" " B-O O-ADJP
5'-flanking B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
incrementally B-O B-ADJP_ADVP_RB
less B-O B-ADVP_RBR
transcriptionally B-O B-RB
" " B-O O-ADVP
" " B-O O-ADVP
active B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
although B-O B-SBAR_IN
0.2 B-O B-S_NP_CD
kb B-O B-NN
" " B-O O-NP
still B-O B-ADVP_RB
" " B-O O-ADVP
mediated B-O B-VP_VBD
a B-O B-NP_NP_DT
12-fold B-O B-JJ
induction B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
PRL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
sequence B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
-1.7 B-O B-NP_QP_CD
and B-O B-CC
-0.2 B-O B-CD
" " B-O O-QP
kb B-O B-NN
" " B-O O-NP
" " B-O O-PP
linked B-O B-VP_VBN
to B-O B-NP_PP_TO
a B-O B-NP_DT
heterologous B-O B-JJ
thymidine B-O B-NN
kinase B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
respond B-O B-VP_VB
to B-O B-PP_TO
PRL B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
upstream B-O B-NP_JJ
PRL B-O B-NN
response B-O B-NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
require B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
assaying B-O B-S_NP_VP_VBG
CAT B-O B-NP_NP_NN
enzyme B-O B-NN
activity B-O B-NN
" " B-O O-NP
across B-O B-PP_IN
a B-O B-NP_DT
24-h B-O B-JJ
PRL B-O B-NN
induction B-O B-NN
time B-O B-NN
course B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
were B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
assign B-O B-VP_VB
vs. B-O B-NP_NP_NP_NP_CC
phase B-O B-NP_NN
PRL B-O B-NN
responses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IRF-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-PP_TO
different B-O B-NP_NP_JJ
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
0.2-kb B-O B-JJ
IRF-CAT B-O B-NN
construct B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
PRL B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
the B-O B-NP_NP_DT
G1 B-O B-NN
phase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
1.7-kb B-O B-JJ
IRF-CAT B-O B-NN
construct B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
inducible B-O B-ADJP_JJ
by B-O B-PP_IN
PRL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
during B-O B-PP_IN
both B-O B-NP_NP_NP_CC
G1 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
S B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
phase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Hence B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
PRL-induced B-O B-JJ
biphasic B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IRF-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
separate B-O B-NP_JJ
PRL-responsive B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
elements B-O B-S_S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
first B-O B-JJ
0.2 B-O B-CD
kb B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IRF-1 B-O B-NN
promoter B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
act B-O B-VP_VBP
during B-O B-PP_IN
early B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
elements B-O B-S_NP_NP_NNS
" " B-O O-NP
between B-O B-PP_IN
0.2 B-O B-NP_QP_CD
and B-O B-CC
1.7 B-O B-CD
" " B-O O-QP
kb B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
act B-O B-VP_VBP
in B-O B-PP_IN
concert B-O B-NN
with B-O B-IN
the B-O B-NP_DT
proximal B-O B-JJ
0.2-kb B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
S B-O B-NP_NN
phase B-O B-NN
progression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Nonpituitary B-O B-S_S_NP_JJ
human B-O B-JJ
prolactin B-O B-NN
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
independent B-O B-UCP_ADJP_JJ
of B-O B-PP_IN
Pit-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
and B-O B-CC
differentially B-O B-ADVP_RB
" " B-O O-ADVP
controlled B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
endometrial B-O B-NP_JJ
stroma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Expression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
PRL B-O B-NN
( B-O B-LRB
hPRL B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
extrapituitary B-O B-NP_NP_JJ
sites B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
the B-O B-NP_NP_NP_DT
uterus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
directed B-O B-VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_NP_DT
alternative B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-S_NP_VP_TO
delineate B-O B-VP_VB
the B-O B-NP_NP_DT
tissue-specific B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
governing B-O B-VP_VBG
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
cloned B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
sequenced B-O B-VP_VBN
" " B-O B-NP_O-VP
3 B-O B-NP_NP_CD
kb B-O B-NN
5'-flanking B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
upstream B-O B-JJ
decidual/lymphoid B-O B-JJ
( B-O B-LRB
dPRL B-O B-NN
) B-O B-RRB
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Based B-O B-S_PP_VBN
on B-O B-PP_IN
sequence B-O B-NP_NN
homology B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
identified B-O B-VP_VBD
two B-O B-NP_NP_NP_CD
binding B-O B-VBG
motifs B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
Pit-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
seven B-O B-NP_NP_CD
half-sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NP_NN
receptor/progesterone B-O B-NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
focused B-O B-VP_VBD
our B-O B-NP_PRPP
studies B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_PP_IN
Pit-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
of B-O B-PP_IN
PR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
as B-O B-PP_IN
potential B-O B-NP_JJ
transcriptional B-O B-JJ
regulators B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
since B-O B-SBAR_IN
the B-O B-S_S_NP_DT
POU B-O B-NP_NP_NN
domain B-O B-NN
protein B-O B-NN
" " B-O O-NP
Pit-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
progesterone B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
decidual B-O B-NP_NP_NP_JJ
transformation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
differentiation B-O B-NN
process B-O B-NN
" " B-O O-NP
" " B-O B-SBAR_WHPP_S_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
in B-O B-PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NP_NN
types B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
endometrial B-O B-NP_JJ
stroma B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
that B-O B-SBAR_IN
Pit-1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
experiments B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
show B-O B-VP_VBP
that B-O B-SBAR_IN
activated B-O B-S_NP_VBN
PR B-O B-NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
confer B-O B-VP_VB
direct B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
transcriptional B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
control B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
dPRL B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
we B-O B-S_NP_PRP
" " B-O O-NP
compared B-O B-VP_VBD
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
transfected B-O B-VBN
dPRL B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
PRL-secreting B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
nonsecreting B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
3 B-O B-CD
kb B-O B-NN
5'-flanking B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
dPRL B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VP_VBD
not B-O B-RB
contain B-O B-VP_VB
" " B-O B-NP_NP_VP_O-VP
" " B-O O-VP
but B-O B-CC
allowed B-O B-VP_VBD
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
was B-O B-VP_VBD
in B-O B-PP_IN
sharp B-O B-NP_NP_JJ
contrast B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
endometrial B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
3 B-O B-S_NP_CD
kb B-O B-NN
5'-flanking B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
, B-O B-VP_VP_COMMA
but B-O B-CC
" " B-O B-VP_ADVP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
dPRL B-O B-NN
promoter B-O B-NN
construct B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
these B-O B-NP_DT
undifferentiated B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
however B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cAMP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
progesterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
signal B-O B-NN
" " B-O O-NP
transduced B-O B-VP_VBN
through B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
primary B-O B-JJ
inducer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
early B-O B-NP_NP_JJ
growth B-O B-NN
response B-O B-NN
1 B-O B-CD
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
and B-O B-CC
pp90rsk B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
monocytic B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
present B-O B-JJ
work B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
studied B-O B-VP_VBN
mechanisms B-O B-NP_NP_NNS
" " B-O O-NP
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
during B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Differentiation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
U-937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
12-O-tetradecanoylphorbol-13-acetate B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
TPA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
activator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
serine/threonine B-O B-NN
protein B-O B-NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
transcriptional B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
EGR-1 B-O B-NP_NN
promoter-reporter B-O B-JJ
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
EGR-1 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
six B-O B-NP_CD
CC(A/T)6GG B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
CArG B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
two B-O B-CD
5'-most B-O B-JJ
distal B-O B-JJ
CArG B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
conferred B-O B-VP_VBD
TPA B-O B-NP_NN
inducibility B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
little B-O B-NP_NP_JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TPA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
EGR-1 B-O B-NP_NP_NN
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
TPA-resistant B-O B-JJ
U-937 B-O B-NN
cell B-O B-NN
variant B-O B-NN
" " B-O O-NP
, B-O B-COMMA
designated B-O B-VP_VBN
" " B-O B-S_NP_NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
U-937 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
TUR B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
okadaic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
serine/threonine B-O B-NP_NN
protein B-O B-NN
phosphatases B-O B-NNS
1 B-O B-NP_CD
" " B-O O-NP
and B-O B-CC
2A B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
monocytic B-O B-NP_NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
and B-O B-CC
EGR-1 B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-NP
through B-O B-PP_IN
the B-O B-NP_DT
5'-most B-O B-JJ
CArG B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
these B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
supported B-O B-VP_VBD
the B-O B-NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
serine/threonine B-O B-NP_NN
protein B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
EGR-1 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
40S B-O B-NN
ribosomal B-O B-JJ
protein B-O B-NN
S6 B-O B-NN
serine/threonine B-O B-NN
kinases B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
pp70S6K B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
pp90rsk B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
both B-O B-S_NP_DT
kinases B-O B-NNS
" " B-O O-NP
participate B-O B-VP_VBP
in B-O B-PP_IN
regulating B-O B-S_NP_VP_VBG
cell B-O B-NP_NN
growth B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
there B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_NP_DT
detectable B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
pp70S6K B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
TPA- B-O B-NP_NP_NN
" " B-O B-ADJP_NP_O-NP
or B-O B-CC
okadaic B-O B-NP_ADJP_JJ
acid-induced B-O B-JJ
" " B-O B-NP_O-ADJP
" " B-O O-NP
monocytic B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
rapamycin B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
pp70S6K B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
EGR-1 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
analysis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
pp90rsk B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
peptide B-O B-NN
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
S6 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
kinase B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
TPA-treated B-O B-NP_ADJP_JJ
" " B-O O-ADJP
U-937 B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
not B-O B-RB
TUR B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Okadaic B-O B-S_NP_NP_JJ
acid B-O B-NN
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
pp90rsk B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Effects B-O B-NP_NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
prostaglandin B-O B-NP_NN
E2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
Th0-type B-O B-NP_JJ
human B-O B-JJ
T B-O B-NN
cell B-O B-NN
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
modulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
functions B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
prostaglandin B-O B-NP_NP_NN
E2 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PGE2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
cytokine B-O B-NP_NP_NN
production B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
proliferation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD4+ B-O B-JJ
human B-O B-JJ
helper B-O B-NN
T B-O B-NN
cell B-O B-NN
clone B-O B-NN
SP-B21 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
investigated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
anti-CD3 B-O B-NP_JJ
mAb B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
PGE2 B-O B-NP_NN
" " B-O O-NP
inhibited B-O B-VP_VBD
cell B-O B-NP_NP_NN
proliferation B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
all B-O B-NP_NP_PDT
the B-O B-DT
cytokines B-O B-NNS
" " B-O O-NP
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Addition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
rIL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
fully B-O B-VP_VP_ADVP_RB
" " B-O O-ADVP
restored B-O B-VBD
the B-O B-NP_DT
proliferative B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
partially B-O B-VP_ADVP_RB
" " B-O O-ADVP
restored B-O B-VBD
the B-O B-NP_NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-4 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
phorbol B-O B-NP_NP_NP_NN
myristate B-O B-NN
acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
/A23187 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
PGE2 B-O B-NP_NN
" " B-O O-NP
enhanced B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-4 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
only B-O B-ADVP_RB
partially B-O B-RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
PGE2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
vary B-O B-VP_VBP
depending B-O B-PP_VBG
on B-O B-PP_IN
the B-O B-NP_NP_DT
mode B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_DT
IL-4 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
IL-5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
regulated B-O B-VP_VBN
differently B-O B-NP_ADVP_RB
" " B-O O-ADVP
from B-O B-PP_IN
other B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
a B-O B-NP_DT
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
only B-O B-NP_ADVP_RB
" " B-O O-ADVP
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
( B-O B-LRB
p50/p50 B-O B-NN
) B-O B-RRB
homodimer B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
complex B-O B-NN
" " B-O O-NP
formed B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
kappa B-O B-NN
B B-O B-NN
sequence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
cells B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
anti-CD3 B-O B-NP_NP_JJ
mAb B-O B-NN
" " B-O O-NP
or B-O B-CC
PMA/A23187 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
a B-O B-S_NP_NP_DT
complex B-O B-NN
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NP_NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
p50/p65 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
heterodimer B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
kappa B-O B-NN
B B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
induced B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
PGE2 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
di-butyryl B-O B-NP_NN
( B-O B-LRB
Bt2 B-O B-NN
) B-O B-RRB
cAMP B-O B-NN
" " B-O O-NP
" " B-O O-NP
abolished B-O B-VP_VBD
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
( B-O B-LRB
p50/p65 B-O B-NN
) B-O B-RRB
heterodimer B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_NP_DT
kappa B-O B-NN
B B-O B-NN
sequence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
but B-O B-NP_PP_PP_CC
" " B-O B-PP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
target B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PGE2 B-O B-NP_NN
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
component B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
signal B-O B-NN
transduction B-O B-NN
pathway B-O B-NN
" " B-O O-NP
leading B-O B-VP_VBG
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
T B-O B-NN
cell B-O B-NN
activation B-O B-NN
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
PGE2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
selective B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PGE2 B-O B-S_NP_NN
" " B-O O-NP
enhanced B-O B-VP_VBD
the B-O B-NP_NP_DT
complex B-O B-NN
formation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
NF-AT B-O B-NP_NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
AP-1 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
CLE0 B-O B-NP_NN
" " B-O B-NP_O-NP
sequences B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
either B-O B-NP_CC
anti-CD3 B-O B-NP_JJ
mAb B-O B-NN
" " B-O B-NP_O-NP
or B-O B-CC
PMA/A23187 B-O B-NP_NN
" " B-O B-NP_O-NP
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
seems B-O B-VP_VBZ
therefore B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
PGE2 B-O B-S_NP_NN
, B-O B-COMMA
" " B-O O-NP
by B-O B-PP_IN
elevating B-O B-S_NP_VP_VBG
cAMP B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
interferes B-O B-VP_VBZ
with B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
pathway B-O B-NN
" " B-O O-NP
for B-O B-PP_PP_IN
but B-O B-NP_CC
not B-O B-PP_RB
for B-O B-IN
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Description B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
functional B-O B-NP_JJ
implications B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
novel B-O B-JJ
mutation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
sex-determining B-O B-JJ
gene B-O B-NN
SRY B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
sex-determining B-O B-JJ
gene B-O B-NN
SRY B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
screened B-O B-VP_VBN
for B-O B-NP_PP_IN
molecular B-O B-NP_NP_JJ
alteration B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
an B-O B-NP_DT
XY B-O B-ADJP_NN
sex-reversed B-O B-JJ
" " B-O O-ADJP
female B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
single-strand B-O B-NP_NP_NP_JJ
conformation B-O B-NN
polymorphism B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
SSCP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
technique B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_DT
A-to-G B-O B-JJ
transition B-O B-NN
" " B-O O-NP
" " B-O B-SBAR_O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
which B-O B-NP_SBAR_WHNP_WDT
" " B-O O-WHNP
leads B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
an B-O B-NP_NP_DT
exchange B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
by B-O B-NP_PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
affected B-O B-VBN
tyrosine B-O B-NN
residue B-O B-NN
" " B-O O-NP
located B-O B-ADJP_JJ
at B-O B-PP_IN
the B-O B-NP_NP_DT
C B-O B-NN
terminus B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
DNA B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
is B-O B-VP_VBZ
evolutionarily B-O B-VP_ADVP_RB
strongly B-O B-RB
" " B-O O-ADVP
conserved B-O B-VBN
among B-O B-NP_PP_IN
the B-O B-NP_NP_DT
members B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HMG B-O B-ADJP_NN
box B-O B-NN
containing B-O B-VBG
" " B-O O-ADJP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
gel B-O B-NP_NP_NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
and B-O B-CC
peptide B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
such B-O B-NP_PDT
a B-O B-DT
mutation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
abolish B-O B-VP_VB
the B-O B-NP_DT
SRY B-O B-NN
protein B-O B-NN
DNA B-O B-NN
binding B-O B-NN
ability B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
particular B-O B-JJ
amino B-O B-NN
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
binding B-O B-NN
specificity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
discussed B-O B-VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
IL-4 B-O B-S_S_NP_NN
" " B-O O-NP
down-regulates B-O B-VP_VBZ
IL-2- B-O B-NP_NP_NN
" " B-O B-ADJP_NP_O-NP
, B-O B-COMMA
IL-3- B-O B-NP_NN
" " B-O B-ADJP_NP_O-NP
, B-O B-COMMA
and B-O B-CC
GM-CSF-induced B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
cytokine B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
IL-4 B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
product B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
T-helper B-O B-NN
0 B-O B-NP_NP_CD
" " B-O O-NP
( B-O B-PRN_LRB
Th0 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
and B-O B-CC
2 B-O B-NP_NP_CD
" " B-O O-NP
( B-O B-PRN_LRB
Th2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
subset B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VP_VBD
originally B-O B-ADVP_RB
" " B-O O-ADVP
described B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_DT
B-cell B-O B-NN
stimulatory B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
has B-O B-VP_VBZ
subsequently B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
found B-O B-VP_VBN
to B-O B-S_NP_VP_VP_TO
, B-O B-VP_COMMA
and B-O B-CC
to B-O B-VP_TO
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
evoked B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
IL-3 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
GM-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
IL-4 B-O B-S_NP_NN
" " B-O O-NP
down-regulated B-O B-VP_VBD
mRNA B-O B-NP_NP_NN
accumulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
proinflammatory B-O B-JJ
cytokines B-O B-NNS
" " B-O O-NP
IL-1 B-O B-NP_NP_NN
beta B-O B-NN
" " B-O O-NP
, B-O B-COMMA
IL-8 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
TNF-alpha B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
IL-3 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
GM-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-4 B-O B-S_NP_NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
suppressed B-O B-VP_VBD
the B-O B-NP_DT
IL-2-induced B-O B-JJ
IL-6 B-O B-NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Temporal B-O B-S_NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-4 B-O B-NN
down-regulatory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
IL-2- B-O B-NP_NN
" " B-O B-ADJP_NP_O-NP
, B-O B-COMMA
IL-3- B-O B-NP_NN
" " B-O B-ADJP_NP_O-NP
, B-O B-COMMA
or B-O B-CC
GM-CSF-induced B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
proinflammatory B-O B-NP_JJ
cytokine B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
provided B-O B-VP_VBD
evidence B-O B-NP_NN
that B-O B-SBAR_IN
IL-4 B-O B-S_NP_NN
acts B-O B-VP_VBZ
predominantly B-O B-ADVP_RB
" " B-O O-ADVP
on B-O B-PP_IN
the B-O B-NP_DT
post-transcriptional B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
was B-O B-VP_VBD
supported B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
observation B-O B-NN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
down-regulatory B-O B-JJ
capacity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
appeared B-O B-VP_VBD
" " B-O B-S_NP_VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-4 B-O B-S_NP_NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
exert B-O B-VP_VB
significant B-O B-NP_NP_JJ
influence B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
by B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
Long-term B-O B-S_S_NP_NP_JJ
inositol B-O B-NN
phosphate B-O B-NN
release B-O B-NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
tyrosine B-O B-NP_NN
kinase B-O B-NN
activity B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
IL-2 B-O B-NP_NP_NP_NN
secretion B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-AT B-O B-NP_NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
anti-CD3-activated B-O B-NP_JJ
peripheral B-O B-JJ
human B-O B-JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
cascade B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
events B-O B-NP_NP_NNS
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_NP_DT
first B-O B-ADJP_JJ
few B-O B-JJ
" " B-O O-ADJP
minutes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
well B-O B-ADVP_RB
" " B-O O-ADVP
characterized B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Although B-O B-S_SBAR_IN
many B-O B-S_NP_JJ
second B-O B-JJ
messengers B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-ADJP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-S_NP_NP_DT
rate-limiting B-O B-JJ
step B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
not B-O B-RB
been B-O B-VP_VBN
demonstrated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_S_NP_VP_TO
model B-O B-VP_VB
effective B-O B-NP_NP_ADJP_JJ
" " B-O B-NP_O-ADJP
" " B-O O-NP
versus B-O B-CC
ineffective B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
CD3-mediated B-O B-NP_JJ
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
used B-O B-VP_VBD
two B-O B-NP_CD
anti-CD3 B-O B-JJ
mAbs B-O B-NNS
" " B-O B-NP_O-NP
" " B-O O-VP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
differ B-O B-S_NP_VP_VBP
in B-O B-PP_IN
their B-O B-NP_PRPP
ability B-O B-NN
" " B-O B-S_NP_VP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-S
" " B-O O-S
: B-O B-COLON
OKT3 B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
causes B-O B-S_NP_VP_VP_VBZ
early B-O B-NP_JJ
second B-O B-JJ
messenger B-O B-NN
generation B-O B-NN
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
is B-O B-VP_VBZ
unable B-O B-ADJP_JJ
" " B-O B-S_NP_VP_O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
64.1 B-O B-NP_NP_CD
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
stimulates B-O B-S_NP_VP_VBZ
T B-O B-NP_NN
cell B-O B-NN
proliferation B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
its B-O B-NP_PRPP
own B-O B-JJ
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
tyrosine B-O B-S_NP_NN
kinase B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
similar B-O B-ADJP_JJ
for B-O B-PP_IN
both B-O B-NP_DT
mAbs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
over B-O B-PP_IN
a B-O B-NP_NP_DT
period B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
inositol B-O B-NN
phosphate B-O B-NN
response B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
stronger B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
for B-O B-PP_IN
64.1 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
than B-O B-PP_IN
for B-O B-PP_IN
OKT3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
tie B-O B-VP_VB
these B-O B-NP_DT
events B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
gene B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
measured B-O B-VP_VBD
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
NF-AT B-O B-NP_NN
" " B-O B-NP_O-NP
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
anti-CD3 B-O B-NP_JJ
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_DT
stimuli B-O B-NNS
" " B-O O-NP
induced B-O B-VP_VBD
the B-O B-NP_NP_NP_NP_DT
appearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
NF-kappa B-O B-NN
B B-O B-NN
components B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
only B-O B-NP_ADVP_RB
" " B-O O-ADVP
64.1 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
induced B-O B-VP_VBD
NF-AT B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
correlating B-O B-S_NP_VP_VBG
with B-O B-PP_IN
its B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
NF-AT B-O B-NP_NP_NN
induction B-O B-NN
" " B-O O-NP
and B-O B-CC
IL-2 B-O B-NP_NN
secretion B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
correlated B-O B-VP_VBN
with B-O B-NP_PP_PP_IN
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
inositol B-O B-NP_NN
phosphate B-O B-NN
release B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
with B-O B-IN
gross B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
tyrosine B-O B-NP_NP_NN
kinase B-O B-NN
activity B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
" " B-O B-NP_ADVP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-NP_DT
other B-O B-JJ
hand B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
induction B-O B-NN
" " B-O O-NP
and B-O B-CC
IL-2 B-O B-NP_NN
receptor B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
occurred B-O B-VP_VBD
even B-O B-PP_ADVP_RB
" " B-O O-ADVP
with B-O B-IN
the B-O B-NP_NP_DT
smaller B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
second B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
messenger B-O B-NN
response B-O B-NN
" " B-O O-NP
generated B-O B-VP_VBN
by B-O B-NP_PP_IN
OKT3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Corticosteroid B-O B-S_NP_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
a B-O B-FRAG_NP_NP_DT
possible B-O B-JJ
marker B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
brain B-O B-NP_NN
involution B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-FRAG
? B-O B-PERIOD
" " B-O O-NP
" " B-O O-S
  
A B-O B-S_S_NP_DT
similarity B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
recently B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
found B-O B-VP_VBN
between B-O B-NP_PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
corticosteroid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
and B-O B-NP_CC
in B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
studied B-O B-VP_VBN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
corticosteroid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
possible B-O B-JJ
marker B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
brain B-O B-NP_NN
involution B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Type B-O B-S_NP_NN
I B-O B-CD
corticosteroid B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
down B-O B-ADVP_RB
" " B-O O-ADVP
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
excess B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_PP_IN
" " B-O B-NP_NP_NP_PRN_O-NP
" " B-O O-PP
and B-O B-CC
of B-O B-PP_IN
glucocorticoids B-O B-NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Type B-O B-S_NP_NN
II B-O B-CD
corticosteroid B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
reduced B-O B-VP_VBN
by B-O B-NP_PP_IN
excess B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
endogenous B-O B-NP_NP_JJ
corticosteroids B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
Cushing B-O B-NP_NN
's B-O B-POS
syndrome B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
normal B-O B-NP_JJ
adults B-O B-NNS
" " B-O O-NP
" " B-O O-PP
there B-O B-NP_EX
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
direct B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
significant B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_PP_IN
plasma B-O B-NP_NP_NN
cortisol B-O B-NN
" " B-O O-NP
and B-O B-CC
Type B-O B-NP_NN
I B-O B-CD
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
between B-O B-PP_IN
plasma B-O B-NP_NP_NN
cortisol B-O B-NN
" " B-O O-NP
and B-O B-CC
Type B-O B-NP_NN
II B-O B-CD
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
receptors B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
while B-O B-SBAR_IN
in B-O B-S_PP_IN
Cushing B-O B-NP_NN
's B-O B-POS
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
correlation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
inverse B-O B-ADJP_JJ
between B-O B-PP_IN
and B-O B-NP_NP_NP_PP_CC
Type B-O B-NP_NN
II B-O B-CD
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
an B-O B-NP_DT
aged B-O B-JJ
population B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-S_S_NP_NP_DT
mean B-O B-JJ
numbers B-O B-NNS
" " B-O O-NP
of B-O B-PP_PP_IN
Type B-O B-NP_NN
I B-O B-CD
" " B-O B-NP_O-NP
" " B-O O-PP
and B-O B-CC
of B-O B-PP_IN
Type B-O B-NP_NN
II B-O B-CD
" " B-O B-NP_O-NP
" " B-O O-PP
receptors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
lower B-O B-ADJP_JJR
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
plasma B-O B-S_NP_NN
cortisol B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
higher B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
in B-O B-PP_IN
adult B-O B-NP_JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
the B-O B-S_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
plasma B-O B-NP_NN
cortisol B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
followed B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
clinical B-O B-JJ
picture B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hypercorticism B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Corticosteroid B-O B-S_NP_NN
Type B-O B-NP_NN
I B-O B-CD
" " B-O B-NP_O-NP
and B-O B-CC
Type B-O B-NP_NN
II B-O B-CD
" " B-O B-NP_O-NP
receptors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
inversely B-O B-ADVP_RB
" " B-O O-ADVP
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
age B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_PP_IN
dexamethasone B-O B-NP_NP_NN
suppression B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
1 B-O B-NP_CD
mg B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
11 B-O B-NP_CD
p.m. B-O B-NN
" " B-O O-NP
" " B-O O-PP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
Type B-O B-NP_NN
I B-O B-CD
receptors B-O B-NNS
" " B-O O-NP
always B-O B-ADVP_RB
" " B-O O-ADVP
decrease B-O B-VP_VBP
in B-O B-PP_IN
controls B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
while B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Type B-O B-NP_NN
II B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
homogeneous B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
an B-O B-NP_NP_DT
aged B-O B-JJ
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
both B-O B-NP_DT
receptors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
reduced B-O B-VP_VBN
by B-O B-NP_PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
age B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
of B-O B-PP_IN
corticosteroid B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
possibly B-O B-ADVP_RB
" " B-O O-ADVP
related B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
this B-O B-S_NP_DT
reduction B-O B-NN
" " B-O O-NP
does B-O B-VP_VBZ
increase B-O B-VP_VB
plasma B-O B-NP_NN
cortisol B-O B-NN
concentration B-O B-NN
" " B-O O-NP
, B-O B-COMMA
without B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Mitogen B-O B-S_S_NP_NP_NN
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
the B-O B-NP_NP_DT
formation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
new B-O B-NP_JJ
cyclic B-O B-JJ
AMP B-O B-NN
response B-O B-NN
element-binding B-O B-JJ
protein B-O B-NN
nuclear B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_S_NP_NP_DT
large B-O B-JJ
body B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
evidence B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicates B-O B-VP_VBZ
that B-O B-SBAR_IN
experimental B-O B-S_NP_NP_JJ
agents B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
raise B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
inhibit B-O B-VP_VBP
T B-O B-NP_NN
cell B-O B-NN
growth B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
division B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
By B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
many B-O B-NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
reported B-O B-VP_VBN
that B-O B-SBAR_IN
mitogen B-O B-S_NP_NP_NN
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increases B-O B-VP_VBZ
cAMP B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
implying B-O B-S_NP_VP_VBG
in B-O B-NP_NP_PP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
mitogen B-O B-S_NP_NP_NN
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
nuclear B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
form B-O B-S_NP_VP_VBP
" " B-O B-NP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Four B-O B-S_NP_CD
complexes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
identified B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
electrophoretic B-O B-JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
, B-O B-COMMA
two B-O B-SBAR_WHNP_NP_CD
" " B-O O-NP
of B-O B-WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
induced B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_DT
four B-O B-CD
complexes B-O B-NNS
" " B-O O-NP
contain B-O B-VP_VP_VBP
CREB B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
are B-O B-VP_VBP
bound B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
cAMP B-O B-NN
response B-O B-NN
element B-O B-NN
( B-O B-LRB
CRE B-O B-NN
) B-O B-RRB
core B-O B-NN
sequence B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TGACGTCA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
as B-O B-SBAR_IN
indicated B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
antibody B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
oligonucleotide B-O B-NP_NN
" " B-O B-NP_O-NP
competition B-O B-NP_NN
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
four B-O B-CD
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
CRE B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
prevented B-O B-VP_VBN
by B-O B-NP_PP_IN
dephosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
restored B-O B-VP_VBN
by B-O B-NP_PP_IN
rephosphorylation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
cAMP-dependent B-O B-NP_NP_JJ
protein B-O B-NN
kinase B-O B-NN
" " B-O O-NP
or B-O B-CC
endogenous B-O B-NP_JJ
kinases B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_NP_JJ
complexes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mitogen B-O B-S_NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
electrophoretic B-O B-JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
accounted B-O B-VP_VBN
for B-O B-NP_PP_IN
by B-O B-PP_PP_IN
protein B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
by B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CREB B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Rather B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
mitogen B-O B-S_NP_NN
" " B-O O-NP
increases B-O B-VP_VBZ
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
nuclear B-O B-JJ
factor B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
new B-O B-NP_JJ
CREB B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
implies B-O B-VP_VBZ
a B-O B-NP_NP_DT
physiological B-O B-JJ
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
cAMP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
mitogen B-O B-NP_NP_NN
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
ZAP-70 B-O B-NP_NP_NP_NP_NN
tyrosine B-O B-NN
kinase B-O B-NN
" " B-O B-NP_O-NP
, B-O B-COMMA
CD45 B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
T B-O B-NP_NN
cell B-O B-NN
receptor B-O B-NN
" " B-O B-NP_O-NP
involvement B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
UV- B-O B-NP_NP_NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
H2O2-induced B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
T B-O B-NP_NN
cell B-O B-NN
signal B-O B-NN
transduction B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Several B-O B-S_S_NP_NP_NP_JJ
mammalian B-O B-JJ
responses B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
UV B-O B-NP_NN
irradiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
believed B-O B-VP_VBN
to B-O B-S_NP_VP_TO
involve B-O B-VP_VB
tyrosine B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
UV B-O B-S_NP_NP_NP_NN
irradiation B-O B-NN
" " B-O O-NP
and B-O B-CC
H2O2 B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induce B-O B-VP_VBP
protein B-O B-NP_NP_NP_NN
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
and B-O B-CC
Ca2+ B-O B-NP_NN
signals B-O B-NNS
" " B-O O-NP
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
those B-O B-NP_NP_DT
" " B-O O-NP
observed B-O B-VP_VBN
following B-O B-NP_PP_VBG
biological B-O B-NP_JJ
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NN
surface B-O B-NN
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
responses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Normal B-O B-S_NP_NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
whose B-O B-SBAR_WHNP_WPP
surface B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
depleted B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
showed B-O B-VP_VBD
impaired B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
UV-induced B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
tyrosine B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
and B-O B-CC
Ca2+ B-O B-NP_NN
signals B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similarly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
Jurkat B-O B-NP_NP_NN
T B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
deficient B-O B-ADJP_JJ
in B-O B-PP_IN
CD3 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
or B-O B-CC
CD45 B-O B-NP_NN
" " B-O B-NP_O-NP
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
gave B-O B-VP_VBD
impaired B-O B-NP_JJ
UV B-O B-NN
responses B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
all B-O B-NP_PDT
these B-O B-DT
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
still B-O B-ADVP_RB
" " B-O O-ADVP
gave B-O B-VP_VBD
strong B-O B-NP_ADJP_JJ
" " B-O O-ADJP
Ca2+ B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
tyrosine B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O B-NP_O-NP
responses B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
to B-O B-PP_TO
H2O2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
T B-O B-NN
cell B-O B-NN
tyrosine B-O B-NN
kinase B-O B-NN
ZAP-70 B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
highly B-O B-ADJP_RB
responsive B-O B-JJ
to B-O B-PP_TO
and B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
ZAP-70 B-O B-S_NP_NP_NN
responsiveness B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
UV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
required B-O B-VP_VBD
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
CD3 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
CD45 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
only B-O B-S_NP_JJ
CD3 B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
required B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_DT
response B-O B-NN
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
UV-induced B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
CD3 B-O B-NP_NN
depletion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
importance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
such B-O B-NP_JJ
cell B-O B-NN
surface B-O B-NN
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
biological B-O B-NP_NP_JJ
responses B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
UV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
nonlymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
epidermal B-O B-JJ
growth B-O B-NN
factor B-O B-NN
receptor B-O B-NN
" " B-O O-NP
displayed B-O B-VP_VBD
increased B-O B-NP_VBN
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
within B-O B-PP_IN
seconds B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
UV B-O B-NP_NN
irradiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
UV-induced B-O B-S_NP_JJ
signal B-O B-NN
transduction B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
via B-O B-NP_PP_IN
cell B-O B-NP_NP_NN
surface B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
whereas B-O B-SBAR_IN
H2O2 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
able B-O B-ADJP_JJ
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inhibition B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
sodium B-O B-NP_NP_NN
salicylate B-O B-NN
" " B-O O-NP
and B-O B-CC
aspirin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
[ B-O B-S_LRB
see B-O B-NP_VP_VB
comments B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
nuclear B-O B-NP_NP_JJ
factor-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
critical B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_DT
inducible B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_NP_CC
involved B-O B-NP_NP_VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
anti-inflammatory B-O B-JJ
drugs B-O B-NNS
" " B-O O-NP
sodium B-O B-NP_NP_NN
salicylate B-O B-NN
" " B-O O-NP
and B-O B-CC
aspirin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
further B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
explains B-O B-VP_VBZ
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
inhibition B-O B-NN
" " B-O O-NP
prevented B-O B-VP_VBD
the B-O B-NP_NP_DT
degradation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
inhibitor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
retained B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
cytosol B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Sodium B-O B-S_NP_NP_NN
salicylate B-O B-NN
" " B-O O-NP
and B-O B-CC
aspirin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
NF-kappa B-O B-NP_NP_NP_NN
B-dependent B-O B-JJ
transcription B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
Ig B-O B-NN
kappa B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
( B-O B-LRB
HIV B-O B-NN
) B-O B-RRB
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
LTR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
transfected B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Effects B-O B-NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
rheumatoid B-O B-NP_JJ
arthritis B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Diminished B-O B-S_NP_VBN
glucocorticoid B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
result B-O B-VP_VB
in B-O B-PP_IN
glucocorticoid B-O B-NP_NN
resistance B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
OBJECTIVE B-O B-NP_NP_NN
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Lymphocytes B-O B-S_S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
rheumatoid B-O B-NP_NP_JJ
arthritis B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
diminished B-O B-NP_VBN
receptor B-O B-NN
density B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
should B-O B-VP_MD
show B-O B-VP_VB
partial B-O B-NP_NP_JJ
resistance B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_DT
glucocorticoid B-O B-NN
sensitivity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
RA B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
compared B-O B-PP_VBN
with B-O B-PP_IN
healthy B-O B-NP_JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
METHODS B-O B-NP_NNS
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
determined B-O B-VP_VBD
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
lymphocyte B-O B-NP_NP_NN
proliferation B-O B-NN
" " B-O O-NP
and B-O B-CC
cytokine B-O B-NP_NN
release B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
RESULTS B-O B-NP_NNS
. B-O B-PERIOD
" " B-O O-NP
  
Proliferation B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
cytokine B-O B-NP_NN
release B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
inhibited B-O B-VP_VBN
in B-O B-NP_PP_IN
RA B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_NP_DT
same B-O B-JJ
extent B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
in B-O B-PP_IN
healthy B-O B-NP_JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CONCLUSION B-O B-NP_NN
. B-O B-PERIOD
" " B-O O-NP
  
Diminished B-O B-S_NP_NP_VBN
receptor B-O B-NN
density B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
RA B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
result B-O B-VP_VB
in B-O B-PP_IN
glucocorticoid B-O B-NP_NN
resistance B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Positive B-O B-NP_NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
negative B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
regulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
role B-O B-FRAG_NP_NN
" " B-O O-NP
of B-O B-PP_IN
multiple B-O B-NP_JJ
regulatory B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Interleukin B-O B-S_S_NP_NP_NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
important B-O B-JJ
lymphokine B-O B-NN
" " B-O O-NP
required B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
process B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_DT
IL-2 B-O B-NN
gene B-O B-NN
" " B-O O-NP
displays B-O B-VP_VBZ
both B-O B-NP_CC
T B-O B-NN
cell B-O B-NN
specific B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
inducible B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
it B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
only B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
CD4+ B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
antigenic B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
or B-O B-CC
mitogenic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Several B-O B-S_NP_JJ
cis-acting B-O B-JJ
regulatory B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
analysed B-O B-VP_VBN
the B-O B-NP_NP_DT
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cis-acting B-O B-JJ
regulatory B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
context B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
native B-O B-ADJP_JJ
" " B-O O-ADJP
IL-2 B-O B-NP_NN
enhancer B-O B-NN
" " B-O O-NP
and B-O B-CC
promoter B-O B-NP_NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
results B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
NFAT B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
-276 B-O B-NP_CD
to B-O B-TO
-261 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
distal B-O B-JJ
octamer B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
-256 B-O B-NP_CD
to B-O B-TO
-248 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
and B-O B-CC
the B-O B-NP_NP_DT
proximal B-O B-JJ
octamer B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
-75 B-O B-NP_CD
to B-O B-TO
-66 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
sites B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
not B-O B-CONJP_RB
only B-O B-RB
" " B-O O-CONJP
act B-O B-VP_VP_VBP
as B-O B-PP_IN
enhancers B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
have B-O B-VP_VBP
a B-O B-NP_NP_DT
silencing B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_S_NP_CD
other B-O B-JJ
sites B-O B-NNS
" " B-O B-NP_O-NP
display B-O B-VP_VBP
disparate B-O B-NP_NP_JJ
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
different B-O B-NP_JJ
T B-O B-NN
leukemia B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
the B-O B-NP_NP_NP_DT
distal B-O B-JJ
purine B-O B-NN
box B-O B-NN
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
-291 B-O B-NP_CD
to B-O B-TO
-277 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
proximal B-O B-JJ
purine B-O B-NN
box B-O B-NN
" " B-O B-NP_O-NP
sites B-O B-NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
-145 B-O B-NP_CD
to B-O B-TO
-128 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_NP_DT
AP-1 B-O B-NN
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
-186 B-O B-NP_CD
to B-O B-TO
-176 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
kappa B-O B-NN
B B-O B-NN
" " B-O B-NP_O-NP
sites B-O B-NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
-206 B-O B-NP_CD
to B-O B-TO
-195 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
respond B-O B-VP_VBP
to B-O B-PP_TO
different B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
cellular B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
EL4 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
AP-1 B-O B-NN
site B-O B-NN
" " B-O O-NP
mediated B-O B-VP_VBD
the B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
PMA B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
while B-O B-SBAR_IN
the B-O B-S_NP_DT
kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
responded B-O B-VP_VBD
to B-O B-PP_TO
IL-1 B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_S_NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
complex B-O B-JJ
process B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
multiple B-O B-S_NP_JJ
cis-acting B-O B-JJ
regulatory B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
interact B-O B-VP_VBP
to B-O B-S_NP_VP_TO
exert B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Tat-binding B-O B-S_S_NP_JJ
protein B-O B-NN
7 B-O B-CD
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
26S B-O B-NN
protease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Subunit B-O B-S_S_NP_NP_NP_NN
6 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
S6 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
integral B-O B-JJ
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
26S B-O B-NN
protease B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
human B-O B-NP_JJ
erythrocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
studied B-O B-VP_VBN
by B-O B-NP_PP_IN
SDS-PAGE B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
peptide B-O B-NP_NN
mapping B-O B-NN
" " B-O O-NP
and B-O B-CC
sequence B-O B-NP_NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
S6 B-O B-S_S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
cleaved B-O B-VP_VBN
with B-O B-NP_PP_IN
CNBr B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
three B-O B-S_NP_CD
internal B-O B-JJ
peptides B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
sequenced B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
comparison B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
known B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
Genbank B-O B-NP_NNP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
all B-O B-S_NP_DT
three B-O B-CD
S6 B-O B-NN
peptides B-O B-NNS
" " B-O O-NP
match B-O B-VP_VBP
the B-O B-NP_NP_DT
predicted B-O B-VBN
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TBP7 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Tat-binding B-O B-NP_JJ
protein B-O B-NN
7 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Based B-O B-S_PP_VBN
on B-O B-PP_IN
peptide B-O B-NP_NP_NP_NN
matches B-O B-NNS
" " B-O O-NP
covering B-O B-VP_VBG
more B-O B-NP_NP_QP_JJR
than B-O B-IN
10 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TBP7 B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_DT
fact B-O B-NN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
migration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
on B-O B-NP_PP_IN
" " B-O B-NP_O-NP
is B-O B-VP_VBZ
consistent B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
subunit B-O B-S_NP_NP_NN
6 B-O B-CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
26S B-O B-NN
protease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
TBP7 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Superantigens B-O B-S_S_NP_NNS
" " B-O O-NP
activate B-O B-VP_VBP
HIV-1 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Binding B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
superantigens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
transduction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
biochemical B-O B-NP_NP_JJ
signals B-O B-NNS
" " B-O O-NP
leading B-O B-VP_VBG
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
staphylococcal B-O B-JJ
superantigens B-O B-NNS
" " B-O O-NP
toxic B-O B-NP_NP_NP_JJ
shock B-O B-NN
syndrome B-O B-NN
toxin-1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TSST-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
staphylococcal B-O B-NP_NP_JJ
enterotoxin B-O B-NN
A B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
SEA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
activate B-O B-VP_VBP
HIV-1-LTR-driven B-O B-NP_NP_JJ
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
chloramphenicol B-O B-NP_NN
acetyl B-O B-NN
transferase B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_NP_NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1-LTR-driven B-O B-NP_JJ
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
THP-1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
superantigens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
factor-kappa B-O B-NN
B B-O B-NN
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Superantigens B-O B-S_NP_NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBD
viral B-O B-NP_NP_JJ
protein B-O B-NN
secretion B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
granulocyte-macrophage B-O B-JJ
colony-stimulating B-O B-JJ
factor-pretreated B-O B-JJ
chronically B-O B-RB
infected B-O B-JJ
human B-O B-JJ
monocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
U1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
superantigens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurred B-O B-VP_VBD
via B-O B-PP_IN
tumor B-O B-NP_NN
necrosis B-O B-NN
factor-alpha-dependent B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
-independent B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
mechanisms B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
superantigens B-O B-S_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
other B-O B-NP_JJ
MHC B-O B-NN
class B-O B-NN
II B-O B-CD
ligands B-O B-NNS
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
activate B-O B-VP_VB
HIV-1 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
monocytes/macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Leiomyosarcoma B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
vulva B-O B-NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
report B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
case B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
A B-O B-S_S_NP_DT
52-year-old B-O B-JJ
female B-O B-JJ
" " B-O O-NP
presented B-O B-VP_VBN
with B-O B-PP_IN
a B-O B-NP_DT
progressively B-O B-ADJP_RB
enlarging B-O B-VBG
" " B-O O-ADJP
vulvar B-O B-JJ
mass B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Pathological B-O B-S_NP_JJ
evaluation B-O B-NN
" " B-O O-NP
revealed B-O B-VP_VBD
a B-O B-NP_DT
high-grade B-O B-JJ
vulvar B-O B-JJ
leiomyosarcoma B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Immunohistochemical B-O B-S_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
ultrastructural B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
studies B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
performed B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
support B-O B-VP_VB
the B-O B-NP_DT
diagnosis B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
an B-O B-NP_DT
effort B-O B-NN
to B-O B-S_NP_PP_TO
better B-O B-ADVP_RBR
" " B-O O-ADVP
understand B-O B-VP_VB
the B-O B-NP_NP_DT
biology B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
tumor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-PP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
additional B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
immunohistochemical B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
studies B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_NP_DT
protein B-O B-NN
product B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p53 B-O B-NP_NN
tumor B-O B-NN
suppressor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
estrogen B-O B-NP_NN
receptor B-O B-NN
expression B-O B-NN
by B-O B-PP_IN
tumor B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
the B-O B-NP_NP_DT
type B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immune B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
infiltrating B-O B-VP_VBG
the B-O B-NP_DT
tumor B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
performed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tumor B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VP_VBD
an B-O B-NP_NP_DT
overexpression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p53 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
were B-O B-VP_VBD
estrogen B-O B-ADJP_NN
receptor-positive B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Macrophages B-O B-S_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
T B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
B B-O B-NP_NN
" " B-O B-NP_O-NP
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
infiltrated B-O B-VP_VBD
the B-O B-NP_DT
tumor B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
moderate B-O B-NP_JJ
numbers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
occasional B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
lymphoid B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
aggregate B-O B-NN
formation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
study B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
first B-O B-JJ
attempt B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
better B-O B-ADVP_RBR
" " B-O O-ADVP
understand B-O B-VP_VB
the B-O B-NP_NP_DT
biology B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
tumors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
DNA-binding B-O B-NP_NP_NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
transcriptional B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
regulatory B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O B-NP_O-NP
properties B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
hepatic B-O B-NP_NP_JJ
leukemia B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HLF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
t(17;19) B-O B-NN
acute B-O B-JJ
lymphoblastic B-O B-JJ
leukemia B-O B-NN
chimera B-O B-NN
E2A-HLF B-O B-JJ
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
t(17;19) B-O B-NN
translocation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
acute B-O B-NP_JJ
lymphoblastic B-O B-JJ
leukemias B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
creation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
chimeric B-O B-NP_NP_NP_NP_PRN_JJ
proteins B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
An B-O B-S_NP_DT
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
binding B-O B-VBG
site B-O B-NN
selection B-O B-NN
procedure B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_O-VP
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
DNA B-O B-NP_NP_NN
sequences B-O B-NNS
" " B-O O-NP
preferentially B-O B-VP_ADVP_RB
" " B-O O-ADVP
bound B-O B-VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_DT
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
selectively B-O B-ADVP_RB
" " B-O O-ADVP
bind B-O B-VP_VB
the B-O B-NP_DT
consensus B-O B-NN
sequence B-O B-NN
5'-GTTACGTAAT-3' B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
high B-O B-NP_JJ
affinity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Wild-type B-O B-S_S_NP_NP_JJ
" " B-O O-NP
and B-O B-CC
chimeric B-O B-NP_JJ
HLF B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
bound B-O B-VP_VBD
closely B-O B-ADVP_RB
" " B-O O-ADVP
related B-O B-NP_NP_JJ
sites B-O B-NNS
" " B-O O-NP
identified B-O B-VP_VBN
previously B-O B-NP_ADVP_RB
" " B-O O-ADVP
for B-O B-PP_IN
bZIP B-O B-NP_NP_NN
proteins B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
the B-O B-DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
however B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
E2A-HLF B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
significantly B-O B-ADJP_ADVP_RB
less B-O B-JJR
" " B-O O-ADVP
tolerant B-O B-JJ
of B-O B-PP_IN
certain B-O B-NP_NP_JJ
deviations B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
HLF B-O B-NN
consensus B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
differences B-O B-NNS
" " B-O O-NP
were B-O B-VP_VP_VBD
directly B-O B-ADJP_RB
attributable B-O B-JJ
to B-O B-PP_TO
loss B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
HLF B-O B-NN
ancillary B-O B-NN
DNA-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
all B-O B-NP_DT
E2A-HLF B-O B-JJ
chimeras B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
were B-O B-VP_VBD
further B-O B-ADVP_RB
" " B-O O-ADVP
exacerbated B-O B-ADJP_JJ
by B-O B-PP_IN
a B-O B-NP_NP_DT
zipper B-O B-NN
mutation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
one B-O B-NP_CD
isolate B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
wild-type B-O B-NP_JJ
" " B-O O-NP
and B-O B-CC
chimeric B-O B-NP_JJ
HLF B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
displayed B-O B-VP_VBD
transcriptional B-O B-NP_JJ
activator B-O B-NN
properties B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
lymphoid B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
nonlymphoid B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
reporter B-O B-NP_NP_NN
genes B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VBG
HLF B-O B-NP_NP_NN
" " B-O B-NP_O-NP
or B-O B-CC
C/EBP B-O B-NP_NN
" " B-O B-NP_O-NP
consensus B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
But B-O B-S_CC
on B-O B-PP_IN
reporter B-O B-NP_NP_NN
genes B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
nonoptimal B-O B-NP_JJ
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
their B-O B-S_S_NP_PRPP
transcriptional B-O B-JJ
properties B-O B-NNS
" " B-O O-NP
diverged B-O B-VP_VBD
" " B-O O-VP
" " B-O O-S
and B-O B-CC
E2A-HLF B-O B-S_NP_JJ
" " B-O O-NP
competitively B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
activation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
wild-type B-O B-NP_JJ
PAR B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
establish B-O B-VP_VBP
a B-O B-NP_NP_DT
spectrum B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
binding B-O B-NP_NP_VBG
site-specific B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
transcriptional B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
properties B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
E2A-HLF B-O B-NP_NP_JJ
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Displacement B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
E-box-binding B-O B-JJ
repressor B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
basic B-O B-NP_JJ
helix-loop-helix B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
implications B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
B-cell B-O B-NP_NP_NN
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
immunoglobulin B-O B-NN
heavy-chain B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
immunoglobulin B-O B-NN
heavy-chain B-O B-JJ
( B-O B-LRB
IgH B-O B-NN
) B-O B-RRB
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
restricted B-O B-VP_VBN
to B-O B-NP_PP_TO
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
although B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
binds B-O B-VP_VBZ
both B-O B-NP_CC
B-cell-restricted B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
ubiquitous B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
non-B B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
overexpression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
basic B-O B-NP_NP_JJ
helix-loop-helix B-O B-JJ
( B-O B-LRB
bHLH B-O B-JJ
) B-O B-RRB
protein B-O B-NN
" " B-O O-NP
E2A B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
mediated B-O B-VP_VBN
not B-O B-NP_PP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
by B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
by B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
a B-O B-NP_NP_DT
"""" B-O B-LQT
two-handed B-O B-JJ
"""" B-O B-RQT
zinc B-O B-NN
finger B-O B-NN
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
denoted B-O B-VP_VBN
ZEB B-O B-S_NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
DNA-binding B-O B-JJ
specificity B-O B-NN
" " B-O O-NP
" " B-O B-SBAR_WHPP_S_O-NP
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
employing B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
derivative B-O B-JJ
E B-O B-NN
box B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
" " B-O B-NP_NP_CONJP_NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_S_NP_DT
repressor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
active B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_DT
IgH B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
silenced B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Hence B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
necessary B-O B-JJ
prerequisite B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
enhancer B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
B-cell-specific B-O B-JJ
displacement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
ZEB-like B-O B-JJ
repressor B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
bHLH B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inhibition B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factor B-O B-NN
AP-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
CD28 B-O B-NP_NP_NN
signalling B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T-cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Co-stimulation B-O B-S_S_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T-lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
T-cell B-O B-NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TcR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
occupancy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD28 B-O B-NN
surface B-O B-NN
molecule B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
enhanced B-O B-NP_NP_VBN
proliferation B-O B-NN
" " B-O O-NP
and B-O B-CC
interleukin B-O B-NP_NP_NP_NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
triggered B-O B-VP_VBN
by B-O B-NP_PP_IN
CD28 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
a B-O B-NP_NP_DT
kappa B-O B-NN
B-like B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
5'-regulatory B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
IL-2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
, B-O B-COMMA
called B-O B-VP_VBN
" " B-O B-S_NP_NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T-cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
agonistic B-O B-NP_JJ
anti-CD28 B-O B-JJ
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
conjunction B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
phorbol B-O B-NP_NP_NP_NP_NN
12-myristate B-O B-NN
13-acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
- B-O B-COLON
" " B-O B-ADJP_NP_O-NP
or B-O B-CC
TcR-derived B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
signals B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
the B-O B-NP_NP_DT
enhanced B-O B-VBN
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NP_NP_NN
factor B-O B-NN
" " B-O O-NP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
CD28 B-O B-S_NP_NN
engagement B-O B-NN
, B-O B-COMMA
" " B-O O-NP
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
exerts B-O B-VP_VBZ
opposite B-O B-NP_JJ
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
AP-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Whereas B-O B-S_SBAR_IN
anti-CD28 B-O B-S_NP_NN
" " B-O O-NP
together B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
increased B-O B-VP_VBD
the B-O B-NP_NP_DT
DNA B-O B-NP_NN
binding B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
trans-activation B-O B-NP_NN
" " B-O B-NP_O-NP
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
PMA-induced B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
suppressed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
exerted B-O B-VP_VBN
by B-O B-NP_PP_IN
anti-CD28 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
at B-O B-NP_PP_PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
functional B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
reporter-gene B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
two B-O B-CD
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VP_VBP
independently B-O B-ADVP_RB
" " B-O O-ADVP
regulated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
and B-O B-CC
may B-O B-VP_MD
perform B-O B-VP_VB
different B-O B-NP_JJ
functions B-O B-NNS
" " B-O O-NP
during B-O B-PP_IN
T-cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Involvement B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
phospholipase B-O B-NP_NN
D B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factor B-O B-NN
AP-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
lymphoid B-O B-JJ
Jurkat B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
AP-1 B-O B-NP_NP_NN
" " B-O O-NP
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
ascribed B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
early B-O B-JJ
events B-O B-NNS
" " B-O O-NP
leading B-O B-VP_VBG
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_DT
possibility B-O B-NN
that B-O B-SBAR_IN
stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
may B-O B-VP_MD
regulate B-O B-VP_VB
by B-O B-NP_NP_PP_PP_PP_IN
" " B-O B-S_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
detected B-O B-VP_VBN
activatable B-O B-NP_JJ
PLD B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
found B-O B-VP_VBN
that B-O B-SBAR_IN
addition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VP_VBZ
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
incorporated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
and B-O B-CC
leads B-O B-VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
anti-CD3 B-O B-NP_JJ
mAb B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
activated B-O B-VP_VBD
both B-O B-NP_CC
PLD B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
transcription B-O B-NP_NN
factor B-O B-NN
AP-1 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Wortmannin B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
receptor-coupled B-O B-NP_JJ
PLD B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
blocked B-O B-VP_VBD
the B-O B-NP_DT
anti-CD3-induced B-O B-JJ
increases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_CC
PLD B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
a B-O B-NP_NP_DT
good B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
transfected B-O B-VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
between B-O B-PP_IN
PLD B-O B-NP_NP_NN
activation B-O B-NN
" " B-O O-NP
and B-O B-CC
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
under B-O B-PP_IN
different B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
experimental B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
conditions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
ethanol B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
PLD B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
blocked B-O B-VP_VBD
the B-O B-NP_DT
anti-CD3-stimulated B-O B-JJ
AP-1 B-O B-NN
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
this B-O B-NP_DT
anti-CD3-mediated B-O B-JJ
response B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
neomycin B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
phosphoinositide B-O B-NP_JJ
hydrolysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
increases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
AP-1 B-O B-NP_NP_NN
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
PA B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
anti-CD3 B-O B-NP_JJ
mAb B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
efficiently B-O B-ADVP_RB
" " B-O O-ADVP
abrogated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
propranolol B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_NP_DT
PA- B-O B-NN
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
the B-O B-NP_DT
anti-CD3-induced B-O B-JJ
" " B-O B-NP_O-NP
increases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
AP-1 B-O B-NP_NN
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
blocked B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
by B-O B-PP_IN
PKC B-O B-NP_NN
down-regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VP_VBP
that B-O B-SBAR_IN
PLD B-O B-S_NP_NN
stimulation B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
activate B-O B-VP_VB
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
AP-1 B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
enhancer B-O B-NN
factor B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
PA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
via B-O B-NP_PP_PP_IN
, B-O B-NP_COMMA
either B-O B-PP_CC
or B-O B-PP_CC
" " B-O B-PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
provide B-O B-VP_VBP
evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
a B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PLD-derived B-O B-NP_JJ
lipids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
resulting B-O B-VP_VBG
from B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
increased B-O B-S_NP_VBN
PLD B-O B-NN
activity B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
play B-O B-VP_VB
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Induction B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-8 B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
uses B-O B-VP_VBZ
the B-O B-NP_DT
CD28 B-O B-NN
costimulatory B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
IL-8 B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
potent B-O B-JJ
chemotactic B-O B-JJ
factor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
neutrophil B-O B-NP_NP_NN
granulocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
proinflammatory B-O B-JJ
cytokine B-O B-NN
" " B-O O-NP
secreted B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD28 B-O B-NN
cell B-O B-NN
surface B-O B-NN
molecule B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
delivers B-O B-VP_VBZ
costimulatory B-O B-NP_NP_JJ
signals B-O B-NNS
" " B-O O-NP
essential B-O B-ADJP_JJ
for B-O B-PP_IN
lymphokine B-O B-NP_NP_NN
production B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
via B-O B-PP_IN
a B-O B-NP_NP_DT
conserved B-O B-VBN
sequence B-O B-NN
element B-O B-NN
" " B-O O-NP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
promoter B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_JJ
lymphokine B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Anti-CD28-stimulated B-O B-S_S_NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
produced B-O B-VP_VBD
significant B-O B-NP_NP_JJ
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
IL-8 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
additionally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
costimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
anti-CD3 B-O B-NP_NP_JJ
" " B-O O-NP
and B-O B-CC
anti-CD28 B-O B-NP_JJ
Abs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_DT
synergistic B-O B-JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-8 B-O B-NP_NN
secretion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Sequence B-O B-S_NP_NP_NN
homology B-O B-NN
" " B-O B-NP_O-NP
, B-O B-COMMA
single B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
nucleotide B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
mutations B-O B-NNS
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
anti-CD28 B-O B-NP_JJ
Ab B-O B-NN
stimulation B-O B-NN
" " B-O B-NP_O-NP
studies B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
established B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
NF-kappa B-O B-NN
B-like B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
promoter B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-8 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
functioned B-O B-VP_VBD
as B-O B-PP_IN
a B-O B-NP_DT
CD28 B-O B-NN
response B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
cyclosporin B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
rapamycin B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
blocked B-O B-VP_VBD
the B-O B-NP_NP_DT
synergistic B-O B-JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-8 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
achieved B-O B-VP_VBN
with B-O B-NP_PP_IN
anti-CD3 B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
anti-CD28 B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
costimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
CD28 B-O B-NN
response B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-8 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
provide B-O B-VP_VB
new B-O B-NP_JJ
insights B-O B-NNS
" " B-O O-NP
into B-O B-PP_IN
the B-O B-NP_NP_NP_DT
pathogenesis B-O B-NN
" " B-O O-NP
and B-O B-CC
persistence B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
immune B-O B-NP_NP_JJ
disorders B-O B-NNS
" " B-O O-NP
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
, B-O B-COMMA
such B-O B-PP_JJ
as B-O B-IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_S_NP_NP_DT
severe B-O B-JJ
phenotype B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
females B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
tiny B-O B-NP_JJ
ring B-O B-NN
X B-O B-NN
chromosomes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
inability B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
chromosomes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
undergo B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Mental B-O B-S_S_NP_NP_NP_JJ
retardation B-O B-NN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
constellation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
congenital B-O B-NP_JJ
malformations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
not B-O B-RB
usually B-O B-ADVP_RB
" " B-O O-ADVP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
Turner B-O B-NP_NN
syndrome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
some B-O B-NP_NP_DT
females B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_DT
mosaic B-O B-JJ
45,X/46,X,r(X) B-O B-NN
karyotype B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Studies B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
females B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
XIST B-O B-NN
locus B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
their B-O B-NP_PRPP
tiny B-O B-JJ
ring B-O B-NN
X B-O B-NN
chromosomes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
either B-O B-UCP_CC
not B-O B-ADJP_RB
present B-O B-JJ
" " B-O O-ADJP
or B-O B-CC
not B-O B-VP_RB
expressed B-O B-VBN
" " B-O B-NP_O-VP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_SBAR_IN
XIST B-O B-S_NP_NN
transcription B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
well B-O B-ADVP_RB
" " B-O O-ADVP
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
inactivation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
X B-O B-NN
chromosome B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
nonexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
locus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
even B-O B-SBAR_WHADVP_RB
when B-O B-WRB
" " B-O O-WHADVP
it B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
present B-O B-ADJP_JJ
" " B-O B-ADVP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
these B-O B-S_NP_DT
chromosomes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
transcriptionally B-O B-ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ring B-O B-NP_NP_NN
X B-O B-NN
chromosomes B-O B-NNS
" " B-O O-NP
lacking B-O B-VP_VBG
XIST B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
XISTE- B-O B-NP_JJ
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
from B-O B-PP_IN
three B-O B-NP_NP_CD
females B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
severe B-O B-NP_JJ
phenotypes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
two B-O B-CD
tiny B-O B-JJ
ring B-O B-NN
X B-O B-NN
chromosomes B-O B-NNS
" " B-O O-NP
studied B-O B-VP_VBN
with B-O B-NP_PP_IN
an B-O B-NP_NP_DT
antibody B-O B-NN
" " B-O O-NP
specific B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_DT
acetylated B-O B-VBN
isoforms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
labeled B-O B-VP_VBN
at B-O B-NP_PP_IN
a B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
their B-O B-S_NP_PRPP
" " B-O O-NP
being B-O B-VP_VBG
" " B-O B-ADJP_O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
examined B-O B-VP_VBD
tow B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
XISTE- B-O B-JJ
ring B-O B-NN
chromosomes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
genes B-O B-S_NP_NP_NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Analyses B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
hybrid B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
TIMP B-O B-S_NP_NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
ZXDA B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
ZXDB B-O B-NP_NN
loci B-O B-NNS
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
proximal B-O B-JJ
short B-O B-JJ
arm B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
AR B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
PHKA1 B-O B-NP_NN
loci B-O B-NNS
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
long B-O B-JJ
arm B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
well B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_NP_DT
tiny B-O B-JJ
ring B-O B-NN
X B-O B-NN
chromosome B-O B-NN
" " B-O O-NP
lacking B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Studies B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
ring B-O B-NN
chromosome B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
has B-O B-S_NP_VP_VP_VBZ
XIST B-O B-NP_NN
DNA B-O B-NN
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
does B-O B-VP_VBZ
not B-O B-RB
transcribe B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
its B-O B-S_NP_PRPP
AR B-O B-NN
allele B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
transcribed B-O B-VP_VBN
along B-O B-NP_PP_IN
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
Signals B-O B-NP_NP_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
nuclear B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
regulate B-O B-S_NP_VP_VBP
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interleukin-4 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
interleukin-5 B-O B-NP_NN
" " B-O B-NP_O-NP
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
helper B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Mouse B-O B-S_S_NP_NN
thymoma B-O B-NN
line B-O B-NN
EL-4 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
produce B-O B-VP_VBP
cytokines B-O B-NP_NP_NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
interleukin B-O B-NP_NP_NN
( B-O B-LRB
IL B-O B-NN
) B-O B-RRB
-2 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
IL-3 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
IL-4 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
IL-10 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
granulocyte-macrophage B-O B-NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
phorbol B-O B-NP_NP_NN
12-myristate B-O B-NN
13-acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
EL-4 B-O B-S_S_NP_NN
cells B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
produce B-O B-VP_VBP
low B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
IL-5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
stimulated B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
PMA B-O B-NP_NP_NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
however B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
cAMP B-O B-NP_NN
" " B-O O-NP
greatly B-O B-ADVP_RB
" " B-O O-ADVP
augments B-O B-VP_VBZ
PMA-dependent B-O B-NP_JJ
IL-5 B-O B-NN
production B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
transient B-O B-JJ
transfection B-O B-NN
assay B-O B-NN
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
two B-O B-S_NP_NP_CD
signals B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
PMA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
cAMP B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
optimal B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
cAMP B-O B-NP_NN
" " B-O O-NP
almost B-O B-ADVP_RB
completely B-O B-RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
PMA-dependent B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
endogenous B-O B-JJ
IL-2 B-O B-NN
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
the B-O B-NP_DT
transfected B-O B-VBN
IL-2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
IL-5 B-O B-NN
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
positively B-O B-ADVP_RB
" " B-O O-ADVP
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
cAMP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_NP_DT
manner B-O B-NN
" " B-O O-NP
opposite B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
NFs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
regulates B-O B-S_NP_VP_VBZ
the B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-5 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
cAMP B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
has B-O B-VP_VBZ
properties B-O B-NP_NP_NNS
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
NF B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
activated B-O B-NP_VBN
t B-O B-NN
cell B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
P B-O B-NN
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-4 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
defined B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_NP_DT
responsive B-O B-JJ
element B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
PMA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
calcium B-O B-NP_NP_NN
ionophore B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
shares B-O B-VP_VBZ
sequence B-O B-NP_NP_NN
similarity B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
NF B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
the B-O B-NP_DT
NF-activated B-O B-JJ
T B-O B-NN
cell B-O B-NN
" " B-O B-NP_O-NP
binding B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
attempted B-O B-VP_VBD
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
NF(P) B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
, B-O B-NP_NP_ADJP_COMMA
" " B-O O-NP
is B-O B-VP_VBZ
related B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
electromobility B-O B-NP_NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
both B-O B-NP_CC
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
P65 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
P65/P50 B-O B-NP_NN
heterodimer B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
bound B-O B-VP_VBD
to B-O B-PP_TO
the B-O B-NP_DT
P B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
sequence B-O B-S_S_NP_NP_NN
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
more B-O B-ADJP_RBR
similar B-O B-JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
NF(P) B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
only B-O B-S_NP_NP_RB
a B-O B-DT
small B-O B-JJ
amount B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
P65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
NF(P) B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
component B-O B-NN
" " B-O B-PP_O-NP
or B-O B-CC
components B-O B-NP_NNS
" " B-O B-PP_O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
the B-O B-NP_DT
potential B-O B-NN
to B-O B-S_NP_VP_TO
reconstitute B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NP_NN
B B-O B-NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
account B-O B-VP_VB
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
these B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
NF-AT-like B-O B-S_NP_JJ
factors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
An B-O B-NP_NP_NP_DT
interleukin-4-induced B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
: B-O B-COLON
" " B-O O-NP
IL-4 B-O B-NP_NN
Stat B-O B-NN
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Interleukin-4 B-O B-S_S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-4 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
immunomodulatory B-O B-JJ
cytokine B-O B-NN
" " B-O O-NP
secreted B-O B-VP_VBN
by B-O B-NP_PP_IN
activated B-O B-NP_VBN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
basophils B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
mast B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
plays B-O B-VP_VBZ
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
modulating B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
balance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
helper B-O B-NN
( B-O B-LRB
Th B-O B-NN
) B-O B-RRB
cell B-O B-NN
subsets B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
favoring B-O B-S_NP_VP_VBG
expansion B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
Th2 B-O B-NN
lineage B-O B-NN
" " B-O O-NP
relative B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Imbalance B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
T B-O B-NN
lymphocyte B-O B-NN
subsets B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
implicated B-O B-VP_VBN
in B-O B-NP_PP_IN
immunological B-O B-NP_NP_JJ
diseases B-O B-NNS
" " B-O O-NP
including B-O B-PP_VBG
allergy B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
inflammation B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
autoimmune B-O B-NP_JJ
disease B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-4 B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
mediate B-O B-VP_VB
its B-O B-NP_PRPP
biological B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
at B-O B-PP_ADVP_IN
least B-O B-JJS
" " B-O O-ADVP
in B-O B-IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
by B-O B-PP_IN
activating B-O B-S_NP_VP_VBG
a B-O B-NP_DT
tyrosine-phosphorylated B-O B-JJ
DNA B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
protein B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
now B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
purified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
its B-O B-S_NP_PRPP
encoding B-O B-JJ
gene B-O B-NN
" " B-O O-NP
cloned B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Examination B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
primary B-O B-JJ
amino B-O B-NN
acid B-O B-NN
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicates B-O B-VP_VBZ
that B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_NP_PP_COMMA
hereby B-O B-ADVP_RB
" " B-O O-ADVP
designated B-O B-VP_VBN
" " B-O B-S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Study B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
inhibitory B-O B-JJ
activities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
phosphotyrosine-containing B-O B-NP_NP_JJ
peptides B-O B-NNS
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_DT
intracellular B-O B-JJ
domain B-O B-NN
of B-O B-IN
the B-O B-DT
IL-4 B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
provided B-O B-VP_VBD
evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
direct B-O B-NP_NP_JJ
coupling B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
receptor B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
the B-O B-NP_DT
IL-4 B-O B-NN
Stat B-O B-NN
activation B-O B-NN
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Such B-O B-S_NP_JJ
observations B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
IL-4 B-O B-S_NP_NN
Stat B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
the B-O B-NP_DT
same B-O B-JJ
functional B-O B-JJ
domain B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
both B-O B-NP_CC
receptor B-O B-NN
coupling B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
dimerization B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Structure B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
GATA3 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
GATA3 B-O B-S_S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GATA B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
abundantly B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
T-lymphocyte B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
participate B-O B-VP_VB
in B-O B-PP_IN
T-cell B-O B-NP_NN
receptor B-O B-NN
gene B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
understand B-O B-VP_VB
GATA3 B-O B-NP_NN
gene B-O B-NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
cloned B-O B-VP_VBD
the B-O B-NP_NP_DT
human B-O B-JJ
gene B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
5' B-O B-NN
end B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
mouse B-O B-NN
GATA3 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
human B-O B-JJ
GATA3 B-O B-NN
gene B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
six B-O B-NP_NP_CD
exons B-O B-NNS
" " B-O O-NP
distributed B-O B-VP_VBN
over B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
two B-O B-CD
human B-O B-JJ
GATA3 B-O B-NN
zinc B-O B-NN
fingers B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
encoded B-O B-VP_VBN
by B-O B-NP_PP_IN
two B-O B-NP_NP_CD
separate B-O B-JJ
exons B-O B-NNS
" " B-O O-NP
highly B-O B-VP_ADVP_RB
" " B-O O-ADVP
conserved B-O B-VBN
with B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
no B-O B-S_NP_NP_DT
other B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
structural B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
homologies B-O B-NNS
" " B-O O-NP
between B-O B-PP_IN
these B-O B-NP_DT
two B-O B-CD
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
human B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
mouse B-O B-NP_NN
" " B-O B-NP_O-NP
GATA3 B-O B-NP_NN
transcription B-O B-NN
units B-O B-NNS
" " B-O O-NP
" " B-O O-NP
start B-O B-VP_VBP
at B-O B-PP_IN
a B-O B-NP_DT
major B-O B-JJ
initiation B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
promoter B-O B-NN
sequence B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
two B-O B-CD
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
are B-O B-VP_VP_VBP
embedded B-O B-ADJP_JJ
within B-O B-NP_PP_IN
a B-O B-NP_DT
CpG B-O B-NN
island B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
share B-O B-VP_VBP
structural B-O B-NP_NP_JJ
features B-O B-NNS
" " B-O O-NP
often B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
DNA B-O B-NN
fragment B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_NP_DT
human B-O B-JJ
GATA3 B-O B-NN
transcription B-O B-NN
unit B-O B-NN
" " B-O O-NP
, B-O B-COMMA
upstream B-O B-ADVP_ADVP_NP_RB
and B-O B-PP_CC
" " B-O B-ADVP_NP_PP_O-ADVP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
displays B-O B-VP_VBZ
T-cell B-O B-NP_NN
specificity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Mechanisms B-O B-NP_NP_NP_NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
growth B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
by B-O B-PP_IN
anti-MHC B-O B-NP_JJ
class B-O B-NN
II B-O B-CD
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
growth B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
by B-O B-PP_IN
anti-MHC B-O B-NP_NP_JJ
class B-O B-NN
II B-O B-CD
antibodies B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
compared B-O B-VP_VBN
with B-O B-NP_PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_IN
anti-IgM B-O B-NP_JJ
Ab-induced B-O B-JJ
B104 B-O B-NN
growth B-O B-NN
inhibition B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Two B-O B-S_NP_NP_CD
anti-MHC B-O B-JJ
class B-O B-NN
II B-O B-CD
Ab B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
L227 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
2.06 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
growth B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B104 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
although B-O B-SBAR_IN
2.06 B-O B-S_NP_NP_CD
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
L227 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
needed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
further B-O B-ADVP_RBR
" " B-O O-ADVP
cross-linked B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
to B-O B-S_NP_VP_TO
show B-O B-VP_VB
the B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
L227 B-O B-S_NP_NN
" " B-O O-NP
induced B-O B-VP_VBD
an B-O B-NP_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
intracellular B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
free B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
Ca2+ B-O B-NP_NP_NN
concentration B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
[Ca2+]i B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
the B-O B-NP_DT
intracellular B-O B-JJ
pool B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
little B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
or B-O B-CC
no B-O B-NP_DT
" " B-O B-NP_O-NP
protein B-O B-NP_NP_NN
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
phosphatidyl B-O B-NP_JJ
inositol B-O B-NN
turnover B-O B-NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Egr-1 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
2.06 B-O B-S_NP_NP_CD
" " B-O O-NP
plus B-O B-CC
GAM B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
induced B-O B-VP_VBD
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
[Ca2+]i B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
both B-O B-NP_CC
the B-O B-NP_DT
" " B-O B-ADJP_NP_O-NP
and B-O B-CC
, B-O B-COMMA
in B-O B-PP_IN
, B-O B-NP_COMMA
the B-O B-NP_DT
" " B-O B-ADJP_NP_O-NP
pools B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B104 B-O B-NP_NP_NN
cell B-O B-NN
growth B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
anti-MHC B-O B-NP_JJ
class B-O B-NN
II B-O B-CD
Ab B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
Ca(2+)-independent B-O B-UCP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
not B-O B-RB
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
actinomycin B-O B-NP_NP_JJ
D B-O B-NN
" " B-O O-NP
or B-O B-CC
cyclosporin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
cell B-O B-S_NP_NP_NN
cycle B-O B-NN
arrest B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
G2/M B-O B-NN
interphase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
features B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
very B-O B-ADJP_RB
different B-O B-JJ
from B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
B104 B-O B-NP_NP_NN
cell B-O B-NN
death B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Neither B-O B-S_NP_DT
DNA B-O B-NP_NN
fragmentation B-O B-NN
" " B-O O-NP
nor B-O B-CC
the B-O B-NP_NP_DT
morphology B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
apoptosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
cross-linking B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
MHC B-O B-NP_NN
class B-O B-NN
II B-O B-CD
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
transduced B-O B-VP_VBD
the B-O B-NP_DT
negative B-O B-JJ
signals B-O B-NNS
" " B-O O-NP
through B-O B-PP_IN
intracellular B-O B-NP_NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
different B-O B-ADJP_JJ
from B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-S_NP_JJ
CD4 B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
recognize B-O B-VP_VBP
a B-O B-NP_NP_DT
peptide B-O B-NN
" " B-O O-NP
representing B-O B-VP_VBG
the B-O B-NP_NP_DT
fusion B-O B-NN
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
hybrid B-O B-NN
protein B-O B-NN
pml/RAR B-O B-NN
alpha B-O B-NN
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Fusion B-O B-S_NP_NP_NN
proteins B-O B-NNS
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
leukemic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
frequently B-O B-ADVP_RB
" " B-O O-ADVP
contain B-O B-VP_VBP
a B-O B-NP_DT
new B-O B-JJ
amino B-O B-NN
acid B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
fusion B-O B-NN
point B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
tested B-O B-VP_VBD
whether B-O B-SBAR_IN
a B-O B-S_NP_NP_NP_DT
peptide B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
BCR1/25 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
encompassing B-O B-VP_VBG
the B-O B-NP_NP_DT
fusion B-O B-NN
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hybrid B-O B-NN
molecule B-O B-NN
pml/RAR B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
expressed B-O B-VP_ADVP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
human B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CD4+ B-O B-S_NP_NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
at B-O B-PP_IN
both B-O B-NP_ADJP_CC
polyclonal B-O B-ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
clonal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
recognized B-O B-VP_VBD
peptide B-O B-NP_NN
BCR1/25 B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
an B-O B-NP_DT
HLA-DR--restricted B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
presentation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_PP_IN
autologous B-O B-NP_JJ
antigen-presenting B-O B-NP_NP_JJ
cell B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
by B-O B-PP_IN
APC B-O B-NP_NP_NN
" " B-O O-NP
expressing B-O B-VP_VBG
the B-O B-NP_DT
HLA-DR11 B-O B-NN
restricting B-O B-NN
molecule B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Control B-O B-S_NP_NP_NN
peptides B-O B-NNS
" " B-O O-NP
corresponding B-O B-VP_VBG
to B-O B-PP_TO
the B-O B-NP_DT
normal B-O B-NP_NP_JJ
pml B-O B-NN
" " B-O O-NP
and B-O B-CC
RAR B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
recognized B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
clone B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
DEG5 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
exerted B-O B-VP_VBD
a B-O B-NP_NP_DT
high B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
cytotoxicity B-O B-NN
" " B-O O-NP
against B-O B-PP_IN
autologous B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
pulsed B-O B-VP_VBN
with B-O B-NP_PP_IN
BCR1/25 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
autologous B-O B-JJ
DE B-O B-NN
LCL B-O B-NN
" " B-O O-NP
containing B-O B-VP_VP_VBG
a B-O B-NP_DT
transduced B-O B-VBN
pml/RAR B-O B-NN
alpha B-O B-NN
fusion B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
expressing B-O B-VP_VBG
a B-O B-NP_NP_DT
bcr1 B-O B-NN
type B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
pml/RAR B-O B-NN
alpha B-O B-NN
hybrid B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-NP
induced B-O B-VP_VBD
the B-O B-NP_NP_DT
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DE B-O B-NP_NN
anti-BCR1/25 B-O B-CD
T B-O B-NN
cell B-O B-NN
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
concluded B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
bcr1 B-O B-NN
type-pml/RAR B-O B-NN
alpha B-O B-NN
fusion B-O B-NN
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
APL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contains B-O B-VP_VBZ
an B-O B-NP_NP_DT
antigenic B-O B-JJ
site B-O B-NN
" " B-O O-NP
, B-O B-COMMA
absent B-O B-UCP_ADJP_JJ
and B-O B-PP_CC
recognized B-O B-VP_VBN
" " B-O B-NP_PP_O-UCP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
NF-kappa B-O B-S_S_S_NP_NN
B B-O B-NN
" " B-O O-NP
controls B-O B-VP_VBZ
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
inhibitor B-O B-NP_NN
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
an B-O B-NP_DT
inducible B-O B-JJ
autoregulatory B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
eukaryotic B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
nuclear B-O B-NP_NP_JJ
factor-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
participates B-O B-VP_VBZ
in B-O B-PP_IN
many B-O B-NP_NP_JJ
parts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
genetic B-O B-JJ
program B-O B-NN
" " B-O O-NP
mediating B-O B-VP_VBG
T B-O B-NP_NN
lymphocyte B-O B-NN
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurs B-O B-VP_VBZ
after B-O B-PP_IN
its B-O B-NP_NP_PRPP
induced B-O B-VBN
dissociation B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
its B-O B-NP_PRPP
cytoplasmic B-O B-JJ
inhibitor B-O B-NN
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Phorbol B-O B-S_NP_NP_NP_NP_NN
ester B-O B-NN
" " B-O O-NP
and B-O B-CC
tumor B-O B-NP_NN
necrosis B-O B-NN
factor-alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
both B-O B-NP_CC
the B-O B-NP_NP_DT
degradation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
performed B-O B-NP_VBN
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transfection B-O B-S_NP_NN
studies B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
specifically B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
65-kilodalton B-O B-JJ
transactivating B-O B-VBG
subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Association B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
newly B-O B-ADJP_RB
synthesized B-O B-VBN
" " B-O O-ADJP
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
restores B-O B-VP_VP_VBZ
intracellular B-O B-NP_NP_JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
prolongs B-O B-VP_VBZ
the B-O B-NP_NP_DT
survival B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
labile B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
controls B-O B-VP_VBZ
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
means B-O B-NNS
of B-O B-IN
an B-O B-NP_DT
inducible B-O B-JJ
autoregulatory B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_DT
Sp1 B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
binds B-O B-VP_VP_VBZ
the B-O B-NP_DT
CD11b B-O B-NN
promoter B-O B-NN
" " B-O O-NP
specifically B-O B-PP_RB
in B-O B-IN
myeloid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
myeloid-specific B-O B-NP_JJ
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
myeloid B-O B-JJ
integrin B-O B-NN
CD11b B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
selectively B-O B-NP_ADVP_RB
" " B-O O-ADVP
on B-O B-PP_IN
the B-O B-NP_NP_DT
surface B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mature B-O B-NP_NP_JJ
macrophages B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
monocytes B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
neutrophils B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
natural B-O B-NP_JJ
killer B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Lineage-specific B-O B-S_NP_JJ
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
controlled B-O B-VP_VBN
at B-O B-NP_PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mRNA B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recent B-O B-S_NP_NP_JJ
isolation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD11b B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
shows B-O B-VP_VBZ
that B-O B-SBAR_IN
92 B-O B-S_NP_NP_CD
base B-O B-NP_NP_NN
pairs B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
bp B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
5'-flanking B-O B-NP_JJ
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
sufficient B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
direct B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
characterize B-O B-VP_VB
regulatory B-O B-NP_NP_JJ
sequences B-O B-NNS
" " B-O O-NP
important B-O B-ADJP_JJ
for B-O B-PP_IN
promoter B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
performed B-O B-VP_VP_VBD
linker B-O B-NP_NP_NN
scanning B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
92-bp B-O B-JJ
CD11b B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
demonstrate B-O B-VP_VB
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
sequence B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
bp B-O B-NP_NN
-60 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
CD11b B-O B-NP_NN
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
this B-O B-S_NP_DT
sequence B-O B-NN
" " B-O O-NP
binds B-O B-VP_VBZ
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
Sp1 B-O B-NN
" " B-O O-NP
in B-O B-ADVP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
and B-O B-CC
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
the B-O B-NP_DT
Sp1 B-O B-NN
site B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
bound B-O B-VP_VBN
only B-O B-NP_PP_PP_RB
in B-O B-IN
myeloid B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
U937 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
not B-O B-PP_RB
in B-O B-IN
cervical B-O B-NP_NP_NP_JJ
carcinoma B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HeLa B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
macrophage B-O B-NN
transcription B-O B-NN
factor B-O B-NN
PU.1 B-O B-NN
" " B-O O-NP
binds B-O B-VP_VBZ
the B-O B-NP_DT
CD11b B-O B-NN
promoter B-O B-NN
" " B-O O-NP
in B-O B-ADVP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
and B-O B-CC
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-ADVP
close B-O B-ADVP_RB
to B-O B-PP_TO
the B-O B-NP_DT
Sp1 B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
a B-O B-NP_NP_DT
model B-O B-NN
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
binding B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
myeloid-specific B-O B-JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
allows B-O B-VP_VBZ
a B-O B-S_NP_NP_DT
general B-O B-JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
to B-O B-VP_TO
bind B-O B-VP_VB
" " B-O B-PP_O-VP
" " B-O O-S
thereby B-O B-PP_S_ADVP_RB
" " B-O O-ADVP
contributing B-O B-NP_VP_VBG
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
primary B-O B-NP_JJ
human B-O B-JJ
T-lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
CD2 B-O B-NP_NP_NP_NN
" " B-O O-NP
plus B-O B-CC
CD28 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
adhesion B-O B-NN
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
long-term B-O B-NP_NP_JJ
nuclear B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
highly B-O B-NP_ADJP_RB
purified B-O B-VBN
" " B-O O-ADJP
human B-O B-JJ
T-cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
via B-O B-PP_IN
CD2 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
CD28 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
adhesion B-O B-NN
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VP_VP_VBZ
" " B-O B-NP_O-VP
and B-O B-CC
maintains B-O B-VP_VBZ
" " B-O B-NP_PP_O-VP
" " B-O O-VP
proliferation B-O B-NP_NN
" " B-O O-NP
for B-O B-PP_IN
more B-O B-NP_QP_JJR
than B-O B-IN
3 B-O B-CD
" " B-O O-QP
weeks B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
potent B-O B-JJ
interleukin B-O B-ADJP_NN
2 B-O B-CD
( B-O B-LRB
IL-2 B-O B-NN
) B-O B-RRB
-dependent B-O B-JJ
" " B-O O-ADJP
activation B-O B-NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
require B-O B-VP_VB
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
or B-O B-CC
accessory B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Long-lasting B-O B-S_NP_JJ
IL-2 B-O B-NN
receptivity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
high-level B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
inducible B-O B-JJ
IL-2 B-O B-NP_NP_NN
receptor B-O B-NN
alpha B-O B-NN
chain B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
regulated B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Increase B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-2R B-O B-NP_NN
alpha B-O B-NN
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
the B-O B-NP_NP_DT
enhanced B-O B-VBN
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
its B-O B-NP_NP_PRPP
consensus B-O B-NN
sequence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
5'-regulatory B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2R B-O B-NN
alpha B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
dissect B-O B-VP_VB
the B-O B-NP_NP_DT
molecular B-O B-JJ
basis B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
unusually B-O B-ADJP_RB
persistent B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2R B-O B-NN
alpha B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
analyzed B-O B-VP_VBD
nuclear B-O B-NP_NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
binding B-O B-VBG
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_DT
radiolabeled B-O B-VBN
IL-2R B-O B-NN
alpha B-O B-NN
kappa B-O B-ADJP_NN
B-specific B-O B-JJ
" " B-O O-ADJP
oligonucleotide B-O B-NN
probe B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
the B-O B-NP_NP_DT
time B-O B-NN
course B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD2 B-O B-NP_NP_NP_NN
" " B-O O-NP
+ B-O B-CC
CD28 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Resting B-O B-S_NP_VBG
T-cell B-O B-NN
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
contained B-O B-VP_VBD
KBF1/p50 B-O B-NP_NN
homodimer B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_PP_IN
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
two B-O B-NP_CD
new B-O B-JJ
kappa B-O B-ADJP_NN
B-specific B-O B-JJ
" " B-O O-ADJP
complexes B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
as B-O B-NP_PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
p50-p65 B-O B-NN
heterodimer B-O B-NN
" " B-O O-NP
and B-O B-CC
putative B-O B-NP_JJ
c-Rel B-O B-NP_NP_NN
homodimer B-O B-NN
" " B-O O-NP
or B-O B-CC
c-Rel-p65 B-O B-NP_NN
heterodimer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_DT
inducible B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
persisted B-O B-VP_VBD
for B-O B-PP_IN
at B-O B-NP_QP_IN
least B-O B-JJS
3 B-O B-CD
" " B-O O-QP
weeks B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Their B-O B-S_NP_PRPP
relative B-O B-JJ
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
very B-O B-ADJP_RB
similar B-O B-JJ
" " B-O O-ADJP
for B-O B-PP_IN
the B-O B-NP_NP_DT
duration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
proliferation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
parallel B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
CD2 B-O B-NP_NP_NP_NN
" " B-O O-NP
+ B-O B-CC
CD28 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
triggered B-O B-VP_VBD
a B-O B-NP_DT
significant B-O B-JJ
intracellular B-O B-JJ
thiol B-O B-NN
decrease B-O B-NN
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
oxygen B-O B-S_NP_NN
radicals B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
micromolar B-O B-NP_NP_JJ
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
pyrrolidine B-O B-NP_NP_NN
dithiocarbamate B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
oxygen B-O B-ADJP_NN
radical B-O B-NN
" " B-O O-ADJP
scavenger B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
efficiently B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
blocked B-O B-VP_VBD
" " B-O B-NP_NP_PP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
IL-2 B-O B-NP_NP_NN
secretion B-O B-NN
" " B-O O-NP
, B-O B-COMMA
IL-2R B-O B-NP_NN
alpha B-O B-NN
cell B-O B-NN
surface B-O B-NN
expression B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
T-cell B-O B-NP_NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
plays B-O B-VP_VBZ
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
long-term B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
primary B-O B-JJ
T-lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
via B-O B-PP_IN
+ B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Synergism B-O B-NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_DT
CD3 B-O B-ADJP_ADJP_NP_NN
antigen- B-O B-NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
CD2 B-O B-ADJP_NN
antigen-derived B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Exploration B-O B-NP_NP_NP_NN
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
DNA-binding B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
characterization B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
inhibitory B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cyclosporine B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
demonstrated B-O B-VP_VBN
earlier B-O B-ADVP_RBR
" " B-O O-ADVP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
crosslinkage B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD3/TCR B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
CD2 B-O B-NN
antigen B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
proliferation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
synergism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
perceptible B-O B-ADJP_JJ
" " B-O O-ADJP
at B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
induction B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
process B-O B-NN
" " B-O O-NP
critical B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
further B-O B-ADVP_RB
" " B-O O-ADVP
understand B-O B-VP_VB
the B-O B-NP_NP_DT
molecular B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
nuclear B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
basis B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
this B-O B-NP_DT
synergism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
explored B-O B-VP_VBN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DNA-binding B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
highly B-O B-NP_NP_ADJP_RB
purified B-O B-VBN
" " B-O O-ADJP
normal B-O B-JJ
human B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
signaled B-O B-VP_VBN
via B-O B-NP_PP_IN
the B-O B-NP_DT
proteins B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transmembrane B-O B-NP_NP_NN
signaling B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
ionomycin B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
and/or B-O B-CC
sn-1,2 B-O B-NP_NN
dioctanoyl B-O B-NN
glycerol B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
determined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
emergence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
using B-O B-NP_S_NP_VP_VBG
interleukin-2 B-O B-NP_ADJP_NN
sequence B-O B-NN
specific B-O B-JJ
" " B-O O-ADJP
oligonucleotide B-O B-NN
probes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
electrophoretic B-O B-JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
studies B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
for B-O B-PP_IN
the B-O B-NP_DT
first B-O B-JJ
time B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
CD3 B-O B-S_NP_NP_ADJP_NN
antigen-derived B-O B-JJ
" " B-O O-ADJP
signals B-O B-NNS
" " B-O O-NP
and B-O B-CC
CD2 B-O B-NP_ADJP_NN
antigen-derived B-O B-JJ
" " B-O O-ADJP
signals B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
synergistic B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
inducing B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
cyclosporine B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
at B-O B-PP_IN
concentrations B-O B-NP_NP_NNS
" " B-O O-NP
readily B-O B-VP_ADVP_RB
" " B-O O-ADVP
accomplished B-O B-VBN
in B-O B-NP_PP_IN
clinical B-O B-NP_JJ
practice B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
the B-O B-NP_NP_DT
emergence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
DNA-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
and B-O B-NP_CC
in B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Antisense B-O B-S_NP_NP_JJ
oligonucleotides B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
p65 B-O B-NN
subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
block B-O B-VP_VP_VBP
CD11b B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
alter B-O B-VP_VBP
adhesion B-O B-NP_NP_NN
properties B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
differentiated B-O B-NP_VBN
HL-60 B-O B-NN
granulocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
pleiotropic B-O B-JJ
regulator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
implicated B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
function B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
attributed B-O B-VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
coordinated B-O B-VBN
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
subunits B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
to B-O B-PP_TO
distinct B-O B-NP_NP_JJ
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Antisense B-O B-S_NP_NP_JJ
phosphorothioate B-O B-JJ
oligonucleotides B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
p50 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
subunits B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
define B-O B-VP_VB
the B-O B-NP_NP_DT
physiologic B-O B-JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
granulocytes B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
reduction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
produced B-O B-VP_VBN
by B-O B-NP_PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
phosphorothioate B-O B-JJ
antisense B-O B-JJ
oligodeoxynucleotide B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
reduction B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
rapid B-O B-NP_NP_JJ
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
cellular B-O B-JJ
adhesion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
effects B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
marked B-O B-JJ
reduction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
CD11b B-O B-NP_NP_NN
integrin B-O B-JJ
expression B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
p65 B-O B-NN
antisense B-O B-JJ
oligomer B-O B-NN
" " B-O O-NP
effectively B-O B-ADVP_RB
" " B-O O-ADVP
abolished B-O B-VP_VBD
an B-O B-NP_NP_DT
upregulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD11b B-O B-NP_NP_NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
produced B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
p65 B-O B-NN
antisense B-O B-JJ
phosphorothioate B-O B-JJ
oligodeoxynucleotide B-O B-NN
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
significant B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_PP_IN
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
reactive B-O B-NP_JJ
oxygen B-O B-NN
intermediates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
on B-O B-PP_IN
phagocytosis B-O B-NP_NP_NNS
" " B-O O-NP
by B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
antisense B-O B-S_NP_NP_JJ
oligomers B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-NP_JJ
interferon B-O B-NN
regulatory B-O B-JJ
factor B-O B-NN
2 B-O B-CD
gene B-O B-NN
. B-O B-PERIOD
" " B-O O-NP
  
Intron-exon B-O B-NP_NP_NP_JJ
organization B-O B-NN
" " B-O O-NP
and B-O B-CC
functional B-O B-NP_JJ
analysis B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
5'-flanking B-O B-NP_JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Interferon B-O B-S_NP_NP_NN
regulatory B-O B-JJ
factor B-O B-NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
IRF-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
transcriptional B-O B-JJ
regulatory B-O B-JJ
protein B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
terminates B-O B-S_NP_VP_VBZ
interferon B-O B-NP_NP_NN
beta B-O B-NN
expression B-O B-NN
" " B-O O-NP
initiated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
isolated B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
genomic B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
human B-O B-NP_JJ
IRF-2 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
determined B-O B-VP_VBD
the B-O B-NP_NP_DT
intron-exon B-O B-JJ
structure B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
IRF-2 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
mapped B-O B-VP_VBD
the B-O B-NP_DT
major B-O B-JJ
transcription B-O B-NN
initiation B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
identified B-O B-VP_VBD
a B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
potential B-O B-NP_NP_JJ
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
5'-flanking B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
localized B-O B-VP_VBD
the B-O B-NP_NP_DT
IRF-2 B-O B-NN
gene B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
human B-O B-NP_JJ
chromosome B-O B-NN
4 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
IRF-2 B-O B-NN
promoter B-O B-NN
region B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
CpG B-O B-NN
island B-O B-NN
" " B-O O-NP
, B-O B-COMMA
with B-O B-PP_IN
several B-O B-NP_NP_JJ
GC B-O B-NN
boxes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
putative B-O B-JJ
NF-kappa B-O B-ADJP_NN
B-binding B-O B-JJ
" " B-O O-ADJP
site B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
a B-O B-NP_DT
CAAT B-O B-NN
box B-O B-NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CC
no B-O B-NP_DT
TATA B-O B-NN
box B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
promoter B-O B-NN
region B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
linked B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_DT
heterologous B-O B-JJ
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
promoter B-O B-NN
region B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
inducible B-O B-ADJP_JJ
by B-O B-PP_IN
both B-O B-NP_CC
and B-O B-NP_NP_PRN_CC
interferon B-O B-NP_NN
regulatory B-O B-JJ
factor B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
region B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
induced B-O B-S_NP_VP_VBD
these B-O B-NP_DT
inductions B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
as B-O B-NP_PP_IN
being B-O B-S_NP_VP_VBG
confined B-O B-VP_VBN
to B-O B-NP_PP_TO
40 B-O B-NP_CD
nucleotides B-O B-NNS
" " B-O O-NP
to B-O B-PP_NP_TO
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
by B-O B-PP_IN
testing B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
clones B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
with B-O B-PP_IN
truncated B-O B-NP_NP_VBN
promoter B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
region B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
elements B-O B-NP_NP_NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
shared B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
interferon B-O B-S_NP_NN
regulatory B-O B-JJ
factor B-O B-NN
1 B-O B-CD
" " B-O O-NP
not B-O B-VP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
triggers B-O B-VP_VBZ
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
interferon B-O B-NN
signal B-O B-NN
transduction B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
may B-O B-VP_MD
play B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Overproduction B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NFKB2 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
lyt-10 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
c-Rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
a B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
HTLV-I B-O B-NP_NP_NN
Tax-mediated B-O B-JJ
trans-activation B-O B-NN
" " B-O O-NP
via B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
signalling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Molecular B-O B-S_S_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
biochemical B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
epidemiological B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
evidence B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
implicate B-O B-VP_VBP
HTLV-I B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
an B-O B-NP_NP_DT
etiologic B-O B-JJ
agent B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
adult B-O B-NP_NP_JJ
T B-O B-NN
cell B-O B-NN
leukemia B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ATL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
Tax B-O B-NN
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HTLV-I B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
positive B-O B-JJ
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HTLV-I B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
viral B-O B-JJ
oncogene B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
also B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
increases B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
cellular B-O B-JJ
targets B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
trans-activating B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Tax B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
NF-kappa B-O B-NN
B/Rel B-O B-NN
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
pleiotropic B-O B-NP_NP_JJ
regulators B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_ADJP_NP_O-NP
, B-O B-COMMA
cytokine B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
NFKB2 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
lyt-10 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
c-Rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VP_VBP
overexpressed B-O B-VP_VBN
in B-O B-NP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
, B-O B-COMMA
together B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
account B-O B-VP_VBP
for B-O B-PP_IN
the B-O B-NP_NP_DT
majority B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Most B-O B-S_ADVP_RBS
importantly B-O B-RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
a B-O B-NP_NP_DT
Tax-dependent B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
expression B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NFKB2 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
processing B-O B-NP_NN
to B-O B-PP_TO
form B-O B-NP_NP_NP_PRN_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
trans-activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B-mediated B-O B-JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
NFKB2 B-O B-NN
precursor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
physically B-O B-ADVP_RB
" " B-O O-ADVP
associated B-O B-VP_VBN
with B-O B-NP_PP_PP_IN
c-Rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
with B-O B-PP_IN
Tax B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_NN
HTLV-I B-O B-NP_NN
infected B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
NFKB2 B-O B-S_S_NP_NN
synthesis B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
processing B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
allows B-O B-VP_VBZ
continuous B-O B-NP_NP_JJ
nuclear B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
cytoplasmic B-O B-ADVP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
, B-O B-COMMA
in B-O B-S_PP_IN
conjunction B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NFKB2 B-O B-NP_NN
" " B-O O-NP
alters B-O B-VP_VP_VBZ
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
signalling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
contributes B-O B-VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Autoregulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
transactivator B-O B-NN
RelA B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
p65 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
multiple B-O B-NP_NP_JJ
cytoplasmic B-O B-JJ
inhibitors B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VBG
ankyrin B-O B-NP_NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
RelA B-O B-S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
p65 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
functions B-O B-VP_VP_VBZ
as B-O B-PP_IN
the B-O B-NP_NP_DT
critical B-O B-JJ
transactivating B-O B-VBG
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
heterodimeric B-O B-JJ
p50-p65 B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
high-affinity B-O B-JJ
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
its B-O B-NP_NP_PRPP
cytoplasmic B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_PP_IN
cellular B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
rapidly B-O B-VP_ADVP_RB
" " B-O O-ADVP
degraded B-O B-VBN
in B-O B-NP_PP_IN
concert B-O B-NN
with B-O B-IN
the B-O B-NP_NP_DT
induced B-O B-VBN
nuclear B-O B-JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
demonstrates B-O B-VP_VBZ
that B-O B-SBAR_IN
tumor B-O B-S_NP_NP_ADJP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha-induced B-O B-JJ
" " B-O O-ADJP
degradation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
preceded B-O B-VP_VBN
by B-O B-NP_PP_IN
its B-O B-NP_NP_PRPP
rapid B-O B-JJ
phosphorylation B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
result B-O B-VP_VBP
in B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
mobilization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
only B-O B-NP_NP_RB
a B-O B-DT
fraction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
entire B-O B-JJ
cytoplasmic B-O B-JJ
pool B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Subsequent B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
revealed B-O B-VP_VBN
that B-O B-SBAR_IN
( B-O B-S_S_LST_LRB
i B-O B-LS
) B-O B-RRB
" " B-O O-LST
cytoplasmic B-O B-NP_JJ
RelA B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
stably B-O B-VP_ADVP_RB
" " B-O O-ADVP
associated B-O B-VBN
" " B-O B-NP_PP_CONJP_PP_CONJP_PP_O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
( B-O B-S_LST_LRB
ii B-O B-LS
) B-O B-RRB
" " B-O O-LST
in B-O B-PP_IN
contrast B-O B-NN
to B-O B-TO
RelA-I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
RelA-p100 B-O B-NP_NN
cytoplasmic B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
dissociated B-O B-VP_VBN
following B-O B-NP_PP_VBG
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
( B-O B-S_LST_LRB
iii B-O B-LS
) B-O B-RRB
" " B-O O-LST
p100 B-O B-NP_NN
" " B-O O-NP
functions B-O B-VP_VBZ
as B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
( B-O B-S_LST_LRB
iv B-O B-LS
) B-O B-RRB
" " B-O O-LST
the B-O B-NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
but B-O B-NP_NP_NP_PP_CONJP_CC
not B-O B-RB
" " B-O O-CONJP
, B-O B-NP_NP_PP_COMMA
" " B-O B-SBAR_O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
( B-O B-S_LST_LRB
v B-O B-LS
) B-O B-RRB
" " B-O O-LST
p100 B-O B-NP_NP_NN
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RelA B-O B-NP_NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
the B-O B-NP_NP_DT
C-terminal B-O B-JJ
ankyrin B-O B-NN
motif B-O B-NN
domain B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
and B-O B-CC
( B-O B-S_LST_LRB
vi B-O B-LS
) B-O B-RRB
" " B-O O-LST
as B-O B-SBAR_IN
observed B-O B-S_NP_VP_VBN
" " B-O B-NP_PP_O-S
" " B-O O-SBAR
, B-O B-COMMA
nuclear B-O B-NP_JJ
RelA B-O B-NN
" " B-O O-NP
stimulates B-O B-VP_VBZ
p100 B-O B-NP_NN
and B-O B-NP_NP_CC
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
thus B-O B-ADVP_RB
" " B-O O-ADVP
reveal B-O B-VP_VBP
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
second B-O B-JJ
inducible B-O B-JJ
autoregulated B-O B-JJ
inhibitory B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
helps B-O B-S_NP_VP_VBZ
" " B-O B-S_NP_VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Calcineurin B-O B-S_NP_NN
" " B-O O-NP
acts B-O B-VP_VBZ
in B-O B-PP_IN
synergy B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
inactivate B-O B-VP_VB
I B-O B-NP_NP_NN
kappa B-O B-NN
B/MAD3 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
interleukin-2 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
promoter B-O B-NN
" " B-O O-NP
consists B-O B-VP_VBZ
of B-O B-PP_IN
several B-O B-NP_JJ
independent B-O B-JJ
T B-O B-ADJP_NP_NP_NN
cell B-O B-NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TcR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
responsive B-O B-JJ
" " B-O O-ADJP
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
promoters B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
these B-O B-NP_DT
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
is B-O B-VP_VBZ
inhibitable B-O B-ADJP_JJ
by B-O B-PP_IN
the B-O B-NP_DT
immunosuppressants B-O B-NNS
cyclosporin B-O B-NP_NP_NP_NN
A B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CsA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
tacrolimus B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
FK-506 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Calcineurin B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
Ca2+/calmodulin-dependent B-O B-JJ
protein B-O B-NN
phosphatase B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
FK-506- B-O B-ADJP_NN
and B-O B-ADJP_CC
CsA-sensitive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
enzyme B-O B-NN
" " B-O O-NP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
TcR B-O B-NP_NP_ADJP_NN
mediated B-O B-JJ
" " B-O O-ADJP
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
constitutively B-O B-ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
calcineurin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
partially B-O B-VP_VP_ADVP_RB
" " B-O O-ADVP
substitutes B-O B-VBZ
for B-O B-PP_IN
the B-O B-NP_NP_DT
Ca2+ B-O B-NN
co-stimulus B-O B-NN
" " B-O O-NP
required B-O B-VP_VBN
" " B-O B-NP_S_O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
completely B-O B-VP_ADVP_RB
" " B-O O-ADVP
substitutes B-O B-VBZ
for B-O B-PP_IN
the B-O B-NP_NP_DT
Ca2+ B-O B-NN
co-stimulus B-O B-NN
" " B-O O-NP
required B-O B-VP_VBN
" " B-O B-NP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Calcineurin B-O B-S_NP_NN
" " B-O O-NP
stimulates B-O B-VP_VBZ
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
element B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
enhancing B-O B-S_NP_VP_VP_VBG
inactivation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
thereby B-O B-VP_ADVP_RB
" " B-O O-ADVP
increasing B-O B-VBG
the B-O B-NP_NP_DT
amount B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VP_VBP
the B-O B-NP_NP_DT
first B-O B-JJ
demonstration B-O B-NN
" " B-O B-SBAR_O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
that B-O B-SBAR_IN
activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
protein B-O B-NN
phosphatase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
inactivate B-O B-VP_VB
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
suggest B-O B-VP_VBP
one B-O B-NP_NP_CD
possible B-O B-JJ
explanation B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
mechanism-based B-O B-NP_NP_JJ
toxicities B-O B-NNS
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
demonstrating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
these B-O B-S_NP_DT
drugs B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Direct B-O B-S_NP_NP_JJ
exposure B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
2,3,7,8-tetrachlorodibenzo-p-dioxin B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
TCDD B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increases B-O B-VP_VBZ
infectivity B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
erythrocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_DT
malarial B-O B-JJ
parasite B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Direct B-O B-S_NP_NP_JJ
exposure B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
10 B-O B-NP_ADJP_CD
nM B-O B-NN
" " B-O O-ADJP
2,3,7,8-TCDD B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
caused B-O B-VP_VBD
a B-O B-NP_NP_NP_DT
75 B-O B-CD
% B-O B-NN
increase B-O B-NN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
2-fold B-O B-QP_JJ
" " B-O O-QP
increase B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
infectivity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
isolated B-O B-NP_VBN
human B-O B-JJ
erythrocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
P. B-O B-NP_FW
falciparum B-O B-FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
after B-O B-PP_IN
48 B-O B-NP_NP_CD
hours B-O B-NNS
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
parasites B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
erythrocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
10 B-O B-NP_NP_ADJP_CD
microM B-O B-NN
" " B-O O-ADJP
sodium B-O B-NP_NP_NN
orthovanadate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NaOV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
plasma B-O B-NP_NP_NN
membrane B-O B-NN
Ca-ATPase B-O B-NN
" " B-O O-NP
and B-O B-CC
phosphotyrosine B-O B-NP_NN
phosphatase B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
decreased B-O B-VP_VBD
parasitemia B-O B-NP_NN
" " B-O O-NP
by B-O B-PP_IN
30 B-O B-NP_CD
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Co-treatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
RBCs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
TCDD B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NaOV B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
completely B-O B-ADVP_RB
" " B-O O-ADVP
blocked B-O B-VP_VBD
the B-O B-NP_NP_DT
TCDD-induced B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
parasitemia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
erythrocytes B-O B-S_NP_NNS
" " B-O O-NP
are B-O B-VP_VBP
anucleated B-O B-VP_JJ
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
discussed B-O B-VP_VBN
as B-O B-NP_PP_IN
evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
biochemical B-O B-NP_NP_JJ
changes B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
TCDD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
without B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
trans-activation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
a B-O B-NP_DT
cDNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
its B-O B-NP_NP_PRPP
genomic B-O B-JJ
clones B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
herpesvirus-6 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Human B-O B-S_S_S_NP_NP_JJ
herpesvirus B-O B-NN
6 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HHV-6 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
lymphotropic B-O B-JJ
herpesvirus B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
in B-O B-S_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
can B-O B-VP_MD
productively B-O B-ADVP_RB
" " B-O O-ADVP
infect B-O B-VP_VB
human B-O B-NP_JJ
CD4+ B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
as B-O B-PP_IN
HIV-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Co-infection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
HIV-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
HHV-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
lead B-O B-VP_VB
to B-O B-PP_TO
both B-O B-NP_CC
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
acceleration B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cytopathic B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_S_NP_NP_NP_DT
HHV-6 B-O B-NN
( B-O B-LRB
GS B-O B-NN
) B-O B-RRB
cDNA B-O B-NN
clone B-O B-NN
" " B-O O-NP
, B-O B-COMMA
pCD41 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
encoding B-O B-VP_VBG
for B-O B-PP_IN
a B-O B-NP_DT
41-kDa B-O B-JJ
nuclear B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
identified B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
characterized B-O B-VP_VBN
" " B-O B-NP_O-VP
previously B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
Chang B-O B-NP_NP_NP_NNP
" " B-O O-NP
and B-O B-CC
Balachandran B-O B-NP_NNP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
J. B-O B-NP_NNP
Virol B-O B-NNP
. B-O B-PERIOD
65 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
2884-2894 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
7085 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
1991 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
Sequence B-O B-S_NP_NN
analyses B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
this B-O B-S_NP_DT
protein B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
significant B-O B-NP_NP_JJ
homology B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-JJ
cytomegalovirus B-O B-NN
UL44 B-O B-NN
gene B-O B-NN
" " B-O O-NP
coding B-O B-VP_VBG
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
this B-O B-NP_DT
cDNA B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
the B-O B-NP_DT
probe B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
a B-O B-S_NP_NP_DT
3.8-kb B-O B-JJ
EcoRI B-O B-NN
genomic B-O B-JJ
fragment B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
the B-O B-NP_DT
HHV-6 B-O B-NN
( B-O B-LRB
GS B-O B-NN
) B-O B-RRB
P41 B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
cloned B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
designated B-O B-VP_VBN
as B-O B-NP_PP_IN
pGD41 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
cotransfected B-O B-S_NP_VP_VBN
with B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NN
LTR B-O B-NN
CAT B-O B-NN
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
CV-1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
both B-O B-S_NP_CC
the B-O B-DT
pCD41 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
pGD41 B-O B-NP_NN
" " B-O B-NP_O-NP
clones B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
trans-activated B-O B-VP_VBD
the B-O B-NP_DT
HIV B-O B-NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Sequence B-O B-S_NP_NP_NN
analyses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
pCD41 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
there B-O B-S_NP_EX
" " B-O O-NP
are B-O B-VP_VBP
two B-O B-NP_NP_NP_CD
potential B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_NP_PRN_O-NP
, B-O B-COMMA
A B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletion B-O B-S_NP_NP_NN
constructs B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
pCD41 B-O B-NN
clone B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
ORF-A B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
critical B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NN
LTR B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletion B-O B-S_NP_NP_NP_NN
analyses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
pCD41 B-O B-NN
ORF-A B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
promoter B-O B-NP_NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
mapped B-O B-VP_VBD
an B-O B-NP_DT
internal B-O B-JJ
functional B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_NP_DT
pCD41 B-O B-NN
sequence B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
can B-O B-S_NP_VP_MD
direct B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
using B-O B-S_NP_VP_VBG
HIV B-O B-NP_NN
LTR B-O B-NN
deletion B-O B-NN
mutants B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
critical B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Isolation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
characterization B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
gelatinase B-O B-NP_NP_NN
granules B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
human B-O B-NP_JJ
neutrophils B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
recently B-O B-ADVP_RB
" " B-O O-ADVP
confirmed B-O B-VP_VBD
the B-O B-NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gelatinase B-O B-NP_NN
granules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
subpopulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
peroxidase-negative B-O B-NP_JJ
granules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_PP_IN
double-labeling B-O B-NP_NP_JJ
immunogold B-O B-JJ
electron B-O B-NN
microscopy B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
intact B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
by B-O B-PP_IN
subcellular B-O B-NP_JJ
fractionation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Further B-O B-S_NP_NP_JJ
characterization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gelatinase B-O B-NP_NN
granules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
hampered B-O B-VP_VBN
by B-O B-NP_PP_IN
poor B-O B-NP_NP_JJ
separation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_ADJP_NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
granules B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
both B-O B-NP_CC
two-layer B-O B-NP_JJ
Percoll B-O B-NN
gradients B-O B-NNS
" " B-O O-NP
and B-O B-CC
sucrose B-O B-NP_NN
gradients B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
developed B-O B-VP_VBN
a B-O B-NP_NP_DT
three-layer B-O B-JJ
Percoll B-O B-NN
density B-O B-NN
gradient B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
allows B-O B-S_NP_VP_VBZ
" " B-O B-NP_NP_PP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
in B-O B-S_PP_IN
particular B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
allows B-O B-VP_VBZ
separation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
gelatinase B-O B-NP_ADJP_NN
" " B-O O-ADJP
" " B-O B-NP_O-NP
granules B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
allows B-O B-VP_VBZ
us B-O B-S_NP_PRP
" " B-O O-NP
to B-O B-VP_TO
characterize B-O B-VP_VB
these B-O B-NP_DT
two B-O B-CD
granule B-O B-NN
populations B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
regard B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
gelatinase B-O B-S_NP_NP_NN
granules B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
defined B-O B-VP_VBN
as B-O B-NP_PP_IN
peroxidase-negative B-O B-NP_NP_JJ
granules B-O B-NNS
" " B-O O-NP
but B-O B-VP_VP_CC
" " B-O B-VP_O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
contain B-O B-VP_VBP
50 B-O B-NP_NP_CD
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
total B-O B-NP_JJ
cell B-O B-NN
gelatinase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
with B-O B-PP_IN
the B-O B-S_NP_DT
remaining B-O B-VBG
" " B-O O-NP
residing B-O B-NP_NN
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
20 B-O B-S_NP_NP_CD
% B-O B-NN
to B-O B-TO
25 B-O B-CD
% B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
the B-O B-NP_DT
adhesion B-O B-NN
protein B-O B-NN
Mac-1 B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
" " B-O B-NP_NP_NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
localized B-O B-ADJP_JJ
in B-O B-PP_IN
gelatinase B-O B-NP_NN
granules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
no B-O B-S_NP_DT
qualitative B-O B-JJ
difference B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
between B-O B-NP_PP_IN
specific B-O B-NP_NP_JJ
granules B-O B-NNS
" " B-O O-NP
and B-O B-CC
gelatinase B-O B-NP_NN
granules B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
respect B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
neutrophil B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
FMLP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_DT
selective B-O B-JJ
mobilization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
least B-O B-ADJP_RBS
dense B-O B-JJ
peroxidase-negative B-O B-JJ
" " B-O O-ADJP
granules B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
ie B-O B-PP_FW
" " B-O O-PP
, B-O B-COMMA
gelatinase B-O B-NP_NP_NN
granules B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
shows B-O B-VP_VBZ
that B-O B-SBAR_IN
gelatinase B-O B-S_NP_NN
granules B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
functionally B-O B-ADJP_RB
important B-O B-JJ
" " B-O O-ADJP
relative B-O B-ADJP_JJ
to B-O B-PP_TO
specific B-O B-NP_JJ
granules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
in B-O B-PP_IN
mediating B-O B-S_NP_VP_VBG
responses B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Stress B-O B-NP_NP_NP_NP_NN
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
senescent B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
reduced B-O B-S_NP_VBN
hsp70 B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
independent B-O B-ADJP_JJ
of B-O B-PP_IN
the B-O B-NP_DT
proliferative B-O B-JJ
block B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Senescent B-O B-S_S_NP_JJ
human B-O B-JJ
T B-O B-NN
lymphocyte B-O B-NN
cultures B-O B-NNS
" " B-O O-NP
are B-O B-VP_VP_VBP
unable B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
undergo B-O B-VP_VB
proliferation B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
show B-O B-VP_VBP
no B-O B-NP_NP_DT
difference B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
early B-O B-NP_NP_JJ
passage B-O B-NN
cells B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_NP_NP_DT
second B-O B-JJ
feature B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
senescent B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
dramatic B-O B-JJ
reduction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
hsp70 B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
heat B-O B-NP_NN
shock B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
decline B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
consensus B-O B-NN
heat B-O B-NN
shock B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interestingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
progressive B-O B-JJ
decline B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
heat B-O B-NN
shock B-O B-NN
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
of B-O B-PP_IN
cultured B-O B-NP_VBD
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_PP_IN
the B-O B-NP_NP_DT
percent B-O B-JJ
proliferative B-O B-JJ
life B-O B-NN
span B-O B-NN
" " B-O O-NP
completed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
with B-O B-PP_IN
the B-O B-NP_NP_DT
actual B-O B-JJ
proliferative B-O B-JJ
activity B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_NP_DT
time B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
heat B-O B-NP_NN
shock B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
for B-O B-S_PP_IN
senescent B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
reduced B-O B-VBN
ability B-O B-NN
to B-O B-S_NP_VP_TO
respond B-O B-VP_VB
to B-O B-PP_TO
by B-O B-NP_PP_IN
" " B-O B-S_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
" " B-O O-NP
although B-O B-SBAR_IN
possibly B-O B-S_ADVP_RB
" " B-O O-ADVP
lying B-O B-NP_VP_VBG
at B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
may B-O B-VP_MD
nevertheless B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
unrelated B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_ADVP_VP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-S_S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
interleukin B-O B-NN
6 B-O B-CD
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
Mycobacterium B-O B-NP_NP_NN
tuberculosis B-O B-NN
" " B-O O-NP
or B-O B-CC
lipopolysaccharide B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
nuclear B-O B-NP_NP_JJ
factors B-O B-NNS
NF-IL6 B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
[ B-O B-S_LRB
published B-O B-NP_VBN
erratum B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
in B-O B-PP_IN
Proc B-O B-NP_NP_NP_NNP
Natl B-O B-NN
Acad B-O B-NNP
Sci B-O B-NNP
U B-O B-NNP
S B-O B-NNP
A B-O B-NNP
" " B-O O-NP
1995 B-O B-NP_CD
Apr B-O B-NN
11 B-O B-CD
" " B-O O-NP
" " B-O O-NP
; B-O B-COLON
92 B-O B-NP_CD
( B-O B-LRB
8 B-O B-CD
) B-O B-RRB
: B-O B-COLON
3632 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
host B-O B-NN
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
Mycobacterium B-O B-NP_NN
tuberculosis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
includes B-O B-VP_VBZ
granuloma B-O B-NP_NP_NP_NN
formation B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
sites B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
infection B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
systemic B-O B-NP_JJ
symptoms B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Cytokines B-O B-S_NP_NNS
" " B-O O-NP
have B-O B-VP_VP_VBP
been B-O B-VP_VBN
identified B-O B-VP_VBN
by B-O B-NP_PP_IN
immunohistochemistry B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
are B-O B-VP_VBP
released B-O B-VP_VBN
by B-O B-NP_PP_IN
mononuclear B-O B-NP_NP_JJ
phagocytes B-O B-NNS
" " B-O O-NP
upon B-O B-PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
regard B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
cytokine B-O B-NN
interleukin B-O B-NP_NP_NN
6 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
IL-6 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
may B-O B-VP_MD
play B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
clinical B-O B-NP_JJ
manifestations B-O B-NNS
" " B-O O-NP
and B-O B-CC
pathological B-O B-NP_JJ
events B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
tuberculosis B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
lipoarabinomannan B-O B-S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
LAM B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_NP_DT
mycobacterial B-O B-JJ
cell B-O B-NN
wall B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
stimulated B-O B-VP_VBD
mononuclear B-O B-S_NP_JJ
phagocytes B-O B-NNS
" " B-O O-NP
to B-O B-VP_TO
release B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LAM B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
potent B-O B-NP_NP_JJ
inducers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
IL-6 B-O B-NP_NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
LAM- B-O B-NP_NN
" " B-O B-ADJP_O-NP
and B-O B-CC
LPS-inducible B-O B-NP_JJ
IL-6 B-O B-NN
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
localized B-O B-ADJP_JJ
to B-O B-PP_TO
a B-O B-NP_NP_DT
DNA B-O B-NN
fragment B-O B-NN
" " B-O O-NP
, B-O B-COMMA
positions B-O B-NP_NP_NNS
" " B-O O-NP
-158 B-O B-QP_CD
to B-O B-TO
-49 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
by B-O B-PP_IN
deletion B-O B-NP_NP_NN
analysis B-O B-NN
" " B-O O-NP
and B-O B-CC
chloramphenicol B-O B-NP_NN
acetyltransferase B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_NP_CD
nuclear B-O B-JJ
factor B-O B-NN
NF-IL6 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
positions B-O B-NP_NP_NP_NNS
" " B-O O-NP
-153 B-O B-QP_CD
to B-O B-TO
-145 B-O B-CD
" " B-O O-QP
" " B-O O-NP
and B-O B-CC
-83 B-O B-NP_NP_QP_CD
to B-O B-TO
-75 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
one B-O B-NP_CD
nuclear B-O B-JJ
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
( B-O B-LRB
positions B-O B-NNS
-72 B-O B-CD
to B-O B-TO
-63 B-O B-CD
) B-O B-RRB
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
present B-O B-ADJP_JJ
within B-O B-PP_IN
this B-O B-NP_DT
fragment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Site-directed B-O B-S_NP_NP_JJ
mutagenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
one B-O B-NP_NP_NP_CD
" " B-O O-NP
or B-O B-CC
more B-O B-NP_JJR
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_NP_DT
motifs B-O B-NNS
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_DT
IL-6 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_SBAR_IN
each B-O B-S_NP_DT
" " B-O O-NP
has B-O B-VP_VBZ
positive B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
regulatory B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
they B-O B-S_NP_PRP
could B-O B-VP_MD
act B-O B-VP_VB
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-NP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
all B-O B-NP_DT
three B-O B-CD
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
abolished B-O B-VP_VBD
inducibility B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-6 B-O B-NP_NP_NN
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
both B-O B-NP_CC
LAM B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
NF-IL6 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O B-NP_O-NP
sites B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
mediate B-O B-VP_VBP
IL-6 B-O B-NP_NN
induction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
both B-O B-NP_CC
and B-O B-NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
acting B-O B-S_NP_VP_VBG
as B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Calcineurin B-O B-S_S_NP_NN
" " B-O O-NP
activates B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
GM-CSF B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
synergy B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
either B-O B-NP_NP_CC
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
or B-O B-CC
NF-kappa B-O B-NP_NN
B/AP-1 B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Two B-O B-S_S_NP_NP_CD
cis-acting B-O B-JJ
elements B-O B-NNS
GM-kappa B-O B-NP_NP_NN
B/GC-box B-O B-NN
" " B-O O-NP
and B-O B-CC
CLE0 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
of B-O B-PP_IN
the B-O B-NP_DT
granulocyte-macrophage B-O B-JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
( B-O B-LRB
GM-CSF B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
maximal B-O B-NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
costimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
GM-kappa B-O B-NN
B B-O B-NN
sequence B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
mainly B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
CLE0 B-O B-NN
sequence B-O B-NN
" " B-O O-NP
interacts B-O B-VP_VBZ
with B-O B-PP_IN
factors B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
related B-O B-ADJP_JJ
to B-O B-PP_TO
a B-O B-NP_NP_DT
PMA-induced B-O B-JJ
AP-1 B-O B-NN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
PMA/A23187-induced B-O B-JJ
NF-AT B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
whether B-O B-SBAR_IN
signal B-O B-S_NP_NP_NN
transducing B-O B-NN
components B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
activate B-O B-VP_VB
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GM-CSF B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cotransfection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
( B-O B-LRB
p50/p65 B-O B-NN
) B-O B-RRB
- B-O B-COLON
" " B-O B-NP_O-NP
or B-O B-CC
AP-1 B-O B-NP_NN
( B-O B-LRB
c-Jun/c-Fos B-O B-NN
) B-O B-RRB
- B-O B-COLON
" " B-O B-NP_O-NP
expression B-O B-NP_NN
vectors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
Jurkat B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
luciferase B-O B-NN
reporter B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_DT
GM-CSF B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
stimulate B-O B-VP_VB
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
GM-CSF B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
cotransfection B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
significantly B-O B-ADVP_RB
" " B-O O-ADVP
augmented B-O B-VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_NP_DT
GM-CSF B-O B-NN
promoter B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_NP_DT
GM-kappa B-O B-NN
B/GC-box B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
constitutively B-O B-ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
calcineurin B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
CN B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
Ca2+/calmodulin-dependent B-O B-JJ
protein B-O B-NN
phosphatase B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
potentiated B-O B-VP_VBD
by B-O B-PP_IN
two B-O B-NP_CD
fold B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
NF-kappa B-O B-NP_NN
B/AP-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
constitutively B-O B-NP_NP_ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
CN B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PKC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
GM-CSF B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
cooperation B-O B-S_NP_NP_NN
" " B-O O-NP
among B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B- B-O B-NN
" " B-O B-NP_NP_O-NP
, B-O B-COMMA
AP-1- B-O B-NP_NN
" " B-O B-NP_NP_O-NP
and B-O B-CC
NF-AT-binding B-O B-NP_JJ
" " B-O B-NP_O-NP
sequences B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
through B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Characterization B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF(P) B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
nuclear B-O B-JJ
factor B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
interacts B-O B-S_NP_VP_VBZ
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
relationship B-O B-NP_NN
to B-O B-PP_TO
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_NP_DT
P B-O B-NN
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-JJ
interleukin-4 B-O B-NN
( B-O B-LRB
IL-4 B-O B-NN
) B-O B-RRB
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
defined B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
shares B-O B-VP_VBZ
sequence B-O B-NP_NN
similarity B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
and B-O B-CC
the B-O B-DT
NF-AT B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
whether B-O B-SBAR_IN
NF(P) B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
nuclear B-O B-JJ
factor B-O B-NN
" " B-O O-NP
specific B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_DT
P B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
related B-O B-ADJP_JJ
to B-O B-PP_TO
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-kappa B-O B-S_NP_NP_NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
P65 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
P65/P50 B-O B-NP_NN
heterodimer B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
bound B-O B-VP_VP_VBD
to B-O B-PP_TO
the B-O B-NP_NP_DT
P B-O B-NN
sequence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
electrophoretic B-O B-NP_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
EMSA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
activated B-O B-VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
through B-O B-PP_IN
the B-O B-NP_DT
P B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
expression B-O B-S_NP_NN
plasmids B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
cotransfected B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
EMSAs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NF(P) B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
the B-O B-NP_DT
unlabeled B-O B-JJ
NF-AT B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
by B-O B-IN
the B-O B-NP_DT
unlabeled B-O B-JJ
AP1 B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
purified B-O B-S_NP_VBN
NF-AT B-O B-NN
" " B-O O-NP
contained B-O B-VP_VBD
an B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bound B-O B-S_NP_VP_VBD
to B-O B-PP_TO
the B-O B-NP_DT
P B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_S_NP_NP_CC
mobility B-O B-NP_NN
shift B-O B-NN
" " B-O O-NP
and B-O B-CC
sequence B-O B-NP_NN
specificity B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
similar B-O B-ADJP_JJ
to B-O B-PP_TO
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
NF(P) B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
only B-O B-S_NP_NP_RB
a B-O B-DT
small B-O B-JJ
amount B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
P65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
NF(P) B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
extracts B-O B-NP_ADJP_ADJP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
component B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
the B-O B-NP_DT
potential B-O B-NN
to B-O B-S_NP_VP_TO
reconstitute B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-NP
whereas B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NP_NN
B B-O B-NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
can B-O B-VP_MD
not B-O B-RB
account B-O B-VP_VB
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Unlike B-O B-S_PP_IN
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NF(P) B-O B-NP_NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
contain B-O B-VP_VB
AP1 B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
its B-O B-NP_PRPP
DNA B-O B-NN
binding B-O B-NN
component B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Hypoxia B-O B-S_S_NP_NN
" " B-O O-NP
causes B-O B-VP_VBZ
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
through B-O B-PP_IN
the B-O B-NP_NP_DT
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
tyrosine B-O B-NP_NN
residues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mammalian B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
stress B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
transcriptional B-O B-NP_NP_JJ
regulatory B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
" " B-O B-NP_NP_NP_PRN_SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
exposure B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
hypoxia B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
O2 B-O B-NP_ADJP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
degradation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
increased B-O B-NP_VBN
NF-kappa B-O B-NN
B B-O B-NN
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
transactivation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Pretreatment B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
protein B-O B-NP_NP_NN
tyrosine B-O B-NN
kinase B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
dominant B-O B-JJ
negative B-O B-JJ
allele B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Raf-1 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
Raf B-O B-NP_NN
301 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibited B-O B-VP_VBD
I B-O B-NP_NP_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
degradation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
NF-kappa B-O B-NP_NN
B B-O B-NN
binding B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
transactivation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
kappa B-O B-NP_NN
B B-O B-NN
reporter B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
by B-O B-PP_IN
hypoxia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
demonstrate B-O B-VP_VB
a B-O B-NP_NP_DT
direct B-O B-JJ
link B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
changes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
immunoprecipitated B-O B-VP_VP_VBD
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
varying B-O B-NP_NP_VBG
times B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
hypoxic B-O B-NP_JJ
exposure B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
found B-O B-VP_VBD
that B-O B-SBAR_IN
its B-O B-S_NP_PRPP
tyrosine B-O B-NN
phosphorylation B-O B-NN
status B-O B-NN
" " B-O O-NP
increased B-O B-VP_VBD
during B-O B-PP_IN
hypoxic B-O B-NP_JJ
exposure B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
transfer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tyrosine B-O B-NP_NN
phosphoryl B-O B-NN
groups B-O B-NNS
" " B-O O-NP
" " B-O O-PP
onto B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
prevented B-O B-VP_VBD
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
degradation B-O B-NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
comparison B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
other B-O B-NP_NP_JJ
activators B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
such B-O B-PP_JJ
as B-O B-IN
phorbol B-O B-NP_NP_NN
myristate B-O B-NN
acetate B-O B-NN
" " B-O O-NP
or B-O B-CC
tumor B-O B-NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
detect B-O B-VP_VB
changes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
tyrosine B-O B-NN
phosphorylation B-O B-NN
status B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
following B-O B-PP_VBG
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
either B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
tyrosine B-O B-S_NP_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
hypoxia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
important B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
proximal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
step B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
precedes B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_S_NP_DT
transcriptional B-O B-JJ
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
nuclease-hypersensitive B-O B-JJ
site B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
pol B-O B-NN
gene B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Analysis B-O B-S_S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
chromatin B-O B-NN
organization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
integrated B-O B-VBN
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
( B-O B-LRB
HIV-1 B-O B-NN
) B-O B-RRB
genome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
previously B-O B-ADVP_RB
" " B-O O-ADVP
revealed B-O B-VP_VBN
a B-O B-NP_NP_DT
major B-O B-JJ
constitutive B-O B-JJ
DNase B-O B-NN
I-hypersensitive B-O B-JJ
site B-O B-NN
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
pol B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
E B-O B-NP_NP_NNP
. B-O B-PERIOD
Verdin B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
J B-O B-NP_NNP
. B-O B-PERIOD
Virol B-O B-NNP
. B-O B-PERIOD
65 B-O B-CD
" " B-O O-NP
: B-O B-COLON
6790-6799 B-O B-NP_CD
" " B-O O-NP
, B-O B-COMMA
1991 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
high-resolution B-O B-NP_NP_JJ
mapping B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
DNase B-O B-NP_NP_NN
I B-O B-CD
" " B-O O-NP
and B-O B-CC
micrococcal B-O B-NP_JJ
nuclease B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
identified B-O B-VP_VBD
a B-O B-NP_NP_DT
nucleosome-free B-O B-JJ
region B-O B-NN
" " B-O O-NP
centered B-O B-VP_VBN
around B-O B-NP_PP_IN
nucleotides B-O B-NP_NNS
( B-O B-LRB
nt B-O B-NNS
) B-O B-RRB
4490 B-O B-CD
to B-O B-TO
4766 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
500-bp B-O B-JJ
fragment B-O B-NN
" " B-O O-NP
encompassing B-O B-VP_VBG
this B-O B-NP_NP_DT
hypersensitive B-O B-JJ
site B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
nt B-O B-NP_NNS
4481 B-O B-CD
to B-O B-TO
4982 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
exhibited B-O B-VP_VBD
transcription-enhancing B-O B-NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
two- B-O B-NP_CD
to B-O B-TO
threefold B-O B-JJ
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
cloned B-O B-VP_VBN
in B-O B-NP_PP_IN
its B-O B-NP_PRPP
natural B-O B-JJ
position B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
respect B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
after B-O B-PP_IN
transient B-O B-NP_NP_JJ
transfection B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
footprinting B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
gel B-O B-NP_NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
four B-O B-NP_NP_CD
distinct B-O B-JJ
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
nuclear B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
within B-O B-PP_IN
this B-O B-NP_DT
positive B-O B-JJ
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Site B-O B-S_S_NP_NP_NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
nt B-O B-NP_NNS
4519 B-O B-CD
to B-O B-TO
4545 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
bound B-O B-VP_VBD
four B-O B-NP_CD
distinct B-O B-JJ
nuclear B-O B-JJ
protein B-O B-NN
complexes B-O B-NNS
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
a B-O B-NP_NP_DT
ubiquitous B-O B-JJ
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
T-cell-specific B-O B-JJ
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
B-cell-specific B-O B-JJ
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_NP_DT
monocyte/macrophage- B-O B-NN
and B-O B-CC
B-cell-specific B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
PU.1/Spi-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
most B-O B-NP_NP_JJS
HIV-1 B-O B-NN
isolates B-O B-NNS
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
this B-O B-S_NP_DT
PU B-O B-NN
box B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
conserved B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
replaced B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
related B-O B-JJ
factor B-O B-NN
Ets1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Factors B-O B-S_NP_NP_NNS
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
site B-O B-NP_NP_NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
nt B-O B-NP_NNS
4681 B-O B-CD
to B-O B-TO
4701 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
had B-O B-VP_VBD
a B-O B-NP_NP_DT
DNA-binding B-O B-JJ
specificity B-O B-NN
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
factors B-O B-NP_NP_NNS
" " B-O O-NP
binding B-O B-VP_VBG
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
, B-O B-COMMA
except B-O B-PP_IN
for B-O B-PP_IN
PU.1/Spi-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
GC B-O B-NN
box B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
a B-O B-NP_NP_DT
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
Sp1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-PRN_O-NP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
( B-O B-PRN_LRB
nt B-O B-NP_NNS
4623 B-O B-CD
to B-O B-TO
4631 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
Site B-O B-S_NP_NP_NN
D B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
nt B-O B-NP_NNS
4816 B-O B-CD
to B-O B-TO
4851 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
bound B-O B-VP_VBD
a B-O B-NP_DT
ubiquitously B-O B-RB
expressed B-O B-VBN
factor B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
identify B-O B-VP_VP_VBP
a B-O B-NP_NP_DT
transcriptional B-O B-JJ
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
nuclease-hypersensitive B-O B-JJ
site B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
its B-O B-S_NP_PRPP
activity B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Androgen B-O B-NP_NP_NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
human B-O B-JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
healthy B-O B-NP_ADJP_JJ
" " B-O O-ADJP
males B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
females B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Androgen B-O B-S_S_NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
circulating B-O B-NP_NP_VBG
human B-O B-JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Cells B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
separated B-O B-VP_VP_VBN
from B-O B-NP_PP_IN
blood B-O B-NP_NP_NN
samples B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
a B-O B-NP_DT
Ficoll B-O B-NN
gradient B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
incubated B-O B-VP_VBN
with B-O B-NP_PP_IN
different B-O B-NP_NP_JJ
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
[3H]testosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
presence B-O B-NP_NN
" " B-O B-PP_O-NP
or B-O B-CC
absence B-O B-NP_NN
" " B-O B-PP_O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
400-fold B-O B-JJ
excess B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_NP_NN
data B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
Scatchard B-O B-NP_NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
fulfil B-O B-VP_VP_VBP
the B-O B-NP_NP_DT
required B-O B-JJ
criteria B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
specific B-O B-NP_JJ
steroid B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
however B-O B-ADVP_RB
" " B-O O-ADVP
differ B-O B-VP_VBP
somewhat B-O B-ADVP_RB
" " B-O O-ADVP
from B-O B-PP_IN
the B-O B-NP_NP_DT
classic B-O B-JJ
androgen B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
genital B-O B-NP_JJ
skin B-O B-NN
fibroblast B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
in B-O B-S_PP_IN
fertile B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
adult B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
males B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
n B-O B-NP_NP_NN
" " B-O O-NP
= B-O B-ADJP_JJ
20 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
( B-O B-NP_NP_LST_LRB
1 B-O B-LS
) B-O B-RRB
" " B-O O-LST
a B-O B-NP_NP_NP_DT
high B-O B-JJ
affinity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
testosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
nM B-O B-NP_NP_QP_NN
" " B-O O-NP
; B-O B-COLON
mean B-O B-NP_NN
+/- B-O B-CC
SD B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
( B-O B-NP_LST_LRB
2 B-O B-LS
) B-O B-RRB
" " B-O O-LST
a B-O B-NP_NP_DT
saturable B-O B-JJ
capacity B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
; B-O B-NP_NP_NP_PP_COLON
mean B-O B-NP_NN
+/- B-O B-CC
SD B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
( B-O B-NP_LST_LRB
3 B-O B-LS
) B-O B-RRB
" " B-O O-LST
a B-O B-NP_NP_NP_DT
binding B-O B-ADJP_ADJP_ADJP_NN
profile B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
other B-O B-NP_JJ
steroid B-O B-NN
hormones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
: B-O B-NP_NP_NP_COLON
, B-O B-NP_COMMA
whereas B-O B-SBAR_IN
" " B-O B-S_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
binding B-O B-NP_VBG
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
determined B-O B-VP_VBN
using B-O B-NP_S_NP_VP_VBG
[3H]dihydrotestosterone B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
[3H]RU-1881 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
[3H]testosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
comparable B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
raises B-O B-VP_VBZ
the B-O B-NP_DT
possibility B-O B-NN
that B-O B-SBAR_IN
androgen B-O B-S_NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
differ B-O B-VP_VBP
from B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_DT
apparent B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
serum B-O B-NP_NP_NN
testosterone B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
and B-O B-CC
androgen B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
fertile B-O B-NP_JJ
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
remarkable B-O B-NP_NP_JJ
changes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
androgen B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
course B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
menstrual B-O B-JJ
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_IN
a B-O B-NP_NP_DT
significant B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
immediate B-O B-ADJP_JJ
preovulatory B-O B-JJ
" " B-O O-ADJP
period B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
androgen B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
peripheral B-O B-NP_JJ
mononuclear B-O B-JJ
leukocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
provides B-O B-VP_VBZ
for B-O B-PP_IN
the B-O B-NP_DT
first B-O B-JJ
time B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
experimental B-O B-JJ
basis B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
an B-O B-NP_NP_DT
hypothesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_ADJP_ADJP_COMMA
effects B-O B-ADJP_NNS
" " B-O O-NP
of B-O B-PP_IN
androgens B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
mature B-O B-NP_JJ
immunocompetent B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
immunological B-O B-JJ
implications B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
discussed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Comparative B-O B-NP_NP_JJ
mapping B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
SRY B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
great B-O B-JJ
apes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Cytogenetic B-O B-S_NP_NP_JJ
studies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
primate B-O B-JJ
Y B-O B-NN
chromosomes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
suggested B-O B-VP_VBN
that B-O B-SBAR_IN
extensive B-O B-S_NP_JJ
rearrangements B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
occurred B-O B-VP_VBN
during B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
used B-O B-VP_VBN
in B-O B-NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
define B-O B-VP_VB
these B-O B-NP_DT
rearrangements B-O B-NNS
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
molecular B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
pHU-14 B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
probe B-O B-NN
" " B-O O-NP
including B-O B-PP_VBG
sequences B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
sex B-O B-NN
determining B-O B-JJ
gene B-O B-NN
SRY B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
hybridizes B-O B-VP_VBZ
close B-O B-ADVP_RB
to B-O B-PP_TO
the B-O B-NP_NP_DT
early B-O B-JJ
replicating B-O B-VBG
pseudoautosomal B-O B-JJ
segment B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
or B-O B-ADJP_ADJP_CC
position B-O B-ADJP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
low B-O B-JJ
copy B-O B-NN
repeat B-O B-NN
" " B-O O-NP
detected B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
probe B-O B-NN
Fr35-II B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
obviously B-O B-ADVP_RB
" " B-O O-ADVP
included B-O B-VP_VBN
in B-O B-NP_PP_IN
Y B-O B-NP_NP_NN
chromosomal B-O B-NN
rearrangements B-O B-NNS
" " B-O O-NP
during B-O B-PP_IN
hominid B-O B-NP_NN
evolution B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
results B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
combined B-O B-VP_VBN
with B-O B-NP_PP_IN
previous B-O B-NP_JJ
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
Y B-O B-NN
chromosome B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
great B-O B-NP_JJ
apes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
a B-O B-NP_NP_DT
conserved B-O B-VBN
region B-O B-NN
" " B-O O-NP
including B-O B-PP_VBG
the B-O B-NP_NP_DT
pseudoautosomal B-O B-JJ
region B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
testis-determining B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
rest B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Y B-O B-NN
chromosome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
undergone B-O B-VP_VBN
several B-O B-NP_JJ
rearrangements B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
different B-O B-JJ
great B-O B-JJ
apes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Detection B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
minimal B-O B-NP_NP_JJ
residual B-O B-JJ
disease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
patient B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
acute B-O B-NP_JJ
promyelocytic B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
RT-PCR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
necessity B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
chemotherapy B-O B-NP_NP_NN
" " B-O O-NP
following B-O B-PP_VBG
ATRA B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
PML/RAR B-O B-NN
alpha B-O B-NN
fusion B-O B-NN
gene B-O B-NN
" " B-O O-NP
resulting B-O B-VP_VBG
from B-O B-PP_IN
the B-O B-NP_DT
"t (15;17)" B-O B-NN
translocation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
specific B-O B-JJ
marker B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
acute B-O B-NP_NP_JJ
promyelocytic B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
APL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
bone B-O B-NP_NN
marrow B-O B-NN
cells B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
reverse B-O B-NP_NP_JJ
transcriptase-polymerase B-O B-NN
chain B-O B-NN
reaction B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RT-PCR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
detect B-O B-VP_VB
residual B-O B-NP_NP_JJ
PML/RAR B-O B-ADJP_NN
alpha B-O B-NN
mRNA-containing B-O B-JJ
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
following B-O B-PP_VBG
and B-O B-NP_NP_NP_PP_CC
cytotoxic B-O B-NP_JJ
chemotherapy B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
patient B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
APL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
RT-PCR B-O B-NN
assay B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
detect B-O B-VP_VB
one B-O B-NP_CD
leukemic B-O B-JJ
cell B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
10(2) B-O B-NP_CD
normal B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
PML/RAR B-O B-S_NP_NN
alpha B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VBD
still B-O B-ADVP_RB
" " B-O O-ADVP
detectable B-O B-ADJP_JJ
" " B-O O-ADJP
despite B-O B-PP_IN
clinical B-O B-NP_NP_JJ
remission B-O B-NN
" " B-O O-NP
following B-O B-PP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
undetectable B-O B-VP_ADJP_JJ
" " B-O O-ADJP
following B-O B-PP_VBG
consolidation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
this B-O B-S_NP_DT
technique B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
useful B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
cytotoxic B-O B-S_NP_NP_JJ
chemotherapy B-O B-NN
" " B-O O-NP
following B-O B-PP_VBG
ATRA B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Expression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
v-src B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
NF-kappa B-O B-S_S_NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
rapidly B-O B-ADJP_RB
inducible B-O B-JJ
" " B-O O-ADJP
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
responds B-O B-S_NP_VP_VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_O-VP
and B-O B-CC
influences B-O B-VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Protein B-O B-S_NP_NN
tyrosine B-O B-NN
kinases B-O B-NNS
" " B-O O-NP
transmit B-O B-VP_VBP
signals B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
cytokine B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
immune B-O B-NP_JJ
" " B-O B-NP_O-NP
receptors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Very B-O B-S_NP_RB
little B-O B-JJ
information B-O B-NN
" " B-O B-VP_O-NP
exists B-O B-VP_VBZ
" " B-O O-VP
linking B-O B-VP_VBG
these B-O B-NP_NP_DT
two B-O B-CD
important B-O B-JJ
classes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
signaling B-O B-NP_VBG
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
now B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
v-src B-O B-S_NP_NN
expression B-O B-NN
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_ADJP_O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-SBAR_IN
detected B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
complex B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
tyrosine B-O B-NN
kinase B-O B-NN
inhibitor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
herbimycin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
v-src-induced B-O B-JJ
complex B-O B-NN
" " B-O O-NP
comprised B-O B-VP_VBD
the B-O B-NP_NP_DT
p50 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
p65 B-O B-NP_NN
" " B-O B-NP_O-NP
components B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
supershift B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
immunoblot B-O B-NP_NN
" " B-O B-NP_O-NP
analysis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_PP_IN
a B-O B-NP_NP_DT
functional B-O B-JJ
correlate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
finding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
transient B-O B-NP_NP_JJ
co-transfection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NP_NN
LTR B-O B-NN
reporter B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
different B-O B-JJ
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
v-src B-O B-S_NP_NN
" " B-O O-NP
activated B-O B-VP_VBD
this B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
kappa B-O B-NN
B-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
transactivation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
v-src B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
more B-O B-ADJP_RBR
sensitive B-O B-JJ
to B-O B-PP_TO
mutations B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
implications B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
T B-O B-NP_NP_NN
cell B-O B-NN
receptor B-O B-NN
signaling B-O B-NN
" " B-O O-NP
and B-O B-CC
HIV-1 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
considered B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Encephalomyocarditis B-O B-NP_NP_NP_NN
virus B-O B-NN
internal B-O B-JJ
ribosomal B-O B-JJ
entry B-O B-NN
site B-O B-NN
RNA-protein B-O B-JJ
interactions B-O B-NNS
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Translational B-O B-S_S_NP_NP_JJ
initiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
encephalomyocarditis B-O B-NP_NN
virus B-O B-NN
( B-O B-LRB
EMCV B-O B-NN
) B-O B-RRB
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurs B-O B-VP_VBZ
by B-O B-PP_PP_IN
ribosomal B-O B-NP_NP_JJ
entry B-O B-NN
" " B-O O-NP
into B-O B-PP_IN
the B-O B-NP_NP_DT
5' B-O B-NN
nontranslated B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
by B-O B-PP_IN
ribosomal B-O B-NP_JJ
scanning B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Internal B-O B-S_NP_JJ
ribosomal B-O B-JJ
binding B-O B-NN
" " B-O O-NP
requires B-O B-VP_VBZ
a B-O B-NP_NP_DT
cis-acting B-O B-JJ
element B-O B-NN
" " B-O O-NP
termed B-O B-VP_VBN
the B-O B-S_NP_NP_DT
internal B-O B-NP_NP_JJ
ribosomal B-O B-JJ
entry B-O B-NN
site B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IRES B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IRES B-O B-S_NP_NNS
elements B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
proposed B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Internal B-O B-S_NP_JJ
ribosome B-O B-NN
binding B-O B-NN
" " B-O O-NP
likely B-O B-ADVP_RB
" " B-O O-ADVP
requires B-O B-VP_VBZ
the B-O B-NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
trans-acting B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
recognize B-O B-S_NP_VP_VBP
both B-O B-NP_CC
and B-O B-NP_CC
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Five B-O B-S_NP_NP_CD
cellular B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
p52 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p57 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
p70 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
p72 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
p100 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-NP
" " B-O O-PRN
" " B-O O-NP
cross-link B-O B-VP_VBP
the B-O B-NP_NP_DT
EMCV B-O B-NN
IRES B-O B-NN
" " B-O O-NP
or B-O B-CC
fragments B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IRES B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
For B-O B-S_PP_IN
one B-O B-NP_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
p57 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
binding B-O B-NP_NP_VBG
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
IRES B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
translation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recently B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
p57 B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
very B-O B-ADJP_RB
similar B-O B-JJ
, B-O B-COMMA
if B-O B-SBAR_IN
not B-O B-FRAG_RB
" " B-O B-ADJP_O-SBAR
, B-O B-COMMA
to B-O B-PP_TO
polypyrimidine B-O B-NP_NN
tract-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-NP_NP_DT
basis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cross-linking B-O B-NP_NP_JJ
results B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
21 B-O B-NP_NP_CD
different B-O B-JJ
EMCV B-O B-NN
IRES B-O B-NN
fragments B-O B-NNS
" " B-O O-NP
and B-O B-CC
cytoplasmic B-O B-NP_NP_JJ
HeLa B-O B-NN
extract B-O B-NN
" " B-O O-NP
or B-O B-CC
rabbit B-O B-NP_NN
reticulocyte B-O B-NN
lysate B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
the B-O B-NP_NP_DT
source B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
polypeptides B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
consensus B-O B-NP_NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
p52 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p57 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
p70 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
p100 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
proposed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
suggested B-O B-VP_VBN
that B-O B-SBAR_IN
each B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
recognizes B-O B-VP_VBZ
primarily B-O B-ADVP_RB
" " B-O O-ADVP
a B-O B-NP_NP_NP_DT
structural B-O B-JJ
feature B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
a B-O B-NP_DT
specific B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-S_S_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
Nef B-O B-NN
protein B-O B-NN
" " B-O O-NP
down-regulates B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
after B-O B-PP_IN
T-cell B-O B-NP_NN
receptor B-O B-NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Human B-O B-S_S_NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
negative B-O B-NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Nef B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
down-regulate B-O B-VP_VB
the B-O B-NP_DT
in B-O B-NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
define B-O B-VP_VB
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Nef B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
the B-O B-S_NP_NP_DT
signal B-O B-NN
transduction B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
may B-O B-S_NP_VP_MD
be B-O B-VP_VB
affected B-O B-VP_VBN
in B-O B-NP_PP_IN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
interleukin-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
lipopolysaccharide B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
the B-O B-NP_DT
recruitment B-O B-NN
of B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_DT
similar B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
whether B-O B-SBAR_IN
or B-O B-CC
not B-O B-RB
the B-O B-S_NP_DT
cells B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VBD
the B-O B-NP_DT
nef B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-NP_DT
other B-O B-JJ
hand B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
mitogens B-O B-NP_NP_NNS
" " B-O O-NP
or B-O B-CC
antibodies B-O B-NP_NP_NNS
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
T-cell B-O B-NN
receptor B-O B-NN
( B-O B-LRB
TCR B-O B-NN
) B-O B-RRB
-CD3 B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
the B-O B-NP_NP_DT
down-regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcriptional B-O B-NP_NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
compared B-O B-NP_NP_NP_VP_PP_VBN
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Because B-O B-S_SBAR_IN
the B-O B-S_NP_DT
Nef B-O B-NN
protein B-O B-NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
affect B-O B-VP_VB
the B-O B-NP_NP_DT
surface B-O B-NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD3-TCR B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
Nef B-O B-NN
protein B-O B-NN
" " B-O O-NP
down-regulates B-O B-VP_VBZ
the B-O B-NP_NP_DT
" " B-O B-NP_NP_NP_O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
through B-O B-PP_IN
an B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Characterization B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-JJ
gene B-O B-NN
" " B-O O-NP
encoding B-O B-VP_NN
LBR B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
integral B-O B-JJ
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-JJ
envelope B-O B-NN
inner B-O B-JJ
membrane B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
characterized B-O B-VP_VBN
the B-O B-NP_NP_DT
human B-O B-JJ
gene B-O B-NN
" " B-O O-NP
encoding B-O B-VP_NN
LBR B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
integral B-O B-JJ
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Restriction B-O B-S_NP_NN
mapping B-O B-NN
" " B-O O-NP
shows B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_DT
transcription B-O B-NN
unit B-O B-NN
" " B-O O-NP
spans B-O B-VP_VBZ
approximately B-O B-NP_QP_RB
35 B-O B-CD
" " B-O O-QP
kilobases B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_S_NP_DT
transcription B-O B-NN
start B-O B-NN
site B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
located B-O B-ADJP_JJ
approximately B-O B-NP_NP_RB
4 B-O B-CD
kilobases B-O B-NNS
5' B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
translation B-O B-NN
initiation B-O B-NN
codon B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
an B-O B-S_NP_NP_DT
RNA B-O B-NN
splice B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
3863 B-O B-NP_CD
bases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurs B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_DT
5'-untranslated B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
generate B-O B-VP_VB
mature B-O B-NP_JJ
HeLa B-O B-NN
cell B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
5' B-O B-S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
identified B-O B-VBN
transcription B-O B-NN
start B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
two B-O B-NP_NP_CD
CCAAT B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
and B-O B-CC
potential B-O B-NP_NP_JJ
recognition B-O B-NN
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
several B-O B-NP_NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
including B-O B-PP_VBG
Sp1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
AP-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
AP-2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
NF-kB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
are B-O B-VP_VBP
13 B-O B-NP_CD
protein B-O B-NN
coding B-O B-NN
exons B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
LBR B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LBR B-O B-S_S_NP_NN
's B-O B-POS
nucleoplasmic B-O B-JJ
domain B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
encoded B-O B-VP_VBN
by B-O B-NP_PP_IN
exons B-O B-NP_NNS
1-4 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
its B-O B-S_NP_NP_PRPP
hydrophobic B-O B-JJ
domain B-O B-NN
" " B-O O-NP
, B-O B-COMMA
with B-O B-PP_IN
eight B-O B-NP_CD
putative B-O B-JJ
transmembrane B-O B-NN
segments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
encoded B-O B-VP_VBN
by B-O B-NP_PP_IN
exons B-O B-NP_NNS
5-13 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
hydrophobic B-O B-JJ
domain B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
homologous B-O B-ADJP_JJ
to B-O B-PP_TO
three B-O B-NP_CD
yeast B-O B-NN
polypeptides B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
this B-O B-S_NP_DT
higher B-O B-JJR
eukaryotic B-O B-JJ
gene B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
have B-O B-VP_VB
evolved B-O B-VP_VBN
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
the B-O B-NP_NP_DT
first B-O B-JJ
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
demonstrate B-O B-VP_VB
the B-O B-NP_NP_DT
structural B-O B-JJ
organization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
novel B-O B-JJ
serine/threonine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
phosphorylates B-O B-S_NP_VP_VBZ
c-Fos B-O B-NP_NN
" " B-O O-NP
upon B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Ligation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Ag B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
B B-O B-NP_NN
" " B-O B-NP_O-NP
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
initiates B-O B-VP_VBZ
signal B-O B-NP_NP_NN
transduction B-O B-NN
cascades B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
alter B-O B-S_NP_VP_VBP
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_NP_DT
transmission B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
signals B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
the B-O B-NP_DT
membrane B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
principally B-O B-NP_ADVP_RB
" " B-O O-ADVP
through B-O B-PP_IN
the B-O B-NP_NP_DT
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
tyrosine B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
serine/threonine B-O B-NP_NN
kinases B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
characterized B-O B-VP_VBN
" " B-O B-NP_O-VP
a B-O B-NP_NP_DT
novel B-O B-JJ
serine/threonine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
phosphorylated B-O B-S_NP_VP_VP_VBD
the B-O B-NP_DT
" " B-O B-NP_O-VP
, B-O B-COMMA
and B-O B-CC
is B-O B-VP_VBZ
termed B-O B-VP_VBN
" " B-O B-S_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Fos B-O B-S_NP_NN
kinase B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
rapidly B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBN
after B-O B-NP_PP_PP_IN
ligation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CD3 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
CD2 B-O B-NP_NN
" " B-O B-NP_O-NP
receptors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Jurkat B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
normal B-O B-NP_JJ
human B-O B-JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
and B-O B-NP_NP_NP_CC
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-PP
" " B-O O-PP
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
phorbol B-O B-NN
ester B-O B-NN
" " B-O O-NP
, B-O B-COMMA
PMA B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
a B-O B-NP_NP_DT
potent B-O B-JJ
inducer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Fos B-O B-NP_NN
kinase B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
all B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
above B-O B-JJ
populations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
PKC B-O B-S_NP_NN
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Fos B-O B-S_S_NP_NN
kinase B-O B-NN
" " B-O O-NP
phosphorylates B-O B-VP_VBZ
c-Fos B-O B-NP_NP_NP_NN
" " B-O O-NP
at B-O B-PP_IN
a B-O B-NP_NP_DT
site B-O B-NN
" " B-O O-NP
near B-O B-PP_JJ
the B-O B-NP_DT
C-terminus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
a B-O B-NP_NP_DT
peptide B-O B-NN
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
this B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
Fos B-O B-S_NP_NN
peptide B-O B-NN
" " B-O O-NP
competitively B-O B-ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VP_VBD
c-Fos B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Fos B-O B-S_NP_NN
kinase B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
distinct B-O B-ADJP_JJ
from B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Fos B-O B-S_NP_NN
kinase B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VBD
purified B-O B-VP_VBN
by B-O B-NP_PP_IN
anion B-O B-NP_NN
exchange B-O B-NN
chromatography B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
exhibited B-O B-VP_VBD
an B-O B-NP_NP_NP_DT
apparent B-O B-JJ
M(r) B-O B-NN
" " B-O O-NP
= B-O B-ADJP_JJ
65,000 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
and B-O B-CC
isoelectric B-O B-NP_NP_JJ
point B-O B-NN
" " B-O O-NP
= B-O B-ADJP_JJ
6.1 B-O B-NP_CD
" " B-O O-NP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Fos B-O B-S_NP_NN
kinase B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
play B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
transcriptional B-O B-NP_JJ
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
its B-O B-NP_PRPP
capacity B-O B-NN
to B-O B-S_NP_VP_TO
phosphorylate B-O B-VP_VB
c-Fos B-O B-NP_NN
" " B-O O-NP
at B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
its B-O B-NP_PRPP
rapid B-O B-JJ
activation B-O B-NN
" " B-O O-NP
suggests B-O B-VP_VBZ
it B-O B-COMP_S_NP_PRP
" " B-O O-NP
may B-O B-VP_MD
have B-O B-VP_VB
a B-O B-NP_DT
wider B-O B-JJR
role B-O B-NN
" " B-O O-NP
within B-O B-PP_IN
signal B-O B-NP_NP_NN
transduction B-O B-NN
cascades B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
neuroblastoma B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
nuclear B-O B-NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
eukaryotic B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
B B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
it B-O B-NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
constitutively B-O B-ADJP_RB
present B-O B-JJ
in B-O B-PP_IN
cell B-O B-NP_NN
nuclei B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
whereas B-O B-SBAR_IN
in B-O B-S_PP_IN
many B-O B-NP_ADJP_JJ
other B-O B-JJ
" " B-O O-ADJP
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
translocates B-O B-VP_VBZ
from B-O B-PP_IN
cytosol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
nucleus B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_NP_DT
result B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
neuroblastoma B-O B-NP_NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
as B-O B-PP_IN
models B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
in B-O B-S_PP_IN
neural B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
present B-O B-VP_ADJP_JJ
and B-O B-PP_CC
translocated B-O B-VP_VBD
" " B-O B-NP_PP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
TNF B-O B-NN
alpha-activated B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
transcriptionally B-O B-ADJP_RB
functional B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-kappa B-O B-S_NP_NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
cell B-O B-NP_NN
differentiation B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
proliferation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
reagents B-O B-NP_NP_NP_NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
nerve B-O B-NP_NP_NP_NN
growth B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NGF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
phorbol B-O B-NN
ester B-O B-NN
phorbol B-O B-NN
12-myristate B-O B-NN
13-acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
induce B-O B-S_NP_VP_VBP
phenotypical B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
SH-SY5Y B-O B-NN
neuroblastoma B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
activated B-O B-VP_VBD
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CC
only B-O B-PP_ADVP_RB
" " B-O O-ADVP
in B-O B-IN
that B-O B-NP_DT
particular B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
a B-O B-NP_DT
NGF-responsive B-O B-NP_NP_JJ
rat B-O B-NN
pheochromocytoma B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
PC12 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
PMA B-O B-NP_NN
" " B-O O-NP
activated B-O B-VP_VBD
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
NGF B-O B-S_NP_NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
other B-O B-NP_NP_JJ
neuroblastoma B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
such B-O B-PP_JJ
as B-O B-IN
SK-N-Be(2) B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
lack B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PMA B-O B-NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
lack B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
, B-O B-COMMA
moreover B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
that B-O B-SBAR_SBAR_IN
in B-O B-S_PP_IN
SK-N-Be(2) B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
protein B-O B-NP_NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PKC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
enzymatic B-O B-JJ
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
much B-O B-ADJP_RB
lower B-O B-JJR
" " B-O O-ADJP
compared B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_DT
low B-O B-JJ
PKC B-O B-NN
enzymatic B-O B-JJ
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
due B-O B-ADJP_JJ
to B-O B-PP_TO
low B-O B-NP_JJ
PKC B-O B-NN
protein B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
retinoic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
induced B-O B-S_NP_VP_VBD
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
NF-kappa B-O B-NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
required B-O B-VP_VBN
for B-O B-NP_PP_IN
neuroblastoma B-O B-NP_NN
cell B-O B-NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
results B-O B-NNS
" " B-O O-NP
obtained B-O B-VP_VBN
with B-O B-NP_PP_IN
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
proved B-O B-VP_VBD
that B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NN
B B-O B-NN
activation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
sufficient B-O B-ADJP_JJ
for B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Genes B-O B-S_NP_NP_NNS
" " B-O O-NP
encoding B-O B-VP_VBG
general B-O B-NP_NP_JJ
initiation B-O B-NN
factors B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
RNA B-O B-NP_NN
polymerase B-O B-NN
II B-O B-CD
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
dispersed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
human B-O B-JJ
genome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
General B-O B-S_NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
accurate B-O B-NP_NP_JJ
initiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
RNA B-O B-NP_NN
polymerase B-O B-NN
II B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_NP_NP_JJ
cDNAs B-O B-NNS
" " B-O O-NP
encoding B-O B-VP_VBG
subunits B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
cloned B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
sequenced B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
fluorescence B-O B-NP_NP_NN
in B-O B-ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
FISH B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
genes B-O B-NNS
" " B-O O-NP
encoding B-O B-VP_VBG
the B-O B-NP_NP_NP_DT
TATA-box B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
TFIIB B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
TFIIE B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
, B-O B-COMMA
TFIIE B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
, B-O B-COMMA
RAP30 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
RAP74 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
subunit B-O B-ADJP_NN
" " B-O O-NP
, B-O B-COMMA
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
located B-O B-ADJP_JJ
at B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-JJ
chromosomal B-O B-JJ
bands B-O B-NNS
, B-O B-NP_COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
dispersed B-O B-JJ
localization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
functionally B-O B-NP_ADJP_RB
related B-O B-JJ
" " B-O O-ADJP
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
provides B-O B-VP_VBZ
insights B-O B-NP_NP_NNS
" " B-O O-NP
into B-O B-PP_IN
the B-O B-NP_NP_NP_DT
molecular B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
genome B-O B-NN
evolution B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
their B-O B-NP_NP_PRPP
possible B-O B-JJ
involvement B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
diseases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_NP_DT
novel B-O B-JJ
heterodimerization B-O B-NN
partner B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
thyroid B-O B-NP_NN
hormone B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Peroxisome B-O B-NP_NN
proliferator-activated B-O B-JJ
receptor B-O B-NN
. B-O B-PERIOD
" " B-O O-NP
  
Retinoid-like B-O B-S_S_NP_JJ
receptors B-O B-NNS
" " B-O O-NP
play B-O B-VP_VBP
a B-O B-NP_DT
central B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
hormonal B-O B-NP_JJ
responses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
forming B-O B-S_NP_VP_VBG
heterodimers B-O B-NP_NNS
" " B-O O-NP
with B-O B-PP_IN
other B-O B-NP_JJ
nuclear B-O B-JJ
hormone B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
the B-O B-NP_DT
peroxisome B-O B-NP_NP_NN
proliferator-activated B-O B-JJ
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PPAR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_DT
new B-O B-JJ
thyroid B-O B-NN
hormone B-O B-NN
receptor B-O B-NN
( B-O B-LRB
THR B-O B-NN
) B-O B-RRB
auxiliary B-O B-JJ
nuclear B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
heterodimerizing B-O B-S_NP_VP_VBG
with B-O B-PP_IN
THR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
solution B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
these B-O B-S_NP_DT
heterodimers B-O B-NNS
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
recognize B-O B-VP_VB
a B-O B-NP_NP_NP_DT
classical B-O B-JJ
thyroid B-O B-NN
hormone B-O B-NN
response B-O B-NN
element B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TRE B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
characterized B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
PPAR B-O B-S_NP_NN
" " B-O O-NP
behaves B-O B-VP_VBZ
as B-O B-PP_IN
a B-O B-NP_NP_DT
dominant B-O B-JJ
negative B-O B-JJ
regulator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
thyroid B-O B-NP_NP_NP_NN
hormone B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
a B-O B-NP_DT
TH-dependent B-O B-JJ
positive B-O B-JJ
effect B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
elicited B-O B-VP_VBN
by B-O B-NP_PP_IN
selective B-O B-NP_NP_JJ
interaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
THR B-O B-NN
beta-PPAR B-O B-NN
" " B-O B-NP_O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
THR B-O B-NN
alpha-PPAR B-O B-NN
heterodimer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
novel B-O B-JJ
TRE B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
DR+2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
critical B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
THR B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
mapped B-O B-VP_VBN
to B-O B-NP_PP_TO
3 B-O B-NP_CD
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
distal B-O B-JJ
box B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
DNA B-O B-NN
binding B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Hence B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
PPAR B-O B-NP_NN
" " B-O O-NP
can B-O B-VP_MD
positively B-O B-ADVP_ADVP_RB
" " B-O O-ADVP
or B-O B-CC
negatively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-ADVP
influence B-O B-VP_VB
TH B-O B-NP_NN
action B-O B-NN
" " B-O O-NP
depending B-O B-PP_VBG
on B-O B-PP_IN
TRE B-O B-NP_NP_NN
structure B-O B-NN
" " B-O O-NP
and B-O B-CC
THR B-O B-NP_NN
isotype B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Hypoxic B-O B-NP_NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interleukin-8 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
endothelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Because B-O B-S_S_SBAR_IN
leukocyte-mediated B-O B-S_NP_JJ
tissue B-O B-NN
damage B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
important B-O B-JJ
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
pathologic B-O B-JJ
picture B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
sought B-O B-VP_VBN
mechanisms B-O B-NP_NP_NNS
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
PMNs B-O B-S_NP_NNS
" " B-O O-NP
are B-O B-VP_VBP
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Incubation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
endothelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
ECs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
hypoxia B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
PO2 B-O B-NP_NP_NN
" " B-O O-NP
approximately B-O B-NP_QP_RB
14-18 B-O B-CD
" " B-O O-QP
Torr B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
led B-O B-VP_VBD
to B-O B-PP_TO
time-dependent B-O B-NP_NP_JJ
release B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-8 B-O B-NP_NN
antigen B-O B-NN
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
the B-O B-NP_DT
conditioned B-O B-JJ
medium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
this B-O B-S_NP_DT
" " B-O O-NP
was B-O B-VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
increased B-O B-NP_NP_NP_VBN
chemotactic B-O B-JJ
activity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
PMNs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Production B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-8 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
hypoxic B-O B-NP_JJ
ECs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurred B-O B-VP_VBD
concomitantly B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
both B-O B-NP_DT
increased B-O B-NP_NP_NP_VBN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
IL-8 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
based B-O B-PP_VBN
on B-O B-PP_IN
polymerase B-O B-NP_NN
chain B-O B-NN
reaction B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
increased B-O B-NP_NP_VBN
IL-8 B-O B-NN
transcription B-O B-NN
" " B-O O-NP
, B-O B-COMMA
based B-O B-PP_VBN
on B-O B-PP_IN
nuclear B-O B-NP_JJ
run-on B-O B-JJ
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mRNA B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
hypoxic B-O B-NP_JJ
ECs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
demonstrated B-O B-VP_VBD
increased B-O B-NP_NP_VBN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
mRNA B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
macrophage B-O B-NP_NP_NN
chemotactic B-O B-NN
protein-1 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
another B-O B-NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-8 B-O B-S_NP_NN
gene B-O B-NN
induction B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
increased B-O B-NP_NP_VBN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Studies B-O B-S_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
human B-O B-NP_NP_JJ
umbilical B-O B-JJ
vein B-O B-NN
segments B-O B-NNS
" " B-O O-NP
exposed B-O B-VP_VBN
to B-O B-NP_PP_TO
hypoxia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
demonstrated B-O B-VP_VBD
increased B-O B-NP_NP_VBN
elaboration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-8 B-O B-NP_NN
antigen B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
compared B-O B-PP_VBN
with B-O B-PP_IN
normoxic B-O B-NP_JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
mice B-O B-NP_NP_NNS
" " B-O O-NP
exposed B-O B-VP_VBN
to B-O B-NP_PP_TO
hypoxia B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
PO2 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_QP_NP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
increased B-O B-NP_VBN
pulmonary B-O B-JJ
leukostasis B-O B-NN
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_S_IN
evidenced B-O B-NP_VP_VBN
by B-O B-NP_PP_IN
increased B-O B-NP_NP_VBN
myeloperoxidase B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
tissue B-O B-NP_NN
homogenates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
parallel B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
increased B-O B-NP_NP_VBN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
transcripts B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
IP-10 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
murine B-O B-NN
homologue B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_ADJP_O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
hypoxic B-O B-NP_JJ
lung B-O B-NN
tissue B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_SBAR_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-SBAR
, B-O B-COMMA
these B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
hypoxia B-O B-S_NP_NN
" " B-O O-NP
constitutes B-O B-VP_VBZ
a B-O B-NP_NP_DT
stimulus B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Function B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B/Rel B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
major B-O B-JJ
histocompatibility B-O B-NN
complex B-O B-NN
class B-O B-NN
II B-O B-CD
invariant B-O B-JJ
chain B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
cell-specific B-O B-NP_NP_JJ
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
different B-O B-NP_JJ
NF-kappa B-O B-NN
B/Rel B-O B-NN
subunits B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
promoter B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
major B-O B-JJ
histocompatibility B-O B-NP_NN
complex B-O B-NN
class B-O B-NN
II-associated B-O B-JJ
invariant-chain B-O B-JJ
gene B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Ii B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contains B-O B-VP_VBZ
two B-O B-NP_NP_CD
NF-kappa B-O B-NN
B/Rel B-O B-NN
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
located B-O B-ADJP_JJ
at B-O B-PP_IN
and B-O B-NP_NP_NP_NP_PRN_CC
" " B-O B-NP_NP_PRN_O-NP
from B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NN
start B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
differential B-O B-JJ
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
each B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
depends B-O B-VP_VBZ
on B-O B-PP_IN
cell-specific B-O B-NP_NP_JJ
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B/Rel B-O B-NN
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Ii B-O B-S_NP_NN
kappa B-O B-NN
B-1 B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
a B-O B-NP_DT
positive B-O B-JJ
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_IN
B-cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
the B-O B-NP_DT
Ii-expressing B-O B-NP_NP_JJ
T-cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
H9 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
acts B-O B-VP_VBZ
as B-O B-PP_IN
a B-O B-NP_DT
negative B-O B-JJ
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
myelomonocytic B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
glia B-O B-NP_NN
" " B-O B-NP_O-NP
cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
protein-DNA B-O B-JJ
contacts B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
detectable B-O B-ADJP_JJ
" " B-O O-ADJP
at B-O B-PP_IN
Ii B-O B-NP_NP_NN
kappa B-O B-NN
B-1 B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
this B-O B-S_NP_DT
site B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-ADJP_PP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Electrophoretic B-O B-S_NP_JJ
mobility B-O B-NN
supershift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
determine B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
members B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
NF-kappa B-O B-NN
B/Rel B-O B-NN
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
bind B-O B-VP_VB
to B-O B-PP_TO
this B-O B-NP_DT
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
DNA-binding B-O B-S_NP_NP_JJ
complexes B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contain B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
correlate B-O B-VP_VBP
with B-O B-PP_IN
positive B-O B-NP_JJ
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
whereas B-O B-SBAR_IN
correlates B-O B-S_NP_NP_PP_VP_VBZ
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Ii B-O B-S_NP_NN
kappa B-O B-NN
B-2 B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
site B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
positive B-O B-NP_JJ
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B-cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
site B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
negative B-O B-NP_JJ
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
H9 B-O B-NP_NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
myelomonocytic B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
glial B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
occupancy B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
observed B-O B-VP_VBN
only B-O B-NP_PP_ADVP_RB
" " B-O O-ADVP
in B-O B-IN
the B-O B-NP_DT
H9 B-O B-NN
T-cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Again B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
supershift B-O B-NN
studies B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p50 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p52 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
p65 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
cRel B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
positive B-O B-NP_JJ
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
whereas B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
differential B-O B-JJ
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_JJ
NF-kappa B-O B-NN
B/Rel B-O B-NN
subunits B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
likely B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
mediate B-O B-VP_VB
the B-O B-NP_NP_DT
disparate B-O B-JJ
functions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
two B-O B-CD
NF-kappa B-O B-NN
B/Rel B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Positive B-O B-NP_NP_NP_JJ
regulators B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
lineage-specific B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
differentiating B-O B-NP_JJ
erythroid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
zinc B-O B-NP_NN
finger B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
major B-O B-JJ
regulator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
erythroid B-O B-NP_NP_JJ
" " B-O B-NP_O-NP
, B-O B-COMMA
megakaryocyte B-O B-NP_NN
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
mast B-O B-NP_NN
" " B-O B-NP_O-NP
cell B-O B-NP_NN
lineages B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
GATA-1 B-O B-S_NP_NN
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
WGATAR B-O B-NP_NP_NN
consensus B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulatory B-O B-JJ
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
virtually B-O B-NP_RB
all B-O B-DT
erythroid B-O B-JJ
cell-specific B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Analyses B-O B-S_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
cultured B-O B-NP_NP_VBN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
cell-free B-O B-NP_JJ
systems B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
provided B-O B-VP_VBN
strong B-O B-NP_JJ
evidence B-O B-NN
that B-O B-SBAR_IN
GATA-1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
during B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Targeted B-O B-S_NP_NP_VBN
mutagenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GATA-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
embryonic B-O B-NP_JJ
stem B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
demonstrated B-O B-VP_VBN
its B-O B-NP_NP_PRPP
requirement B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
normal B-O B-NP_JJ
erythroid B-O B-JJ
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Efficient B-O B-S_NP_NP_JJ
rescue B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
defect B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
an B-O B-NP_NP_DT
intact B-O B-JJ
GATA B-O B-NN
element B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
distal B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
autoregulatory B-O B-NP_NP_JJ
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
examine B-O B-VP_VB
whether B-O B-SBAR_IN
GATA-1 B-O B-S_NP_NN
expression B-O B-NN
" " B-O O-NP
involves B-O B-VP_VP_VBZ
additional B-O B-NP_JJ
regulatory B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-VP
or B-O B-CC
is B-O B-VP_VBZ
maintained B-O B-VP_VBN
" " B-O B-NP_ADVP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
used B-O B-VP_VBN
a B-O B-NP_DT
transient B-O B-JJ
heterokaryon B-O B-NN
system B-O B-NN
" " B-O O-NP
" " B-O O-VP
to B-O B-S_NP_VP_TO
test B-O B-VP_VB
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
erythroid B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
here B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_SBAR_IN
proerythroblasts B-O B-S_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
mature B-O B-NP_JJ
erythroid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
contain B-O B-VP_VBP
a B-O B-NP_NP_NP_DT
diffusible B-O B-JJ
activity B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
this B-O B-S_NP_DT
activity B-O B-NN
" " B-O O-NP
decreases B-O B-VP_VBZ
during B-O B-PP_IN
the B-O B-NP_NP_DT
terminal B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclei B-O B-S_NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
"GATA-1- mutant" B-O B-NP_JJ
embryonic B-O B-JJ
stem B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
still B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
reprogrammed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
to B-O B-SBAR_NP_VP_TO
express B-O B-VP_VB
their B-O B-NP_PRPP
globin B-O B-NN
genes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
erythroid B-O B-NP_JJ
heterokaryons B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-SBAR
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
de B-O B-S_NP_NP_ADJP_FW
novo B-O B-FW
" " B-O O-ADJP
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Patterns B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Pan B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
role B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Pan B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
endocrine B-O B-NP_ADJP_NN
cell B-O B-NN
type-specific B-O B-JJ
" " B-O O-ADJP
complex B-O B-JJ
formation B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
Pan B-O B-NN
gene B-O B-NN
" " B-O O-NP
encodes B-O B-VP_VBZ
at B-O B-NP_NP_QP_IN
least B-O B-JJS
two B-O B-CD
" " B-O O-QP
distinct B-O B-JJ
transcripts B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
Pan-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Pan-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
( B-O B-LRB
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
known B-O B-VBN
as B-O B-NP_PP_IN
E47 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
E12 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
, B-O B-COMMA
" " B-O O-NP
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
alternative B-O B-NP_JJ
RNA B-O B-NN
splicing B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_S_NP_NP_JJ
blot B-O B-NN
analyses B-O B-NNS
" " B-O O-NP
performed B-O B-VP_VBN
on B-O B-NP_PP_IN
rat B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
mouse B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
tissues B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
have B-O B-VP_VBP
detected B-O B-VP_VBN
ubiquitously B-O B-NP_ADJP_RB
expressed B-O B-VBN
" " B-O O-ADJP
Pan B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
the B-O B-S_NP_NP_DT
abundance B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
distribution B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
form B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
Pan B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
not B-O B-RB
been B-O B-VP_VBN
clearly B-O B-ADVP_RB
" " B-O O-ADVP
defined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Studies B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
representing B-O B-VP_VBG
endocrine B-O B-NP_UCP_ADJP_NN
" " B-O O-ADJP
, B-O B-COMMA
fibroblast B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
lymphoid B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-UCP
lineages B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
using B-O B-VP_VBG
polyclonal B-O B-NP_JJ
antisera B-O B-NNS
" " B-O O-NP
to B-O B-S_NP_VP_TO
detect B-O B-VP_VB
E2A B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
have B-O B-VP_VBP
suggested B-O B-VP_VBN
that B-O B-SBAR_IN
significant B-O B-S_NP_JJ
E2A B-O B-NN
protein B-O B-NN
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
restricted B-O B-VP_JJ
to B-O B-NP_PP_TO
B-lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VP_VBP
developed B-O B-VP_VBN
a B-O B-NP_NP_NP_DT
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
, B-O B-COMMA
Yae B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
specific B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
have B-O B-VP_VBP
used B-O B-VP_VBN
the B-O B-NP_DT
Yae B-O B-NN
antibody B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
examine B-O B-VP_VB
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
for B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NN
to B-O B-TO
previous B-O B-NP_NP_JJ
results B-O B-NNS
" " B-O O-NP
obtained B-O B-VP_VBN
using B-O B-NP_S_NP_VP_VBG
polyclonal B-O B-NP_JJ
antiseras B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
detect B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
comparable B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Pan B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
GH/PRL- B-O B-NP_ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
insulin-producing B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
, B-O B-COMMA
B- B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
T-lymphocyte B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IEF-1 B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
pancreatic B-O B-ADJP_JJ
beta-cell B-O B-NN
type-specific B-O B-JJ
" " B-O O-ADJP
complex B-O B-NN
" " B-O O-NP
believed B-O B-VP_VBN
to B-O B-S_NP_VP_TO
regulate B-O B-VP_VB
insulin B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
demonstrated B-O B-VP_VBN
to B-O B-S_NP_VP_TO
consist B-O B-VP_VB
of B-O B-PP_IN
distinct B-O B-NP_NP_QP_JJ
species B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
postulated B-O B-VP_VBN
that B-O B-SBAR_IN
and B-O B-S_NP_NP_CC
share B-O B-NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
native-Western B-O B-NP_NP_JJ
analyses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
pituitary B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
endocrine B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
beta-cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
detect B-O B-VP_VBP
Pan B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
distinct B-O B-NP_JJ
cell B-O B-ADJP_NN
type-specific B-O B-JJ
" " B-O O-ADJP
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Functional B-O B-NP_NP_NP_JJ
block B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
1 B-O B-NP_CD
alpha,25-dihydroxyvitamin B-O B-NN
D3-mediated B-O B-JJ
gene B-O B-NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Elements B-O B-S_S_NP_NP_NP_NNS
" " B-O O-NP
necessary B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-NP
for B-O B-SBAR_WHNP_IN
the B-O B-S_NP_DT
steroid B-O B-NN
hormone B-O B-NN
1 B-O B-NP_CD
alpha,25-dihydroxyvitamin B-O B-NN
D3 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
1 B-O B-NP_CD
alpha,25-(OH)2D3 B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
to B-O B-VP_TO
induce B-O B-VP_VB
a B-O B-NP_DT
biological B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
include B-O B-VP_VBP
the B-O B-NP_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_JJ
intracellular B-O B-NP_NP_JJ
receptors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
modulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
via B-O B-PP_IN
hormone-activated B-O B-NP_NP_JJ
receptor B-O B-NN
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
These B-O B-S_NP_DT
parameters B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VP_VBN
in B-O B-NP_PP_IN
normal B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
Epstein-Barr B-O B-NP_ADJP_JJ
virus-immortalized B-O B-JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
human B-O B-NP_JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
compared B-O B-VP_VBN
with B-O B-NP_PP_IN
1 B-O B-NP_NP_CD
alpha,25-(OH)2D3-responsive B-O B-NN
cells B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
T B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
" " B-O B-NP_ADJP_NP_O-NP
lineages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
resting B-O B-S_NP_ADJP_ADJP_VBG
" " B-O O-ADJP
tonsillar B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
express B-O B-VP_VB
VDR B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
interleukin-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induced B-O B-VP_VBD
VDR B-O B-NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
exogenously B-O B-NP_ADVP_RB
" " B-O O-ADVP
supplemented B-O B-VBN
1 B-O B-CD
alpha,25-(OH)2D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_PP_IN
indicators B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
hormone-mediated B-O B-NP_JJ
gene B-O B-NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
analyzed B-O B-VP_VBD
modulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD23 B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
common B-O B-JJ
B B-O B-NN
cell/monocyte B-O B-NN
surface B-O B-NN
antigen B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
and B-O B-CC
24-hydroxylase B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
1 B-O B-S_NP_CD
alpha,25-(OH)2D3 B-O B-NN
" " B-O O-NP
inhibited B-O B-VP_VP_VBD
CD23 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
yet B-O B-ADVP_RB
" " B-O O-ADVP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
modulate B-O B-VP_VB
CD23 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
1 B-O B-NP_CD
alpha,25-(OH)2D3 B-O B-NN
" " B-O O-NP
induced B-O B-VP_VP_VBD
24-hydroxylase B-O B-NP_NN
mRNA B-O B-NN
expression B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
metabolic B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_CC
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
lectin-activated B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
yet B-O B-ADVP_RB
" " B-O O-ADVP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
24-hydroxylase B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
or B-O B-CC
its B-O B-NP_PRPP
metabolic B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
although B-O B-S_SBAR_IN
human B-O B-S_NP_JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
express B-O B-VP_VB
and B-O B-NP_NP_CC
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
they B-O B-S_NP_PRP
" " B-O O-NP
exhibit B-O B-VP_VBP
a B-O B-NP_NP_DT
functional B-O B-JJ
block B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
gene B-O B-NP_ADJP_NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interferon B-O B-S_NP_NN
alpha B-O B-NN
" " B-O O-NP
selectively B-O B-ADVP_RB
" " B-O O-ADVP
affects B-O B-VP_VBZ
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
myeloid B-O B-JJ
cell B-O B-NN
nuclear B-O B-JJ
differentiation B-O B-NN
antigen B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
late B-O B-NP_NP_JJ
stage B-O B-NN
cells B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_NP_DT
monocytic B-O B-JJ
" " B-O B-NP_O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
granulocytic B-O B-JJ
" " B-O B-NP_O-NP
" " B-O O-NP
lineage B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
human B-O B-JJ
myeloid B-O B-NP_NP_JJ
cell B-O B-NN
nuclear B-O B-JJ
differentiation B-O B-NN
antigen B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MNDA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
constitutively B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
myeloid B-O B-JJ
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
appearing B-O B-S_NP_VP_VP_VBG
in B-O B-PP_IN
myeloblast B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
consistently B-O B-VP_ADVP_RB
" " B-O O-ADVP
being B-O B-VBG
detected B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
as B-O B-NP_CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
human B-O B-JJ
myeloid B-O B-JJ
leukemia B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
HL-60 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
U937 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
THP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
express B-O B-VP_VBP
similar B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
immunochemically B-O B-NP_ADJP_RB
detectable B-O B-JJ
" " B-O O-ADJP
MNDA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
, B-O B-COMMA
the B-O B-S_NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
MNDA B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
primary B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
very B-O B-ADJP_RB
low B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
it B-O B-NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
up-regulated B-O B-VP_VBN
at B-O B-NP_PP_IN
6 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
following B-O B-PP_VBG
the B-O B-NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interferon B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interferon B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_DT
MNDA B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
observed B-O B-VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
cell B-O B-NN
lines B-O B-NNS
HL-60 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
U937 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
THP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
MNDA B-O B-NN
mRNA B-O B-NN
level B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
primary B-O B-NP_JJ
granulocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
unaffected B-O B-VP_JJ
by B-O B-NP_PP_IN
addition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
interferon B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
and B-O B-CC
other B-O B-NP_NP_JJ
agents B-O B-NNS
" " B-O O-NP
including B-O B-PP_VBG
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
MNDA B-O B-NN
mRNA B-O B-NN
level B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
myeloid B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
unaffected B-O B-JJ
by B-O B-NP_PP_IN
the B-O B-NP_DT
latter B-O B-JJ
four B-O B-CD
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
myeloid B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
phorbol B-O B-NP_NN
ester B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
monocyte B-O B-NP_NP_NN
differentiation B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
reduced B-O B-JJ
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mRNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
then B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
elevated B-O B-VP_JJ
with B-O B-NP_PP_IN
subsequent B-O B-NP_JJ
interferon B-O B-NN
alpha B-O B-NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
phorbol B-O B-NP_NN
ester B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
MNDA B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
induced B-O B-NP_VBN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
since B-O B-SBAR_IN
inhibiting B-O B-S_S_S_NP_VP_VBG
cell B-O B-NP_NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
did B-O B-VP_VBD
not B-O B-RB
alter B-O B-VP_VB
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
cell B-O B-S_NP_NP_NN
cycle B-O B-NN
variation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
MNDA B-O B-NP_NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
ability B-O B-NN
" " B-O B-S_O-NP
of B-O B-PP_IN
interferon B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
up-regulate B-O B-VP_VB
MNDA B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
phorbol B-O B-NP_ADJP_NP_NN
ester B-O B-NN
" " B-O O-NP
treated B-O B-JJ
" " B-O O-ADJP
myeloid B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
is B-O B-VP_VBZ
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_NP_DT
observations B-O B-NNS
" " B-O O-NP
made B-O B-VP_VBN
in B-O B-NP_PP_IN
primary B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LRB
ABSTRACT B-O B-NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-S
Effects B-O B-NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
alpha-lipoic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
and B-O B-CC
dihydrolipoic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
proto-oncogene B-O B-NP_NN
c-fos B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
important B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
human B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
mediator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
cellular B-O B-JJ
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
, B-O B-NP_NP_NP_COMMA
, B-O B-NP_COMMA
" " B-O O-NP
and B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
AP-1 B-O B-NN
complex B-O B-NN
" " B-O O-NP
consists B-O B-VP_VBZ
of B-O B-PP_IN
distinct B-O B-NP_NP_JJ
protein B-O B-NN
heterodimers B-O B-NNS
" " B-O O-NP
encoded B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
proto-oncogene B-O B-NN
c-fos B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O B-NP_O-NP
mRNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
whose B-O B-SBAR_WHNP_WPP
gene B-O B-NN
expression B-O B-NN
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recent B-O B-S_NP_JJ
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
an B-O B-NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
reactive B-O B-NP_JJ
oxygen B-O B-NN
species B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
pathway B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TPA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
leading B-O B-VP_VBG
to B-O B-PP_TO
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
investigate B-O B-VP_VB
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
reactive B-O B-NP_JJ
oxygen B-O B-NN
species B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
we B-O B-S_NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
alpha-lipoic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
and B-O B-CC
dihydrolipoic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
natural B-O B-NP_JJ
thiol B-O B-NN
antioxidants B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
Jurkat B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
cells B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
preincubated B-O B-VP_VBN
with B-O B-NP_PP_IN
dihydrolipoic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
0.2 B-O B-NP_CD
mM B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
the B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
suppressed B-O B-VP_VBN
at B-O B-NP_PP_IN
30 B-O B-NP_NP_CD
min B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
whereas B-O B-SBAR_IN
in B-O B-S_PP_IN
the B-O B-NP_NP_DT
case B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
enhanced B-O B-VP_VBN
at B-O B-NP_PP_IN
30 B-O B-NP_CD
min B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
support B-O B-VP_VBP
the B-O B-NP_DT
idea B-O B-NN
that B-O B-SBAR_IN
superoxide B-O B-S_NP_NN
anion B-O B-NN
radical B-O B-NN
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Induction B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
proto-oncogene B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
cytokine B-O B-NP_NN
" " B-O B-NP_O-NP
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
monocytic B-O B-NP_JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
THP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
mycoplasma-derived B-O B-NP_NP_JJ
material B-O B-NN
" " B-O O-NP
MDHM B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Mycoplasma B-O B-S_S_NP_NP_NN
fermentans-derived B-O B-JJ
high-molecular-weight B-O B-JJ
material B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MDHM B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
originally B-O B-ADVP_RB
" " B-O O-ADVP
described B-O B-VP_VBN
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
differentiation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
to B-O B-NP_PP_TO
" " B-O B-NP_O-NP
by B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
This B-O B-S_NP_DT
study B-O B-NN
" " B-O O-NP
shows B-O B-VP_VBZ
that B-O B-SBAR_IN
human B-O B-S_NP_NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
monocytes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
PBMo B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
respond B-O B-VP_VBP
to B-O B-PP_TO
MDHM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
increases B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
, B-O B-NP_NP_COMMA
and B-O B-NP_CC
" " B-O B-NP_NP_O-PP
, B-O B-COMMA
both B-O B-CC
at B-O B-PP_IN
the B-O B-NP_DT
and B-O B-NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
induced B-O B-VBN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-1 B-O B-NP_NP_NN
beta B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
TNF B-O B-NP_NN
alpha B-O B-NN
" " B-O B-NP_O-NP
mRNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
monocytic B-O B-JJ
THP-1 B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
as B-O B-ADJP_RB
quickly B-O B-RB
" " B-O O-ADJP
as B-O B-PP_IN
in B-O B-NP_NP_PP_IN
primary B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
PBMo B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
THP-1 B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
14 B-O B-NP_CD
other B-O B-JJ
monocytic/myeloid B-O B-JJ
leukemia-derived B-O B-JJ
" " B-O B-NP_O-NP
cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
secrete B-O B-VP_VB
measurable B-O B-NP_NP_JJ
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
upon B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
MDHM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-1 B-O B-S_NP_NN
beta B-O B-NN
and B-O B-CC
IL-6 B-O B-NN
genes B-O B-NNS
" " B-O O-NP
contain B-O B-VP_VBP
AP-1 B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
as B-O B-PP_IN
regulatory B-O B-NP_NP_JJ
elements B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
AP-1 B-O B-NN
protein B-O B-NN
" " B-O O-NP
being B-O B-VP_VBG
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
THP-1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
c-jun B-O B-NP_NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
increased B-O B-VP_VBD
after B-O B-PP_IN
incubation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
MDHM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
while B-O B-SBAR_IN
positive B-O B-S_NP_JJ
c-fos B-O B-NN
expression B-O B-NN
" " B-O O-NP
remained B-O B-VP_VBD
unaffected B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
these B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
AP-1 B-O B-COMP_S_NP_NN
" " B-O O-NP
regulated B-O B-VP_VBD
cytokine B-O B-NP_NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
results B-O B-S_NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
PBMo B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
in B-O B-PP_IN
accordance B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
this B-O B-NP_DT
notion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
primary B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
MDHM-induced B-O B-NP_NP_JJ
elevation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
preceded B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
downregulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
while B-O B-SBAR_IN
positive B-O B-S_NP_JJ
c-jun B-O B-NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
modulated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
c-myc B-O B-S_NP_NP_NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
, B-O B-COMMA
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
high B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
THP-1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
MDHM-stimulated B-O B-NP_JJ
PBMo B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
conclusion B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
MDHM-stimulated B-O B-NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
different B-O B-NP_NP_JJ
proto-oncogene B-O B-NN
responses B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
PBMo B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
THP-1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
differences B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
represent B-O B-VP_VB
different B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
regulatory B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
pathways B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
cell B-O B-NN
systems B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Alternatively B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
data B-O B-NNS
" " B-O O-NP
support B-O B-VP_VBP
the B-O B-NP_DT
notion B-O B-NN
that B-O B-SBAR_IN
neither B-O B-S_NP_CC
AP-1 B-O B-NP_NN
" " B-O O-NP
nor B-O B-CC
the B-O B-NP_DT
c-myc B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
present B-O B-JJ
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
clearly B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
mycoplasma B-O B-S_NP_NN
products B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
have B-O B-VP_VB
a B-O B-NP_DT
profound B-O B-JJ
impact B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
status B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
All-trans B-O B-S_S_NP_NP_JJ
retinoic B-O B-JJ
acid B-O B-NN
" " B-O O-NP
and B-O B-CC
1 B-O B-NP_CD
alpha,25-dihydroxyvitamin B-O B-NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-NP
co-operate B-O B-VP_VBP
to B-O B-S_NP_VP_TO
promote B-O B-VP_VB
differentiation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_NP_O-PP
to B-O B-PP_TO
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_S_NP_NP_DT
basis B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
differentiation B-O B-NP_NP_NN
therapy B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
leukemias B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
provided B-O B-VP_VBN
by B-O B-NP_PP_IN
knowledge B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
agents B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
All-trans B-O B-S_NP_JJ
retinoic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
induces B-O B-VP_VP_VBZ
differentiation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HL60 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
neutrophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
treat B-O B-VP_VB
acute B-O B-NP_JJ
promyelocytic B-O B-JJ
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
that B-O B-SBAR_IN
RA B-O B-S_NP_NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
induced B-O B-VP_VBN
neutrophil B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
serum-free B-O B-NP_JJ
grown B-O B-VBN
HL60 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
whereas B-O B-SBAR_IN
50 B-O B-S_NP_QP_CD
nM B-O B-NN
" " B-O O-QP
" " B-O B-NP_NP_PRN_O-NP
induced B-O B-VP_VBD
maximal B-O B-NP_JJ
monocyte B-O B-NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Increasing B-O B-S_NP_VBG
RA B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
reduced B-O B-VP_VBD
the B-O B-NP_NP_DT
D3 B-O B-NN
concentration B-O B-NN
" " B-O O-NP
required B-O B-VP_VBN
for B-O B-NP_PP_IN
monocyte B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cells B-O B-S_S_NP_NP_NNS
" " B-O O-NP
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
5 B-O B-NP_ADJP_CD
nM B-O B-NN
" " B-O O-ADJP
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
showed B-O B-VP_VBD
little B-O B-NP_JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
differentiated B-O B-SINV_VP_VBD
maximally B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-NP_NP_VP_PP_IN
D3 B-O B-NP_NP_ADJP_NN
" " B-O O-NP
and B-O B-CC
RA B-O B-NP_ADJP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-SINV
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
D3 B-O B-NN
analogs B-O B-NNS
" " B-O O-NP
MC903 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
EB1089 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
KH1060 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
more B-O B-NP_NP_ADJP_JJR
potent B-O B-JJ
" " B-O O-ADJP
inducers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
monocyte B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
extent B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHPP_TO
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
analog B-O B-S_NP_NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
increased B-O B-VP_VBN
after B-O B-NP_PP_PP_IN
cotreatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
was B-O B-VP_VBD
inversely B-O B-ADJP_RB
related B-O B-JJ
to B-O B-PP_TO
potency B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Twenty-four B-O B-S_NP_NP_ADJP_CD
hour B-O B-NN
" " B-O O-ADJP
treatment B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
10 B-O B-NP_ADJP_CD
nM B-O B-NN
" " B-O O-ADJP
RA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
primed B-O B-VP_VBD
cells B-O B-NP_NNS
" " B-O O-NP
for B-O B-PP_IN
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
5 B-O B-NP_ADJP_CD
nM B-O B-NN
" " B-O O-ADJP
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
; B-O B-COLON
the B-O B-S_NP_DT
reverse B-O B-NN
sequence B-O B-NN
" " B-O O-NP
being B-O B-VP_VBG
ineffective B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Priming B-O B-S_NP_NP_NP_VBG
" " B-O O-NP
with B-O B-PP_IN
10 B-O B-NP_QP_CD
nM B-O B-NN
" " B-O O-QP
RA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
subsequent B-O B-NP_NP_JJ
treatment B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
D3 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
5 B-O B-NP_CD
nM B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
alter B-O B-VP_VB
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
mRNAs B-O B-NP_NP_NNS
encoding B-O B-VBG
receptors B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
, B-O B-NP_NP_NP_PRN_COMMA
or B-O B-NP_NP_PRN_CC
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
That B-O B-S_SBAR_IN
RA B-O B-S_NP_NN
" " B-O O-NP
promotes B-O B-VP_VBZ
both B-O B-NP_CC
neutrophil B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
monocyte B-O B-NP_NN
" " B-O B-NP_O-NP
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
has B-O B-VP_VP_VBZ
implications B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
D3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
provides B-O B-VP_VBZ
insight B-O B-NP_NP_NN
" " B-O O-NP
into B-O B-PP_IN
mechanisms B-O B-NP_NP_NNS
" " B-O O-NP
whereby B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
, B-O B-S_NP_NP_COMMA
and B-O B-NP_CC
facilitate B-O B-NP_VP_VBP
" " B-O B-NP_ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Alternative B-O B-S_S_NP_NP_JJ
splicing B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RNA B-O B-NP_NP_NN
transcripts B-O B-NNS
" " B-O O-NP
encoded B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
murine B-O B-NN
p105 B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
generates B-O B-VP_VBZ
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
gamma B-O B-NN
isoforms B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
different B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
inhibitory B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
activities B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
gene B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
the B-O B-NP_NP_DT
105-kDa B-O B-JJ
protein B-O B-NN
( B-O B-LRB
p105 B-O B-NN
) B-O B-RRB
precursor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
p50 B-O B-NN
subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
encodes B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
p70 B-O B-NN
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
gamma B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
identical B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
alternative B-O B-S_NP_JJ
RNA B-O B-NN
splicing B-O B-NN
" " B-O O-NP
generates B-O B-VP_VBZ
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
gamma B-O B-NN
isoforms B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
properties B-O B-NP_NP_NNS
" " B-O O-NP
different B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
63-kDa B-O B-JJ
isoform B-O B-NN
" " B-O O-NP
, B-O B-COMMA
termed B-O B-VP_VBN
I B-O B-S_NP_NP_NN
kappa B-O B-NN
B B-O B-NN
gamma-1 B-O B-NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
lacks B-O B-S_NP_VP_VBZ
59 B-O B-NP_NP_CD
amino B-O B-NN
acids B-O B-NNS
C-terminal B-O B-JJ
" " B-O O-NP
to B-O B-PP_TO
ankyrin B-O B-NP_NN
repeat B-O B-NN
7 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
a B-O B-NP_NP_DT
novel B-O B-JJ
35-amino B-O B-NN
acid B-O B-NN
C B-O B-NN
terminus B-O B-NN
" " B-O O-NP
encoded B-O B-VP_VBN
by B-O B-NP_PP_IN
an B-O B-NP_NP_DT
alternative B-O B-JJ
reading B-O B-NN
frame B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
p105 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
55-kDa B-O B-JJ
isoform B-O B-NN
" " B-O O-NP
, B-O B-COMMA
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
gamma-2 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
lacks B-O B-VP_VBZ
the B-O B-NP_NP_DT
190 B-O B-CD
C-terminal B-O B-JJ
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
p70I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
gamma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
p70I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
gamma B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
a B-O B-NP_DT
cytoplasmic B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
gamma-1 B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
found B-O B-VP_VBN
in B-O B-NP_PP_IN
both B-O B-NP_CC
the B-O B-DT
cytoplasm B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
nucleus B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
whereas B-O B-SBAR_IN
I B-O B-S_NP_NN
kappa B-O B-NN
B B-O B-NN
gamma-2 B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
predominantly B-O B-ADJP_RB
nuclear B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
gamma B-O B-NN
isoforms B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
display B-O B-VP_VBP
differences B-O B-NP_NNS
" " B-O O-NP
in B-O B-PP_IN
specificity B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
affinity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
for B-O B-PP_IN
Rel/NF-kappa B-O B-NP_NN
B B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
While B-O B-S_SBAR_IN
p70I B-O B-S_NP_NN
kappa B-O B-NN
B B-O B-NN
gamma B-O B-NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
p50- B-O B-NP_NP_NN
" " B-O B-ADJP_NP_O-NP
, B-O B-COMMA
p65- B-O B-NP_NN
" " B-O B-ADJP_NP_O-NP
, B-O B-COMMA
and B-O B-CC
c-Rel-mediated B-O B-NP_JJ
" " B-O B-NP_O-NP
transactivation B-O B-NP_NP_NN
" " B-O O-NP
and/or B-O B-CC
DNA B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
both B-O B-S_NP_CC
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
gamma-1 B-O B-NN
" " B-O O-NP
and B-O B-CC
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
gamma-2 B-O B-NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VP_VBP
specific B-O B-ADJP_JJ
for B-O B-PP_IN
p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
have B-O B-VP_VBP
different B-O B-NP_NP_JJ
affinities B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
this B-O B-NP_DT
subunit B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
absence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
I B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
gamma-1 B-O B-NN
" " B-O O-NP
and B-O B-CC
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
gamma-2 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
of B-O B-PP_IN
a B-O B-NP_NP_DT
protein B-O B-NN
kinase B-O B-NN
A B-O B-NN
site B-O B-NN
" " B-O O-NP
whose B-O B-SBAR_WHNP_WPP
phosphorylation B-O B-NN
" " B-O O-WHNP
modulates B-O B-S_NP_VP_VBZ
p70I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
gamma B-O B-NN
inhibitory B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
alternative B-O B-S_NP_JJ
RNA B-O B-NN
splicing B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
used B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
to B-O B-S_NP_VP_TO
generate B-O B-VP_VB
" " B-O B-NP_NP_SBAR_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
lymphoblastoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
low-dose B-O B-NP_JJ
ionizing B-O B-VBG
radiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Nuclear B-O B-S_S_NP_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
pleiotropic B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Recent B-O B-S_S_NP_JJ
reports B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
ionizing B-O B-S_NP_NP_VBG
radiation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
dose B-O B-NN
range B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
the B-O B-S_NP_NP_NP_DT
precise B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
involved B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
significance B-O B-NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
yet B-O B-ADVP_RB
" " B-O O-ADVP
known B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
present B-O B-JJ
report B-O B-NN
" " B-O O-NP
demonstrates B-O B-VP_VBZ
that B-O B-SBAR_IN
even B-O B-S_NP_NP_ADJP_RB
lower B-O B-JJR
" " B-O O-ADJP
doses B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
ionizing B-O B-NP_VBG
radiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
0.25-2.0 B-O B-NP_QP_CD
" " B-O O-QP
Gy B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
inducing B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
in B-O B-PP_IN
a B-O B-NP_NP_DT
dose B-O B-NN
range B-O B-NN
" " B-O O-NP
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_NP_DT
viability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remains B-O B-VP_VBZ
very B-O B-ADJP_RB
high B-O B-JJ
" " B-O B-ADVP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_PP_IN
exposure B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
137Cs B-O B-NP_NN
gamma B-O B-NN
rays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
a B-O B-NP_NP_DT
dose B-O B-NN
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1.17 B-O B-NP_CD
Gy/min B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_DT
maximum B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
seen B-O B-VP_VBN
at B-O B-NP_PP_IN
8 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
a B-O B-NP_DT
0.5-Gy B-O B-JJ
exposure B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Time-course B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
revealed B-O B-VP_VBD
a B-O B-NP_DT
biphasic B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
time-dependent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
expression B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
0.5- B-O B-NP_NP_CD
" " B-O B-NP_NP_O-NP
, B-O B-COMMA
1- B-O B-NP_CD
" " B-O B-NP_NP_O-NP
and B-O B-CC
2-Gy B-O B-NP_JJ
" " B-O B-NP_O-NP
exposures B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
for B-O B-PP_IN
each B-O B-NP_NP_DT
time B-O B-NN
" " B-O O-NP
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
maximum B-O B-NP_NN
" " B-O O-NP
after B-O B-PP_IN
the B-O B-NP_DT
0.5-Gy B-O B-JJ
exposure B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
p50 B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
p65 B-O B-NP_NN
" " B-O B-NP_O-NP
NF-kappa B-O B-NP_NN
B B-O B-NN
subunits B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
regulated B-O B-VP_VBN
differentially B-O B-NP_ADVP_RB
" " B-O O-ADVP
after B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Some B-O B-S_S_NP_DT
antioxidants B-O B-NNS
" " B-O O-NP
inhibit B-O B-VP_VBP
, B-O B-COMMA
in B-O B-PP_IN
a B-O B-NP_DT
co-ordinate B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor-alpha B-O B-NN
" " B-O O-NP
, B-O B-COMMA
IL-beta B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
IL-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
mononuclear B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Some B-O B-S_S_NP_NP_DT
antioxidants B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
butylated B-O B-NP_NP_NP_VBN
hydroxyanisole B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
BHA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
tetrahydropapaveroline B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
THP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
nordihydroguiauretic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
10,11-dihydroxyaporphine B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
DHA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
potent B-O B-NP_NP_JJ
inhibitors B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
by B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
gene B-O B-ADJP_ADJP_NN
selective B-O B-JJ
" " B-O O-ADJP
and B-O B-CC
not B-O B-RB
due B-O B-ADJP_JJ
to B-O B-PP_TO
general B-O B-NP_NP_JJ
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
protein B-O B-NP_NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NP_NN
production B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
PBMC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
also B-O B-ADVP_RB
" " B-O O-ADVP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
other B-O B-S_NP_JJ
inducers B-O B-NNS
" " B-O B-PRN_O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
( B-O B-PRN_LRB
staphylococci B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
silica B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
zymosan B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
. B-O B-PERIOD
" " B-O O-S
  
Much B-O B-S_NP_NP_ADJP_RB
higher B-O B-JJR
" " B-O O-ADJP
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_NP_JJ
antioxidants B-O B-NNS
" " B-O O-NP
-- B-O B-COLON
including B-O B-PP_VBG
ascorbic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
, B-O B-COMMA
trolox B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
alpha-tocopherol B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
butylated B-O B-NP_VBN
hydroxytoluene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_DT
5-lipoxygenase B-O B-JJ
inhibitor B-O B-NN
zileuton B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
-- B-O B-COLON
did B-O B-VP_VBD
not B-O B-RB
affect B-O B-VP_VB
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
active B-O B-JJ
compounds B-O B-NNS
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
inhibit B-O B-VP_VB
IL-1-induced B-O B-NP_NP_JJ
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
fibroblasts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
showing B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
cell B-O B-NN
selectivity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Antioxidant-mediated B-O B-S_NP_NP_JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
correlated B-O B-ADJP_JJ
with B-O B-PP_IN
low B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
corresponding B-O B-JJ
messenger B-O B-NN
RNAs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_JJ
run-on B-O B-JJ
experiments B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
THP B-O B-S_NP_NN
" " B-O O-NP
inhibited B-O B-VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-1 B-O B-NN
beta B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
THP B-O B-S_NP_NN
" " B-O O-NP
decreased B-O B-VP_VBD
the B-O B-NP_NP_DT
concentration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
transcription B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
THP B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
DHA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-VP_VBD
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
TNF-alpha B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-1 B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
circulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mice B-O B-NP_NP_NNS
" " B-O O-NP
following B-O B-PP_VBG
LPS B-O B-NP_NN
injection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
antioxidants B-O B-NP_NNS
" " B-O O-NP
vary B-O B-VP_VBP
widely B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
potency B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
inhibitors B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
of B-O B-PP_IN
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
pro-inflammatory B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Coordinate B-O B-S_NP_NP_JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
inflammatory B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
provide B-O B-VP_VB
a B-O B-NP_NP_DT
strategy B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
therapy B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_PP_IN
" " B-O B-NP_NP_PP_O-PP
and B-O B-CC
for B-O B-PP_IN
septic B-O B-NP_JJ
shock B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Calcineurin B-O B-S_S_NP_NN
" " B-O O-NP
potentiates B-O B-VP_VBZ
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
granulocyte-macrophage B-O B-JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
involvement B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
conserved B-O B-VBN
lymphokine B-O B-NN
element B-O B-NN
0 B-O B-CD
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-S
  
Granulocyte-macrophage B-O B-S_NP_NP_NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GM-CSF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
interleukin-2 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
produced B-O B-VP_VBN
by B-O B-NP_PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
phorbol-12-myristate B-O B-NP_NP_NP_NN
acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
calcium B-O B-NP_NP_NN
ionophore B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
leukemia B-O B-NN
Jurkat B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GM-CSF B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
immunosuppressive B-O B-NP_NP_JJ
drugs B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
cyclosporin B-O B-NP_NP_NP_NN
A B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Earlier B-O B-S_NP_NP_JJR
studies B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
overexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
calcineurin B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
Ca2+/calmodulin-dependent B-O B-JJ
protein B-O B-NN
phosphatase B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
stimulate B-O B-VP_VB
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
through B-O B-PP_IN
the B-O B-NP_DT
NF-AT-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
obtained B-O B-VP_VBD
evidence B-O B-NP_NN
that B-O B-SBAR_IN
transfection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
cDNAs B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
augments B-O B-VP_VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
and B-O B-CC
recovers B-O B-VP_VBZ
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
inhibited B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
constitutively B-O B-ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
type B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CN B-O B-NN
A B-O B-NN
subunit B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
lacks B-O B-S_NP_VP_VBZ
the B-O B-NP_DT
auto-inhibitory B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
calmodulin-binding B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
domains B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
acts B-O B-VP_VBZ
in B-O B-PP_IN
synergy B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
GM-CSF B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
active B-O B-JJ
CN B-O B-NN
" " B-O O-NP
partially B-O B-ADVP_RB
" " B-O O-ADVP
replaces B-O B-VP_VBZ
calcium B-O B-NP_NN
ionophore B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
synergy B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
multimerizing B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GM-CSF B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
one B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
target B-O B-NN
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
CN B-O B-NN
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_NP_DT
conserved B-O B-VBN
lymphokine B-O B-NN
element B-O B-NN
0 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
CLE0 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
located B-O B-ADJP_JJ
at B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mobility B-O B-S_NP_NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
CLE0 B-O B-NN
sequence B-O B-NN
" " B-O O-NP
has B-O B-VP_VP_VBZ
an B-O B-NP_DT
AP1-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-VP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-CLE0 B-O B-S_NP_NN
gamma B-O B-NN
binding B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
PMA/A23187 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
CsA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
CN B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
CLE0 B-O B-NN
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GM-CSF B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
functional B-O B-JJ
analogue B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Central B-O B-S_S_NP_JJ
nervous B-O B-JJ
system-derived B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
express B-O B-VP_VBP
a B-O B-NP_NP_DT
kappa B-O B-NN
B-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
enhances B-O B-S_NP_VP_VP_VBZ
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
transcription B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
and B-O B-CC
facilitates B-O B-VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
Tat B-O B-NN
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
potent B-O B-JJ
activator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
long B-O B-NP_JJ
terminal B-O B-JJ
repeat-directed B-O B-JJ
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
While B-O B-S_SBAR_IN
in B-O B-S_PP_IN
most B-O B-NP_JJS
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
activation B-O B-NP_NN
" " B-O O-NP
requires B-O B-VP_VBZ
interaction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Tat B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
unusual B-O B-JJ
transcription B-O B-NP_NP_NN
element B-O B-NN
" " B-O O-NP
TAR B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
astrocytic B-O B-S_NP_JJ
glial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
support B-O B-VP_VBP
TAR-independent B-O B-NP_NP_JJ
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
Tat B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
alternative B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Tat B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
viral B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
kappa B-O B-NN
B B-O B-NN
domain B-O B-NN
" " B-O O-NP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tat B-O B-S_NP_NP_NN
transactivation B-O B-NN
" " B-O O-NP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
kappa B-O B-NN
B B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
sufficient B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
allow B-O B-VP_VB
replication B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TAR-deleted B-O B-NP_JJ
mutant B-O B-JJ
HIV-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
astrocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
demonstrates B-O B-VP_VBZ
the B-O B-NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
kappa B-O B-NP_NP_NN
B-specific B-O B-JJ
binding B-O B-NN
factors B-O B-NNS
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
human B-O B-NP_JJ
glial B-O B-JJ
astrocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
differ B-O B-S_NP_VP_VBP
from B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
novel B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
astrocyte-derived B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
kappa B-O B-NN
B-binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
retained B-O B-VP_VBN
on B-O B-NP_PP_IN
an B-O B-NP_DT
HIV-1 B-O B-NN
Tat B-O B-NN
affinity B-O B-NN
column B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
while B-O B-SBAR_IN
prototypical B-O B-S_NP_NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
transcription B-O B-NN
studies B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
astrocyte-derived B-O B-S_NP_JJ
kappa B-O B-NN
B-binding B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
activate B-O B-VP_VBP
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
this B-O B-S_NP_DT
activation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
the B-O B-NP_DT
kappa B-O B-NN
B B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
TAR-independent B-O B-NP_NP_JJ
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
reproduced B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
in B-O B-PP_IN
an B-O B-NP_NP_DT
astrocyte B-O B-NN
factor-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
correlates B-O B-S_NP_VP_VBZ
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
importance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
central B-O B-JJ
nervous B-O B-JJ
system-enriched B-O B-JJ
kappa B-O B-NN
B B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
discussed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Novel B-O B-NP_NP_NP_JJ
aldosterone B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
: B-O B-COLON
specificity-conferring B-O B-NP_NP_JJ
mechanism B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
membrane B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
  
Functional B-O B-S_NP_NP_JJ
studies B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
extra-renal B-O B-NP_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
nonepithelial B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
smooth B-O B-NP_NP_JJ
muscle B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
more B-O B-NP_ADVP_RBR
recently B-O B-RB
" " B-O O-ADVP
circulating B-O B-NP_VBG
human B-O B-JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
provided B-O B-VP_VBN
increasing B-O B-NP_VBG
evidence B-O B-NN
that B-O B-SBAR_IN
aldosterone B-O B-S_NP_NN
" " B-O O-NP
produces B-O B-VP_VBZ
, B-O B-NP_NP_CONJP_NP_COMMA
on B-O B-CONJP_NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
" " B-O O-NP
involve B-O B-VP_VBP
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
sodium/proton-exchanger B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
membrane B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
very B-O B-NP_NP_ADJP_ADJP_RB
low B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
physiological B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
concentrations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
an B-O B-NP_NP_DT
acute B-O B-JJ
onset B-O B-NN
" " B-O O-NP
within B-O B-PP_IN
1-2 B-O B-NP_QP_CD
" " B-O O-QP
minutes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
second B-O B-JJ
messenger B-O B-NN
cascade B-O B-NN
" " B-O O-NP
involved B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
inositol-1,4,5-trisphosphate/calcium B-O B-NN
pathway B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
responds B-O B-S_NP_VP_VBZ
over B-O B-PP_IN
the B-O B-NP_DT
same B-O B-JJ
rapid B-O B-JJ
time B-O B-NN
course B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Such B-O B-S_NP_JJ
changes B-O B-NNS
" " B-O O-NP
clearly B-O B-ADVP_RB
" " B-O O-ADVP
can B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
explained B-O B-VP_VBN
by B-O B-NP_PP_IN
genomic B-O B-NP_NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NN
to B-O B-TO
its B-O B-NP_PRPP
rapid B-O B-JJ
time B-O B-NN
course B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
unique B-O B-JJ
characteristics B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_NP_DT
new B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
steroid B-O B-NP_NN
action B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
include B-O B-VP_VBP
a B-O B-NP_NP_NP_DT
10000-fold B-O B-JJ
selectivity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
aldosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
over B-O B-PP_IN
cortisol B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
ineffectiveness B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
spironolactones B-O B-NP_NP_NNS
" " B-O O-NP
, B-O B-COMMA
classical B-O B-NP_JJ
mineralocorticoid B-O B-NN
antagonists B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
antagonists B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Subsequently B-O B-S_NP_NP_ADJP_RB
binding B-O B-VBG
" " B-O O-ADJP
sites B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
demonstrated B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
plasma B-O B-NN
membrane B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
show B-O B-S_NP_VP_VBP
identical B-O B-NP_NP_NP_NP_ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
SDS-PAGE B-O B-S_NP_NP_NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
receptor B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
shown B-O B-VP_VBN
a B-O B-NP_NP_DT
molecular B-O B-JJ
weight B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
approximately B-O B-NP_QP_RB
50 B-O B-CD
" " B-O O-QP
kD B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
present B-O B-JJ
paper B-O B-NN
" " B-O O-NP
reviews B-O B-VP_VBZ
the B-O B-NP_NP_DT
data B-O B-NNS
" " B-O O-NP
supporting B-O B-VP_VBG
a B-O B-NP_NP_DT
new B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
two-step B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
model B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
non-genomic B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
genomic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
aldosterone B-O B-NN
effects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
suggests B-O B-VP_VBZ
a B-O B-NP_NP_DT
novel B-O B-JJ
specificity-conferring B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
mineralocorticoid B-O B-NP_NP_NN
action B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
membrane B-O B-NN
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
An B-O B-S_S_NP_NP_DT
intricate B-O B-JJ
arrangement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
binding B-O B-NP_NP_VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
Ets B-O B-NN
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
regulates B-O B-VP_VBZ
activity B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
alpha B-O B-NN
4 B-O B-CD
integrin B-O B-NN
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
alpha B-O B-S_S_NP_NN
4 B-O B-CD
integrins B-O B-NNS
" " B-O O-NP
mediate B-O B-VP_VBP
cell-cell B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
cell-extracellular B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
matrix B-O B-NP_NN
interactions B-O B-NNS
" " B-O O-NP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
critical B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
examine B-O B-VP_VBP
molecular B-O B-NP_NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
controlling B-O B-VP_VBG
the B-O B-NP_NP_DT
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
alpha B-O B-NP_NN
4 B-O B-CD
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
constructs B-O B-NP_NP_NNS
" " B-O O-NP
containing B-O B-VP_VBG
5' B-O B-NP_NP_JJ
deletion B-O B-NN
mutants B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
alpha B-O B-NN
4 B-O B-CD
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
compared B-O B-VP_VBN
in B-O B-NP_PP_IN
transfection B-O B-NP_NP_NN
assays B-O B-NNS
" " B-O O-NP
into B-O B-PP_IN
cell B-O B-NP_NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
and B-O B-CC
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
sequence B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
position B-O B-NP_NP_NN
" " B-O O-NP
-42 B-O B-NP_NP_CD
and B-O B-CC
-76 B-O B-CD
base B-O B-NN
pairs B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
bp B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
required B-O B-VP_VBN
for B-O B-NP_PP_IN
efficient B-O B-NP_NP_JJ
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
showed B-O B-VP_VBD
no B-O B-NP_DT
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HeLa B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
do B-O B-S_NP_VP_VBP
not B-O B-RB
express B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Three B-O B-S_S_NP_NP_CD
binding B-O B-VBG
sites B-O B-NNS
" " B-O B-NP_O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
Ets B-O B-NN
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
found B-O B-VP_VBN
in B-O B-NP_PP_IN
this B-O B-NP_DT
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
two B-O B-NP_NP_NP_CD
adjacent B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
at B-O B-PP_IN
positions B-O B-NP_NP_NNS
" " B-O O-NP
-50 B-O B-NP_CD
and B-O B-CC
-54 B-O B-CD
bp B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
more B-O B-RBR
5' B-O B-JJ
site B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
position B-O B-NP_NP_NN
" " B-O O-NP
-67 B-O B-NP_CD
bp B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
a B-O B-NP_NP_DT
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
constructs B-O B-NP_NP_NNS
" " B-O O-NP
containing B-O B-VP_VBG
and B-O B-NP_NP_NP_CC
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
3'-most B-O B-JJ
site B-O B-NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
was B-O B-VP_VBD
sufficient B-O B-ADJP_JJ
for B-O B-PP_PP_IN
and B-O B-S_CC
for B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
all B-O B-S_NP_DT
three B-O B-CD
sites B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
present B-O B-ADJP_JJ
" " B-O B-ADVP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
a B-O B-S_NP_DT
second B-O B-JJ
complex B-O B-NN
"""" B-O B-LQT
a B-O B-NN
"""" B-O B-RQT
" " B-O B-SBAR_O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contains B-O B-S_NP_VP_VBZ
an B-O B-NP_NP_DT
unknown B-O B-JJ
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Ets B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
. B-O B-PERIOD
" " B-O O-S
  
Formation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
complex B-O B-NP_JJ
a B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VP_VBD
cell-type B-O B-ADJP_NN
specific B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
correlated B-O B-VP_VBD
with B-O B-PP_IN
a B-O B-NP_NP_DT
high B-O B-JJ
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletion B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
5'-most B-O B-JJ
Ets B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
binding B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
GABP B-O B-NP_NN
alpha/GABP B-O B-NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
eliminated B-O B-VP_VBD
a B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Concomitant B-O B-S_ADJP_JJ
with B-O B-PP_IN
this B-O B-NP_NP_DT
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
a B-O B-NP_NP_DT
new B-O B-NP_NP_JJ
Ets-1-containing B-O B-JJ
complex B-O B-NN
" " B-O O-NP
"""" B-O B-LQT
c B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
"""" B-O B-RQT
" " B-O O-NP
" " B-O O-NP
appeared B-O B-VP_VBD
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Complex B-O B-S_NP_NN
c B-O B-NN
" " B-O O-NP
substituted B-O B-VP_VBD
efficiently B-O B-ADVP_RB
" " B-O O-ADVP
for B-O B-PP_IN
complex B-O B-NP_NN
a B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
transcriptional B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
although B-O B-S_SBAR_IN
neither B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
5'-most B-O B-JJ
Ets B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
binds B-O B-VP_VBZ
nuclear B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
they B-O B-S_NP_PRP
" " B-O O-NP
appear B-O B-VP_VBP
to B-O B-S_NP_VP_TO
act B-O B-VP_VB
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_NP_DT
arrangement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Ets B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
coupled B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
tissue- B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
developmental- B-O B-NP_ADJP_JJ
" " B-O B-NP_O-ADJP
" " B-O O-NP
specific B-O B-NP_JJ
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
Ets B-O B-NP_NN
members B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
likely B-O B-ADVP_RB
" " B-O O-ADVP
play B-O B-VP_VBP
a B-O B-NP_DT
key B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
defining B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
alpha B-O B-NP_NN
4 B-O B-CD
integrin B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Lipopolysaccharide B-O B-S_S_NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tissue B-O B-NP_NN
factor B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel/p65 B-O B-NP_NN
heterodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_DT
kappa B-O B-NN
B-like B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Exposure B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
bacterial B-O B-NP_JJ
lipopolysaccharide B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
LPS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
activates B-O B-VP_VP_VBZ
the B-O B-NP_NP_DT
NF-kappa B-O B-NN
B/Rel B-O B-NN
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
proteins B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
leads B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
rapid B-O B-JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
inflammatory B-O B-NP_NP_JJ
gene B-O B-NN
products B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
TF B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
primary B-O B-JJ
cellular B-O B-JJ
initiator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
coagulation B-O B-NN
protease B-O B-NN
cascades B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
the B-O B-NP_NP_DT
characterization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
nuclear B-O B-JJ
complex B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
human B-O B-NP_NP_JJ
monocytic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
nuclear B-O B-JJ
complex B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
kinetics B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
preceded B-O B-S_NP_VP_VBD
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
binding B-O B-NN
studies B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
TF B-O B-NN
site B-O B-NN
" " B-O O-NP
bound B-O B-VP_VBD
translated B-O B-NP_VBN
c-Rel B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
p65 B-O B-NP_NN
" " B-O B-NP_O-NP
homodimers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
p50/p65 B-O B-NP_NP_NN
heterodimers B-O B-NNS
" " B-O O-NP
or B-O B-CC
p50 B-O B-NP_NN
homodimers B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Base-pair B-O B-S_NP_NP_JJ
substitutions B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
TF B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
cytosine B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
position B-O B-NP_NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
precluded B-O B-VP_VBD
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
fact B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
under B-O B-PP_IN
low-ionic-strength B-O B-NP_JJ
conditions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
TF B-O B-NN
complex B-O B-NN
" " B-O O-NP
did B-O B-VP_VP_VBD
not B-O B-RB
migrate B-O B-VP_VB
with B-O B-PP_IN
translated B-O B-NP_VBN
p50/p65 B-O B-NN
dimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
but B-O B-CC
instead B-O B-ADVP_RB
" " B-O O-ADVP
comigrated B-O B-VP_VBD
with B-O B-PP_IN
c-Rel/p65 B-O B-NP_NN
dimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Antibodies B-O B-S_NP_NP_NP_NNS
" " B-O O-NP
against B-O B-PP_IN
the B-O B-NP_NP_DT
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
Rel B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
UV B-O B-NP_NN
cross-linking B-O B-JJ
studies B-O B-NNS
" " B-O O-NP
" " B-O O-NP
revealed B-O B-VP_VP_VBD
the B-O B-NP_NP_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
TF B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
further B-O B-ADVP_RB
" " B-O O-ADVP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
c-Rel/p65 B-O B-S_NP_NN
heterodimers B-O B-NNS
" " B-O O-NP
selectively B-O B-ADVP_RB
" " B-O O-ADVP
bound B-O B-VP_VBD
to B-O B-PP_TO
the B-O B-NP_DT
TF B-O B-NN
kappa B-O B-NN
B-like B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Functional B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
TF B-O B-NN
site B-O B-NN
" " B-O O-NP
conferred B-O B-VP_VP_VBD
LPS B-O B-NP_NN
inducibility B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
a B-O B-NP_DT
heterologous B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
transactivated B-O B-VP_VBN
by B-O B-NP_PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O B-NP_O-VP
" " B-O O-S
, B-O B-COMMA
our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
binding B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel/p65 B-O B-NP_NN
heterodimers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
a B-O B-NP_DT
novel B-O B-JJ
kappa B-O B-NN
B-like B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
mediated B-O B-VP_VBD
LPS B-O B-NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TF B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Prenatal B-O B-S_S_NP_JJ
immune B-O B-JJ
challenge B-O B-NN
" " B-O O-NP
alters B-O B-VP_VBZ
the B-O B-NP_NP_DT
hypothalamic-pituitary-adrenocortical B-O B-JJ
axis B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
adult B-O B-NP_JJ
rats B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
whether B-O B-SBAR_IN
non-abortive B-O B-S_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
maternal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
infections B-O B-NNS
" " B-O O-NP
would B-O B-VP_MD
compromise B-O B-VP_VP_VB
fetal B-O B-NP_JJ
brain B-O B-NN
development B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
alter B-O B-VP_VB
" " B-O B-NP_NP_VP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
study B-O B-VP_VB
putative B-O B-NP_NP_ADJP_JJ
teratogenic B-O B-JJ
" " B-O O-ADJP
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
T B-O B-NN
cell-mediated B-O B-JJ
immune B-O B-JJ
response B-O B-NN
" " B-O O-NP
versus B-O B-CC
an B-O B-NP_DT
endotoxic B-O B-JJ
challenge B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
10-d-pregnant B-O B-S_NP_NP_JJ
rats B-O B-NNS
" " B-O O-NP
received B-O B-VP_VBD
a B-O B-NP_NP_DT
single B-O B-ADJP_JJ
intraperitoneal B-O B-JJ
" " B-O O-ADJP
injection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
5 B-O B-NP_NP_QP_CD
x B-O B-CC
10(8) B-O B-CD
" " B-O O-QP
" " B-O B-NP_NP_PRN_O-NP
or B-O B-CC
endotoxin B-O B-NP_NP_ADJP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
adult B-O B-ADJP_JJ
male B-O B-JJ
" " B-O O-ADJP
progeny B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
3 B-O B-ADJP_NP_CD
mo B-O B-NN
" " B-O O-NP
old B-O B-JJ
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
experimental B-O B-JJ
groups B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
increased B-O B-NP_VBN
basal B-O B-JJ
plasma B-O B-NN
corticosterone B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
after B-O B-PP_IN
novelty B-O B-NP_NN
stress B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
HRBC B-O B-NN
group B-O B-NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
LPS B-O B-NN
group B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
showed B-O B-VP_VBD
increased B-O B-NP_VBN
ACTH B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
corticosterone B-O B-NP_NN
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_DT
groups B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
substantial B-O B-NP_NP_JJ
decreases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
mineralocorticoid B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
MR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
and B-O B-CC
glucocorticoid B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O B-NP_O-NP
levels B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
hippocampus B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
limbic B-O B-JJ
brain B-O B-NN
structure B-O B-NN
" " B-O O-NP
critical B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
whereas B-O B-SBAR_IN
GR B-O B-S_S_NP_NP_NN
concentrations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
hypothalamus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
unchanged B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
in B-O B-S_NP_NP_PP_IN
anterior B-O B-NP_JJ
pituitary B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
slightly B-O B-ADVP_RB
" " B-O O-ADVP
increased B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HRBC B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
indeed B-O B-ADVP_RB
" " B-O O-ADVP
stimulated B-O B-VP_VP_VBD
the B-O B-NP_DT
maternal B-O B-JJ
immune B-O B-JJ
system B-O B-NN
" " B-O O-NP
as B-O B-SBAR_IN
revealed B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
specific B-O B-NP_JJ
anti-HRBC B-O B-JJ
antibody B-O B-NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
enhanced B-O B-VP_VBD
IL-1 B-O B-NP_NP_NN
beta B-O B-NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
splenocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
study B-O B-NN
" " B-O O-NP
demonstrates B-O B-VP_VBZ
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
T B-O B-NN
cell-mediated B-O B-JJ
immune B-O B-JJ
response B-O B-NN
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
an B-O B-NP_NP_DT
endotoxic B-O B-JJ
challenge B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
pregnancy B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
can B-O B-VP_MD
induce B-O B-VP_VB
anomalies B-O B-NP_NNS
" " B-O O-NP
in B-O B-PP_IN
HPA B-O B-NP_NP_NN
axis B-O B-NN
function B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Clinically B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
postulated B-O B-VP_VBN
that B-O B-SBAR_IN
disturbed B-O B-S_NP_NP_JJ
fetal B-O B-JJ
brain B-O B-NN
development B-O B-NN
" " B-O O-NP
due B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-NP
increases B-O B-VP_VBZ
the B-O B-NP_NP_DT
vulnerability B-O B-NN
" " B-O O-NP
" " B-O B-S_NP_VP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
JNK B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
signal B-O B-NP_NP_NN
integration B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
costimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
T B-O B-S_S_NP_NP_NN
lymphocyte B-O B-NN
activation B-O B-NN
" " B-O O-NP
and B-O B-CC
interleukin-2 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
" " B-O O-NP
require B-O B-VP_VBP
at B-O B-NP_NP_QP_IN
least B-O B-JJS
two B-O B-CD
" " B-O O-QP
signals B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
generated B-O B-VP_VBN
by B-O B-NP_PP_IN
and B-O B-NP_NP_NP_NP_PRN_CC
Ca2+ B-O B-NP_NN
ionophore B-O B-NN
" " B-O O-NP
" " B-O O-NP
or B-O B-CC
costimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
these B-O B-S_NP_DT
stimuli B-O B-NNS
" " B-O O-NP
affect B-O B-VP_VBP
mitogen B-O B-NP_NN
activated B-O B-JJ
protein B-O B-NN
( B-O B-LRB
MAP B-O B-NN
) B-O B-RRB
kinases B-O B-NNS
" " B-O O-NP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Full B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
MAP B-O B-NN
kinases B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
phosphorylate B-O B-S_NP_VP_VBP
the B-O B-NP_NP_DT
Jun B-O B-NN
activation B-O B-NN
domain B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
required B-O B-VP_VBD
costimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
either B-O B-NP_NP_CC
TPA B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
Ca2+ B-O B-NP_NN
ionophore B-O B-NN
" " B-O O-NP
" " B-O O-NP
or B-O B-CC
antibodies B-O B-NP_NP_NNS
" " B-O O-NP
to B-O B-PP_TO
TCR B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
CD28 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Alone B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
each B-O B-NP_DT
stimulus B-O B-NN
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
little B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
or B-O B-CC
no B-O B-NP_DT
" " B-O B-NP_O-NP
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Similar B-O B-S_ADVP_JJ
to B-O B-PP_TO
its B-O B-NP_NP_PRPP
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
IL-2 B-O B-NP_NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
cyclosporin B-O B-S_S_S_NP_NP_NN
A B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CsA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
synergistic B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
JNK B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
a B-O B-S_NP_NP_DT
competitive B-O B-JJ
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Jun B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
JNK B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibited B-O B-VP_VBD
IL-2 B-O B-NP_NN
promoter B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
MAP B-O B-NN
kinases B-O B-NNS
" " B-O O-NP
ERK1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
ERK2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VP_VBD
fully B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
TPA B-O B-NP_NP_NN
" " B-O B-NP_O-NP
or B-O B-CC
TCR B-O B-NP_NN
" " B-O B-NP_O-NP
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
were B-O B-VP_VBD
not B-O B-RB
affected B-O B-VP_VBN
by B-O B-NP_PP_IN
Ca2+ B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
CD28 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
CsA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Hence B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
integration B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
signals B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
lead B-O B-S_NP_VP_VBP
to B-O B-PP_TO
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurs B-O B-VP_VBZ
at B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
JNK B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Glucocorticoid-mediated B-O B-NP_NP_JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interleukin-2 B-O B-NP_NP_NN
receptor B-O B-NN
alpha B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
-beta B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
subunit B-O B-NN
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
To B-O B-S_S_NP_VP_TO
determine B-O B-VP_VB
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_ADJP_NN
( B-O B-LRB
GC B-O B-NN
) B-O B-RRB
-mediated B-O B-JJ
" " B-O O-ADJP
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
functions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
dexamethasone B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
DM B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
T B-O B-NP_NP_NN
cell B-O B-NN
proliferation B-O B-NN
" " B-O O-NP
and B-O B-CC
interleukin-2 B-O B-NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2R B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
generation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Dexamethasone B-O B-S_NP_NN
" " B-O O-NP
inhibited B-O B-VP_VBD
IL-2-induced B-O B-NP_JJ
T B-O B-NN
cell B-O B-NN
proliferation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
30 B-O B-NP_CD
% B-O B-NN
- B-O B-TO
88 B-O B-CD
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
relative B-O B-PP_JJ
to B-O B-TO
its B-O B-NP_NP_PRPP
concentration B-O B-NN
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_DT
cultures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
DM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-2R B-O B-NP_NP_NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
beta B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
next B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
purified B-O B-NP_NP_NP_VBN
phytohemagglutinin B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PHA-p B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
4 B-O B-NP_NP_CD
beta-phorbol B-O B-NN
12-myristate B-O B-NN
13-acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
addition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
DM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
cultures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_NP_DT
60 B-O B-CD
% B-O B-NN
reduction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
IL-2R B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
30 B-O B-CD
% B-O B-NN
reduction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
IL-2R B-O B-NP_NN
beta B-O B-NN
membrane B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
cultured B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-DT
absence B-O B-NN
of B-O B-IN
DM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
) B-O B-S_NP_NP_RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Inhibition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
membrane B-O B-NP_NN
IL-2R B-O B-NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
and B-O B-CC
IL-2R B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
10(-6) B-O B-NP_ADJP_CD
M B-O B-NN
" " B-O O-ADJP
DM B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
partially B-O B-ADJP_RB
reversible B-O B-JJ
by B-O B-PP_IN
recombinant B-O B-NP_NP_JJ
human B-O B-JJ
IL-2 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
rhIL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
Northern B-O B-NP_JJ
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
DM B-O B-NP_NN
" " B-O O-NP
caused B-O B-VP_VBD
a B-O B-NP_NP_DT
comparable B-O B-JJ
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_PP_PP_IN
IL-2R B-O B-NP_NN
alpha B-O B-NN
" " B-O B-NP_O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
IL-2R B-O B-NP_NN
beta B-O B-NN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-PP
mRNA B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-PP_TO
membrane B-O B-NP_NP_NN
receptor B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
mitogen-stimulated B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
transcription B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
DM B-O B-NP_NN
" " B-O O-NP
regulated B-O B-VP_VBD
IL-2R B-O B-NP_NP_NN
alpha B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
a B-O B-NP_DT
transcriptional B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
while B-O B-SBAR_IN
transcription B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL-2R B-O B-NP_NN
beta B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
unaffected B-O B-VP_VBN
by B-O B-NP_PP_IN
DM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
action B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
DM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
IL-2R B-O B-NP_NN
alpha B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
by B-O B-NP_PP_IN
determining B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
10(-6) B-O B-S_NP_ADJP_CD
M B-O B-NN
" " B-O O-ADJP
DM B-O B-NN
" " B-O O-NP
increased B-O B-VP_VBD
T B-O B-NP_NN
cell B-O B-NN
p50 B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
mRNA B-O B-NN
levels B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
four-fold B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
" " B-O B-NP_NP_VP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
binding B-O B-S_NP_VP_VBG
to B-O B-PP_TO
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
DM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
sum B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
DM B-O B-NP_NN
" " B-O O-NP
regulates B-O B-VP_VBZ
T B-O B-NP_NP_NN
cell B-O B-NN
membrane B-O B-NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2R B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
more B-O B-NP_QP_JJR
than B-O B-IN
one B-O B-CD
" " B-O O-QP
molecular B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Stimulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NP_NN
replication B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_JJ
phagocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
leukemia B-O B-NP_NN
inhibitory B-O B-JJ
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
This B-O B-S_S_NP_DT
study B-O B-NN
" " B-O O-NP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
leukemia B-O B-NP_NP_NN
inhibitory B-O B-JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
LIF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
human B-O B-NP_NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
replication B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_NP_JJ
phagocytes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
LIF B-O B-S_NP_NN
" " B-O O-NP
induced B-O B-VP_VBD
a B-O B-NP_NP_DT
dose-dependent B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
p24 B-O B-NP_NP_NN
antigen B-O B-NN
production B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
chronically B-O B-RB
infected B-O B-JJ
promonocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
U1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_DT
magnitude B-O B-NN
" " B-O O-NP
and B-O B-CC
time B-O B-NP_NN
kinetics B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
LIF B-O B-NN
effects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
similar B-O B-ADJP_JJ
to B-O B-PP_TO
interleukin B-O B-NP_NP_NP_NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
IL-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
IL-6 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TNF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
other B-O B-NP_NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
characterize B-O B-VP_VB
mechanisms B-O B-NP_NP_NNS
" " B-O O-NP
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
these B-O B-NP_DT
LIF B-O B-NN
effects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
levels B-O B-S_NP_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
protein B-O B-NN
nuclear B-O B-JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF B-O B-NN
) B-O B-RRB
-kB B-O B-NN
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
signal B-O B-NP_NN
transduction B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
potential B-O B-NP_NP_JJ
interactions B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
other B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
analyzed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
LIF B-O B-S_NP_NN
" " B-O O-NP
increased B-O B-VP_VBD
steady-state B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
at B-O B-PP_IN
2.0 B-O B-NP_NP_CD
" " B-O B-NP_O-NP
, B-O B-COMMA
4.3 B-O B-NP_CD
" " B-O B-NP_O-NP
, B-O B-COMMA
and B-O B-CC
9.2 B-O B-NP_CD
" " B-O B-NP_O-NP
kB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
was B-O B-VP_VP_VBD
detectable B-O B-ADJP_JJ
by B-O B-PP_IN
24 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
persisted B-O B-VP_VBD
until B-O B-PP_IN
72 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
DNA B-O B-NN
binding B-O B-NN
protein B-O B-NN
NF-kB B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
central B-O B-JJ
mediator B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cytokine B-O B-NP_NP_NN
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-kB B-O B-S_NP_NN
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
higher B-O B-ADJP_JJR
in B-O B-PP_IN
unstimulated B-O B-NP_JJ
U1 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
as B-O B-SBAR_IN
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
parent B-O B-NP_NP_NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
U937 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
both B-O B-NP_DT
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
LIF B-O B-NP_NN
" " B-O O-NP
increased B-O B-VP_VBD
NF-kB B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Induction B-O B-S_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kB B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
HIV B-O B-NP_NP_NN
replication B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
cytokines B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
at B-O B-PP_ADVP_IN
least B-O B-JJS
" " B-O O-ADVP
in B-O B-IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
reactive B-O B-NP_JJ
oxygen B-O B-NN
intermediates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
oxygen B-O B-NN
radical B-O B-JJ
scavenger B-O B-NN
N-acetyl-L-cysteine B-O B-NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nitric B-O B-NP_JJ
oxide B-O B-NN
synthase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
inhibited B-O B-VP_VBD
LIF-induced B-O B-NP_JJ
HIV B-O B-NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LIF B-O B-S_S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
the B-O B-NP_NP_DT
production B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
but B-O B-CC
its B-O B-S_NP_NP_PRPP
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
HIV B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
inhibited B-O B-VP_VBN
by B-O B-NP_PP_IN
antibodies B-O B-NP_NP_NNS
" " B-O O-NP
to B-O B-PP_TO
IL-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
TNF B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
IL-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
identify B-O B-VP_VBP
LIF B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
stimulus B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-PRN_LRB
ABSTRACT B-O B-NP_NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
Human B-O B-S_S_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
Tat B-O B-NN
" " B-O O-NP
upregulates B-O B-VP_VBZ
interleukin-2 B-O B-NP_NP_NN
secretion B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Dysregulation B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cytokines B-O B-NP_NP_NNS
" " B-O O-NP
secreted B-O B-VP_VBN
by B-O B-NP_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
play B-O B-VP_VB
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
pathogenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AIDS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
investigate B-O B-VP_VB
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
( B-O B-LRB
HIV-1 B-O B-NN
) B-O B-RRB
Tat B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
interleukin-2 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
used B-O B-VP_VBD
IL-2 B-O B-NP_NP_NN
promoter-chloramphenicol B-O B-JJ
acetyltransferase B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
and B-O B-CC
IL-2-secreting B-O B-NP_JJ
Jurkat B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_DT
model B-O B-NN
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Transient B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV-1 B-O B-NP_NN
Tat B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induced B-O B-VP_VBD
a B-O B-NP_NP_DT
five- B-O B-ADJP_CD
to B-O B-TO
eightfold B-O B-JJ
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-2 B-O B-S_NP_NN
secretion B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
increased B-O B-VP_VBN
more B-O B-NP_NP_JJR
than B-O B-IN
twofold B-O B-RB
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_NP_CC
Jurkat B-O B-NP_NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
primary B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
stimulated B-O B-VP_VBN
by B-O B-NP_PP_IN
extracellular B-O B-NP_JJ
HIV-1 B-O B-NN
Tat B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
mRNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
Tat B-O B-S_NP_NN
" " B-O O-NP
exerts B-O B-VP_VBZ
its B-O B-NP_NP_PRPP
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
primarily B-O B-ADVP_RB
" " B-O O-ADVP
at B-O B-PP_IN
the B-O B-NP_DT
transcriptional B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
NF-kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
positions B-O B-NP_NP_NP_NNS
" " B-O O-NP
-206 B-O B-NP_CD
to B-O B-TO
-195 B-O B-CD
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
required B-O B-UCP_VP_VBN
" " B-O B-NP_O-VP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
sufficient B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_DT
Tat B-O B-NN
effect B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
Tat-mediated B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
IL-2 B-O B-NP_NN
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
selectively B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
blocked B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
antisense B-O B-NP_JJ
tat B-O B-NN
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
- B-O B-COLON
unlike B-O B-PP_IN
the B-O B-NP_NP_DT
analogous B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
T-cell B-O B-NN
lymphotropic B-O B-JJ
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
Tax B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
- B-O B-COLON
by B-O B-PP_IN
cyclosporin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
observed B-O B-VBN
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
IL-2 B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
might B-O B-VP_MD
facilitate B-O B-VP_VB
virus B-O B-NP_NP_NN
spread B-O B-VBN
" " B-O O-NP
from B-O B-PP_PP_IN
" " B-O B-NP_O-PP
or B-O B-CC
to B-O B-PP_TO
" " B-O B-NP_O-PP
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
might B-O B-VP_MD
contribute B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_NP_DT
hypergammaglobulinemia B-O B-NN
" " B-O O-NP
or B-O B-CC
, B-O B-COMMA
together B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
other B-O B-NP_NP_JJ
cytokines B-O B-NNS
" " B-O O-NP
found B-O B-VP_VBN
" " B-O B-S_NP_VP_O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
T-helper B-O B-NN
cell B-O B-NN
dysfunctions B-O B-NNS
" " B-O O-NP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
AIDS B-O B-NP_NN
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-NP_NP_DT
impaired B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
AP-1 B-O B-NN
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
subjects B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
some B-O B-NP_NP_DT
symptoms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
study B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
disorders B-O B-NNS
" " B-O O-NP
known B-O B-VP_VBN
as B-O B-NP_PP_IN
premature B-O B-NP_JJ
aging B-O B-NN
syndromes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
provide B-O B-VP_VB
insight B-O B-NP_NP_NN
" " B-O O-NP
into B-O B-PP_IN
the B-O B-NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cellular B-O B-NP_JJ
senescence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
main B-O B-JJ
feature B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cellular B-O B-NP_NP_JJ
senescence B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
cessation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Down B-O B-S_NP_NP_NP_NN
syndrome B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
DS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
neuronal B-O B-NP_NP_JJ
ceroid-lypofuscinosis B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NCL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
clinically B-O B-VP_ADVP_RB
" " B-O O-ADVP
characterized B-O B-VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
premature B-O B-JJ
onset B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
numerous B-O B-NP_NP_JJ
features B-O B-NNS
" " B-O O-NP
normally B-O B-VP_ADVP_RB
" " B-O O-ADVP
associated B-O B-VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Phytohemagglutinin B-O B-S_NP_NP_ADJP_NP_NN
" " B-O O-NP
stimulated B-O B-JJ
" " B-O O-ADJP
lymphocytes B-O B-NNS
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
DS B-O B-NP_NN
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
showed B-O B-VP_VBD
a B-O B-NP_DT
statistically B-O B-ADJP_RB
significant B-O B-JJ
" " B-O O-ADJP
diminished B-O B-VBN
proliferation B-O B-NN
capacity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
comparison B-O B-NN
with B-O B-IN
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
NCL B-O B-NP_UCP_NP_NN
" " B-O O-NP
and B-O B-CC
healthy B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-UCP
individuals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrated B-O B-VP_VBD
, B-O B-COMMA
by B-O B-PP_IN
applying B-O B-S_NP_VP_VBG
the B-O B-NP_DT
electrophoretic B-O B-JJ
mobility B-O B-NN
shift B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
slightly B-O B-NP_NP_NP_ADJP_RB
impaired B-O B-JJ
" " B-O O-ADJP
AP-1 B-O B-NN
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
NCL B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
strong B-O B-NP_ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
DS B-O B-NP_NN
ones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
same B-O B-JJ
molecular B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
proliferation B-O B-NP_NN
cessation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
exist B-O B-VP_VB
in B-O B-PP_PP_IN
" " B-O B-NP_NP_VP_O-PP
and B-O B-CC
in B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Visualization B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
endogenous B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
p50 B-O B-NN
subunit B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
nucleus B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
follicular B-O B-NP_JJ
dendritic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
germinal B-O B-NP_JJ
centers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
NF-kappa B-O B-S_NP_NP_NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
50 B-O B-ADJP_ADJP_CD
kDa/65 B-O B-CD
kDa B-O B-NN
" " B-O O-ADJP
( B-O B-PRN_LRB
p50/p65 B-O B-ADJP_NN
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
heterodimer B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
ubiquitous B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
positive B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
various B-O B-NP_JJ
immune B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
aim B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
related B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
in B-O B-NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
sections B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
non B-O B-NP_ADJP_JJ
HIV B-O B-NN
" " B-O O-ADJP
hyperplastic B-O B-JJ
lymph B-O B-NN
nodes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
gene B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
105 B-O B-ADJP_CD
kDa B-O B-NN
" " B-O O-ADJP
precursor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
overexpressed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
light B-O B-JJ
zone B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_IN
a B-O B-NP_NP_DT
network B-O B-NN
aspect B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
immunohistochemistry B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
p50 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
cytoplasm B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
nucleus B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
FDC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-PP_COMMA
confirming B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
FDC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
p50 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
all B-O B-NP_DT
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
focused B-O B-VP_VBD
our B-O B-NP_PRPP
study B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
isolated B-O B-NP_NP_VBN
FDC B-O B-NN
clusters B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
normal B-O B-NP_JJ
tonsils B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
As B-O B-S_SBAR_IN
showed B-O B-S_NP_VP_VBN
on B-O B-NP_PP_IN
tissue B-O B-NP_NN
sections B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
detected B-O B-VP_VBD
the B-O B-NP_DT
p50 B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_NP_CC
cytoplasm B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
nucleus B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
FDC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclei B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
lymphocytes B-O B-NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
FDC B-O B-NP_NN
clusters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
negative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
next B-O B-ADVP_RB
" " B-O O-ADVP
studied B-O B-VP_VBD
p65 B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-Rel B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
FDC B-O B-NP_NN
clusters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
p65 B-O B-S_S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
FDC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
nuclei B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
negative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
p65 B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
nuclei B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
some B-O B-NP_DT
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
c-Rel B-O B-S_NP_NN
protein B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
only B-O B-NP_PP_PP_RB
in B-O B-IN
the B-O B-NP_NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
not B-O B-PP_RB
in B-O B-IN
the B-O B-NP_NP_DT
nucleus B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
cytoplasm B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
FDC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
, B-O B-COMMA
in B-O B-S_S_PP_IN
the B-O B-DT
context B-O B-NN
of B-O B-IN
T B-O B-NP_NP_ADJP_NN
cell-dependent B-O B-JJ
" " B-O O-ADJP
B B-O B-NN
cell B-O B-NN
immunopoiesis B-O B-NN
" " B-O O-NP
occurring B-O B-VP_VBG
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
p50 B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
mainly B-O B-ADVP_RB
" " B-O O-ADVP
related B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
p65 B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
c-Rel B-O B-S_NP_NN
protein B-O B-NN
" " B-O O-NP
exclusively B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
the B-O B-NP_NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-S
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_NP_DT
two B-O B-CD
subunits B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
c-Rel B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
different B-O B-NP_JJ
roles B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
different B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
B B-O B-NP_NN
cell B-O B-NN
immunopoiesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Involvement B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factor B-O B-NN
YB-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
T-cell B-O B-NN
lymphotropic B-O B-JJ
virus B-O B-NN
type B-O B-NN
I B-O B-CD
basal B-O B-JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Sequences B-O B-S_NP_NP_NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
control B-O B-S_NP_VP_VBP
basal B-O B-NP_JJ
human B-O B-NP_NP_JJ
T-cell B-O B-NN
lymphotropic B-O B-NN
virus B-O B-NN
type B-O B-NN
I B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-I B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
likely B-O B-ADVP_RB
" " B-O O-ADVP
play B-O B-VP_VB
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
initiation B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
maintenance B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
virus B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
previously B-O B-ADVP_RB
" " B-O O-ADVP
identified B-O B-VP_VP_VP_VBD
" " B-O B-NP_O-VP
and B-O B-CC
analyzed B-O B-VP_VBD
" " B-O B-NP_O-VP
" " B-O O-VP
a B-O B-NP_NP_NP_NP_DT
45-nucleotide B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
downstream B-O B-NP_NP_JJ
regulatory B-O B-JJ
element B-O B-NN
1 B-O B-CD
" " B-O O-NP
[ B-O B-PRN_LRB
DRE B-O B-NP_NN
1 B-O B-CD
" " B-O O-NP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
+195 B-O B-NP_NP_CD
" " B-O O-NP
to B-O B-TO
+240 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
at B-O B-PP_IN
the B-O B-NP_NP_DT
boundary B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
R/U5 B-O B-NN
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
identified B-O B-VP_VBD
a B-O B-NP_NP_NP_DT
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
p37 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
specifically B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
bound B-O B-VP_VBD
to B-O B-PP_TO
DRE B-O B-NP_NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_DT
affinity B-O B-NN
column B-O B-NN
fraction B-O B-NN
" " B-O O-NP
, B-O B-COMMA
containing B-O B-VP_VBG
p37 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
stimulated B-O B-VP_VBD
HTLV-I B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
approximately B-O B-ADVP_RB
12-fold B-O B-RB
" " B-O O-ADVP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
now B-O B-ADVP_RB
" " B-O O-ADVP
report B-O B-VP_VBP
the B-O B-NP_NP_DT
identification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_NP_DT
cDNA B-O B-NN
clone B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
15B-7 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
from B-O B-PP_IN
a B-O B-NP_DT
Jurkat B-O B-NN
expression B-O B-NN
library B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
specifically B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cDNA B-O B-NN
fusion B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
similarly B-O B-PP_ADVP_RB
" " B-O O-ADVP
to B-O B-TO
the B-O B-NP_NP_DT
results B-O B-NNS
" " B-O O-NP
obtained B-O B-VP_VBN
with B-O B-NP_PP_IN
purified B-O B-NP_VBN
Jurkat B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
decreased B-O B-VP_VBN
by B-O B-NP_PP_IN
introduction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
site-specific B-O B-NP_JJ
mutations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
DRE B-O B-NN
1 B-O B-CD
regulatory B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
transcription B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
translation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
15B-7 B-O B-NP_NN
cDNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
produced B-O B-VP_VBD
a B-O B-NP_NP_DT
fusion B-O B-NN
protein B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bound B-O B-S_NP_VP_VBD
specifically B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
the B-O B-NP_DT
HTLV-I B-O B-NN
to B-O B-NP_NP_TO
oligonucleotide B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
partial B-O B-JJ
cDNA B-O B-NN
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_NP_DT
protein B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
homologous B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cotransfection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
YB-1 B-O B-NN
expression B-O B-NN
plasmid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increases B-O B-VP_VBZ
HTLV-I B-O B-NP_NN
basal B-O B-JJ
transcription B-O B-NN
" " B-O O-NP
approximately B-O B-ADVP_RB
14-fold B-O B-RB
" " B-O O-ADVP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-DT
basis B-O B-NN
of B-O B-IN
the B-O B-NP_NP_DT
molecular B-O B-JJ
weight B-O B-NN
" " B-O O-NP
, B-O B-COMMA
DNA-binding B-O B-NP_JJ
characteristics B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
in B-O B-NP_ADJP_FW
vivo B-O B-FW
" " B-O O-ADJP
transactivation B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
previously B-O B-ADJP_RB
identified B-O B-VBN
" " B-O O-ADJP
DRE B-O B-ADJP_NN
1-binding B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
p37 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
YB-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Chlorinated B-O B-NP_NP_NP_VBN
dibenzo-p-dioxins B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
dibenzofurans B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
human B-O B-JJ
immune B-O B-JJ
system B-O B-NN
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
1 B-O B-NP_LST_LS
. B-O B-PERIOD
" " B-O O-LST
Blood B-O B-NP_NN
cell B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
volunteers B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
moderately B-O B-NP_ADJP_RB
increased B-O B-VBN
" " B-O O-ADJP
body B-O B-NN
burdens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Using B-O B-S_S_NP_VP_VBG
monoclonal B-O B-NP_NP_NP_JJ
antibodies B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
mAbs B-O B-NP_NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
flow B-O B-NP_NN
cytometry B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
surface B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
on B-O B-PP_IN
lymphocyte B-O B-NP_NP_NN
subpopulations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
workers B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
body B-O B-NP_NP_ADJP_NN
burdens B-O B-NNS
" " B-O O-NP
and B-O B-PP_PP_CC
, B-O B-PP_COMMA
expressed B-O B-VP_VBN
" " B-O B-NP_ADVP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
hypothesis B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
be B-O B-VP_VB
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
was B-O B-VP_VBD
whether B-O B-SBAR_IN
or B-O B-CC
not B-O B-RB
humans B-O B-S_NP_NNS
" " B-O O-NP
exhibit B-O B-VP_VBP
a B-O B-NP_NP_DT
similar B-O B-JJ
susceptibility B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
PCDDs/PCDFs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
with B-O B-PP_IN
respect B-O B-NN
to B-O B-TO
the B-O B-NP_NP_DT
surface B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
found B-O B-VP_VBN
previously B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O B-S_NP_VP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
" " B-O O-NP
are B-O B-VP_VBP
: B-O B-COLON
helper-inducer B-O B-NP_NP_NP_NP_NP_JJ
" " B-O O-NP
( B-O B-PRN_LRB
memory B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
CD4+CD45R0+CD45RA-CD29highCD11a+ B-O B-NP_JJ
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
CD20+ B-O B-NP_JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
cytotoxic B-O B-NP_NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
CD8+CD56+/CD57+ B-O B-NP_JJ
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
68 B-O B-NP_NP_CD
triple-labellings B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
mAbs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
performed B-O B-VP_VBN
on B-O B-NP_PP_IN
the B-O B-NP_NP_DT
cells B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
each B-O B-NP_DT
volunteer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
possibly B-O B-VP_ADVP_RB
" " B-O O-ADVP
generate B-O B-VB
further B-O B-NP_JJ
hypotheses B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
evaluated B-O B-VP_VBN
whether B-O B-SBAR_IN
any B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
variables B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
used B-O B-VP_VBN
as B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_NP_EX
" " B-O O-NP
were B-O B-VP_VBD
two B-O B-NP_NP_CD
main B-O B-JJ
goals B-O B-NNS
" " B-O O-NP
: B-O B-COLON
( B-O B-S_S_LST_LRB
1 B-O B-LS
) B-O B-RRB
" " B-O O-LST
to B-O B-NP_VP_TO
evaluate B-O B-VP_VB
whether B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
( B-O B-S_LST_LRB
2 B-O B-LS
) B-O B-RRB
" " B-O O-LST
to B-O B-NP_VP_TO
clarify B-O B-VP_VB
whether B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Regression B-O B-S_NP_NP_NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
our B-O B-NP_PRPP
data B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
slight B-O B-NP_NP_JJ
trends B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
some B-O B-NP_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
biomarkers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
e.g. B-O B-NP_ADVP_FW
" " B-O O-ADVP
CD45R0+ B-O B-JJ
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
With B-O B-S_PP_IN
one B-O B-NP_CD
exception B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
these B-O B-NP_DT
" " B-O O-NP
were B-O B-VP_VBD
all B-O B-ADVP_DT
" " B-O O-ADVP
increases B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
" " B-O B-S_NP_NP_NN_O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
alterations B-O B-NNS
" " B-O O-NP
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
of B-O B-PP_IN
medical B-O B-NP_JJ
relevance B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
slight B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
percentage B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD4+CD45R0+ B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remained B-O B-VP_VBD
significant B-O B-ADJP_JJ
" " B-O O-ADJP
even B-O B-PP_RB
after B-O B-IN
covariant B-O B-NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
taking B-O B-VP_VBG
age-related B-O B-NP_JJ
changes B-O B-NNS
" " B-O O-NP
into B-O B-PP_IN
account B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Altogether B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
data B-O B-NNS
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
provide B-O B-VP_VB
any B-O B-NP_NP_DT
evidence B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
support B-O B-VP_VB
an B-O B-NP_DT
assumption B-O B-NN
" " B-O B-SBAR_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Adult B-O B-S_NP_JJ
humans B-O B-NNS
" " B-O O-NP
certainly B-O B-ADVP_RB
" " B-O O-ADVP
are B-O B-VP_VBP
less B-O B-ADJP_ADJP_RBR
susceptible B-O B-JJ
to B-O B-PP_TO
this B-O B-NP_NP_DT
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PCDDs/PCDFs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
than B-O B-PP_IN
adolescent B-O B-NP_JJ
Callithrix B-O B-FW
jacchus B-O B-FW
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transient B-O B-NP_NP_JJ
pseudohypoaldosteronism B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
obstructive B-O B-NP_JJ
renal B-O B-JJ
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
transient B-O B-NP_NP_JJ
reduction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphocytic B-O B-NP_JJ
aldosterone B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Results B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
two B-O B-NP_CD
affected B-O B-JJ
infants B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
two B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
transient B-O B-NP_NP_JJ
pseudohypoaldosteronism B-O B-NN
" " B-O O-NP
due B-O B-PP_JJ
to B-O B-TO
obstructive B-O B-NP_JJ
renal B-O B-JJ
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_DT
patients B-O B-NNS
" " B-O O-NP
presented B-O B-VP_VBD
with B-O B-PP_IN
a B-O B-NP_DT
salt-losing B-O B-JJ
episode B-O B-NN
simulating B-O B-VBG
adrenal B-O B-JJ
insufficiency B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
one B-O B-NP_CD
patient B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
transient B-O B-NP_NP_JJ
reduction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
aldosterone B-O B-NP_NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
documented B-O B-VP_VBN
, B-O B-NP_COMMA
while B-O B-SBAR_IN
in B-O B-S_PP_IN
the B-O B-NP_DT
second B-O B-JJ
patient B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
clinical B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
biochemical B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
parameters B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Aldosterone B-O B-S_NP_NN
receptors B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
normal B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
both B-O B-NP_DT
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
when B-O B-SBAR_WHADVP_IN
" " B-O O-WHADVP
studied B-O B-S_NP_VP_VBN
after B-O B-NP_PP_IN
the B-O B-NP_NP_DT
surgical B-O B-JJ
correction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
obstruction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_DT
macrophage B-O B-NN
transcription B-O B-NN
factor B-O B-NN
PU.1 B-O B-NN
" " B-O O-NP
directs B-O B-VP_VBZ
tissue-specific B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
macrophage B-O B-NN
colony-stimulating B-O B-JJ
factor B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
macrophage B-O B-NP_NP_NN
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
M-CSF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
receptor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_DT
tissue-specific B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
two B-O B-NP_NP_CD
distinct B-O B-JJ
promoters B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
monocytes/macrophages B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
placenta B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-TO
further B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
understand B-O B-VP_VB
the B-O B-NP_NP_DT
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
play B-O B-S_NP_VP_VBP
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
initiated B-O B-VP_VBN
an B-O B-NP_NP_DT
investigation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
factors B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
activate B-O B-S_NP_VP_VBP
" " B-O B-NP_ADVP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
human B-O B-JJ
monocytic B-O B-JJ
M-CSF B-O B-NN
receptor B-O B-NN
promoter B-O B-NN
" " B-O O-NP
directs B-O B-VP_VBZ
reporter B-O B-NP_NN
gene B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
tissue-specific B-O B-JJ
fashion B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
one B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
few B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
have B-O B-S_NP_VP_VBP
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_DT
macrophage- B-O B-ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
B-cell-specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
PU.1 B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
whether B-O B-SBAR_IN
PU.1 B-O B-S_NP_NN
" " B-O O-NP
binds B-O B-VP_VP_VP_VBZ
" " B-O B-NP_O-VP
and B-O B-CC
activates B-O B-VP_VBZ
" " B-O B-NP_O-VP
" " B-O O-VP
the B-O B-NP_DT
M-CSF B-O B-NN
receptor B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
both B-O B-S_NP_CC
in B-O B-NP_ADJP_FW
vitro-translated B-O B-VBN
" " B-O O-ADJP
PU.1 B-O B-NN
" " B-O O-NP
and B-O B-CC
PU.1 B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
bind B-O B-VP_VBP
to B-O B-PP_TO
a B-O B-NP_NP_DT
specific B-O B-JJ
site B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
M-CSF B-O B-NN
receptor B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
just B-O B-ADVP_RB
upstream B-O B-JJ
from B-O B-PP_IN
" " B-O B-NP_O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutations B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
eliminate B-O B-S_NP_VP_VB
PU.1 B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
decrease B-O B-VP_VBP
M-CSF B-O B-NP_NN
receptor B-O B-NN
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
significantly B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
macrophage B-O B-NP_NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
only B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
PU.1 B-O B-NP_NN
" " B-O O-NP
transactivates B-O B-VP_VBZ
the B-O B-NP_NP_DT
M-CSF B-O B-NN
receptor B-O B-NN
promoter B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
nonmacrophage B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
PU.1 B-O B-S_NP_NN
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
major B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
macrophage B-O B-NP_NN
gene B-O B-NN
regulation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
development B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
directing B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Steroid-resistant B-O B-NP_JJ
asthma B-O B-NN
. B-O B-PERIOD
" " B-O O-NP
  
Cellular B-O B-NP_NP_JJ
mechanisms B-O B-NNS
" " B-O O-NP
contributing B-O B-VP_VBG
to B-O B-PP_TO
inadequate B-O B-NP_NP_JJ
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
glucocorticoid B-O B-NP_NN
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
current B-O B-JJ
study B-O B-NN
" " B-O O-NP
examined B-O B-VP_VBD
whether B-O B-SBAR_IN
alterations B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contribute B-O B-VP_VBP
to B-O B-PP_TO
poor B-O B-NP_NP_JJ
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
29 B-O B-S_NP_NP_CD
asthma B-O B-NN
patients B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
forced B-O B-NP_NP_NP_NP_NP_VBN
expiratory B-O B-JJ
volume B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
1 B-O B-NP_CD
s B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
FEV1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
< B-O B-NP_QP_JJR
70 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
" " B-O O-NP
predicted B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Patients B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
classified B-O B-VP_VP_VBN
as B-O B-NP_PP_IN
steroid B-O B-ADJP_ADJP_NN
sensitive B-O B-JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
SS B-O B-ADJP_JJ
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
" " B-O O-PP
if B-O B-SBAR_IN
their B-O B-S_NP_PRPP
morning B-O B-NN
FEV1 B-O B-NN
" " B-O O-NP
increased B-O B-VP_VBD
> B-O B-NP_QP_RBR
30 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
steroid B-O B-VP_ADJP_ADJP_NN
resistant B-O B-JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
SR B-O B-ADJP_JJ
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
if B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PBMC B-O B-S_NP_NP_NN
" " B-O O-NP
obtained B-O B-VP_VBN
from B-O B-NP_PP_IN
these B-O B-NP_NP_NP_DT
two B-O B-CD
groups B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
17 B-O B-NP_NP_CD
SR B-O B-JJ
" " B-O O-NP
and B-O B-CC
12 B-O B-NP_CD
SS B-O B-JJ
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
12 B-O B-NP_CD
normal B-O B-JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
analyzed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
SR B-O B-S_S_NP_JJ
patients B-O B-NNS
" " B-O O-NP
had B-O B-VP_VBD
two B-O B-NP_CD
distinguishable B-O B-JJ
GR B-O B-NN
binding B-O B-NN
abnormalities B-O B-NNS
" " B-O O-NP
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
15 B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
17 B-O B-CD
SR B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
a B-O B-NP_DT
significantly B-O B-ADJP_RB
reduced B-O B-VBN
" " B-O O-ADJP
GR B-O B-NN
binding B-O B-NN
affinity B-O B-NN
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_IN
compared B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
and B-O B-NP_NP_NP_PRN_CC
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
defect B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VBD
localized B-O B-VP_JJ
to B-O B-NP_PP_TO
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
reverted B-O B-VP_VBD
to B-O B-PP_TO
normal B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
48 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
culture B-O B-NP_NN
media B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
incubation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
sustained B-O B-VP_VBD
this B-O B-NP_DT
abnormality B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
other B-O B-JJ
two B-O B-CD
SR B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
had B-O B-VP_VBD
an B-O B-NP_NP_DT
abnormally B-O B-ADJP_RB
low B-O B-JJ
" " B-O O-ADJP
GR B-O B-NN
number B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
normal B-O B-NP_NP_JJ
binding B-O B-NN
affinity B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
not B-O B-RB
limited B-O B-ADJP_VBN
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
GR B-O B-NP_NN
number B-O B-NN
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
normalize B-O B-VP_VB
after B-O B-PP_IN
incubation B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Therefore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
SR B-O B-NP_JJ
asthma B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
due B-O B-PP_JJ
to B-O B-TO
more B-O B-NP_NP_QP_JJR
than B-O B-IN
one B-O B-CD
" " B-O O-QP
abnormality B-O B-NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_NP_DT
majority B-O B-NN
" " B-O O-NP
related B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
second B-O B-JJ
" " B-O O-NP
related B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
have B-O B-VP_VB
important B-O B-NP_JJ
implications B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
design B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
alternative B-O B-NP_NP_JJ
treatment B-O B-NN
approaches B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
recalcitrant B-O B-NP_JJ
asthma B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Rhabdomyosarcomas B-O B-S_NP_NNS
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
contain B-O B-VP_VB
mutations B-O B-NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
domains B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
myogenic B-O B-NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Skeletal B-O B-S_NP_JJ
myogenesis B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
group B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
after B-O B-S_PP_IN
a B-O B-NP_NP_DT
mutation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Leu122 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
Arg B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
basic B-O B-JJ
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
MyoD B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
confers B-O B-VP_VBZ
c-myc-like B-O B-NP_JJ
functional B-O B-JJ
characteristics B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
used B-O B-VP_VBD
single-strand B-O B-NP_JJ
conformation B-O B-NN
polymorphism B-O B-NN
analysis B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
such B-O B-S_NP_JJ
mutations B-O B-NNS
" " B-O O-NP
occur B-O B-VP_VBP
naturally B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
found B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
basic B-O B-JJ
domains B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
all B-O B-NP_PDT
the B-O B-DT
myogenic B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remain B-O B-VP_VBP
unaltered B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
rhabdomyosarcomas B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Selection B-O B-S_NP_NP_NN
" " B-O O-NP
against B-O B-PP_IN
such B-O B-NP_JJ
mutations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
the B-O B-NP_NP_DT
result B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
functional B-O B-NP_NP_JJ
redundancy B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
myogenic B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Increased B-O B-NP_NP_VBN
proliferation B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
cytotoxicity B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
after B-O B-PP_IN
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
a B-O B-NP_NP_DT
surface B-O B-NN
ganglioside B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GD3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
[ B-O B-PRN_LRB
published B-O B-S_NP_VBN
erratum B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
in B-O B-PP_IN
J B-O B-NP_NP_NNP
Immunol B-O B-NNP
" " B-O O-NP
1994 B-O B-NP_CD
Jul B-O B-NNP
15 B-O B-CD
" " B-O O-NP
; B-O B-COLON
153 B-O B-NP_CD
( B-O B-LRB
2 B-O B-CD
) B-O B-RRB
" " B-O O-NP
: B-O B-COLON
910 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
  
Previous B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
suggested B-O B-VP_VBN
that B-O B-SBAR_IN
gangliosides B-O B-S_NP_NNS
" " B-O O-NP
have B-O B-VP_VBP
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
cell B-O B-NP_NN
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
their B-O B-NP_NP_PRPP
specific B-O B-JJ
function B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
processes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
not B-O B-RB
been B-O B-VP_VBN
clearly B-O B-ADVP_RB
" " B-O O-ADVP
defined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_NP_DT
mAb B-O B-NN
" " B-O O-NP
, B-O B-COMMA
R24 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
reacts B-O B-S_NP_VP_VBZ
specifically B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
a B-O B-NP_NP_DT
cell B-O B-NN
surface B-O B-NN
ganglioside B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GD3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
demonstrated B-O B-VP_VBN
to B-O B-S_NP_VP_TO
stimulate B-O B-VP_VB
proliferation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
the B-O B-NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
the B-O B-S_NP_DT
R24 B-O B-NN
mAb B-O B-NN
" " B-O O-NP
affects B-O B-VP_VBZ
T B-O B-NP_NN
cell B-O B-NN
functions B-O B-NNS
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
observed B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
R24 B-O B-NN
mAb B-O B-NN
" " B-O O-NP
stimulates B-O B-VP_VBZ
GD3+ B-O B-NP_NP_JJ
T B-O B-NN
cell B-O B-NN
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Additionally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
IFN-gamma B-O B-NP_NP_NN
activity B-O B-NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
IL-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
IL-2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
IL-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
present B-O B-ADJP_JJ
in B-O B-PP_IN
culture B-O B-NP_NN
supernatants B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
72 B-O B-PP_NP_CD
h B-O B-NN
" " B-O O-NP
after B-O B-IN
R24 B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
some B-O B-NP_DT
donors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
increased B-O B-NP_VBN
IL-6 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
TNF-alpha B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
was B-O B-VP_VBD
detected B-O B-VP_VBN
after B-O B-NP_PP_IN
R24 B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
R24 B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
translocation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-rel B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CC
or B-O B-NP_ADJP_ADJP_CC
NF B-O B-ADJP_NN
kappa B-O B-NN
B B-O B-NN
or B-O B-NP_NP_CC
" " B-O B-NP_O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
the B-O B-NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF B-O B-NP_NP_ADJP_NN
kappa B-O B-NN
B B-O B-NN
binding B-O B-NN
" " B-O O-ADJP
complexes B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VBG
and B-O B-NP_NP_CC
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
treatment B-O B-NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
caused B-O B-VP_VBD
increased B-O B-NP_NP_VBN
tyrosine B-O B-NN
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_JJ
protein B-O B-NN
substrates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
R24-stimulated B-O B-S_NP_NP_JJ
increases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
proliferation B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
cytotoxicity B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
cell B-O B-NP_NN
surface B-O B-NN
protein B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
cyclosporin B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
staurosporin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
and B-O B-S_NP_NP_CC
may B-O B-NP_VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Additionally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
herbimycin B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
tyrosine B-O B-NN
kinase B-O B-NN
inhibitor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
blocked B-O B-VP_VBD
the B-O B-NP_NP_DT
R24-stimulated B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
proliferation B-O B-NP_NP_NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
cytotoxicity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
at B-O B-PP_IN
concentrations B-O B-NP_NP_NNS
" " B-O O-NP
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
specificity B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
tyrosine B-O B-NP_NN
kinases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
multiple B-O B-S_NP_JJ
biochemical B-O B-JJ
pathways B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
by B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_DT
SCL B-O B-NN
protein B-O B-NN
" " B-O O-NP
displays B-O B-VP_VBZ
cell-specific B-O B-NP_NP_JJ
heterogeneity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
size B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
SCL B-O B-S_NP_NN
protein B-O B-NN
production B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hemopoietic B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
immunoblotting B-O B-NP_NP_VBG
" " B-O O-NP
using B-O B-VP_VBG
specific B-O B-NP_JJ
polyclonal B-O B-JJ
antisera B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
SCL B-O B-S_NP_NN
protein B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
erythroid B-O B-NP_UCP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
megakaryocyte B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
mast B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
early B-O B-ADJP_JJ
myeloid B-O B-JJ
" " B-O O-ADJP
" " B-O O-UCP
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
in B-O B-PP_IN
several B-O B-NP_NP_JJ
lymphoid B-O B-JJ
leukemia B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
most B-O B-NP_JJS
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
proteins B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
molecular B-O B-NP_NP_JJ
weight B-O B-NN
" " B-O O-NP
49 B-O B-NP_QP_CD
and B-O B-CC
44 B-O B-CD
" " B-O O-QP
kDa B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
however B-O B-S_ADVP_RB
" " B-O O-ADVP
two B-O B-NP_CD
myeloid B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VBD
only B-O B-NP_NP_RB
lower B-O B-JJR
molecular B-O B-JJ
weight B-O B-NN
species B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
24 B-O B-NP_QP_CD
and B-O B-CC
22 B-O B-CD
" " B-O O-QP
kDa B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
size B-O B-NN
discrepancy B-O B-NN
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
due B-O B-PP_JJ
to B-O B-TO
cell-specific B-O B-NP_JJ
translational B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
since B-O B-SBAR_IN
overexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
retrovirally B-O B-ADJP_RB
transfected B-O B-VBN
" " B-O O-ADJP
SCL B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
yielded B-O B-VP_VP_VBD
the B-O B-NP_DT
higher B-O B-JJR
molecular B-O B-JJ
weight B-O B-NN
forms B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
most B-O B-NP_NP_JJS
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
only B-O B-VP_NP_RB
the B-O B-DT
22 B-O B-ADJP_CD
kDa B-O B-NN
" " B-O O-ADJP
form B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
myeloid B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
WEHI-3B/D+ B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Overexpression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
full-length B-O B-NP_JJ
SCL B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
lymphoid B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
SupT1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Raji B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
alter B-O B-VP_VB
cell B-O B-NP_NN
phenotype B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
there B-O B-S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_NP_DT
evidence B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
autoregulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
SCL B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
restricted B-O B-JJ
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
SCL B-O B-NP_NN
protein B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_NP_DT
restricted B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
SCL B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
documented B-O B-VP_VBN
previously B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
present B-O B-JJ
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
SCL B-O B-S_NP_NN
protein B-O B-NN
size B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
by B-O B-NP_PP_IN
regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_DT
cell-specific B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
granulocyte-macrophage B-O B-JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
cooperative B-O B-NP_NP_JJ
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Elf-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
granulocyte-macrophage B-O B-NP_NP_JJ
colony-stimulating B-O B-JJ
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GM-CSF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
gene B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
studied B-O B-VP_VBN
extensively B-O B-NP_ADVP_RB
" " B-O O-ADVP
as B-O B-PP_IN
a B-O B-NP_NP_DT
model B-O B-NN
system B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
GM-CSF B-O B-NN
gene B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
not B-O B-RB
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
resting B-O B-NP_VBG
peripheral B-O B-JJ
blood B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
but B-O B-CC
is B-O B-VP_VBZ
rapidly B-O B-VP_ADVP_RB
" " B-O O-ADVP
induced B-O B-VBN
at B-O B-NP_PP_IN
the B-O B-NP_DT
transcriptional B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
following B-O B-PP_VBG
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
the B-O B-NP_DT
cell B-O B-NN
surface B-O B-NN
T-cell B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
highly B-O B-ADJP_RB
conserved B-O B-VBN
" " B-O O-ADJP
19-bp B-O B-JJ
element B-O B-NN
" " B-O O-NP
located B-O B-ADJP_JJ
immediately B-O B-ADVP_RB
5' B-O B-NP_NP_NP_JJ
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
GM-CSF B-O B-NN
TATA B-O B-NN
box B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
bp B-O B-NP_NP_NN
" " B-O O-NP
-34 B-O B-PP_NP_CD
" " B-O O-NP
to B-O B-TO
-52 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-ADVP
" " B-O O-ADJP
, B-O B-COMMA
herein B-O B-VP_ADVP_RB
" " B-O O-ADVP
called B-O B-VBN
purine B-O B-S_NP_NP_NP_NN
box B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
PB1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_VP_TO
bind B-O B-VP_VB
a B-O B-NP_DT
T-cell B-O B-NN
nuclear B-O B-JJ
protein B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
to B-O B-VP_TO
be B-O B-VP_VB
required B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
PB1 B-O B-NN
sequence B-O B-NN
motif B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
highly B-O B-ADJP_RB
conserved B-O B-VBN
" " B-O O-ADJP
in B-O B-PP_IN
both B-O B-NP_ADJP_CC
human B-O B-ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
murine B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
GM-CSF B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
PB1 B-O B-NN
element B-O B-NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
confers B-O B-VP_VBZ
inducibility B-O B-NP_NN
" " B-O O-NP
on B-O B-PP_IN
a B-O B-NP_DT
heterologous B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
following B-O B-PP_VBG
transfection B-O B-NP_NP_NN
" " B-O O-NP
into B-O B-PP_IN
human B-O B-NP_JJ
Jurkat B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
identify B-O B-VP_VBP
a B-O B-NP_NP_DT
major B-O B-JJ
PB1 B-O B-NN
nuclear B-O B-JJ
protein-binding B-O B-JJ
complex B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VP_VBZ
not B-O B-RB
present B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
but B-O B-CC
is B-O B-VP_VBZ
rapidly B-O B-VP_ADVP_RB
" " B-O O-ADVP
induced B-O B-VBN
following B-O B-NP_PP_VBG
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Sequence B-O B-S_NP_NN
analysis B-O B-NN
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
PB1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
adjacent B-O B-NP_NP_JJ
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
mutagenesis B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
both B-O B-S_NP_CC
the B-O B-DT
Ets B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
AP-1 B-O B-NP_NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
required B-O B-VP_VBN
for B-O B-NP_PP_PP_PP_IN
and B-O B-NP_CC
for B-O B-PP_IN
" " B-O B-NP_O-PP
in B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LRB
ABSTRACT B-O B-NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-S
Human B-O B-S_S_NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
I B-O B-CD
Tax B-O B-NN
" " B-O O-NP
associates B-O B-VP_VP_VP_VBZ
with B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
negatively B-O B-VP_ADVP_RB
" " B-O O-ADVP
regulated B-O B-VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
the B-O B-NP_DT
NF-kappa B-O B-NN
B2 B-O B-NN
p100 B-O B-NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
implications B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
viral B-O B-NP_JJ
latency B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-S
  
Human B-O B-S_NP_NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
I B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-I B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
etiologic B-O B-JJ
agent B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
adult B-O B-JJ
T-cell B-O B-NN
leukemia B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
aggressive B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
fatal B-O B-ADJP_ADVP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
malignancy B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
human B-O B-JJ
CD4 B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HTLV-I B-O B-S_NP_NN
" " B-O O-NP
encodes B-O B-VP_VBZ
an B-O B-NP_NP_DT
essential B-O B-JJ
40-kDa B-O B-JJ
protein B-O B-NN
" " B-O O-NP
termed B-O B-VP_VBN
Tax B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
not B-O B-S_NP_VP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
transactivates B-O B-VP_VBZ
the B-O B-NP_NP_DT
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
induces B-O B-VP_VBZ
an B-O B-NP_NP_DT
array B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tax-mediated B-O B-S_NP_NP_JJ
transformation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
likely B-O B-ADVP_RB
" " B-O O-ADVP
involves B-O B-VP_VBZ
the B-O B-NP_NP_DT
deregulated B-O B-VBN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
various B-O B-NP_NP_JJ
cellular B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
normally B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
regulate B-O B-VP_VBP
" " B-O B-NP_NP_VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
particular B-O B-NP_JJ
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
Tax B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
capable B-O B-ADJP_JJ
of B-O B-PP_IN
modulating B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
or B-O B-NP_NP_CC
" " B-O B-NP_O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
" " B-O B-PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_DT
additional B-O B-JJ
distinguishing B-O B-JJ
characteristic B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HTLV-I B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
profound B-O B-JJ
state B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
viral B-O B-NP_NP_JJ
latency B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
present B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
HTLV-I B-O B-S_NP_NN
Tax B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
physically B-O B-VP_ADVP_RB
" " B-O O-ADVP
associate B-O B-VB
with B-O B-PP_IN
p100 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
, B-O B-NP_NP_PP_COMMA
" " B-O O-NP
" " B-O O-PP
both B-O B-PP_CC
in B-O B-PP_IN
transfected B-O B-NP_VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
HTLV-I-infected B-O B-NP_JJ
leukemic B-O B-JJ
T-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
physical B-O B-JJ
interaction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Tax B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
p100 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Tax-induced B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
and B-O B-NP_NP_CC
long B-O B-NP_JJ
terminal B-O B-JJ
repeats B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
reflecting B-O B-S_NP_VP_VBG
p100-mediated B-O B-NP_NP_JJ
cytoplasmic B-O B-JJ
sequestration B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
normally B-O B-ADJP_ADVP_RB
" " B-O O-ADVP
nuclearly B-O B-RB
expressed B-O B-VBN
" " B-O O-ADJP
Tax B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
a B-O B-NP_NP_DT
mutant B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Tax B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
selectively B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
fails B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
nuclear B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
associate B-O B-VP_VB
with B-O B-PP_IN
p100 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LRB
ABSTRACT B-O B-NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-S
Regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
BZLF1 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
second B-O B-NP_JJ
messengers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
anti-immunoglobulin-treated B-O B-NP_JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Initiation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Epstein-Barr B-O B-NP_NP_JJ
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EBV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
lytic B-O B-JJ
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
BZLF1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
BZLF1 B-O B-NN
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Zp B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
crosslinking B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NN
surface B-O B-NN
immunoglobulin B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
anti-Ig B-O B-NP_JJ
antibody B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
even B-O B-PP_RB
in B-O B-IN
the B-O B-DT
absence B-O B-NN
of B-O B-IN
other B-O B-NP_JJ
viral B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
identified B-O B-VP_VBD
several B-O B-NP_NP_JJ
anti-Ig B-O B-JJ
response B-O B-NN
elements B-O B-NNS
" " B-O O-NP
within B-O B-PP_IN
Zp B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
originally B-O B-VP_ADVP_RB
" " B-O O-ADVP
defined B-O B-VBN
as B-O B-NP_PP_IN
response B-O B-NP_NP_NN
elements B-O B-NNS
" " B-O B-PRN_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
anti-Ig B-O B-S_NP_JJ
crosslinking B-O B-NN
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
and B-O B-CC
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
intracellular B-O B-NP_JJ
calcium B-O B-NN
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
Zp B-O B-NP_NN
" " B-O O-NP
was B-O B-VP_VBD
tested B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
these B-O B-NP_DT
cellular B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
calcium B-O B-NP_NN
ionophore B-O B-NN
A23187 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
Zp B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
calcium B-O B-NN
ionophore B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
in B-O B-NP_PP_IN
conjunction B-O B-NN
with B-O B-IN
TPA B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
PKC B-O B-NN
activator B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_DT
Zp B-O B-NN
induction B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
"1-(5-Isoquinolinyl sulfonyl)-2-methylpiperazine" B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
anti-Ig B-O B-JJ
inducibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Zp B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Calmodulin B-O B-S_NP_NP_NN
antagonists B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
compound B-O B-NP_NP_NN
R24571 B-O B-NN
" " B-O O-NP
and B-O B-CC
trifluoperazine B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
blocked B-O B-VP_VBD
the B-O B-NP_NP_DT
Zp B-O B-NN
activation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
anti-Ig B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
Zp B-O B-S_NP_NN
" " B-O O-NP
responds B-O B-VP_VBZ
directly B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
changes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Requirement B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
tyrosine B-O B-NP_NN
kinase B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
the B-O B-NP_DT
anti-Ig-mediated B-O B-JJ
Zp B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
demonstrated B-O B-VBN
through B-O B-NP_PP_IN
the B-O B-NP_NP_DT
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
tyrosine B-O B-NN
kinase B-O B-NN
inhibitor B-O B-NN
herbimycin B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
cellular B-O B-JJ
gene B-O B-NN
regulatory B-O B-JJ
molecules B-O B-NNS
" " B-O O-NP
induced B-O B-VP_VBN
with B-O B-NP_PP_IN
anti-Ig B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
may B-O B-VP_MD
cooperatively B-O B-VP_ADVP_RB
" " B-O O-ADVP
play B-O B-VB
an B-O B-NP_DT
important B-O B-JJ
part B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
achieving B-O B-S_NP_VP_VBG
efficient B-O B-NP_JJ
EBV B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
as B-O B-SBAR_IN
seen B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
anti-Ig B-O B-NP_NP_JJ
treatment B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Retinoic B-O B-S_NP_JJ
acid B-O B-NN
" " B-O O-NP
downmodulates B-O B-VP_VBZ
erythroid B-O B-NP_NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
and B-O B-CC
GATA1 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
purified B-O B-NP_VBN
adult-progenitor B-O B-JJ
culture B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All-trans B-O B-S_NP_JJ
retinoic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
RA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VP_VBZ
an B-O B-NP_NP_NP_DT
important B-O B-JJ
morphogen B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
vertebrate B-O B-NP_NN
development B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
normal B-O B-JJ
constituent B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
adult B-O B-JJ
blood B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
normal B-O B-NP_JJ
hematopoiesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
using B-O B-S_NP_VP_VBG
early B-O B-NP_NP_JJ
" " B-O B-NP_NP_PRN_O-NP
stringently B-O B-VP_ADVP_RB
" " B-O O-ADVP
purified B-O B-VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
clonogenetic B-O B-NP_NP_JJ
fetal B-O B-ADJP_ADJP_ADJP_JJ
calf B-O B-NN
serum-supplemented B-O B-JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
FCS+ B-O B-ADJP_JJ
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
or B-O B-CC
-nonsupplemented B-O B-ADJP_ADJP_NP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
FCS- B-O B-ADJP_JJ
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
" " B-O O-ADJP
culture B-O B-NN
" " B-O O-NP
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
saturating B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_NP_NP_CC
( B-O B-NP_NP_LRB
) B-O B-PP_RRB
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
RA B-O B-NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
a B-O B-NP_NP_DT
dramatic B-O B-JJ
dose-dependent B-O B-JJ
shift B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
erythroid B-O B-NP_JJ
" " B-O B-NP_O-NP
" " B-O O-PP
to B-O B-PP_TO
granulomonocytic B-O B-NP_JJ
" " B-O B-NP_O-NP
" " B-O O-PP
colony B-O B-NP_NN
formation B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
the B-O B-S_NP_DT
latter B-O B-JJ
colonies B-O B-NNS
" " B-O O-NP
being B-O B-VP_VBG
essentially B-O B-VP_ADVP_RB
" " B-O O-ADVP
represented B-O B-VBN
by B-O B-NP_PP_IN
granulocytic B-O B-NP_JJ
clones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
shift B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
apparently B-O B-ADVP_RB
" " B-O O-ADVP
not B-O B-RB
caused B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_DT
recruitment B-O B-NN
phenomenon B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
because B-O B-SBAR_IN
in B-O B-S_PP_IN
FCS+ B-O B-NP_JJ
culture B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
total B-O B-JJ
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
colonies B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
significantly B-O B-VP_ADVP_RB
" " B-O O-ADVP
modified B-O B-VBN
by B-O B-NP_PP_IN
RA B-O B-NP_NN
addition B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
FCS- B-O B-NP_NP_JJ
liquid-suspension B-O B-NN
culture B-O B-NN
" " B-O O-NP
supplemented B-O B-VP_VBN
with B-O B-NP_PP_IN
saturating B-O B-NP_NP_JJ
Ep B-O B-NN
level B-O B-NN
" " B-O O-NP
and B-O B-CC
low-dose B-O B-NP_JJ
IL-3/GM-CSF B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
adult B-O B-NP_JJ
HPC B-O B-NN
" " B-O O-NP
undergo B-O B-VP_VBP
unilineage B-O B-NP_JJ
erythropoietic B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
again B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
high-dose B-O B-NP_JJ
RA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
a B-O B-NP_NP_DT
shift B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_DT
erythroid B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
to B-O B-TO
granulocytic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
differentiation B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Studies B-O B-S_NP_NP_NNS
" " B-O O-NP
on B-O B-PP_IN
RA B-O B-NP_NP_NN
time-response B-O B-UCP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
pulse B-O B-NP_NN
" " B-O O-NP
" " B-O O-UCP
treatment B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
semisolid B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
liquid B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
culture B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
early B-O B-S_NP_JJ
RA B-O B-NN
addition B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
most B-O B-ADJP_RBS
effective B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
thus B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
indicating B-O B-VP_VBG
that B-O B-SBAR_IN
early B-O B-S_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
but B-O B-CC
not B-O B-ADJP_RB
late B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
HPC B-O B-NN
" " B-O O-NP
are B-O B-VP_VBP
sensitive B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
then B-O B-ADVP_RB
" " B-O O-ADVP
analyzed B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
master B-O B-NN
GATA1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
encodes B-O B-S_NP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
addition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
RA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
HPC B-O B-NP_NP_NN
" " B-O O-NP
stimulated B-O B-VP_VBN
into B-O B-NP_PP_IN
unilineage B-O B-NP_JJ
erythropoietic B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
liquid B-O B-NP_JJ
culture B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
caused B-O B-VP_VBD
a B-O B-NP_NP_DT
virtually B-O B-ADJP_RB
complete B-O B-JJ
" " B-O O-ADJP
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GATA1 B-O B-NP_NN
mRNA B-O B-NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
RA B-O B-S_NP_NN
" " B-O O-NP
directly B-O B-ADVP_RB
" " B-O O-ADVP
inhibits B-O B-VP_VP_VBZ
the B-O B-NP_DT
erythroid B-O B-JJ
differentiation B-O B-NN
program B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
may B-O B-VP_MD
lead B-O B-VP_VB
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
phenomenon B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
correlated B-O B-VP_VBN
with B-O B-NP_PP_IN
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
GATA1 B-O B-NP_NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
early B-O B-JJ
stages B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
erythropoietic B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
phosphatidylinositol B-O B-NP_NP_NN
turnover B-O B-NN
" " B-O O-NP
and B-O B-CC
EGR-1 B-O B-NP_NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
crosslinking B-O B-NP_NP_VBG
" " B-O O-NP
of B-O B-PP_IN
surface B-O B-NP_NP_NN
IgM B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IgD B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
B B-O B-NN
cell B-O B-NN
line B-O B-NN
B104 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
that B-O B-SBAR_SBAR_IN
a B-O B-S_NP_NP_DT
human B-O B-JJ
B B-O B-NN
lymphoma B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
B104 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
expressed B-O B-VP_VBD
and B-O B-NP_NP_CC
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
, B-O B-S_S_NP_NP_PP_PP_COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
induced B-O B-VP_VBD
" " B-O B-NP_PP_O-S
, B-O B-COMMA
whereas B-O B-IN
only B-O B-S_NP_RB
sIgM-crosslinking B-O B-NN
" " B-O O-NP
caused B-O B-VP_VBD
" " B-O B-NP_O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
the B-O B-NP_NP_NP_NP_DT
accumulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cyclic B-O B-NP_NP_JJ
AMP B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
cAMP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_NP_DT
hydrolysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
inositol B-O B-NP_NN
phosphates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
protein B-O B-NP_NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PKC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Egr-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
by B-O B-PP_IN
sIgM- B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
sIgD-crosslinking B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-S_NP_VP_TO
examine B-O B-VP_VB
differences B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
signals B-O B-NNS
" " B-O O-NP
mediated B-O B-VP_VBN
" " B-O B-NP_PP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_NP_CC
sIgM- B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
sIgD-crosslinking B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
with B-O B-PP_IN
antibodies B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induced B-O B-VP_VBD
elevation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cAMP B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
phosphatidylinositol B-O B-NP_NN
turnover B-O B-NN
" " B-O O-NP
, B-O B-COMMA
PKC B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
and B-O B-CC
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Egr-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
although B-O B-SBAR_IN
sIgM-crosslinking B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
more B-O B-ADJP_ADJP_RBR
effective B-O B-JJ
" " B-O O-ADJP
than B-O B-PP_IN
sIgD-crosslinking B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
presumably B-O B-PP_ADVP_RB
" " B-O O-ADVP
due B-O B-JJ
to B-O B-TO
the B-O B-NP_NP_NP_DT
higher B-O B-JJR
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
than B-O B-PP_IN
" " B-O B-FRAG_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Egr-1 B-O B-S_NP_NP_NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
sIgM- B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
sIgD-crosslinking B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
H7 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
erbstatin B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
genistein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
by B-O B-IN
HA1004 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Erbstatin B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
genistein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
sIg-crosslinking-induced B-O B-JJ
Egr-1 B-O B-NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O B-ADJP_O-NP
in B-O B-PP_IN
a B-O B-NP_DT
dose-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
parallel B-O B-ADJP_JJ
to B-O B-PP_TO
that B-O B-NP_NP_WDT
" " B-O O-NP
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Phorbol B-O B-S_S_NP_NN
myristate B-O B-NN
acetate B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBD
Egr-1 B-O B-NP_NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
but B-O B-CC
forskolin B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
dibutyryl B-O B-NP_NN
cyclic B-O B-JJ
AMP B-O B-NN
" " B-O O-NP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
" " B-O B-VP_O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
Egr-1 B-O B-NN
mRNA B-O B-NN
activating B-O B-NN
signals B-O B-NNS
" " B-O O-NP
through B-O B-PP_IN
sIgM B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
sIgD B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
protein B-O B-ADJP_ADJP_ADJP_NP_NN
tyrosine B-O B-NN
kinase- B-O B-NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
PKC-dependent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
, B-O B-COMMA
but B-O B-CC
protein B-O B-ADJP_NN
kinase B-O B-NN
A-independent B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cyclosporin B-O B-S_NP_NP_NP_NN
A B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CsA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
rescued B-O B-VP_VP_VP_VBD
B104 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
death B-O B-NP_NP_NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
anti-IgM B-O B-NP_JJ
Ab B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
did B-O B-VP_VBD
not B-O B-RB
affect B-O B-VP_VB
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_NP_CC
mRNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
showing B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
CsA B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
FK506 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
affect B-O B-VP_VBP
signal B-O B-NP_NN
transducers B-O B-NNS
" " B-O O-NP
differently B-O B-ADVP_RB
" " B-O O-ADVP
or B-O B-UCP_UCP_PP_CC
these B-O B-ADVP_NP_DT
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-UCP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
signals B-O B-NP_NP_NNS
" " B-O O-NP
transduced B-O B-VP_VBN
through B-O B-NP_PP_IN
sIgM B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
sIgD B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B104 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
discussed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
G(Anh)MTetra B-O B-S_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
natural B-O B-JJ
bacterial B-O B-JJ
cell B-O B-NN
wall B-O B-NN
breakdown B-O B-NN
product B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
induces B-O B-VP_VBZ
interleukin-1 B-O B-NP_NP_NP_NP_NN
beta B-O B-NN
" " B-O O-NP
and B-O B-CC
interleukin-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-NP_NP_DT
study B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
molecular B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
inflammatory B-O B-NP_JJ
cytokine B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
[ B-O B-PRN_LRB
published B-O B-S_NP_VBN
erratum B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
in B-O B-PP_IN
J B-O B-NP_NP_NNP
Biol B-O B-NNP
Chem B-O B-NNP
" " B-O O-NP
1994 B-O B-NP_CD
Jun B-O B-NNP
17 B-O B-CD
" " B-O O-NP
; B-O B-COLON
269 B-O B-NP_CD
( B-O B-LRB
24 B-O B-CD
) B-O B-RRB
" " B-O O-NP
: B-O B-COLON
16983 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
believed B-O B-VP_VBN
that B-O B-SBAR_IN
induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cytokine B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
bacterial B-O B-NP_JJ
cell B-O B-NN
wall B-O B-NN
components B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
of B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
most B-O B-NP_JJS
attention B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
focused B-O B-VP_VBN
on B-O B-NP_PP_IN
lipopolysaccharide B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
LPS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O B-S_O-NP
of B-O B-PP_IN
"N-acetylglucosaminyl-1,6-anhydro-N-acetylmuramyl-L-alanyl-D- isoglutamyl-m-diaminopimelyl-D-alanine" B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
G(Anh)MTetra B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
naturally B-O B-ADJP_RB
occurring B-O B-VBG
" " B-O O-ADJP
breakdown B-O B-NN
product B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
peptidoglycan B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
cytokine B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
G(Anh)MTetra B-O B-S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
strongly B-O B-ADVP_RB
" " B-O O-ADVP
induce B-O B-VP_VP_VP_VB
mRNA B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
" " B-O B-NP_O-VP
and B-O B-CC
protein B-O B-VP_NP_NP_NN
secretion B-O B-NN
" " B-O O-NP
after B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
of B-O B-PP_IN
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
mRNA B-O B-NP_NN
accumulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VP_VBD
at B-O B-PP_ADVP_ADVP_IN
least B-O B-JJS
" " B-O O-ADVP
partly B-O B-RB
" " B-O O-ADVP
due B-O B-JJ
to B-O B-TO
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
transcription B-O B-NN
rates B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
respective B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
strong B-O B-JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_NP_CC
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Experiments B-O B-S_NP_NP_NNS
" " B-O O-NP
using B-O B-VP_VBG
inhibitors B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
, B-O B-COMMA
protein B-O B-NP_NN
kinase B-O B-NN
A B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
tyrosine B-O B-NP_ADJP_NN
kinase-dependent B-O B-JJ
" " B-O O-ADJP
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
G(Anh)MTetra-induced B-O B-S_NP_JJ
IL-1 B-O B-NP_NP_NN
beta B-O B-NN
" " B-O O-NP
and B-O B-CC
IL-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
involves B-O B-VP_VBZ
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
H7-inhibitable B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
using B-O B-S_NP_VP_VBG
the B-O B-NP_DT
protein B-O B-NN
synthesis B-O B-NN
inhibitor B-O B-NN
cycloheximide B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
that B-O B-SBAR_IN
G(Anh)MTetra-induced B-O B-S_S_NP_JJ
IL-6 B-O B-NN
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
depends B-O B-VP_VBZ
on B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
G(Anh)MTetra-induced B-O B-S_NP_JJ
IL-1 B-O B-NN
beta B-O B-NN
mRNA B-O B-NN
accumulation B-O B-NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
responses B-O B-S_NP_NP_NNS
" " B-O O-NP
to B-O B-PP_TO
G(Anh)MTetra B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
compared B-O B-VP_VBN
with B-O B-NP_PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
to B-O B-PP_TO
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
optimal B-O B-JJ
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
G(Anh)MTetra B-O B-NP_NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
similar B-O B-ADJP_ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
but B-O B-CC
significantly B-O B-ADJP_ADJP_RB
higher B-O B-JJR
" " B-O O-ADJP
than B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
maximal B-O B-NP_JJ
G(Anh)MTetra-induced B-O B-JJ
IL-1 B-O B-NP_NP_NN
beta B-O B-NN
" " B-O O-NP
and B-O B-CC
IL-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
enhanced B-O B-VP_VBN
by B-O B-NP_PP_IN
co-stimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
LPS B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
MDP B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
different B-O B-S_NP_JJ
were B-O B-NP_VP_VBD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
G(Anh)MTetra B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
IL-1 B-O B-NP_NP_NP_NP_NN
beta B-O B-NN
" " B-O O-NP
and B-O B-CC
IL-6 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggesting B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
possible B-O B-JJ
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Comparative B-O B-NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFAT B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
complex B-O B-JJ
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Nuclear B-O B-S_NP_NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
NFAT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
largely B-O B-ADJP_RB
responsible B-O B-JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Electrophoretic B-O B-S_NP_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
EMSA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
specific B-O B-S_NP_JJ
NFAT B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
human B-O B-NP_JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
B B-O B-NN
cell B-O B-NN
NFAT B-O B-NN
complex B-O B-NN
" " B-O O-NP
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
was B-O B-VP_VBD
not B-O B-RB
functional B-O B-ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
since B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Competition B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_PP_IN
an B-O B-NP_DT
AP-1 B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
with B-O B-PP_IN
anti-Jun B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
anti-Fos B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
abolished B-O B-VP_VBD
binding B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
NFAT B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
both B-O B-NP_NP_CC
T B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
Jun B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
critical B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Purified B-O B-S_NP_VBN
recombinant B-O B-JJ
Jun B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
proteins B-O B-NNS
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
directly B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
the B-O B-NP_DT
NFAT B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
combined B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
unstimulated B-O B-NP_JJ
B B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
T B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
cell B-O B-NN
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
full-length B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
but B-O B-CC
not B-O B-ADJP_RB
truncated B-O B-VBN
" " B-O O-ADJP
, B-O B-COMMA
" " B-O O-ADJP
Jun/Fos B-O B-NN
heterodimers B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
form B-O B-VP_VB
an B-O B-NP_DT
NFAT B-O B-NN
complex B-O B-NN
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_PP_ADJP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_DT
NFAT B-O B-NN
oligonucleotide B-O B-NN
" " B-O O-NP
carrying B-O B-VP_VBG
mutations B-O B-NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
5' B-O B-JJ
purine-rich B-O B-JJ
part B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NFAT B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_VP_VP_TO
form B-O B-VP_VB
a B-O B-NP_DT
complex B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
to B-O B-VP_TO
compete B-O B-VP_VB
with B-O B-PP_IN
the B-O B-NP_DT
wild B-O B-JJ
type B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
NFAT B-O B-NP_NN
complex B-O B-NN
formation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
in B-O B-PP_IN
both B-O B-NP_NP_CC
T B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
propose B-O B-VP_VBP
a B-O B-NP_NP_DT
model B-O B-NN
" " B-O O-NP
whereby B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
a B-O B-S_S_S_NP_NP_DT
core B-O B-NN
NFAT B-O B-NN
complex B-O B-NN
" " B-O O-NP
consisting B-O B-VP_VBG
" " B-O B-PP_O-NP
is B-O B-VP_VBZ
formed B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
and/or B-O B-S_NP_NP_NP_CC
, B-O B-NP_COMMA
missing B-O B-ADJP_VBG
, B-O B-PP_COMMA
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-S
" " B-O B-ADVP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
1,25-Dihydroxy B-O B-S_NP_NP_NN
vitamin B-O B-NN
D3 B-O B-NN
" " B-O O-NP
and B-O B-CC
12-O-tetradecanoyl B-O B-NP_NN
phorbol-13-acetate B-O B-NN
" " B-O O-NP
" " B-O O-NP
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
induce B-O B-VP_VBP
monocytic B-O B-NP_NP_JJ
cell B-O B-NN
differentiation B-O B-NN
" " B-O O-NP
: B-O B-COLON
FOS B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
RB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
1,25-dihydroxy B-O B-S_NP_NP_NN
vitamin B-O B-NN
D3 B-O B-NN
" " B-O O-NP
and B-O B-CC
12-O-tetradecanoyl B-O B-NP_NP_NN
phorbol-13-acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TPA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
interact B-O B-VP_VBP
synergistically B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
monocytic B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
U937 B-O B-NP_NN
histiocytic B-O B-JJ
lymphoma B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Addition B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TPA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
causes B-O B-VP_VBZ
an B-O B-S_NP_NP_DT
otherwise B-O B-ADJP_JJ
ineffective B-O B-JJ
" " B-O O-ADJP
dose B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
1,25-dihydroxy B-O B-NP_NN
vitamin B-O B-NN
D3 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-VP_TO
induce B-O B-VP_VB
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
induced B-O B-VBD
differentiation B-O B-NN
" " B-O O-NP
depends B-O B-VP_VBZ
on B-O B-PP_IN
the B-O B-NP_NP_DT
simultaneous B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-LRB
vs. B-O B-CC
sequential B-O B-ADJP_JJ
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-ADJP
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
agents B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
kinetics B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
induced B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
a B-O B-NP_NP_DT
G1 B-O B-ADJP_NN
specific B-O B-JJ
" " B-O O-ADJP
cellular B-O B-JJ
response B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
initiate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
induced B-O B-VBD
differentiation B-O B-NN
" " B-O O-NP
occurs B-O B-VP_VBZ
with B-O B-PP_IN
down-regulation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
an B-O B-NP_NP_DT
accompanying B-O B-VBG
up-regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
RB B-O B-NP_NN
protein B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
a B-O B-NP_DT
possible B-O B-JJ
need B-O B-NN
for B-O B-SBAR_IN
up-regulated B-O B-S_NP_JJ
RB B-O B-NN
expression B-O B-NN
" " B-O O-NP
to B-O B-VP_TO
and B-O B-VP_VP_CC
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
lymphoid-specific B-O B-NP_JJ
immunoglobulin B-O B-NN
mu B-O B-NN
heavy B-O B-NN
chain B-O B-NN
gene B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
ETS-domain B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
enhancer B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
immunoglobulin B-O B-NN
mu B-O B-NN
heavy B-O B-NN
chain B-O B-NN
gene B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IgH B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
activates B-O B-VP_VBZ
a B-O B-NP_DT
heterologous B-O B-JJ
gene B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_NP_DT
pre-B B-O B-ADJP_JJ
cell B-O B-NN
" " B-O O-ADJP
stage B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B B-O B-NP_NN
lymphocyte B-O B-NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
lymphoid-specific B-O B-JJ
element B-O B-NN
" " B-O O-NP
, B-O B-COMMA
microB B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
enhancer B-O B-NP_NP_NN
function B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
pre-B B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
microB B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
encoded B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
PU.1/Spi-1 B-O B-NN
proto-oncogene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Another B-O B-S_NP_NP_DT
sequence B-O B-NN
element B-O B-NN
" " B-O O-NP
, B-O B-COMMA
microA B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
mu B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
microA B-O B-NN
motif B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
required B-O B-VP_VP_VBN
for B-O B-NP_PP_IN
microB-dependent B-O B-NP_JJ
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
suggests B-O B-S_NP_VP_VBZ
that B-O B-SBAR_IN
a B-O B-S_NP_DT
minimal B-O B-JJ
enhancer B-O B-ADJP_NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Co-expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
PU.1 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
Ets-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
nonlymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
trans-activated B-O B-VP_JJ
reporter B-O B-NP_NP_NN
plasmids B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contained B-O B-S_NP_VP_VBD
the B-O B-NP_DT
minimal B-O B-JJ
mu B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
implicate B-O B-VP_VBP
two B-O B-NP_NP_CD
members B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Ets B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IgH B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Differential B-O B-NP_NP_JJ
autoregulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NN
receptor B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
T- B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
B-cell B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Regulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
its B-O B-NP_PRPP
cognate B-O B-JJ
ligand B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
the B-O B-NP_DT
glucocorticoid-sensitive B-O B-JJ
human B-O B-JJ
leukemic B-O B-JJ
T-cell B-O B-NN
line B-O B-NN
6TG1.1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
B-cell B-O B-NN
line B-O B-NN
IM-9 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NN
to B-O B-TO
the B-O B-NP_NP_DT
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
GR B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
seen B-O B-VP_VBN
in B-O B-NP_PP_IN
IM-9 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
after B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
1 B-O B-NP_ADJP_CD
microM B-O B-NN
" " B-O O-ADJP
dexamethasone B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
16-18 B-O B-NP_QP_CD
" " B-O O-QP
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
treatment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
6TG1.1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
an B-O B-NP_NP_DT
8-fold B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
GR B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-SBAR_IN
determined B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
Northern B-O B-NP_NP_NP_NN
blot B-O B-NN
" " B-O O-NP
and B-O B-CC
RNase B-O B-NP_NN
protection B-O B-NN
" " B-O O-NP
" " B-O O-NP
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
with B-O B-PP_IN
a B-O B-NP_NP_DT
corresponding B-O B-JJ
3- B-O B-ADJP_ADJP_NP_CD
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
to B-O B-TO
4-fold B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
GR B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Half-maximal B-O B-S_S_NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
mRNA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
protein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
6TG1.1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
between B-O B-NP_PP_IN
10-100 B-O B-NP_ADJP_QP_CD
" " B-O O-QP
nM B-O B-NN
" " B-O O-ADJP
dexamethasone B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
inclusion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
1 B-O B-NP_ADJP_CD
microM B-O B-NN
" " B-O O-ADJP
RU B-O B-NN
38486 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
completely B-O B-ADVP_RB
" " B-O O-ADVP
blocked B-O B-VP_VBD
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
100 B-O B-NP_ADJP_CD
nM B-O B-NN
" " B-O O-ADJP
dexamethasone B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
demonstrating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
positive B-O B-S_NP_NP_JJ
autoregulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
" " B-O B-NP_O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
receptor-mediated B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Positive B-O B-S_NP_NP_JJ
autoregulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
observed B-O B-VBN
in B-O B-NP_PP_IN
glucocorticoid-resistant B-O B-NP_NP_JJ
CEM-C1 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_SBAR_WHNP_WDT
" " B-O O-WHNP
contain B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
, B-O B-COMMA
but B-O B-CC
whose B-O B-SBAR_WHNP_WPP
growth B-O B-NN
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
positive B-O B-NP_JJ
autoregulation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
neither B-O B-NP_NP_CC
a B-O B-NP_DT
consequence B-O B-NN
" " B-O O-NP
nor B-O B-CC
the B-O B-NP_DT
sole B-O B-JJ
cause B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
growth B-O B-NP_NN
arrest B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
degree B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
negative B-O B-NP_NP_NP_JJ
autoregulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
IM-9 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
positive B-O B-NP_NP_JJ
autoregulation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
6TG1.1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
unaffected B-O B-VP_VBN
by B-O B-NP_PP_IN
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NP_NN
synthesis B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
cycloheximide B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Measurement B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
GR B-O B-NP_NP_NN
mRNA B-O B-NN
turnover B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
6TG1.1 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
actinomycin-D B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
a B-O B-NP_NP_DT
half-life B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
2.5 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
unaffected B-O B-VP_JJ
by B-O B-NP_PP_IN
dexamethasone B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
similar B-O B-JJ
half-life B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VBD
determined B-O B-VP_VBN
in B-O B-NP_PP_IN
IM-9 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
unaffected B-O B-VP_JJ
by B-O B-NP_PP_IN
steroid B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_DT
interpretation B-O B-NN
that B-O B-SBAR_IN
glucocorticoid-mediated B-O B-S_NP_NP_JJ
autoregulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
tissue-specific B-O B-JJ
primary B-O B-JJ
transcriptional B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_NP_DT
p65 B-O B-NN
subunit B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
regulates B-O B-VP_VBZ
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
two B-O B-NP_CD
distinct B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transcription B-O B-S_NP_NP_NN
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
p50/p65 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
generally B-O B-VP_ADVP_RB
" " B-O O-ADVP
localized B-O B-JJ
to B-O B-NP_PP_TO
the B-O B-NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
its B-O B-NP_PRPP
inhibitor B-O B-NN
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Overproduced B-O B-S_NP_NP_JJ
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
free B-O B-ADJP_JJ
from B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
rapidly B-O B-VP_ADVP_RB
" " B-O O-ADVP
degraded B-O B-VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Overexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increases B-O B-VP_VBZ
endogenous B-O B-NP_NP_JJ
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
protein B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
both B-O B-NP_CC
carcinoma B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
two B-O B-NP_NP_CD
mechanisms B-O B-NNS
" " B-O O-NP
: B-O B-COLON
protein B-O B-NP_NP_NN
stabilization B-O B-NN
" " B-O O-NP
and B-O B-CC
increased B-O B-NP_NP_VBN
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
p65 B-O B-NP_NP_NN
delta B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
naturally B-O B-ADJP_RB
occurring B-O B-VBG
" " B-O O-ADJP
splice B-O B-NN
variant B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
fails B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
markedly B-O B-VP_ADVP_RB
" " B-O O-ADVP
augment B-O B-VB
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
protein B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_S_S_NP_CC
overexpressed B-O B-NP_JJ
p65 B-O B-NN
" " B-O O-NP
and B-O B-CC
coexpressed B-O B-NP_JJ
p50 B-O B-NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
cytoplasmic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
p65 B-O B-S_NP_NN
delta B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
partly B-O B-ADJP_RB
nuclear B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
can B-O B-VP_MD
maintain B-O B-VP_VB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
p65 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
linked B-O B-VP_VBN
in B-O B-NP_PP_IN
an B-O B-NP_DT
autoregulatory B-O B-JJ
loop B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
ensuring B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
held B-O B-VP_VBN
" " B-O B-NP_PP_SBAR_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cell B-O B-S_NP_NP_NN
cycle B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E2F B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
primary B-O B-NP_JJ
human B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reveals B-O B-VP_VBZ
novel B-O B-NP_NP_JJ
E2F B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
and B-O B-CC
biochemically B-O B-NP_NP_ADJP_RB
distinct B-O B-JJ
" " B-O O-ADJP
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
free B-O B-NP_JJ
E2F B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
transcription B-O B-NN
factor B-O B-NN
E2F B-O B-NN
" " B-O O-NP
activates B-O B-VP_VBZ
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
multiple B-O B-NP_NP_JJ
genes B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
cell B-O B-NP_NN
proliferation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
such B-O B-PP_JJ
as B-O B-IN
c-myc B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
dihydrofolate B-O B-JJ
reductase B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Regulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
E2F B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
its B-O B-NP_NP_PRPP
interactions B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
other B-O B-NP_NP_JJ
cellular B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
the B-O B-NP_NP_NP_DT
retinoblastoma B-O B-NN
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
Rb-related B-O B-JJ
protein B-O B-NN
p107 B-O B-NN
" " B-O O-NP
, B-O B-COMMA
cyclin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
cdk2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
undertook B-O B-VP_VBD
a B-O B-NP_NP_DT
detailed B-O B-JJ
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E2F B-O B-NP_NP_NP_NN
DNA-binding B-O B-JJ
activities B-O B-NNS
" " B-O O-NP
and B-O B-CC
their B-O B-NP_PRPP
cell B-O B-NN
cycle B-O B-NN
behavior B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
primary B-O B-NP_JJ
human B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Three B-O B-S_NP_CD
E2F B-O B-NN
DNA-binding B-O B-JJ
activities B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
in B-O B-PP_IN
resting B-O B-NP_VBG
( B-O B-LRB
G0 B-O B-NN
) B-O B-RRB
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-S_NP_PP_IN
mobilities B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-ADJP_PP_IN
gel B-O B-NP_NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
distinct B-O B-JJ
from B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
activities B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
a B-O B-NP_DT
novel B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
less B-O B-ADJP_RBR
abundant B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
Rb-E2F B-O B-ADJP_NN
" " B-O O-ADJP
" " B-O O-ADJP
complex B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
most B-O B-ADJP_RBS
prominent B-O B-JJ
" " B-O O-ADJP
E2F B-O B-NN
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
resting B-O B-NP_VBG
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
( B-O B-LRB
termed B-O B-VP_VBN
complex B-O B-S_NP_NP_JJ
X B-O B-NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
) B-O B-RRB
" " B-O O-NP
was B-O B-VP_VP_VP_VBD
abundant B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
both B-O B-NP_CC
G0 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
G1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
disappeared B-O B-VP_VBD
as B-O B-SBAR_IN
cells B-O B-S_NP_NNS
" " B-O O-NP
entered B-O B-VP_VBD
S B-O B-NP_NN
phase B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
possible B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
negatively B-O B-NP_ADJP_RB
regulating B-O B-VBG
" " B-O O-ADJP
E2F B-O B-NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Complex B-O B-S_NP_NN
X B-O B-NN
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
dissociated B-O B-VP_VBN
by B-O B-NP_PP_IN
adenovirus B-O B-NP_NN
E1A B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
requirement B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
an B-O B-NP_DT
intact B-O B-JJ
E1A B-O B-NN
conserved B-O B-VBN
region B-O B-NN
2 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
X B-O B-NP_NN
" " B-O O-NP
failed B-O B-VP_VBD
to B-O B-S_NP_VP_TO
react B-O B-VP_VB
with B-O B-PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
implicating B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
involvement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
E1A-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
other B-O B-PP_JJ
than B-O B-IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NN
to B-O B-TO
these B-O B-NP_DT
novel B-O B-JJ
E2F B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
three B-O B-NP_NP_CD
distinct B-O B-JJ
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
unbound B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
( B-O B-PRN_LRB
free B-O B-ADJP_JJ
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
E2F B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
resolved B-O B-VP_VBN
in B-O B-NP_PP_IN
gel B-O B-NP_NN
shift B-O B-NN
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
species B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
different B-O B-NP_JJ
cell B-O B-NN
cycle B-O B-NN
kinetics B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
UV B-O B-S_NP_NN
cross-linking B-O B-JJ
experiments B-O B-NNS
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
a B-O B-S_NP_DT
distinct B-O B-JJ
E2F B-O B-NN
DNA-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
uniquely B-O B-VP_ADVP_RB
" " B-O O-ADVP
associated B-O B-VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
S-phase B-O B-NN
p107 B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
not B-O B-RB
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
Rb B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
E2F B-O B-S_NP_NN
" " B-O O-NP
consists B-O B-VP_VBZ
of B-O B-PP_IN
, B-O B-NP_NP_ADJP_ADJP_COMMA
DNA-binding B-O B-ADJP_JJ
proteins B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Occurrence B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
silencer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
interleukin-2 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_PP_IN
naive B-O B-NP_JJ
" " B-O B-NP_O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
memory B-O B-NP_NN
resting B-O B-VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-PP
T B-O B-NP_NN
helper B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
In B-O B-S_PP_IN
the B-O B-NP_DT
immune B-O B-JJ
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_NP_DT
first B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
naive B-O B-JJ
T B-O B-NN
cell B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
antigen B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
key B-O B-JJ
step B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
shaping B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
peripheral B-O B-JJ
T B-O B-NN
cell B-O B-NN
specificity B-O B-NN
repertoire B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
maintenance B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
self-tolerance B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
analysis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
interleukin-2 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
gene B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
shows B-O B-VP_VBZ
that B-O B-SBAR_IN
naive B-O B-S_NP_NP_JJ
human B-O B-JJ
helper B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
cord B-O B-NP_NP_NN
blood B-O B-NN
CD4+ B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
adult B-O B-NP_JJ
CD4+CD45RO- B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
regulate B-O B-VP_VBP
IL-2 B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
a B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
involving B-O B-VP_VBG
" " B-O B-NP_NP_VP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
memory B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
either B-O B-NP_CC
in B-O B-NP_NP_ADJP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
activated B-O B-VBN
" " B-O O-ADJP
helper B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
reverting B-O B-VP_VBG
to B-O B-PP_TO
a B-O B-NP_DT
resting B-O B-JJ
state B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
CD4+ B-O B-NP_JJ
T B-O B-NN
( B-O B-LRB
memory B-O B-NN
) B-O B-RRB
clones B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
CD4+CD45RO+ B-O B-NP_NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
isolated B-O B-VP_VBN
ex B-O B-NP_ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
no B-O B-ADVP_RB
longer B-O B-RB
" " B-O O-ADVP
have B-O B-VP_VBP
a B-O B-NP_DT
silencer B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Their B-O B-S_S_NP_PRPP
IL-2 B-O B-NN
transcription B-O B-NN
" " B-O O-NP
seems B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
controlled B-O B-VP_VBN
solely B-O B-NP_PP_RB
by B-O B-IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
in B-O B-S_S_PP_IN
resting B-O B-NP_VBG
memory B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
activator B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
located B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
inactive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
in B-O B-S_PP_IN
stimulated B-O B-NP_VBN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
it B-O B-NP_PRP
" " B-O O-NP
is B-O B-VP_VP_VBZ
functional B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
promoting B-O B-S_NP_VP_VBG
transcription B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
now B-O B-VP_ADVP_RB
" " B-O O-ADVP
resides B-O B-VBZ
in B-O B-PP_IN
the B-O B-NP_DT
nucleus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
gene B-O B-NN
coding B-O B-VBG
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
main B-O B-JJ
T B-O B-NN
cell B-O B-NN
growth B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
changes B-O B-VP_VBZ
irreversibly B-O B-ADVP_RB
" " B-O O-ADVP
after B-O B-PP_IN
the B-O B-NP_NP_DT
first B-O B-JJ
encounter B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
antigen B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
most B-O B-ADJP_RBS
likely B-O B-JJ
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
silencer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contributes B-O B-VP_VBZ
to B-O B-PP_TO
the B-O B-NP_NP_DT
activation B-O B-ADJP_NN
requirements B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Single B-O B-NP_NP_NP_JJ
strand B-O B-NN
conformation B-O B-NN
polymorphism B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
androgen B-O B-NP_NP_NN
receptor B-O B-NN
gene B-O B-NN
mutations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
androgen B-O B-NP_NN
insensitivity B-O B-NN
syndromes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
application B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
diagnosis B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
genetic B-O B-NP_JJ
counseling B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
therapy B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Recent B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
mutations B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
androgen B-O B-NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
androgen B-O B-NP_NP_NN
insensitivity B-O B-NN
syndromes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
address B-O B-VP_VBP
the B-O B-NP_NP_DT
possibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
rapid B-O B-NP_NP_JJ
mutational B-O B-JJ
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
androgen B-O B-NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
initial B-O B-NP_NP_NP_JJ
diagnosis B-O B-NN
" " B-O O-NP
, B-O B-COMMA
genetic B-O B-NP_JJ
counseling B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
molecular B-O B-NP_JJ
subclassification B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNA B-O B-S_NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
leukocytes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
six B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
five B-O B-NP_CD
families B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
various B-O B-NP_NP_JJ
degrees B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Exons B-O B-S_NP_NP_NNS
2 B-O B-NP_NP_CD
" " B-O O-NP
to B-O B-TO
8 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
androgen B-O B-NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
analyzed B-O B-VP_VBN
using B-O B-NP_S_NP_VP_VBG
a B-O B-NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
single B-O B-NP_NP_JJ
strand B-O B-NN
conformation B-O B-NN
polymorphism B-O B-NN
analysis B-O B-NN
" " B-O O-NP
and B-O B-CC
direct B-O B-NP_JJ
DNA B-O B-NN
sequencing B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Female B-O B-S_NP_JJ
family B-O B-NN
members B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
studied B-O B-VBN
to B-O B-NP_S_NP_VP_TO
identify B-O B-VP_VB
heterozygote B-O B-NP_NN
carriers B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Point B-O B-S_S_NP_NP_NN
mutations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
AR B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
identified B-O B-VP_VBN
in B-O B-NP_PP_IN
all B-O B-NP_QP_DT
six B-O B-CD
" " B-O O-QP
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
all B-O B-S_NP_DT
mutations B-O B-NNS
" " B-O O-NP
caused B-O B-VP_VBD
amino B-O B-NP_NN
acid B-O B-NN
substitutions B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
patient B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
incomplete B-O B-NP_JJ
androgen B-O B-NN
insensitivity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_NP_DT
mosaic B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
mutation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Four B-O B-S_NP_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
five B-O B-CD
mothers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
a B-O B-NP_NP_DT
young B-O B-JJ
sister B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
one B-O B-NP_CD
patient B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
carriers B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
mutation B-O B-NN
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_DT
affected B-O B-VBN
child B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
data B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
new B-O B-S_NP_JJ
mutations B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
occur B-O B-VP_VB
in B-O B-PP_IN
the B-O B-NP_DT
androgen B-O B-NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
leading B-O B-S_NP_VP_VBG
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Molecular B-O B-S_NP_NP_JJ
genetic B-O B-JJ
characterization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
variant B-O B-JJ
allele B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_VP_MD
serve B-O B-VP_VB
as B-O B-PP_IN
a B-O B-NP_NP_DT
primary B-O B-JJ
tool B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
diagnosis B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
subsequent B-O B-NP_JJ
therapy B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
can B-O B-VP_MD
provide B-O B-VP_VB
a B-O B-NP_NP_DT
basis B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
distinguishing B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
identification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
carriers B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
of B-O B-PP_IN
substantial B-O B-NP_JJ
clinical B-O B-JJ
importance B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
genetic B-O B-NP_JJ
counseling B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Nuclear B-O B-NP_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
mediator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lipopolysaccharide B-O B-NP_NN
effects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
Exposure B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
certain B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
bacterial B-O B-NP_JJ
lipopolysaccharide B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
LPS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_DT
inducible B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
's B-O B-POS
" " B-O O-NP
unique B-O B-JJ
properties B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
its B-O B-NP_NP_PRPP
posttranslational B-O B-JJ
activation B-O B-NN
" " B-O O-NP
via B-O B-PP_IN
release B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
inhibitory B-O B-JJ
subunit B-O B-NN
" " B-O O-NP
, B-O B-COMMA
called B-O B-VP_VBN
" " B-O B-S_NP_NP_O-VP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
a B-O B-NP_DT
sequestered B-O B-JJ
cytoplasmic B-O B-JJ
form B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
event B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
triggered B-O B-VBN
under B-O B-NP_PP_IN
various B-O B-NP_NP_JJ
other B-O B-JJ
conditions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
biomedical B-O B-NP_JJ
importance B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Other B-O B-S_NP_NP_JJ
bacterial B-O B-JJ
toxins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor-alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TNF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
interleukin-1 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
T B-O B-NP_NN
cell B-O B-NN
mitogens B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
UV B-O B-NP_NN
light B-O B-NN
" " B-O O-NP
, B-O B-COMMA
gamma B-O B-NP_NN
rays B-O B-NNS
" " B-O O-NP
and B-O B-CC
oxidative B-O B-NP_JJ
stress B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
reported B-O B-VP_VBN
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
activated B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
rapidly B-O B-VP_ADVP_RB
" " B-O O-ADVP
taken B-O B-VBN
up B-O B-PRT_RP
" " B-O O-PRT
into B-O B-NP_PP_IN
nuclei B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
initiates B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
immediate B-O B-NP_JJ
early B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_NP_DT
wide B-O B-JJ
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Most B-O B-S_NP_NP_JJS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
target B-O B-NN
genes B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VP_VBP
of B-O B-PP_IN
relevance B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
the B-O B-NP_DT
immune B-O B-JJ
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
can B-O B-VP_MD
be B-O B-VP_VB
grouped B-O B-VP_VBN
into B-O B-NP_PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
encoding B-O B-VP_JJ
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-NP_CC
" " B-O B-NP_O-VP
, B-O B-COMMA
such B-O B-PP_JJ
as B-O B-IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
will B-O B-VP_MD
discuss B-O B-VP_VB
recent B-O B-NP_NP_JJ
experimental B-O B-JJ
evidences B-O B-NNS
" " B-O O-NP
suggesting B-O B-VP_VBG
that B-O B-SBAR_IN
LPS B-O B-S_NP_NN
" " B-O O-NP
might B-O B-VP_MD
share B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
common B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
involve B-O B-VP_VB
reactive B-O B-NP_NP_JJ
oxygen B-O B-NN
intermediates B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
ROI B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
as B-O B-PP_IN
messenger B-O B-NP_NN
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-S_NP_JJ
T B-O B-NN
cell B-O B-NN
transcription B-O B-NN
factor B-O B-NN
GATA-3 B-O B-NN
" " B-O O-NP
stimulates B-O B-VP_VBZ
HIV-1 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_NP_DT
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcriptional B-O B-NP_JJ
activating B-O B-VBG
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
GATA B-O B-NN
factors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
to B-O B-PP_TO
a B-O B-NP_DT
consensus B-O B-NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
a B-O B-NP_DT
C4 B-O B-ADJP_NN
zinc B-O B-NN
finger B-O B-NN
DNA B-O B-NN
binding B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_NP_CD
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
multigene B-O B-JJ
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
GATA-3 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
most B-O B-ADVP_RBS
abundantly B-O B-RB
" " B-O O-ADVP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
T B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
cellular B-O B-JJ
target B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
and B-O B-NP_NP_NP_PRN_NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
DNase B-O B-NN
I B-O B-CD
footprinting B-O B-NN
analysis B-O B-NN
" " B-O O-NP
revealed B-O B-VP_VBD
six B-O B-NP_NP_CD
hGATA-3 B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_NP_DT
U3 B-O B-NN
region B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
the B-O B-NP_DT
transcriptional B-O B-ADJP_JJ
regulatory B-O B-JJ
" " B-O O-ADJP
domain B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cotransfection B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
hGATA-3 B-O B-NN
expression B-O B-NN
plasmid B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
a B-O B-NP_NP_DT
reporter B-O B-NN
plasmid B-O B-NN
" " B-O O-NP
whose B-O B-SBAR_WHNP_WPP
transcription B-O B-NN
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
directed B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
6- B-O B-NP_NP_QP_CD
to B-O B-TO
10-fold B-O B-JJ
" " B-O O-QP
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
LTR-mediated B-O B-NP_JJ
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
site B-O B-S_NP_NP_ADJP_NN
specific B-O B-JJ
" " B-O O-ADJP
mutation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
GATA B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
virtual B-O B-NP_NP_JJ
abrogation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
hGATA-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
deletion B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hGATA-3 B-O B-NN
transcriptional B-O B-JJ
activation B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
abolished B-O B-VP_VBD
GATA-dependent B-O B-NP_JJ
HIV-1 B-O B-NN
trans-activation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
showing B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
direct B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Introduction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
HIV-1 B-O B-NN
plasmids B-O B-NNS
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
the B-O B-S_NP_DT
GATA B-O B-NN
sites B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
mutated B-O B-VP_VBN
" " B-O B-NP_PP_PP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
caused B-O B-VP_VBD
a B-O B-NP_NP_DT
significant B-O B-JJ
reduction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
LTR-mediated B-O B-NP_JJ
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
at B-O B-PP_PP_IN
both B-O B-NP_CC
the B-O B-DT
basal B-O B-JJ
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
( B-O B-NP_ADJP_LRB
PHA- B-O B-NP_NP_NN
" " B-O O-NP
plus B-O B-CC
PMA- B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
stimulated B-O B-JJ
" " B-O O-ADJP
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
in B-O B-S_PP_IN
addition B-O B-NN
to B-O B-TO
its B-O B-NP_NP_PRPP
normal B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocyte B-O B-NN
gene B-O B-NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
hGATA-3 B-O B-NP_NN
" " B-O O-NP
may B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
play B-O B-VP_VB
a B-O B-NP_DT
significant B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HIV-1 B-O B-NP_NN
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Analysis B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
preexisting B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
nuclear B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
forms B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_NP_NP_DT
nuclear B-O B-JJ
factor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
NF-AT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
3 B-O B-CD
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
inducible B-O B-JJ
DNA-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-AT B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
thought B-O B-VP_VBN
to B-O B-S_NP_VP_TO
consist B-O B-VP_VB
of B-O B-PP_IN
two B-O B-NP_NP_CD
components B-O B-NNS
" " B-O O-NP
: B-O B-COLON
, B-O B-NP_NP_COMMA
and B-O B-CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
nuclear B-O B-S_NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
form B-O B-VP_VBP
two B-O B-NP_NP_CD
inducible B-O B-JJ
NF-AT B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
, B-O B-COMMA
although B-O B-SBAR_IN
form B-O B-S_NP_NP_PP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
ability B-O B-NN
to B-O B-S_NP_VP_TO
detect B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
essential B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
strikingly B-O B-ADJP_RB
dependent B-O B-JJ
on B-O B-PP_IN
the B-O B-NP_NP_DT
precise B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
present B-O B-VP_VBP
evidence B-O B-NP_NN
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_NP_DT
component B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
derived B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
Fos B-O B-S_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
proteins B-O B-NNS
" " B-O O-NP
stabilize B-O B-VP_VBP
its B-O B-NP_NP_PRPP
interaction B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
discussed B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
context B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
model B-O B-NN
" " B-O O-NP
relating B-O B-VP_VBG
the B-O B-NP_DT
two B-O B-CD
nuclear B-O B-JJ
NF-AT B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Enhancing B-O B-NP_NP_NN
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
17 B-O B-NP_CD
beta-estradiol B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
human B-O B-NP_JJ
NK B-O B-NN
cell B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
in B-O B-ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
17 B-O B-NP_CD
beta-estradiol B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
NK B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
proliferation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NK B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
YT-N17 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
a B-O B-NP_DT
human B-O B-JJ
NK-like B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
enhanced B-O B-VP_VBN
by B-O B-NP_PP_IN
17 B-O B-NP_NP_CD
beta-estradiol B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
E2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_DT
enhancement B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
blocked B-O B-VP_VBN
by B-O B-NP_PP_IN
tamoxifen B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
Tx B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
antagonist B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
E2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-NP_DT
contrary B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
other B-O B-NP_NP_JJ
steroid B-O B-NN
hormones B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
Tx B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
progesterone B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
testosterone B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VBD
no B-O B-NP_DT
effect B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
YT-N17 B-O B-S_NP_NN
" " B-O O-NP
contained B-O B-VP_VBD
11.8 B-O B-NP_NP_NP_NP_ADJP_CD
fmol/mg B-O B-NN
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
estrogen B-O B-NP_NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
mean B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_CD
independent B-O B-JJ
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
value B-O B-NN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
5-10-fold B-O B-ADJP_ADJP_RB
higher B-O B-JJR
" " B-O O-ADJP
than B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_S_NP_NP_DT
enhancement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NK B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
E2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
seen B-O B-VBN
in B-O B-NP_PP_IN
large B-O B-NP_NP_JJ
granular B-O B-JJ
lymphocytes B-O B-NNS
" " B-O O-NP
obtained B-O B-VP_VBN
from B-O B-NP_PP_IN
normal B-O B-NP_JJ
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
again B-O B-VP_ADVP_RB
" " B-O O-ADVP
suppressed B-O B-VBN
by B-O B-NP_PP_IN
Tx B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
E2 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
activating B-O B-VBG
factors B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_DT
Epstein-Barr B-O B-JJ
virus B-O B-NN
nuclear B-O B-JJ
antigen B-O B-NN
2 B-O B-CD
" " B-O O-NP
interacts B-O B-VP_VBZ
with B-O B-PP_IN
an B-O B-NP_NP_DT
EBNA2 B-O B-ADJP_NN
responsive B-O B-JJ
" " B-O O-ADJP
cis-element B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
terminal B-O B-JJ
protein B-O B-NN
1 B-O B-CD
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
Epstein-Barr B-O B-JJ
virus B-O B-NN
protein B-O B-NN
EBNA2 B-O B-NN
" " B-O O-NP
acts B-O B-VP_VP_VBZ
as B-O B-PP_IN
a B-O B-NP_NP_DT
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cellular B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
viral B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
plays B-O B-VP_VBZ
a B-O B-NP_DT
crucial B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
immortalization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
primary B-O B-JJ
B-cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
EBV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
previously B-O B-ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
EBNA2 B-O B-S_NP_NN
" " B-O O-NP
transactivates B-O B-VP_VBZ
the B-O B-NP_NP_DT
promoters B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
latent B-O B-JJ
membrane B-O B-NN
antigens B-O B-NNS
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
promoter B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TP1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
chosen B-O B-VP_VBN
as B-O B-NP_PP_IN
a B-O B-NP_NP_DT
model B-O B-JJ
system B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHADVP_S_NP_VP_TO
study B-O B-VP_VB
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
identify B-O B-VP_VB
an B-O B-NP_DT
EBNA2 B-O B-ADJP_NN
dependent B-O B-JJ
" " B-O O-ADJP
cis-acting B-O B-JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
various B-O B-NP_JJ
TP1 B-O B-NN
promoter-reporter B-O B-NN
gene B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
transfected B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
absence B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
presence B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
EBNA2 B-O B-NN
expression B-O B-NN
vector B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
into B-O B-PP_IN
the B-O B-NP_DT
established B-O B-JJ
B-cell B-O B-NN
line B-O B-NN
BL41-P3HR1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
were B-O B-VP_VBD
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
delineate B-O B-VP_VB
an B-O B-NP_NP_DT
81 B-O B-CD
bp B-O B-NN
EBNA2 B-O B-ADJP_NN
responsive B-O B-JJ
" " B-O O-ADJP
region B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
element B-O B-NN
" " B-O O-NP
worked B-O B-VP_VP_VBD
in B-O B-PP_IN
either B-O B-NP_DT
orientation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
could B-O B-VP_MD
mediate B-O B-VP_VB
EBNA2 B-O B-NP_NP_ADJP_NN
dependent B-O B-JJ
" " B-O O-ADJP
transactivation B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
a B-O B-NP_DT
heterologous B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Electrophoretic B-O B-S_NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
revealed B-O B-VP_VBD
three B-O B-NP_NP_CD
specific B-O B-JJ
protein-DNA B-O B-NN
complexes B-O B-NNS
" " B-O O-NP
formed B-O B-VP_VBN
with B-O B-NP_PP_IN
sequences B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
EBNA2 B-O B-ADJP_NN
responsive B-O B-JJ
" " B-O O-ADJP
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
cell B-O B-ADJP_NP_NN
type B-O B-NN
" " B-O O-NP
specific B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
the B-O B-S_NP_DT
third B-O B-JJ
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
only B-O B-NP_PP_RB
in B-O B-IN
EBNA2 B-O B-NP_ADJP_NN
positive B-O B-JJ
" " B-O O-ADJP
cell B-O B-NN
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Gel-shift B-O B-S_NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
EBNA2 B-O B-NP_ADJP_NN
specific B-O B-JJ
" " B-O O-ADJP
monoclonal B-O B-JJ
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
EBNA2 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
third B-O B-JJ
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
experiments B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
EBNA2 B-O B-S_NP_NN
" " B-O O-NP
interacts B-O B-VP_VBZ
with B-O B-PP_IN
an B-O B-NP_NP_DT
EBNA2 B-O B-ADJP_NN
responsive B-O B-JJ
" " B-O O-ADJP
cis-element B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TP1 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_DT
interleukin B-O B-NN
2 B-O B-CD
CD28-responsive B-O B-JJ
complex B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
at B-O B-NP_NP_NP_QP_IN
least B-O B-JJS
three B-O B-CD
" " B-O O-QP
members B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF B-O B-NN
kappa B-O B-NN
B B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
: B-O B-COLON
c-Rel B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p50 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Optimal B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
at B-O B-NP_QP_IN
least B-O B-JJS
two B-O B-CD
" " B-O O-QP
signals B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_S_NP_CD
signal B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
delivered B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
antigen-specific B-O B-JJ
T-cell B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_DT
second B-O B-JJ
signal B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
provided B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
costimulatory B-O B-JJ
molecule B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
delivered B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
antigen-presenting B-O B-JJ
cell B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
CD28 B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
T-cell B-O B-NN
surface B-O B-NN
molecule B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
through B-O B-PP_IN
this B-O B-NP_DT
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
plays B-O B-VP_VBZ
an B-O B-NP_DT
important B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
delivering B-O B-S_NP_VP_VBG
the B-O B-NP_DT
second B-O B-JJ
activation B-O B-NN
signal B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
in B-O B-S_PP_IN
human B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
CD28-mediated B-O B-NP_JJ
signal B-O B-NN
transduction B-O B-NN
" " B-O O-NP
involves B-O B-VP_VBZ
the B-O B-NP_NP_DT
rel B-O B-NN
family B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
-- B-O B-COLON
c-Rel B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p50 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
phorbol B-O B-NP_NP_NP_NN
12-myristate B-O B-NN
13-acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
anti-CD28 B-O B-NP_NP_JJ
monoclonal B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
mAb B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
augmentation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
c-Rel B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p50 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
this B-O B-S_NP_DT
augmentation B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
occur B-O B-VP_VB
in B-O B-PP_IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
the B-O B-NP_DT
immunosuppressant B-O B-JJ
cyclosporin B-O B-NN
A B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
in B-O B-PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
, B-O B-COMMA
in B-O B-S_PP_IN
response B-O B-NN
to B-O B-TO
PMA/anti-CD28 B-O B-NP_NP_JJ
mAb B-O B-NN
" " B-O O-NP
or B-O B-CC
anti-CD3/anti-CD28 B-O B-NP_JJ
mAb B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
c-Rel B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p50 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_NP_ADJP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
functional B-O B-JJ
significance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel B-O B-NP_NP_NN
involvement B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
CD28-responsive B-O B-JJ
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
demonstrated B-O B-VP_VBN
by B-O B-NP_PP_IN
transient B-O B-NP_NP_JJ
transfection B-O B-NN
analysis B-O B-NN
" " B-O O-NP
, B-O B-COMMA
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
cotransfection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
augments B-O B-VP_VBZ
" " B-O B-NP_NP_PP_ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
interleukin-1 B-O B-NP_NP_NP_NP_NN
alpha B-O B-NN
" " B-O O-NP
and B-O B-CC
interleukin-1 B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
protein B-O B-NP_NN
phosphatase B-O B-NN
1 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
2A B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Protein B-O B-S_NP_NN
phosphatases B-O B-NNS
1 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
2A B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
important B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
regulating B-O B-S_NP_VP_VBG
cellular B-O B-NP_JJ
functions B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
controlling B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_NP_DT
inhibitors B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
phosphatases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
okadaic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
and B-O B-CC
calyculin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
increase B-O B-VP_VB
the B-O B-NP_NP_DT
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
increased B-O B-VBN
mRNA B-O B-NN
accumulation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
primarily B-O B-PP_RB
because B-O B-IN
of B-O B-IN
the B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
interleukin-1 B-O B-NP_NN
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
caused B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
factor B-O B-NN
activities B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
, B-O B-NP_COMMA
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
these B-O B-NP_DT
protein B-O B-NN
phosphatase B-O B-NN
inhibitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Okadaic B-O B-S_NP_JJ
acid B-O B-NN
" " B-O O-NP
increased B-O B-VP_VBD
the B-O B-NP_NP_NP_DT
synthesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
interleukin-1 B-O B-NN
beta B-O B-NN
precursor B-O B-UCP_NP_NN
" " B-O O-NP
and B-O B-CC
mature B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-UCP
forms B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
their B-O B-NP_PRPP
secretion B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
increased B-O B-VBD
processing B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
secretion B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
correlated B-O B-VP_VBN
with B-O B-PP_IN
the B-O B-NP_NP_DT
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-1 B-O B-NP_NN
beta B-O B-NN
convertase B-O B-NN
mRNA B-O B-NN
accumulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interleukin-1 B-O B-NP_NN
alpha B-O B-NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
more B-O B-ADJP_ADJP_RBR
modest B-O B-JJ
" " B-O O-ADJP
than B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
interleukin-1 B-O B-NP_NN
beta B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
precursor B-O B-NN
interleukin-1 B-O B-NN
alpha B-O B-NN
cytokine B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
increased B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
show B-O B-VP_VP_VBP
that B-O B-SBAR_IN
protein B-O B-S_NP_NN
phosphatase B-O B-NN
1 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
2A B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibitors B-O B-NNS
" " B-O O-NP
exert B-O B-VP_VBP
multiple B-O B-NP_JJ
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
cytokine B-O B-NP_NP_NN
production B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
these B-O B-S_NP_DT
two B-O B-CD
phosphatases B-O B-NNS
" " B-O O-NP
play B-O B-VP_VBP
important B-O B-NP_JJ
roles B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
regulating B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_NP_DT
lytic B-O B-JJ
transition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Epstein-Barr B-O B-NP_JJ
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
imitated B-O B-VP_VBN
by B-O B-NP_PP_IN
recombinant B-O B-NP_JJ
B-cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Lytic B-O B-S_NP_NP_JJ
transition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Epstein-Barr B-O B-NP_NP_JJ
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EBV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
initiated B-O B-VP_VBN
by B-O B-NP_PP_IN
distinct B-O B-NP_NP_JJ
immediate B-O B-JJ
early B-O B-JJ
regulators B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
viral B-O B-JJ
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
synchronization B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
, B-O B-NP_NP_ADJP_ADJP_COMMA
conditions B-O B-ADJP_NNS
" " B-O O-NP
during B-O B-PP_IN
host B-O B-NP_NN
cell B-O B-NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
developed B-O B-VP_VBD
eukaryotic B-O B-NP_NP_JJ
vectors B-O B-NNS
" " B-O O-NP
suitable B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
imitate B-O B-VP_VB
the B-O B-NP_NP_DT
processes B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_S_NP_CD
stable B-O B-JJ
B B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
established B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
R59Z B-O B-S_NP_NN
activator B-O B-NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
induce B-O B-VP_VB
lytic B-O B-NP_JJ
EBV B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
constitutive B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
R7-57 B-O B-S_NP_NN
reporter B-O B-NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
on B-O B-PP_IN
the B-O B-NP_DT
other B-O B-JJ
hand B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
signaled B-O B-VP_VBD
induced B-O B-NP_NP_VBN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
lytic B-O B-JJ
origin B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
EBV B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
ori B-O B-NP_NN
Lyt B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Different B-O B-S_NP_NP_JJ
modes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
like B-O B-PP_IN
chemical B-O B-NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
, B-O B-COMMA
lytic B-O B-NP_NP_JJ
superinfection B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
EBV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
single B-O B-NP_JJ
gene B-O B-NN
trans-activation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
converted B-O B-VP_VBD
the B-O B-NP_NP_DT
recombinant B-O B-JJ
ori B-O B-NN
Lyt B-O B-NN
element B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
R7-57 B-O B-NP_NN
reporter B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
BZLF B-O B-S_NP_NP_NN
1 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
transiently B-O B-VP_ADVP_RB
" " B-O O-ADVP
expressed B-O B-VBN
in B-O B-NP_PP_IN
R7-57 B-O B-NP_NN
reporter B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
the B-O B-NP_NP_DT
only B-O B-JJ
EBV B-O B-NN
trans-activator B-O B-NN
" " B-O O-NP
found B-O B-VP_VBN
" " B-O B-NP_O-VP
, B-O B-COMMA
sufficient B-O B-ADJP_JJ
in B-O B-PP_NN
inducing B-O B-S_NP_VP_VBG
the B-O B-NP_DT
viral B-O B-JJ
lytic B-O B-JJ
cycle B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Basing B-O B-S_PP_VBG
on B-O B-PP_IN
these B-O B-NP_DT
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
trans-cellular B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
EBV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
tested B-O B-VP_VBN
by B-O B-NP_PP_IN
cocultivation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
BZLF B-O B-NP_ADJP_NN
1-expressing B-O B-JJ
" " B-O O-ADJP
R59Z B-O B-NN
activator B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
R7-57 B-O B-NN
reporter B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_NP_DT
lytic B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
reporter B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
measured B-O B-VP_VBN
, B-O B-NP_COMMA
neither B-O B-PP_CC
by B-O B-PP_IN
cocultivation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
activator B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
nor B-O B-CC
by B-O B-PP_IN
coincubation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_ADJP_NN
lysates B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Latency B-O B-S_NP_NN
breaking B-O B-NN
activity B-O B-NN
" " B-O O-NP
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
was B-O B-VP_VBD
transferred B-O B-VP_VBN
from B-O B-NP_PP_IN
activator B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
reporter B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
active B-O B-S_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
exogenous B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
virus B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
added B-O B-VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
cell B-O B-NN
system B-O B-NN
" " B-O O-NP
described B-O B-VP_VBN
in B-O B-NP_PP_IN
these B-O B-NP_DT
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
provides B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
tool B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
detection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
EBV B-O B-NP_NN
reactivation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
demonstrates B-O B-VP_VBZ
the B-O B-NP_NP_DT
potential B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
lytic B-O B-JJ
regulatory B-O B-JJ
gene B-O B-NN
BZLF B-O B-NN
1 B-O B-CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-S_NP_JJ
CD3-CD16+ B-O B-JJ
natural B-O B-JJ
killer B-O B-NN
cells B-O B-NNS
" " B-O O-NP
express B-O B-VP_VBP
the B-O B-NP_NP_DT
hGATA-3 B-O B-NN
T B-O B-NN
cell B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
and B-O B-CC
an B-O B-NP_DT
unrearranged B-O B-JJ
2.3-kb B-O B-JJ
TcR B-O B-NN
delta B-O B-NN
transcript B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-S_S_NP_PRP
" " B-O O-NP
analyzed B-O B-VP_VBD
the B-O B-NP_NP_DT
T B-O B-NP_NP_NN
cell B-O B-NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TcR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
delta B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VBN
by B-O B-NP_PP_IN
CD3-CD16+ B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
we B-O B-S_NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
whether B-O B-SBAR_IN
these B-O B-S_NP_DT
cells B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VBD
the B-O B-NP_NP_DT
hGATA-3 B-O B-NN
T B-O B-NN
cell B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
recombination-activating B-O B-JJ
gene B-O B-NN
( B-O B-LRB
RAG B-O B-NN
) B-O B-RRB
-1 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Multiple B-O B-S_NP_NP_JJ
TcR B-O B-NN
delta B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
deriving B-O B-VP_VBG
from B-O B-PP_IN
an B-O B-NP_DT
unrearranged B-O B-JJ
TcR B-O B-NN
delta B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
both B-O B-NP_ADJP_CC
polyclonal B-O B-ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
clonal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
CD3-CD16+ B-O B-JJ
natural B-O B-NP_NP_JJ
killer B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NK B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_CD
unrearranged B-O B-JJ
TcR B-O B-NN
delta B-O B-NN
transcripts B-O B-NNS
" " B-O O-NP
had B-O B-VP_VBD
a B-O B-NP_NP_DT
size B-O B-NN
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
found B-O B-NP_NP_NP_PRN_VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Sequence B-O B-S_NP_NP_NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nine B-O B-NP_NP_CD
different B-O B-JJ
2.3-kb B-O B-JJ
cDNA B-O B-NN
clones B-O B-NNS
" " B-O O-NP
obtained B-O B-VP_VBN
from B-O B-NP_PP_IN
NK-derived B-O B-NP_JJ
polyA+ B-O B-JJ
RNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
confirmed B-O B-VP_VBD
that B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
corresponded B-O B-VP_VBD
to B-O B-PP_TO
an B-O B-NP_DT
unrearranged B-O B-JJ
TcR B-O B-NN
delta B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_S_NP_DT
cDNA B-O B-NN
" " B-O O-NP
were B-O B-VP_VBD
2343 B-O B-ADJP_NP_CD
bp B-O B-NN
" " B-O O-NP
long B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
their B-O B-S_NP_PRPP
transcription B-O B-NN
initiation B-O B-NN
site B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
located B-O B-ADJP_JJ
814 B-O B-ADVP_NP_CD
bp B-O B-NN
" " B-O O-NP
upstream B-O B-RB
from B-O B-PP_IN
the B-O B-NP_DT
J B-O B-NN
delta B-O B-NN
1 B-O B-CD
segment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
sequence B-O B-NN
" " B-O O-NP
located B-O B-ADJP_JJ
upstream B-O B-ADVP_RB
of B-O B-PP_IN
the B-O B-NP_DT
J B-O B-NN
delta B-O B-NN
1 B-O B-CD
segment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-NP
corresponded B-O B-VP_VBD
to B-O B-PP_TO
the B-O B-NP_DT
previously B-O B-ADJP_RB
reported B-O B-VBN
" " B-O O-ADJP
germ-line B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
J B-O B-NN
delta B-O B-NN
1 B-O B-CD
segment B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
correctly B-O B-VP_ADVP_RB
" " B-O O-ADVP
spliced B-O B-VBN
to B-O B-NP_PP_TO
C B-O B-NP_NN
delta B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
in B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
the B-O B-NP_DT
four B-O B-CD
C B-O B-NN
delta B-O B-NN
exons B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
already B-O B-VP_ADVP_RB
" " B-O O-ADVP
assembled B-O B-VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_CD
polyadenylation B-O B-NN
sites B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
present B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_DT
fourth B-O B-JJ
C B-O B-NN
delta B-O B-NN
exon B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
only B-O B-NP_NP_JJ
that B-O B-WDT
" " B-O O-NP
located B-O B-ADJP_JJ
at B-O B-PP_IN
the B-O B-NP_DT
3' B-O B-JJ
end B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
utilized B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
2.3-kb B-O B-JJ
cDNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hGATA-3 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
T B-O B-ADJP_NN
cell-specific B-O B-JJ
" " B-O O-ADJP
factor B-O B-NN
" " B-O O-NP
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
analyzed B-O B-VP_VBN
by B-O B-NP_PP_IN
Northern B-O B-NP_NN
blot B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_PP_IN
cultured B-O B-NP_VBN
NK B-O B-NN
cell B-O B-NP_NP_NN
population B-O B-NN
" " B-O O-NP
and B-O B-CC
clones B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
( B-O B-LRB
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
freshly B-O B-NP_ADJP_RB
derived B-O B-VBN
" " B-O O-ADJP
cell B-O B-NN
populations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
) B-O B-RRB
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_NP_DT
NK B-O B-NN
clones B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
cell B-O B-NP_NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
express B-O B-VP_VB
hGATA-3-specific B-O B-NP_JJ
mRNA B-O B-NN
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
" " B-O B-S_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
no B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
RAG-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
all B-O B-NP_NP_DT
NK B-O B-NN
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
or B-O B-CC
clones B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
analyzed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Hypertension B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
pregnancy B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Pregnancy-induced B-O B-S_NP_NP_JJ
hypertension B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PIH B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
frequent B-O B-JJ
cause B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
maternal B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
neonatal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
morbidity B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
mortality B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
focused B-O B-VP_VBD
on B-O B-PP_PP_IN
the B-O B-NP_NP_DT
pathophysiology B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PIH B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
mainly B-O B-PP_RB
on B-O B-IN
the B-O B-NP_NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mineralocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
reversed B-O B-NP_VBN
blood B-O B-NN
pressure B-O B-NN
patterns B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_NP_DT
resulting B-O B-VBG
necessity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
continuous B-O B-NP_NP_JJ
monitoring B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Problems B-O B-S_S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
antihypertensive B-O B-NP_JJ
therapy B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
discussed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_NP_DT
first B-O B-JJ
results B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
pilot B-O B-NN
study B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
Urapidil B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
presented B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
examine B-O B-VP_VB
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mineralocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
pathophysiology B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PIH B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
plasma B-O B-NP_NP_NP_NP_NN
aldosterone B-O B-NN
" " B-O O-NP
and B-O B-CC
18-hydroxy-corticosterone B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
18-OH-B B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_PP_IN
25 B-O B-NP_NP_CD
women B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
PIH B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
in B-O B-PP_IN
25 B-O B-NP_CD
healthy B-O B-JJ
pregnant B-O B-JJ
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
evaluated B-O B-VP_VBD
the B-O B-NP_NP_NP_NP_DT
mineralocorticoid B-O B-NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
count B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_NP_JJ
leukocytes B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
2 B-O B-CD
groups B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
MR-count B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
significantly B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
PIH-group B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
values B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
plasma B-O B-NP_NP_NN
aldosterone B-O B-NN
" " B-O O-NP
and B-O B-CC
18-OH-B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
low B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
not B-O B-RB
be B-O B-VP_VB
explained B-O B-VP_VBN
by B-O B-NP_PP_IN
receptor B-O B-NP_NP_NN
down-regulation B-O B-NN
" " B-O O-NP
due B-O B-PP_JJ
to B-O B-TO
higher B-O B-NP_NP_JJR
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Perhaps B-O B-S_ADVP_RB
" " B-O O-ADVP
deoxycorticosterone B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
a B-O B-NP_DT
hitherto B-O B-RB
unknown B-O B-JJ
mineralocorticoid B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_DT
hypertension B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
altered B-O B-NP_JJ
MR-status B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
first B-O B-JJ
results B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
continuous B-O B-NP_NP_JJ
blood B-O B-NN
pressure B-O B-NN
measurements B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_DT
noninvasive B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
real-time B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
blood B-O B-NN
pressure B-O B-NN
monitor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Finapres B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
presented B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
comparison B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
obtained B-O B-VBN
values B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
intraarterial B-O B-NP_JJ
measurements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrates B-O B-VP_VBZ
a B-O B-NP_NP_DT
good B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
methods B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
report B-O B-VP_VBP
on B-O B-PP_IN
the B-O B-NP_NP_DT
first B-O B-JJ
experiences B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
Urapidil B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hypertension B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
hypertension B-O B-S_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
preeclamptic B-O B-NP_JJ
women B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
treated B-O B-VP_VBN
by B-O B-NP_PP_IN
Urapidil B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
without B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
will B-O B-VP_MD
have B-O B-VP_VB
to B-O B-S_NP_VP_TO
prove B-O B-VP_VB
if B-O B-SBAR_IN
Urapidil B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_NP_DT
chimeric B-O B-JJ
type B-O B-NN
II B-O B-CD
/ B-O B-COLON
type B-O B-NN
I B-O B-CD
interleukin-1 B-O B-NN
receptor B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
mediate B-O B-VP_VB
interleukin-1 B-O B-NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
type B-O B-NN
I B-O B-CD
interleukin-1 B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-1R B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
capable B-O B-ADJP_JJ
of B-O B-PP_IN
transducing B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
signal B-O B-NN
" " B-O O-NP
resulting B-O B-VP_VBG
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
signal B-O B-NN
transduction B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
the B-O B-NP_NP_DT
cytoplasmic B-O B-JJ
domain B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
consists B-O B-S_NP_VP_VBZ
of B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NN
to B-O B-TO
the B-O B-NP_DT
type B-O B-NN
I B-O B-CD
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-S_S_NP_DT
type B-O B-NN
II B-O B-CD
IL-1R B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
a B-O B-NP_DT
small B-O B-JJ
cytoplasmic B-O B-JJ
tail B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
it B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
not B-O B-RB
clear B-O B-ADJP_JJ
" " B-O O-ADJP
whether B-O B-SBAR_IN
this B-O B-S_NP_DT
receptor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
or B-O B-NP_NP_NP_CC
molecule B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
type B-O B-NN
II B-O B-CD
IL-1R B-O B-NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
mediate B-O B-VP_VB
gene B-O B-NP_NP_NN
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
a B-O B-NP_NP_DT
hybrid B-O B-NN
receptor B-O B-NN
" " B-O O-NP
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
the B-O B-NP_NP_DT
extracellular B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
transmembrane B-O B-ADJP_NN
" " B-O O-ADJP
" " B-O O-ADJP
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
human B-O B-JJ
type B-O B-NN
II B-O B-CD
interleukin-1 B-O B-NN
" " B-O O-NP
fused B-O B-VP_VBN
to B-O B-NP_PP_TO
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
capable B-O B-ADJP_JJ
of B-O B-PP_IN
transducing B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
signal B-O B-NN
" " B-O O-NP
" " B-O B-VP_O-NP
across B-O B-PP_IN
the B-O B-NP_DT
membrane B-O B-NN
" " B-O O-NP
" " B-O O-PP
resulting B-O B-VP_VBG
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
extracellular B-O B-JJ
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
type B-O B-NN
II B-O B-CD
IL-1R B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
capable B-O B-ADJP_JJ
of B-O B-PP_IN
and B-O B-S_NP_VP_VP_CC
" " B-O B-VP_O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Mice B-O B-S_NP_NP_NNS
" " B-O O-NP
deficient B-O B-ADJP_NN
for B-O B-PP_IN
the B-O B-NP_DT
55 B-O B-ADJP_CD
kd B-O B-JJ
" " B-O O-ADJP
tumor B-O B-NN
necrosis B-O B-NN
factor B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
are B-O B-VP_VP_VBP
resistant B-O B-ADJP_JJ
to B-O B-PP_TO
endotoxic B-O B-NP_JJ
shock B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
yet B-O B-RB
succumb B-O B-VP_VBP
to B-O B-PP_TO
L. B-O B-NP_FW
monocytogenes B-O B-NNS
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
multiple B-O B-JJ
biological B-O B-JJ
activities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TNF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
two B-O B-NP_NP_CD
distinct B-O B-JJ
cell B-O B-NN
surface B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
55 B-O B-NP_NP_NP_CD
kd B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
75 B-O B-NP_NP_CD
kd B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
gene B-O B-NP_NN
targeting B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
generated B-O B-VP_VBD
a B-O B-NP_DT
TNFRp55-deficient B-O B-JJ
mouse B-O B-NN
strain B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cells B-O B-S_NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
TNFRp55-/-mutant B-O B-NP_JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
lack B-O B-VP_VP_VBP
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TNFRp55 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
display B-O B-VP_VBP
normal B-O B-NP_NP_JJ
numbers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
high B-O B-NP_JJ
affinity B-O B-NN
TNFRp75 B-O B-NN
molecules B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thymocyte B-O B-S_S_NP_NP_NN
development B-O B-NN
" " B-O O-NP
and B-O B-CC
lymphocyte B-O B-NP_NN
populations B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
unaltered B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
clonal B-O B-S_NP_NP_JJ
deletion B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
potentially B-O B-NP_ADJP_RB
self-reactive B-O B-JJ
" " B-O O-ADJP
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
impaired B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
TNF B-O B-NP_NN
signaling B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
largely B-O B-VP_ADVP_RB
" " B-O O-ADVP
abolished B-O B-VBN
, B-O B-NP_COMMA
as B-O B-SBAR_IN
judged B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
failure B-O B-NN
" " B-O B-S_O-NP
of B-O B-PP_IN
" " B-O B-NP_S_NP_VP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TNFRp55 B-O B-NP_NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
renders B-O B-VP_VBZ
mice B-O B-S_NP_NNS
" " B-O O-NP
resistant B-O B-ADJP_JJ
to B-O B-PP_TO
lethal B-O B-NP_NP_JJ
dosages B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_CC
lipopolysaccharides B-O B-NP_NNS
" " B-O O-NP
or B-O B-CC
S. B-O B-NP_FW
aureus B-O B-FW
enterotoxin B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
TNFRp55-deficient B-O B-NP_JJ
mice B-O B-NNS
" " B-O O-NP
are B-O B-VP_VP_VBP
severely B-O B-ADJP_RB
impaired B-O B-JJ
to B-O B-S_NP_VP_TO
clear B-O B-VP_VB
L. B-O B-NP_FW
monocytogenes B-O B-FW
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
readily B-O B-VP_ADVP_RB
" " B-O O-ADVP
succumb B-O B-VBP
to B-O B-PP_TO
infection B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
55 B-O B-CD
kd B-O B-NN
TNFR B-O B-NN
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
decisive B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_NP_DT
host B-O B-NN
's B-O B-POS
" " B-O O-NP
defense B-O B-NN
" " B-O O-NP
against B-O B-PP_IN
microorganisms B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
their B-O B-NP_PRPP
pathogenic B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cell-specific B-O B-NP_NP_JJ
bifunctional B-O B-JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Jun B-O B-NP_NN
oncogene B-O B-NN
family B-O B-NN
members B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
glucocorticoid B-O B-NP_ADJP_NN
receptor-dependent B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Interaction B-O B-S_NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
protein B-O B-NP_ADJP_ADJP_NP_NN
kinase B-O B-NN
C B-O B-NN
( B-O B-LRB
PKC B-O B-NN
) B-O B-RRB
- B-O B-COLON
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
glucocorticoid B-O B-ADJP_NN
receptor B-O B-NN
( B-O B-LRB
GR B-O B-NN
) B-O B-RRB
-mediated B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
signaling B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
suggested B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O B-S_O-NP
of B-O B-PP_IN
the B-O B-NP_DT
PKC B-O B-NN
activating B-O B-NN
phorbol B-O B-NN
ester B-O B-NN
12-O-tetradecanoylphorbol-13-acetate B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
this B-O B-S_NP_DT
interference B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
cell B-O B-ADJP_NN
specific B-O B-JJ
" " B-O O-ADJP
, B-O B-COMMA
as B-O B-SBAR_IN
TPA B-O B-S_NP_NN
" " B-O O-NP
augmented B-O B-VP_VP_VBD
but B-O B-NP_PP_CC
was B-O B-VP_VBD
" " B-O B-ADJP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TPA-GR B-O B-S_NP_NN
synergism B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
to B-O B-S_NP_VP_TO
have B-O B-VP_VB
occurred B-O B-VP_VBN
at B-O B-PP_IN
the B-O B-NP_DT
level B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
by B-O B-PP_IN
functional B-O B-NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
deletion B-O B-NP_NP_NP_NN
mutants B-O B-NNS
" " B-O O-NP
or B-O B-CC
synthetic B-O B-NP_JJ
GRE B-O B-NN
oligonucleotides B-O B-NNS
" " B-O O-NP
" " B-O O-NP
driving B-O B-VP_VBG
chloramphenicol B-O B-NP_NN
acetyl-transferase B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Synergism B-O B-S_S_NP_NN
" " B-O O-NP
required B-O B-VP_VBD
an B-O B-NP_DT
intact B-O B-JJ
GR B-O B-NN
DNA-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
amino- B-O B-S_NP_ADJP_ADJP_NN
" " B-O B-ADJP_O-ADJP
or B-O B-CC
carboxyl-terminal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
domains B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
dispensable B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
abrogated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
PKC B-O B-NN
inhibitor B-O B-NN
staurosporine B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Increased B-O B-S_NP_NP_NP_VBN
c-jun B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
jun-B B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
jun-D B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
above B-O B-PP_IN
basal B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
increased B-O B-NP_NP_VBN
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1/TPA B-O B-NP_NP_NN
responsive B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
fused B-O B-VP_VBN
to B-O B-NP_PP_TO
chloramphenicol B-O B-NP_NN
acetyl-transferase B-O B-NN
vectors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
T B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
TPA B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-UCP_ADVP_CC
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
ability B-O B-NN
" " B-O B-S_O-NP
of B-O B-PP_IN
Jun B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
cooperate B-O B-VP_VB
with B-O B-PP_IN
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
investigated B-O B-VP_VBN
after B-O B-NP_PP_IN
transfection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_NP_COMMA
, B-O B-NP_COMMA
or B-O B-CC
expression B-O B-NP_NN
vectors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
augmented B-O B-S_NP_VP_VBD
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Conversely B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
c-jun B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
jun-B B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
transfection B-O B-NN
" " B-O O-NP
blunted B-O B-VP_VBD
GR-dependent B-O B-NP_NP_JJ
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
had B-O B-VP_VP_VBD
a B-O B-NP_DT
negative B-O B-JJ
influence B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
GR B-O B-NP_NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
correlated B-O B-VP_VBD
with B-O B-PP_IN
the B-O B-NP_NP_DT
cell-specific B-O B-JJ
synergistic B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
antagonistic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
respect B-O B-NN
to B-O B-TO
GR B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
high B-O B-S_NP_NP_NP_JJ
basal B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
AP-1 B-O B-NP_NP_NN
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
and B-O B-CC
transcriptional B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
overexpression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
exogenous B-O B-NP_JJ
c-fos B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
an B-O B-NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
GR-dependent B-O B-NP_NP_JJ
transcription B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
GRE B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
Jun B-O B-S_NP_NN
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
bifunctional B-O B-JJ
role B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
GR-dependent B-O B-NP_NP_JJ
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GRE B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
selecting B-O B-S_NP_VP_VBG
either B-O B-NP_ADJP_CC
or B-O B-ADJP_CC
activity B-O B-ADJP_NN
" " B-O O-NP
depending B-O B-PP_VBG
on B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
regard B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
intracellular B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appear B-O B-VP_VBP
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
influential B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_DT
concatenated B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Epstein-Barr B-O B-NP_JJ
viral B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
lymphoblastoid B-O B-NP_NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
transfection B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
BZLF1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
replicative B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Epstein-Barr B-O B-NP_NP_NP_JJ
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EBV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
using B-O B-NP_S_NP_VP_VBG
two B-O B-NP_NP_NP_CD
lymphoblastoid B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
X50-7 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
6F11 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
lytic B-O B-JJ
cycle B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
EBV B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
transfection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_NP_DT
BRLF1/BZLF1 B-O B-NN
coding B-O B-NN
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
P3HR-1 B-O B-NN
defective B-O B-JJ
genome B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
combined B-O B-VP_VBD
two B-O B-NP_CD
techniques B-O B-NNS
" " B-O O-NP
to B-O B-S_NP_VP_TO
identify B-O B-VP_VB
the B-O B-NP_NP_DT
productive B-O B-JJ
replicative B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Epstein-Barr B-O B-NP_JJ
viral B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
lytic B-O B-ADJP_JJ
cycle-induced B-O B-JJ
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Restriction B-O B-S_NP_NP_NN
enzyme B-O B-NN
analysis B-O B-NN
" " B-O O-NP
followed B-O B-VP_VBN
by B-O B-NP_PP_IN
Southern B-O B-NP_NN
blot B-O B-NN
hybridization B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
identified B-O B-VP_VBD
a B-O B-NP_NP_DT
significant B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
fused B-O B-VBN
fragment B-O B-NN
" " B-O O-NP
encompassing B-O B-VP_VBG
both B-O B-NP_NP_DT
ends B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
EBV B-O B-NP_NN
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
indicates B-O B-VP_VBZ
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
either B-O B-NP_CC
episomal B-O B-NP_JJ
DNA B-O B-NN
" " B-O O-NP
or B-O B-CC
concatameric B-O B-NP_JJ
linear B-O B-JJ
DNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Southern B-O B-S_NP_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
lysing B-O B-VBG
gels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
cellular B-O B-JJ
content B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
linear B-O B-NP_JJ
EBV B-O B-NN
DNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
increased B-O B-VBN
significantly B-O B-NP_ADVP_RB
" " B-O O-ADVP
after B-O B-PP_IN
the B-O B-NP_NP_DT
initiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
while B-O B-SBAR_IN
remained B-O B-S_NP_NP_PP_VP_VBD
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
from B-O B-PP_IN
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_NP_DT
source B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
fused B-O B-VBN
fragment B-O B-NN
" " B-O O-NP
encompassing B-O B-VP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_DT
concatenated B-O B-VBN
linear B-O B-JJ
EBV B-O B-NN
DNA B-O B-NN
molecule B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
such B-O B-S_NP_PDT
a B-O B-DT
concatenated B-O B-VBN
molecule B-O B-NN
" " B-O O-NP
most B-O B-ADVP_RBS
likely B-O B-RB
" " B-O O-ADVP
represents B-O B-VP_VBZ
a B-O B-NP_NP_DT
replicative B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Defective B-O B-S_NP_NP_JJ
translocation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
multidrug-resistant B-O B-NP_JJ
HL-60 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
confers B-O B-VP_VBZ
a B-O B-NP_NP_DT
reversible B-O B-JJ
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
phorbol B-O B-NP_ADJP_NN
ester-induced B-O B-JJ
" " B-O O-ADJP
monocytic B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Previous B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
human B-O B-S_NP_JJ
HL-60 B-O B-NN
myeloid B-O B-JJ
leukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
differentiate B-O B-VP_VBP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
phorbol B-O B-NP_NN
esters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
event B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
induction B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-jun B-O B-NN
early B-O B-JJ
response B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
appearance B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
monocytic B-O B-JJ
phenotype B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
present B-O B-JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
vincristine-selected B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
multidrug B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
resistance B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
12-O-tetradecanoylphorbol-13-acetate B-O B-NP_ADJP_NN
( B-O B-LRB
TPA B-O B-NN
) B-O B-RRB
-induced B-O B-JJ
" " B-O O-ADJP
HL-60 B-O B-NN
cell B-O B-NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
multidrug-resistant B-O B-S_NP_NP_JJ
HL-60 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
designated B-O B-VP_VBN
HL-60/vinc B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
fail B-O B-VP_VBP
to B-O B-S_NP_VP_TO
respond B-O B-VP_VB
to B-O B-PP_TO
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
treatment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HL-60/vinc B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
okadaic B-O B-NP_NP_JJ
acid B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
serine/threonine B-O B-NP_NN
protein B-O B-NN
phosphatases B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
induces B-O B-VP_VBZ
c-jun B-O B-NP_NP_NN
transcription B-O B-NN
" " B-O O-NP
, B-O B-COMMA
growth B-O B-NP_NN
arrest B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-fms B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Studies B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
performed B-O B-VBN
with B-O B-NP_PP_IN
an B-O B-NP_NP_DT
HL-60/vinc B-O B-ADJP_ADJP_NN
revertant B-O B-NN
" " B-O O-ADJP
( B-O B-PRN_LRB
HL-60/vinc/R B-O B-ADJP_NN
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
line B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
has B-O B-S_NP_VP_VBZ
regained B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
finding B-O B-NN
that B-O B-SBAR_IN
HL-60/vinc/R B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
respond B-O B-VP_VBP
to B-O B-PP_TO
TPA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
induction B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
c-jun B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
c-jun B-O B-S_NP_NN
induction B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
obligatory B-O B-ADJP_JJ
for B-O B-PP_IN
monocytic B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Other B-O B-S_S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
jun-B B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
fra-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
genes B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
induced B-O B-VP_VBN
by B-O B-NP_PP_IN
TPA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
cells B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
c-fos B-O B-S_NP_NN
expression B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
attenuated B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
HL-60/vinc B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
TPA B-O B-S_NP_NN
" " B-O O-NP
activates B-O B-VP_VBZ
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PKC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
translocation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
from B-O B-PP_IN
the B-O B-NP_DT
cytosol B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
membrane B-O B-NN
fraction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
HL-60 B-O B-S_NP_UCP_NP_NN
" " B-O O-NP
and B-O B-CC
HL-60/vinc/R B-O B-ADJP_NN
" " B-O O-ADJP
" " B-O O-UCP
cells B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
translocation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
this B-O B-NP_DT
subcellular B-O B-JJ
redistribution B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
undetectable B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
HL-60/vinc B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activity B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
mitogen-activated B-O B-JJ
protein B-O B-NN
kinase B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
associated B-O B-NP_NP_JJ
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Jun B-O B-NP_NN
Y-peptide B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
markedly B-O B-VP_ADVP_RB
" " B-O O-ADVP
diminished B-O B-VBN
in B-O B-NP_PP_IN
TPA-treated B-O B-NP_JJ
HL-60/vinc B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
response B-O B-NN
to B-O B-TO
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
these B-O B-NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
vincristine B-O B-S_NP_NN
resistance B-O B-NN
" " B-O O-NP
confers B-O B-VP_VP_VBZ
insensitivity B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
TPA-induced B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
can B-O B-VP_MD
include B-O B-VP_VB
defects B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Differential B-O B-NP_NP_JJ
contribution B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
herpes B-O B-NP_NN
simplex B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
gene B-O B-NP_NP_NN
products B-O B-NNS
" " B-O O-NP
and B-O B-CC
cellular B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
provirus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
reported B-O B-VP_VBN
that B-O B-SBAR_IN
infection B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
herpes B-O B-NP_NP_NN
simplex B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
activates B-O B-VP_VBZ
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
provirus B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
provirus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
binding B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
proteins B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
kappa B-O B-NN
B B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
50-kDa B-O B-JJ
HLP-1 B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Further B-O B-S_NP_NP_RB
examination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
system B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
shown B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HSV-1 B-O B-NP_NN
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
antiviral B-O B-JJ
drug B-O B-NN
acyclovir B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
inhibit B-O B-VP_VB
HSV-1-mediated B-O B-NP_NP_JJ
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Surprisingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
HLP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
binding B-O B-NN
activities B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
substantially B-O B-VP_ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VBN
in B-O B-NP_PP_IN
acyclovir-treated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
the B-O B-NP_DT
transient-transfection B-O B-JJ
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
ICP0 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
ICP4 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
activated B-O B-VP_VBD
the B-O B-NP_DT
HIV-1 B-O B-NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
promoter B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ICP0 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
greatly B-O B-VP_ADVP_RB
" " B-O O-ADVP
enhanced B-O B-VBN
in B-O B-NP_PP_IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
involves B-O B-S_NP_NP_PP_VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Minimally B-O B-S_NP_NP_ADJP_RB
modified B-O B-VBN
low B-O B-JJ
density B-O B-NN
lipoprotein-induced B-O B-JJ
" " B-O O-ADJP
inflammatory B-O B-JJ
responses B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
cyclic B-O B-NP_JJ
adenosine B-O B-NN
monophosphate B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
minimally B-O B-S_NP_NP_ADJP_RB
oxidized B-O B-VBN
" " B-O O-ADJP
LDL B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MM-LDL B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
activated B-O B-VP_VBD
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
to B-O B-S_NP_VP_TO
increase B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
, B-O B-COMMA
inducing B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
signaling B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
this B-O B-S_NP_DT
monocyte-specific B-O B-JJ
response B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
induced B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_NP_CC
induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
monocyte B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
mRNA B-O B-NP_NP_NN
levels B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
M-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
by B-O B-PP_IN
MM-LDL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
inhibited B-O B-VP_VBN
in B-O B-NP_PP_IN
protein B-O B-NP_ADJP_NN
kinase B-O B-NN
C-depleted B-O B-JJ
" " B-O O-ADJP
endothelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
our B-O B-NP_PRPP
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
cAMP B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
second B-O B-JJ
messenger B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
cited B-O B-NP_VP_VBN
" " B-O B-NP_ADVP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Incubation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
endothelial B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
MM-LDL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
caused B-O B-VP_VBD
a B-O B-NP_NP_DT
173 B-O B-ADJP_CD
% B-O B-NN
" " B-O O-ADJP
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
intracellular B-O B-NP_JJ
cAMP B-O B-NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Agents B-O B-S_NP_NP_NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
increased B-O B-S_NP_VP_VBD
cAMP B-O B-NP_NN
levels B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
including B-O B-PP_VBG
cholera B-O B-NP_NP_NN
toxin B-O B-NN
" " B-O O-NP
, B-O B-COMMA
pertussis B-O B-NP_NN
toxin B-O B-NN
" " B-O O-NP
, B-O B-COMMA
dibutyryl B-O B-NP_NN
cAMP B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
isoproterenol B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
mimicked B-O B-VP_VBD
the B-O B-NP_NP_DT
actions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
MM-LDL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Agents B-O B-S_NP_NP_NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
elevated B-O B-S_NP_VP_VBD
cAMP B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
activate B-O B-VP_VB
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_PP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
endothelial B-O B-S_NP_NP_NP_JJ
leukocyte B-O B-NN
adhesion B-O B-NN
molecule B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ELAM B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
mRNA B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
ELAM B-O B-S_S_NP_NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
expressed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
ELAM B-O B-S_NP_NN
mRNA B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
only B-O B-ADVP_RB
slightly B-O B-RB
" " B-O O-ADVP
elevated B-O B-VP_JJ
in B-O B-NP_PP_IN
response B-O B-NN
to B-O B-TO
MM-LDL B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
present B-O B-VP_VBP
evidence B-O B-NP_NN
that B-O B-SBAR_IN
induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
neutrophil B-O B-NP_NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
LPS B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
actually B-O B-ADVP_RB
" " B-O O-ADVP
suppressed B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_SBAR_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Costimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cAMP B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-NP
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibits B-O B-VP_VP_VBZ
the B-O B-NP_DT
CD3-dependent B-O B-JJ
T B-O B-NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
leads B-O B-VP_VBZ
to B-O B-PP_TO
a B-O B-NP_NP_DT
persistent B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
AP-1 B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
combined B-O B-JJ
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
pathways B-O B-NP_ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
investigated B-O B-VP_VBN
in B-O B-NP_PP_IN
different B-O B-NP_JJ
cellular B-O B-JJ
systems B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
shown B-O B-VP_VBN
that B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
may B-O B-VP_MD
" " B-O B-VP_O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
upon B-O B-S_PP_IN
the B-O B-NP_NP_DT
stimulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
became B-O B-VP_VBD
refractory B-O B-ADJP_JJ
to B-O B-PP_TO
activation B-O B-NP_NP_NN
" " B-O O-NP
via B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
T B-O B-S_S_NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
preincubated B-O B-VP_VBN
with B-O B-NP_PP_IN
phorbol B-O B-NP_NP_NP_NN
12-myristate B-O B-NN
13-acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
dibutyryl B-O B-NP_NP_NN
cAMP B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Bt2cAMP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
displayed B-O B-VP_VBD
a B-O B-NP_DT
deficient B-O B-JJ
proliferative B-O B-JJ
ability B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
anti-CD3 B-O B-NP_JJ
mAb B-O B-NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
lymphocytes B-O B-S_NP_NP_NNS
" " B-O O-NP
treated B-O B-VP_VBN
individually B-O B-NP_ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
either B-O B-NP_CC
Bt2cAMP B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
responded B-O B-VP_VBD
comparably B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
untreated B-O B-NP_JJ
samples B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
detected B-O B-VP_VBD
an B-O B-NP_NP_DT
association B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
reduced B-O B-NP_NP_VBN
mitogenic B-O B-JJ
response B-O B-NN
" " B-O O-NP
and B-O B-CC
low B-O B-NP_JJ
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_CC
interleukin-2 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
of B-O B-NP_NP_NP_PRN_PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
intracellular B-O B-NP_JJ
Ca2+ B-O B-NN
mobilization B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
CD3/TcR-dependent B-O B-JJ
signal B-O B-NN
transduction B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
impaired B-O B-VP_JJ
in B-O B-NP_PP_IN
PMA/Bt2cAMP-treated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Remarkably B-O B-S_S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
that B-O B-SBAR_IN
these B-O B-S_NP_DT
samples B-O B-NNS
" " B-O O-NP
displayed B-O B-VP_VBD
a B-O B-NP_NP_DT
persistent B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-fos B-O B-NN
protooncogene B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
associated B-O B-VP_VBN
to B-O B-NP_PP_TO
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
no B-O B-S_NP_NP_DT
variations B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
CREB B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
NF-kB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Neither B-O B-S_NP_CC
Bt2cAMP B-O B-NP_NN
" " B-O O-NP
nor B-O B-CC
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
individually B-O B-ADVP_RB
" " B-O O-ADVP
mediated B-O B-VP_VBD
these B-O B-NP_NP_DT
sustained B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
therefore B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
appear B-O B-VP_VBP
as B-O B-PP_IN
a B-O B-NP_NP_DT
consequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Altogether B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
data B-O B-NNS
" " B-O O-NP
provide B-O B-VP_VBP
the B-O B-NP_DT
evidence B-O B-NN
that B-O B-SBAR_IN
both B-O B-S_NP_DT
pathways B-O B-NNS
" " B-O O-NP
complement B-O B-VP_VP_VBP
each B-O B-NP_DT
other B-O B-JJ
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-VP
and B-O B-CC
, B-O B-COMMA
conversely B-O B-VP_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
downregulate B-O B-VBP
the B-O B-NP_DT
TcR B-O B-NN
transduction B-O B-NN
mechanisms B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Tumor B-O B-NP_NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
receptor B-O B-NN
expression B-O B-NN
" " B-O O-NP
and B-O B-CC
signal B-O B-NP_NN
transduction B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
HIV-1-infected B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
OBJECTIVE B-O B-S_NP_NN
: B-O B-COLON
" " B-O O-NP
To B-O B-S_NP_VP_TO
examine B-O B-VP_VB
the B-O B-NP_NP_DT
inter-relationship B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
HIV-1 B-O B-NP_NP_NN
infection B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
cell B-O B-NN
surface B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
DESIGN B-O B-S_NP_NN
: B-O B-COLON
" " B-O O-NP
Infected B-O B-S_NP_JJ
promyelocytic B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
promonocytic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
because B-O B-NP_SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
normally B-O B-ADVP_RB
" " B-O O-ADVP
express B-O B-VP_VBP
both B-O B-NP_NP_DT
types B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
METHODS B-O B-S_NP_NNS
: B-O B-COLON
" " B-O O-NP
TNF B-O B-S_S_NP_NN
receptor B-O B-NN
surface B-O B-NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
by B-O B-NP_PP_IN
specific B-O B-NP_NP_JJ
monoclonal B-O B-JJ
antibody B-O B-NN
recognition B-O B-NN
" " B-O O-NP
and B-O B-CC
flow B-O B-NP_NN
cytometry B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
signal B-O B-S_NP_NN
transduction B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
detected B-O B-VP_VBN
by B-O B-NP_PP_IN
gel B-O B-NP_NN
shift B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
HIV-1 B-O B-S_NP_NN
activation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
quantitated B-O B-VP_VBN
by B-O B-NP_PP_IN
reverse B-O B-NP_JJ
transcriptase B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
RESULTS B-O B-S_NP_NNS
: B-O B-COLON
" " B-O O-NP
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
OM-10.1 B-O B-NN
promyelocytic B-O B-JJ
model B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
chronic B-O B-NP_JJ
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
TNF-alpha-induced B-O B-NP_JJ
HIV-1 B-O B-NN
expression B-O B-NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
resulted B-O B-VP_VBD
in B-O B-PP_IN
a B-O B-NP_NP_DT
substantial B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
75 B-O B-NP_NP_NP_CD
kd B-O B-NN
TNF B-O B-NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
although B-O B-SBAR_IN
55 B-O B-S_NP_NP_NP_CD
kD B-O B-NN
TNF B-O B-NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TR55 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
dramatically B-O B-ADVP_RB
" " B-O O-ADVP
altered B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_NP_NP_DT
series B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
uninfected B-O B-NP_JJ
parental B-O B-JJ
HL-60 B-O B-NN
subclones B-O B-NNS
" " B-O O-NP
" " B-O O-PP
all B-O B-ADVP_DT
" " B-O O-ADVP
" " B-O O-NP
reduced B-O B-VP_VBD
TR75 B-O B-NP_NN
surface B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
TNF-alpha B-O B-NP_NN
treatment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Enhanced B-O B-S_NP_NP_VBN
TR75 B-O B-NN
expression B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
OM-10.1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
followed B-O B-VP_VBD
the B-O B-NP_NP_DT
same B-O B-JJ
TNF-alpha-dose B-O B-NN
dependency B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
that B-O B-NP_NP_WDT
" " B-O O-NP
observed B-O B-VP_VBN
for B-O B-NP_PP_IN
HIV-1 B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
An B-O B-S_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
TR75 B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
evident B-O B-ADJP_JJ
" " B-O O-ADJP
during B-O B-PP_IN
the B-O B-NP_NP_DT
peak B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_NP_DT
acute B-O B-JJ
HIV-1 B-O B-NN
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HL-60 B-O B-NP_NN
promyelocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
TR55 B-O B-S_NP_NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
unaltered B-O B-ADJP_JJ
" " B-O O-ADJP
during B-O B-PP_IN
TNF-alpha-induced B-O B-NP_JJ
HIV B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
this B-O B-NP_DT
receptor B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
still B-O B-ADVP_RB
" " B-O O-ADVP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
viral B-O B-JJ
activation B-O B-NN
process B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Antibody B-O B-S_NP_NP_NN
cross-linking B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
TR55 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
in B-O B-PP_IN
the B-O B-DT
absence B-O B-NN
of B-O B-IN
exogenous B-O B-NP_JJ
TNF-alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
induced B-O B-VP_VBN
maximal B-O B-NP_NP_NP_JJ
HIV-1 B-O B-NN
expression B-O B-NN
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
up-modulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
surface B-O B-NP_NN
TR75 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
nuclear B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
OM-10.1 B-O B-NP_NN
cultures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Surprisingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
this B-O B-NP_DT
" " B-O O-NP
was B-O B-VP_VBD
the B-O B-NP_DT
case B-O B-NN
" " B-O O-NP
even B-O B-SBAR_WHADVP_RB
when B-O B-WRB
" " B-O O-WHADVP
an B-O B-S_NP_DT
antagonistic B-O B-JJ
anti-TR55 B-O B-JJ
antibody B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
" " B-O B-NP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Anti-TR55 B-O B-S_NP_NP_JJ
antibody B-O B-NN
cross-linking B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
chronically B-O B-NP_ADJP_RB
infected B-O B-JJ
" " B-O O-ADJP
U1 B-O B-NN
promonocytic B-O B-JJ
cultures B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
only B-O B-ADVP_RB
partially B-O B-RB
" " B-O O-ADVP
substitute B-O B-VP_VB
for B-O B-PP_IN
TNF-alpha-induced B-O B-NP_JJ
HIV-1 B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CONCLUSIONS B-O B-S_NP_NNS
: B-O B-COLON
" " B-O O-NP
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
HIV-1 B-O B-S_NP_NN
infection B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
selectively B-O B-ADVP_RB
" " B-O O-ADVP
influence B-O B-VP_VB
the B-O B-NP_NP_DT
surface B-O B-NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
, B-O B-COMMA
potentially B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
and B-O B-VP_VP_CC
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
Involvement B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
Alu B-O B-NP_NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
cell-specific B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
gamma B-O B-NN
chain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
receptors B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
Fc B-O B-NN
epsilon B-O B-NN
RI-gamma B-O B-NN
chains B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VBN
in B-O B-NP_PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hematopoietic B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
where B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
They B-O B-S_NP_PRP
" " B-O O-NP
are B-O B-VP_VBP
part B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
high B-O B-JJ
affinity B-O B-NN
IgE B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
mast B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
basophils B-O B-NP_NNS
" " B-O O-NP
, B-O B-COMMA
Langerhans B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
possibly B-O B-NP_RB
other B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
; B-O B-COLON
a B-O B-NP_NP_DT
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
low B-O B-JJ
affinity B-O B-NN
receptor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
IgG B-O B-NP_NN
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
natural B-O B-NP_NP_JJ
killer B-O B-NN
cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
macrophages B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
; B-O B-COLON
and B-O B-CC
part B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
T B-O B-NN
cell B-O B-NN
antigen B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
subsets B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
gamma B-O B-NN
chain B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
analyzing B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
2.5-kilobase B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
upstream B-O B-ADVP_JJ
of B-O B-PP_IN
" " B-O B-NP_O-ADVP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
sequence B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
promoter B-O B-NN
" " B-O O-NP
specific B-O B-ADJP_JJ
to B-O B-PP_TO
cells B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
hematopoietic B-O B-NP_JJ
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
tissue B-O B-NN
specificity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
only B-O B-ADJP_RB
partial B-O B-JJ
" " B-O O-ADJP
because B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
active B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
all B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
regardless B-O B-ADVP_RB
of B-O B-PP_IN
whether B-O B-SBAR_IN
" " B-O B-S_NP_ADVP_VP_O-SBAR
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
two B-O B-NP_NP_CD
adjacent B-O B-JJ
cis-acting B-O B-JJ
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
both B-O B-SBAR_WHNP_NP_DT
" " B-O O-NP
of B-O B-WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
part B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
first B-O B-JJ
" " B-O O-NP
( B-O B-PRN_LRB
-445/-366 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
positive B-O B-JJ
element B-O B-NN
" " B-O O-NP
active B-O B-ADJP_JJ
in B-O B-PP_IN
both B-O B-NP_CC
basophils B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
second B-O B-JJ
" " B-O O-NP
( B-O B-PRN_LRB
-365/-264 B-O B-NP_CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
binds B-O B-VP_VP_VBZ
to B-O B-PP_TO
nuclear B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
appear B-O B-S_NP_VP_VBP
" " B-O B-S_NP_VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
acts B-O B-VP_VP_VBZ
as B-O B-PP_IN
a B-O B-NP_DT
negative B-O B-JJ
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
basophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
as B-O B-VP_PP_IN
a B-O B-NP_DT
positive B-O B-JJ
one B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
this B-O B-NP_NP_DT
Alu B-O B-NN
repeat B-O B-NN
" " B-O O-NP
( B-O B-LRB
90 B-O B-ADJP_NP_CD
% B-O B-NN
" " B-O O-NP
identical B-O B-JJ
to B-O B-PP_TO
Alu B-O B-NP_NN
consensus B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-NP
has B-O B-VP_VBZ
evolved B-O B-VP_VBN
to B-O B-S_NP_VP_TO
become B-O B-VP_VB
both B-O B-NP_CC
a B-O B-DT
positive B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
negative B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
regulator B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Human B-O B-S_NP_NP_JJ
immunodeficiency B-O B-NN
viruses B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VBG
heterologous B-O B-NP_JJ
enhancer/promoters B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VP_VBP
replication B-O B-ADJP_NN
competent B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
exhibit B-O B-VP_VBP
different B-O B-NP_JJ
lymphocyte B-O B-NN
tropisms B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
type B-O B-NN
1 B-O B-CD
long B-O B-NP_NP_JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
LTR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
contains B-O B-VP_VBZ
binding B-O B-NP_NP_VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
nuclear B-O B-NP_NP_NP_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
constitutively B-O B-ADJP_RB
expressed B-O B-VBN
" " B-O O-ADJP
transcription B-O B-NN
factor B-O B-NN
Sp1 B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
both B-O B-SBAR_WHNP_NP_DT
" " B-O O-NP
of B-O B-WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
conserved B-O B-VP_ADVP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_VP_TO
delineate B-O B-VP_VB
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
replicative B-O B-JJ
capacity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
to B-O B-VP_TO
explore B-O B-VP_VB
the B-O B-NP_NP_DT
possibility B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
extending B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
known B-O B-NP_VBN
heterologous B-O B-JJ
enhancer/promoters B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
inserted B-O B-VP_VBN
into B-O B-NP_PP_IN
the B-O B-NP_DT
HIV-1 B-O B-NN
LTR B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
place B-O B-NN
of B-O B-IN
the B-O B-NP_DT
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
Sp1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
substitutions B-O B-NNS
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_PP_IN
viral B-O B-NP_NP_JJ
replication B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
transfected B-O B-NP_VBN
HeLa B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
on B-O B-PP_IN
HIV B-O B-NP_NP_NN
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
or B-O B-CC
continuous B-O B-NP_JJ
T-leukemia B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
evaluated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
HIVs B-O B-S_NP_NP_NN
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
the B-O B-S_NP_NP_DT
NF- B-O B-NN
kappa B-O B-NN
B/Sp1 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
plus B-O B-CC
the B-O B-NP_DT
downstream B-O B-JJ
TATA B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
replaced B-O B-VP_VBN
with B-O B-NP_PP_IN
heterologous B-O B-NP_JJ
enhancer/promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
constructed B-O B-VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Viruses B-O B-S_NP_NP_NNS
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_DT
human B-O B-JJ
cytomegalovirus B-O B-NN
immediate-early B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
exhibited B-O B-VP_VP_VBD
infectious B-O B-NP_NP_JJ
kinetics B-O B-NNS
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
wild-type B-O B-NP_JJ
HIV B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
in B-O B-PP_IN
activated B-O B-NP_NP_VBN
human B-O B-JJ
peripheral B-O B-JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
AA2 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
but B-O B-CC
replicated B-O B-VP_VBD
less B-O B-ADVP_RBR
efficiently B-O B-RB
" " B-O O-ADVP
in B-O B-PP_IN
H9 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
CEM B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
heterologous B-O B-S_NP_JJ
enhancer B-O B-NN
elements B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
restoring B-O B-S_NP_VP_VBG
" " B-O B-NP_PP_O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Tyrosine B-O B-S_NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
mandatory B-O B-JJ
proximal B-O B-JJ
step B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
radiation-induced B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
protein B-O B-NN
kinase B-O B-NN
C B-O B-NN
signaling B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
B- B-O B-NN
lymphocyte B-O B-NN
precursors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
[ B-O B-PRN_LRB
published B-O B-S_NP_VBN
erratum B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
in B-O B-PP_IN
Proc B-O B-NP_NP_NNP
Natl B-O B-NNP
Acad B-O B-NNP
Sci B-O B-NNP
U B-O B-NNP
S B-O B-NNP
A B-O B-NNP
" " B-O O-NP
1993 B-O B-NP_CD
Apr B-O B-NNP
15 B-O B-CD
" " B-O O-NP
; B-O B-COLON
90 B-O B-NP_CD
( B-O B-LRB
8 B-O B-CD
) B-O B-RRB
: B-O B-COLON
3775 B-O B-CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
] B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-S
  
Ionizing B-O B-S_NP_VBG
radiation B-O B-NN
" " B-O O-NP
triggers B-O B-VP_VBZ
a B-O B-NP_NP_DT
signal B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
B-lymphocyte B-O B-NN
precursors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
intimately B-O B-VP_ADVP_RB
" " B-O O-ADVP
linked B-O B-VBN
to B-O B-NP_PP_TO
an B-O B-NP_DT
active B-O B-JJ
protein-tyrosine B-O B-NN
kinase B-O B-NN
regulatory B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
in B-O B-S_PP_IN
B-lymphocyte B-O B-NP_NN
precursors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
irradiation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
gamma-rays B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
( B-O B-NP_NP_LST_LRB
i B-O B-LS
) B-O B-RRB
" " B-O O-LST
stimulation B-O B-NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
; B-O B-COLON
( B-O B-NP_LST_LRB
ii B-O B-LS
) B-O B-RRB
" " B-O O-LST
downstream B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_O-NP
; B-O B-COLON
and B-O B-CC
( B-O B-NP_LST_LRB
iii B-O B-LS
) B-O B-RRB
" " B-O O-LST
activation B-O B-NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
radiation-induced B-O B-JJ
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
effectively B-O B-VP_ADVP_RB
" " B-O O-ADVP
prevented B-O B-VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
protein-tyrosine B-O B-NN
kinase B-O B-NN
inhibitors B-O B-NNS
genistein B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
herbimycin B-O B-NP_NN
A B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
tyrosine B-O B-NP_NN
phosphorylation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
an B-O B-NP_NP_DT
important B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
perhaps B-O B-ADJP_ADVP_RB
" " B-O O-ADVP
mandatory B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
proximal B-O B-JJ
step B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
protein B-O B-NN
kinase B-O B-NN
C B-O B-NN
signaling B-O B-NN
cascade B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
B-lymphocyte B-O B-NN
precursors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
report B-O B-VBP
" " B-O O-NP
expands B-O B-VP_NNS
current B-O B-NP_NP_JJ
knowledge B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
radiation-induced B-O B-JJ
signaling B-O B-NN
cascade B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
clarifying B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
chronological B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
biochemical B-O B-NP_NP_JJ
events B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-NP_NP_DT
human B-O B-JJ
putative B-O B-JJ
lymphocyte B-O B-NN
G0/G1 B-O B-NN
switch B-O B-VBP
gene B-O B-NN
" " B-O O-NP
homologous B-O B-ADJP_JJ
to B-O B-PP_TO
a B-O B-NP_NP_DT
rodent B-O B-JJ
gene B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
a B-O B-NP_DT
zinc-binding B-O B-JJ
potential B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
. B-O B-PERIOD
" " B-O O-NP
  
G0S24 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
set B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Comparison B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
full-length B-O B-JJ
cDNA B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
corresponding B-O B-JJ
genomic B-O B-JJ
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reveals B-O B-VP_VBZ
an B-O B-NP_NP_DT
open B-O B-JJ
reading B-O B-NN
frame B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
326 B-O B-NP_CD
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
distributed B-O B-VP_VBN
across B-O B-NP_PP_IN
two B-O B-NP_CD
exons B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Potential B-O B-S_NP_JJ
phosphorylation B-O B-NN
sites B-O B-NNS
" " B-O O-NP
include B-O B-VP_VBP
the B-O B-NP_NP_DT
sequence B-O B-NN
PSPTSPT B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
resembles B-O B-S_NP_VP_VBZ
an B-O B-NP_NP_DT
RNA B-O B-NN
polymerase B-O B-NN
II B-O B-CD
repeat B-O B-NN
" " B-O O-NP
reported B-O B-VP_VBN
" " B-O B-S_NP_VP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Comparison B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
derived B-O B-VBN
protein B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
rodent B-O B-NP_JJ
homologs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
allows B-O B-VP_VBZ
classification B-O B-NP_NP_NN
" " B-O O-NP
into B-O B-PP_IN
three B-O B-NP_CD
groups B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Group B-O B-S_NP_NN
1 B-O B-CD
" " B-O O-NP
contains B-O B-VP_VBZ
G0S24 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
rat B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
mouse B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
TIS11 B-O B-NN
genes B-O B-NNS
" " B-O O-NP
( B-O B-LRB
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
known B-O B-VBN
as B-O B-NP_PP_IN
TTP B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Nup475 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
Zfp36 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Members B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
group B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
three B-O B-NP_CD
tetraproline B-O B-JJ
repeats B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Groups B-O B-S_NP_NNS
1 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
2 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
have B-O B-VP_VBP
a B-O B-NP_NP_DT
serine-rich B-O B-JJ
region B-O B-NN
" " B-O O-NP
and B-O B-CC
an B-O B-NP_NP_DT
"""" B-O B-LQT
arginine B-O B-NN
element B-O B-NN
"""" B-O B-RQT
" " B-O O-NP
( B-O B-PRN_LRB
RRLPIF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
carboxyl B-O B-NN
terminus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_DT
groups B-O B-NNS
" " B-O O-NP
contain B-O B-VP_VBP
cysteine- B-O B-NP_NP_ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
histidine-rich B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
putative B-O B-JJ
zinc B-O B-NN
finger B-O B-NN
domains B-O B-NNS
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
serine-phenylalanine B-O B-JJ
"""" B-O B-LQT
SFS B-O B-NNS
"""" B-O B-RQT
domain B-O B-NN
" " B-O O-NP
similar B-O B-ADJP_JJ
to B-O B-PP_TO
part B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Comparison B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
group B-O B-NP_NN
1 B-O B-CD
human B-O B-UCP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
mouse B-O B-NP_NN
" " B-O O-NP
" " B-O O-UCP
genomic B-O B-JJ
sequences B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
shows B-O B-VP_VBZ
high B-O B-NP_NP_JJ
conservation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
5' B-O B-JJ
flank B-O B-NN
" " B-O O-NP
and B-O B-CC
exons B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
CpG B-O B-NN
island B-O B-NN
" " B-O O-NP
suggests B-O B-VP_VBZ
expression B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
germ B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
G0S24 B-O B-S_S_NP_NN
" " B-O O-NP
has B-O B-VP_VBZ
potential B-O B-NP_NP_JJ
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
5' B-O B-JJ
flank B-O B-NN
" " B-O O-NP
and B-O B-CC
intron B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
these B-O B-S_NP_DT
" " B-O O-NP
include B-O B-VP_VBP
a B-O B-NP_DT
serum B-O B-NN
response B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Protein B-O B-S_NP_UCP_NP_NN
" " B-O O-NP
and B-O B-CC
genomic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-UCP
sequences B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
similarities B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_DT
G0S24 B-O B-NN
product B-O B-NN
" " B-O O-NP
has B-O B-VP_VBZ
a B-O B-NP_DT
similar B-O B-JJ
role B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interleukin-4 B-O B-S_NP_NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
the B-O B-NP_NP_DT
lipopolysaccharide-induced B-O B-NP_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_NP_CC
messenger B-O B-NP_NN
RNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
activator B-O B-NP_NN
protein-1 B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interleukin-4 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-4 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
lipopolysaccharide B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
LPS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_CD
immediate B-O B-JJ
early B-O B-JJ
genes B-O B-NNS
c-fos B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
genes B-O B-NNS
" " B-O O-NP
encode B-O B-VP_VBP
proteins B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
form B-O B-S_NP_VP_VBP
the B-O B-NP_NP_NP_DT
dimeric B-O B-JJ
complex B-O B-NN
activator B-O B-NN
protein-1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Maximal B-O B-S_NP_NP_JJ
accumulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_NP_CC
c-fos B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
messenger B-O B-NP_NP_NN
RNA B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
mRNA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurred B-O B-VP_VBD
30 B-O B-PP_NP_CD
minutes B-O B-NNS
" " B-O O-NP
after B-O B-IN
LPS B-O B-NP_NN
addition B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
cells B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
treated B-O B-VP_VBN
with B-O B-NP_PP_IN
IL-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
5 B-O B-NP_CD
hours B-O B-NNS
" " B-O O-NP
" " B-O O-PP
before B-O B-PP_IN
LPS B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
both B-O B-NP_NP_CC
the B-O B-NP_DT
c-fos B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
the B-O B-NP_DT
c-jun B-O B-NN
" " B-O B-NP_O-NP
" " B-O O-NP
mRNA B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-NP
was B-O B-VP_VBD
decreased B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
IL-4 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
LPS-treated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
due B-O B-PP_JJ
to B-O B-TO
a B-O B-NP_NP_DT
lower B-O B-JJR
transcription B-O B-NN
rate B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IL-4 B-O B-S_NP_NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
affect B-O B-VP_VB
the B-O B-NP_NP_DT
stability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-fos B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
using B-O B-S_NP_VP_VBG
electrophoretic B-O B-NP_JJ
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
evidence B-O B-NP_NN
" " B-O B-SBAR_O-NP
was B-O B-VP_VBD
obtained B-O B-VP_VBN
that B-O B-NP_SBAR_IN
IL-4 B-O B-S_NP_NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
LPS-induced B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
IL-4 B-O B-S_NP_NN
" " B-O O-NP
suppresses B-O B-VP_VBZ
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
activated B-O B-VBN
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Ras B-O B-S_NP_NP_NN
oncogene B-O B-NN
transformation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
B B-O B-NN
lymphoblasts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_PP_IN
lymphocyte B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
with B-O B-PP_IN
a B-O B-NP_NP_DT
block B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
p21ras B-O B-NN
small B-O B-JJ
GTP B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
participate B-O B-VP_VP_VBP
in B-O B-PP_IN
signal B-O B-NP_NP_JJ
transduction B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
cell B-O B-NP_NN
surface B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
affect B-O B-VP_VB
neoplastic B-O B-NP_NP_JJ
transformation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
development B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
many B-O B-NP_JJ
different B-O B-JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
relationship B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
ras B-O B-NP_NP_NN
transformation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
B B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
constitutive B-O B-JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
T24 B-O B-NN
Ha-ras B-O B-NN
oncogene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
EBV-immortalized B-O B-NP_JJ
B B-O B-NN
lymphoblasts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
with B-O B-PP_IN
an B-O B-NP_NP_DT
impaired B-O B-JJ
immunoglobulin B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
, B-O B-COMMA
altered B-O B-NP_JJ
adhesion B-O B-NN
properties B-O B-NNS
" " B-O O-NP
and B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Since B-O B-S_SBAR_IN
induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
receptor B-O B-NN
alpha B-O B-NN
subunit B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
hallmark B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphocyte B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
p21ras B-O B-S_NP_NN
" " B-O O-NP
naturally B-O B-ADVP_RB
" " B-O O-ADVP
triggers B-O B-VP_VBZ
B B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
ras-transformed B-O B-JJ
lymphocytes B-O B-NNS
" " B-O O-NP
displayed B-O B-VP_VBD
a B-O B-NP_DT
fully B-O B-ADJP_RB
functional B-O B-JJ
" " B-O O-ADJP
IL-2r B-O B-NN
" " B-O O-NP
, B-O B-COMMA
as B-O B-SBAR_IN
assessed B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
c-fos B-O B-NP_NP_NN
induction B-O B-NN
" " B-O O-NP
following B-O B-PP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
nevertheless B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
they B-O B-NP_PRP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
growth B-O B-NP_NP_NN
" " B-O O-NP
stimulated B-O B-VP_VBN
by B-O B-NP_PP_IN
this B-O B-NP_DT
lymphokine B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
decreased B-O B-VBN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
immunoglobulin B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicates B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_DT
ras B-O B-NN
oncogene B-O B-NN
" " B-O O-NP
blocks B-O B-VP_VBZ
terminal B-O B-NP_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
plasma B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
possibly B-O B-PP_ADVP_RB
" " B-O O-ADVP
by B-O B-IN
inhibiting B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Somewhat B-O B-S_ADVP_RB
unexpectedly B-O B-RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
constitutive B-O B-JJ
p21ras B-O B-NN
activity B-O B-NN
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
cause B-O B-VP_VB
an B-O B-NP_NP_DT
increased B-O B-VBN
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
PEA1 B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
PEA3 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
Oct-2 B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
NF-kB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcription B-O B-NP_NP_NP_NN
factor B-O B-NN
GATA-1 B-O B-NN
" " B-O O-NP
and B-O B-CC
erythroid B-O B-NP_JJ
development B-O B-NN
" " B-O O-NP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
  
In B-O B-S_PP_IN
summary B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
derived B-O B-VP_VBD
an B-O B-NP_NP_DT
experimental B-O B-JJ
system B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
allows B-O B-S_NP_VP_VBZ
us B-O B-S_NP_PRP
" " B-O O-NP
to B-O B-VP_TO
dissect B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
established B-O B-VP_VBN
the B-O B-NP_NP_DT
essential B-O B-JJ
nature B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
both B-O B-NP_ADJP_CC
primitive B-O B-ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
definitive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
erythropoiesis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
ablating B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
endogenous B-O B-JJ
GATA-1 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
are B-O B-VP_VBP
in B-O B-PP_IN
a B-O B-NP_NP_DT
position B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHADVP_S_NP_VP_TO
introduce B-O B-VP_VB
" " B-O B-NP_NP_PP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
can B-O B-VP_MD
now B-O B-ADVP_RB
" " B-O O-ADVP
study B-O B-VP_VP_VB
regulatory B-O B-NP_NP_NP_JJ
regions B-O B-NNS
" " B-O O-NP
and B-O B-CC
functional B-O B-NP_JJ
domains B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
context B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
true B-O B-JJ
erythroid B-O B-JJ
environment B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
experiments B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
have B-O B-S_NP_VP_VBP
not B-O B-RB
been B-O B-VP_VBN
possible B-O B-ADJP_JJ
" " B-O O-ADJP
heretofore B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
the B-O B-S_NP_DT
assay B-O B-NN
" " B-O O-NP
involves B-O B-VP_VBZ
the B-O B-NP_NP_DT
dramatic B-O B-JJ
loss B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
red B-O B-NP_JJ
cell B-O B-NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
it B-O B-NP_NP_PRP
" " B-O O-NP
" " B-O B-S_O-NP
should B-O B-VP_MD
be B-O B-VP_VB
possible B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
define B-O B-VP_VB
important B-O B-NP_NP_JJ
regulatory B-O B-JJ
domains B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
ideal B-O B-JJ
situation B-O B-NN
" " B-O O-NP
would B-O B-VP_MD
be B-O B-VP_VB
analyses B-O B-NP_NP_NNS
" " B-O O-NP
conducted B-O B-VP_VBN
in B-O B-NP_PP_IN
GATA-1- B-O B-NP_JJ
erythroid B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
impossible B-O B-ADJP_JJ
to B-O B-SBAR_WHNP_S_NP_VP_TO
generate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-ADJP
given B-O B-PP_VBN
the B-O B-NP_NP_DT
requirement B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
Epo B-O B-NP_NP_NN
receptor B-O B-NN
expression B-O B-NN
" " B-O O-NP
and B-O B-CC
red B-O B-NP_JJ
cell B-O B-NN
viability B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
( B-O B-PRN_LRB
C. B-O B-FRAG_NP_NP_NNP
Simon B-O B-NNP
" " B-O O-NP
and B-O B-CC
S. B-O B-NP_NNP
Orkin B-O B-NNP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
unpublished B-O B-NP_JJ
observations B-O B-NNS
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_NP_PRP
" " B-O O-NP
" " B-O B-S_O-NP
may B-O B-VP_MD
be B-O B-VP_VB
possible B-O B-ADJP_JJ
" " B-O O-ADJP
to B-O B-S_NP_VP_TO
produce B-O B-VP_VB
such B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
and B-O B-S_NP_VP_VP_CC
" " B-O B-VP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
If B-O B-S_SBAR_IN
GATA-1- B-O B-S_NP_JJ
red B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
available B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_DT
analyses B-O B-NNS
" " B-O O-NP
would B-O B-VP_MD
involve B-O B-VP_VB
the B-O B-NP_DT
actual B-O B-NP_NP_NP_JJ
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-PP
" " B-O O-NP
or B-O B-CC
chromatin B-O B-NP_NP_NN
structure B-O B-NN
" " B-O O-NP
surrounding B-O B-VP_VBG
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-NP
the B-O B-NP_DT
globin B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Structure-function B-O B-S_S_NP_NP_JJ
studies B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GATA-1 B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
greatly B-O B-VP_ADVP_RB
" " B-O O-ADVP
simplified B-O B-VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
a B-O B-S_NP_NP_DT
larger B-O B-JJR
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mutants B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
ES B-O B-NN
cell B-O B-NN
system B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
used B-O B-VP_VBN
as B-O B-NP_PP_IN
an B-O B-NP_DT
alternative B-O B-NN
" " B-O O-NP
" " B-O O-PP
until B-O B-SBAR_IN
targeted B-O B-S_NP_VBN
erythroleukemia B-O B-NN
cells B-O B-NNS
" " B-O O-NP
become B-O B-VP_VBP
available B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Other B-O B-S_NP_JJ
applications B-O B-NNS
" " B-O O-NP
involve B-O B-VP_VBP
the B-O B-NP_NP_DT
introduction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_JJ
GATA-binding B-O B-JJ
protein B-O B-NN
family B-O B-NN
members B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-SBAR_WHADVP_S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
If B-O B-S_SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
can B-O B-VP_MD
not B-O B-RB
" " B-O B-VP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
chimeric B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
tested B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
identify B-O B-VP_VB
which B-O B-SBAR_WHNP_WDT
amino B-O B-NN
acids B-O B-NNS
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
feel B-O B-VP_VBP
that B-O B-SBAR_IN
these B-O B-S_NP_DT
experiments B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
vital B-O B-ADJP_JJ
to B-O B-PP_TO
understanding B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
How B-O B-SBARQ_WHADVP_WRB
" " B-O O-WHADVP
does B-O B-SQ_VBZ
GATA-1 B-O B-NP_NN
" " B-O O-NP
regulate B-O B-VP_VB
red B-O B-NP_NP_JJ
cell B-O B-NN
genes B-O B-NNS
" " B-O O-NP
like B-O B-PP_IN
globin B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
the B-O B-NP_DT
Epo B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O B-ADVP_O-VP
" " B-O O-SQ
? B-O B-PERIOD
" " B-O O-SBARQ
  
Once B-O B-S_SBAR_IN
we B-O B-S_NP_PRP
" " B-O O-NP
identify B-O B-VP_VB
the B-O B-NP_NP_DT
functional B-O B-JJ
domains B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
GATA-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
hope B-O B-VP_VBP
to B-O B-S_NP_VP_TO
learn B-O B-VP_VB
what B-O B-SBAR_WHNP_WP
proteins B-O B-NNS
" " B-O O-WHNP
GATA-1 B-O B-S_NP_NN
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_O-PP
or B-O B-PP_PP_CC
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Is B-O B-SQ_VBZ
GATA-1 B-O B-NP_NN
" " B-O O-NP
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
globin B-O B-NP_NN
gene B-O B-NN
switching B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
? B-O B-PERIOD
" " B-O O-SQ
  
GATA-1 B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
modified B-O B-VP_VBN
differently B-O B-NP_ADVP_RB
" " B-O O-ADVP
during B-O B-PP_IN
development B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
so B-O B-SBAR_IN
that B-O B-IN
the B-O B-S_NP_DT
locus B-O B-NN
control B-O B-NN
region B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
interact B-O B-VP_VB
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
may B-O B-VP_MD
find B-O B-VP_VB
that B-O B-SBAR_IN
one B-O B-S_S_NP_NP_CD
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
another B-O B-S_NP_DT
" " B-O O-NP
for B-O B-PP_IN
adult B-O B-NP_JJ
globin B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cell-type-specific B-O B-NP_NP_JJ
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
parathyroid B-O B-ADJP_JJ
hormone-related B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
human B-O B-NP_NP_NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
I B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-I B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
tax B-O B-NN
" " B-O O-NP
and B-O B-CC
HTLV-II B-O B-NP_NN
tax B-O B-NN
" " B-O O-NP
" " B-O O-NP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
human B-O B-NP_NP_NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
virus B-O B-NN
type B-O B-NN
I B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
HTLV-I B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
HTLV-II B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
Tax B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
potent B-O B-NP_NP_JJ
transactivators B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
viral B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
cellular B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
deletion B-O B-NP_NN
mutants B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
the B-O B-NP_DT
downstream B-O B-JJ
parathyroid B-O B-NP_NP_ADJP_JJ
hormone-related B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PTHrP B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
promoter B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
responsive B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_CONJP_NP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transactivation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
PTHrP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
Tax B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
seen B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
B-cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
or B-O B-CC
fibroblasts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
carboxy B-O B-NN
terminal B-O B-JJ
Tax B-O B-NN
deletion B-O B-NN
mutant B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
deficient B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
transactivation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_NP_CC
the B-O B-DT
PTHrP B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL2R B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
promoters B-O B-NNS
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
HTLV-I B-O B-NN
long B-O B-NP_NP_JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Exogenous B-O B-S_NP_NP_JJ
provision B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFkB B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
rescued B-O B-VP_VBD
IL2R B-O B-NP_NP_NN
alpha B-O B-NN
expression B-O B-NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
PTHrP B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
HTLV-I B-O B-NP_NP_NN
Tax B-O B-NN
" " B-O O-NP
, B-O B-COMMA
HTLV-II B-O B-NP_NN
Tax B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
c-jun B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
transactivate B-O B-VP_VP_VBP
PTHrP B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
may B-O B-VP_MD
contribute B-O B-VP_VB
to B-O B-PP_TO
the B-O B-NP_NP_DT
pathogenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
hypercalcemia B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
adult B-O B-NP_JJ
T-cell B-O B-NN
leukemia B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interleukin-3 B-O B-S_NP_NP_NN
expression B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involves B-O B-VP_VBZ
an B-O B-NP_NP_DT
inducible B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
T-cell-specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
factor B-O B-NN
" " B-O O-NP
and B-O B-CC
an B-O B-NP_DT
octamer B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Interleukin-3 B-O B-S_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
exclusively B-O B-VP_VP_ADVP_RB
" " B-O O-ADVP
expressed B-O B-VBN
by B-O B-NP_PP_IN
activated B-O B-NP_NP_NP_VBN
T B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
natural B-O B-NP_JJ
killer B-O B-NN
" " B-O B-NP_O-NP
" " B-O O-NP
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
a B-O B-NP_NP_DT
function B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
tightly B-O B-ADVP_RB
" " B-O O-ADVP
controlled B-O B-VP_VBN
" " B-O B-NP_PP_PP_NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
the B-O B-NP_NP_DT
protein B-O B-NP_NP_NN
binding B-O B-NN
characteristics B-O B-NNS
" " B-O O-NP
and B-O B-CC
functional B-O B-NP_JJ
importance B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
ACT-1-activating B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-3 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
region B-O B-NN
" " B-O O-NP
binds B-O B-VP_VBZ
an B-O B-NP_DT
inducible B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
T-cell-specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
factor B-O B-NN
" " B-O O-NP
over B-O B-PP_IN
its B-O B-NP_NP_PRPP
5' B-O B-JJ
end B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
site B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
necessary B-O B-ADJP_JJ
in B-O B-PP_PP_IN
the B-O B-DT
absence B-O B-NN
of B-O B-IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Over B-O B-S_PP_IN
its B-O B-NP_PRPP
3' B-O B-JJ
end B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
binds B-O B-VP_VBZ
a B-O B-NP_NP_DT
factor B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
ubiquitously B-O B-ADVP_ADVP_RB
" " B-O O-ADVP
and B-O B-CC
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-ADVP
expressed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
factor B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
Oct-1 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
an B-O B-NP_DT
immunologically B-O B-ADJP_RB
related B-O B-JJ
" " B-O O-ADJP
octamer-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
it B-O B-S_NP_PRP
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
coordinating B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
several B-O B-NP_JJ
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
characteristics B-O B-NNS
" " B-O O-NP
make B-O B-VP_VBP
the B-O B-S_NP_DT
ACT-1 B-O B-NN
site B-O B-NN
" " B-O O-NP
analogous B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
activating B-O B-VBG
ARRE-1 B-O B-NN
site B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_UCP_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
and B-O B-CC
despite B-O B-PP_IN
a B-O B-NP_NP_DT
lack B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
sequence B-O B-NP_NN
homology B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-UCP
, B-O B-COMMA
the B-O B-NP_NP_DT
promoters B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
IL-3 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
share B-O B-VP_VBP
an B-O B-NP_NP_DT
organizational B-O B-JJ
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
regulatory B-O B-NP_JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
likely B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
ras B-O B-S_NP_NN
protein B-O B-NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
T-cell B-O B-NP_NN
antigen B-O B-NN
receptor B-O B-NN
signal B-O B-NN
transduction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
a B-O B-NP_NP_DT
Jurkat B-O B-NN
cell B-O B-NN
model B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
T-cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
an B-O B-NP_DT
interleukin-2 B-O B-NN
promoter/reporter B-O B-NN
gene B-O B-NN
construct B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
antigen B-O B-NP_NP_NN
receptor B-O B-NN
agonism B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
combination B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
lymphokine B-O B-NN
interleukin-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Antigen B-O B-S_NP_NN
receptor B-O B-NN
signals B-O B-NNS
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
mimicked B-O B-VP_VBN
by B-O B-NP_PP_IN
suboptimal B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
phorbol B-O B-NP_NN
esters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
combination B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
calcium B-O B-NP_NP_NN
mobilization B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
cotransfection B-O B-NP_NN
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
oncogenic B-O B-NP_JJ
rats B-O B-NNS
" " B-O O-NP
obviated B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
need B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
PKC B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
did B-O B-VP_VBD
not B-O B-RB
replace B-O B-VP_VB
either B-O B-NP_CC
the B-O B-NP_DT
calcium B-O B-NN
signal B-O B-NN
" " B-O O-NP
or B-O B-CC
interleukin-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Activated B-O B-S_NP_VBN
ras B-O B-NN
expression B-O B-NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
replaced B-O B-VP_VBD
the B-O B-NP_NP_DT
requirement B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
PKC B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
T-cell B-O B-NN
transcription B-O B-NN
factor B-O B-NN
NF-AT B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_DT
dominant B-O B-JJ
inhibitory B-O B-JJ
ras B-O B-NN
mutant B-O B-NN
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
blocked B-O B-VP_VBD
antigen B-O B-NP_NN
receptor B-O B-NN
agonism B-O B-NN
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
ras B-O B-S_NP_NN
activity B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
required B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
an B-O B-NP_NP_DT
inhibitor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PKC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
blocked B-O B-VP_VBD
both B-O B-NP_CC
activated B-O B-NP_VBD
ras B-O B-NN
" " B-O O-NP
and B-O B-CC
phorbol B-O B-NP_NN
ester B-O B-NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
a B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
ras B-O B-NP_NP_NN
" " B-O O-NP
upstream B-O B-ADVP_JJ
of B-O B-PP_IN
" " B-O B-NP_O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Characterization B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
nuclear B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
cytoplasmic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
components B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
lymphoid-specific B-O B-JJ
nuclear B-O B-NP_NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
NF-AT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
lymphoid-specific B-O B-JJ
transcription B-O B-NN
complex B-O B-NN
" " B-O O-NP
, B-O B-COMMA
NF-AT B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VP_VBZ
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
early B-O B-NP_NP_JJ
gene B-O B-NN
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
assembled B-O B-VP_VBN
from B-O B-NP_PP_IN
a B-O B-NP_NP_DT
pre-existing B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
restricted B-O B-ADJP_NP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
cytoplasmic B-O B-JJ
factor B-O B-NN
" " B-O O-NP
and B-O B-CC
an B-O B-NP_DT
inducible B-O B-JJ
ubiquitous B-O B-JJ
nuclear B-O B-JJ
component B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
within B-O B-PP_NP_QP_IN
30 B-O B-CD
" " B-O O-QP
min B-O B-NN
" " B-O O-NP
after B-O B-IN
activation B-O B-NP_NP_NN
" " B-O O-NP
through B-O B-PP_IN
the B-O B-NP_DT
antigen B-O B-NN
receptor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recent B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
implicated B-O B-VP_VBN
the B-O B-NP_NP_DT
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP1 B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-PP_IN
components B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
murine B-O B-JJ
NF-AT B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Evidence B-O B-S_NP_NN
" " B-O B-SBAR_O-NP
is B-O B-VP_VBZ
provided B-O B-VP_VBN
here B-O B-NP_ADVP_RB
" " B-O O-ADVP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
nuclear B-O B-JJ
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
NF-AT B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contains B-O B-VP_VBZ
the B-O B-NP_NP_DT
phorbol B-O B-ADJP_NN
ester-inducible B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
factor B-O B-NN
AP1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Jun/Fos B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
characterize B-O B-VP_VBP
which B-O B-SBAR_WHNP_WDT
AP1 B-O B-NN
family B-O B-NN
members B-O B-NNS
" " B-O O-WHNP
can B-O B-S_NP_VP_MD
assume B-O B-VP_VB
this B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Antisera B-O B-S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
Fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibits B-O B-VP_VBZ
NF-AT B-O B-NP_NN
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
as B-O B-SBAR_IN
does B-O B-SINV_VBZ
an B-O B-NP_NP_DT
oligonucleotide B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
a B-O B-NP_NP_DT
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
AP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O B-VP_O-SINV
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Constitutive B-O B-S_NP_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
of B-O B-PP_IN
Fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
to B-O B-NP_PP_TO
a B-O B-NP_DT
lesser B-O B-JJR
extent B-O B-NN
" " B-O O-NP
" " B-O O-PP
Fra-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
eliminates B-O B-VP_VBZ
the B-O B-NP_NP_DT
requirement B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
phorbol B-O B-NP_NP_NP_NN
12-myristate B-O B-NN
13-acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
leaving B-O B-S_NP_VP_VBG
NF-AT-directed B-O B-S_NP_JJ
transcription B-O B-NN
" " B-O O-NP
responsive B-O B-ADJP_JJ
to B-O B-PP_TO
calcium B-O B-NP_NP_NN
ionophore B-O B-NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Overexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cJun B-O B-NP_NP_NP_NN
" " B-O O-NP
or B-O B-CC
JunD B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
JunB B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
eliminates B-O B-VP_VBZ
the B-O B-NP_NP_DT
requirement B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
many B-O B-S_NP_ADJP_ADJP_JJ
" " B-O O-ADJP
but B-O B-CC
not B-O B-ADJP_RB
all B-O B-DT
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O B-ADJP_ADJP_NP_ADJP_O-ADJP
and B-O B-CC
Fos-related B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
proteins B-O B-NNS
" " B-O O-NP
functionally B-O B-ADVP_RB
" " B-O O-ADVP
activate B-O B-VP_VBP
NF-AT-dependent B-O B-NP_JJ
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
the B-O B-NP_DT
cytoplasmic B-O B-JJ
component B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-AT B-O B-S_NP_NN
DNA B-O B-NN
binding B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
reconstituted B-O B-VP_VBN
in B-O B-NP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
using B-O B-S_NP_VP_VBG
semi-purified B-O B-NP_NP_JJ
AP1 B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
mixed B-O B-VP_VBN
with B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Fos B-O B-S_S_NP_NN
proteins B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
not B-O B-RB
needed B-O B-VP_VBN
for B-O B-NP_PP_IN
this B-O B-NP_DT
reconstitution B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
although B-O B-S_SBAR_IN
JunB B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
functional B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
can B-O B-VP_MD
participate B-O B-VP_VB
in B-O B-PP_IN
the B-O B-NP_DT
NF-AT B-O B-NN
DNA B-O B-NN
binding B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VP_VBP
partially B-O B-ADVP_RB
" " B-O O-ADVP
purified B-O B-VP_VBN
the B-O B-NP_NP_DT
cytoplasmic B-O B-JJ
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
show B-O B-VP_VBP
by B-O B-PP_IN
elution B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
renaturation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
from B-O B-PP_IN
SDS-polyacrylamide B-O B-NP_NN
gel B-O B-NN
electrophoresis B-O B-NN
gels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
it B-O B-S_NP_PRP
" " B-O O-NP
has B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
molecular B-O B-JJ
mass B-O B-NN
" " B-O O-NP
kDa B-O B-NP_QP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
may B-O B-VP_MD
have B-O B-VP_VB
multiple B-O B-NP_JJ
forms B-O B-ADJP_NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_DT
c-rel B-O B-NN
protooncogene B-O B-NN
product B-O B-NN
" " B-O O-NP
represses B-O B-VP_VBZ
NF-kappa B-O B-NP_NP_ADJP_NN
B B-O B-NN
p65-mediated B-O B-JJ
" " B-O O-ADJP
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
type B-O B-NP_NN
1 B-O B-CD
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_NP_DT
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
LTR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
type B-O B-NN
1 B-O B-CD
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
5' B-O B-JJ
regulatory B-O B-JJ
region B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
gene B-O B-NN
" " B-O O-NP
encoding B-O B-VP_VBG
the B-O B-NP_NP_DT
interleukin B-O B-NN
2 B-O B-CD
receptor B-O B-NN
alpha B-O B-NN
subunit B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
IL-2R B-O B-NP_NN
alpha B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
share B-O B-VP_NN
functional B-O B-NP_NP_JJ
kappa B-O B-NN
B B-O B-NN
enhancer B-O B-NN
elements B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
inducible B-O B-JJ
transcription B-O B-NN
units B-O B-NNS
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
T-cell B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
kappa B-O B-NN
B B-O B-NN
enhancer B-O B-NN
elements B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
structurally B-O B-ADJP_RB
related B-O B-JJ
" " B-O O-ADJP
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interactive B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
includes B-O B-S_NP_VP_VBZ
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recent B-O B-S_NP_JJ
biochemical B-O B-JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
p65 B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
form B-O B-VP_VBP
the B-O B-NP_NP_DT
prototypical B-O B-JJ
NF-kappa B-O B-NN
B B-O B-NN
complex B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
intracellular B-O B-JJ
signaling B-O B-NN
complex B-O B-NN
" " B-O O-NP
potently B-O B-ADVP_RB
" " B-O O-ADVP
stimulates B-O B-VP_VBZ
kappa B-O B-NP_NP_ADJP_NN
B-directed B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
either B-O B-NP_CC
the B-O B-NP_DT
HIV-1 B-O B-NN
LTR B-O B-NN
" " B-O O-NP
or B-O B-CC
the B-O B-NP_DT
IL-2R B-O B-NN
alpha B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
via B-O B-PP_IN
the B-O B-NP_NP_DT
strong B-O B-JJ
transactivation B-O B-NN
domain B-O B-NN
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
now B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
nuclear B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
c-Rel B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
induced B-O B-VP_VBN
" " B-O B-NP_PP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
markedly B-O B-ADVP_RB
" " B-O O-ADVP
represses B-O B-VP_VBZ
p65-mediated B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
transcription B-O B-NN
units B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_NP_DT
inhibitory B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-Rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlate B-O B-VP_VBP
with B-O B-PP_PP_IN
its B-O B-NP_PRPP
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
with B-O B-IN
its B-O B-NP_PRPP
ability B-O B-NN
to B-O B-S_NP_VP_TO
heterodimerize B-O B-VP_VB
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
c-Rel B-O B-S_NP_NN
inhibition B-O B-NN
" " B-O O-NP
involves B-O B-VP_VBZ
competition B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
for B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
one B-O B-S_NP_NP_CD
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
as B-O B-S_PP_IN
a B-O B-NP_NP_DT
physiologic B-O B-JJ
repressor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
serving B-O B-NP_VP_VBG
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Protease B-O B-S_NP_NP_NN
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
distinguishes B-O B-VP_VBZ
between B-O B-PP_IN
class B-O B-NP_NP_NN
II B-O B-CD
MHC B-O B-NN
X1 B-O B-NN
box B-O B-NN
DNA-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
wild-type B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
class B-O B-ADJP_NN
II-deficient B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
X B-O B-NN
box B-O B-NN
region B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
critical B-O B-ADJP_JJ
for B-O B-PP_IN
directing B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
class B-O B-NP_NN
II B-O B-CD
major B-O B-JJ
histocompatibility B-O B-NN
complex B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
several B-O B-S_NP_JJ
class B-O B-NN
II B-O B-CD
promoter-specific B-O B-JJ
DNA B-O B-NN
binding B-O B-NN
factors B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
described B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
only B-O B-NP_NP_RB
the B-O B-DT
X B-O B-NN
box B-O B-NN
region B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
RFX B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
shows B-O B-VP_VBZ
a B-O B-NP_NP_DT
genetic B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
class B-O B-NP_NN
II B-O B-CD
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
being B-O B-S_NP_VP_VBG
deficient B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
some B-O B-NP_NP_DT
B B-O B-NN
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
further B-O B-VP_ADVP_RB
" " B-O O-ADVP
evaluate B-O B-VB
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
X B-O B-NP_NN
box B-O B-NN
DNA-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
class B-O B-NP_NN
II B-O B-CD
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
X B-O B-NN
box B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
examined B-O B-VP_VBN
in B-O B-NP_PP_IN
both B-O B-NP_ADJP_DT
class B-O B-ADJP_NN
II-positive B-O B-JJ
" " B-O O-ADJP
and B-O B-CC
-negative B-O B-ADJP_NP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NN
to B-O B-TO
the B-O B-NP_DT
wild-type B-O B-JJ
B B-O B-NN
cell B-O B-NN
line B-O B-NN
Raji B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
two B-O B-NP_NP_NP_CD
class B-O B-ADJP_NN
II B-O B-CD
transcriptional B-O B-JJ
" " B-O O-ADJP
mutant B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
SJO B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
RJ2.2.5 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
and B-O B-CC
Jurkat B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
class B-O B-ADJP_NN
II B-O B-CD
negative B-O B-JJ
" " B-O O-ADJP
T B-O B-NN
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
examined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NN
to B-O B-TO
wild-type B-O B-NP_JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
neither B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
class B-O B-NN
II B-O B-CD
mutant B-O B-JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
use B-O B-VP_VB
the B-O B-NP_DT
X B-O B-NN
box B-O B-NN
region B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
direct B-O B-VP_VB
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
reporter B-O B-ADJP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_DT
X B-O B-ADJP_NN
box-dependent B-O B-JJ
" " B-O O-ADJP
transcriptional B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
defective B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
X1 B-O B-NN
box B-O B-NN
DNA-binding B-O B-JJ
protein B-O B-NN
RFX B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VP_VBD
examined B-O B-VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
present B-O B-ADJP_JJ
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
but B-O B-CC
was B-O B-VP_VBD
absent B-O B-ADJP_JJ
in B-O B-PP_IN
SJO B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Jurkat B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
other B-O B-NP_JJ
X1 B-O B-ADJP_NN
box-specific B-O B-JJ
" " B-O O-ADJP
activities B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
detected B-O B-VP_VBN
in B-O B-NP_PP_IN
all B-O B-NP_DT
these B-O B-DT
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
these B-O B-S_NP_DT
different B-O B-JJ
X1 B-O B-NN
box B-O B-NN
activities B-O B-NNS
" " B-O O-NP
represented B-O B-VP_VBD
distinct B-O B-NP_NP_JJ
DNA B-O B-NN
binding B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
or B-O B-CC
" " B-O B-NP_NP_PP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
protease B-O B-NP_NP_NN
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
crude B-O B-JJ
nuclear B-O B-JJ
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
followed B-O B-VP_VBN
by B-O B-NP_PP_IN
DNA-binding B-O B-NP_JJ
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VP_VBD
carried B-O B-VP_VBN
out B-O B-PRT_RP
" " B-O O-PRT
" " B-O B-NP_O-VP
" " B-O O-VP
and B-O B-CC
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
B B-O B-S_NP_NN
cell B-O B-NN
extracts B-O B-NNS
" " B-O O-NP
contain B-O B-VP_VBP
at B-O B-NP_QP_IN
least B-O B-JJS
two B-O B-CD
" " B-O O-QP
X1-specific B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
cleaved B-O B-VBN
products B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
band B-O B-NP_NN
1 B-O B-CD
pk B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
RFX B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
similar B-O B-JJ
comparison B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
protease-treated B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
prepared B-O B-VP_VBN
from B-O B-NP_PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrated B-O B-VP_VBD
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
band B-O B-NN
1pk B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
despite B-O B-PP_IN
an B-O B-NP_NP_DT
absence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
native B-O B-JJ
RFX B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
protease B-O B-NP_NP_NN
treatment B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
analysis B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
SJO B-O B-NP_NN
extracts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
no B-O B-NP_NP_DT
detectable B-O B-JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
band B-O B-NN
1pk B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
multiple B-O B-S_NP_JJ
X1 B-O B-ADJP_NN
box-specific B-O B-JJ
" " B-O O-ADJP
DNA-binding B-O B-JJ
activities B-O B-NNS
" " B-O O-NP
exist B-O B-VP_VBP
in B-O B-PP_IN
all B-O B-NP_DT
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
the B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
actively B-O B-ADJP_RB
binding B-O B-NN
" " B-O O-ADJP
RFX B-O B-NN
species B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
class B-O B-NP_NN
II B-O B-CD
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
Replication B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
type B-O B-NP_NP_NN
1 B-O B-CD
human B-O B-JJ
immunodeficiency B-O B-NN
viruses B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VBG
linker B-O B-NP_NN
substitution B-O B-NN
mutations B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
-201 B-O B-NP_NP_CD
" " B-O O-NP
to B-O B-TO
-130 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
region B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
In B-O B-S_PP_IN
previous B-O B-NP_NP_JJ
transfection B-O B-NN
analyses B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
the B-O B-NP_DT
chloramphenicol B-O B-JJ
acetyltransferase B-O B-NN
reporter B-O B-NN
gene B-O B-NN
system B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
determined B-O B-VP_VBD
that B-O B-SBAR_IN
linker B-O B-S_NP_NP_NP_NP_NN
substitution B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
LS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
mutations B-O B-NNS
" " B-O O-NP
between B-O B-PP_IN
-201 B-O B-NP_NP_NP_CD
" " B-O O-NP
and B-O B-CC
-130 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
( B-O B-LRB
relative B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
) B-O B-RRB
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
caused B-O B-VP_VBD
moderate B-O B-NP_NP_JJ
decreases B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
LTR B-O B-NP_NP_NN
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
( B-O B-PRN_LRB
S.L.Zeichner B-O B-FRAG_NP_NP_NNP
" " B-O O-NP
, B-O B-COMMA
J.Y.H. B-O B-NP_NNP
Kim B-O B-NNP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
J.C.Alwine B-O B-NP_NNP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
J.Virol. B-O B-NP_NNP
65 B-O B-CD
: B-O B-COLON
2436-2444 B-O B-CD
" " B-O O-NP
, B-O B-COMMA
1991 B-O B-NP_CD
" " B-O O-NP
" " B-O O-FRAG
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-TO
confirm B-O B-S_NP_VP_VB
the B-O B-NP_NP_DT
significance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
context B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
viral B-O B-NP_JJ
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
constructed B-O B-VP_VP_VBD
several B-O B-NP_NP_NP_NP_JJ
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
LS B-O B-NN
mutations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
-201 B-O B-NP_NP_NP_CD
" " B-O O-NP
to B-O B-TO
"- 184" B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
-183 B-O B-NP_NP_CD
" " B-O O-NP
to B-O B-TO
-166 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
-165 B-O B-NP_NP_CD
" " B-O O-NP
to B-O B-TO
-148 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
-148 B-O B-NP_NP_CD
" " B-O O-NP
to B-O B-TO
-130 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
proviruses B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
prepared B-O B-VP_VBD
viral B-O B-NP_JJ
stocks B-O B-NNS
" " B-O O-NP
by B-O B-PP_IN
cocultivation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
transfected B-O B-NP_VBN
RD B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
CEMx174 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
two B-O B-NP_NP_CD
mutations B-O B-NNS
" " B-O O-NP
between B-O B-PP_PP_IN
-93 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
-76 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
between B-O B-PP_IN
-75 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
-58 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
utilized B-O B-VP_VBN
, B-O B-NP_COMMA
since B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
affect B-O B-VP_VP_VBP
the B-O B-NP_DT
and B-O B-ADJP_ADJP_CC
sites B-O B-ADJP_NNS
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
were B-O B-VP_VBD
expected B-O B-VP_VBN
" " B-O B-S_NP_VP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
while B-O B-S_SBAR_IN
transfection B-O B-S_NP_NN
analyses B-O B-NNS
" " B-O O-NP
offer B-O B-VP_VBP
an B-O B-NP_NP_DT
adequate B-O B-JJ
approximation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_NP_DT
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
viral B-O B-NP_NP_JJ
replication B-O B-NN
" " B-O O-NP
using B-O B-VP_VBG
a B-O B-NP_DT
mutant B-O B-JJ
viral B-O B-JJ
stock B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
presents B-O B-VP_VBZ
a B-O B-NP_NP_DT
more B-O B-ADJP_RBR
accurate B-O B-JJ
" " B-O O-ADJP
picture B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
" " B-O B-ADVP_PP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Three B-O B-S_S_NP_NP_CD
mutants B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
-201/-184 B-O B-NP_NP_CD
NXS B-O B-NN
" " B-O O-NP
, B-O B-COMMA
-165/-148 B-O B-NP_CD
NXS B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
-147/-130 B-O B-NP_CD
NXS B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
had B-O B-VP_VBD
effects B-O B-NP_NP_NNS
" " B-O O-NP
" " B-O B-SBAR_O-NP
on B-O B-PP_IN
viral B-O B-NP_JJ
replication B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
much B-O B-ADJP_ADJP_ADVP_RB
more B-O B-RBR
" " B-O O-ADVP
severe B-O B-JJ
" " B-O O-ADJP
than B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_NP_CD
LS B-O B-NN
mutations B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
-201/-184 B-O B-NP_NP_CD
NXS B-O B-NN
" " B-O O-NP
and B-O B-CC
-183/-166 B-O B-NP_CD
NXS B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
predicted B-O B-VP_VBN
by B-O B-NP_PP_IN
their B-O B-NP_NP_PRPP
effects B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
transfection B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
cell B-O B-NP_NP_ADJP_NN
type-specific B-O B-JJ
" " B-O O-ADJP
permissiveness B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
replication B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
some B-O B-NP_DT
mutant B-O B-JJ
viruses B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
tested B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
LS B-O B-NN
mutations B-O B-NNS
" " B-O O-NP
indicated B-O B-VP_VBD
an B-O B-NP_NP_DT
apparent B-O B-JJ
requirement B-O B-NN
" " B-O O-NP
not B-O B-PP_CONJP_RB
only B-O B-RB
" " B-O O-CONJP
for B-O B-PP_IN
the B-O B-NP_DT
intact B-O B-JJ
NF-kappa B-O B-ADJP_ADJP_NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
SP1-binding B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CONJP_CC
also B-O B-RB
" " B-O O-CONJP
for B-O B-PP_IN
several B-O B-NP_NP_JJ
regions B-O B-NNS
" " B-O O-NP
between B-O B-PP_IN
-201 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
-130 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
not B-O B-VP_RB
previously B-O B-ADVP_RB
" " B-O O-ADVP
associated B-O B-VBN
with B-O B-NP_PP_IN
viral B-O B-NP_JJ
infectivity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Dimerization B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-KB2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
RelA(p65) B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
regulates B-O B-VP_VBZ
DNA B-O B-NP_NP_NN
binding B-O B-NN
" " B-O O-NP
, B-O B-COMMA
transcriptional B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
inhibition B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
by B-O B-PP_IN
an B-O B-NP_NP_DT
I B-O B-NN
kappa B-O B-NN
B-alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MAD-3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Inducible B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
cellular B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
NF-kappa B-O B-S_S_NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
distinct B-O B-NP_JJ
subunits B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
five B-O B-S_NP_NP_NP_CD
independent B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
NFKB1(p105) B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
NFKB2(p100) B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
RelA(p65) B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
c-rel B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
relB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
encode B-O B-S_NP_VP_VBP
related B-O B-NP_NP_JJ
proteins B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
isolated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-VP_ADVP_RB
" " B-O O-ADVP
found B-O B-VBN
that B-O B-SBAR_IN
NFKB2(p49/p52) B-O B-S_NP_NN
" " B-O O-NP
acts B-O B-VP_VBZ
in B-O B-PP_IN
concert B-O B-NN
with B-O B-IN
RelA(p65) B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
stimulate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
examine B-O B-VP_VBP
the B-O B-NP_NP_DT
biochemical B-O B-JJ
basis B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
NFKB2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
Scatchard B-O B-NP_NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
determined B-O B-VP_VBN
the B-O B-NP_NP_DT
dissociation B-O B-NN
constants B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
homodimeric B-O B-NP_NP_JJ
p49 B-O B-NN
" " B-O O-NP
and B-O B-CC
heterodimeric B-O B-NP_JJ
p49/p65 B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
binding B-O B-S_NP_VP_NN
to B-O B-PP_TO
the B-O B-NP_DT
HIV B-O B-NN
kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
p49 B-O B-S_NP_NN
" " B-O O-NP
has B-O B-VP_VBZ
a B-O B-NP_NP_NP_NP_DT
approximately B-O B-ADJP_RB
18-fold-lower B-O B-JJ
" " B-O O-ADJP
affinity B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NN
kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
KD B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
69.1 B-O B-NP_CD
pM B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
than B-O B-SBAR_IN
does B-O B-SINV_VBZ
the B-O B-NP_NP_DT
approximately B-O B-ADJP_RB
50-kDa B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
NFKB1(p50) B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
( B-O B-PRN_LRB
KD B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
" " B-O B-NP_O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O B-VP_O-SINV
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
affinity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
heterodimeric B-O B-NP_JJ
NFKB2(p49)/RelA(p65) B-O B-NN
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
this B-O B-NP_DT
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
approximately B-O B-ADJP_ADJP_ADJP_RB
6-fold B-O B-RB
higher B-O B-JJR
" " B-O O-ADJP
( B-O B-PRN_LRB
KD B-O B-S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
11.8 B-O B-NP_CD
pM B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-ADJP
than B-O B-PP_IN
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
p49 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Consistent B-O B-S_S_NP_ADJP_JJ
with B-O B-PP_IN
these B-O B-NP_DT
findings B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-S
, B-O B-COMMA
in B-O B-NP_ADJP_FW
vitro B-O B-FW
" " B-O O-ADJP
transcription B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
stimulated B-O B-VP_VBN
18-fold B-O B-NP_ADVP_RB
" " B-O O-ADVP
by B-O B-PP_IN
the B-O B-NP_NP_DT
addition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
preformed B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
heterodimeric B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
NFKB2(p49)/RelA(p65) B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transcriptional B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
subject B-O B-ADJP_JJ
to B-O B-PP_TO
regulation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
recently B-O B-NP_ADJP_RB
cloned B-O B-VBN
" " B-O O-ADJP
I B-O B-NP_NP_NN
kappa B-O B-NN
B-alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recombinant B-O B-S_NP_JJ
I B-O B-NP_NP_NN
kappa B-O B-NN
B-alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MAD-3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
inhibited B-O B-VP_VP_VBD
the B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p65 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p49/p65 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
p50/p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
but B-O B-CC
stimulated B-O B-VP_VBD
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NFKB2(p49) B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
NFKB1(p50) B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Functional B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
HIV B-O B-NN
reporter B-O B-NN
plasmid B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
p49/p65 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
transiently B-O B-NP_ADJP_RB
transfected B-O B-VBN
" " B-O O-ADJP
Jurkat B-O B-ADJP_NN
T-leukemia B-O B-JJ
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
inhibited B-O B-VBN
by B-O B-NP_PP_IN
coexpression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
MAD-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LRB
ABSTRACT B-O B-NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
250 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-S
The B-O B-S_NP_DT
human B-O B-JJ
prointerleukin B-O B-NN
1 B-O B-CD
beta B-O B-NN
gene B-O B-NN
" " B-O O-NP
requires B-O B-VP_VBZ
DNA B-O B-NP_NP_NN
sequences B-O B-NNS
" " B-O O-NP
both B-O B-ADJP_ADJP_CC
proximal B-O B-ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
distal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
to B-O B-PP_TO
the B-O B-NP_DT
transcription B-O B-NN
start B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
for B-O B-PP_IN
tissue-specific B-O B-NP_JJ
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
these B-O B-NP_DT
studies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
DNA B-O B-NP_NP_NP_NN
sequences B-O B-NNS
" " B-O O-NP
and B-O B-CC
specific B-O B-NP_JJ
protein B-O B-NN
interactions B-O B-NNS
" " B-O O-NP
" " B-O O-NP
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
gene B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
cell-type-independent B-O B-JJ
lipopolysaccharide B-O B-ADJP_NN
( B-O B-LRB
LPS B-O B-NN
) B-O B-RRB
-responsive B-O B-JJ
" " B-O O-ADJP
enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
located B-O B-ADJP_JJ
between B-O B-PP_IN
-3757 B-O B-NP_NP_NP_CD
" " B-O O-NP
and B-O B-CC
-2729 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
bp B-O B-NN
" " B-O O-NP
" " B-O O-PP
upstream B-O B-ADVP_RB
from B-O B-PP_IN
the B-O B-NP_NP_DT
transcription B-O B-NN
start B-O B-NN
site B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
cap B-O B-NP_NN
site B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-NP
consisted B-O B-VP_VBD
of B-O B-PP_IN
at B-O B-NP_NP_QP_IN
least B-O B-JJS
six B-O B-CD
" " B-O O-QP
discrete B-O B-JJ
subregions B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
were B-O B-S_NP_VP_VBD
essential B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
enhancer B-O B-NN
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
mediate B-O B-VP_VB
phorbol B-O B-NP_NP_NP_NN
myristate B-O B-NN
acetate B-O B-NN
induction B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
IL-1 B-O B-NP_NP_NN
responsiveness B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
fibroblasts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletion B-O B-S_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
base B-O B-NP_NN
substitution B-O B-NN
mutations B-O B-NNS
" " B-O O-NP
" " B-O O-NP
along B-O B-CONJP_IN
with B-O B-IN
" " B-O O-CONJP
DNA B-O B-NP_NN
binding B-O B-NN
studies B-O B-NNS
" " B-O O-NP
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
enhancer B-O B-NN
" " B-O O-NP
contained B-O B-VP_VBD
a B-O B-NP_NP_DT
minimum B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
three B-O B-NP_NP_CD
functional B-O B-JJ
protein B-O B-NN
binding B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
essential B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
bound B-O B-S_NP_VP_VBD
to B-O B-PP_TO
the B-O B-NP_DT
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
similar B-O B-ADJP_ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
identical B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
to B-O B-PP_TO
members B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
C/EBP B-O B-NN
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
ligated B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_NP_DT
proIL-1 B-O B-NN
beta B-O B-NN
cap B-O B-ADJP_NN
site-proximal B-O B-JJ
" " B-O O-ADJP
region B-O B-NN
" " B-O O-NP
( B-O B-LRB
located B-O B-ADJP_JJ
between B-O B-PP_IN
to B-O B-NP_NP_TO
" " B-O B-NP_O-PP
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
both B-O B-NP_CC
the B-O B-NP_DT
proIL-1 B-O B-NN
beta B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
simian B-O B-JJ
virus B-O B-NN
40 B-O B-CD
enhancer B-O B-NN
elements B-O B-NNS
" " B-O O-NP
" " B-O O-NP
functioned B-O B-VP_VBD
more B-O B-ADVP_ADVP_RBR
efficiently B-O B-RB
" " B-O O-ADVP
" " B-O B-PP_O-ADVP
in B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
than B-O B-PP_IN
in B-O B-FRAG_PP_IN
HeLa B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
not B-O B-RB
" " B-O B-ADVP_ADJP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
ligated B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
the B-O B-NP_DT
murine B-O B-JJ
c-fos B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
proIL-1 B-O B-NN
beta B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
inducible B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
phorbol B-O B-NP_ADJP_NN
myristate B-O B-NN
acetate-stimulated B-O B-JJ
" " B-O O-ADJP
HeLa B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
proIL-1 B-O B-ADJP_NN
beta B-O B-NN
promoter-proximal B-O B-JJ
" " B-O O-ADJP
requirement B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
tissue B-O B-NP_NN
specificity B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
PILOT B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_DT
putative B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VP_VP_VBZ
two B-O B-NP_CD
signals B-O B-NNS
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
cyclosporin B-O B-ADJP_NP_NN
A B-O B-NN
" " B-O O-NP
sensitive B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Few B-O B-S_S_S_NP_NP_JJ
known B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
members B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-8 B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
interferon-gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
are B-O B-VP_VBP
induced B-O B-VP_VBN
in B-O B-NP_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
only B-O B-PP_RB
through B-O B-IN
the B-O B-NP_NP_DT
combined B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
only B-O B-NP_RB
these B-O B-DT
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
fully B-O B-VP_ADVP_RB
" " B-O O-ADVP
suppressed B-O B-VBN
by B-O B-NP_PP_IN
Cyclosporin B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
identified B-O B-VP_VBN
a B-O B-NP_NP_DT
putative B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
designated B-O B-VP_VBN
PILOT B-O B-S_NP_NP_NN
" " B-O O-NP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
with B-O B-PP_IN
an B-O B-NP_NP_DT
identical B-O B-JJ
dual B-O B-JJ
signal B-O B-NN
requirement B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
expression B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
PILOT B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
detectable B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
20 B-O B-PP_NP_CD
min B-O B-NN
" " B-O O-NP
following B-O B-VBG
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-DT
presence B-O B-NN
of B-O B-IN
cycloheximide B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
fully B-O B-VP_ADVP_RB
" " B-O O-ADVP
suppressed B-O B-VBN
by B-O B-NP_PP_IN
CyA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
PILOT B-O B-NN
protein B-O B-NN
" " B-O O-NP
has B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
calculated B-O B-VBN
M(r) B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
42.6 B-O B-NP_CD
kDa B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
contains B-O B-VP_VBZ
three B-O B-NP_NP_CD
zinc B-O B-NN
fingers B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
C2H2-type B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-SBAR_O-NP
at B-O B-PP_IN
the B-O B-NP_DT
carboxyl-terminus B-O B-NN
" " B-O O-NP
" " B-O O-PP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
highly B-O B-ADJP_RB
homologous B-O B-JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NN
to B-O B-TO
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
fibroblasts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
PILOT B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
requires B-O B-VP_VP_VBZ
only B-O B-NP_NP_QP_RB
one B-O B-CD
" " B-O O-QP
signal B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
not B-O B-RB
affected B-O B-VP_VBN
by B-O B-NP_PP_IN
CyA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
observation B-O B-NN
" " B-O O-NP
directly B-O B-ADVP_RB
" " B-O O-ADVP
demonstrates B-O B-VP_VBZ
the B-O B-NP_NP_DT
existence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
Ca2+ B-O B-ADJP_NN
signal-dependent B-O B-JJ
" " B-O O-ADJP
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
obligatory B-O B-ADJP_JJ
for B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
but B-O B-NP_PP_PP_CC
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
differential B-O B-JJ
expression B-O B-NN
model B-O B-NN
" " B-O O-NP
will B-O B-VP_MD
be B-O B-VP_VB
valuable B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
the B-O B-NP_NP_NP_DT
dissection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
dual B-O B-JJ
signal B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
CyA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
it B-O B-NP_PRP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_NP_NP_DT
serum B-O B-NN
response B-O B-NN
element B-O B-NN
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
NF-Y B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
mediate B-O B-VP_VB
the B-O B-NP_NP_DT
serum B-O B-NN
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
thrombospondin B-O B-NN
1 B-O B-CD
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
thrombospondin B-O B-NP_NP_NP_NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
TSP B-O B-NP_NN
1 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
member B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TSP B-O B-NN
gene B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
rapidly B-O B-VP_ADVP_RB
" " B-O O-ADVP
induced B-O B-VBN
by B-O B-NP_PP_IN
growth B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
tested B-O B-VP_VBD
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O B-S_O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
TSP B-O B-NN
1-chloramphenicol B-O B-JJ
acetyltransferase B-O B-NN
constructs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
respond B-O B-VP_VB
to B-O B-PP_TO
serum B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
stably B-O B-NP_ADJP_RB
transfected B-O B-VBN
" " B-O O-ADJP
NIH-3T3 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Two B-O B-S_NP_NP_NP_CD
transcriptional B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
TSP B-O B-NN
1 B-O B-CD
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_NP_DT
distal B-O B-JJ
element B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
-1280 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
a B-O B-NP_NP_DT
proximal B-O B-JJ
element B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
-65 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
required B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
TSP B-O B-NN
1 B-O B-CD
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
serum B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
distal B-O B-JJ
element B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
the B-O B-NP_NP_DT
"5'-CC(A + T)6GG-3'" B-O B-NN
consensus B-O B-NN
sequence B-O B-NN
" " B-O O-NP
characteristic B-O B-ADJP_JJ
of B-O B-PP_IN
a B-O B-NP_NP_DT
serum-response B-O B-JJ
element B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
SRE B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletions B-O B-S_NP_NP_NP_NNS
" " B-O O-NP
or B-O B-CC
mutations B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reduced B-O B-VP_VBD
the B-O B-NP_NP_DT
serum B-O B-NN
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
TSP B-O B-NN
1 B-O B-CD
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
80-90 B-O B-NP_QP_CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_S_PP_IN
gel-shift B-O B-NP_JJ
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
-1280 B-O B-CD
element B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
c-fos B-O B-NN
SRE B-O B-NN
" " B-O O-NP
" " B-O O-NP
cross-competed B-O B-VP_VBD
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
their B-O B-S_NP_PRPP
functional B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
binding B-O B-ADJP_VBG
" " B-O O-ADJP
" " B-O O-ADJP
mutants B-O B-NNS
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
" " B-O B-VP_O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
proximal B-O B-JJ
element B-O B-NN
" " B-O O-NP
contains B-O B-VP_VBZ
the B-O B-NP_NP_DT
sequence B-O B-NN
5'-GGCCAATGGG-3' B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
closely B-O B-S_NP_VP_ADVP_RB
" " B-O O-ADVP
resembles B-O B-VBZ
the B-O B-NP_NP_DT
consensus B-O B-NN
binding B-O B-NN
motif B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletions B-O B-S_NP_NP_NP_NNS
" " B-O O-NP
or B-O B-CC
mutations B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBD
the B-O B-NP_DT
serum B-O B-NN
response B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
80-90 B-O B-NP_QP_CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Methylation B-O B-S_S_NP_NP_NN
interference B-O B-NN
analysis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
-65 B-O B-CD
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
identified B-O B-VP_VBD
a B-O B-NP_NP_NP_DT
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
contacts B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
nuclear B-O B-NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
resembling B-O B-VP_VBG
that B-O B-NP_NP_DT
" " B-O O-NP
for B-O B-PP_IN
NF-Y B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
an B-O B-NP_NP_NP_DT
NF-Y-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
proximal B-O B-JJ
TSP B-O B-NN
1 B-O B-CD
element B-O B-NN
" " B-O O-NP
" " B-O O-NP
cross-competed B-O B-VP_VBD
in B-O B-NP_PP_IN
gel-shift B-O B-NP_JJ
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
their B-O B-S_NP_PRPP
binding B-O B-VBG
mutants B-O B-NNS
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
" " B-O B-VP_O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
an B-O B-NP_NP_DT
abbreviated B-O B-VBN
TSP B-O B-NN
1 B-O B-CD
promoter/5'-flank B-O B-NN
" " B-O O-NP
, B-O B-COMMA
containing B-O B-VP_VBG
the B-O B-NP_DT
SRE- B-O B-ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
NF-Y-binding B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
sites B-O B-NNS
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
mediated B-O B-VP_VBD
a B-O B-NP_NP_DT
serum B-O B-NN
response B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
was B-O B-S_NP_VP_VBD
close B-O B-ADJP_JJ
" " B-O B-PP_O-ADJP
in B-O B-PP_IN
magnitude B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
serum B-O B-NN
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
TSP B-O B-NN
1 B-O B-CD
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
requires B-O B-VP_VBZ
the B-O B-NP_NP_DT
coordinated B-O B-VBN
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
and B-O B-ADJP_ADJP_CC
site B-O B-ADJP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Suppression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
cellular B-O B-JJ
differentiation B-O B-NN
program B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
phorbol B-O B-NP_NN
esters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
coincides B-O B-VP_VBZ
with B-O B-PP_IN
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
binding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
cell-specific B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
an B-O B-NP_NP_DT
enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
required B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Induction B-O B-S_NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
hemin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increases B-O B-VP_VBZ
, B-O B-NP_COMMA
while B-O B-SBAR_IN
induction B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
12-O-tetradecanoylphorbol-13-acetate B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
TPA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
represses B-O B-VP_VBZ
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
erythroid-specific B-O B-NP_NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
cell B-O B-NN
line B-O B-NN
K562 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
analyzed B-O B-VP_VBD
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
hemin B-O B-NP_NP_NP_NN
" " B-O O-NP
or B-O B-CC
TPA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
binding B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
activity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
a B-O B-NP_NP_DT
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
found B-O B-VP_VBN
within B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TPA B-O B-S_NP_NN
induction B-O B-NN
" " B-O O-NP
increases B-O B-VP_VBZ
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ubiquitous B-O B-NP_JJ
AP-1 B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
this B-O B-NP_DT
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TPA B-O B-S_NP_NN
induction B-O B-NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
lineage B-O B-ADJP_NN
limited B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
factor B-O B-NN
NF-E2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
this B-O B-NP_DT
transcriptional B-O B-JJ
control B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Hemin B-O B-S_NP_NP_NN
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
facilitate B-O B-VP_VB
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-E2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
its B-O B-NP_PRPP
recognition B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Hemin B-O B-S_NP_NN
induction B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
nonspecifically B-O B-ADVP_RB
" " B-O O-ADVP
increase B-O B-VP_VB
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transiently B-O B-NP_ADJP_RB
transfected B-O B-VBN
" " B-O O-ADJP
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Beyond B-O B-S_PP_IN
this B-O B-NP_NP_DT
nonspecific B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
hemin B-O B-NP_NN
induction B-O B-NN
" " B-O O-NP
acts B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
increase B-O B-VP_VB
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
lineage B-O B-ADJP_NN
limited B-O B-JJ
" " B-O O-ADJP
transcription B-O B-NN
factor B-O B-NN
NF-E2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
divergent B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
hemin B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
TPA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
gene B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
mediated B-O B-VP_VBN
, B-O B-NP_PP_COMMA
in B-O B-PP_IN
part B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
by B-O B-IN
their B-O B-NP_NP_PRPP
contrasting B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
NF-E2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
Tat B-O B-NN
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HIV1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
promonocytic B-O B-JJ
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Numerous B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
, B-O B-COMMA
upon B-O B-S_PP_IN
HIV1 B-O B-NP_NN
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
human B-O B-NP_JJ
promonocytic B-O B-JJ
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
induced B-O B-VP_VBN
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
viral B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
this B-O B-NP_DT
process B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
the B-O B-NP_DT
Tat B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Indeed B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
this B-O B-NP_NP_DT
viral B-O B-JJ
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
essential B-O B-ADJP_JJ
for B-O B-PP_IN
productive B-O B-NP_JJ
infection B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
has B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
display B-O B-VP_VB
growth-stimulating B-O B-NP_NP_JJ
properties B-O B-NNS
" " B-O O-NP
and B-O B-CC
immunomodulatory B-O B-NP_JJ
activities B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-TO
apprehend B-O B-S_NP_VP_VB
the B-O B-NP_NP_DT
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV1 B-O B-NN
tat B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
inducing B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
successfully B-O B-ADVP_RB
" " B-O O-ADVP
introduced B-O B-VP_VBN
this B-O B-NP_DT
gene B-O B-NN
" " B-O O-NP
into B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
infecting B-O B-S_NP_VP_VBG
them B-O B-NP_PRP
" " B-O O-NP
with B-O B-PP_IN
retroviral B-O B-NP_JJ
particles B-O B-NNS
transducing B-O B-VBG
tat B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
Tat B-O B-NN
protein B-O B-NN
" " B-O O-NP
constitutively B-O B-VP_ADVP_RB
" " B-O O-ADVP
expressed B-O B-VBN
by B-O B-NP_PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
upon B-O B-PP_IN
their B-O B-NP_PRPP
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
then B-O B-ADVP_RB
" " B-O O-ADVP
evaluated B-O B-VP_VBN
by B-O B-NP_PP_IN
looking B-O B-S_NP_VP_VBG
for B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
" " B-O B-PP_PP_NP_SBAR_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_S_NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
revealed B-O B-VP_VBD
in B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
two B-O B-CD
proto-oncogenes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
this B-O B-S_NP_DT
increase B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
amplified B-O B-VP_VBN
after B-O B-NP_PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
phorbol B-O B-NP_NN
myristate B-O B-NN
acetate B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_DT
such B-O B-JJ
increase B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
control B-O B-NP_NN
U937 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VP_VBP
that B-O B-SBAR_IN
, B-O B-COMMA
among B-O B-S_PP_IN
HIV1 B-O B-NP_NN
gene B-O B-NN
products B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
Tat B-O B-NN
protein B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
trigger B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
this B-O B-S_NP_DT
viral B-O B-JJ
protein B-O B-NN
" " B-O O-NP
directs B-O B-VP_VBZ
progenitors B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
monocyte/macrophage B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
towards B-O B-PP_IN
a B-O B-NP_NP_DT
differentiation B-O B-NN
stage B-O B-NN
" " B-O O-NP
" " B-O B-SBAR_WHPP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcriptional B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
pyruvate B-O B-NN
kinase B-O B-NN
erythroid-specific B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Mammal B-O B-S_NP_JJ
pyruvate B-O B-NN
kinases B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
encoded B-O B-VP_VBN
by B-O B-NP_PP_IN
two B-O B-NP_CD
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
L B-O B-NN
gene B-O B-NN
" " B-O O-NP
produces B-O B-VP_VBZ
the B-O B-NP_NP_NP_NP_DT
erythroid B-O B-JJ
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
R-PK B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
or B-O B-CC
the B-O B-NP_NP_DT
hepatic B-O B-JJ
" " B-O B-NP_O-NP
( B-O B-PRN_LRB
L-PK B-O B-NP_JJ
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
isozymes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_NP_DT
alternative B-O B-JJ
use B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_CD
promoters B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
the B-O B-NP_NP_DT
characterization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
cis- B-O B-ADJP_ADJP_NP_JJ
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
trans-acting B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
elements B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
tissue-specific B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
R-PK B-O B-NN
DNA B-O B-NN
fragment B-O B-NN
" " B-O O-NP
extending B-O B-VP_VBG
from B-O B-PP_PP_IN
-870 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
+54 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
relative B-O B-PP_JJ
to B-O B-TO
the B-O B-NP_DT
cap B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
confers B-O B-VP_VBZ
erythroid B-O B-NP_JJ
specificity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
a B-O B-NP_DT
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Within B-O B-S_PP_IN
this B-O B-NP_DT
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
define B-O B-VP_VBP
a B-O B-NP_NP_NP_DT
minimal B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
-62 B-O B-NP_NP_CD
" " B-O O-NP
to B-O B-TO
+54 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
displays B-O B-S_NP_VP_VP_VBZ
erythroid-specific B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
contains B-O B-VP_VBZ
two B-O B-NP_CD
DNA B-O B-NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_S_NP_NP_CD
" " B-O O-NP
, B-O B-COMMA
located B-O B-ADJP_JJ
at B-O B-PP_IN
-50 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
" " B-O O-NP
binds B-O B-VP_VBZ
members B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CCACC/Sp1 B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
and B-O B-CC
the B-O B-S_NP_NP_DT
other B-O B-JJ
" " B-O O-NP
, B-O B-COMMA
located B-O B-ADJP_JJ
at B-O B-PP_IN
-20 B-O B-NP_CD
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
" " B-O O-NP
binds B-O B-VP_VBZ
the B-O B-NP_DT
erythroid B-O B-JJ
factor B-O B-NN
GATA-1 B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
the B-O B-S_NP_NP_DT
-20 B-O B-CD
GATA B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
AGATAA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
a B-O B-NP_DT
potential B-O B-JJ
TFIID B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
bind B-O B-VP_VB
TFIID B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
substitution B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
GATA B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
a B-O B-NP_DT
canonical B-O B-JJ
TFIID B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suppresses B-O B-VP_VBZ
the B-O B-NP_DT
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mutations B-O B-S_NP_NP_NP_NNS
" " B-O O-NP
and B-O B-CC
deletions B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
only B-O B-S_NP_NP_RB
the B-O B-DT
association B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CCACC/Sp1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
GATA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
drive B-O B-VP_VB
and B-O B-NP_NP_ADJP_ADJP_CC
expression B-O B-ADJP_NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
R-PK B-O B-NN
minimal B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
by B-O B-PP_IN
co-transfection B-O B-NP_NN
experiments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
study B-O B-VP_VBD
the B-O B-NP_NP_DT
elements B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
hGATA-1 B-O B-NN
transactivation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
R-PK B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
HeLa B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcription B-O B-S_NP_NN
factor B-O B-NN
jun-B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
target B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
autoreactive B-O B-NP_NP_JJ
T-cells B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
IDDM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Target B-O B-S_NP_NP_NN
antigens B-O B-NNS
" " B-O O-NP
defined B-O B-VP_VBN
by B-O B-NP_PP_IN
autoantibodies B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
IDDM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
include B-O B-VP_VBP
insulin B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
putative B-O B-JJ
glycolipid B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
reacts B-O B-S_NP_VP_VBZ
with B-O B-PP_IN
islet B-O B-NP_NN
cell B-O B-NN
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
a B-O B-NP_NP_DT
64,000-M(r) B-O B-JJ
protein B-O B-NN
" " B-O O-NP
recently B-O B-VP_ADVP_RB
" " B-O O-ADVP
identified B-O B-VBN
as B-O B-NP_PP_IN
glutamic B-O B-NP_JJ
acid B-O B-NN
decarboxylase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
some B-O B-NP_NP_DT
IDDM B-O B-NN
sera B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contain B-O B-S_NP_VP_VBP
antibodies B-O B-NP_NP_NNS
" " B-O O-NP
to B-O B-PP_TO
glutamic B-O B-NP_JJ
acid B-O B-NN
decarboxylase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
coprecipitate B-O B-VP_VBP
a B-O B-NP_NP_DT
38,000-M(r) B-O B-JJ
protein B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
islets B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
study B-O B-NN
" " B-O O-NP
used B-O B-VP_VP_VBD
a B-O B-NP_DT
high B-O B-JJ
titer B-O B-NN
anti-38,000-M(r) B-O B-JJ
serum B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
screen B-O B-VP_VB
bacteriophage B-O B-NP_NN
lambda B-O B-NN
cDNA B-O B-NN
expression B-O B-NN
libraries B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
and B-O B-CC
identified B-O B-VP_VBD
human B-O B-NP_NP_NP_JJ
islet B-O B-NN
" " B-O O-NP
and B-O B-CC
placental B-O B-NP_JJ
clones B-O B-NNS
" " B-O O-NP
" " B-O O-NP
encoding B-O B-VP_VBG
jun-B B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
the B-O B-NP_DT
nuclear B-O B-JJ
transcription B-O B-NN
protein B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
of B-O B-PP_IN
predicted B-O B-NP_VBN
38,000 B-O B-CD
M(r) B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Peripheral B-O B-S_NP_JJ
blood B-O B-NN
T-cells B-O B-NNS
" " B-O O-NP
exhibited B-O B-VP_VBD
significant B-O B-NP_JJ
proliferation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
response B-O B-NN
to B-O B-TO
a B-O B-NP_NP_DT
recombinant B-O B-JJ
fragment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
jun-B B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
amino B-O B-NP_NN
acids B-O B-NNS
1-180 B-O B-CD
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
recent-onset B-O B-NP_NP_QP_JJ
IDDM B-O B-NN
subjects B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
, B-O B-NP_NP_PP_COMMA
other B-O B-NP_QP_JJ
autoimmune B-O B-JJ
disease B-O B-NN
subjects B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
healthy B-O B-NP_QP_JJ
control B-O B-NN
subjects B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Proliferation B-O B-S_NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
tetanus B-O B-NP_NN
toxoid B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
differ B-O B-VP_VB
significantly B-O B-ADVP_RB
" " B-O O-ADVP
between B-O B-PP_IN
the B-O B-NP_DT
groups B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Responses B-O B-S_NP_NP_NNS
" " B-O O-NP
to B-O B-PP_TO
jun-B B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
related B-O B-ADJP_JJ
to B-O B-PP_TO
age B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
sex B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
or B-O B-CC
human B-O B-NP_JJ
leukocyte B-O B-NN
antigen B-O B-NN
status B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
autoreactive B-O B-NP_JJ
T-cells B-O B-NNS
" " B-O O-NP
identify B-O B-VP_VP_VBP
a B-O B-NP_NP_NP_DT
novel B-O B-JJ
antigen B-O B-NN
" " B-O O-NP
, B-O B-COMMA
p38 B-O B-NP_NN
jun-B B-O B-NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
in B-O B-PP_IN
IDDM B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
appear B-O B-VP_VBP
to B-O B-S_NP_VP_TO
indicate B-O B-VP_VB
subjects B-O B-NP_NP_NNS
" " B-O O-NP
at B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcriptional B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
interleukin B-O B-NP_NP_NP_NN
3 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
IL3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
primary B-O B-NP_JJ
human B-O B-JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Role B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
AP-1- B-O B-NP_ADJP_ADJP_NP_NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
octamer-binding B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
control B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
IL3 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
the B-O B-NP_NP_DT
molecular B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
biochemical B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
basis B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
gene B-O B-NP_NP_NP_NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
following B-O B-PP_VBG
receptor B-O B-NP_NP_NP_NN
by B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
transfection B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
reporter B-O B-NP_NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-NP
assays B-O B-NNS
" " B-O O-NP
specifically B-O B-VP_ADVP_RB
" " B-O O-ADVP
designed B-O B-VBN
for B-O B-NP_PP_IN
primary B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
conjunction B-O B-NN
with B-O B-IN
gel B-O B-NP_NP_NN
retardation B-O B-NN
assays B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
Western B-O B-NP_NN
blot B-O B-NN
analyses B-O B-NNS
" " B-O O-NP
and B-O B-CC
UV B-O B-NP_NN
cross-linking B-O B-JJ
studies B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
c-Jun B-O B-S_NP_UCP_NP_NN
" " B-O O-NP
, B-O B-COMMA
c-Fos B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
octamer-binding B-O B-ADJP_NN
" " B-O O-ADJP
" " B-O O-UCP
proteins B-O B-NNS
" " B-O O-NP
play B-O B-VP_VBP
a B-O B-NP_DT
major B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL3 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
via B-O B-PP_IN
their B-O B-NP_NP_PRPP
interaction B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Additionally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
region B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
bases B-O B-NP_NP_NNS
-107 B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
-59 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
IL3 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
putative B-O B-NP_JJ
and B-O B-NP_NP_CC
binding B-O B-NP_NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
appears B-O B-VP_VBZ
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
basal B-O B-NP_NP_JJ
level B-O B-NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL3 B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
CD2 B-O B-S_NP_NP_NN
receptor B-O B-NN
activation B-O B-NN
" " B-O O-NP
and B-O B-CC
phytohemagglutinin B-O B-NP_NP_NP_NN
" " B-O O-NP
plus B-O B-CC
phorbol B-O B-NP_NN
12-myristate B-O B-NN
13-acetate B-O B-NN
" " B-O O-NP
" " B-O O-NP
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-NP
augment B-O B-VP_VBP
T B-O B-NP_NN
cell B-O B-NN
IL3 B-O B-NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
the B-O B-NP_DT
same B-O B-JJ
" " B-O B-ADJP_ADJP_NP_ADJP_O-ADJP
and B-O B-CC
trans-activating B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
signals B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
should B-O B-VP_MD
contribute B-O B-VP_VB
to B-O B-PP_TO
a B-O B-NP_NP_DT
better B-O B-JJR
understanding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcriptional B-O B-NP_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
zeta B-O B-NN
2 B-O B-CD
globin B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_NP_DT
alpha B-O B-NN
globin B-O B-NN
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HS-40 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
functional B-O B-NP_NP_JJ
role B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
specific B-O B-NP_ADJP_JJ
nuclear B-O B-JJ
factor-DNA B-O B-JJ
" " B-O O-ADJP
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
studied B-O B-VP_VBD
the B-O B-NP_NP_DT
functional B-O B-JJ
interaction B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
human B-O B-NP_NP_JJ
embryonic B-O B-JJ
zeta B-O B-NN
2 B-O B-CD
globin B-O B-NN
promoter B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_NP_DT
alpha B-O B-NN
globin B-O B-NN
regulatory B-O B-JJ
element B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HS-40 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
located B-O B-ADJP_JJ
40 B-O B-ADVP_NP_CD
kb B-O B-NN
" " B-O O-NP
upstream B-O B-RB
of B-O B-PP_IN
" " B-O B-NP_O-ADVP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
was B-O B-VP_VBD
shown B-O B-VP_VBN
by B-O B-PP_IN
transient B-O B-NP_JJ
expression B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
HS-40 B-O B-S_NP_NN
" " B-O O-NP
behaved B-O B-VP_VBD
as B-O B-PP_IN
, B-O B-NP_NP_NP_PP_COMMA
" " B-O B-NP_NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
sequences B-O B-S_NP_NP_NNS
" " B-O O-NP
located B-O B-ADJP_JJ
between B-O B-PP_IN
-559 B-O B-NP_NP_NP_CD
" " B-O O-NP
and B-O B-CC
-88 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
zeta B-O B-NN
2 B-O B-CD
globin B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
were B-O B-VP_VBD
dispensable B-O B-ADJP_JJ
for B-O B-PP_IN
its B-O B-NP_NP_PRPP
expression B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
enhancerless B-O B-NP_NN
plasmids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
they B-O B-NP_PRP
" " B-O O-NP
were B-O B-VP_VBD
required B-O B-VP_VBN
for B-O B-NP_PP_IN
the B-O B-NP_NP_DT
HS-40 B-O B-ADJP_NN
enhancer-mediated B-O B-JJ
" " B-O O-ADJP
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
zeta B-O B-NN
2 B-O B-CD
globin B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Site-directed B-O B-S_NP_JJ
mutagenesis B-O B-NN
" " B-O O-NP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
this B-O B-S_NP_DT
HS-40 B-O B-ADJP_NN
enhancer-zeta B-O B-NN
2 B-O B-CD
globin B-O B-NN
promoter B-O B-NN
" " B-O O-ADJP
interaction B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
two B-O B-CD
GATA-1 B-O B-NN
factor B-O B-NN
binding B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
located B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
functional B-O B-JJ
domains B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
HS-40 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
also B-O B-VP_ADVP_RB
" " B-O O-ADVP
mapped B-O B-VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Bal B-O B-S_NP_NN
31 B-O B-CD
deletion B-O B-NN
mapping B-O B-VBG
data B-O B-NNS
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
one B-O B-S_NP_NP_NP_CD
GATA-1 B-O B-NN
motif B-O B-NN
" " B-O O-NP
, B-O B-COMMA
one B-O B-NP_CD
GT B-O B-NN
motif B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
two B-O B-NP_CD
NF-E2/AP1 B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-NP
together B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
formed B-O B-VP_VBD
the B-O B-NP_NP_DT
functional B-O B-JJ
core B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HS-40 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
erythroid-specific B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
zeta B-O B-NN
2 B-O B-CD
globin B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Site-directed B-O B-S_NP_JJ
mutagenesis B-O B-NN
" " B-O O-NP
further B-O B-ADVP_RBR
" " B-O O-ADVP
demonstrated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
enhancer B-O B-NN
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
through B-O B-NP_PP_IN
its B-O B-NP_NP_PRPP
binding B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Finally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
did B-O B-VP_VBD
genomic B-O B-NP_NP_JJ
footprinting B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
HS-40 B-O B-NN
enhancer B-O B-NN
region B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
K562 B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
adult B-O B-NP_JJ
nucleated B-O B-JJ
erythroblasts B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
different B-O B-NP_JJ
nonerythroid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
All B-O B-S_NP_NP_DT
sequence B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
within B-O B-PP_IN
the B-O B-NP_NP_DT
functional B-O B-JJ
core B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
HS-40 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
as B-O B-SBAR_IN
mapped B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
transient B-O B-NP_JJ
expression B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
appeared B-O B-VP_VBD
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
a B-O B-NP_NP_DT
nuclear B-O B-JJ
factor B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
in B-O B-PP_PP_IN
living B-O B-NP_VBG
K562 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
nonerythroid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-NP_DT
other B-O B-JJ
hand B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
only B-O B-NP_NP_QP_RB
one B-O B-CD
" " B-O O-QP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
apparently B-O B-ADJP_RB
nonfunctional B-O B-JJ
" " B-O O-ADJP
sequence B-O B-NN
motifs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
bound B-O B-VP_VBN
with B-O B-NP_PP_IN
factors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
comparison B-O B-NN
to B-O B-TO
K562 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
nucleated B-O B-NP_NP_JJ
erythroblasts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
adult B-O B-NP_JJ
human B-O B-JJ
bone B-O B-NN
marrow B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
exhibited B-O B-VP_VBD
a B-O B-NP_NP_DT
similar B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
but B-O B-CC
nonidentical B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
pattern B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
binding B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_DT
HS-40 B-O B-NN
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
transcriptional B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
embryonic B-O B-JJ
zeta B-O B-NN
2 B-O B-CD
globin B-O B-NN
gene B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
fetal/adult B-O B-JJ
alpha B-O B-NN
globin B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
complexes B-O B-NP_NP_ADJP_NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Interaction B-O B-S_NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
NF-kappa B-O B-NP_ADJP_ADJP_NP_NN
B- B-O B-NN
" " B-O O-NP
" " B-O B-ADJP_O-ADJP
and B-O B-CC
serum B-O B-ADJP_NN
response B-O B-NN
factor-binding B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
activates B-O B-VP_VBZ
an B-O B-NP_DT
interleukin-2 B-O B-NN
receptor B-O B-NN
alpha-chain B-O B-JJ
enhancer B-O B-NN
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
T B-O B-NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
find B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_NP_DT
short B-O B-JJ
enhancer B-O B-NN
element B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_NP_DT
NF-kappa B-O B-NN
B B-O B-NN
binding B-O B-NN
site B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
is B-O B-VP_VBZ
preferentially B-O B-VP_ADVP_RB
" " B-O O-ADVP
activated B-O B-VBN
in B-O B-NP_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
IL-2R B-O B-NN
alpha B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
binds B-O B-VP_VP_VBZ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
poorly B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
only B-O B-VP_ADVP_RB
weakly B-O B-RB
" " B-O O-ADVP
activated B-O B-VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
NF-kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Serum B-O B-S_S_NP_NP_NN
response B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
SRF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
binds B-O B-VP_VBZ
to B-O B-PP_TO
a B-O B-NP_NP_DT
site B-O B-NN
" " B-O O-NP
adjacent B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
NF-kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
both B-O B-S_NP_NP_DT
sites B-O B-NNS
" " B-O O-NP
together B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
have B-O B-VP_VBP
strong B-O B-NP_JJ
transcriptional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Surprisingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
SRF B-O B-NP_NP_NN
" " B-O O-NP
constitutively B-O B-VP_ADVP_RB
" " B-O O-ADVP
expressed B-O B-VBN
in B-O B-NP_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
consistently B-O B-ADVP_RB
" " B-O O-ADVP
higher B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
than B-O B-PP_IN
in B-O B-FRAG_PP_IN
other B-O B-NP_JJ
cell B-O B-NN
types B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Overexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
SRF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
causes B-O B-VP_VBZ
the B-O B-S_NP_DT
IL-2R B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
to B-O B-VP_TO
function B-O B-VP_VB
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
as B-O B-SBAR_RB
well B-O B-RB
as B-O B-IN
it B-O B-S_NP_PRP
" " B-O O-NP
does B-O B-VP_VBZ
in B-O B-VP_NP_PP_IN
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
high B-O B-JJ
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
is B-O B-VP_VBZ
functionally B-O B-ADVP_RB
" " B-O O-ADVP
important B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
The B-O B-S_NP_NP_DT
transcriptionally B-O B-ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
factors B-O B-NNS
" " B-O O-NP
mediating B-O B-VP_VBG
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HTLV-I B-O B-NN
Tax B-O B-NN
transactivator B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_DT
IL-2R B-O B-NN
alpha B-O B-NN
kappa B-O B-NN
B B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
include B-O B-VP_VBP
the B-O B-NP_NP_DT
product B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
c-rel B-O B-NN
proto-oncogene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
transactivator B-O B-NN
HTLV-I B-O B-NN
Tax B-O B-NN
" " B-O O-NP
activates B-O B-VP_VBZ
the B-O B-NP_NP_DT
promoter B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
gene B-O B-NN
" " B-O O-NP
coding B-O B-VP_VBG
for B-O B-PP_IN
the B-O B-NP_NP_DT
interleukin B-O B-NN
2 B-O B-CD
alpha-chain B-O B-JJ
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
via B-O B-PP_IN
a B-O B-NP_NP_DT
kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Tax1 B-O B-S_NP_NN
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
activates B-O B-VP_VBZ
the B-O B-NP_NP_DT
enhancer B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
motif B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
in B-O B-PP_IN
both B-O B-NP_NP_CC
epithelial B-O B-NP_JJ
HeLa B-O B-NN
" " B-O O-NP
and B-O B-CC
lymphoid B-O B-NP_JJ
Jurkat B-O B-NN
" " B-O O-NP
" " B-O O-NP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
activation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
not B-O B-RB
observed B-O B-VP_VBN
in B-O B-NP_PP_IN
undifferentiated B-O B-NP_JJ
embryocarcinoma B-O B-NN
F9 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Overexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
p50 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p65 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
Rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
proteins B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
significant B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2R B-O B-NN
alpha B-O B-NN
kappa B-O B-NN
B B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
only B-O B-NP_PP_RB
with B-O B-IN
Rel B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
plus B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
whereas B-O B-SBAR_IN
both B-O B-S_NP_CC
Tax B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
phorbol B-O B-NP_NP_NN
12-myristate B-O B-NN
13-acetate B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
efficiently B-O B-VP_ADVP_RB
" " B-O O-ADVP
induce B-O B-VB
" " B-O B-NP_NP_PP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
PMA B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
functionally B-O B-ADVP_RB
" " B-O O-ADVP
inactive B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
the B-O B-NP_DT
DNA B-O B-NN
affinity B-O B-NN
precipitation B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
observed B-O B-VP_VBD
that B-O B-SBAR_IN
Tax1 B-O B-S_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
able B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
PMA B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
" " B-O B-ADJP_O-VP
" " B-O O-S
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
established B-O B-VP_VBD
a B-O B-NP_NP_DT
clear B-O B-JJ
difference B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
both B-O B-NP_DT
stimuli B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
Rel B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_DT
functionally B-O B-ADJP_RB
active B-O B-JJ
" " B-O O-ADJP
factor B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
conclude B-O B-VP_VBP
from B-O B-PP_IN
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_NP_DT
functional B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
members B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
Rel B-O B-S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
a B-O B-NP_DT
potent B-O B-JJ
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
specific B-O B-NP_JJ
kappa B-O B-NN
B B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
p105 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
p98 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
precursor B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
play B-O B-VP_VBP
an B-O B-NP_DT
active B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
NF-kappa B-O B-NP_ADJP_NN
B-mediated B-O B-JJ
" " B-O O-ADJP
signal B-O B-NN
transduction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
Rel/NF-kappa B-O B-NN
B B-O B-NN
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
composed B-O B-VP_VBN
of B-O B-NP_PP_IN
two B-O B-NP_NP_CD
distinct B-O B-JJ
subgroups B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
proteins B-O B-NP_NP_NP_NP_NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
( B-O B-PRN_LRB
, B-O B-NP_NP_COMMA
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
those B-O B-NP_NP_NP_DT
" " B-O O-NP
without B-O B-PP_IN
" " B-O B-NP_SBAR_WHNP_S_O-NP
( B-O B-PRN_LRB
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
p105 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
p98 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
precursors B-O B-NNS
" " B-O O-NP
share B-O B-VP_VBP
functional B-O B-NP_JJ
properties B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
I B-O B-NN
kappa B-O B-NN
B B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_ADVP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
p105 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
p98 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
to B-O B-S_NP_VP_TO
form B-O B-VP_VB
stable B-O B-NP_JJ
complexes B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
other B-O B-NP_NP_JJ
Rel/NF-kappa B-O B-NN
B B-O B-NN
family B-O B-NN
members B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Association B-O B-S_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_DT
precursors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
sufficient B-O B-ADJP_JJ
for B-O B-PP_IN
cytoplasmic B-O B-NP_NP_JJ
retention B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_NP_CC
p65 B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
c-Rel B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O B-SBAR_WHNP_NP_WHPP_S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
complexes B-O B-NNS
" " B-O O-NP
undergo B-O B-VP_VBP
stimulus-responsive B-O B-NP_JJ
processing B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
produce B-O B-VP_VB
active B-O B-NP_JJ
p50/c-Rel B-O B-ADJP_ADJP_NN
" " B-O O-ADJP
and B-O B-CC
p55/c-Rel B-O B-ADJP_NN
" " B-O O-ADJP
" " B-O O-ADJP
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
observations B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
a B-O B-NP_NP_DT
second B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
leading B-O B-VP_VBG
to B-O B-PP_TO
NF-kappa B-O B-NP_NN
B B-O B-NN
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
processing B-O B-S_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
precursors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
rather B-O B-CONJP_RB
than B-O B-IN
" " B-O O-CONJP
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
major B-O B-JJ
role B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Mutual B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
transcriptional B-O B-JJ
activator B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
its B-O B-NP_NP_PRPP
inhibitor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
I B-O B-NP_NN
kappa B-O B-NN
B-alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
NK-kappa B-O B-NN
B B-O B-NN
transcription B-O B-NN
factor B-O B-NN
complex B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
sequestered B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
cytoplasm B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
the B-O B-NP_DT
inhibitory B-O B-JJ
protein B-O B-NN
I B-O B-NP_NP_NN
kappa B-O B-NN
B-alpha B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
MAD-3 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Various B-O B-S_NP_JJ
cellular B-O B-JJ
stimuli B-O B-NNS
" " B-O O-NP
relieve B-O B-VP_VBP
this B-O B-NP_DT
inhibition B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
mechanisms B-O B-NP_NP_NNS
" " B-O O-NP
largely B-O B-ADJP_RB
unknown B-O B-JJ
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
leading B-O B-S_NP_VP_VBG
to B-O B-PP_TO
NF-kappa B-O B-NP_NP_NN
B B-O B-NN
nuclear B-O B-JJ
localization B-O B-NN
" " B-O O-NP
and B-O B-CC
transactivation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
its B-O B-NP_PRPP
target B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
demonstrated B-O B-VP_VBN
here B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
human B-O B-NP_JJ
T B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
and B-O B-CC
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
different B-O B-S_NP_NP_JJ
stimuli B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
tumor B-O B-NP_NP_NN
necrosis B-O B-NN
factor B-O B-NN
alpha B-O B-NN
" " B-O O-NP
and B-O B-CC
phorbol B-O B-NP_NN
12-myristate B-O B-NN
13-acetate B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
cause B-O B-VP_VB
rapid B-O B-NP_NP_JJ
degradation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B-alpha B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
with B-O B-PP_IN
concomitant B-O B-NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
, B-O B-COMMA
followed B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transfection B-O B-S_NP_NN
studies B-O B-NNS
" " B-O O-NP
reveal B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
I B-O B-NN
kappa B-O B-NN
B-alpha B-O B-NN
mRNA B-O B-NN
" " B-O O-NP
and B-O B-CC
the B-O B-NP_DT
encoded B-O B-VBN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
potently B-O B-ADVP_RB
" " B-O O-ADVP
induced B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
by B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
a B-O B-NP_NP_DT
model B-O B-NN
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
NF-kappa B-O B-S_NP_NP_NN
B B-O B-NN
" " B-O O-NP
and B-O B-CC
I B-O B-NP_NN
kappa B-O B-NN
B-alpha B-O B-NN
" " B-O O-NP
" " B-O O-NP
mutually B-O B-ADVP_RB
" " B-O O-ADVP
regulate B-O B-VP_VBP
each B-O B-NP_DT
other B-O B-JJ
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
cycle B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
saturating B-O B-S_NP_NP_JJ
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
inhibitory B-O B-JJ
I B-O B-NN
kappa B-O B-NN
B-alpha B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
destroyed B-O B-VP_VBN
upon B-O B-NP_PP_IN
stimulation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
allowing B-O B-S_NP_VP_VBG
rapid B-O B-NP_VP_JJ
activation B-O B-NN
" " B-O O-VP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Subsequently B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
I B-O B-NP_NN
kappa B-O B-NN
B-alpha B-O B-NN
mRNA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
protein B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
levels B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
quickly B-O B-VP_ADVP_RB
" " B-O O-ADVP
induced B-O B-VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
activated B-O B-VBN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
resurgence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
I B-O B-NP_NN
kappa B-O B-NN
B-alpha B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
acts B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
restore B-O B-VP_VB
an B-O B-NP_NP_DT
equilibrium B-O B-NN
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-ADVP_VP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Induced B-O B-NP_NP_NP_VBN
myeloid B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
downregulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
erythroid B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
megakaryocytic B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
a B-O B-NP_NP_DT
novel B-O B-JJ
experimental B-O B-JJ
model B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
hemopoietic B-O B-NP_JJ
lineage B-O B-NN
restriction B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_NP_DT
human B-O B-JJ
erythroleukemia B-O B-NN
cell B-O B-NN
line B-O B-NN
K562 B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
induced B-O B-VP_VBN
to B-O B-S_NP_VP_TO
differentiate B-O B-VP_VB
along B-O B-PP_IN
the B-O B-NP_DT
lineages B-O B-ADJP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
hexamethylene B-O B-S_NP_NP_NN
bisacetamide B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HMBA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
induced B-O B-VP_VBD
K562 B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
to B-O B-VP_TO
differentiate B-O B-VP_VB
along B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
was B-O B-VP_VBD
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
downregulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
two B-O B-NP_NP_CD
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
normally B-O B-VP_ADVP_RB
" " B-O O-ADVP
expressed B-O B-VBN
in B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Northern B-O B-S_NP_NN
analysis B-O B-NN
" " B-O O-NP
demonstrated B-O B-VP_VBD
coordinate B-O B-NP_NP_JJ
downregulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
alpha B-O B-NP_NP_NN
globin B-O B-NN
" " B-O O-NP
and B-O B-CC
gamma B-O B-NP_NN
globin B-O B-NN
" " B-O O-NP
in B-O B-CONJP_IN
addition B-O B-NN
to B-O B-TO
" " B-O O-CONJP
the B-O B-NP_NP_DT
two B-O B-CD
lineage-restricted B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
SCL B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Proliferation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
K562 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
also B-O B-ADVP_RB
" " B-O O-ADVP
suppressed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Clonal B-O B-S_NP_JJ
assay B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
suppression B-O B-NN
" " B-O O-NP
was B-O B-VP_VP_VBD
irreversible B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
appeared B-O B-VP_VBD
analogous B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_NP_PP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NN
to B-O B-TO
MEL B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
however B-O B-ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
acquired B-O B-VP_VP_VBD
a B-O B-NP_DT
macrophage-like B-O B-JJ
morphology B-O B-NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
exhibited B-O B-VP_VBD
a B-O B-NP_DT
complete B-O B-JJ
failure B-O B-NN
to B-O B-S_NP_VP_TO
generate B-O B-VP_VB
benzidine-positive B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Electron B-O B-S_NP_NN
microscopy B-O B-NN
" " B-O O-NP
revealed B-O B-VP_VBD
a B-O B-NP_NP_DT
marked B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
granules B-O B-NP_NP_NNS
" " B-O O-NP
resembling B-O B-VP_VBG
those B-O B-NP_NP_DT
" " B-O O-NP
specific B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Surface B-O B-S_NP_NN
marker B-O B-NN
analysis B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
HMBA-induced B-O B-S_NP_JJ
cells B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VBD
reduced B-O B-NP_NP_VBN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
glycophorin B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
, B-O B-COMMA
CD5 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
CD7 B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
CD11b B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
No B-O B-S_NP_NP_DT
upregulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
megakaryocyte B-O B-NP_ADJP_ADJP_NN
" " B-O O-ADJP
or B-O B-CC
lymphoid B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
markers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurred B-O B-VP_VBD
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
the B-O B-NP_NP_DT
response B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
K562 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
HMBA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
provide B-O B-VP_VB
a B-O B-NP_NP_DT
useful B-O B-JJ
experimental B-O B-JJ
system B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
studying B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
molecular B-O B-JJ
mechanisms B-O B-NNS
" " B-O O-NP
responsible B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Costimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
peripheral B-O B-NP_JJ
blood B-O B-NN
T B-O B-NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
human B-O B-NP_JJ
endothelial B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Enhanced B-O B-S_NP_VBD
IL-2 B-O B-NN
transcription B-O B-NN
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
increased B-O B-NP_NP_VBN
c-fos B-O B-NN
synthesis B-O B-NN
" " B-O O-NP
and B-O B-CC
increased B-O B-NP_NP_VBN
Fos B-O B-NN
content B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Endothelial B-O B-S_NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
EC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
act B-O B-VP_VP_VBP
as B-O B-PP_IN
APC B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
resting B-O B-NP_VBG
PBL B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
may B-O B-VP_MD
have B-O B-VP_VB
important B-O B-NP_JJ
roles B-O B-NNS
" " B-O O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
in B-O B-PP_IN
the B-O B-NP_NP_DT
pathogenesis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
allograft B-O B-NP_NP_NN
rejection B-O B-NN
" " B-O O-NP
and B-O B-CC
delayed B-O B-NP_VBN
hypersensitivity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
previously B-O B-ADVP_RB
" " B-O O-ADVP
reported B-O B-VP_VBD
that B-O B-SBAR_IN
human B-O B-S_NP_JJ
umbilical B-O B-JJ
vein B-O B-NN
EC B-O B-NN
" " B-O O-NP
provide B-O B-VP_VBP
costimulatory B-O B-NP_JJ
signals B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
PHA-stimulated B-O B-NP_JJ
PBL B-O B-NN
" " B-O O-NP
" " B-O O-PP
via B-O B-PP_IN
CD2:lymphocyte B-O B-NP_NP_ADJP_NN
function-associated B-O B-JJ
" " B-O O-ADJP
Ag-3 B-O B-NN
" " B-O O-NP
and B-O B-CC
an B-O B-NP_DT
unidentified B-O B-JJ
ligand B-O B-NN
pair B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
resulting B-O B-S_NP_VP_VBG
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
physiologic B-O B-JJ
relevance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
increase B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
demonstrated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
proliferative B-O B-JJ
advantage B-O B-NN
" " B-O O-NP
provided B-O B-VP_VBN
by B-O B-NP_PP_IN
EC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
PBL B-O B-NP_NP_NN
" " B-O O-NP
stimulated B-O B-VP_ADVP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
now B-O B-ADVP_RB
" " B-O O-ADVP
report B-O B-VP_VBP
that B-O B-SBAR_IN
EC B-O B-S_NP_NN
costimulation B-O B-NN
" " B-O O-NP
causes B-O B-VP_VBZ
increased B-O B-NP_NP_VBN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
result B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
therefore B-O B-ADVP_RB
" " B-O O-ADVP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
EC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
T B-O B-NP_NP_NN
cell B-O B-NN
nuclear B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
regulate B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
, B-O B-COMMA
including B-O B-PP_VBG
and B-O B-NP_NP_NP_NP_CC
components B-O B-NP_NNS
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PBL B-O B-S_S_NP_NN
" " B-O O-NP
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
express B-O B-VP_VBP
c-jun B-O B-NP_NN
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-jun B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-RB
altered B-O B-VP_VBN
by B-O B-NP_PP_IN
PHA B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
absence B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
presence B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
EC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
c-fos B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
absent B-O B-ADJP_JJ
from B-O B-PP_IN
resting B-O B-NP_VBG
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
induced B-O B-VP_VBN
on B-O B-NP_PP_IN
PHA B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
EC B-O B-S_NP_NP_NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
do B-O B-VP_VP_VBP
not B-O B-RB
induce B-O B-VP_VB
c-fos B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
but B-O B-CC
augment B-O B-VP_VBP
the B-O B-NP_NP_DT
level B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
PHA-activated B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
3- B-O B-NP_CD
to B-O B-TO
10-fold B-O B-RB
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
effect B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
largely B-O B-ADJP_RB
independent B-O B-JJ
of B-O B-PP_IN
the B-O B-NP_DT
CD2:lymphocyte B-O B-ADJP_NN
function-associated B-O B-JJ
" " B-O O-ADJP
Ag-3 B-O B-NN
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Gel-shift B-O B-S_NP_NN
analysis B-O B-NN
" " B-O O-NP
reveals B-O B-VP_VBZ
the B-O B-NP_NP_DT
constitutive B-O B-JJ
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_O-NP
" " B-O O-PP
in B-O B-PP_IN
resting B-O B-NP_VBG
PBL B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_SBAR_WHNP_WDT
" " B-O O-WHNP
bind B-O B-S_NP_VP_VBP
to B-O B-PP_TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_WHNP_IN
" " B-O O-WHNP
contain B-O B-S_NP_VP_VBP
immunoreactive B-O B-NP_JJ
protein B-O B-NP_NP_CONJP_NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
AP-1 B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
PHA-activated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contains B-O B-VP_VBZ
c-Jun B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
low B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-Fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Strikingly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
costimulation B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
EC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
a B-O B-NP_NP_NP_DT
dramatic B-O B-JJ
increase B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
up B-O B-NP_QP_NN
to B-O B-TO
15-fold B-O B-JJ
" " B-O O-QP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
c-Fos B-O B-NN
content B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Levels B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_NP_JJ
nuclear B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
IL-2 B-O B-NP_NN
regulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
altered B-O B-VP_VBN
by B-O B-NP_PP_IN
EC B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
although B-O B-SBAR_IN
NFAT-DNA B-O B-S_NP_NN
complexes B-O B-NNS
" " B-O O-NP
migrated B-O B-VP_VBD
at B-O B-PP_IN
a B-O B-NP_DT
slightly B-O B-ADJP_RB
different B-O B-JJ
" " B-O O-ADJP
mobility B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
summary B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
our B-O B-NP_PRPP
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
changes B-O B-S_NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
composition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcription B-O B-NP_NN
factor B-O B-NN
AP-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
key B-O B-JJ
molecular B-O B-JJ
mechanism B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
increasing B-O B-NP_VBG
IL-2 B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
may B-O B-VP_MD
underlie B-O B-VP_VB
the B-O B-NP_NP_DT
phenomenon B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
A B-O B-S_NP_NP_DT
protein B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
AP-1 B-O B-NN
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_NP_NP_JJ
factor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
NF-AT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
transcriptional B-O B-JJ
activator B-O B-NN
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IL-2 B-O B-NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
response B-O B-NN
element B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
sequence B-O B-NN
" " B-O O-NP
localized B-O B-VP_JJ
between B-O B-NP_PP_IN
-285/-254 B-O B-NP_NP_CD
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
regulatory B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
composition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-AT B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
still B-O B-ADVP_RB
" " B-O O-ADVP
not B-O B-ADVP_RB
fully B-O B-RB
" " B-O O-ADVP
elucidated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
, B-O B-COMMA
in B-O B-S_PP_IN
normal B-O B-NP_JJ
human B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
an B-O B-NP_DT
AP-1 B-O B-NN
protein B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
component B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-AT B-O B-NN
protein B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
" " B-O O-NP
was B-O B-VP_VBD
evidenced B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O B-S_O-NP
of B-O B-PP_IN
the B-O B-NP_DT
AP-1 B-O B-NN
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
compete B-O B-VP_VB
" " B-O B-PP_PP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
by B-O B-PP_IN
the B-O B-NP_NP_DT
capacity B-O B-NN
" " B-O B-S_O-NP
of B-O B-PP_IN
immobilized B-O B-NP_VBN
and B-O B-ADJP_ADJP_CC
antibodies B-O B-ADJP_NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
deplete B-O B-VP_VB
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
There B-O B-S_S_NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_NP_DT
detectable B-O B-JJ
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_ADJP_ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
translated B-O B-VBN
" " B-O O-ADJP
Jun/Fos B-O B-NP_NP_NN
heterodimer B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
AP-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
NF-AT B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_DT
NF-AT B-O B-NN
sequence B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
unable B-O B-ADJP_JJ
to B-O B-S_NP_VP_TO
inhibit B-O B-VP_VB
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
to B-O B-NP_PP_TO
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
an B-O B-NP_DT
AP-1 B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_DT
NF-AT B-O B-NN
protein B-O B-NN
complex B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
regulate B-O B-VP_VB
NF-AT-binding B-O B-NP_JJ
activity B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
protein-protein B-O B-NP_JJ
interaction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Immobilization B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
recovery B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
fusion B-O B-NP_NP_NN
proteins B-O B-NNS
" " B-O O-NP
and B-O B-CC
B-lymphocyte B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
using B-O B-VP_VBG
magnetic B-O B-NP_JJ
separation B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-NP
  
A B-O B-S_NP_NP_DT
new B-O B-JJ
approach B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHADVP_S_NP_VP_TO
facilitate B-O B-VP_VB
immobilization B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
affinity B-O B-NP_NN
purification B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
developed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Using B-O B-S_S_NP_VP_VBG
magnetic B-O B-NP_NP_JJ
beads B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
attached B-O B-NP_NP_VBN
DNA B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_DT
Escherichia B-O B-FW
coli B-O B-FW
lac B-O B-NN
operator B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
fusion B-O B-NP_NP_NN
proteins B-O B-NNS
" " B-O O-NP
comprising B-O B-VP_VBG
the B-O B-NP_DT
DNA-binding B-O B-JJ
lac B-O B-NN
repressor B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
affinity-purified B-O B-VP_VP_VP_JJ
" " B-O B-NP_O-VP
and B-O B-CC
recovered B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
by B-O B-PP_PP_IN
gentle B-O B-NP_NP_JJ
elution B-O B-NN
conditions B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
such B-O B-PP_JJ
as B-O B-IN
" " B-O B-FRAG_PP_O-PP
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
by B-O B-PP_IN
enzymatic B-O B-NP_NP_JJ
means B-O B-NNS
" " B-O O-NP
using B-O B-VP_VBG
either B-O B-NP_CC
or B-O B-NP_CC
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
show B-O B-VP_VBP
for B-O B-PP_IN
the B-O B-NP_DT
first B-O B-JJ
time B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_IN
a B-O B-S_NP_DT
DNA-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
used B-O B-VP_VBN
for B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
as B-O B-SBAR_IN
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
approach B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
further B-O B-ADVP_RB
" " B-O O-ADVP
extended B-O B-VP_VBN
to B-O B-NP_PP_TO
cell B-O B-NP_NP_NN
separation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_NP_DT
efficient B-O B-JJ
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Negative B-O B-NP_NP_JJ
transcriptional B-O B-JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
interleukin B-O B-NP_NP_NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
interference B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
nuclear B-O B-NP_JJ
transcription B-O B-NN
factors B-O B-NNS
AP-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
IL-2 B-O B-S_NP_NN
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
affected B-O B-VP_VBN
by B-O B-NP_PP_IN
several B-O B-NP_JJ
nuclear B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
asked B-O B-VP_VBD
whether B-O B-SBAR_IN
dexamethasone B-O B-S_NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
Dex B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
cyclosporin B-O B-NP_NP_NN
A B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
CsA B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
inhibit B-O B-VP_VBP
IL-2 B-O B-NP_NN
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
interfering B-O B-S_NP_VP_VBG
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
primary B-O B-PP_JJ
human B-O B-JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
analyzed B-O B-VP_VBN
by B-O B-NP_PP_IN
electrophoretic B-O B-NP_JJ
DNA B-O B-NN
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_CC
Dex B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
CsA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
AP-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
but B-O B-CC
not B-O B-PP_RB
of B-O B-IN
NF-kB B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
OCT-1/OAF B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
, B-O B-COMMA
to B-O B-PP_TO
their B-O B-NP_NP_PRPP
corresponding B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_DT
IL-2 B-O B-NN
gene B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
correlate B-O B-VP_VP_VB
changes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
nuclear B-O B-NP_JJ
factor B-O B-NN
binding B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-ADVP_FW
vitro B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
with B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
activity B-O B-NN
" " B-O O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
define B-O B-VP_VB
the B-O B-NP_NP_DT
structural B-O B-JJ
requirements B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
IL-2 B-O B-NP_NN
promoter B-O B-NN
repression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
used B-O B-VP_VBD
transient B-O B-NP_JJ
DNA B-O B-NN
transfections B-O B-NNS
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Jurkat B-O B-S_NP_NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
transfected B-O B-VP_VBN
with B-O B-NP_PP_IN
plasmids B-O B-NP_NP_NNS
" " B-O O-NP
containing B-O B-VP_VBG
either B-O B-NP_CC
the B-O B-NP_DT
intact B-O B-JJ
IL-2 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
or B-O B-CC
its B-O B-NP_PRPP
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
motifs B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Dex B-O B-S_NP_NN
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_NP_NP_DT
IL-2 B-O B-NN
promoter B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
the B-O B-NP_DT
AP-1 B-O B-NN
" " B-O B-NP_O-NP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
NF-AT B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF-kB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O B-NP_O-NP
" " B-O O-NP
plasmids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
CsA B-O B-NP_NN
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_NP_NP_DT
IL-2 B-O B-NN
promoter B-O B-NN
" " B-O B-NP_O-NP
and B-O B-CC
the B-O B-NP_DT
NF-AT B-O B-NN
" " B-O B-NP_O-NP
" " B-O O-NP
, B-O B-COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
the B-O B-NP_DT
AP-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF-kB B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O B-NP_O-NP
" " B-O O-NP
plasmids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
in B-O B-S_PP_IN
human B-O B-NP_JJ
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
both B-O B-NP_CC
Dex B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
CsA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
inhibited B-O B-VP_VBD
IL-2 B-O B-NP_NN
gene B-O B-NN
transcription B-O B-NN
" " B-O O-NP
through B-O B-PP_IN
interference B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
transcription B-O B-NP_NN
factors B-O B-NNS
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
propose B-O B-VP_VBP
that B-O B-SBAR_IN
, B-O B-COMMA
while B-O B-S_SBAR_IN
maximum B-O B-S_NP_NN
inhibition B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
involve B-O B-VP_VB
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
AP-1 B-O B-NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_NP_DT
primary B-O B-JJ
target B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Dex B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Lymphocytes B-O B-S_NP_NP_NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_NP_DT
site B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
disease B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggest B-O B-VP_VBP
adenovirus B-O B-SBAR_COMP_S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
one B-O B-NP_NP_CD
cause B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
or B-O B-NP_ADJP_ADJP_CC
inflammatory B-O B-ADJP_JJ
arthritis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
assessment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
synovial B-O B-NP_NP_JJ
lymphocyte B-O B-NN
reactivity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
adenovirus B-O B-NP_NN
antigen B-O B-NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
undertaken B-O B-VP_VBN
in B-O B-NP_PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
persistent B-O B-NP_ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
recurrent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
inflammatory B-O B-JJ
arthritis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
3H-thymidine B-O B-JJ
uptake B-O B-NN
procedure B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
employed B-O B-VP_VBN
, B-O B-NP_COMMA
incorporating B-O B-S_NP_VP_VBG
multiple B-O B-NP_JJ
microbiological B-O B-JJ
antigens B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Five B-O B-S_S_NP_CD
patients B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
found B-O B-VP_VBN
with B-O B-S_NP_PP_IN
repeated B-O B-NP_NP_VBN
maximal B-O B-JJ
responses B-O B-NNS
" " B-O O-NP
to B-O B-PP_TO
adenovirus B-O B-NP_NN
antigen B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
in B-O B-S_PP_IN
one B-O B-NP_NP_CD
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
adenovirus B-O B-NP_NN
nucleotide B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
present B-O B-ADJP_JJ
in B-O B-PP_IN
a B-O B-NP_DT
synovial B-O B-JJ
biopsy B-O B-NN
specimen B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
concluded B-O B-VP_VBN
that B-O B-SBAR_IN
adenovirus B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
one B-O B-NP_NP_CD
cause B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cell-specific B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
helix-loop-helix B-O B-NP_NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
encoded B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
E2A B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_DT
E2A B-O B-NN
gene B-O B-NN
" " B-O O-NP
encodes B-O B-VP_VBZ
transcription B-O B-NP_NP_NN
factors B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
helix-loop-helix B-O B-JJ
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
implicated B-O B-VP_VBN
in B-O B-NP_PP_IN
cell-specific B-O B-NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
It B-O B-S_NP_PRP
" " B-O O-NP
has B-O B-VP_VBZ
previously B-O B-ADVP_RB
" " B-O O-ADVP
been B-O B-VP_VBN
shown B-O B-VP_VBN
that B-O B-SBAR_IN
transcripts B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
E2A B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
detected B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
now B-O B-ADVP_RB
" " B-O O-ADVP
examined B-O B-VP_VBN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
mouse B-O B-NN
E2A B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
at B-O B-PP_IN
the B-O B-NP_DT
protein B-O B-NN
level B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
using B-O B-S_NP_VP_VBG
polyclonal B-O B-NP_NP_JJ
antisera B-O B-NNS
" " B-O O-NP
directed B-O B-VP_VBN
against B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-NP
to B-O B-S_NP_VP_TO
probe B-O B-VP_NN
" " B-O B-NP_NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_S_NP_DT
73 B-O B-CD
kDa B-O B-NN
protein B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
by B-O B-NP_PP_IN
this B-O B-NP_DT
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
: B-O B-COLON
" " B-O O-S
this B-O B-S_NP_DT
protein B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
highly B-O B-ADJP_RB
enriched B-O B-VBN
" " B-O O-ADJP
in B-O B-PP_IN
cell B-O B-NP_NP_NN
lines B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
B B-O B-NP_NN
lymphoid B-O B-JJ
origin B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
as B-O B-SBAR_IN
compared B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
pancreatic B-O B-NP_NP_JJ
beta-cells B-O B-NNS
" " B-O O-NP
and B-O B-CC
fibroblast B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
detection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
selectively B-O B-PP_RB
in B-O B-IN
extracts B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
E B-O B-ADJP_NN
box-binding B-O B-JJ
" " B-O O-ADJP
activity B-O B-NN
LEF1/BCF1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
this B-O B-S_NP_DT
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
previously B-O B-ADVP_RB
" " B-O O-ADVP
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
efficiently B-O B-ADVP_RB
" " B-O O-ADVP
recognized B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Transfection B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
full B-O B-NP_JJ
length B-O B-NN
E2A B-O B-NN
cDNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
appearance B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NP_NN
" " B-O O-NP
co-migrating B-O B-VP_VP_VBG
with B-O B-PP_IN
on B-O B-NP_PP_IN
" " B-O B-NP_O-VP
and B-O B-CC
co-migrating B-O B-VP_VBG
with B-O B-PP_IN
on B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
consistent B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_DT
view B-O B-NN
that B-O B-SBAR_IN
the B-O B-S_NP_DT
DNA-binding B-O B-JJ
activity B-O B-NN
LEF1/BCF1 B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
the B-O B-S_NP_NP_DT
selective B-O B-JJ
appearance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
this B-O B-NP_DT
putative B-O B-JJ
cell-specific B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
B B-O B-NP_NN
lymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
seems B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
attributable B-O B-ADJP_JJ
, B-O B-PP_COMMA
in B-O B-PP_ADVP_IN
, B-O B-NP_COMMA
to B-O B-TO
" " B-O B-NP_NP_PP_O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
HIV-1 B-O B-S_NP_NN
Nef B-O B-NN
protein B-O B-NN
" " B-O O-NP
inhibits B-O B-VP_VBZ
the B-O B-NP_NP_DT
recruitment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NP_NN
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
T-cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
human B-O B-JJ
immunodeficiency B-O B-NN
virus B-O B-NN
type B-O B-NN
1 B-O B-CD
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
, B-O B-COMMA
HIV-1-LTR B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
contains B-O B-VP_VBZ
binding B-O B-NP_NP_VBG
sites B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
several B-O B-NP_NP_JJ
cellular B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
contribute B-O B-S_NP_VP_VBP
to B-O B-PP_TO
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_NP_PRPP
previous B-O B-JJ
studies B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
the B-O B-NP_NP_DT
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
HIV-1-encoded B-O B-JJ
Nef B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggested B-O B-VP_VBD
that B-O B-SBAR_IN
Nef B-O B-S_NP_NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
an B-O B-NP_DT
inhibitor B-O B-NN
HIV-1 B-O B-NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
Nef B-O B-S_NP_NN
" " B-O O-NP
affects B-O B-VP_VBZ
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
implicated B-O B-NP_VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
32P-labeled B-O B-NP_NP_JJ
oligonucleotides B-O B-NNS
" " B-O O-NP
corresponding B-O B-VP_VBG
to B-O B-PP_TO
the B-O B-NP_DT
binding B-O B-VBG
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
incubated B-O B-VP_VBN
with B-O B-NP_PP_IN
nuclear B-O B-NP_NP_JJ
extracts B-O B-NNS
" " B-O O-NP
prepared B-O B-VP_VBN
from B-O B-NP_PP_IN
Nef-expressing B-O B-NP_NP_JJ
T-cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
found B-O B-VP_VBD
that B-O B-SBAR_IN
Nef B-O B-S_NP_NN
" " B-O O-NP
inhibited B-O B-VP_VBD
the B-O B-NP_NP_DT
recruitment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NP_NN
DNA-binding B-O B-JJ
activity B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Additionally B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
Nef B-O B-NP_NN
expressing B-O B-NN
cells B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
transiently B-O B-VP_ADVP_RB
" " B-O O-ADVP
transfected B-O B-VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
plasmid B-O B-NN
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
HIV-1 B-O B-S_NP_NN
AP-1 B-O B-NN
DNA B-O B-NN
recognition B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
cloned B-O B-VP_VBN
" " B-O B-NP_ADVP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Mitogen-mediated B-O B-S_NP_NP_JJ
transcriptional B-O B-JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
CAT B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
this B-O B-NP_DT
construct B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
in B-O B-NP_PP_PP_IN
Nef-expressing B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
but B-O B-CC
not B-O B-PP_RB
in B-O B-IN
control B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
studies B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
, B-O B-COMMA
by B-O B-S_PP_IN
inhibiting B-O B-S_NP_VP_VBG
AP-1 B-O B-NP_NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
, B-O B-COMMA
Nef B-O B-NP_NN
" " B-O O-NP
may B-O B-VP_MD
play B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
regulating B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Cloning B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
functional B-O B-NP_JJ
characterization B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
early B-O B-NP_NP_JJ
B-cell B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
regulator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lymphocyte-specific B-O B-NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Early B-O B-S_NP_NP_JJ
B-cell B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
EBF B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
identified B-O B-VP_VBN
previously B-O B-NP_ADVP_RB
" " B-O O-ADVP
as B-O B-PP_IN
a B-O B-NP_NP_DT
tissue-specific B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
and B-O B-CC
differentiation B-O B-ADJP_NN
stage-specific B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
DNA-binding B-O B-JJ
protein B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
participates B-O B-S_NP_VP_VBZ
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Partial B-O B-S_NP_NP_JJ
amino B-O B-NN
acid B-O B-NN
sequences B-O B-NNS
" " B-O O-NP
obtained B-O B-VP_VBN
from B-O B-NP_PP_IN
purified B-O B-NP_VBN
EBF B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
were B-O B-VP_VBD
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
isolate B-O B-VP_VB
cDNA B-O B-NP_NP_NN
clones B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_PP_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
recombinant B-O B-JJ
polypeptide B-O B-NN
" " B-O O-NP
formed B-O B-VP_VBD
sequence-specific B-O B-NP_NP_JJ
complexes B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
EBF-binding B-O B-NN
site B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
mb-1 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_S_NP_DT
cDNA B-O B-NN
" " B-O O-NP
hybridized B-O B-VP_VBD
to B-O B-PP_TO
multiple B-O B-NP_JJ
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
pre-B B-O B-NP_NP_NP_JJ
" " B-O B-NP_O-NP
and B-O B-CC
B-cell B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
but B-O B-CC
transcripts B-O B-S_NP_NNS
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
detected B-O B-VP_VBN
at B-O B-NP_PP_IN
significant B-O B-NP_JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
plasmacytoma B-O B-NP_UCP_NP_NN
" " B-O O-NP
, B-O B-COMMA
T-cell B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
nonlymphoid B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-UCP
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
recombinant B-O B-NP_JJ
EBF B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
transfected B-O B-NP_VBN
nonlymphoid B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBD
transcription B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
reporter B-O B-NP_NP_NN
plasmids B-O B-NNS
" " B-O O-NP
containing B-O B-VP_VBG
functional B-O B-NP_JJ
EBF-binding B-O B-JJ
sites B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
DNA B-O B-NP_NP_NN
binding B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
deletion B-O B-NP_NP_NN
mutants B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
EBF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
identified B-O B-VP_VBD
an B-O B-NP_NP_DT
amino-terminal B-O B-JJ
cysteine-rich B-O B-JJ
DNA-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
lacking B-O B-VP_VBG
obvious B-O B-NP_NP_JJ
sequence B-O B-NN
similarity B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
known B-O B-NP_JJ
transcription B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
DNA-binding B-O B-S_NP_NP_JJ
assays B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
cotranslated B-O B-NP_NP_NP_NP_VBN
wild-type B-O B-JJ
" " B-O B-NP_O-NP
and B-O B-CC
truncated B-O B-NP_JJ
" " B-O B-NP_O-NP
" " B-O O-NP
forms B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
EBF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
the B-O B-S_NP_DT
protein B-O B-NN
" " B-O O-NP
interacts B-O B-VP_VBZ
with B-O B-PP_IN
its B-O B-NP_PRPP
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
as B-O B-PP_IN
a B-O B-NP_DT
homodimer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Deletions B-O B-S_NP_NNS
" " B-O O-NP
delineated B-O B-VP_VBD
a B-O B-NP_NP_DT
carboxy-terminal B-O B-JJ
dimerization B-O B-NN
region B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
two B-O B-NP_NP_CD
repeats B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
15 B-O B-NP_CD
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
show B-O B-S_NP_VP_VBP
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Together B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
data B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
EBF B-O B-S_NP_NN
" " B-O O-NP
represents B-O B-VP_VBZ
a B-O B-NP_NP_DT
novel B-O B-JJ
regulator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
B B-O B-NP_ADJP_NN
lymphocyte-specific B-O B-JJ
" " B-O O-ADJP
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
[ B-O B-NP_LRB
The B-O B-NP_DT
trend B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
molecular B-O B-NP_NP_JJ
biology B-O B-NN
study B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
eosinophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
] B-O B-RRB
" " B-O O-NP
  
Recently B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
many B-O B-NP_JJ
investigators B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
interested B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_NP_DT
study B-O B-NN
" " B-O O-NP
on B-O B-PP_IN
eosinophil B-O B-NP_NN
biology B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
since B-O B-SBAR_IN
genes B-O B-S_NP_NP_NNS
association B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
eosinophils B-O B-NP_NP_NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
were B-O B-VP_VBD
isolated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
molecular B-O B-JJ
basis B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
commitment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
progenitors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_DT
eosinophil B-O B-NN
lineage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
not B-O B-RB
been B-O B-VP_VBN
determined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
eosinophil-specific B-O B-S_NP_NP_JJ
genes B-O B-NNS
" " B-O O-NP
encoding B-O B-VP_VBG
and B-O B-NP_NP_ADJP_ADJP_CC
granule B-O B-ADJP_NN
proteins B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_ADVP_NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
expressed B-O B-VP_VP_VP_VBN
" " B-O B-NP_O-VP
and B-O B-CC
regulated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
during B-O B-PP_IN
eosinophilopoiesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
is B-O B-VP_VBZ
also B-O B-ADVP_RB
" " B-O O-ADVP
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
paper B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
I B-O B-NP_PRP
" " B-O O-NP
described B-O B-VP_VBD
the B-O B-NP_NP_NP_DT
characterization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
encoding B-O B-VP_VBG
eosinophil B-O B-NP_NN
granule B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
the B-O B-NP_NP_DT
mRNA B-O B-NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NN
binding B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
eosinophil B-O B-NP_NN
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Ets-related B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
Elf-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
binding B-O B-S_NP_VP_VBG
to B-O B-PP_TO
the B-O B-NP_DT
retinoblastoma B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
retinoblastoma B-O B-NN
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Rb B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
nuclear B-O B-JJ
phosphoprotein B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
regulates B-O B-S_NP_VP_VBZ
cell B-O B-NP_NN
cycle B-O B-NN
progression B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Elf-1 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
lymphoid-specific B-O B-JJ
Ets B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
regulates B-O B-S_NP_VP_VBZ
inducible B-O B-NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
report B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
demonstrated B-O B-VP_VBN
that B-O B-SBAR_IN
Elf-1 B-O B-S_NP_NN
" " B-O O-NP
contains B-O B-VP_VBZ
a B-O B-NP_NP_DT
sequence B-O B-NN
motif B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Elf-1 B-O B-S_NP_NN
" " B-O O-NP
binds B-O B-VP_VP_VBZ
exclusively B-O B-ADVP_RB
" " B-O O-ADVP
to B-O B-PP_TO
the B-O B-NP_NP_DT
underphosphorylated B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Rb B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
fails B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
to B-O B-PP_TO
Rb B-O B-NP_NP_NN
mutants B-O B-NNS
" " B-O O-NP
derived B-O B-VP_VBN
" " B-O B-NP_PP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Co-immunoprecipitation B-O B-S_NP_NN
experiments B-O B-NNS
" " B-O O-NP
demonstrated B-O B-VP_VBD
an B-O B-NP_NP_DT
association B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
Elf-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
Rb B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
resting B-O B-NP_VBG
normal B-O B-JJ
human B-O B-JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
phosphorylation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Rb B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
the B-O B-NP_NP_DT
release B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Elf-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
correlated B-O B-VP_VBN
temporally B-O B-NP_ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Overexpression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
phosphorylation-defective B-O B-JJ
form B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Rb B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
inhibited B-O B-VP_VBD
Elf-1-dependent B-O B-NP_JJ
transcription B-O B-NN
" " B-O O-NP
during B-O B-PP_IN
T B-O B-NP_NN
cell B-O B-NN
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
Rb B-O B-S_NP_NN
" " B-O O-NP
interacts B-O B-VP_VBZ
specifically B-O B-ADVP_RB
" " B-O O-ADVP
with B-O B-PP_IN
a B-O B-NP_DT
lineage-restricted B-O B-JJ
Ets B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
regulated B-O B-JJ
interaction B-O B-NN
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
important B-O B-ADJP_JJ
" " B-O O-ADJP
for B-O B-PP_IN
the B-O B-NP_NP_DT
coordination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
lineage-specific B-O B-NP_NP_JJ
effector B-O B-NN
functions B-O B-NNS
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
lymphokine B-O B-NP_NN
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
cell B-O B-NP_NP_NN
cycle B-O B-NN
progression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Oxidoreductive B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
nuclear B-O B-NP_JJ
factor B-O B-NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Involvement B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
cellular B-O B-JJ
reducing B-O B-NN
catalyst B-O B-NN
thioredoxin B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
investigated B-O B-VP_VBN
an B-O B-NP_NP_DT
oxidoreductive B-O B-JJ
regulatory B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
DNA B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
pleiotropic B-O B-JJ
cellular B-O B-JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
, B-O B-NP_NP_PRN_COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VBZ
been B-O B-VBN
investigated B-O B-VBN
by B-O B-PP_IN
using B-O B-S_NP_VP_VBG
NF B-O B-NP_NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
prepared B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
a B-O B-S_NP_DT
cellular B-O B-JJ
reducing B-O B-NN
catalyst B-O B-NN
thioredoxin B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
Trx B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
major B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
activation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
and B-O B-CC
stimulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
evidence B-O B-NP_NP_NN
" " B-O O-NP
suggesting B-O B-VP_VBG
that B-O B-SBAR_IN
redox B-O B-S_NP_NP_NN
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
Trx B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
exerted B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
examine B-O B-VP_VB
the B-O B-NP_NP_DT
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Trx B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
intact B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
performed B-O B-VP_VBD
transient B-O B-NP_JJ
assay B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_NP_NP_DT
chloramphenicol B-O B-ADJP_NN
acetyltransferase-expressing B-O B-JJ
" " B-O O-ADJP
plasmid B-O B-NN
" " B-O O-NP
under B-O B-PP_IN
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
long B-O B-NP_NP_JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
an B-O B-NP_NP_DT
effector B-O B-NN
plasmid B-O B-NN
" " B-O O-NP
expressing B-O B-VP_VBG
human B-O B-NP_JJ
Trx B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
from B-O B-PP_IN
HIV B-O B-NP_NN
long B-O B-JJ
terminal B-O B-JJ
repeat B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
greatly B-O B-VP_ADVP_RB
" " B-O O-ADVP
augmented B-O B-VBN
by B-O B-NP_PP_IN
co-transfecting B-O B-S_NP_VP_VBG
the B-O B-NP_NP_DT
Trx-expressing B-O B-NN
plasmid B-O B-NN
" " B-O O-NP
, B-O B-COMMA
whose B-O B-SBAR_WHNP_WPP
effect B-O B-NN
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
findings B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
suggested B-O B-VP_VBN
that B-O B-SBAR_SBAR_IN
cysteine B-O B-S_NP_NP_NN
residue B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
of B-O B-PP_IN
NF B-O B-NP_NN
kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
involved B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
redox B-O B-NN
control B-O B-NN
mechanism B-O B-NN
" " B-O O-NP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
might B-O B-VP_MD
have B-O B-VP_VB
a B-O B-NP_DT
regulatory B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
may B-O B-VP_MD
also B-O B-ADVP_RB
" " B-O O-ADVP
provide B-O B-VP_VB
a B-O B-NP_NP_DT
clue B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
understanding B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
molecular B-O B-JJ
process B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Expression B-O B-NP_NP_NP_NN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
thyrotropin B-O B-NN
receptor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
autoimmune B-O B-NP_JJ
thyroid B-O B-NN
disease B-O B-NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
coregulation B-O B-NP_NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
parameters B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
thyroid B-O B-NP_NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
inverse B-O B-NP_NP_JJ
relation B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
major B-O B-NP_JJ
histocompatibility B-O B-NN
complex B-O B-NN
classes B-O B-NNS
I B-O B-NP_NP_CD
" " B-O O-NP
and B-O B-CC
II B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Using B-O B-S_S_S_NP_VP_VBG
a B-O B-NP_DT
human B-O B-JJ
TSH B-O B-NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TSH-R B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
cDNA B-O B-NN
probe B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
investigated B-O B-VP_VBD
TSH-R B-O B-NP_NP_NN
transcript B-O B-NN
levels B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
13 B-O B-NP_CD
human B-O B-JJ
thyroid B-O B-NN
fragments B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
by B-O B-PP_IN
Northern B-O B-NP_NN
blot B-O B-NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
; B-O B-COLON
" " B-O O-S
7 B-O B-S_NP_NP_CD
Graves B-O B-NP_NN
' B-O B-POS
" " B-O O-NP
disease B-O B-NN
" " B-O O-NP
, B-O B-COMMA
2 B-O B-NP_CD
Hashimoto B-O B-NP_NN
's B-O B-POS
" " B-O O-NP
disease B-O B-NN
" " B-O O-NP
, B-O B-COMMA
3 B-O B-NP_CD
endemic B-O B-JJ
goiter B-O B-NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
1 B-O B-NP_CD
healthy B-O B-JJ
thyroid B-O B-NN
gland B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
studied B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
TSH-R B-O B-S_NP_NN
expression B-O B-NN
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VP_VBD
variable B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
displayed B-O B-VP_VBD
a B-O B-NP_NP_DT
close B-O B-JJ
correlation B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_NP_PRN_COMMA
, B-O B-NP_NP_PRN_COMMA
and B-O B-CC
, B-O B-NP_NP_PRN_COMMA
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
c-myc B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Overall B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
TSH-R B-O B-NP_NN
transcript B-O B-NN
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
low B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
absent B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
in B-O B-PP_IN
those B-O B-NP_NP_DT
thyroids B-O B-NNS
" " B-O O-NP
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-NP
was B-O B-VP_VBD
high B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O B-PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
thus B-O B-S_ADVP_RB
" " B-O O-ADVP
establishing B-O B-NP_VP_VBG
an B-O B-NP_DT
inverse B-O B-JJ
relation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
( B-O B-PRN_LRB
MHC B-O B-NP_S_LST_NN
I B-O B-NN
" " B-O O-LST
, B-O B-COMMA
r B-O B-S_S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
-0.791 B-O B-NP_CD
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
P B-O B-S_NP_NN
" " B-O O-NP
< B-O B-NP_QP_JJR
0.01 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-S
" " B-O O-S
" " B-O O-S
; B-O B-COLON
MHC B-O B-S_LST_NN
II B-O B-CD
" " B-O O-LST
, B-O B-COMMA
r B-O B-S_S_NP_NN
" " B-O O-NP
= B-O B-VP_JJ
-0.784 B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
P B-O B-S_NP_NN
" " B-O O-NP
< B-O B-NP_QP_JJR
0.01 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-S
" " B-O O-S
" " B-O O-S
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_NP_ADJP_FW
situ B-O B-FW
" " B-O O-ADJP
hybridization B-O B-NN
" " B-O O-NP
showed B-O B-VP_VBD
that B-O B-SBAR_IN
apart B-O B-S_PP_RB
from B-O B-IN
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
thyroid B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
themselves B-O B-NP_PRP
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
the B-O B-NP_NP_DT
source B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
MHC B-O B-NP_NN
II B-O B-CD
transcripts B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
gamma-Interferon B-O B-S_NP_NN
expression B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
only B-O B-ADJP_RB
detectable B-O B-JJ
" " B-O O-ADJP
in B-O B-PP_IN
1 B-O B-NP_CD
Hashimoto B-O B-NP_NN
's B-O B-POS
" " B-O O-NP
goiter B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
findings B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
next B-O B-S_ADVP_JJ
to B-O B-PP_TO
lymphocyte B-O B-NP_NN
infiltration B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
active B-O B-NP_NP_JJ
regulatory B-O B-JJ
events B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
thyrocyte B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
responsible B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_DT
inverse B-O B-JJ
relation B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Calcium B-O B-NP_NP_ADJP_NN
dependent B-O B-JJ
" " B-O O-ADJP
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-AT B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
p59fyn B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
A B-O B-S_NP_NP_DT
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
under B-O B-PP_IN
the B-O B-NP_NP_DT
control B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
T-cell B-O B-NN
antigen B-O B-NN
receptor B-O B-NN
element B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
activated B-O B-VP_VBN
in B-O B-NP_PP_IN
Jurkat B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_PP_IN
antigen B-O B-NP_NN
receptor B-O B-NN
triggering B-O B-NN
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
by B-O B-PP_IN
a B-O B-NP_NP_DT
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
, B-O B-NP_NP_NP_COMMA
, B-O B-SBAR_COMMA
" " B-O O-NP
and B-O B-CC
a B-O B-NP_DT
calcium B-O B-NN
ionophore B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Both B-O B-S_NP_DT
these B-O B-DT
signals B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
necessary B-O B-ADJP_JJ
for B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
co-transfected B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
construct B-O B-NN
" " B-O O-NP
capable B-O B-ADJP_JJ
of B-O B-PP_IN
" " B-O B-S_NP_VP_O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-NP_DT
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
activated B-O B-VP_VBN
by B-O B-NP_PP_IN
PMA B-O B-NP_NP_NN
" " B-O O-NP
alone B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
p59fyn B-O B-NP_NN
" " B-O O-NP
could B-O B-VP_MD
replace B-O B-VP_VB
the B-O B-NP_NP_DT
calcium B-O B-NN
ionophore B-O B-NN
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
activation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
p59fyn B-O B-NP_NP_NN
" " B-O O-NP
plus B-O B-CC
PMA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
blocked B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
EGTA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
by B-O B-PP_IN
the B-O B-NP_DT
immunosuppressant B-O B-JJ
drug B-O B-NN
cyclosporin B-O B-NN
A B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
beta-globin B-O B-NN
locus B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Transcription B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
human B-O B-JJ
beta-globin B-O B-NN
gene B-O B-NN
cluster B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
depends B-O B-VP_VBZ
upon B-O B-PP_IN
upstream B-O B-NP_NP_JJ
regulatory B-O B-JJ
sequences B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
collectively B-O B-VP_ADVP_RB
" " B-O O-ADVP
termed B-O B-VBN
" " B-O B-S_NP_NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Recent B-O B-S_NP_JJ
studies B-O B-NNS
" " B-O O-NP
have B-O B-VP_VBP
provided B-O B-VP_VBN
new B-O B-NP_NP_JJ
insights B-O B-NNS
" " B-O O-NP
into B-O B-PP_IN
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_NP_DT
individual B-O B-JJ
genes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
are B-O B-VP_VBP
regulated B-O B-VP_VBN
" " B-O B-NP_PP_ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
crux B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcriptional B-O B-NP_JJ
activation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
how B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
locus B-O B-NN
control B-O B-NN
region B-O B-NN
" " B-O O-NP
communicates B-O B-VP_VBZ
with B-O B-PP_IN
the B-O B-NP_DT
gene-proximal B-O B-JJ
regulatory B-O B-JJ
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Ectopic B-O B-S_NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
conditional B-O B-JJ
GATA-2/estrogen B-O B-NN
receptor B-O B-NN
chimera B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
arrests B-O B-VP_VBZ
erythroid B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
hormone-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
GATA B-O B-NN
factors B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
a B-O B-NP_NP_DT
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
regulatory B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
eukaryotes B-O B-NP_NP_NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
One B-O B-S_NP_NP_CD
enigmatic B-O B-JJ
aspect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GATA B-O B-NP_NN
factor B-O B-NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
that B-O B-SBAR_IN
several B-O B-S_NP_NP_JJ
GATA B-O B-NN
proteins B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
ostensibly B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
share B-O B-VP_VBP
the B-O B-NP_DT
same B-O B-JJ
DNA-binding B-O B-JJ
site B-O B-NN
specificity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
coexpressed B-O B-VP_VBN
in B-O B-NP_PP_IN
erythroid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
elucidate B-O B-VP_VB
the B-O B-NP_NP_DT
roles B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
individual B-O B-NP_JJ
GATA B-O B-NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
erythropoiesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
conditional B-O B-NP_NP_JJ
alleles B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
GATA-2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
GATA-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
prepared B-O B-VP_VBN
by B-O B-NP_PP_IN
fusing B-O B-S_NP_VP_VBG
each B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
hormone-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
GATA/ER B-O B-NN
chimeric B-O B-JJ
factors B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
shown B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
hormone-inducible B-O B-NP_JJ
trans-activating B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
in B-O B-PP_IN
transient B-O B-NP_JJ
transfection B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
stably B-O B-S_NP_ADVP_RB
" " B-O O-ADVP
introduced B-O B-VP_VBN
into B-O B-NP_PP_IN
primary B-O B-NP_NP_JJ
erythroblasts B-O B-NNS
" " B-O O-NP
or B-O B-CC
conditionally B-O B-NP_ADJP_RB
transformed B-O B-VBN
" " B-O O-ADJP
erythroid B-O B-JJ
progenitors B-O B-NNS
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
exogenous B-O B-NP_JJ
GATA-2/ER B-O B-NN
" " B-O O-NP
promoted B-O B-VP_VP_VP_VBD
proliferation B-O B-NP_NN
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
inhibited B-O B-VP_VBD
terminal B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
in B-O B-PP_IN
an B-O B-NP_DT
estrogen-dependent B-O B-JJ
manner B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
phenotypic B-O B-JJ
effects B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
specifically B-O B-ADVP_RB
" " B-O O-ADVP
attributable B-O B-ADJP_JJ
to B-O B-PP_TO
the B-O B-NP_NP_DT
action B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
ectopically B-O B-NP_ADJP_RB
expressed B-O B-VBN
" " B-O O-ADJP
GATA-2/ER B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
because B-O B-SBAR_SBAR_IN
erythroblasts B-O B-S_NP_NP_NNS
" " B-O O-NP
expressing B-O B-VP_VBG
exogenous B-O B-NP_JJ
GATA-2 B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
are B-O B-VP_VBP
constitutively B-O B-VP_ADVP_RB
" " B-O O-ADVP
arrested B-O B-VBN
in B-O B-NP_PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
because B-O B-SBAR_IN
erythroid B-O B-S_NP_NP_JJ
progenitors B-O B-NNS
" " B-O O-NP
expressing B-O B-VP_VBG
either B-O B-NP_CC
Gal/ER B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
GATA-3/ER B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
display B-O B-VP_VB
a B-O B-NP_DT
hormone-responsive B-O B-JJ
block B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
differentiation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_DT
GATA-2 B-O B-NN
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
play B-O B-VP_VB
a B-O B-NP_DT
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
regulating B-O B-S_NP_VP_VBG
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Lipopolysaccharide B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
phosphorylation B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
MAD3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
related B-O B-NP_JJ
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytic B-O B-JJ
THP-1 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Many B-O B-S_NP_NP_JJ
effects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
lipopolysaccharide B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
LPS B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
gene B-O B-NP_NN
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
including B-O B-PP_VBG
that B-O B-NP_NP_DT
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
monocytic B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
kappa B-O B-NP_NN
B B-O B-NN
DNA-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_NP_DT
specific B-O B-JJ
members B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
NF-kappa B-O B-NN
B/Rel B-O B-NN
transcription B-O B-NN
factor B-O B-NN
family B-O B-NN
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
LPS B-O B-NN
response B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
the B-O B-NP_NP_DT
mechanisms B-O B-NNS
" " B-O O-NP
through B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
LPS-generated B-O B-S_NP_JJ
signals B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
transduced B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
remain B-O B-VP_VBP
unclear B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
LPS B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
nuclear B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel/p50 B-O B-NP_NP_NN
heterodimers B-O B-NNS
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
kappa B-O B-NP_NP_NN
B B-O B-NN
DNA-binding B-O B-JJ
complexes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
monocytic B-O B-JJ
THP-1 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_NP_JJ
localization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
occurred B-O B-VP_VP_VBD
concomitantly B-O B-PP_RB
with B-O B-IN
a B-O B-NP_NP_DT
rapid B-O B-JJ
decrease B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
their B-O B-NP_PRPP
cytosolic B-O B-JJ
levels B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
was B-O B-VP_VBD
independent B-O B-ADJP_JJ
of B-O B-PP_IN
phorbol B-O B-NP_ADJP_NN
ester-sensitive B-O B-JJ
" " B-O O-ADJP
protein B-O B-NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Within B-O B-S_PP_IN
24 B-O B-NP_NP_CD
h B-O B-NN
" " B-O O-NP
following B-O B-PP_VBG
LPS B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
a B-O B-NP_DT
striking B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
c-Rel B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
p105 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
p50 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
cytosol B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
increased B-O B-VBN
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
correlated B-O B-VP_VBD
with B-O B-PP_IN
increases B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
amounts B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
their B-O B-NP_PRPP
mRNAs B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
LPS B-O B-NP_NP_NN
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
THP-1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
LPS B-O B-S_NP_NP_NN
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
THP-1 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
resulted B-O B-VP_VBD
in B-O B-PP_IN
phosphorylation B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
MAD3 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
an B-O B-NP_DT
protein B-O B-ADJP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
rapid B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
MAD3 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
MAD3 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
2 B-O B-NP_CD
h B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
LPS B-O B-NP_NP_NN
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
monocytic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VP_VBZ
in B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-Rel/p50 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
p50/p65 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
induces B-O B-VP_VBZ
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
MAD3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Induction B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CD8 B-O B-NP_NN
antigen B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
suppressor B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
glucocorticoids B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_DT
CEM B-O B-NN
human B-O B-JJ
leukemic B-O B-JJ
cell B-O B-NN
clone B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
relationship B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
glucocorticoid B-O B-NP_NP_NN
effect B-O B-NN
" " B-O O-NP
and B-O B-CC
regulation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
cell B-O B-NP_NN
surface B-O B-NN
antigens B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
in B-O B-NP_PP_IN
two B-O B-NP_NP_NP_CD
models B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
leukemic B-O B-NP_JJ
cell B-O B-NN
lines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
CEM B-O B-NP_NP_NP_NN
C7 B-O B-NN
" " B-O O-NP
denoted B-O B-VP_VBN
" " B-O B-NP_O-VP
( B-O B-LRB
r+ B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
ly+ B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-NP
and B-O B-CC
CEM B-O B-NP_NP_NN
C1 B-O B-NN
" " B-O O-NP
( B-O B-LRB
r+ B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
, B-O B-COMMA
ly- B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
reactivity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
murine B-O B-NP_NP_JJ
monoclonal B-O B-JJ
antibodies B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
anti-CD4-FITC B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
anti-CD8-FITC B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
anti-CD2-FITC B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
anti-calla-FITC B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
analyzed B-O B-VP_VBN
using B-O B-NP_S_NP_VP_VBG
flow B-O B-NP_NN
cytometry B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
suppressor B-O B-NN
function B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
using B-O B-NP_S_NP_VP_VBG
[3H]thymidine B-O B-NP_NP_NN
incorporation B-O B-NN
" " B-O O-NP
into B-O B-PP_IN
phytohemagglutinin-activated B-O B-NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Dexamethasone B-O B-S_NP_NP_NN
treatment B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_DT
human B-O B-JJ
leukemic B-O B-JJ
cell B-O B-NN
clone B-O B-NN
CEM B-O B-NN
C7 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
caused B-O B-VP_VBD
an B-O B-NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
subset B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
cells B-O B-NP_NP_NNS
" " B-O O-NP
expressing B-O B-VP_VBG
, B-O B-NP_NP_COMMA
" " B-O B-SBAR_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
comparison B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_NP_DT
modification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
CD4 B-O B-NP_NP_NN
antigen B-O B-NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
After B-O B-S_PP_IN
two B-O B-NP_NP_CD
days B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
treatment B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
5 B-O B-NP_ADJP_QP_CD
x B-O B-NN
10(-8) B-O B-CD
" " B-O O-QP
M B-O B-NN
" " B-O O-ADJP
dexamethasone B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
CEM B-O B-NP_NN
C7 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
a B-O B-NP_NP_DT
two-fold B-O B-JJ
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
suppressor B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
compared B-O B-PP_VBN
to B-O B-PP_TO
untreated B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
there B-O B-NP_EX
" " B-O O-NP
was B-O B-VP_VBD
no B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
glucocorticoids B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_NP_CC
the B-O B-DT
or B-O B-NP_NP_CC
antigens B-O B-NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
leukemic B-O B-JJ
clone B-O B-NN
CEM B-O B-NN
C1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
no B-O B-NP_NP_DT
modification B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
suppressor B-O B-NN
function B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
CEM B-O B-NP_NN
C1 B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
dexamethasone B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
the B-O B-NP_NP_DT
human B-O B-JJ
leukemic B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
studied B-O B-VP_VBN
here B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_DT
ability B-O B-NN
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
CD8 B-O B-NP_NN
antigen B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
CD4+ B-O B-JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
correlates B-O B-VP_VBZ
with B-O B-PP_IN
the B-O B-NP_DT
ability B-O B-NN
to B-O B-S_NP_VP_TO
induce B-O B-VP_VB
cell B-O B-NP_NN
lysis B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_DT
glucocorticoid B-O B-NN
receptor B-O B-NN
positive B-O B-JJ
cell B-O B-NN
population B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Molecular B-O B-NP_NP_JJ
basis B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
multiple B-O B-JJ
lymphokine B-O B-NN
deficiency B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
patient B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
severe B-O B-NP_JJ
combined B-O B-JJ
immunodeficiency B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
reported B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
child B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
defective B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
the B-O B-NP_NP_DT
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
determine B-O B-VP_VB
whether B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
defect B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NP_NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
involved B-O B-VP_VBD
a B-O B-NP_NP_DT
trans-acting B-O B-JJ
factor B-O B-NN
" " B-O O-NP
common B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
examined B-O B-VP_VBD
the B-O B-NP_NP_DT
ability B-O B-NN
" " B-O B-S_O-NP
of B-O B-PP_IN
nuclear B-O B-NP_NP_JJ
factors B-O B-NNS
" " B-O O-NP
from B-O B-PP_IN
the B-O B-NP_NP_DT
patient B-O B-NN
's B-O B-POS
" " B-O O-NP
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
bind B-O B-VP_VB
response B-O B-NP_NP_NN
elements B-O B-NNS
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Nuclear B-O B-S_NP_NP_JJ
factor B-O B-NN
NF-kB B-O B-NN
" " B-O O-NP
, B-O B-COMMA
activation B-O B-NP_NP_NN
protein B-O B-NN
1 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
AP-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
OCT-1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
NF-IL-2B B-O B-NP_NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
normal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_NP_DT
nuclear B-O B-JJ
factor B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
activated B-O B-NP_VBN
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
NF-AT B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_PP_TO
its B-O B-NP_NP_PRPP
response B-O B-NN
element B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
IL2 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
and B-O B-CC
to B-O B-PP_TO
an B-O B-NP_NP_DT
NF-AT-like B-O B-JJ
response B-O B-NN
element B-O B-NN
" " B-O O-NP
present B-O B-ADJP_JJ
in B-O B-PP_IN
the B-O B-NP_DT
IL4 B-O B-NN
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
abnormal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
ascertain B-O B-VP_VB
whether B-O B-SBAR_IN
the B-O B-S_NP_DT
abnormal B-O B-JJ
NF-AT B-O B-NN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
related B-O B-ADJP_JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
transfected B-O B-VP_VBD
patient B-O B-NP_NP_NP_NN
" " B-O O-NP
and B-O B-CC
control B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
T B-O B-NN
lymphocytes B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
constructs B-O B-NP_NP_NNS
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_NP_DT
reporter B-O B-NN
gene B-O B-NN
" " B-O O-NP
encoding B-O B-VP_JJ
under B-O B-NP_NP_NP_PRN_PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CAT B-O B-S_NP_NP_NN
expression B-O B-NN
" " B-O O-NP
directed B-O B-VP_VBN
by B-O B-NP_PP_PP_IN
the B-O B-NP_DT
IL2 B-O B-NN
regulatory B-O B-JJ
region B-O B-NN
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
by B-O B-PP_IN
a B-O B-NP_NP_DT
multimer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
NF-AT-binding B-O B-JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
markedly B-O B-ADJP_RB
lower B-O B-JJR
" " B-O O-ADJP
in B-O B-PP_IN
the B-O B-NP_DT
patient B-O B-NN
" " B-O O-NP
" " B-O O-PP
relative B-O B-PP_JJ
to B-O B-TO
controls B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
CAT B-O B-NP_NP_NN
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
directed B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
multimer B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
OCT-1 B-O B-ADJP_NN
proximal B-O B-NN
( B-O B-LRB
OCT-1p B-O B-NN
) B-O B-RRB
-binding B-O B-JJ
" " B-O O-ADJP
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
was B-O B-VP_VBD
equivalent B-O B-ADJP_JJ
" " B-O O-ADJP
in B-O B-PP_IN
patient B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
controls B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
an B-O B-S_NP_NP_DT
abnormality B-O B-NN
" " B-O O-NP
of B-O B-UCP_UCP_PP_IN
" " B-O B-NP_O-PP
/or B-O B-CC
influencing B-O B-VP_JJ
" " B-O B-NP_O-VP
" " B-O O-UCP
NF-AT B-O B-NP_NN
" " B-O O-NP
" " B-O O-UCP
" " B-O O-NP
may B-O B-VP_MD
underlie B-O B-VP_VB
the B-O B-NP_NP_DT
multiple B-O B-JJ
lymphokine B-O B-NN
deficiency B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
this B-O B-NP_DT
patient B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Expression B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
mRNA B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
GATA-binding B-O B-JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
eosinophils B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
basophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
potential B-O B-NP_NP_JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
gene B-O B-NP_NN
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
hematopoietic B-O B-JJ
transcription B-O B-NN
factors B-O B-NNS
GATA-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
GATA-2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
GATA-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
in B-O B-NP_PP_IN
eosinophils B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
basophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Eosinophils B-O B-S_NP_NNS
" " B-O O-NP
express B-O B-VP_VBP
mRNA B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
GATA-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
GATA-2 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
GATA-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Basophils B-O B-S_NP_NNS
" " B-O O-NP
express B-O B-VP_VBP
GATA-2 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
GATA-3 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Treatment B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
HL-60 B-O B-NP_NN
eosinophilic B-O B-JJ
sublines B-O B-NNS
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
either B-O B-NP_CC
interleukin-5 B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
butyric B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
increased B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
concomitant B-O B-ADJP_JJ
with B-O B-PP_IN
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
eosinophil-specific B-O B-NP_JJ
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
levels B-O B-S_NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
GATA-2 B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
remained B-O B-VP_VBD
relatively B-O B-ADJP_RB
constant B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mRNA B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
these B-O B-NP_DT
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
eosinophils B-O B-NP_NP_NNS
" " B-O O-NP
and B-O B-CC
basophils B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
suggests B-O B-VP_VBZ
that B-O B-SBAR_IN
gene B-O B-S_NP_NP_NN
transcription B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
these B-O B-NP_DT
lineages B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
be B-O B-VP_VB
regulated B-O B-VP_VBN
by B-O B-NP_PP_IN
GATA-binding B-O B-NP_JJ
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Proliferation B-O B-NP_NP_NN
index B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
a B-O B-NP_NP_DT
prognostic B-O B-JJ
marker B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
breast B-O B-NP_NN
cancer B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
BACKGROUND B-O B-NP_NN
. B-O B-PERIOD
" " B-O O-NP
  
The B-O B-S_NP_NP_DT
proliferative B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
tumors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
been B-O B-VP_VBN
extensively B-O B-VP_ADVP_RB
" " B-O O-ADVP
investigated B-O B-VBN
with B-O B-NP_PP_IN
different B-O B-NP_NP_JJ
approaches B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
among B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
represents B-O B-S_NP_NP_PP_VP_VBZ
" " B-O B-NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-S_S_NP_NP_DT
proliferative B-O B-JJ
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
129 B-O B-NP_CD
primary B-O B-JJ
breast B-O B-NN
cancers B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
investigated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
related B-O B-VP_JJ
to B-O B-NP_PP_TO
prognosis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
METHODS B-O B-NP_NNS
. B-O B-PERIOD
" " B-O O-NP
  
Tumor B-O B-S_NP_NP_NN
samples B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
obtained B-O B-VP_VBN
from B-O B-NP_PP_IN
129 B-O B-NP_NP_CD
patients B-O B-NNS
" " B-O O-NP
who B-O B-SBAR_WHNP_WP
" " B-O O-WHNP
underwent B-O B-S_NP_VP_VBD
surgery B-O B-NP_NN
" " B-O O-NP
between B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
were B-O B-VP_VBD
processed B-O B-VP_VBN
for B-O B-NP_PP_IN
staining B-O B-NP_VBG
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
an B-O B-NP_NP_DT
immunohistochemical B-O B-JJ
procedure B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
avidin-biotin B-O B-NP_NN
complex B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
median B-O B-JJ
time B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
observation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
42 B-O B-NP_CD
months B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
range B-O B-S_NP_NN
" " B-O O-NP
, B-O B-COMMA
31-55 B-O B-NP_QP_CD
" " B-O O-QP
months B-O B-NNS
" " B-O O-NP
" " B-O O-S
) B-O B-RRB
" " B-O O-PRN
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Life-table B-O B-S_NP_NP_JJ
analysis B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Mantel-Cox B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
was B-O B-VP_VBD
used B-O B-VP_VBN
to B-O B-NP_S_NP_VP_TO
assess B-O B-VP_VB
the B-O B-NP_NP_DT
probability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
RESULTS B-O B-NP_NNS
. B-O B-PERIOD
" " B-O O-NP
  
Tumors B-O B-S_NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
high B-O B-NP_NP_JJ
Ki-67 B-O B-NN
proliferation B-O B-NN
indices B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
> B-O B-NP_QP_JJR
20 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
a B-O B-NP_NP_DT
higher B-O B-JJR
4-year B-O B-JJ
probability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
( B-O B-NP_NP_NP_NP_PP_PRN_LRB
; B-O B-NP_COLON
) B-O B-S_RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
death B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
; B-O B-NP_COLON
) B-O B-S_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
compared B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
tumors B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
this B-O B-NP_DT
proliferative B-O B-JJ
parameter B-O B-NN
" " B-O O-NP
maintained B-O B-VP_VBD
its B-O B-NP_PRPP
prognostic B-O B-JJ
significance B-O B-NN
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
the B-O B-S_NP_DT
patients B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
stratified B-O B-VP_VBN
according B-O B-NP_PP_VBG
to B-O B-PP_TO
, B-O B-NP_NP_COMMA
, B-O B-NP_COMMA
and B-O B-CC
" " B-O B-NP_O-PP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CONCLUSIONS B-O B-NP_NNS
. B-O B-PERIOD
" " B-O O-NP
  
Tumor B-O B-S_NP_NP_NN
proliferative B-O B-JJ
activity B-O B-NN
" " B-O O-NP
as B-O B-SBAR_IN
evaluated B-O B-S_NP_VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
monoclonal B-O B-JJ
antibody B-O B-NN
Ki-67 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
seems B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
an B-O B-NP_NP_DT
effective B-O B-JJ
indicator B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
prognosis B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
for B-O B-PP_IN
DFS B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
OS B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Glucocorticoid B-O B-NP_NP_NN
receptors B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
mononuclear B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
patients B-O B-NP_NP_NNS
" " B-O O-NP
with B-O B-PP_IN
sepsis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Glucocorticoid B-O B-S_NP_NP_NP_NN
receptor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
GR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
hormone-binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
studied B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_DT
whole-cell B-O B-JJ
method B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
mononuclear B-O B-NP_NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
MNC B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
from B-O B-PP_IN
peripheral B-O B-NP_NP_JJ
blood B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
7 B-O B-NP_CD
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
the B-O B-NP_NP_DT
hemodynamic B-O B-JJ
compensatory B-O B-JJ
phase B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
sepsis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
4 B-O B-S_NP_CD
patients B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
receiving B-O B-VP_VBG
dopamine B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
did B-O B-S_NP_VP_VBD
not B-O B-RB
affect B-O B-VP_VB
the B-O B-NP_DT
GR B-O B-NN
count B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
patients B-O B-NNS
' B-O B-POS
" " B-O O-NP
plasma B-O B-NN
cortisol B-O B-NN
concentrations B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
normal B-O B-ADJP_ADJP_JJ
" " B-O O-ADJP
or B-O B-CC
slightly B-O B-ADJP_RB
elevated B-O B-JJ
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Despite B-O B-S_PP_IN
a B-O B-NP_DT
wide B-O B-JJ
range B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
the B-O B-NP_NP_DT
mean B-O B-NN
GR B-O B-NN
count B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
affinity B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
MNC B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
septic B-O B-NP_JJ
patients B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
did B-O B-VP_VBD
not B-O B-RB
differ B-O B-VP_VB
from B-O B-PP_IN
those B-O B-NP_NP_DT
" " B-O O-NP
in B-O B-PP_IN
normal B-O B-NP_JJ
controls B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
glucocorticoids B-O B-S_NP_NNS
" " B-O O-NP
could B-O B-VP_MD
" " B-O B-VP_ADVP_VP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Dependence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_NP_DT
proliferative B-O B-JJ
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
erythropoietin B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
an B-O B-NP_DT
established B-O B-JJ
erythroid B-O B-JJ
differentiation B-O B-NN
program B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
a B-O B-NP_NP_DT
human B-O B-JJ
hematopoietic B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
UT-7 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
  
Erythroid B-O B-S_NP_JJ
differentiation B-O B-NN
" " B-O O-NP
involves B-O B-VP_VBZ
the B-O B-NP_NP_DT
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
erythroid-specific B-O B-NP_NP_JJ
genes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
, B-O B-SBAR_WHNP_NP_WHPP_COMMA
, B-O B-PP_COMMA
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_SBAR_IN
order B-O B-NN
to B-O B-TO
understand B-O B-S_NP_VP_VB
the B-O B-NP_NP_DT
relationship B-O B-NN
" " B-O O-NP
" " B-O B-PP_O-NP
, B-O B-COMMA
if B-O B-SBAR_IN
any B-O B-FRAG_NP_DT
" " B-O O-NP
" " B-O O-FRAG
" " B-O O-SBAR
, B-O B-COMMA
between B-O B-PP_IN
expression B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
, B-O B-COMMA
response B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
Epo B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
erythroid B-O B-NP_JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
analyzed B-O B-VP_VBD
the B-O B-NP_NP_DT
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Epo-R B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
globin B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
an B-O B-NP_NP_DT
Epo-dependent B-O B-JJ
human B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
, B-O B-COMMA
UT-7 B-O B-NP_NN
Epo B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
compared B-O B-VP_VBN
to B-O B-NP_PP_TO
those B-O B-NP_NP_DT
" " B-O O-NP
obtained B-O B-VP_VBN
with B-O B-NP_PP_IN
, B-O B-NP_NP_NP_COMMA
, B-O B-NP_COMMA
" " B-O O-NP
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
UT-7 B-O B-S_NP_NP_NN
Epo B-O B-NN
" " B-O O-NP
and B-O B-CC
UT-7 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
expressed B-O B-VP_VBD
similar B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
and B-O B-CC
binding B-O B-NP_NN
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
two B-O B-CD
lines B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
expressed B-O B-VP_VBD
comparable B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Epo-R B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
while B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Epo-binding B-O B-NP_NP_JJ
sites B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
UT-7 B-O B-NP_NN
Epo B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
one-sixth B-O B-NP_NP_NP_CD
the B-O B-DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
UT-7 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
vs. B-O B-NP_NP_QP_CC
" " B-O B-NP_QP_O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_NP_DT
difference B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
binding B-O B-NP_VBG
sites B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
due B-O B-PP_JJ
to B-O B-TO
differences B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_PP_IN
cell B-O B-NP_NP_NN
surface B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-S_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
or B-O B-CC
in B-O B-PP_IN
receptor B-O B-NP_NN
turnover B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
Northern B-O B-NP_NN
analysis B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
UT-7 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VBD
detectable B-O B-NP_NP_JJ
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
beta- B-O B-NP_NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
gamma-globin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
alpha-globin B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
comparison B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
UT-7 B-O B-NP_NN
Epo B-O B-NN
cells B-O B-NNS
" " B-O O-NP
expressed B-O B-VP_VBD
alpha-globin B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
higher B-O B-NP_NP_JJR
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
gamma-globin B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
5-fold B-O B-ADJP_JJ
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
beta-globin B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
detectable B-O B-ADJP_PP_JJ
" " B-O O-ADJP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Globin B-O B-S_NP_NP_NN
chains B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
alpha B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
beta B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
gamma B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
were B-O B-VP_VBD
clearly B-O B-ADJP_RB
detectable B-O B-JJ
" " B-O O-ADJP
by B-O B-PP_IN
affinity B-O B-NP_NN
chromatography B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_PP_IN
UT-7 B-O B-NP_NN
Epo B-O B-NN
" " B-O O-NP
" " B-O O-PP
but B-O B-CONJP_CC
not B-O B-RB
" " B-O O-CONJP
in B-O B-PP_IN
UT-7 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
frequency B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
cells B-O B-NNS
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
expressed B-O B-S_NP_VP_VBD
and B-O B-NP_NP_NP_CC
" " B-O B-NP_O-NP
in B-O B-PP_IN
the B-O B-NP_DT
two B-O B-CD
cell B-O B-NN
populations B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
was B-O B-VP_VBD
measured B-O B-VP_VBN
by B-O B-NP_PP_IN
immunofluorescence B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_ADJP_ADJP_NP_ADJP_O-ADJP
and B-O B-CC
gamma-specific B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_NP_NP_DT
number B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
gamma-positive B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
and B-O B-CC
their B-O B-NP_PRPP
fluorescence B-O B-NN
intensity B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O B-NP_O-NP
were B-O B-VP_VBD
higher B-O B-ADJP_ADJP_JJR
" " B-O O-ADJP
" " B-O B-PP_O-ADJP
in B-O B-PP_IN
UT-7 B-O B-NP_NN
Epo B-O B-NN
" " B-O O-NP
" " B-O O-PP
than B-O B-PP_IN
in B-O B-FRAG_PP_IN
UT-7 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-FRAG
" " B-O O-PP
( B-O B-LRB
0 B-O B-NP_NP_NP_NP_QP_CD
to B-O B-TO
17 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
barely B-O B-NP_ADJP_RB
positive B-O B-JJ
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
23 B-O B-NP_NP_QP_CD
to B-O B-TO
40 B-O B-CD
" " B-O O-QP
% B-O B-NN
" " B-O O-NP
clearly B-O B-NP_ADJP_RB
positive B-O B-JJ
" " B-O O-ADJP
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
respectively B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
) B-O B-RRB
, B-O B-COMMA
indicating B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
increase B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
is B-O B-VP_VBZ
due B-O B-PP_JJ
to B-O B-TO
both B-O B-NP_CC
and B-O B-NP_CC
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
levels B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
Epo-R B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
globin B-O B-NP_NN
mRNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
expressed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
affected B-O B-VP_VBN
by B-O B-NP_PP_IN
a B-O B-NP_NP_DT
24-hour B-O B-JJ
incubation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_CC
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
Epo B-O B-NP_NP_NN
" " B-O O-NP
, B-O B-COMMA
GM-CSF B-O B-NP_NN
" " B-O O-NP
or B-O B-CC
interleukin-3 B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
( B-O B-S_LRB
ABSTRACT B-O B-NP_NN
" " B-O O-NP
TRUNCATED B-O B-VP_VBN
AT B-O B-NP_PP_IN
400 B-O B-NP_CD
WORDS B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
) B-O B-RRB
" " B-O O-S
Transcriptional B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
macrophage B-O B-NN
colony-stimulating B-O B-JJ
factor B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VP_VBZ
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
secretion B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
bioactive B-O B-NP_JJ
macrophage B-O B-NN
colony-stimulating B-O B-JJ
factor B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
monocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
and B-O B-CC
involves B-O B-VP_VBZ
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_S_S_NP_JJ
peripheral B-O B-JJ
blood B-O B-NN
monocytes B-O B-NP_NP_NNS
" " B-O O-NP
( B-O B-PRN_LRB
Mo B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
constitutively B-O B-ADVP_RB
" " B-O O-ADVP
display B-O B-VP_VBP
the B-O B-NP_NP_DT
beta-chain B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
receptor B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
whereas B-O B-IN
expression B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
IL-2R B-O B-NN
alpha-chain B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
not B-O B-ADJP_ADJP_RB
constitutive B-O B-ADJP_JJ
" " B-O B-PP_O-ADJP
but B-O B-CC
inducible B-O B-ADJP_JJ
" " B-O B-PP_O-ADJP
" " B-O O-ADJP
with B-O B-PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
we B-O B-NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
binding B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
IL-2 B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
its B-O B-NP_PRPP
binding B-O B-VBG
site B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
transcriptional B-O B-NP_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
in B-O B-NP_PP_IN
resulting B-O B-NP_VP_VBG
" " B-O B-PP_O-NP
and B-O B-CC
inhibition B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
by B-O B-NP_PP_IN
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Transcriptional B-O B-S_NP_NP_JJ
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
M-CSF B-O B-NN
gene B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
IL-2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
preceded B-O B-VP_VBN
by B-O B-NP_PP_IN
enhanced B-O B-NP_NP_VBN
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
transcription B-O B-NN
factor B-O B-NN
NF-kappa B-O B-NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
its B-O B-NP_NP_PRPP
recognition B-O B-NN
sequence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Moreover B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
using B-O B-S_NP_VP_VBG
a B-O B-NP_NP_NP_NP_DT
heterologous B-O B-JJ
promoter B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
herpes B-O B-NP_NN
thymidine B-O B-NN
kinase B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
construct B-O B-NN
" " B-O O-NP
containing B-O B-VP_VBG
the B-O B-NP_DT
NF-kappa B-O B-NN
B B-O B-NN
consensus B-O B-NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
is B-O B-VP_VBZ
shown B-O B-VP_VBN
that B-O B-SBAR_IN
NF-kappa B-O B-S_NP_NP_NN
B B-O B-NN
binding B-O B-NN
" " B-O O-NP
by B-O B-PP_IN
an B-O B-NP_DT
IL-2-induced B-O B-JJ
monocyte-derived B-O B-JJ
nuclear B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
confers B-O B-VP_VBZ
reporter B-O B-NP_NP_NP_NN
gene B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Taken B-O B-S_S_NP_VP_VBN
together B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
our B-O B-NP_PRPP
findings B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VP_VBP
that B-O B-SBAR_IN
IL-2 B-O B-S_NP_NN
" " B-O O-NP
induces B-O B-VP_VBZ
gene B-O B-NP_NP_NN
expression B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
M-CSF B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
human B-O B-NP_JJ
blood-derived B-O B-JJ
Mo B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
and B-O B-CC
provide B-O B-VP_VBP
evidence B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
involvement B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
transcriptional B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Synergy B-O B-S_S_S_NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
signal B-O B-NP_NN
transduction B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
obligatory B-O B-ADJP_JJ
for B-O B-PP_IN
expression B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
implication B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
c-fos B-O B-NP_NP_NP_NN
" " B-O O-NP
control B-O B-NN
" " B-O O-NP
via B-O B-PP_IN
surface B-O B-NP_NP_NN
immunoglobulin B-O B-NN
" " B-O O-NP
and B-O B-CC
T B-O B-NP_NN
cell B-O B-NN
antigen B-O B-NN
receptors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Expression B-O B-S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
protooncogene B-O B-NP_NN
c-fos B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
controlled B-O B-VP_VBN
by B-O B-NP_PP_IN
three B-O B-NP_NP_CD
main B-O B-JJ
regulatory B-O B-JJ
pathways B-O B-NNS
" " B-O O-NP
involving B-O B-VP_VBG
kinase B-O B-NP_NP_NN
C B-O B-NN
" " B-O O-NP
, B-O B-COMMA
cAMP B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
calcium B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
Kinase B-O B-S_S_NP_NN
C B-O B-NN
" " B-O O-NP
mediates B-O B-VP_VBZ
its B-O B-NP_PRPP
effects B-O B-NNS
" " B-O O-NP
via B-O B-PP_IN
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
serum B-O B-NP_NP_NP_NN
response B-O B-NN
factor B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
cAMP B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
calcium B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
mediate B-O B-VP_VBP
their B-O B-NP_PRPP
effects B-O B-NNS
" " B-O O-NP
via B-O B-PP_IN
phosphorylation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
CREB B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
cAMP B-O B-NP_NN
regulatory B-O B-JJ
element B-O B-NN
binding B-O B-NN
protein B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
presumably B-O B-PP_ADVP_RB
" " B-O O-ADVP
by B-O B-IN
activation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
or B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
examined B-O B-VP_VBN
the B-O B-NP_NP_DT
function B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
these B-O B-NP_DT
elements B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
in B-O B-PP_IN
Burkitt B-O B-NP_NP_NP_NN
's B-O B-POS
lymphoma B-O B-NN
cells B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
Ramos B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
Daudi B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
a B-O B-NP_DT
T B-O B-NP_NP_NN
lymphocytic B-O B-JJ
cell B-O B-NN
line B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
Jurkat B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
found B-O B-VP_VBN
that B-O B-SBAR_IN
stimulation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
alone B-O B-NP_NP_NP_PP_ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
has B-O B-VP_VBZ
little B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
or B-O B-CC
no B-O B-NP_DT
" " B-O B-NP_O-NP
effect B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
on B-O B-PP_IN
c-fos B-O B-NP_NP_NN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
kinase B-O B-NP_NP_NP_NP_NN
C B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
PMA B-O B-NP_NN
stimulation B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
combined B-O B-VP_VBN
with B-O B-NP_PP_IN
either B-O B-NP_CC
cAMP B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
forskolin B-O B-NP_NP_NN
" " B-O O-NP
plus B-O B-CC
MIX B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
or B-O B-CC
calcium B-O B-NP_NP_NN
stimulation B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
ionophore B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
leads B-O B-VP_VBZ
to B-O B-PP_TO
greatly B-O B-NP_ADJP_RB
enhanced B-O B-VBN
" " B-O O-ADJP
c-fos B-O B-NP_NN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
cAMP B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
presence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
calcium B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
shows B-O B-VP_VBZ
no B-O B-NP_NP_DT
synergy B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
c-fos B-O B-NP_NP_NN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Okadaic B-O B-S_NP_JJ
acid B-O B-NN
" " B-O O-NP
augments B-O B-VP_VP_VBZ
PMA- B-O B-NP_NP_ADJP_ADJP_NN
" " B-O B-ADJP_O-ADJP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
calcium-mediated B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-ADJP
activation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
has B-O B-VP_VBZ
little B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
or B-O B-CC
no B-O B-NP_DT
" " B-O B-NP_O-NP
effect B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
combined B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
cAMP B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
main B-O B-JJ
difference B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
Ramos B-O B-NP_NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
and B-O B-CC
Jurkat B-O B-NP_NP_NN
" " B-O O-NP
( B-O B-PRN_LRB
T B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
that B-O B-SBAR_IN
cAMP B-O B-S_NP_NP_NN
" " B-O O-NP
plus B-O B-CC
calcium B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VP_VBZ
strongly B-O B-ADJP_RB
synergistic B-O B-JJ
in B-O B-PP_IN
Jurkat B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
without B-O B-PP_IN
effect B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
in B-O B-PP_IN
Ramos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Analysis B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
AP-1 B-O B-NP_NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-PP
using B-O B-VP_VBG
gel B-O B-NP_NN
mobility B-O B-NN
shift B-O B-NN
assays B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
confirms B-O B-VP_VBZ
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
requirements B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
synergy B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
paralleled B-O B-VP_VBN
by B-O B-NP_PP_IN
requirements B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Signaling B-O B-S_NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
B B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
due B-O B-ADJP_JJ
to B-O B-PP_TO
anti-Ig B-O B-NP_NP_JJ
" " B-O O-NP
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
involves B-O B-VP_VP_VBZ
both B-O B-NP_CC
kinase B-O B-NP_NP_NN
C B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
and B-O B-CC
release B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
intracellular B-O B-NP_JJ
calcium B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
, B-O B-COMMA
and B-O B-CC
results B-O B-VP_VBZ
in B-O B-PP_IN
c-fos B-O B-NP_NP_NN
mRNA B-O B-NN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Our B-O B-S_NP_PRPP
results B-O B-NNS
" " B-O O-NP
indicate B-O B-VP_VBP
that B-O B-SBAR_IN
synergy B-O B-S_NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
the B-O B-NP_NP_DT
kinase B-O B-NP_NN
C B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
and B-O B-CC
calcium B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
needed B-O B-VP_VBN
for B-O B-NP_PP_IN
efficient B-O B-NP_JJ
c-fos B-O B-NP_NN
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
since B-O B-SBAR_IN
alone B-O B-S_NP_NP_NP_PP_ADVP_RB
" " B-O O-ADVP
" " B-O O-NP
induces B-O B-VP_VBZ
c-fos B-O B-NP_NN
" " B-O O-NP
well B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
That B-O B-S_SBAR_IN
synergy B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
signaling B-O B-NP_NN
pathways B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
relevant B-O B-ADJP_JJ
for B-O B-PP_IN
the B-O B-NP_NP_DT
anti-Ig B-O B-NP_JJ
" " B-O O-NP
induction B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
c-fos B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
is B-O B-VP_VBZ
supported B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
fact B-O B-NN
that B-O B-SBAR_IN
cAMP-inducing B-O B-S_NP_NP_JJ
agents B-O B-NNS
" " B-O O-NP
and B-O B-CC
okadaic B-O B-NP_JJ
acid B-O B-NN
" " B-O O-NP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
enhance B-O B-VP_VBP
" " B-O B-NP_NP_PP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
cell-specific B-O B-S_NP_NP_JJ
patterns B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
synergy B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VP_VBP
an B-O B-NP_NP_DT
essential B-O B-JJ
feature B-O B-NN
" " B-O O-NP
for B-O B-PP_IN
induction B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
may B-O B-VP_MD
be B-O B-VP_VB
relevant B-O B-ADJP_JJ
for B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Protein B-O B-S_S_NP_NN
kinase B-O B-NN
C-zeta B-O B-NN
" " B-O O-NP
mediates B-O B-VP_VBZ
NF-kappa B-O B-NP_NP_NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
human B-O B-NP_JJ
immunodeficiency B-O B-NN
virus-infected B-O B-JJ
monocytes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_S_NP_NP_DT
molecular B-O B-NN
mechanisms B-O B-NNS
" " B-O O-NP
regulating B-O B-VP_VBG
human B-O B-NP_NP_NP_NP_JJ
immunodeficiency B-O B-NN
virus B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
HIV B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
persistence B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
a B-O B-NP_NP_DT
major B-O B-JJ
cell B-O B-NN
reservoir B-O B-NN
" " B-O O-NP
such B-O B-PP_JJ
as B-O B-IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-NP
remain B-O B-VP_VBP
unknown B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
NF-kappa B-O B-S_NP_NN
B B-O B-NN
" " B-O O-NP
is B-O B-VP_VP_VBZ
a B-O B-NP_NP_DT
transcription B-O B-NP_NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_NP_DT
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
selectively B-O B-ADVP_RB
" " B-O O-ADVP
activated B-O B-VP_VBN
following B-O B-NP_PP_VBG
HIV B-O B-NP_NP_NN
infection B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_JJ
macrophages B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Although B-O B-S_SBAR_IN
little B-O B-S_NP_NP_JJ
information B-O B-NN
" " B-O O-NP
as B-O B-PP_IN
to B-O B-PP_TO
what B-O B-SBAR_WHNP_WP
signal B-O B-NN
transduction B-O B-NN
pathways B-O B-NNS
" " B-O O-WHNP
mediate B-O B-S_NP_VP_VBP
" " B-O B-NP_O-S
" " B-O O-SBAR
" " B-O O-PP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
available B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
our B-O B-S_NP_PRPP
previous B-O B-JJ
work B-O B-NN
" " B-O O-NP
indicated B-O B-VP_VBD
that B-O B-SBAR_IN
classical B-O B-S_NP_JJ
protein B-O B-NP_NN
kinase B-O B-NN
C B-O B-NN
( B-O B-LRB
PKC B-O B-NN
) B-O B-RRB
isoenzymes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
not B-O B-RB
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
the B-O B-NP_DT
HIV-mediated B-O B-JJ
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
this B-O B-NP_DT
study B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
focused B-O B-VP_VBN
on B-O B-PP_IN
atypical B-O B-NP_JJ
PKC B-O B-NP_NN
isoenzymes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
PKC-zeta B-O B-S_NP_NN
" " B-O O-NP
belongs B-O B-VP_VP_VBZ
to B-O B-PP_TO
this B-O B-NP_DT
family B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
is B-O B-VP_VBZ
known B-O B-VP_VBN
to B-O B-S_NP_VP_TO
be B-O B-VP_VB
an B-O B-NP_NP_DT
important B-O B-JJ
step B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Immunoblotting B-O B-S_NP_NP_NN
experiments B-O B-NNS
" " B-O O-NP
with B-O B-PP_IN
U937 B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
demonstrate B-O B-VP_VBP
that B-O B-UCP_SBAR_IN
PKC-zeta B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
present B-O B-ADJP_JJ
in B-O B-PP_IN
these B-O B-NP_DT
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
its B-O B-COMP_NP_PRPP
expression B-O B-NN
" " B-O O-NP
can B-O B-VP_MD
be B-O B-VP_VB
downmodulated B-O B-VP_VBN
by B-O B-NP_PP_IN
antisense B-O B-NP_NP_JJ
oligonucleotides B-O B-NNS
" " B-O O-NP
( B-O B-PRN_LRB
) B-O B-NP_RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_DT
HIV-mediated B-O B-JJ
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
activation B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
selectively B-O B-ADVP_RB
" " B-O O-ADVP
reduced B-O B-VP_VBN
by B-O B-NP_PP_IN
AO B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
PKC-zeta B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
addition B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
cotransfection B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_NP_DT
negative B-O B-JJ
dominant B-O B-JJ
molecule B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PKC-zeta B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
( B-O B-PRN_LRB
PKC-zeta B-O B-NP_NN
mut B-O B-NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
NF-kappa B-O B-NP_NN
B-dependent B-O B-JJ
reporter B-O B-NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
selectively B-O B-ADVP_RB
" " B-O O-ADVP
inhibits B-O B-VP_VBZ
the B-O B-NP_NP_DT
HIV- B-O B-NP_NN
" " B-O B-ADJP_NP_O-NP
but B-O B-CC
not B-O B-NP_RB
phorbol B-O B-NP_NN
myristate B-O B-NN
acetate- B-O B-NN
" " B-O B-ADJP_NP_O-NP
or B-O B-CC
lipopolysaccharide-mediated B-O B-NP_JJ
" " B-O B-NP_O-NP
activation B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
That B-O B-S_SBAR_IN
PKC-zeta B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
specific B-O B-ADJP_JJ
in B-O B-PP_IN
regulating B-O B-S_NP_VP_VBG
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
is B-O B-VP_VBZ
concluded B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_NP_DT
inability B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
PKC-zeta B-O B-NP_NN
( B-O B-LRB
mut B-O B-NN
) B-O B-RRB
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
interfere B-O B-VP_VB
with B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Lastly B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
demonstrate B-O B-VP_VBP
a B-O B-NP_NP_NP_DT
selective B-O B-JJ
inhibition B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
p24 B-O B-NP_NP_NN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
HIV-infected B-O B-NP_JJ
human B-O B-JJ
macrophages B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
when B-O B-SBAR_WHADVP_WRB
" " B-O O-WHADVP
treated B-O B-S_NP_VP_VBN
with B-O B-NP_PP_IN
AO B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
PKC-zeta B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Altogether B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
these B-O B-NP_DT
results B-O B-NNS
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
atypical B-O B-S_NP_NP_JJ
PKC B-O B-NN
isoenzymes B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
PKC-zeta B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
participate B-O B-VP_VBP
in B-O B-PP_IN
the B-O B-NP_NP_DT
signal B-O B-NN
transduction B-O B-NN
pathways B-O B-NNS
" " B-O O-NP
by B-O B-SBAR_WHPP_IN
" " B-O B-WHNP_S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Initiation B-O B-S_S_S_S_NP_NP_NN
binding B-O B-NN
repressor B-O B-NN
" " B-O O-NP
, B-O B-COMMA
a B-O B-NP_NP_DT
factor B-O B-NN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
" " B-O B-PP_O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
glycosylated B-O B-NP_VBN
member B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
[ B-O B-PRN_LRB
corrected B-O B-ADJP_JJ
" " B-O O-ADJP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-S
[ B-O B-S_LRB
published B-O B-NP_VBN
erratum B-O B-NN
" " B-O O-NP
appears B-O B-VP_VBZ
in B-O B-PP_IN
Mol B-O B-NP_NP_NNP
Cell B-O B-NNP
Biol B-O B-NNP
1996 B-O B-CD
Feb B-O B-NNP
" " B-O O-NP
; B-O B-COLON
16 B-O B-NP_CD
( B-O B-LRB
2 B-O B-CD
) B-O B-RRB
" " B-O O-NP
: B-O B-COLON
735 B-O B-NP_CD
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
] B-O B-RRB
" " B-O O-S
" " B-O O-S
" " B-O O-S
  
Initiation B-O B-S_S_NP_NP_NP_NN
binding B-O B-NN
repressor B-O B-NN
" " B-O O-NP
[ B-O B-PRN_LRB
corrected B-O B-VP_VBN
" " B-O O-VP
] B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
( B-O B-PRN_LRB
IBR B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_NP_DT
chicken B-O B-NP_NN
erythrocyte B-O B-NN
factor B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
apparent B-O B-NP_NP_JJ
molecular B-O B-JJ
mass B-O B-NN
" " B-O O-NP
, B-O B-COMMA
70 B-O B-NP_QP_CD
to B-O B-TO
73 B-O B-CD
" " B-O O-QP
kDa B-O B-NN
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
binds B-O B-S_NP_VP_VBZ
to B-O B-PP_TO
" " B-O B-NP_NP_VP_O-PP
, B-O B-COMMA
repressing B-O B-S_NP_VP_VBG
" " B-O B-NP_O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_NP_NP_DT
variety B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
other B-O B-NP_NP_JJ
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
including B-O B-PP_VBG
transformed B-O B-NP_VBN
erythroid B-O B-JJ
precursors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
do B-O B-VP_VBP
not B-O B-RB
have B-O B-VP_VB
IBR B-O B-NP_NP_NN
" " B-O O-NP
but B-O B-CC
a B-O B-NP_NP_NP_DT
factor B-O B-NN
" " B-O O-NP
referred B-O B-VP_VBN
to B-O B-PP_TO
" " B-O B-NP_O-PP
as B-O B-PP_IN
" " B-O B-NP_NP_PRN_O-PP
" " B-O O-VP
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
recognizes B-O B-S_NP_VP_VBZ
the B-O B-NP_DT
same B-O B-JJ
sites B-O B-NP_NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
cloned B-O B-VP_VP_VBN
the B-O B-NP_DT
IBR B-O B-NP_NN
cDNA B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
studied B-O B-VP_VBN
the B-O B-NP_NP_DT
relationship B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
IBR B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
IBF B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
IBR B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
a B-O B-NP_NP_DT
503-amino-acid-long B-O B-NP_JJ
acidic B-O B-JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
is B-O B-S_NP_VP_VBZ
99.0 B-O B-ADJP_ADJP_NP_CD
% B-O B-NN
" " B-O O-NP
identical B-O B-JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
and B-O B-CC
highly B-O B-ADJP_RB
related B-O B-JJ
to B-O B-PP_TO
" " B-O B-NP_O-ADJP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
present B-O B-VP_VBP
evidence B-O B-NP_NN
that B-O B-SBAR_IN
IBR B-O B-S_NP_NP_NN
" " B-O O-NP
and B-O B-CC
IBF B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
most B-O B-NP_NP_ADJP_RBS
likely B-O B-RB
identical B-O B-JJ
" " B-O O-ADJP
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
differing B-O B-S_NP_VP_VBG
in B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
analyzed B-O B-VP_VP_VBN
several B-O B-NP_NP_ADJP_JJ
molecular B-O B-JJ
" " B-O O-ADJP
aspects B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
IBR/F B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
shown B-O B-VP_VBN
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_DT
factor B-O B-NN
" " B-O O-NP
associates B-O B-VP_VBZ
as B-O B-PP_IN
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_DT
dimer B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_DT
" " B-O B-NP_O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
evolutionarily B-O B-ADJP_RB
conserved B-O B-VBN
" " B-O O-ADJP
N-terminal B-O B-NP_JJ
half B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
IBR/F B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
harbors B-O B-VP_VBZ
the B-O B-NP_NP_NP_DT
DNA-binding/dimerization B-O B-NP_JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
outer B-O B-NP_NP_JJ
limits B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
127 B-O B-NP_QP_CD
to B-O B-TO
283 B-O B-CD
" " B-O O-QP
" " B-O O-NP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
one B-O B-NP_NP_NP_CD
" " B-O B-NP_O-NP
or B-O B-CC
several B-O B-NP_JJ
" " B-O B-NP_O-NP
casein B-O B-NP_NN
kinase B-O B-NN
II B-O B-CD
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
37 B-O B-NP_QP_CD
to B-O B-TO
67 B-O B-CD
" " B-O O-QP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
, B-O B-COMMA
and B-O B-CC
a B-O B-NP_NP_NP_DT
bipartite B-O B-NP_JJ
nuclear B-O B-JJ
localization B-O B-NN
signal B-O B-NN
" " B-O O-NP
" " B-O O-NP
( B-O B-PRN_LRB
89 B-O B-NP_QP_CD
to B-O B-TO
106 B-O B-CD
" " B-O O-QP
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
appears B-O B-S_NP_VP_VBZ
to B-O B-S_NP_VP_TO
" " B-O B-VP_O-S
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Binding B-O B-S_NP_VBG
site B-O B-NN
selection B-O B-NN
" " B-O O-NP
revealed B-O B-VP_VBD
that B-O B-SBAR_SBAR_IN
the B-O B-S_NP_DT
alternating B-O B-NP_VBG
RCGCRYGCGY B-O B-NN
consensus B-O B-NN
" " B-O O-NP
" " B-O O-NP
constitutes B-O B-VP_VBZ
high-affinity B-O B-NP_JJ
IBR/F B-O B-NP_NN
binding B-O B-NN
sites B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_DT
direct-repeat B-O B-NP_NP_JJ
palindrome B-O B-NN
" " B-O O-NP
TGCGCATGCGCA B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
the B-O B-NP_DT
optimal B-O B-NP_JJ
site B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
A B-O B-S_NP_NP_DT
survey B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
genes B-O B-NP_NP_NNS
" " B-O O-NP
potentially B-O B-VP_ADVP_RB
" " B-O O-ADVP
regulated B-O B-VBN
by B-O B-NP_PP_IN
this B-O B-NP_NP_DT
family B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
factors B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
primarily B-O B-ADVP_RB
" " B-O O-ADVP
revealed B-O B-VP_VBD
genes B-O B-NP_NP_NNS
" " B-O O-NP
involved B-O B-VP_VBN
in B-O B-NP_PP_IN
growth-related B-O B-NP_JJ
metabolism B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Inhibition B-O B-NP_NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
NF-AT-dependent B-O B-NP_JJ
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-PP
: B-O B-COLON
" " B-O O-NP
implications B-O B-NP_NP_NNS
" " B-O O-NP
for B-O B-PP_IN
differential B-O B-NP_NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
T B-O B-NP_NN
helper B-O B-NN
cell B-O B-NN
subsets B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Activation B-O B-S_S_S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
individual B-O B-NP_JJ
CD4+ B-O B-NP_JJ
T B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
results B-O B-VP_VBZ
in B-O B-PP_IN
differential B-O B-NP_JJ
lymphokine B-O B-NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
: B-O B-COLON
interleukin B-O B-S_NP_NP_NN
2 B-O B-CD
" " B-O O-NP
( B-O B-PRN_LRB
IL-2 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
" " B-O O-PRN
" " B-O O-NP
is B-O B-VP_VBZ
preferentially B-O B-ADVP_RB
" " B-O O-ADVP
produced B-O B-VP_VBN
by B-O B-NP_PP_IN
T B-O B-NP_NP_NN
helper B-O B-NN
type B-O B-NN
1 B-O B-CD
( B-O B-LRB
TH1 B-O B-NN
) B-O B-RRB
cells B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
" " B-O B-S_NP_VP_O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
whereas B-O B-SBAR_IN
IL-4 B-O B-S_NP_NN
" " B-O O-NP
is B-O B-VP_VBZ
synthesized B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
The B-O B-S_NP_DT
Ca(2+)-dependent B-O B-NP_JJ
factor B-O B-NN
" " B-O O-NP
NF-ATp B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
plays B-O B-VP_VBZ
a B-O B-NP_DT
key B-O B-JJ
role B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
inducible B-O B-JJ
transcription B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
both B-O B-NP_DT
these B-O B-DT
lymphokine B-O B-NP_NN
genes B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
while B-O B-SBAR_IN
IL2 B-O B-S_NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
requires B-O B-VP_VBZ
the B-O B-NP_NP_DT
contribution B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Ca(2+)- B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
protein B-O B-NP_NN
kinase B-O B-NN
C-dependent B-O B-JJ
signals B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
report B-O B-VP_VBP
that B-O B-SBAR_IN
activation B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
human B-O B-NP_NP_JJ
IL4 B-O B-NN
" " B-O O-NP
transcription B-O B-NN
" " B-O O-NP
" " B-O O-PP
through B-O B-PP_IN
the B-O B-NP_DT
Ca(2+)-dependent B-O B-JJ
pathway B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
diminished B-O B-VP_VBN
by B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
phenomenon B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
due B-O B-ADJP_JJ
to B-O B-PP_TO
mutually B-O B-NP_NP_ADJP_RB
exclusive B-O B-JJ
" " B-O O-ADJP
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
NF-ATp B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF-kappa B-O B-NP_NN
B B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
the B-O B-NP_NP_DT
P B-O B-NP_NN
sequence B-O B-NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
an B-O B-NP_NP_DT
element B-O B-NN
" " B-O O-NP
located B-O B-ADJP_JJ
" " B-O B-PP_O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Human B-O B-S_NP_JJ
IL4 B-O B-NN
promoter-mediated B-O B-JJ
transcription B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
downregulated B-O B-VP_VP_VBN
in B-O B-NP_PP_IN
Jurkat B-O B-NP_NP_NN
cells B-O B-NNS
" " B-O O-NP
stimulated B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
and B-O B-CC
suppressed B-O B-VP_VBN
in B-O B-NP_PP_IN
RelA-overexpressing B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
protein B-O B-NP_NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
stimulation B-O B-NN
" " B-O O-NP
or B-O B-CC
RelA B-O B-NP_NP_NN
" " B-O O-NP
overexpression B-O B-NN
" " B-O O-NP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
affect B-O B-VP_VB
the B-O B-NP_NP_DT
activity B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
a B-O B-NP_NP_DT
human B-O B-NP_JJ
IL4 B-O B-NN
promoter B-O B-NN
" " B-O O-NP
" " B-O O-NP
containing B-O B-VP_VBG
a B-O B-NP_NP_DT
, B-O B-NP_COMMA
" " B-O B-SBAR_WHNP_S_O-NP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Thus B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
competition B-O B-NP_NP_NN
" " B-O O-NP
between B-O B-PP_IN
two B-O B-NP_NP_CD
general B-O B-JJ
transcriptional B-O B-NP_JJ
activators B-O B-NNS
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
RelA B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
NF-ATp B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
mediates B-O B-VP_VP_VBZ
the B-O B-NP_NP_DT
inhibitory B-O B-JJ
effect B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
protein B-O B-NP_NP_NN
kinase B-O B-NN
C B-O B-NN
" " B-O O-NP
stimulation B-O B-NN
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
IL4 B-O B-NP_NP_NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
may B-O B-VP_MD
contribute B-O B-VP_VB
to B-O B-PP_TO
differential B-O B-NP_NP_JJ
gene B-O B-NN
expression B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
TH B-O B-NP_NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Hemoglobin B-O B-S_S_NP_NP_NP_NN
" " B-O O-NP
switching B-O B-NN
" " B-O O-NP
in B-O B-PP_IN
humans B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
accompanied B-O B-VP_VBN
by B-O B-NP_PP_IN
changes B-O B-NP_NP_NNS
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_NP_DT
ratio B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
BACKGROUND B-O B-NP_NP_NN
: B-O B-COLON
" " B-O O-NP
Understanding B-O B-S_S_NP_VP_VBG
the B-O B-NP_NP_DT
mechanism B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
developmental B-O B-NP_NP_JJ
regulation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
switching B-O B-NP_NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
has B-O B-VP_VBZ
scientific B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
as B-O B-CONJP_RB
well B-O B-RB
as B-O B-IN
" " B-O O-CONJP
clinical B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
relevance B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
because B-O B-PP_IN
of B-O B-IN
the B-O B-NP_NP_DT
influence B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
production B-O B-NP_NP_NP_NP_PRN_NN
" " B-O O-NP
in B-O B-PP_IN
adulthood B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
on B-O B-PP_IN
the B-O B-NP_NP_DT
clinical B-O B-JJ
manifestation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
and B-O B-NP_NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-NP
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
previously B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBN
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
normal B-O B-JJ
developmental B-O B-JJ
patterns B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
globin B-O B-NP_NP_NN
gene B-O B-NN
" " B-O O-NP
expression B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
recapitulated B-O B-VP_VBN
in B-O B-NP_PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
further B-O B-ADVP_RB
" " B-O O-ADVP
found B-O B-VP_VBD
that B-O B-SBAR_IN
high B-O B-S_NP_NP_JJ
activities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
transcriptional B-O B-NP_NP_JJ
activators B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
and B-O B-NP_NP_CC
" " B-O B-NP_O-NP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
" " B-O O-NP
are B-O B-VP_VBP
associated B-O B-VP_VBN
with B-O B-NP_PP_IN
normal B-O B-NP_JJ
adult B-O B-JJ
erythroid B-O B-JJ
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
MATERIALS B-O B-NP_NP_NP_NNS
" " B-O O-NP
AND B-O B-CC
METHODS B-O B-NP_NNS
" " B-O O-NP
: B-O B-COLON
" " B-O O-NP
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
work B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
studied B-O B-VP_VBN
, B-O B-COMMA
the B-O B-NP_NP_DT
activities B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
GATA-1 B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
SP1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
during B-O B-PP_IN
differentiation B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_NP_VP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
  
RESULTS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
The B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
high B-O B-NP_NP_NP_JJ
GATA-1 B-O B-NP_NN
" " B-O O-NP
binding B-O B-NN
activity B-O B-NN
" " B-O O-NP
and B-O B-CC
very B-O B-NP_ADJP_RB
low B-O B-JJ
" " B-O O-ADJP
SP1 B-O B-NP_NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
the B-O B-NP_DT
fetal B-O B-NP_JJ
liver B-O B-NN
cultures B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
  
This B-O B-S_NP_DT
pattern B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
in B-O B-PP_IN
contrast B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
cultures B-O B-NP_NP_NP_NNS
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
" " B-O B-NP_O-VP
" " B-O O-NP
, B-O B-COMMA
in B-O B-SBAR_WHPP_IN
which B-O B-WHNP_WDT
" " B-O O-WHNP
" " B-O O-WHPP
both B-O B-S_NP_CC
and B-O B-NP_CC
were B-O B-NP_NP_VP_VBD
" " B-O B-ADJP_O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Cord B-O B-S_NP_NN
blood B-O B-NN
cultures B-O B-NNS
" " B-O O-NP
showed B-O B-VP_VBD
an B-O B-NP_NP_DT
additive B-O B-JJ
combination B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
"""" B-O B-NP_NP_ADJP_LQT
adult B-O B-JJ
"""" B-O B-RQT
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
"""" B-O B-NP_ADJP_LQT
fetal B-O B-JJ
"""" B-O B-RQT
" " B-O O-ADJP
" " B-O B-NP_O-NP
patterns B-O B-NP_NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
progenitors B-O B-NNS
" " B-O O-NP
derived B-O B-VP_VBN
from B-O B-NP_PP_IN
a B-O B-NP_NP_DT
beta B-O B-NN
zero-thalassemia B-O B-JJ
patient B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
high B-O B-NP_JJ
HbF B-O B-NP_NN
" " B-O O-NP
production B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
showed B-O B-VP_VBD
"""" B-O B-NP_LQT
fetal B-O B-JJ
"""" B-O B-RQT
pattern B-O B-NN
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
On B-O B-S_PP_IN
the B-O B-NP_DT
other B-O B-JJ
hand B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
in B-O B-PP_IN
cultures B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
2 B-O B-NP_NP_CD
beta B-O B-NN
zero-thalassemia B-O B-JJ
patients B-O B-NNS
" " B-O O-NP
without B-O B-PP_IN
high B-O B-NP_JJ
HbF B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
"""" B-O B-NP_LQT
adult B-O B-JJ
"""" B-O B-RQT
pattern B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
CONCLUSIONS B-O B-NP_NP_NNS
: B-O B-COLON
" " B-O O-NP
In B-O B-S_PP_IN
the B-O B-NP_DT
present B-O B-JJ
work B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_SBAR_IN
human B-O B-S_NP_JJ
fetal B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
adult B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
erythroid B-O B-NP_JJ
progenitors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
are B-O B-VP_VBP
distinct B-O B-ADJP_JJ
in B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
and B-O B-CC
that B-O B-SBAR_IN
the B-O B-S_NP_NP_DT
commitment B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
or B-O B-NP_NP_CC
" " B-O B-NP_NP_O-PP
" " B-O O-NP
occurs B-O B-VP_VBZ
at B-O B-PP_IN
a B-O B-NP_DT
differentiation B-O B-ADJP_NN
stage B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-NP
  
Our B-O B-S_NP_PRPP
studies B-O B-NNS
" " B-O O-NP
also B-O B-ADVP_RB
" " B-O O-ADVP
demonstrate B-O B-VP_VBP
that B-O B-SBAR_IN
under B-O B-S_PP_IN
anemic B-O B-NP_JJ
stress B-O B-NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
recruitment B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
fetal B-O B-NP_JJ
progenitors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
may B-O B-VP_MD
occur B-O B-VP_VB
in B-O B-PP_IN
adulthood B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Transcriptional B-O B-NP_NP_NP_ADJP_JJ
" " B-O O-ADJP
activation B-O B-NP_NN
" " B-O O-NP
and B-O B-CC
repression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
two B-O B-NP_NP_CD
properties B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
lymphoid-specific B-O B-NP_NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
Oct-2a B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
The B-O B-S_S_NP_DT
lymphoid-specific B-O B-NP_NP_JJ
transcription B-O B-NN
factor B-O B-NN
" " B-O O-NP
Oct-2a B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
contains B-O B-VP_VBZ
two B-O B-NP_NP_CD
transcriptional B-O B-NP_JJ
activation B-O B-NN
domains B-O B-NNS
" " B-O O-NP
" " B-O O-NP
which B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
are B-O B-S_NP_VP_VBP
located B-O B-ADJP_JJ
within B-O B-PP_IN
" " B-O B-NP_O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
To B-O B-S_S_NP_VP_TO
study B-O B-VP_VB
their B-O B-NP_PRPP
differential B-O B-JJ
activation B-O B-NN
properties B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
we B-O B-S_NP_PRP
" " B-O O-NP
linked B-O B-VP_VBD
the B-O B-NP_DT
isolated B-O B-VBN
effector B-O B-NP_NN
domains B-O B-NNS
" " B-O O-NP
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
GAL4 B-O B-NP_NN
DNA-binding B-O B-JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
shown B-O B-VP_VBN
that B-O B-SBAR_IN
both B-O B-S_NP_NP_DT
activating B-O B-VBG
regions B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
Oct-2a B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
their B-O B-NP_PRPP
natural B-O B-JJ
context B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
can B-O B-VP_MD
activate B-O B-VP_VB
transcription B-O B-NP_NN
" " B-O O-NP
as B-O B-PP_IN
promoter B-O B-NP_NN
factors B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
contrast B-O B-NP_NP_NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_DT
C-terminus B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
activation B-O B-NP_NP_NN
" " B-O O-NP
by B-O B-PP_IN
the B-O B-NP_DT
N-terminal B-O B-NP_JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
dependent B-O B-ADJP_JJ
on B-O B-PP_IN
a B-O B-NP_NP_DT
yet B-O B-ADJP_RB
unidentified B-O B-JJ
" " B-O O-ADJP
factor B-O B-NN
( B-O B-LRB
s B-O B-NNS
) B-O B-RRB
" " B-O O-NP
binding B-O B-VP_VBG
to B-O B-PP_TO
the B-O B-NP_DT
simian B-O B-NP_JJ
virus B-O B-NN
40 B-O B-CD
enhancer B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
results B-O B-NNS
" " B-O O-NP
obtained B-O B-VP_VBN
by B-O B-NP_PP_IN
duplication B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
activation B-O B-NP_NN
domains B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
or B-O B-CC
their B-O B-NP_PRPP
mixed B-O B-JJ
combination B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
the B-O B-S_NP_DT
domains B-O B-NNS
" " B-O O-NP
are B-O B-VP_VBP
functionally B-O B-ADJP_RB
independent B-O B-JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
However B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
activation B-O B-NP_NP_NN
" " B-O O-NP
from B-O B-PP_IN
a B-O B-NP_DT
remote B-O B-JJ
position B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
could B-O B-VP_MD
only B-O B-ADVP_RB
" " B-O O-ADVP
be B-O B-VP_VB
achieved B-O B-VP_VBN
with B-O B-NP_PP_IN
the B-O B-NP_NP_DT
C-terminus B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
Oct-2a B-O B-NP_NP_NN
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
In B-O B-S_PP_IN
lymphoid B-O B-NP_JJ
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
higher B-O B-NP_JJR
activation B-O B-NN
levels B-O B-NNS
" " B-O O-NP
were B-O B-VP_VBD
observed B-O B-VP_VBN
" " B-O B-NP_O-VP
, B-O B-COMMA
suggesting B-O B-S_NP_VP_VBG
that B-O B-SBAR_IN
distinct B-O B-S_NP_NP_JJ
B-cell-specific B-O B-NP_JJ
cofactors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_NP_PP_O-PP
" " B-O O-NP
might B-O B-VP_MD
be B-O B-VP_VB
involved B-O B-VP_VBN
" " B-O B-NP_PP_O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
identified B-O B-VP_VBD
a B-O B-NP_DT
repression B-O B-NN
domain B-O B-NN
" " B-O O-NP
at B-O B-PP_IN
the B-O B-NP_NP_DT
N-terminus B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Oct-2a B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
When B-O B-S_SBAR_WHADVP_WRB
" " B-O O-WHADVP
transferred B-O B-S_NP_VP_VBN
to B-O B-NP_PP_TO
a B-O B-NP_DT
potent B-O B-JJ
activator B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O B-ADVP_O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
transcriptional B-O B-S_NP_JJ
stimulation B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
inhibited B-O B-VP_VBN
efficiently B-O B-NP_ADVP_RB
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
These B-O B-S_NP_DT
results B-O B-NNS
" " B-O O-NP
underscore B-O B-VP_VP_VBP
the B-O B-NP_NP_DT
modular B-O B-JJ
structure B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Oct-2a B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
separable B-O B-NP_NP_JJ
domains B-O B-NNS
" " B-O O-NP
for B-O B-PP_IN
activation B-O B-NP_NP_NN
" " B-O O-NP
and B-O B-CC
repression B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
suggest B-O B-VP_VBP
that B-O B-SBAR_IN
Oct-2a B-O B-S_NP_NN
" " B-O O-NP
might B-O B-VP_MD
have B-O B-VP_VB
complex B-O B-NP_JJ
regulatory B-O B-JJ
functions B-O B-NNS
" " B-O O-NP
in B-O B-ADVP_FW
vivo B-O B-FW
" " B-O O-ADVP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Circumvention B-O B-NP_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
tolerance B-O B-NP_NP_NN
" " B-O O-NP
for B-O B-PP_IN
the B-O B-NP_DT
nuclear B-O B-NP_NP_JJ
T B-O B-NN
cell B-O B-NN
protein B-O B-NN
" " B-O O-NP
TCF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
by B-O B-PP_IN
immunization B-O B-NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
TCF-1 B-O B-NP_NP_NN
" " B-O O-NP
knock-out B-O B-JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
Molecular B-O B-S_S_NP_NP_JJ
events B-O B-NNS
" " B-O O-NP
that B-O B-SBAR_WHNP_WDT
" " B-O O-WHNP
underlie B-O B-S_NP_VP_VBP
the B-O B-NP_NP_DT
changes B-O B-ADJP_ADJP_ADJP_NNS
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
are B-O B-VP_VBP
poorly B-O B-ADVP_RB
" " B-O O-ADVP
understood B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
A B-O B-S_NP_NP_NP_DT
candidate B-O B-NN
gene B-O B-NN
" " B-O O-NP
to B-O B-SBAR_WHNP_S_NP_VP_TO
control B-O B-VP_VB
thymocyte B-O B-NP_NP_NN
" " B-O O-NP
differentiation B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-NP
, B-O B-COMMA
T B-O B-NP_NP_NN
cell B-O B-NN
factor-1 B-O B-NN
" " B-O O-NP
( B-O B-PRN_LRB
TCF-1 B-O B-NP_NN
" " B-O O-NP
) B-O B-RRB
* B-O B-SYM
" " B-O O-PRN
" " B-O O-NP
" " B-O O-NP
encodes B-O B-VP_VBZ
a B-O B-NP_DT
DNA-binding B-O B-NP_JJ
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Its B-O B-S_NP_PRPP
mRNA B-O B-NN
expression B-O B-NN
pattern B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
complex B-O B-ADJP_ADJP_JJ
during B-O B-PP_IN
embryogenesis B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
, B-O B-COMMA
yet B-O B-RB
restricted B-O B-ADJP_JJ
to B-O B-PP_TO
lymphocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
postnatally B-O B-ADVP_RB
" " B-O O-ADVP
" " B-O O-ADJP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Expression B-O B-S_NP_NP_NN
studies B-O B-NNS
" " B-O O-NP
on B-O B-PP_IN
TCF-1 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
have B-O B-VP_VBP
been B-O B-VP_VBN
hampered B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_NP_DT
difficulty B-O B-NN
" " B-O O-NP
to B-O B-S_NP_VP_TO
raise B-O B-VP_VB
" " B-O B-NP_O-VP
" " B-O O-S
due B-O B-ADJP_JJ
to B-O B-PP_TO
conservation B-O B-NP_ADJP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
TCF-1 B-O B-S_NP_NP_NP_NN
" " B-O O-NP
knock-out B-O B-JJ
mice B-O B-NNS
" " B-O O-NP
, B-O B-COMMA
generated B-O B-VP_VBN
recently B-O B-NP_ADVP_RB
" " B-O O-ADVP
in B-O B-PP_IN
our B-O B-NP_PRPP
laboratory B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
, B-O B-COMMA
" " B-O O-NP
have B-O B-VP_VP_VBP
strongly B-O B-ADVP_RB
" " B-O O-ADVP
decreased B-O B-VP_VBN
numbers B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
thymocytes B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
, B-O B-COMMA
but B-O B-CC
are B-O B-VP_VBP
otherwise B-O B-ADVP_RB
" " B-O O-ADVP
normal B-O B-ADJP_JJ
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
We B-O B-S_NP_PRP
" " B-O O-NP
have B-O B-VP_VBP
used B-O B-VP_VBN
these B-O B-NP_DT
mice B-O B-NNS
" " B-O O-NP
" " B-O O-VP
to B-O B-S_NP_VP_TO
generate B-O B-VP_VB
anti-TCF-1 B-O B-NP_NN
antibodies B-O B-NNS
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
By B-O B-S_PP_IN
immunization B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
a B-O B-NP_DT
recombinant B-O B-NP_JJ
fusion B-O B-NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
show B-O B-VP_VBP
that B-O B-SBAR_IN
TCF-1 B-O B-S_NP_NP_NN
" " B-O O-NP
knock-out B-O B-JJ
mice B-O B-NNS
" " B-O O-NP
readily B-O B-ADVP_RB
" " B-O O-ADVP
yield B-O B-VP_VBP
antiserum B-O B-NP_NN
titers B-O B-NNS
" " B-O O-NP
against B-O B-PP_IN
human B-O B-NP_NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
and B-O B-CC
mouse B-O B-NP_NN
" " B-O B-NP_O-NP
TCF-1 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Wild-type B-O B-S_NP_JJ
littermates B-O B-NNS
" " B-O O-NP
remain B-O B-VP_VBP
unresponsive B-O B-ADJP_JJ
to B-O B-PP_TO
TCF-1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
while B-O B-SBAR_IN
they B-O B-S_NP_PRP
" " B-O O-NP
mount B-O B-VP_VBP
a B-O B-NP_NP_DT
high-titer B-O B-JJ
antibody B-O B-NN
response B-O B-NN
" " B-O O-NP
to B-O B-PP_TO
the B-O B-NP_NP_DT
, B-O B-NP_COMMA
" " B-O B-NP_NP_PRN_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Subsequently B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
TCF-1-specific B-O B-NP_JJ
hybridomas B-O B-NNS
" " B-O O-NP
could B-O B-VP_MD
be B-O B-VP_VB
prepared B-O B-VP_VBN
from B-O B-NP_PP_IN
the B-O B-NP_NP_DT
spleens B-O B-NNS
" " B-O O-NP
of B-O B-PP_IN
immunized B-O B-NP_VBN
knock-out B-O B-JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_NP_DT
study B-O B-NN
" " B-O O-NP
illustrates B-O B-VP_VP_VBZ
the B-O B-NP_NP_DT
almost B-O B-ADJP_RB
complete B-O B-JJ
" " B-O O-ADJP
tolerance B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
mice B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
human B-O B-NP_JJ
TCF-1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
and B-O B-CC
demonstrates B-O B-VP_VBZ
that B-O B-SBAR_IN
this B-O B-S_NP_DT
tolerance B-O B-NN
" " B-O O-NP
is B-O B-VP_VBZ
readily B-O B-ADVP_RB
" " B-O O-ADVP
broken B-O B-VP_VBN
by B-O B-NP_PP_IN
gene B-O B-NP_NN
knock-out B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Furthermore B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-NP_NP_DT
usefulness B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
knock-out B-O B-NP_JJ
mice B-O B-NNS
" " B-O O-NP
" " B-O O-PP
for B-O B-PP_IN
the B-O B-NP_NP_DT
generation B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
monoclonal B-O B-NP_NP_JJ
antibodies B-O B-NNS
" " B-O O-NP
against B-O B-PP_IN
the B-O B-NP_NP_DT
gene B-O B-NN
product B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
is B-O B-VP_VBZ
underscored B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
Functional B-O B-NP_NP_NP_JJ
characterization B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_NP_DT
murine B-O B-NP_JJ
homolog B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
B B-O B-NP_NP_NN
cell-specific B-O B-JJ
coactivator B-O B-NN
" " B-O O-NP
BOB.1/OBF.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
. B-O B-PERIOD
" " B-O O-NP
" " B-O O-NP
  
B B-O B-S_S_NP_NP_NN
cell-specific B-O B-JJ
transcriptional B-O B-JJ
promoter B-O B-NN
activity B-O B-NN
" " B-O O-NP
mediated B-O B-VP_VBN
by B-O B-NP_PP_IN
the B-O B-NP_DT
octamer B-O B-NP_NN
motif B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-NP
requires B-O B-VP_VBZ
the B-O B-NP_NP_DT
Oct1 B-O B-NP_NP_NN
" " B-O O-NP
" " B-O B-NP_O-NP
or B-O B-CC
Oct2 B-O B-NP_NN
protein B-O B-NN
" " B-O O-NP
" " B-O O-NP
and B-O B-CC
additional B-O B-NP_JJ
B B-O B-NP_NN
cell-restricted B-O B-JJ
cofactors B-O B-NNS
" " B-O O-NP
" " B-O O-NP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
" " B-O O-S
  
One B-O B-S_NP_NP_CD
such B-O B-JJ
cofactor B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
, B-O B-COMMA
BOB.1/OBF.1 B-O B-NP_NN
" " B-O O-NP
, B-O B-COMMA
" " B-O O-NP
was B-O B-VP_VBD
recently B-O B-ADVP_RB
" " B-O O-ADVP
isolated B-O B-VP_VBN
from B-O B-NP_PP_IN
human B-O B-NP_JJ
B B-O B-NN
cells B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Here B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
we B-O B-NP_PRP
" " B-O O-NP
describe B-O B-VP_VBP
the B-O B-NP_NP_NP_DT
isolation B-O B-NN
" " B-O O-NP
and B-O B-CC
detailed B-O B-NP_JJ
characterization B-O B-NN
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
murine B-O B-NP_JJ
homolog B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Full-length B-O B-S_S_NP_JJ
cDNAs B-O B-NP_NNS
" " B-O O-NP
and B-O B-CC
genomic B-O B-NP_JJ
clones B-O B-NNS
" " B-O O-NP
" " B-O O-NP
were B-O B-VP_VBD
isolated B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
the B-O B-S_NP_DT
gene B-O B-NN
structure B-O B-NN
" " B-O O-NP
was B-O B-VP_VBD
determined B-O B-VP_VBN
" " B-O B-NP_O-VP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Comparison B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
deduced B-O B-VBN
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
shows B-O B-VP_VBZ
88 B-O B-NP_NP_ADJP_CD
% B-O B-NN
" " B-O O-ADJP
sequence B-O B-NN
identity B-O B-NN
" " B-O O-NP
between B-O B-PP_IN
mouse B-O B-NP_NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
human B-O B-NP_ADJP_JJ
" " B-O O-ADJP
" " B-O B-NP_O-NP
BOB.1/OBF.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
The B-O B-S_NP_NP_DT
NH2-terminal B-O B-NP_JJ
126 B-O B-CD
amino B-O B-NN
acids B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
BOB.1/OBF.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
are B-O B-VP_VBP
both B-O B-ADJP_CC
essential B-O B-ADJP_JJ
" " B-O B-PP_O-ADJP
and B-O B-CC
sufficient B-O B-ADJP_JJ
" " B-O B-PP_O-ADJP
for B-O B-PP_IN
interaction B-O B-NP_NP_NN
" " B-O O-NP
with B-O B-PP_IN
the B-O B-NP_NP_DT
POU B-O B-NP_NN
domains B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
either B-O B-NP_CC
or B-O B-NP_CC
" " B-O B-NP_O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
This B-O B-S_S_NP_DT
protein-protein B-O B-JJ
interaction B-O B-NN
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
require B-O B-VP_VB
the B-O B-NP_NP_DT
simultaneous B-O B-JJ
binding B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
Oct B-O B-NP_NN
proteins B-O B-NNS
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
DNA B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
, B-O B-COMMA
and B-O B-CC
high B-O B-S_NP_NP_JJ
resolution B-O B-NN
footprinting B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
the B-O B-NP_DT
Oct-DNA B-O B-NN
interaction B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reveals B-O B-VP_VBZ
that B-O B-SBAR_IN
binding B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
BOB.1/OBF.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
to B-O B-PP_TO
Oct1 B-O B-NP_NP_NN
" " B-O O-NP
or B-O B-CC
Oct2 B-O B-NP_NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
does B-O B-VP_VBZ
not B-O B-RB
alter B-O B-VP_VB
the B-O B-NP_NP_DT
interaction B-O B-NN
" " B-O O-NP
with B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
BOB.1/OBF.1 B-O B-S_S_NP_NN
" " B-O O-NP
can B-O B-VP_MD
efficiently B-O B-ADVP_RB
" " B-O O-ADVP
activate B-O B-VP_VB
octamer-dependent B-O B-NP_NP_JJ
promoters B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
fibroblasts B-O B-NP_NNS
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
; B-O B-COLON
however B-O B-S_ADVP_RB
" " B-O O-ADVP
, B-O B-COMMA
it B-O B-NP_PRP
" " B-O O-NP
fails B-O B-VP_VBZ
to B-O B-S_NP_VP_TO
stimulate B-O B-VP_VB
octamer-dependent B-O B-NP_NP_JJ
enhancer B-O B-NN
" " B-O O-NP
activity B-O B-NN
" " B-O O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
  
Fusion B-O B-S_NP_NP_NN
" " B-O O-NP
of B-O B-PP_IN
subdomains B-O B-NP_NP_NNS
" " B-O O-NP
of B-O B-PP_IN
BOB.1/OBF.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
" " B-O O-PP
with B-O B-PP_IN
the B-O B-NP_DT
GAL4 B-O B-NP_NN
DNA B-O B-NN
binding B-O B-NN
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
reveals B-O B-VP_VBZ
that B-O B-UCP_SBAR_IN
both B-O B-S_NP_NP_CC
NH2- B-O B-NP_NN
" " B-O B-NP_O-NP
and B-O B-CC
COOH-terminal B-O B-NP_JJ
domains B-O B-NNS
" " B-O O-NP
" " B-O O-NP
of B-O B-PP_IN
BOB.1/OBF.1 B-O B-NP_NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-NP
contribute B-O B-VP_VBP
to B-O B-PP_TO
full B-O B-NP_JJ
transactivation B-O B-NN
function B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
" " B-O O-SBAR
, B-O B-COMMA
the B-O B-COMP_NP_DT
COOH-terminal B-O B-NP_JJ
domain B-O B-NN
" " B-O O-NP
" " B-O O-NP
is B-O B-VP_VBZ
more B-O B-ADJP_RBR
efficient B-O B-JJ
in B-O B-PP_IN
this B-O B-NP_DT
transactivation B-O B-NN
assay B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADJP
" " B-O O-VP
" " B-O O-UCP
" " B-O O-VP
. B-O B-PERIOD
" " B-O O-S
  
Consistent B-O B-S_ADVP_JJ
with B-O B-PP_IN
the B-O B-NP_NP_DT
failure B-O B-NN
" " B-O O-NP
of B-O B-PP_IN
full-length B-O B-NP_JJ
BOB.1/OBF.1 B-O B-NN
" " B-O O-NP
" " B-O O-PP
to B-O B-S_NP_VP_TO
stimulate B-O B-VP_VB
octamer-dependent B-O B-NP_NP_JJ
enhancer B-O B-NN
elements B-O B-NNS
" " B-O O-NP
in B-O B-PP_IN
" " B-O B-NP_O-NP
" " B-O O-VP
" " B-O O-VP
" " B-O O-S
" " B-O O-NP
" " B-O O-PP
" " B-O O-ADVP
, B-O B-COMMA
the B-O B-S_NP_DT
GAL4 B-O B-NP_NN
fusions B-O B-NNS
" " B-O O-NP
" " B-O O-NP
likewise B-O B-ADVP_RB
" " B-O O-ADVP
only B-O B-ADVP_RB
" " B-O O-ADVP
stimulate B-O B-VP_VBP
from B-O B-PP_IN
a B-O B-NP_DT
promoter-proximal B-O B-JJ
position B-O B-NN
" " B-O O-NP
" " B-O O-PP
" " B-O O-VP
" " B-O O-S
. B-O B-PERIOD
" " B-O O-S
